|
6186 genotypes with 12504 annotations displayed
of selected term and subterms
|
|
Searched Term: abnormal blood cell morphology
|
1700008O03Riktm1a(KOMP)Wtsi/1700008O03Riktm1a(KOMP)Wtsi
(C57BL/6N-1700008O03Riktm1a(KOMP)Wtsi/Wtsi)
|
increased hematocrit
|
J:211773
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(C.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93488
|
| increased neutrophil cell number
|
J:194800
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(involves: FVB/N)
|
decreased neutrophil cell number
|
J:193548
|
1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan/0
(B6.FVB-1700016L21RikTg(Itgax-HBEGF/EGFP)57Lan)
|
decreased neutrophil cell number
|
J:194800
|
| increased neutrophil cell number
|
J:194800
|
1700019D03Riktm1.1(NCOM)Mfgc/1700019D03Riktm1.1(NCOM)Mfgc
(C57BL/6N-1700019D03Riktm1.1(NCOM)Mfgc/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytosis
|
J:211773
|
1700025G04Rikem1(IMPC)Mbp/1700025G04Rikem1(IMPC)Mbp
(C57BL/6NCrl-1700025G04Rikem1(IMPC)Mbp/Mmucd)
|
increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
3425401B19Rikem2(IMPC)Ccpcz/3425401B19Rikem2(IMPC)Ccpcz
(C57BL/6NCrl-3425401B19Rikem2(IMPC)Ccpcz/Ph)
|
increased eosinophil cell number
|
J:211773
|
4921509C19Riktm1.1(KOMP)Vlcg/4921509C19Riktm1.1(KOMP)Vlcg
(B6N(Cg)-4921509C19Riktm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
4930404H24Riktm1a(KOMP)Wtsi/4930404H24Riktm1a(KOMP)Wtsi
(C57BL/6N-4930404H24Riktm1a(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
4930591A17Riktm1a(KOMP)Wtsi/4930591A17Riktm1a(KOMP)Wtsi
(C57BL/6N-4930591A17Riktm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
4933402N03Riktm2a(KOMP)Wtsi/4933402N03Riktm2a(KOMP)Wtsi
(C57BL/6N-4933402N03Riktm2a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
4933430I17Riktm1a(EUCOMM)Wtsi/4933430I17Riktm1a(EUCOMM)Wtsi
(C57BL/6N-4933430I17Riktm1a(EUCOMM)Wtsi/Ics)
|
increased mean corpuscular volume
|
J:211773
|
a/a
Hps6ru/Hps6ru
(B6.Cg-Hps6ru)
|
decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet dense granule number
|
J:7327
|
| decreased platelet serotonin level
|
J:7327,
J:29748
|
a/a
Rab27aash/Rab27aash
(involves: C3H/HeSnJ * C57BL/6J)
|
decreased platelet serotonin level
|
J:77395
|
A1cftm1b(EUCOMM)Hmgu/A1cftm1b(EUCOMM)Hmgu
(B6N(Cg)-A1cftm1b(EUCOMM)Hmgu/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Atm1Brd/Atm1Brd
Ypel4tm1a(EUCOMM)Wtsi/Ypel4tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Ypel4tm1a(EUCOMM)Wtsi/WtsiIeg)
|
abnormal red blood cell deformability
|
J:313842
|
| anisocytosis
|
J:313842
|
| elliptocytosis
|
J:313842
|
| increased hematocrit
|
J:313842
|
| increased mean corpuscular volume
|
J:313842
|
| macrocytosis
|
J:313842
|
| polycythemia
|
J:313842
|
Aars2tm1(KOMP)Wtsi/Aars2+
(C57BL/6N-Aars2tm1(KOMP)Wtsi/Nju)
|
decreased red blood cell distribution width
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Abca1tm1Jdm/Abca1tm1Jdm
(DBA/1LacJ-Abca1tm1Jdm)
|
thrombocytopenia
|
J:60210
|
Abca1tm1Jdm/Abca1tm1Jdm
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6 * DBA * DBA/1LacJ)
|
abnormal common myeloid progenitor cell morphology
|
J:190966
|
| extramedullary hematopoiesis
|
J:190966
|
| increased neutrophil cell number
|
J:190966
|
Abca4tm1a(EUCOMM)Wtsi/Abca4+
(C57BL/6N-Abca4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Abca6tm2b(KOMP)Wtsi/Abca6tm2b(KOMP)Wtsi
(C57BL/6N-Abca6tm2b(KOMP)Wtsi/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased hematocrit
|
J:211773
|
Abca8aem1(IMPC)J/Abca8aem1(IMPC)J
(C57BL/6NJ-Abca8aem1(IMPC)J/Mmjax)
|
increased hematocrit
|
J:211773
|
Abcb1amds/Abcb1amds
(involves: CF-1)
|
increased eosinophil cell number
|
J:64725
|
Abcb1atm1Bor/Abcb1atm1Bor
Abcb1btm1Bor/Abcb1btm1Bor
(FVBTac.129P2-Abcb1btm1Bor Abcb1atm1Bor)
|
increased double-positive T cell number
|
J:102640
|
Abcb4em1(IMPC)H/Abcb4em1(IMPC)H
(C57BL/6NTac-Abcb4em1(IMPC)H/H)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Abcb6tm1Jsch/Abcb6tm1Jsch
(involves: 129)
|
abnormal stress erythropoiesis
|
J:184574
|
Abcb10tm1.1Tafu/Abcb10tm1.2Tafu
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6NCrlj * CBA/J * CBA/JNCrlJ)
|
abnormal erythropoiesis
|
J:223428
|
| abnormal hemoglobin
|
J:223428
|
| decreased erythrocyte cell number
|
J:223428
|
| decreased hemoglobin content
|
J:223428
|
| decreased mean corpuscular hemoglobin concentration
|
J:223428
|
| decreased mean corpuscular volume
|
J:223428
|
Abcb10tm1.2Tafu/Abcb10tm1.2Tafu
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal blood cell morphology
|
J:223428
|
| abnormal embryonic hematopoiesis
|
J:223428
|
| abnormal hemoglobin
|
J:223428
|
Abcc2tm1Ahs/Abcc2tm1Ahs
(involves: 129P2/OlaHsd * FVB)
|
decreased hemoglobin content
|
J:107822
|
Abcc2tm2b(KOMP)Wtsi/Abcc2tm2b(KOMP)Wtsi
(C57BL/6N-Abcc2tm2b(KOMP)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
| decreased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Abcc5em1(IMPC)H/Abcc5em1(IMPC)H
(C57BL/6N-Abcc5em1(IMPC)H/H)
|
decreased eosinophil cell number
|
J:211773
|
Abcc9em1(IMPC)H/Abcc9+
(C57BL/6N-Abcc9em1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Abce1tm1.1(KOMP)Vlcg/Abce1+
(C57BL/6N-Abce1tm1.1(KOMP)Vlcg/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Abcg1tm1Dgen/Abcg1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal monocyte differentiation
|
J:132952
|
| increased eosinophil cell number
|
J:132952
|
| increased neutrophil cell number
|
J:132952
|
Abcg5trac/Abcg5trac
(A/J-Abcg5trac)
|
abnormal neutrophil morphology
|
J:157223
|
| abnormal platelet alpha-granule morphology
|
J:157223
|
| abnormal platelet morphology
|
J:157223
|
| anisocytosis
|
J:157223
|
| decreased hematocrit
|
J:157223
|
| giant platelets
|
J:157223
|
| increased mean platelet volume
|
J:157223
|
| stomatocytosis
|
J:157223
|
| thrombocytopenia
|
J:157223
|
Abcg8tm1b(KOMP)Wtsi/Abcg8tm1b(KOMP)Wtsi
(C57BL/6N-Abcg8tm1b(KOMP)Wtsi/Ccpcz)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Abhd5tm1.1Rze/Abhd5tm1.1Rze
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal granulocyte morphology
|
J:160725
|
Abhd10em1(IMPC)Mbp/Abhd10em1(IMPC)Mbp
(C57BL/6NCrl-Abhd10em1(IMPC)Mbp/Mmucd)
|
increased eosinophil cell number
|
J:211773
|
Abi3bptm1e.1(KOMP)Mbp/Abi3bptm1e.1(KOMP)Mbp
(C57BL/6N-Abi3bptm1e.1(KOMP)Mbp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Abl1m1/Abl1m1
(either: 129S/SvEv-Abl1m1 or (involves: 129S/SvEv * CD-1) or (involves: 129S/SvEv * C57BL/6 * DBA/2))
|
abnormal B cell differentiation
|
J:14644
|
| decreased immature B cell number
|
J:14644
|
| decreased pro-B cell number
|
J:14644
|
Abl1m1/Abl1m1
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:28795
|
| decreased pro-B cell number
|
J:28795
|
Abl1m1/Abl1m1
(involves: 129S/SvEv * C57BL/6)
|
abnormal lymphopoiesis
|
J:148105
|
| decreased pro-B cell number
|
J:148105
|
Ablim3em1(IMPC)Tcp/Ablim3em1(IMPC)Tcp
(C57BL/6N-Ablim3em1(IMPC)Tcp/Tcp)
|
decreased basophil cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Acbd3tm1b(EUCOMM)Hmgu/Acbd3+
(C57BL/6N-Acbd3tm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Acbd5tm1b(EUCOMM)Wtsi/Acbd5tm1b(EUCOMM)Wtsi
(C57BL/6N-Acbd5tm1b(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Ace2tm1a(KOMP)Wtsi/Y
Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac)
|
increased neutrophil cell number
|
J:282139
|
Ace2tm1a(KOMP)Wtsi/Ace2tm1a(KOMP)Wtsi
Tg(FOXJ1-cre)F26Htzm/0
(involves: C57BL/6N * C57BL/6NTac)
|
increased neutrophil cell number
|
J:282139
|
Ace2tm1Pngr/Y
(involves: 129P2/OlaHsd)
|
increased neutrophil cell number
|
J:282139
|
Ace2tm1Pngr/Ace2tm1Pngr
(involves: 129P2/OlaHsd)
|
increased neutrophil cell number
|
J:282139
|
Acetm1.1(KOMP)Vlcg/Ace+
(C57BL/6N-Acetm1.1(KOMP)Vlcg/MbpMmucd)
|
increased basophil cell number
|
J:211773
|
Acetm4Keb/Acetm4Keb
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased hematocrit
|
J:83894
|
Acetm4Keb/Acetm4Keb
Bdkrb2tm1Jfh/Bdkrb2tm1Jfh
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ)
|
decreased hematocrit
|
J:83894
|
Acer1tm1a(EUCOMM)Wtsi/Acer1tm1a(EUCOMM)Wtsi
(C57BL/6N-Acer1tm1a(EUCOMM)Wtsi)
|
increased eosinophil cell number
|
J:235775
|
Acheem1(IMPC)Mbp/Ache+
(C57BL/6N-Acheem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Ackr3tm2b(EUCOMM)Wtsi/Ackr3+
(C57BL/6N-Ackr3tm2b(EUCOMM)Wtsi/Ics)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ackr4tm1.1Rjbn/Ackr4tm1.1Rjbn
(B6.129S6-Ackr4tm1.1Rjbn)
|
abnormal T-helper 17 cell differentiation
|
J:166490
|
Acmsdtm1b(EUCOMM)Hmgu/Acmsdtm1b(EUCOMM)Hmgu
(C57BL/6N-Acmsdtm1b(EUCOMM)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Aco1em1(IMPC)J/Aco1em1(IMPC)J
(C57BL/6NJ-Aco1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular volume
|
J:211773
|
Acot2em1(IMPC)J/Acot2em1(IMPC)J
(C57BL/6NJ-Acot2em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
Acot5tm1a(KOMP)Wtsi/Acot5tm1a(KOMP)Wtsi
(C57BL/6N-Acot5tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Acoxlem1(IMPC)Mbp/Acoxlem1(IMPC)Mbp
(C57BL/6NCrl-Acoxlem1(IMPC)Mbp/Mmucd)
|
increased neutrophil cell number
|
J:211773
|
Acp2tm1a(EUCOMM)Wtsi/Acp2tm1a(EUCOMM)Wtsi
(C57BL/6N-Acp2tm1a(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:165965
|
Acsf2tm1.1(KOMP)Vlcg/Acsf2tm1.1(KOMP)Vlcg
(B6N(Cg)-Acsf2tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Acsl4tm1a(EUCOMM)Wtsi/Y
(B6Brd;B6Dnk;B6N-Tyrc-Brd Acsl4tm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:175295
|
Acsl4tm1a(EUCOMM)Wtsi/Acsl4+
(B6Brd;B6Dnk;B6N-Tyrc-Brd Acsl4tm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:175295
|
Acsl5tm1Lex/Acsl5tm1Lex
(B6;129S5-Acsl5tm1Lex/Mmucd)
|
thrombocytopenia
|
J:171883
|
Acsm1em1(IMPC)Mhzh/Acsm1em1(IMPC)Mhzh
(C57BL/6N-Acsm1em1(IMPC)Mhzh/Mhzh)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Actl6atm1.1Grc/Actl6a+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
decreased common myeloid progenitor cell number
|
J:192124
|
| decreased granulocyte number
|
J:192124
|
Actl6atm1.1Grc/Actl6atm1.1Grc
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
abnormal definitive hematopoiesis
|
J:192124
|
| decreased common myeloid progenitor cell number
|
J:192124
|
| decreased erythrocyte cell number
|
J:192124
|
| decreased granulocyte number
|
J:192124
|
| decreased hemoglobin content
|
J:192124
|
| polycythemia
|
J:192124
|
| thrombocytopenia
|
J:192124
|
Actr8tm1.1(KOMP)Vlcg/Actr8+
(B6N(Cg)-Actr8tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Acvr2atm1.1(KOMP)Vlcg/Acvr2a+
(C57BL/6N-Acvr2atm1.1(KOMP)Vlcg/Ucd)
|
decreased eosinophil cell number
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
Acvrl1tm1Dyl/Acvrl1tm1Dyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:85366,
J:65521
|
Acvrl1tm2.1Spo/Acvrl1tm2.1Spo
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sor+
(involves: 129 * 129S1/Sv * 129X1/SvJ)
|
decreased hematocrit
|
J:154620
|
Acy3em1(IMPC)J/Acy3em1(IMPC)J
(C57BL/6NJ-Acy3em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Adatm1Mw/Adatm1Mw
Tg(PLADA)4118Rkmb/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-positive T cell number
|
J:73418
|
| increased double-negative T cell number
|
J:73418
|
| increased eosinophil cell number
|
J:73418
|
| increased granulocyte number
|
J:73418
|
Adatm1Vlr/Adatm1Vlr
(either: 129P2/OlaHsd-Adatm1Vlr or (involves: (129P2/OlaHsd * FVB/N))
|
extramedullary hematopoiesis
|
J:26731
|
Adaltm1a(EUCOMM)Wtsi/Adaltm1a(EUCOMM)Wtsi
(C57BL/6N-Adaltm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Adam5em1(IMPC)J/Adam5em1(IMPC)J
(C57BL/6NJ-Adam5em1(IMPC)J/Mmjax)
|
decreased mean corpuscular volume
|
J:211773
|
Adam10tm1.1Dhc/Adam10tm1.1Dhc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal B cell differentiation
|
J:158127
|
| decreased transitional stage T2 B cell number
|
J:158127
|
| increased transitional stage T1 B cell number
|
J:158127
|
Adam10tm1.1Khr/Adam10tm1.1Khr
Csf3rtm1Link/Csf3rtm1Link
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6N)
|
abnormal granulocyte differentiation
|
J:179060
|
| myeloid hyperplasia
|
J:179060
|
Adam10tm1.1Khr/Adam10tm1.1Khr
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6N)
|
abnormal definitive hematopoiesis
|
J:179060
|
| abnormal granulocyte differentiation
|
J:179060
|
| abnormal T cell differentiation
|
J:179060
|
| decreased double-positive T cell number
|
J:179060
|
| decreased erythrocyte cell number
|
J:179060
|
| decreased hematocrit
|
J:179060
|
| decreased hemoglobin content
|
J:179060
|
| increased neutrophil cell number
|
J:179060
|
| myeloid hyperplasia
|
J:179060
|
Adam10tm1Zhu/Adam10tm1.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
| decreased double-positive T cell number
|
J:139042
|
Adam10tm1Zhu/Adam10tm1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J)
|
abnormal T cell differentiation
|
J:139042
|
| decreased double-positive T cell number
|
J:139042
|
Adam17tm1.2Bbl/Adam17tm1.2Bbl
Sox9tm3(cre)Crm/Sox9+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased hematocrit
|
J:144795
|
| extramedullary hematopoiesis
|
J:144795
|
| increased hemoglobin content
|
J:144795
|
| increased neutrophil cell number
|
J:144795
|
| thrombocytosis
|
J:144795
|
Adam17tm1a(EUCOMM)Wtsi/Adam17+
(involves: C57BL/6 * C57BL/6N)
|
increased erythrocyte cell number
|
J:213427
|
| myeloid hyperplasia
|
J:213427
|
Adamdec1tm1Dgen/Adamdec1tm1Dgen
(B6.129P2-Adamdec1tm1Dgen)
|
increased neutrophil cell number
|
J:301741
|
Adamts3tm1.2Itl/Adamts3tm1.2Itl
(involves: BALB/cJ * C57BL/6NTac * SJL)
|
abnormal erythrocyte morphology
|
J:245044
|
Adamts7tm1a(KOMP)Wtsi/Adamts7tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal erythrocyte cell number
|
J:230573
|
Adamts13tm1Dgi/Adamts13tm1Dgi
(involves: 129X1/SvJ * C57BL/6J * CASA/Rk)
|
abnormal erythrocyte morphology
|
J:101752
|
| thrombocytopenia
|
J:101752
|
Adamts13tm1Dgi/Adamts13tm1Dgi
Vwftm1Wgr/Vwftm1Wgr
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * CASA/Rk)
|
abnormal platelet morphology
|
J:133469
|
Adamts14Gt(511E11)Cmhd/Adamts14Gt(511E11)Cmhd
Adamts2tm1Prc/Adamts2tm1Prc
(involves: 129 * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
cutaneous mastocytosis
|
J:271185
|
Adamts18tm1.1(KOMP)Vlcg/Adamts18tm1.1(KOMP)Vlcg
(C57BL/6N-Adamts18tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Adamtsl4em1(IMPC)J/Adamtsl4em1(IMPC)J
(C57BL/6NJ-Adamtsl4em1(IMPC)J/J)
|
increased erythrocyte cell number
|
J:211773
|
Adartm1.1Phs/Adartm2Phs
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:142338
|
Adartm1Phs/Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent common myeloid progenitor cells
|
J:87715
|
Adartm1Phs/Adartm1Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
absent common myeloid progenitor cells
|
J:87715
|
Adartm2Knk/Adar+
(chimera involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal embryonic erythropoiesis
|
J:65981
|
Adartm2Phs/Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent common myeloid progenitor cells
|
J:87715
|
Adartm2Phs/Adartm2Phs
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
absent common myeloid progenitor cells
|
J:87715
|
Adcy1tm1b(EUCOMM)Wtsi/Adcy1tm1b(EUCOMM)Wtsi
(C57BL/6N-Adcy1tm1b(EUCOMM)Wtsi/H)
|
increased mean corpuscular volume
|
J:211773
|
Adcy3tm1a(EUCOMM)Wtsi/Adcy3+
(C57BL/6N-Adcy3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Add1tm1Llp/Add1tm1Llp
(involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:138919
|
| decreased hematocrit
|
J:138919
|
| decreased mean corpuscular hemoglobin
|
J:138919
|
| decreased mean corpuscular volume
|
J:138919
|
| decreased mean platelet volume
|
J:138919
|
| increased hemoglobin concentration distribution width
|
J:138919
|
| increased mean corpuscular hemoglobin concentration
|
J:138919
|
| spherocytosis
|
J:138919
|
| thrombocytosis
|
J:138919
|
Add2tm1Feb/Add2tm1Feb
(B6.129-Add2tm1Feb)
|
decreased hematocrit
|
J:63047
|
| decreased hemoglobin content
|
J:63047
|
| decreased mean corpuscular hemoglobin
|
J:63047
|
| increased mean corpuscular hemoglobin concentration
|
J:63047
|
| microcytosis
|
J:63047
|
| poikilocytosis
|
J:63047
|
Add2tm1Llp/Add2tm1Llp
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:161920
|
| anisopoikilocytosis
|
J:161920,
J:71029
|
| decreased hematocrit
|
J:161920,
J:71029
|
| decreased mean corpuscular volume
|
J:71029
|
| increased mean corpuscular hemoglobin concentration
|
J:71029
|
| microcytosis
|
J:71029
|
| spherocytosis
|
J:161920,
J:71029
|
Add2tm1Llp/Add2tm1Llp
Add3tm1.2Llp/Add3tm1.2Llp
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
abnormal erythrocyte morphology
|
J:161920
|
| anisopoikilocytosis
|
J:161920
|
| decreased hematocrit
|
J:161920
|
| decreased mean corpuscular volume
|
J:161920
|
| spherocytosis
|
J:161920
|
Adgbem1(IMPC)Mbp/Adgb+
(C57BL/6NCrl-Adgbem1(IMPC)Mbp/Mmucd)
|
increased eosinophil cell number
|
J:211773
|
Adgre5tm1.1Joha/Adgre5tm1.1Joha
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
increased granulocyte number
|
J:140713
|
Adgre5tm1Kake/Adgre5tm1Kake
(B6.129S6-Adgre5tm1Kake)
|
increased granulocyte number
|
J:118705
|
Adgrf5tm1b(KOMP)Wtsi/Adgrf5tm1b(KOMP)Wtsi
(C57BL/6N-Adgrf5tm1b(KOMP)Wtsi/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Adgrg3tm1Zgwg/Adgrg3tm1Zgwg
(involves: 129 * C57BL/6)
|
decreased transitional stage T1 B cell number
|
J:222670
|
| increased transitional stage T2 B cell number
|
J:222670
|
Adgrl4em1(IMPC)Mbp/Adgrl4em1(IMPC)Mbp
(C57BL/6N-Adgrl4em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Adigtm1.1(KOMP)Vlcg/Adigtm1.1(KOMP)Vlcg
(C57BL/6N-Adigtm1.1(KOMP)Vlcg/Ucd)
|
decreased hemoglobin content
|
J:211773
|
Adipor1tm1b(EUCOMM)Hmgu/Adipor1tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor1tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Adipor2tm1b(EUCOMM)Hmgu/Adipor2tm1b(EUCOMM)Hmgu
(C57BL/6N-Adipor2tm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
Adora1tm1b(KOMP)Wtsi/Adora1tm1b(KOMP)Wtsi
(B6N(Cg)-Adora1tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Adora2aem1(IMPC)H/Adora2aem1(IMPC)H
(C57BL/6N-Adora2aem1(IMPC)H/H)
|
decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Adss2tm1b(EUCOMM)Wtsi/Adss2+
(C57BL/6N-Adss2tm1b(EUCOMM)Wtsi/Bay)
|
decreased eosinophil cell number
|
J:211773
|
Adtrptm1.1Clu/Adtrptm1.1Clu
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased mast cell number
|
J:295059
|
Afap1l2tm1b(KOMP)Wtsi/Afap1l2tm1b(KOMP)Wtsi
(C57BL/6N-Afap1l2tm1b(KOMP)Wtsi/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Afdnem1(IMPC)Mbp/Afdn+
(C57BL/6N-Afdnem1(IMPC)Mbp/MbpMmucd)
|
increased hematocrit
|
J:211773
|
Aff1Rob/Aff1+
(involves: BALB/cAnNCrl * C3H/HeN)
|
abnormal double-negative T cell morphology
|
J:82265
|
Aff1tm1Cim/Aff1tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal T cell differentiation
|
J:63253
|
| decreased double-positive T cell number
|
J:63253
|
Afmtm1a(KOMP)Wtsi/Afmtm1a(KOMP)Wtsi
(C57BL/6N-Afmtm1a(KOMP)Wtsi/Ics)
|
increased hemoglobin content
|
J:165965
|
Afmidtm1b(EUCOMM)Wtsi/Afmidtm1b(EUCOMM)Wtsi
(C57BL/6N-Afmidtm1b(EUCOMM)Wtsi/H)
|
increased mean corpuscular volume
|
J:211773
|
Aftphem1(IMPC)J/Aftph+
(C57BL/6NJ-Aftphem1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu/Agbl4Tn(pb-Act-RFP)1.080115015-HRAZhu
(involves: FVB/N)
|
abnormal platelet alpha-granule morphology
|
J:233744
|
| abnormal platelet morphology
|
J:233744
|
| abnormal platelet shape
|
J:233744
|
| decreased platelet alpha-granule number
|
J:233744
|
| thrombocytosis
|
J:233744
|
Agfg2em1(IMPC)J/Agfg2em1(IMPC)J
(C57BL/6NJ-Agfg2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ago2tm1.1Tara/Ago2tm1.1Tara
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal erythrocyte morphology
|
J:165967
|
| abnormal erythropoiesis
|
J:165967
|
| decreased erythrocyte cell number
|
J:165967
|
| decreased hematocrit
|
J:165967
|
| decreased hemoglobin content
|
J:165967
|
| decreased mean corpuscular hemoglobin
|
J:165967
|
| decreased mean corpuscular volume
|
J:165967
|
| increased number of Heinz bodies
|
J:165967
|
| increased red blood cell distribution width
|
J:165967
|
Ago2tm3.1Ghan/Ago2tm3.1Ghan
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA * Swiss Webster)
|
decreased erythrocyte cell number
|
J:161968
|
Agpat1tm1.1(KOMP)Vlcg/Agpat1+
(B6N(Cg)-Agpat1tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Agr2tm1.2Erle/Agr2tm1.2Erle
(involves: 129S4/SvJae * FVB/N)
|
increased mast cell number
|
J:148339
|
Agtpbp1atms/Agtpbp1atms
(MRL/Mp-Agtpbp1atms)
|
abnormal T cell differentiation
|
J:103944
|
Agtr1aem1(IMPC)Rbrc/Agtr1aem1(IMPC)Rbrc
(C57BL/6NJcl-Agtr1aem1(IMPC)Rbrc/Rbrc)
|
abnormal erythrocyte cell number
|
J:211773
|
| abnormal hematocrit
|
J:211773
|
| abnormal hemoglobin content
|
J:211773
|
| abnormal mean corpuscular hemoglobin
|
J:211773
|
| abnormal platelet cell number
|
J:211773
|
| abnormal red blood cell distribution width
|
J:211773
|
Agtr1atm1Ecl/Agtr1atm1Ecl
(involves: 129S2/SvPas * C57BL/6)
|
high mean erythrocyte cell number
|
J:124206
|
| increased hemoglobin content
|
J:124206
|
Ahcytm1b(EUCOMM)Hmgu/Ahcy+
(C57BL/6N-Ahcytm1b(EUCOMM)Hmgu/Tcp)
|
increased basophil cell number
|
J:211773
|
Ahcyl1tm1a(EUCOMM)Wtsi/Ahcyl1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ahcyl1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Ahrtm1Bra/Ahrtm1Bra
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
extramedullary hematopoiesis
|
J:33827
|
Ahrrtm1b(KOMP)Wtsi/Ahrrtm1b(KOMP)Wtsi
(B6N(Cg)-Ahrrtm1b(KOMP)Wtsi/J)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ahsptm1.1Mjwe/Ahsp+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased number of Heinz bodies
|
J:94421
|
Ahsptm1.1Mjwe/Ahsp+
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased hematocrit
|
J:94421
|
Ahsptm1.1Mjwe/Ahsptm1.1Mjwe
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:94421
|
| abnormal erythrocyte morphology
|
J:94421
|
| abnormal hemoglobin
|
J:94421
|
| abnormal hemoglobin content
|
J:94421
|
| acanthocytosis
|
J:94421
|
| anisopoikilocytosis
|
J:94421
|
| decreased hematocrit
|
J:94421
|
| decreased mean corpuscular hemoglobin
|
J:94421
|
| decreased mean corpuscular volume
|
J:94421
|
| increased hemoglobin concentration distribution width
|
J:94421
|
| increased number of Heinz bodies
|
J:94421
|
| increased red blood cell distribution width
|
J:94421
|
| leptocytosis
|
J:94421
|
| polychromatophilia
|
J:94421
|
Ahsptm1.1Mjwe/Ahsptm1.1Mjwe
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal erythrocyte morphology
|
J:94421
|
| anisocytosis
|
J:94421
|
| decreased hematocrit
|
J:94421
|
| decreased mean corpuscular volume
|
J:94421
|
| increased hemoglobin concentration distribution width
|
J:94421
|
| increased nucleated erythrocyte cell number
|
J:94421
|
| increased number of Heinz bodies
|
J:94421
|
Ahsptm1Mjwe/Ahsp+
(involves: 129S6/SvEvTac * C57BL/6)
|
increased number of Heinz bodies
|
J:94421
|
Ahsptm1Mjwe/Ahsp+
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased hematocrit
|
J:94421
|
Ahsptm1Mjwe/Ahsptm1Mjwe
(involves: 129 * C57BL/6)
|
abnormal erythropoiesis
|
J:77038
|
| abnormal hemoglobin
|
J:77038
|
| acanthocytosis
|
J:77038
|
| increased number of Heinz bodies
|
J:77038
|
Ahsptm1Mjwe/Ahsptm1Mjwe
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:94421
|
| abnormal erythrocyte morphology
|
J:94421
|
| abnormal hemoglobin
|
J:94421
|
| abnormal hemoglobin content
|
J:94421
|
| acanthocytosis
|
J:94421
|
| anisocytosis
|
J:94421
|
| anisopoikilocytosis
|
J:94421
|
| decreased hematocrit
|
J:94421
|
| decreased mean corpuscular hemoglobin
|
J:94421
|
| decreased mean corpuscular volume
|
J:94421
|
| increased hemoglobin concentration distribution width
|
J:94421
|
| increased number of Heinz bodies
|
J:94421
|
| leptocytosis
|
J:94421
|
| polychromatophilia
|
J:94421
|
Ahsptm1Mjwe/Ahsptm1Mjwe
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal erythrocyte morphology
|
J:94421
|
| anisocytosis
|
J:94421
|
| decreased hematocrit
|
J:94421
|
| decreased mean corpuscular volume
|
J:94421
|
| increased hemoglobin concentration distribution width
|
J:94421
|
| increased nucleated erythrocyte cell number
|
J:94421
|
| increased number of Heinz bodies
|
J:94421
|
Aicdaem1Jaych/Aicdaem1Jaych
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:305843
|
Aicdatm1.1Fwa/Aicdatm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:209271
|
| abnormal somatic hypermutation frequency
|
J:209271
|
Aicdatm1b(EUCOMM)Hmgu/Aicdatm1b(EUCOMM)Hmgu
(C57BL/6N-Aicdatm1b(EUCOMM)Hmgu/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Aicdatm1Hon/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:136224,
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm1Hon/Aicdatm1.1Fwa
(involves: 129S/SvEv * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal class switch recombination
|
J:209271
|
Aicdatm1Hon/Aicdatm1Hon
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427,
J:73659,
J:120658
|
| abnormal somatic hypermutation frequency
|
J:136224,
J:141427
|
Aicdatm1Hon/Aicdatm1Hon
Bcl6tm1.1Jwan/Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal somatic hypermutation frequency
|
J:190534
|
Aicdatm1Hon/Aicdatm1Hon
Exo1tm1Wed/Exo1tm1Wed
Ightm4.1Mnz/Igh+
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm1Hon
Exo1tm1Wed/Exo1tm1Wed
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA/JNCrlj * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm1Hon
Ightm3Mnz/Ightm4.1Mnz
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:159173
|
Aicdatm1Hon/Aicdatm1Hon
Ightm4.1Mnz/Igh+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm1Hon
Ightm4.1Mnz/Igh+
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:194603
|
Aicdatm1Hon/Aicdatm3Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm1Hon/Aicdatm4Mnz
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm2.1Hon/Aicdatm2.1Hon
(C57BL/6-Aicdatm2.1Hon)
|
abnormal somatic hypermutation frequency
|
J:169227
|
Aicdatm3.1Mnz/Aicdatm3.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
Aicdatm3Mnz/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aicdatm4.1Mnz/Aicdatm4.1Mnz
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:147109
|
| abnormal somatic hypermutation frequency
|
J:147109
|
Aicdatm4Mnz/Aicda+
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:141427
|
| abnormal somatic hypermutation frequency
|
J:141427
|
Aif1tm1Nsib/Aif1tm1Nsib
(involves: 129S/SvEv * C57BL/6)
|
thrombocytopenia
|
J:204462
|
Airetm1.1Doi/Airetm1.1Doi
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
Airetm1Mand/Aire+
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:135154
|
Airetm1Pltn/Airetm1Pltn
(B6.129S4-Airetm1Pltn)
|
abnormal definitive hematopoiesis
|
J:115076
|
| abnormal myelopoiesis
|
J:115076
|
Ajubaem1(IMPC)H/Ajubaem1(IMPC)H
(C57BL/6N-Ajubaem1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Ak4em1(IMPC)Kmpc/Ak4em1(IMPC)Kmpc
(C57BL/6NTac-Ak4em1(IMPC)Kmpc/Kmpc)
|
decreased erythrocyte cell number
|
J:211773
|
Akap8lem1(IMPC)J/Akap8lem1(IMPC)J
(C57BL/6NJ-Akap8lem1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Akap10tm1.1(KOMP)Vlcg/Akap10+
(C57BL/6N-Akap10tm1.1(KOMP)Vlcg/Ucd)
|
increased hematocrit
|
J:211773
|
Akap13tm1Segj/Akap13+
(involves: 129)
|
decreased transitional stage T2 B cell number
|
J:181088
|
| increased transitional stage T1 B cell number
|
J:181088
|
Aknatm1Mak/Aknatm1Mak
(B6.129P2-Aknatm1Mak)
|
increased neutrophil cell number
|
J:233952
|
Akr1c19em1(IMPC)J/Akr1c19em1(IMPC)J
(C57BL/6NJ-Akr1c19em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
| decreased double-positive T cell number
|
J:135903
|
| increased double-negative T cell number
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt2tm1.1Mbb/Akt2tm1.1Mbb
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:135903
|
| decreased double-positive T cell number
|
J:135903
|
| increased double-negative T cell number
|
J:135903
|
Akt1tm1Pnt/Akt1tm1Pnt
Akt3tm1Mbb/Akt3tm1Mbb
Tg(Lck-cre)1Cwi/0
(Not Specified)
|
decreased double-positive T cell number
|
J:135903
|
Aladem1(IMPC)Tcp/Alad+
(C57BL/6NCrl-Aladem1(IMPC)Tcp/Tcp)
|
decreased red blood cell distribution width
|
J:211773
|
Alas2tm1Mym/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal embryonic erythropoiesis
|
J:58508
|
| abnormal embryonic hematopoiesis
|
J:58508
|
Aldh2tm1a(EUCOMM)Wtsi/Aldh2tm1a(EUCOMM)Wtsi
Fancd2tm1Hou/Fancd2tm1Hou
(involves: 129S4/SvJae * C57BL/6J * C57BL/6N)
|
abnormal lymphopoiesis
|
J:193232
|
| decreased erythrocyte cell number
|
J:188123,
J:193232
|
| decreased hematocrit
|
J:188123
|
| decreased hemoglobin content
|
J:188123,
J:193232
|
| extramedullary hematopoiesis
|
J:188123
|
| increased double-positive T cell number
|
J:193232
|
| increased mean corpuscular volume
|
J:188123
|
| thrombocytopenia
|
J:188123
|
Aldh3a2tm1a(EUCOMM)Wtsi/Aldh3a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh3a2tm1a(EUCOMM)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
| decreased mean corpuscular volume
|
J:165965
|
| increased mean corpuscular volume
|
J:165965
|
Aldh9a1tm1b(KOMP)Wtsi/Aldh9a1tm1b(KOMP)Wtsi
(C57BL/6N-Aldh9a1tm1b(KOMP)Wtsi/Bay)
|
decreased hemoglobin content
|
J:211773
|
Alg1tm1b(KOMP)Wtsi/Alg1+
(C57BL/6N-Alg1tm1b(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Alkbh8tm1b(EUCOMM)Hmgu/Alkbh8tm1b(EUCOMM)Hmgu
(C57BL/6N-Alkbh8tm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Alo1/Alo1
(involves: C3H/HeJ * C57BL/6J)
|
extramedullary hematopoiesis
|
J:109802
|
Alo1/Alo1+
(involves: C3H/HeJ * C57BL/6J)
|
extramedullary hematopoiesis
|
J:109802
|
Alo2/Alo2
(involves: C3H/HeJ * C57BL/6J)
|
extramedullary hematopoiesis
|
J:109802
|
Alo2/Alo2+
(involves: C3H/HeJ * C57BL/6J)
|
extramedullary hematopoiesis
|
J:109802
|
Alox15tm1Fun/Alox15tm1Fun
(B6.129S2-Alox15tm1Fun/J)
|
abnormal myelopoiesis
|
J:119405
|
| increased basophil cell number
|
J:119405
|
Amelxem1(IMPC)Ccpcz/Amelx+
(C57BL/6N-Amelxem1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Amhr2tm3(cre)Bhr/Amhr2+
Ctnnb1tm1Mmt/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129S4/SvJae * 129S7/SvEvBrd * 129X1/SvJ)
|
decreased hematocrit
|
J:142150
|
| extramedullary hematopoiesis
|
J:142150
|
Ampd1tm1b(KOMP)Wtsi/Ampd1+
(C57BL/6N-Ampd1tm1b(KOMP)Wtsi/Ucd)
|
decreased neutrophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Ampd3tm1Tm/Ampd3tm1Tm
(Not Specified)
|
increased mean corpuscular volume
|
J:203909
|
Ampd3tm1Tm/Ampd3tm1Tm
Pklrslc/Pklrslc
(involves: CBA/NSlc)
|
abnormal erythrocyte morphology
|
J:203909
|
Amtem1(IMPC)Tcp/Amt+
(C57BL/6NCrl-Amtem1(IMPC)Tcp/Tcp)
|
increased erythrocyte cell number
|
J:211773
|
Anapc2tm1Kna/Anapc2tm2Kna
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased hemoglobin content
|
J:87782
|
Anapc7em1(IMPC)J/Anapc7em1(IMPC)J
(C57BL/6NJ-Anapc7em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Anapc13tm2b(EUCOMM)Wtsi/Anapc13+
(C57BL/6N-Anapc13tm2b(EUCOMM)Wtsi/Bay)
|
increased mean corpuscular volume
|
J:211773
|
anem/anem
(BALB/c-anem)
|
decreased erythrocyte cell number
|
J:227974
|
Angtm1.1(KOMP)Vlcg/Angtm1.1(KOMP)Vlcg
(C57BL/6N-Angtm1.1(KOMP)Vlcg/Ucd)
|
increased eosinophil cell number
|
J:211773
|
Angtm1Dats/Angtm1Dats
(Not Specified)
|
abnormal common myeloid progenitor cell morphology
|
J:236081
|
Angel1tm1(NCOM)Cmhd/Angel1tm1(NCOM)Cmhd
(C57BL/6N-Angel1tm1(NCOM)Cmhd/2Tcp)
|
increased hematocrit
|
J:165965
|
| increased hemoglobin content
|
J:165965
|
Ank1ity16/Ank1+
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
extramedullary hematopoiesis
|
J:199427
|
| increased erythrocyte cell number
|
J:199427
|
Ank1ity16/Ank1ity16
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
abnormal erythrocyte morphology
|
J:199427
|
| abnormal erythropoiesis
|
J:199427
|
| anisocytosis
|
J:199427
|
| decreased erythrocyte cell number
|
J:199427
|
| decreased hematocrit
|
J:199427
|
| decreased hemoglobin content
|
J:199427
|
| increased neutrophil cell number
|
J:199427
|
Ank1M1Btlr/Ank1+
(C57BL/6J-Ank1m1Btlr)
|
decreased mean corpuscular hemoglobin
|
J:203831
|
| decreased mean corpuscular volume
|
J:203831
|
| increased erythrocyte cell number
|
J:203831
|
Ank1M1Btlr/Ank1M1Btlr
(C57BL/6J-Ank1m1Btlr)
|
abnormal erythrocyte morphology
|
J:203831
|
| decreased mean corpuscular hemoglobin
|
J:203831
|
| decreased mean corpuscular volume
|
J:203831
|
| extramedullary hematopoiesis
|
J:203831
|
| increased erythrocyte cell number
|
J:203831
|
| microcytosis
|
J:203831
|
| spherocytosis
|
J:203831
|
| stomatocytosis
|
J:203831
|
Ank1M1Wlst/Ank1+
(involves: C3H/HeJ * C57BL/6)
|
decreased cellular hemoglobin content
|
J:170562
|
| decreased mean corpuscular volume
|
J:170562
|
| increased erythrocyte cell number
|
J:170562
|
Ank1M1Wlst/Ank1+
(involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)
|
abnormal erythrocyte morphology
|
J:170562
|
Ank1M1Wlst/Ank1+
(C3.B6-Ank1M1Wlst)
|
decreased cellular hemoglobin content
|
J:170562
|
| decreased mean corpuscular hemoglobin concentration
|
J:170562
|
| decreased mean corpuscular volume
|
J:170562
|
| increased erythrocyte cell number
|
J:170562
|
| polychromatophilia
|
J:170562
|
Ank1M1Wlst/Ank1M1Wlst
(involves: C3H/HeJ * C57BL/6)
|
decreased hematocrit
|
J:170562
|
| decreased hemoglobin content
|
J:170562
|
| decreased mean corpuscular hemoglobin concentration
|
J:170562
|
| decreased mean corpuscular volume
|
J:170562
|
| increased erythrocyte cell number
|
J:170562
|
Ank1M1Wlst/Ank1M1Wlst
(involves: 129S1/SvImJ * C3H/HeJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:170562
|
| abnormal erythrocyte morphology
|
J:170562
|
| abnormal myelopoiesis
|
J:170562
|
| decreased common myeloid progenitor cell number
|
J:170562
|
| decreased hematocrit
|
J:170562
|
| extramedullary hematopoiesis
|
J:170562
|
| increased nucleated erythrocyte cell number
|
J:170562
|
| polychromatophilia
|
J:170562
|
| spherocytosis
|
J:170562
|
Ank1MRI23420/Ank1+
(SJL/J-Ank1MRI23420)
|
abnormal erythrocyte morphology
|
J:187820
|
| decreased mean corpuscular hemoglobin
|
J:187820
|
| decreased mean corpuscular volume
|
J:187820
|
| hyperchromasia
|
J:187820
|
| increased erythrocyte cell number
|
J:187820
|
| microcytosis
|
J:187820
|
| polycythemia
|
J:187820
|
| thrombocytosis
|
J:187820
|
Ank1MRI23420/Ank1MRI23420
(SJL/J-Ank1MRI23420)
|
abnormal erythrocyte morphology
|
J:187820
|
| poikilocytosis
|
J:187820
|
| spherocytosis
|
J:187820
|
Ank1nb/Ank1+
(involves: C57BL/6J * WB/Re)
|
abnormal erythrocyte morphology
|
J:111131
|
| increased erythrocyte protoporphyrin level
|
J:5985
|
Ank1nb/Ank1nb
(either: (involves: non-inbred stock) or (involves: C57BL/6) or (involves: WB/Re))
|
decreased erythrocyte cell number
|
J:30699
|
| decreased hematocrit
|
J:30699
|
| decreased hemoglobin content
|
J:30699
|
Ank1nb/Ank1nb
(involves: C57BL/6J * WB/Re)
|
abnormal erythrocyte morphology
|
J:42526,
J:111131,
J:7501
|
| acanthocytosis
|
J:111131
|
| anisocytosis
|
J:111131
|
| anisopoikilocytosis
|
J:111131
|
| increased erythrocyte protoporphyrin level
|
J:5985
|
| low mean erythrocyte cell number
|
J:3122
|
| microcytosis
|
J:111131
|
| poikilocytosis
|
J:111131
|
| spherocytosis
|
J:3122
|
| stomatocytosis
|
J:111131
|
Ank1nb/Ank1nb
((WB.Cg-Ank1nb/BrkJ x B6.Cg-Ank1nb/BrkJ)F1)
|
abnormal erythrocyte morphology
|
J:62355
|
| anisopoikilocytosis
|
J:162532
|
| decreased hematocrit
|
J:162532
|
| decreased hemoglobin content
|
J:162532
|
| extramedullary hematopoiesis
|
J:162532
|
| increased nucleated erythrocyte cell number
|
J:162532
|
| low mean erythrocyte cell number
|
J:162532
|
| microcytosis
|
J:62355
|
| poikilocytosis
|
J:162532
|
| schistocytosis
|
J:162532
|
Ank1Rbc2/Ank1+
(involves: 129S1/Sv * BALB/c)
|
decreased mean corpuscular volume
|
J:148127
|
Ank1Rbc2/Ank1Rbc2
(involves: 129S1/Sv * BALB/c)
|
abnormal erythrocyte morphology
|
J:148127
|
| anisocytosis
|
J:148127
|
| decreased erythrocyte cell number
|
J:148127
|
| decreased hematocrit
|
J:148127
|
| decreased hemoglobin content
|
J:148127
|
| decreased mean corpuscular hemoglobin concentration
|
J:148127
|
| extramedullary hematopoiesis
|
J:148127
|
| increased hemoglobin concentration distribution width
|
J:148127
|
| increased nucleated erythrocyte cell number
|
J:148127
|
| poikilocytosis
|
J:148127
|
| spherocytosis
|
J:148127
|
Ankrd9tm1(KOMP)Wtsi/Ankrd9tm1(KOMP)Wtsi
(C57BL/6N-Ankrd9tm1(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
Ankrd13cem1(IMPC)Tcp/Ankrd13cem1(IMPC)Tcp
(C57BL/6N-Ankrd13cem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Ankrd44em1(IMPC)J/Ankrd44em1(IMPC)J
(C57BL/6NJ-Ankrd44em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Antxr2em1(IMPC)Wtsi/Antxr2em1(IMPC)Wtsi
(C57BL/6N-Antxr2em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
anx/anx
Tyro3m1/Tyro3m1
(involves: C3HeB/FeJLe * C57BL/6J)
|
abnormal platelet morphology
|
J:241666
|
Anxa7tm1Ngl/Anxa7tm1Ngl
(involves: 129S2/SvPas)
|
abnormal erythrocyte morphology
|
J:91188
|
| thrombocytosis
|
J:91188
|
Aopeptm1b(KOMP)Wtsi/Aopeptm1b(KOMP)Wtsi
(C57BL/6N-Aopeptm1b(KOMP)Wtsi/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Ap2a1em1(IMPC)J/Ap2a1em1(IMPC)J
(C57BL/6NJ-Ap2a1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Ap2a2tm1b(EUCOMM)Wtsi/Ap2a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap2a2tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ap3b1pe-rim2/Ap3b1pe-rim2
(involves: B10.A(R201) * C57BL/10Slc)
|
decreased platelet ADP level
|
J:42685
|
| decreased platelet ATP level
|
J:42685
|
Ap3b1pe/Ap3b1pe
(involves: C3H/He)
|
decreased platelet dense granule number
|
J:7327
|
| decreased platelet serotonin level
|
J:7327
|
Ap3b1pe/Ap3b1pe
(B6.C3-Ap3b1pe/J)
|
abnormal platelet dense granule morphology
|
J:152219
|
| decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet dense granule number
|
J:7327
|
| decreased platelet serotonin level
|
J:7327
|
Ap3b2em1(IMPC)H/Ap3b2em1(IMPC)H
(C57BL/6N-Ap3b2em1(IMPC)H/H)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ap3d1mh/Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J)
|
abnormal platelet dense granule morphology
|
J:29151
|
| decreased platelet dense granule number
|
J:29151
|
| decreased platelet serotonin level
|
J:29151
|
Ap4e1tm1a(KOMP)Wtsi/Ap4e1tm1a(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1a(KOMP)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:175295
|
| decreased mean corpuscular hemoglobin
|
J:175295
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Wtsi)
|
increased hematocrit
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Ccpcz)
|
increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Ap4m1tm1b(EUCOMM)Wtsi/Ap4m1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ap4m1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased hematocrit
|
J:211773
|
Apbb1ipem1(IMPC)Ccpcz/Apbb1ipem1(IMPC)Ccpcz
(C57BL/6N-Apbb1ipem1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
ApcMin/Apc+
(involves: AKR/J * C57BL/6J)
|
decreased hematocrit
|
J:10209
|
Apctm1Kk/Apctm1Kk
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:100461
|
| arrested T cell differentiation
|
J:100461
|
| increased double-negative T cell number
|
J:100461
|
| increased mast cell number
|
J:128606
|
Apctm1Tno/Apc+
Tg(CDX2-cre)101Erf/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased hematocrit
|
J:126018
|
Apctm2Rak/Apc+
Tg(Car1-cre)5Flt/0
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased hematocrit
|
J:164247
|
Apctm2Rak/Apctm2Rak
Tg(Car1-cre)5Flt/0
(involves: 129/Sv * C57BL/6J * SJL)
|
decreased hematocrit
|
J:164247
|
Apex2em1(IMPC)H/Apex2em1(IMPC)H
(C57BL/6NTac-Apex2em1(IMPC)H/H)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Apex2tm1Yun/Y
(B6.129S-Apex2tm1Yun)
|
decreased erythrocyte cell number
|
J:95267
|
AplfGt(RRF189)Byg/AplfGt(RRF189)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:168260
|
Aplp2tm2b(EUCOMM)Hmgu/Aplp2tm2b(EUCOMM)Hmgu
(C57BL/6N-Aplp2tm2b(EUCOMM)Hmgu/Bay)
|
decreased mean corpuscular volume
|
J:211773
|
Apoc4tm1.1(KOMP)Mbp/Apoc4tm1.1(KOMP)Mbp
(C57BL/6N-Apoc4tm1.1(KOMP)Mbp/Ieg)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
decreased hematocrit
|
J:108154
|
Apoetm1Unc/Apoetm1Unc
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal erythrocyte morphology
|
J:75090
|
| decreased hematocrit
|
J:75090
|
| decreased hemoglobin content
|
J:75090
|
| echinocytosis
|
J:75090
|
| macrocytosis
|
J:75090
|
| poikilocytosis
|
J:75090
|
Apoftm1.1(KOMP)Vlcg/Apoftm1.1(KOMP)Vlcg
(C57BL/6N-Apoftm1.1(KOMP)Vlcg/Ucd)
|
increased basophil cell number
|
J:211773
|
Appl1tm1.2Test/Appl1tm1.2Test
(involves: 129X1/SvJ)
|
increased hematocrit
|
J:227340
|
Appl1tm1.2Test/Appl1tm1.2Test
Appl2tm1.1Test/Appl2tm1.1Test
(involves: 129X1/SvJ)
|
decreased mean corpuscular hemoglobin concentration
|
J:227340
|
| increased hematocrit
|
J:227340
|
| increased mean corpuscular volume
|
J:227340
|
Appl2tm1.1Test/Appl2tm1.1Test
(Not Specified)
|
decreased mean corpuscular hemoglobin concentration
|
J:227340
|
| increased hematocrit
|
J:227340
|
| increased mean corpuscular volume
|
J:227340
|
Aprttm1Jat/Aprttm1Jat
(involves: 129S2/SvPas * Black Swiss)
|
decreased hematocrit
|
J:111451
|
Aptxtm1Pmc/Aptxtm1Pmc
Atmtm2.1Mfgc/Atmtm2.1Mfgc
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:316365
|
Aqp1tm1Ask/Aqp1tm1Ask
Slc14a1tm1Ask/Slc14a1tm1Ask
(involves: C57BL/6J)
|
abnormal mean corpuscular volume
|
J:79279
|
| high mean erythrocyte cell number
|
J:79279
|
| increased hematocrit
|
J:79279
|
Aqp1tm1b(EUCOMM)Wtsi/Aqp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Aqp1tm1b(EUCOMM)Wtsi/H)
|
increased neutrophil cell number
|
J:211773
|
Aqp2tm1(cre)Blyg/Aqp2tm1(cre)Blyg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased hematocrit
|
J:121445
|
Aqp12tm1.1(KOMP)Vlcg/Aqp12tm1.1(KOMP)Vlcg
(C57BL/6N-Aqp12tm1.1(KOMP)Vlcg/Ucd)
|
thrombocytopenia
|
J:211773
|
ArTfm/Y
(involves: STOCK EdaTa Atp7aMo-blo)
|
abnormal erythropoiesis
|
J:110923
|
| increased immature B cell number
|
J:110923
|
Arap1tm1b(EUCOMM)Wtsi/Arap1tm1b(EUCOMM)Wtsi
(C57BL/6N-Arap1tm1b(EUCOMM)Wtsi/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Aregtm2b(EUCOMM)Hmgu/Aregtm2b(EUCOMM)Hmgu
(C57BL/6N-Aregtm2b(EUCOMM)Hmgu/H)
|
increased mean corpuscular volume
|
J:211773
|
Arfgef1em1(IMPC)Hmgu/Arfgef1+
(C57BL/6NCrl-Arfgef1em1(IMPC)Hmgu/Ieg)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Arhgap10em1(IMPC)Tcp/Arhgap10em1(IMPC)Tcp
(C57BL/6N-Arhgap10em1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
Arhgap15tm1Ehi/Arhgap15tm1Ehi
(B6.129-Arhgap15tm1Ehi)
|
decreased neutrophil cell number
|
J:174896
|
Arhgap17tm1b(EUCOMM)Wtsi/Arhgap17tm1b(EUCOMM)Wtsi
(C57BL/6N-Arhgap17tm1b(EUCOMM)Wtsi/Wtsi)
|
increased transitional stage T1 B cell number
|
J:211773
|
Arhgap21Gt(RRR629)Byg/Arhgap21+
(B6.129P2-Arhgap21Gt(RRR629)Byg)
|
decreased erythrocyte cell number
|
J:262703
|
| decreased hemoglobin content
|
J:262703
|
| increased neutrophil cell number
|
J:262703
|
| thrombocytopenia
|
J:262703
|
Arhgap22tm1a(KOMP)Wtsi/Arhgap22tm1a(KOMP)Wtsi
(C57BL/6N-Arhgap22tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(C57BL/6N-Arhgap25tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Arhgap25tm1a(KOMP)Wtsi/Arhgap25tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
increased neutrophil cell number
|
J:240521
|
Arhgap26tm1b(EUCOMM)Hmgu/Arhgap26tm1b(EUCOMM)Hmgu
(C57BL/6N-Arhgap26tm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Arhgap30tm1a(EUCOMM)Wtsi/Arhgap30tm1a(EUCOMM)Wtsi
(C57BL/6N-Arhgap30tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Arhgap45em1Ciphe/Arhgap45em1Ciphe
(C57BL/6-Arhgap45em1Ciphe)
|
decreased DN1 thymic pro-T cell number
|
J:309971
|
Arhgdiatm1Ytk/Arhgdiatm1Ytk
Arhgdibtm1Miyo/Arhgdibtm1Miyo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:140671
|
| decreased immature B cell number
|
J:140671
|
| decreased transitional stage B cell number
|
J:140671
|
| increased eosinophil cell number
|
J:140671
|
Arhgef1tm1a(EUCOMM)Wtsi/Arhgef1tm1a(EUCOMM)Wtsi
(C57BL/6N-Arhgef1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Arhgef1tm1Djle/Arhgef1tm1Djle
(involves: 129S4/SvJae * C57BL/6)
|
extramedullary hematopoiesis
|
J:129331
|
Arhgef2em1(IMPC)Mbp/Arhgef2em1(IMPC)Mbp
(C57BL/6N-Arhgef2em1(IMPC)Mbp/MbpMmucd)
|
thrombocytopenia
|
J:211773
|
Arhgef3tm1(KOMP)Wtsi/Arhgef3tm1(KOMP)Wtsi
(C57BL/6N-Arhgef3tm1(KOMP)Wtsi/DkrsJ)
|
increased mean platelet volume
|
J:241286
|
Arhgef4tm1a(KOMP)Wtsi/Arhgef4tm1a(KOMP)Wtsi
(C57BL/6N-Arhgef4tm1a(KOMP)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:165965
|
Arhgef5tm1.1Dwu/Arhgef5tm1.1Dwu
(involves: 129S1/Sv * 129S6/SvEvTac)
|
decreased eosinophil cell number
|
J:157812
|
Arhgef15tm1.1(KOMP)Vlcg/Arhgef15tm1.1(KOMP)Vlcg
(C57BL/6N-Arhgef15tm1.1(KOMP)Vlcg/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Arhgef18tm1b(KOMP)Mbp/Arhgef18+
(C57BL/6N-Arhgef18tm1b(KOMP)Mbp/H)
|
increased basophil cell number
|
J:211773
|
Arid3atm1b(KOMP)Wtsi/Arid3a+
(B6N(Cg)-Arid3atm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Arid3atm1Pwt/Arid3atm1Pwt
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:169178
|
| abnormal class switch recombination
|
J:169178
|
| abnormal embryonic erythropoiesis
|
J:169178
|
| abnormal erythropoiesis
|
J:197237
|
| decreased common myeloid progenitor cell number
|
J:169178
|
| decreased pro-B cell number
|
J:169178
|
| decreased transitional stage B cell number
|
J:169178
|
| decreased transitional stage T1 B cell number
|
J:169178
|
| decreased transitional stage T2 B cell number
|
J:169178
|
Arid3btm1c(KOMP)Wtsi/Arid3btm1c(KOMP)Wtsi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * SJL)
|
abnormal B cell differentiation
|
J:236980
|
| decreased immature B cell number
|
J:236980
|
| decreased pre-pro B cell number
|
J:236980
|
| decreased pro-B cell number
|
J:236980
|
| decreased transitional stage B cell number
|
J:236980
|
Arid4atm1Alb/Arid4atm1Alb
(involves: 129S7/SvEvBrd)
|
abnormal common myeloid progenitor cell morphology
|
J:141004
|
| abnormal definitive hematopoiesis
|
J:141004
|
| abnormal mononuclear cell differentiation
|
J:141004
|
| decreased erythrocyte cell number
|
J:141004
|
| decreased neutrophil cell number
|
J:141004
|
| extramedullary hematopoiesis
|
J:141004
|
| increased erythrocyte cell number
|
J:141004
|
| poikilocytosis
|
J:141004
|
| thrombocytopenia
|
J:141004
|
Arid4atm1Alb/Arid4atm1Alb
Arid4btm1Alb/Arid4b+
(involves: 129S7/SvEvBrd)
|
abnormal common myeloid progenitor cell morphology
|
J:141004
|
| abnormal definitive hematopoiesis
|
J:141004
|
| abnormal leukopoiesis
|
J:141004
|
| decreased erythrocyte cell number
|
J:141004
|
| extramedullary hematopoiesis
|
J:141004
|
| increased erythrocyte cell number
|
J:141004
|
| increased neutrophil cell number
|
J:141004
|
| thrombocytopenia
|
J:141004
|
Arid5btm1Pjh/Arid5btm1Pjh
(involves: 129S4/SvJae * BALB/c)
|
abnormal lymphopoiesis
|
J:70658
|
| decreased double-positive T cell number
|
J:70658
|
| decreased pro-B cell number
|
J:70658
|
Arl6ip1tm1b(EUCOMM)Hmgu/Arl6ip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Arl6ip1tm1b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular volume
|
J:211773
|
Armc2tm1b(EUCOMM)Hmgu/Armc2+
(C57BL/6N-Armc2tm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
Arntem1(IMPC)H/Arnt+
(C57BL/6N-Arntem1(IMPC)H/H)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Arnttm1.1Gonz/Arnttm1.1Gonz
Tg(Vil1-cre)20Syr/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased erythrocyte cell number
|
J:189504
|
| decreased hematocrit
|
J:189504
|
| decreased hemoglobin content
|
J:189504
|
Arpc1btm1a(EUCOMM)Wtsi/Arpc1btm1a(EUCOMM)Wtsi
(C57BL/6N-Arpc1btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Arpc2tm1a(EUCOMM)Wtsi/Arpc2+
(B6JTyr;B6N-Arpc2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Arpc4tm1a(EUCOMM)Wtsi/Arpc4+
(B6JTyr;B6N-Arpc4tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular volume
|
J:165965
|
Arrb1tm1b(KOMP)Wtsi/Arrb1tm1b(KOMP)Wtsi
(B6N(Cg)-Arrb1tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Arrdc4em1(IMPC)Tcp/Arrdc4em1(IMPC)Tcp
(C57BL/6N-Arrdc4em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Arrdc5tm1b(EUCOMM)Wtsi/Arrdc5tm1b(EUCOMM)Wtsi
(C57BL/6N-Arrdc5tm1b(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Art1tm1b(EUCOMM)Wtsi/Art1tm1b(EUCOMM)Wtsi
(C57BL/6N-Art1tm1b(EUCOMM)Wtsi/Tcp)
|
increased basophil cell number
|
J:211773
|
Art4tm1a(KOMP)Wtsi/Art4tm1a(KOMP)Wtsi
(C57BL/6N-Art4tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Asah1tm1.2Geno/Asah1tm1.2Geno
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:285931
|
| decreased mean corpuscular hemoglobin
|
J:285931
|
| decreased mean corpuscular volume
|
J:285931
|
| increased erythrocyte cell number
|
J:285931
|
| increased granulocyte number
|
J:285931
|
Asah1tm1Medin/Asah1tm1Medin
(involves: 129S6/SvEvTac * CD-1)
|
increased eosinophil cell number
|
J:232306
|
| increased erythrocyte cell number
|
J:232306
|
| increased hemoglobin content
|
J:232306
|
| increased neutrophil cell number
|
J:232306
|
Asap1em1(IMPC)Wtsi/Asap1em1(IMPC)Wtsi
(C57BL/6NCrl-Asap1em1(IMPC)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Asb2tm2b(KOMP)Wtsi/Asb2+
(C57BL/6N-Asb2tm2b(KOMP)Wtsi/Kmpc)
|
increased eosinophil cell number
|
J:211773
|
Asb10tm2b(KOMP)Wtsi/Asb10tm2b(KOMP)Wtsi
(B6N(Cg)-Asb10tm2b(KOMP)Wtsi/J)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Ash1ltm2b(EUCOMM)Hmgu/Ash1l+
(C57BL/6N-Ash1ltm2b(EUCOMM)Hmgu/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Asltm1Brle/Asltm1Brle
(involves: 129S7/SvEvBrd)
|
abnormal erythrocyte morphology
|
J:180208
|
| acanthocytosis
|
J:180208
|
Asnstm1a(EUCOMM)Wtsi/Asnstm1a(EUCOMM)Wtsi
(C57BL/6N-Asnstm1a(EUCOMM)Wtsi/H)
|
decreased hemoglobin content
|
J:165965
|
Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi
(C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Aspgem1(IMPC)Tcp/Aspgem1(IMPC)Tcp
(C57BL/6NCrl-Aspgem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Aspmtm1a(KOMP)Wtsi/Aspmtm1a(KOMP)Wtsi
(C57BL/6N-Aspmtm1a(KOMP)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Aspntm1b(EUCOMM)Hmgu/Aspntm1b(EUCOMM)Hmgu
(C57BL/6N-Aspntm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Aspscr1em1(IMPC)Tcp/Aspscr1em1(IMPC)Tcp
(C57BL/6NCrl-Aspscr1em1(IMPC)Tcp/Tcp)
|
decreased neutrophil cell number
|
J:211773
|
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:208092
|
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:208092
|
| decreased hemoglobin content
|
J:208092
|
| decreased neutrophil cell number
|
J:208092
|
| extramedullary hematopoiesis
|
J:208092
|
| increased nucleated erythrocyte cell number
|
J:208092
|
Asxl1tm1.1Iaai/Asxl1tm1.1Iaai
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:208092
|
| abnormal myelopoiesis
|
J:208092
|
| decreased hemoglobin content
|
J:208092
|
| decreased neutrophil cell number
|
J:208092
|
| increased nucleated erythrocyte cell number
|
J:208092
|
Asxl1tm1.1Mjxu/Asxl1+
(involves: 129 * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:208085
|
| abnormal myelopoiesis
|
J:208085
|
| abnormal neutrophil morphology
|
J:208085
|
| decreased neutrophil cell number
|
J:208085
|
| polychromatophilia
|
J:208085
|
| thrombocytopenia
|
J:208085
|
Asxl1tm1.1Mjxu/Asxl1tm1.1Mjxu
(involves: 129 * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:208085
|
| abnormal neutrophil morphology
|
J:208085
|
| increased number of Howell-Jolly bodies
|
J:208085
|
| myeloid hyperplasia
|
J:208085
|
| polychromatophilia
|
J:208085
|
| thrombocytopenia
|
J:208085
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(B6Dnk;B6Brd;B6N-Asxl1tm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH)
|
decreased hemoglobin content
|
J:175295
|
| decreased mean corpuscular hemoglobin
|
J:175295
|
Asxl1tm1a(EUCOMM)Wtsi/Asxl1+
(C57BL/6N-Asxl1tm1a(EUCOMM)Wtsi/Cnrm)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Asxl1tm1Bc/Asxl1tm1Bc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal common myeloid progenitor cell morphology
|
J:155898
|
| abnormal lymphopoiesis
|
J:155898
|
| extramedullary hematopoiesis
|
J:155898
|
| increased double-negative T cell number
|
J:155898
|
Asxl2tm1b(EUCOMM)Hmgu/Asxl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Asxl2tm1b(EUCOMM)Hmgu/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Atf2tm1b(EUCOMM)Hmgu/Atf2+
(C57BL/6N-Atf2tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Atf2tm1Nicj/Atf2tm1Nicj
Atf7tm1Nicj/Atf7tm1Nicj
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:123909
|
Atf2tm2Nicj/Atf2tm2Nicj
Atf7tm1Nicj/Atf7tm1Nicj
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:123909
|
Atf4tm1(KOMP)Mbp/Atf4+
(C57BL/6NCrl-Atf4tm1(KOMP)Mbp/MbpMmucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Atf4tm1Tow/Atf4tm1Tow
(involves: 129S1/Sv * 129X1/SvJ * NIH Black Swiss)
|
absent common myeloid progenitor cells
|
J:74479
|
| decreased hematocrit
|
J:74479
|
Atg5tm1Myok/Atg5tm1Myok
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv)
|
increased neutrophil cell number
|
J:235399
|
Atg7tm1Tchi/Atg7tm1Tchi
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
decreased common myeloid progenitor cell number
|
J:176843
|
Atg7tm1Tchi/Atg7tm1Tchi
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrlj * CBA/JNCrlj)
|
increased neutrophil cell number
|
J:235399
|
Atg16l1tm1a(EUCOMM)Wtsi/Atg16l1+
(C57BL/6N-Atg16l1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Atl2tm2b(EUCOMM)Hmgu/Atl2+
(C57BL/6N-Atl2tm2b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular volume
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
AtmM4Btlr/AtmM4Btlr
(C57BL/6J-AtmM4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272821
|
Atmm6Btlr/Atmm6Btlr
(C57BL/6J-Atmm6Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274964
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274964
|
| abnormal T cell differentiation
|
J:274964
|
Atmtm1Awb/Atmtm1Awb
(either: 129S6/SvEvTac-Atmtm1Awb or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
decreased double-positive T cell number
|
J:34193
|
| increased double-positive T cell number
|
J:34193
|
Atmtm1Awb/Atmtm1Awb
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150435
|
Atmtm1Awb/Atmtm1Awb
(129S6/SvEvTac-Atmtm1Awb/J)
|
increased double-positive T cell number
|
J:226414
|
Atmtm1Awb/Atmtm1Awb
Paxxem1Spj/Paxxem1Spj
(involves: A/J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:236776
|
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae * C57BL/6)
|
decreased immature B cell number
|
J:61201
|
Atmtm1Fwa/Atmtm1Fwa
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:191288
|
Atmtm1Led/Atmtm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
abnormal T cell differentiation
|
J:36561
|
| increased double-positive T cell number
|
J:36561
|
Atmtm1Mfl/Atmtm1Mfl
(involves: 129T2/SvEms * C57BL/6J)
|
abnormal T cell differentiation
|
J:69726
|
| increased double-negative T cell number
|
J:69726
|
Atmtm1Shzh/Atmtm2.1Fwa
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sor+
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:191288
|
Atmtm2.1Mfgc/Atmtm2.1Mfgc
(C57BL/6-Atmtm2.1Mfgc)
|
abnormal T cell differentiation
|
J:316365
|
Atmintm1.1Jhh/Atmintm1.1Jhh
Cd79atm1(cre)Reth/Cd79a+
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh)
|
decreased immature B cell number
|
J:230105
|
Atmintm1.1Jhh/Atmintm1.1Jhh
Cd79atm1(cre)Reth/Cd79a+
Tg(IghMyc)22Bri/0
(B6.Cg-Cd79atm1(Cre)Reth Atmintm1.1Jhh Tg(IghMyc)22Bri)
|
decreased immature B cell number
|
J:230105
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
increased immature B cell number
|
J:191832
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:191832
|
| decreased immature B cell number
|
J:191832
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:191832
|
Atmintm1.2Jhh/Atmintm1.2Jhh
Trp53tm1Brn/Trp53tm1Brn
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased immature B cell number
|
J:191832
|
Atn1tm1b(EUCOMM)Wtsi/Atn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Atn1tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Atp2a2tm1b(EUCOMM)Hmgu/Atp2a2+
(C57BL/6N-Atp2a2tm1b(EUCOMM)Hmgu/H)
|
decreased mean platelet volume
|
J:211773
|
Atp2b4tm1Ksch/Atp2b4tm1Ksch
(involves: 129P2/OlaHsd * C57BL/6)
|
increased mean corpuscular hemoglobin concentration
|
J:245643
|
Atp2c2em1(IMPC)Tcp/Atp2c2em1(IMPC)Tcp
(C57BL/6NCrl-Atp2c2em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
Atp4am1Btlr/Atp4am1Btlr
(involves: C57BL/6J)
|
abnormal erythrocyte morphology
|
J:179090
|
| abnormal erythropoiesis
|
J:179090
|
| anisocytosis
|
J:179090
|
| decreased hematocrit
|
J:179090
|
| decreased hemoglobin content
|
J:179090
|
| decreased mean corpuscular hemoglobin
|
J:179090
|
| decreased mean corpuscular volume
|
J:179090
|
| extramedullary hematopoiesis
|
J:179090
|
| increased red blood cell distribution width
|
J:179090
|
| poikilocytosis
|
J:179090
|
| thrombocytosis
|
J:179090
|
Atp5f1etm1b(EUCOMM)Wtsi/Atp5f1e+
(C57BL/6N-Atp5f1etm1b(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Atp5if1em1Jpy/Atp5if1em1Jpy
(C57BL/6J-Atp5if1em1Jpy)
|
decreased neutrophil cell number
|
J:312819
|
Atp5mc1em1(IMPC)H/Atp5mc1em1(IMPC)H
(C57BL/6NTac-Atp5mc1em1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Atp5mgtm1b(EUCOMM)Hmgu/Atp5mg+
(C57BL/6N-Atp5mgtm1b(EUCOMM)Hmgu/H)
|
decreased eosinophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Atp5mktm1b(EUCOMM)Wtsi/Atp5mktm1b(EUCOMM)Wtsi
(C57BL/6N-Atp5mktm1b(EUCOMM)Wtsi/H)
|
decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Atp6v0bem1(IMPC)J/Atp6v0b+
(C57BL/6NJ-Atp6v0bem1(IMPC)J/Mmjax)
|
increased hematocrit
|
J:211773
|
Atp6v0d1tm1b(EUCOMM)Hmgu/Atp6v0d1+
(C57BL/6N-Atp6v0d1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Atp6v1b2tm1b(KOMP)Wtsi/Atp6v1b2+
(C57BL/6N-Atp6v1b2tm1b(KOMP)Wtsi/Tcp)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Atp6v1c1tm1b(NCOM)Mfgc/Atp6v1c1+
(C57BL/6N-Atp6v1c1tm1b(NCOM)Mfgc/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Atp6v1dtm1b(EUCOMM)Hmgu/Atp6v1d+
(C57BL/6N-Atp6v1dtm1b(EUCOMM)Hmgu/Tcp)
|
decreased mean platelet volume
|
J:211773
|
| thrombocytosis
|
J:211773
|
Atp7btx-J/Atp7btx-J
(C3H/HeJ-Atp7btx-J/J)
|
increased eosinophil cell number
|
J:24233
|
Atp8a1tm1a(EUCOMM)Wtsi/Atp8a1tm1a(EUCOMM)Wtsi
(C57BL/6N-Atp8a1tm1a(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:165965
|
| increased mean corpuscular hemoglobin concentration
|
J:165965
|
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Atp11bem1(IMPC)Tcp/Atp11bem1(IMPC)Tcp
(C57BL/6N-Atp11bem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Atp11cambr/Y
(C57BL/6-Atp11cambr)
|
abnormal B cell differentiation
|
J:171924
|
| decreased erythrocyte cell number
|
J:171924
|
| decreased immature B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
Atp11cambr/Y
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6JApb)
|
decreased immature B cell number
|
J:171924
|
| decreased pro-B cell number
|
J:171924
|
Atp11cambr/Y
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6 * C57BL/6J * C57BL/6JApb)
|
decreased immature B cell number
|
J:171924
|
Atp11cem1(IMPC)J/Y
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Atp11cem1(IMPC)J/Atp11cem1(IMPC)J
(C57BL/6NJ-Atp11cem1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Atp11cm1Btlr/Y
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:171925
|
| decreased immature B cell number
|
J:171925
|
| decreased transitional stage B cell number
|
J:171925
|
| decreased transitional stage T1 B cell number
|
J:171925
|
| decreased transitional stage T2 B cell number
|
J:171925
|
| decreased transitional stage T3 B cell number
|
J:171925
|
Atp13a3em1(IMPC)J/Atp13a3em1(IMPC)J
(C57BL/6NJ-Atp13a3em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Atrntm1.1(KOMP)Vlcg/Atrntm1.1(KOMP)Vlcg
(C57BL/6N-Atrntm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Auhem1(IMPC)Tcp/Auhem1(IMPC)Tcp
(C57BL/6NCrl-Auhem1(IMPC)Tcp/Tcp)
|
increased eosinophil cell number
|
J:211773
|
Avptm1b(EUCOMM)Wtsi/Avp+
(C57BL/6N-Avptm1b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
Avpr1atm1Sbhu/Avpr1atm1Sbhu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:105892
|
Avpr2tm1Jwe/Y
(involves: 129S1/Sv * 129X1/SvJ * CF-1)
|
increased hematocrit
|
J:66094
|
Azi2tm1Aki/Azi2tm1Aki
(Not Specified)
|
abnormal dendritic cell differentiation
|
J:204786
|
B2mtm1Jae/B2mtm1Jae
Foxp3sfOtcspf/Y
(involves: 129/Rl * 129S2/SvPas)
|
decreased hematocrit
|
J:20865
|
B2mtm1Jae/B2mtm1Jae
Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * 129S2/SvPas * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
B2mtm1Jae/B2mtm1Jae
Rr96tm1.1Yzo/Rr96tm1.1Yzo
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
B2mtm1Jae/B2mtm1Jae
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:151075
|
B2mtm1Jae/B2mtm1Jae
Zbtb7btm1Litt/Zbtb7btm1.2Litt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
| abnormal double-positive T cell morphology
|
J:141144
|
B2mtm1Unc/B2mtm1Unc
Il2tm1Hor/Il2tm1Hor
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:39981
|
B2mtm1Unc/B2mtm1Unc
Prkdcscid/Prkdcscid
(NOD.Cg-B2mtm1Unc Prkdcscid)
|
arrested B cell differentiation
|
J:102141
|
| arrested T cell differentiation
|
J:102141
|
B4galnt2tm1Jbl/B4galnt2tm1Jbl
(involves: 129S1/Sv)
|
increased neutrophil cell number
|
J:217719
|
B4galt1tm1Yiw/B4galt1tm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased erythrocyte cell number
|
J:106669
|
| decreased hematocrit
|
J:106669
|
| decreased hemoglobin content
|
J:106669
|
| extramedullary hematopoiesis
|
J:106669
|
| increased neutrophil cell number
|
J:106669
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:123547
|
| abnormal T-helper 17 cell differentiation
|
J:169839
|
B9d2/Tgfb1tm1Flv/Tgfb1tm2Flv
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2+
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:169839
|
B9d2/Tgfb1tm1Flv/B9d2+
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:169839
|
Baatem1(IMPC)Mbp/Baatem1(IMPC)Mbp
(C57BL/6NCrl-Baatem1(IMPC)Mbp/Mmucd)
|
increased mean corpuscular volume
|
J:211773
|
Babam1em1(IMPC)Ccpcz/Babam1em1(IMPC)Ccpcz
(C57BL/6NCrl-Babam1em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Babam1Gt(IST11207B9)Tigm/Babam1Gt(IST11207B9)Tigm
(involves: C57BL/6N)
|
thrombocytosis
|
J:223526
|
Babam1Gt(IST11207B9)Tigm/Babam1Gt(IST11207B9)Tigm
Mpltm1Mwm/Mpltm1Mwm
(involves: 129S2/SvPas * C57BL/6N)
|
thrombocytopenia
|
J:223526
|
Bach2m1Ccg/Bach2m1Ccg
(C57BL/6-Bach2m1Ccg)
|
myeloid hyperplasia
|
J:94077
|
Bach2m2Anu/Bach2m2Anu
(C57BL/6NCrlAnu-Bach2m2Anu)
|
increased immature B cell number
|
J:104190
|
Bach2tm1a(EUCOMM)Wtsi/Bach2tm1a(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased eosinophil cell number
|
J:211773
|
| increased immature B cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased transitional stage B cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased granulocyte number
|
J:211773
|
Bach2tm1Igar/Bach2tm1Igar
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:91110
|
| abnormal class switch recombination
|
J:91110
|
| abnormal somatic hypermutation frequency
|
J:91110
|
Badtm1Meg/Badtm1Meg
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:88139
|
| abnormal T cell differentiation
|
J:88139
|
| decreased pro-B cell number
|
J:88139
|
Bag1tm1a(EUCOMM)Hmgu/Bag1tm1a(EUCOMM)Hmgu
(C57BL/6N-Bag1tm1a(EUCOMM)Hmgu/Ics)
|
decreased mean corpuscular volume
|
J:165965
|
| increased hemoglobin content
|
J:165965
|
Bag3tm1.1Jhl/Bag3tm1.1Jhl
(B6.129S2-Bag3tm1.1Jhl)
|
decreased neutrophil cell number
|
J:144416
|
Bahd1tm2b(KOMP)Wtsi/Bahd1+
(C57BL/6N-Bahd1tm2b(KOMP)Wtsi/Ics)
|
increased neutrophil cell number
|
J:211773
|
Baiap2tm1b(KOMP)Wtsi/Baiap2+
(C57BL/6N-Baiap2tm1b(KOMP)Wtsi/Tcp)
|
thrombocytopenia
|
J:211773
|
Baiap2l2tm1b(EUCOMM)Hmgu/Baiap2l2tm1b(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1b(EUCOMM)Hmgu/Ics)
|
decreased hematocrit
|
J:211773
|
Bak1tm1Thsn/Bak1+
Bcl2l1Plt20/Bcl2l1+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal platelet morphology
|
J:149205
|
Bak1tm1Thsn/Bak1+
Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo Bak1tm1Thsn)
|
abnormal platelet morphology
|
J:149205
|
Bak1tm1Thsn/Bak1tm1Thsn
(B6.129-Bak1tm1Thsn)
|
thrombocytosis
|
J:149205
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:66872
|
| thrombocytopenia
|
J:66872
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased pro-B cell number
|
J:100463
|
| increased transitional stage B cell number
|
J:100463
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm2Sjk
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:100463
|
Bak1tm1Thsn/Bak1tm1Thsn
Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo Bak1tm1Thsn)
|
thrombocytosis
|
J:149205
|
Bap1tm1.1Geno/Bap1tm1.1Geno
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal erythrocyte morphology
|
J:187380
|
| abnormal erythropoiesis
|
J:187380
|
| abnormal granulocyte morphology
|
J:187380
|
| abnormal myelopoiesis
|
J:187380
|
| abnormal neutrophil morphology
|
J:187380
|
| anisopoikilocytosis
|
J:187380
|
| extramedullary hematopoiesis
|
J:187380
|
| giant platelets
|
J:187380
|
| increased neutrophil cell number
|
J:187380
|
| increased nucleated erythrocyte cell number
|
J:187380
|
| myeloid hyperplasia
|
J:187380
|
| thrombocytopenia
|
J:187380
|
Batf3tm1Kmm/Batf3tm1Kmm
(involves: 129S6/SvEvTac * BALB/cJ)
|
abnormal dendritic cell differentiation
|
J:141064
|
Batftm1.1Ejt/Batftm1.1Ejt
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:160935
|
| abnormal T-helper 2 cell differentiation
|
J:160935
|
Batftm1.1Kmm/Batftm1.1Kmm
(129S6/SvEvTac-Batftm1.1Kmm)
|
abnormal CD4-positive T cell differentiation
|
J:150643
|
Baz1atm1b(EUCOMM)Hmgu/Baz1atm1b(EUCOMM)Hmgu
(C57BL/6N-Baz1atm1b(EUCOMM)Hmgu/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Bbc3tm1Gpz/Bbc3tm1Gpz
Bnip3ltm1Ney/Bnip3ltm1Ney
(involves: 129P2/OlaHsd)
|
abnormal erythrocyte morphology
|
J:141545
|
Bbs5tm1b(EUCOMM)Wtsi/Bbs5tm1b(EUCOMM)Wtsi
(C57BL/6NTac-Bbs5tm1b(EUCOMM)Wtsi/H)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
BC049715tm1b(KOMP)Mbp/BC049715tm1b(KOMP)Mbp
(C57BL/6N-BC049715tm1b(KOMP)Mbp/Mhzh)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Bcar3em1(IMPC)Mbp/Bcar3em1(IMPC)Mbp
(C57BL/6N-Bcar3em1(IMPC)Mbp/MbpMmucd)
|
increased basophil cell number
|
J:211773
|
Bckdhaem1(IMPC)Tcp/Bckdha+
(C57BL/6NCrl-Bckdhaem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Bcl2tm1Dlo/Bcl2tm1Dlo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:73660
|
Bcl2tm1Dlo/Bcl2tm1Dlo
(B6.129P2-Bcl2tm1Dlo)
|
abnormal leukopoiesis
|
J:73316
|
Bcl2tm1Dlo/Bcl2tm1Dlo
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129-Bcl2tm1Dlo Bcl2l11tm1.1Ast)
|
abnormal leukopoiesis
|
J:73316
|
Bcl2tm1Lbox/Bcl2tm1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal B cell differentiation
|
J:114637
|
| decreased immature B cell number
|
J:114637
|
Bcl2tm1Sjk/Bcl2tm1Sjk
(involves: 129S2/SvPas * C57BL/6)
|
decreased double-positive T cell number
|
J:15224
|
| increased double-negative T cell number
|
J:15224
|
Bcl2tm2.1Lbox/Bcl2+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased immature B cell number
|
J:175730
|
Bcl2tm2.1Lbox/Bcl2tm2.1Lbox
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
increased immature B cell number
|
J:175730
|
Bcl2l1Plt16/Bcl2l1+
(involves: BALB/c * C57BL/6)
|
thrombocytopenia
|
J:149205
|
Bcl2l1Plt20/Bcl2l1+
(involves: BALB/c * C57BL/6)
|
thrombocytopenia
|
J:149205
|
Bcl2l1Plt20/Bcl2l1Plt16
(involves: BALB/c * C57BL/6)
|
thrombocytopenia
|
J:149205
|
Bcl2l1Plt20/Bcl2l1Plt20
(involves: BALB/c * C57BL/6)
|
extramedullary hematopoiesis
|
J:149205
|
| thrombocytopenia
|
J:149205
|
Bcl2l1tm1Dlo/Bcl2l1+
(B6.Cg-Bcl2l1tm1Dlo)
|
thrombocytopenia
|
J:149205
|
Bcl2l1tm1Dlo/Bcl2l1Plt20
(involves: BALB/c * C57BL/6)
|
thrombocytopenia
|
J:149205
|
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:137400
|
Bcl2l1tm1Ywh/Bcl2l1tm1Ywh
Tg(Lck-cre)548Jxm/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:99012
|
Bcl2l11em1(IMPC)H/Bcl2l11em1(IMPC)H
(C57BL/6NTac-Bcl2l11em1(IMPC)H/H)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Bcl2l11em1Flv/Bcl2l11+
Morrbid+/Morrbidem1Flv
(C57BL/6N-Bcl2l11em1Flv +/+ Morrbidem1Flv)
|
decreased eosinophil cell number
|
J:236609
|
| decreased neutrophil cell number
|
J:236609
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(involves: 129S1/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:58641
|
| increased double-negative T cell number
|
J:58641
|
| increased granulocyte number
|
J:58641
|
| increased immature B cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
| thrombocytopenia
|
J:58641
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
(B6.129S1-Bcl2l11tm1.1Ast)
|
abnormal leukopoiesis
|
J:73316
|
| increased immature B cell number
|
J:133084
|
| increased transitional stage B cell number
|
J:133084
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Biktm1Ast/Biktm1Ast
(B6.Cg-Bcl2l11tm1.1Ast Biktm1Ast)
|
abnormal B cell differentiation
|
J:103605
|
| abnormal T cell differentiation
|
J:103605
|
| decreased immature B cell number
|
J:103605
|
| decreased pro-B cell number
|
J:103605
|
| increased granulocyte number
|
J:103605
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Bnip3lGt(XT0573)Wtsi/Bnip3lGt(XT0573)Wtsi
(involves: 129S1/Sv * C57BL/6)
|
decreased erythrocyte cell number
|
J:137609
|
Bcl2l11tm1.1Ast/Bcl2l11tm1.1Ast
Faslpr/Faslpr
(B6.Cg-Bcl2l11tm1.1Ast Faslpr)
|
increased immature B cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
Bcl2l11tm1Ast/Bcl2l11tm1Ast
Dicer1tm1Bdh/Dicer1tm1Bdh
Aicdatm1(cre)Njen/Aicda+
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:181782
|
Bcl2l11tm1Sjk/Bcl2l11tm1Sjk
(involves: 129X1/SvJ)
|
increased transitional stage B cell number
|
J:100463
|
Bcl2l12tm1.1(KOMP)Vlcg/Bcl2l12tm1.1(KOMP)Vlcg
(C57BL/6N-Bcl2l12tm1.1(KOMP)Vlcg/Ucd)
|
increased hematocrit
|
J:211773
|
Bcl2l15tm1b(EUCOMM)Hmgu/Bcl2l15tm1b(EUCOMM)Hmgu
(C57BL/6N-Bcl2l15tm1b(EUCOMM)Hmgu/Ieg)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Bcl3tm1b(EUCOMM)Wtsi/Bcl3tm1b(EUCOMM)Wtsi
(C57BL/6N-Bcl3tm1b(EUCOMM)Wtsi/H)
|
thrombocytopenia
|
J:211773
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:39747
|
| abnormal class switch recombination
|
J:39747
|
Bcl3tm1Sbn/Bcl3tm1Sbn
(involves: 129S4/SvJae)
|
decreased transitional stage T1 B cell number
|
J:207111
|
| decreased transitional stage T2 B cell number
|
J:207111
|
Bcl6tm1.1Dent/Bcl6tm1.1Dent
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T follicular helper cell differentiation
|
J:202372
|
Bcl6tm1.1Jwan/Bcl6tm1.1Jwan
(involves: 129S6/SvEvTac)
|
abnormal somatic hypermutation frequency
|
J:190534
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * C57BL/6JJcl)
|
abnormal somatic hypermutation frequency
|
J:190943
|
Bcl6tm1.1Mtto/Bcl6tm1.1Mtto
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * DBA/2)
|
abnormal somatic hypermutation frequency
|
J:190943
|
Bcl6tm1Rdf/Bcl6tm1Rdf
(involves: 129S1/Sv)
|
increased eosinophil cell number
|
J:40769
|
Bcl6tm2Rdf/Bcl6tm2Rdf
(involves: 129S1/Sv)
|
increased eosinophil cell number
|
J:40769
|
Bcl6btm2Dent/Bcl6btm2Dent
(involves: 129/Sv * C57BL/6)
|
decreased neutrophil cell number
|
J:123621
|
| increased erythrocyte cell number
|
J:123621
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:67297
|
| decreased double-positive T cell number
|
J:67297
|
| increased double-negative T cell number
|
J:67297
|
Bcl10tm1Swm/Bcl10tm1Swm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:85147
|
Bcl11atm1.1Pwt/Bcl11atm1.1Pwt
(Not Specified)
|
abnormal erythropoiesis
|
J:151995
|
| abnormal hemoglobin content
|
J:151995
|
Bcl11atm1Mbu/Bcl11atm1Mbu
Eportm1.1(EGFP/icre)Uk/Epor+
Tg(HBB)8.1Gvs/0
(involves: 129 * BALB/cJ * FVB/N)
|
abnormal erythropoiesis
|
J:196405
|
| decreased erythrocyte cell number
|
J:196405
|
| decreased hematocrit
|
J:196405
|
| decreased hemoglobin content
|
J:196405
|
Bcl11atm1Mbu/Bcl11atm1Mbu
Klf1tm1Nimr/Klf1+
Eportm1.1(EGFP/icre)Uk/Epor+
Tg(HBB)8.1Gvs/0
(involves: 129P2/OlaHsd * BALB/cJ * FVB/N)
|
abnormal erythropoiesis
|
J:196405
|
| polychromatophilia
|
J:196405
|
Bcl11atm1Mbu/Bcl11atm1Mbu
Klf1tm1Nimr/Klf1+
Tg(HBB)8.1Gvs/0
(involves: 129P2/OlaHsd * FVB)
|
abnormal erythropoiesis
|
J:196405
|
| decreased erythrocyte cell number
|
J:196405
|
| decreased hematocrit
|
J:196405
|
| decreased hemoglobin content
|
J:196405
|
| decreased mean corpuscular hemoglobin
|
J:196405
|
| decreased mean corpuscular volume
|
J:196405
|
| polychromatophilia
|
J:196405
|
Bcl11atm1Ngc/Bcl11a+
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
| decreased DN2 thymocyte number
|
J:194616
|
Bcl11atm1Ngc/Bcl11atm1Ngc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal dendritic cell differentiation
|
J:207383
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:83646
|
| increased double-negative T cell number
|
J:83646
|
Bcl11atm1Pwt/Bcl11atm1Pwt
Dnmt1tm2Jae/Dnmt1+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:196140
|
Bcl11atm1Pwt/Bcl11atm1Pwt
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal dendritic cell differentiation
|
J:207383
|
Bcl11atm1Pwt/Bcl11atm1Pwt
Kdm1atm1.1Sho/Kdm1a+
Eportm1.1(EGFP/icre)Uk/Epor+
(involves: 129 * BALB/cJ)
|
decreased erythrocyte cell number
|
J:196140
|
| decreased hemoglobin content
|
J:196140
|
Bcl11atm1Pwt/Bcl11atm1Pwt
Kdm1atm1.1Sho/Kdm1atm1.1Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:196140
|
| decreased hemoglobin content
|
J:196140
|
Bcl11atm2.1Peli/Bcl11atm2.1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal T cell differentiation
|
J:194616
|
| decreased DN2 thymocyte number
|
J:194616
|
| decreased immature B cell number
|
J:194616
|
| decreased pro-B cell number
|
J:194616
|
Bcl11btm1Avram/Bcl11btm1Avram
Tcratm1Mom/Tcratm1Mom
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased double-negative T cell number
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
Bcl11btm1Avram/Bcl11btm1Avram
Tg(Cd4-cre)1Cwi/?
Tg(LCKprBCL2)36Sjk/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:128515
|
| decreased double-positive T cell number
|
J:128515
|
Bcl11btm1Jpk/Bcl11btm1Jpk
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:83651
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:83651
|
| decreased double-positive T cell number
|
J:83651
|
| increased double-negative T cell number
|
J:83651
|
Bcl11btm1Peli/Bcl11btm1Peli
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6J)
|
abnormal NK cell differentiation
|
J:161373
|
Bcl11btm2.1Jpk/Bcl11b+
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:210122
|
| increased double-negative T cell number
|
J:210122
|
Bcmd2CAST/EiJ/Bcmd2CAST/EiJ
(AW.CAST-Bcmd2)
|
increased mast cell number
|
J:75340
|
Bcortm1.1Vjba/Y
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * CBA/Ca)
|
increased neutrophil cell number
|
J:231455
|
Bcorl1em1(IMPC)Tcp/Y
(C57BL/6N-Bcorl1em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Bcorl1em1(IMPC)Tcp/Bcorl1em1(IMPC)Tcp
(C57BL/6N-Bcorl1em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Bcrtm1(BCR/ABL)Tsr/Bcr+
Runx1tm3Dow/Runx1+
Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:203111
|
| thrombocytopenia
|
J:203111
|
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S2/SvPas)
|
abnormal definitive hematopoiesis
|
J:23804
|
| increased neutrophil cell number
|
J:23804
|
Bcs1ltm1.1Levp/Bcs1ltm1.1Levp
(B6.129-Bcs1ltm1.1Levp)
|
increased neutrophil cell number
|
J:273501
|
Bdh2tm1a(EUCOMM)Wtsi/Bdh2tm1a(EUCOMM)Wtsi
(C57BL/6NTac-Bdh2tm1a(EUCOMM)Wtsi/WtsiH)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Bdkrb1em1(IMPC)H/Bdkrb1em1(IMPC)H
(B6N;B6NTac-Bdkrb1em1(IMPC)H/H)
|
decreased neutrophil cell number
|
J:211773
|
Bdp1em1(IMPC)Tcp/Bdp1+
(C57BL/6NCrl-Bdp1em1(IMPC)Tcp/Tcp)
|
decreased neutrophil cell number
|
J:211773
|
Bean1em1(IMPC)H/Bean1em1(IMPC)H
(C57BL/6N-Bean1em1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
Becn1tm1Ebr/Becn1tm1Ebr
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
increased neutrophil cell number
|
J:235399
|
Bex2tm1b(EUCOMM)Hmgu/Bex2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bex2tm1b(EUCOMM)Hmgu/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
Bex6tm1.1(KOMP)Vlcg/Bex6tm1.1(KOMP)Vlcg
(B6N(Cg)-Bex6tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Bhlhe40tm1b(KOMP)Wtsi/Bhlhe40tm1b(KOMP)Wtsi
(C57BL/6N-Bhlhe40tm1b(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Bhlhe40tm1Tan/Bhlhe40tm1Tan
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal CD4-positive T cell differentiation
|
J:72651
|
| decreased double-positive T cell number
|
J:72651
|
| increased double-negative T cell number
|
J:72651
|
Bhlhe41tm1.1Cdon/Bhlhe41tm1.1Cdon
(B6.129S6-Bhlhe41tm1.1Cdon)
|
abnormal T-helper 2 cell differentiation
|
J:157740
|
| decreased eosinophil cell number
|
J:157740
|
| decreased neutrophil cell number
|
J:157740
|
Bhmttm1b(EUCOMM)Hmgu/Bhmttm1b(EUCOMM)Hmgu
(C57BL/6N-Bhmttm1b(EUCOMM)Hmgu/Bay)
|
decreased hemoglobin content
|
J:211773
|
Bicraem1(IMPC)J/Bicra+
(C57BL/6NJ-Bicraem1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Bicralem1(IMPC)J/Bicralem1(IMPC)J
(C57BL/6NJ-Bicralem1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Bin2em1(IMPC)Wtsi/Bin2em1(IMPC)Wtsi
(C57BL/6N-Bin2em1(IMPC)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Bin2tm1.1Beni/Bin2tm1.1Beni
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal platelet calcium level
|
J:302510
|
Bin3tm1Gcp/Bin3tm1Gcp
(involves: 129 * C57BL/6)
|
extramedullary hematopoiesis
|
J:133313
|
Birc3tm1Jda/Birc3tm1Jda
(B6.Cg-Birc3tm1Jda)
|
decreased immature B cell number
|
J:166899
|
Birc5tm1Mak/Birc5tm1Mak
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd)
|
decreased double-negative T cell number
|
J:90892
|
Birc5tm1Wnt/Birc5tm1Emc
Tg(Cd4-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:87435
|
Birc5tm1Wnt/Birc5tm1Emc
Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:87435
|
| increased double-negative T cell number
|
J:87435
|
Birc6tm1Sjen/Birc6tm1Sjen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:94169
|
| abnormal embryonic hematopoiesis
|
J:94169
|
Birc7em1(IMPC)H/Birc7em1(IMPC)H
(C57BL/6N-Birc7em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Blktm1Tara/Blktm1Tara
Fyntm1Sor/Fyntm1Sor
Lyntm1Ard/Lyntm1Ard
(either: B6.129-Lyntm1Ard Fyntm1Sor Blktm1Tara or (involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6))
|
abnormal B cell differentiation
|
J:115080
|
| abnormal pro-B cell differentiation
|
J:115080
|
| arrested B cell differentiation
|
J:115080
|
| decreased immature B cell number
|
J:115080
|
Blmtm1Ches/Blmtm1Ches
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal erythrocyte morphology
|
J:50843
|
| abnormal erythropoiesis
|
J:50843
|
| macrocytosis
|
J:50843
|
Blmtm3Ches/Blmtm3Ches
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal erythrocyte morphology
|
J:86827
|
| anisopoikilocytosis
|
J:86827
|
Blmtm4Ches/Blmtm4Ches
Trp53bp1tm1Jc/Trp53bp1tm1Jc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:194603
|
Blnkem1(IMPC)H/Blnkem1(IMPC)H
(C57BL/6N-Blnkem1(IMPC)H/H)
|
decreased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Blnkm1Btlr/Blnkm1Btlr
(C57BL/6J-Blnkm1Btlr)
|
arrested B cell differentiation
|
J:159439
|
Blnkm1Btlr/Blnkm1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
Blnktm1Achn/Blnktm1Achn
(involves: 129X1/SvJ)
|
abnormal B cell differentiation
|
J:58805
|
| arrested B cell differentiation
|
J:58805
|
| increased pro-B cell number
|
J:58805
|
Blnktm1Dkit/Blnktm1Dkit
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:84040
|
| abnormal immature B cell morphology
|
J:94297
|
| abnormal plasma cell differentiation
|
J:143854
|
| arrested B cell differentiation
|
J:143854
|
| decreased immature B cell number
|
J:84040
|
| decreased transitional stage B cell number
|
J:143854
|
Blnktm1Dkit/Blnktm1Dkit
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
absent immature B cells
|
J:84040
|
| arrested B cell differentiation
|
J:84040
|
Blnktm1Dkit/Blnktm1Dkit
Igh-Jtm1(3H9-VDJ)Mwg/Igh-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
Blnktm1Dkit/Blnktm1Dkit
Igh-Jtm1(3H9-VDJ)Mwg/Igh-J+
Igk-Jtm1Mwg/Igk-J+
(involves: C57BL/6 * NZB)
|
abnormal immature B cell morphology
|
J:94297
|
Blnktm1Dkit/Blnktm1Dkit
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6 * NZB)
|
abnormal plasma cell differentiation
|
J:143854
|
| arrested B cell differentiation
|
J:143854
|
Blnktm1Kplm/Blnktm1Kplm
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:61130,
J:131161
|
| decreased immature B cell number
|
J:61130
|
| increased pro-B cell number
|
J:61130,
J:131161
|
Blnktm1Kplm/Blnktm1Kplm
Ightm4Cgn/Igh+
Igktm1Rsky/Igk+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:120460
|
| increased transitional stage B cell number
|
J:120460
|
Blnktm1Pjln/Blnktm1Pjln
(involves: BALB/c)
|
arrested B cell differentiation
|
J:58740
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:94768
|
| decreased immature B cell number
|
J:94768
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Gsv/Y
Tg(CD19-BTK*K430R)XK24Rwhe/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB)
|
abnormal B cell differentiation
|
J:94768
|
Blnktm1Pjln/Blnktm1Pjln
Btktm1Wk/Btktm1Wk
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:70406
|
Bloc1s2tm1.1(KOMP)Mbp/Bloc1s2+
(B6N(Cg)-Bloc1s2tm1.1(KOMP)Mbp/J)
|
thrombocytopenia
|
J:211773
|
Bloc1s4cno/Bloc1s4cno
(C3H/HeJ-Bloc1s4cno)
|
decreased platelet ATP level
|
J:61187
|
| decreased platelet calcium level
|
J:61187
|
| decreased platelet dense granule number
|
J:61187
|
| decreased platelet serotonin level
|
J:61187
|
Bloc1s5mu/Bloc1s5mu
(involves: STOCK t)
|
abnormal platelet dense granule morphology
|
J:29151
|
| decreased platelet ATP level
|
J:29151
|
| decreased platelet serotonin level
|
J:29151
|
Bloc1s5mu/Bloc1s5mu
(CHMU/Le)
|
abnormal platelet dense granule morphology
|
J:29151
|
| decreased platelet dense granule number
|
J:29151
|
| decreased platelet serotonin level
|
J:29151
|
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J)
|
decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet dense granule number
|
J:7327
|
| decreased platelet serotonin level
|
J:7327
|
Blvratm1.1Rsto/Blvratm1.1Rsto
(involves: C57BL/6)
|
decreased mean corpuscular hemoglobin
|
J:331733
|
| decreased mean corpuscular volume
|
J:331733
|
| high mean erythrocyte cell number
|
J:331733
|
| increased mean corpuscular hemoglobin concentration
|
J:331733
|
Bmal1tm1Bra/Bmal1tm1Bra
(B6.129-Bmal1tm1Bra)
|
decreased basophil cell number
|
J:191844
|
| increased eosinophil cell number
|
J:191844
|
| increased neutrophil cell number
|
J:110697,
J:191844
|
| thrombocytosis
|
J:191844
|
Bmal1tm1Bra/Bmal1tm1Bra
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:118522
|
| decreased transitional stage B cell number
|
J:118522
|
| increased neutrophil cell number
|
J:135933
|
| thrombocytosis
|
J:135933
|
Bmftm1.1Ast/Bmftm1.1Ast
(B6.Cg-Bmftm1.1Anst)
|
increased immature B cell number
|
J:133084
|
| increased transitional stage B cell number
|
J:133084
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
abnormal definitive hematopoiesis
|
J:17712
|
| abnormal double-negative T cell morphology
|
J:17712
|
| decreased immature B cell number
|
J:17712
|
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:134271
|
Bmi1tm1Brn/Bmi1tm1Brn
E2f6tm1Lees/E2f6tm1Lees
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:134271
|
Bmi1tm1Sgon/Bmi1tm1Sgon
Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * CBA/Ca)
|
abnormal erythropoiesis
|
J:221849
|
| abnormal hemopoiesis
|
J:221849
|
| decreased common myeloid progenitor cell number
|
J:221849
|
Bmp4tm1Blh/Bmp4tm1Blh
(B6.129S2-Bmp4tm1Blh)
|
decreased erythrocyte cell number
|
J:28717
|
Bmp6em1(IMPC)Ccpcz/Bmp6em1(IMPC)Ccpcz
(C57BL/6N-Bmp6em1(IMPC)Ccpcz/Ccpcz)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Bmp7tm1a(EUCOMM)Hmgu/Bmp7+
(C57BL/6N-Bmp7tm1a(EUCOMM)Hmgu/H)
|
decreased erythrocyte cell number
|
J:165965
|
| increased mean corpuscular volume
|
J:165965
|
Bmrbc1C57BL/6Ola/?
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc2C57BL/6Ola/Bmrbc2CBA/HOla
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc2CBA/HOla/Bmrbc2CBA/HOla
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc3C57BL/6Ola/Bmrbc3C57BL/6Ola
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc3C57BL/6Ola/Bmrbc3CBA/HOla
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc4C57BL/6Ola/Bmrbc4C57BL/6Ola
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc4C57BL/6Ola/Bmrbc4CBA/HOla
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bmrbc4CBA/HOla/Bmrbc4CBA/HOla
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Bnc1em1(IMPC)H/Bnc1em1(IMPC)H
(C57BL/6NTac-Bnc1em1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Bnip1tm2b(KOMP)Wtsi/Bnip1+
(C57BL/6N-Bnip1tm2b(KOMP)Wtsi/Nju)
|
increased eosinophil cell number
|
J:211773
|
Bnip2tm1b(EUCOMM)Wtsi/Bnip2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bnip2tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Bnip3lGt(XT0573)Wtsi/Bnip3lGt(XT0573)Wtsi
(B6.Cg-Bnip3lGt(XT0573)Wtsi)
|
abnormal erythrocyte morphology
|
J:137609
|
| decreased erythrocyte cell number
|
J:137609
|
| decreased mean corpuscular volume
|
J:137609
|
| polychromatophilia
|
J:137609
|
Bnip3ltm1.1Gwd/Bnip3ltm1.1Gwd
(involves: 129 * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:141583
|
| abnormal erythrocyte morphology
|
J:141583
|
| abnormal thrombopoiesis
|
J:141583
|
| anisocytosis
|
J:141583
|
| increased mean corpuscular volume
|
J:141583
|
| poikilocytosis
|
J:141583
|
| polychromatophilia
|
J:141583
|
Bnip3ltm1Ney/Bnip3ltm1Ney
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:141545
|
| abnormal erythrocyte morphology
|
J:141545
|
| decreased erythrocyte cell number
|
J:141545
|
| decreased hematocrit
|
J:141545
|
| poikilocytosis
|
J:141545
|
| polychromatophilia
|
J:141545
|
| spherocytosis
|
J:141545
|
Boctm1b(KOMP)Wtsi/Boctm1b(KOMP)Wtsi
(C57BL/6N-Boctm1b(KOMP)Wtsi/H)
|
increased basophil cell number
|
J:211773
|
Bod1tm1b(KOMP)Wtsi/Bod1+
(C57BL/6N-Bod1tm1b(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Bod1lem1Bltn/Bod1lem1Bltn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal class switch recombination
|
J:337726
|
Boktm1b(EUCOMM)Hmgu/Boktm1b(EUCOMM)Hmgu
(C57BL/6N-Boktm1b(EUCOMM)Hmgu/Tcp)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Bola1tm1.1(KOMP)Vlcg/Bola1tm1.1(KOMP)Vlcg
(B6N(Cg)-Bola1tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Bola2tm1(KOMP)Wtsi/Bola2tm1(KOMP)Wtsi
(C57BL/6N-Bola2tm1(KOMP)Wtsi/Nju)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Bpgmm1Pgrs/Bpgmm1Pgrs
(involves: C57BL/6 * C57BL/10J)
|
abnormal erythropoiesis
|
J:301620
|
| abnormal stress erythropoiesis
|
J:301620
|
| increased hematocrit
|
J:301620
|
| increased hemoglobin content
|
J:301620
|
| increased mean corpuscular hemoglobin
|
J:301620
|
| macrocytosis
|
J:301620
|
| polycythemia
|
J:301620
|
Braftm1Cpri/Braf+
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:104375
|
| extramedullary hematopoiesis
|
J:104375
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Shld1em1Nus/Shld1em1Nus
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
Brca1tm2.1Cxd/Brca1tm2.1Cxd
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:307190
|
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:63282
|
| increased double-negative T cell number
|
J:63282
|
Brca1tm2Mak/Brca1tm2Mak
Tg(Lck-cre)548Jxm/?
Tg(TcrLCMV)327Sdz/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:63282
|
| increased double-negative T cell number
|
J:63282
|
Brca2tm1Kamc/Brca2tm1Kamc
(involves: 129P2/OlaHsd * BALB/c)
|
decreased common myeloid progenitor cell number
|
J:144998
|
Brcc3em1(IMPC)Wtsi/Brcc3em1(IMPC)Wtsi
(C57BL/6N-Brcc3em1(IMPC)Wtsi/WtsiCnrm)
|
thrombocytosis
|
J:211773
|
Brd1tm1Hko/Brd1tm1Hko
(B6.129-Brd1tm1Hko)
|
abnormal embryonic erythropoiesis
|
J:177092
|
| abnormal embryonic hematopoiesis
|
J:177092
|
| abnormal erythropoiesis
|
J:177092
|
Brd2em1(IMPC)Wtsi/Brd2+
(C57BL/6N-Brd2em1(IMPC)Wtsi/WtsiIeg)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Brd9em1(IMPC)Tcp/Brd9+
(C57BL/6NCrl-Brd9em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Brip1em1(IMPC)J/Brip1em1(IMPC)J
(C57BL/6NJ-Brip1em1(IMPC)J/Mmjax)
|
increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Brix1tm1b(KOMP)Mbp/Brix1+
(C57BL/6N-Brix1tm1b(KOMP)Mbp/Mhzh)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Bsgtm1.1Znc/Bsgtm1.1Znc
Tg(Lck-cre)19Hhan/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
decreased double-positive T cell number
|
J:207886
|
Bsndtm1Suc/Bsndtm1Suc
(involves: 129S4/SvJae * C57BL/6)
|
increased hematocrit
|
J:175265
|
Bst1tm1Thir/Bst1tm1Thir
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:111424
|
Btbd2em1(IMPC)Mbp/Btbd2em1(IMPC)Mbp
(C57BL/6N-Btbd2em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Btcem1(IMPC)Mbp/Btcem1(IMPC)Mbp
(C57BL/6N-Btcem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Btf3em1(IMPC)Tcp/Btf3+
(C57BL/6NCrl-Btf3em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Btg1em1(IMPC)Mbp/Btg1em1(IMPC)Mbp
(C57BL/6NCrl-Btg1em1(IMPC)Mbp/Mmucd)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Btg2tm1b(KOMP)Mbp/Btg2tm1b(KOMP)Mbp
(B6N(Cg)-Btg2tm1b(KOMP)Mbp/2J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Btkm2Anu/Btkm2Anu
(C57BL/6NCrlAnu-Btkm2Anu)
|
increased immature B cell number
|
J:104190
|
Btktm1Gsv/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:35769
|
| decreased immature B cell number
|
J:35769
|
Btktm1Wk/Btktm1Wk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:28968
|
| increased pro-B cell number
|
J:28968
|
Btktm1Wk/Btktm1Wk
Tectm1Welm/Tectm1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:66080
|
Btkxid/Btkxid
(CBA/CaHN-Btkxid/J)
|
decreased neutrophil cell number
|
J:92639
|
| impaired myelopoiesis
|
J:92639
|
Btkxid/Btkxid
(CBA/HN-Btkxid)
|
abnormal lymphopoiesis
|
J:7981
|
Btkxid/Btkxid
(B6.CBA-Btkxid)
|
decreased transitional stage B cell number
|
J:145687
|
Btrctm1b(KOMP)Wtsi/Btrctm1b(KOMP)Wtsi
(C57BL/6N-Btrctm1b(KOMP)Wtsi/H)
|
increased mean corpuscular volume
|
J:211773
|
Bub1bGt(neo-btk)1Dai/Bub1b+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:88223
|
| absent common myeloid progenitor cells
|
J:88223
|
| decreased erythrocyte cell number
|
J:88223
|
C1galt1ptl1/C1galt1ptl1
(C57BL/6-C1galt1ptl1)
|
abnormal thrombopoiesis
|
J:115272
|
| increased mean platelet volume
|
J:115272
|
| thrombocytopenia
|
J:115272
|
C1galt1ptl1/C1galt1ptl1
Rag1tm1Bal/Rag1tm1Bal
(involves: 129S4/SvJae * C57BL/6)
|
increased mean platelet volume
|
J:115272
|
| thrombocytopenia
|
J:115272
|
C1galt1tm1.1Staka/C1galt1tm1.2Staka
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA * DBA/2)
|
abnormal platelet morphology
|
J:202276
|
| giant platelets
|
J:202276
|
| thrombocytopenia
|
J:202276
|
C1ql3em1(IMPC)H/C1ql3em1(IMPC)H
(C57BL/6NTac-C1ql3em1(IMPC)H/H)
|
decreased eosinophil cell number
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
C1ql4tm1Lex/C1ql4tm1Lex
(B6.129S5-C1ql4tm1Lex)
|
increased hematocrit
|
J:344722
|
| increased hemoglobin content
|
J:344722
|
C1qtnf4em1Smoc/C1qtnf4em1Smoc
(C57BL/6J-C1qtnf4em1Smoc/Smoc)
|
abnormal macrophage differentiation
|
J:302282
|
C2cd3em1(IMPC)Tcp/C2cd3+
(C57BL/6N-C2cd3em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
C2cd4aem1(IMPC)H/C2cd4aem1(IMPC)H
(C57BL/6NTac-C2cd4aem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
C2cd4bem1(IMPC)Wtsi/C2cd4bem1(IMPC)Wtsi
(C57BL/6N-C2cd4bem1(IMPC)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
decreased mast cell number
|
J:44240
|
| decreased neutrophil cell number
|
J:44240
|
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr)
|
abnormal neutrophil morphology
|
J:113463
|
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
abnormal T-helper 2 cell differentiation
|
J:80071
|
| decreased eosinophil cell number
|
J:80071
|
| decreased neutrophil cell number
|
J:80071
|
C4btm1Crr/C4btm1Crr
(involves: 129S4/SvJae * C57BL/6J)
|
increased neutrophil cell number
|
J:111811
|
C5ar2em1(IMPC)H/C5ar2em1(IMPC)H
(C57BL/6NTac-C5ar2em1(IMPC)H/H)
|
decreased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
C8btm1b(EUCOMM)Hmgu/C8btm1b(EUCOMM)Hmgu
(C57BL/6N-C8btm1b(EUCOMM)Hmgu/H)
|
decreased red blood cell distribution width
|
J:211773
|
C9orf72em1Eggn/C9orf72em1Eggn
(involves: C57BL/6)
|
decreased hematocrit
|
J:240357
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
decreased erythrocyte cell number
|
J:240357
|
| decreased hematocrit
|
J:240357
|
| decreased mean corpuscular volume
|
J:240357
|
| increased neutrophil cell number
|
J:240357
|
| thrombocytopenia
|
J:240357
|
C9orf72tm1Eggn/C9orf72tm1Eggn
(involves: C57BL/6 * C57BL/6N)
|
decreased erythrocyte cell number
|
J:240357
|
| decreased hematocrit
|
J:240357
|
| decreased mean corpuscular volume
|
J:240357
|
| increased neutrophil cell number
|
J:240357
|
| thrombocytopenia
|
J:240357
|
C9orf72tm1Lagi/C9orf72tm1Lagi
(involves: C57BL/6 * C57BL/6N)
|
decreased hematocrit
|
J:232242
|
| decreased hemoglobin content
|
J:232242
|
| increased neutrophil cell number
|
J:232242
|
Cab39ltm1b(EUCOMM)Wtsi/Cab39ltm1b(EUCOMM)Wtsi
(C57BL/6N-Cab39ltm1b(EUCOMM)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
Cabp1tm1b(EUCOMM)Wtsi/Cabp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Cabp1tm1b(EUCOMM)Wtsi/H)
|
increased neutrophil cell number
|
J:211773
|
Cacnb4lh/Cacnb4lh
(B6EiC3Sn a/A-Cacnb4lh/J)
|
decreased double-positive T cell number
|
J:115345
|
Cacybptm1b(EUCOMM)Wtsi/Cacybp+
(C57BL/6N-Cacybptm1b(EUCOMM)Wtsi/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Cadm1Gt(Ayu21-W34)Imeg/Cadm1Gt(Ayu21-W34)Imeg
(involves: C57BL/6 * CBA/JNCrlj)
|
abnormal T cell differentiation
|
J:178612
|
| abnormal T cell receptor V(D)J recombination
|
J:178612
|
| increased double-positive T cell number
|
J:178612
|
Cadps2em1(IMPC)Rbrc/Cadps2em1(IMPC)Rbrc
(C57BL/6NJcl-Cadps2em1(IMPC)Rbrc/Rbrc)
|
abnormal mean corpuscular hemoglobin
|
J:211773
|
Camkmttm1b(EUCOMM)Wtsi/Camkmttm1b(EUCOMM)Wtsi
(C57BL/6N-Camkmttm1b(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Camltm1Rjb/Camltm2Rjb
Tg(Lck-cre)1Cwi/0
Tg(TcraTcrb)1100Mjb/0
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:100536
|
| abnormal positive T cell selection
|
J:100536
|
Camptm1Rlg/Camptm1Rlg
(involves: 129X1/SvJ * C57BL/6)
|
increased neutrophil cell number
|
J:199719
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3+
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:211773
|
Camsap3tm1a(EUCOMM)Wtsi/Camsap3tm1a(EUCOMM)Wtsi
(C57BL/6N-Camsap3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased neutrophil cell number
|
J:211773
|
Cand2tm1a(EUCOMM)Wtsi/Cand2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cand2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Cap2tm1b(EUCOMM)Wtsi/Cap2+
(C57BL/6N-Cap2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Capns1tm1Pag/Capns1tm1Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased nucleated erythrocyte cell number
|
J:74966
|
Capza1em1(IMPC)Tcp/Capza1em1(IMPC)Tcp
(C57BL/6NCrl-Capza1em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Capza2tm1b(KOMP)Wtsi/Capza2+
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Car6em1(IMPC)Ccpcz/Car6em1(IMPC)Ccpcz
(C57BL/6NCrl-Car6em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Card11em1Welu/Card11+
(involves: C57BL/6)
|
decreased transitional stage T1 B cell number
|
J:292926
|
| decreased transitional stage T3 B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
Card11em1Welu/Card11em1Welu
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:292926
|
| abnormal plasma cell differentiation
|
J:292926
|
| decreased transitional stage T1 B cell number
|
J:292926
|
| decreased transitional stage T3 B cell number
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
Card11em2Welu/Card11em2Welu
(involves: C57BL/6)
|
abnormal plasma cell differentiation
|
J:292926
|
| increased transitional stage T2 B cell number
|
J:292926
|
Card11m1Btlr/Card11m1Btlr
(C57BL/6J-Card11m1Btlr)
|
abnormal double-negative T cell morphology
|
J:149767,
J:139069
|
Card11M7Btlr/Card11M7Btlr
(C57BL/6J-Card11M7Btlr)
|
abnormal T cell differentiation
|
J:274762
|
Card11m8Btlr/Card11m8Btlr
(C57BL/6J-Card11m8Btlr)
|
abnormal B cell differentiation
|
J:274940
|
Card11tm1Litt/Card11tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal double-negative T cell morphology
|
J:89322
|
| abnormal T cell differentiation
|
J:89322
|
Card11tm1Pngr/Card11tm1Pngr
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:84036
|
Card11tm1Vmd/Card11tm1Vmd
(involves: 129S6/SvEvTac * C57BL/6N)
|
absent immature B cells
|
J:95800
|
Card11tm1Xav/Card11tm1Xav
(involves: 129 * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:132226
|
Card11unm/Card11unm
(C57BL/6JSfdAnu-Card11unm/Anu)
|
abnormal B cell differentiation
|
J:84042
|
Carm1tm1Mtb/Carm1tm1Mtb
(involves: 129S6/SvEvTac)
|
arrested T cell differentiation
|
J:159958
|
Carm1tm2.1Mtb/Carm1tm2.1Mtb
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * Black Swiss)
|
arrested T cell differentiation
|
J:159958
|
Casp3tm1Flv/Casp3tm1Flv
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
increased neutrophil cell number
|
J:100854
|
Casp8em1Hbz/Casp8em1Hbz
Mlklem1Hbz/Mlklem1Hbz
(involves: C57BL/6)
|
increased granulocyte number
|
J:342732
|
Casp8em1Hbz/Casp8em1Hbz
Ripk3tm1Xidw/Ripk3tm1Xidw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased granulocyte number
|
J:342732
|
Casp8tm1Hed/Casp8tm1Hed
Tg(KRT14-cre)1Efu/0
(Not Specified)
|
increased mast cell number
|
J:167299
|
Casp8tm1Syon/Casp8tm1Syon
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:103506
|
Casp8tm1Wll/Casp8tm1.1Yuan
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
abnormal macrophage differentiation
|
J:92722
|
Casp8tm1Yuan/Casp8tm1Yuan
(involves: 129S1/Sv * 129X1/SvJ * MF1)
|
increased erythrocyte cell number
|
J:49459
|
Casrtm1Ces/Casrtm1Ces
(involves: 129X1/SvJ * Black Swiss)
|
increased hematocrit
|
J:29900
|
Catiptm1b(KOMP)Wtsi/Catiptm1b(KOMP)Wtsi
(C57BL/6N-Catiptm1b(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Cav1em2(IMPC)Ics/Cav1em2(IMPC)Ics
(C57BL/6N-Cav1em2(IMPC)Ics/Ics)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Cavin3tm1.1(KOMP)Vlcg/Cavin3tm1.1(KOMP)Vlcg
(C57BL/6N-Cavin3tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Cbfa2t3tm1.1Swh/Cbfa2t3tm1.1Swh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:140967
|
| abnormal myelopoiesis
|
J:140967
|
| abnormal stress erythropoiesis
|
J:140967
|
| decreased immature B cell number
|
J:140967
|
| extramedullary hematopoiesis
|
J:140967
|
| increased number of Howell-Jolly bodies
|
J:140967
|
Cbfbtm1Itan/Cbfbtm1Itan
Rr94tm3.1Litt/Rr94tm3.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal double-positive T cell morphology
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
| increased double-positive T cell number
|
J:158962
|
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:125953
|
| abnormal T-helper 1 cell differentiation
|
J:125953
|
| increased double-positive T cell number
|
J:158962
|
Cbfbtm1Itan/Cbfbtm1Itan
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd)
|
abnormal CD4-positive T cell differentiation
|
J:125953
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
| abnormal double-positive T cell morphology
|
J:125953
|
| abnormal T-helper 1 cell differentiation
|
J:125953
|
Cbfbtm1Itan/Cbfbtm1Itan
Zbtb7btm2Litt/Zbtb7b+
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
Cbfbtm1Itan/Cbfbtm1Itan
Zbtb7btm2Litt/Zbtb7btm1.2Litt
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
Cbfbtm1Lhc/Cbfbtm1Lhc
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:105040
|
| thrombocytopenia
|
J:105040
|
Cbfbtm1Ppl/Cbfb+
(either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
extramedullary hematopoiesis
|
J:36594
|
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)1Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1) or (involves: 129S4/SvJae * C57BL/6 * CD-1))
|
abnormal common myeloid progenitor cell morphology
|
J:80670
|
| abnormal definitive hematopoiesis
|
J:80670
|
| abnormal erythropoiesis
|
J:80670
|
| abnormal myelopoiesis
|
J:80670
|
Cbfbtm1Spe/Cbfbtm1Spe
Tg(Tek-GFP/Cbfb)2Spe/0
(either: (involves: 129S4/SvJae * BALB/c * CD-1 * Swiss Webster) or (involves: 129S4/SvJae * C57BL/6 * CD-1 * Swiss Webster))
|
abnormal common myeloid progenitor cell morphology
|
J:80670
|
| abnormal definitive hematopoiesis
|
J:80670
|
| abnormal erythropoiesis
|
J:80670
|
| abnormal myelopoiesis
|
J:80670
|
Cbfbtm1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
| decreased double-positive T cell number
|
J:124224
|
| extramedullary hematopoiesis
|
J:124224
|
| thrombocytopenia
|
J:124224
|
Cbfbtm1Tno/Cbfbtm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:40963
|
| abnormal embryonic hematopoiesis
|
J:40963
|
Cbfbtm1Tok/Cbfbtm1Tok
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:36250
|
Cbfbtm1Tok/Cbfbtm1Tok
Tg(Gata1-Cbfb)1Tok/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:80668
|
Cbfbtm2.1Spe/Cbfbtm2.1Spe
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:124224
|
| decreased double-positive T cell number
|
J:124224
|
Cbfbtm5Ppl/Cbfb+
(Not Specified)
|
abnormal mononuclear cell differentiation
|
J:193140
|
| myeloid hyperplasia
|
J:193140
|
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
Cbltm1.1Hua/Cbltm1.1Hua
Lcp2tm1Gak/Lcp2tm1Gak
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:91369
|
Cbltm1Ddlb/Cbltm1Ddlb
(involves: 129S1/Sv * C57BL/6J)
|
extramedullary hematopoiesis
|
J:76895
|
| thrombocytosis
|
J:76895
|
Cbltm1Ddlb/Cbltm2Wlan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:103366
|
| abnormal T cell differentiation
|
J:103366
|
Cbltm1Wlan/Cbltm1Wlan
(involves: 129S1/Sv * C57BL/6)
|
myeloid hyperplasia
|
J:81965
|
Cbltm2Hua/Cbltm2Hua
Cblbtm1Hua/Cblbtm1Hua
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
extramedullary hematopoiesis
|
J:80427
|
Cblbtm1Pngr/Cblbtm1Pngr
Itktm1Litt/Itktm1Litt
(B6.129-Itktm1Litt Cblbtm1Pngr)
|
abnormal T-helper 2 cell differentiation
|
J:141390
|
Cbliftm1a(KOMP)Wtsi/Cbliftm1a(KOMP)Wtsi
(C57BL/6N-Cbliftm1a(KOMP)Wtsi)
|
decreased erythrocyte cell number
|
J:236022
|
| extramedullary hematopoiesis
|
J:236022
|
| increased mean corpuscular volume
|
J:236022
|
Cbstm1Unc/Cbstm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
extramedullary hematopoiesis
|
J:23321
|
Cbx2tm1Cim/Cbx2tm1Cim
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:38487
|
Cbx4tm1.1Gxu/Cbx4tm1.2Gxu
Tg(Foxn1-cre)1Tbo/0
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal lymphopoiesis
|
J:194053
|
| decreased double-positive T cell number
|
J:194053
|
Cbx6tm1a(EUCOMM)Wtsi/Cbx6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cbx6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean platelet volume
|
J:211773
|
Cby1tm1Ktkm/Cby1tm1Ktkm
(B6.129-Cby1tm1Ktkm)
|
decreased hematocrit
|
J:147413
|
Ccbe1tm1Mlkn/Ccbe1tm1Mlkn
(either: B6.129-Ccbe1tm1Mlkn or (involves: 129 * C57BL/6))
|
abnormal erythropoiesis
|
J:196696
|
| decreased fetal derived definitive erythrocyte cell number
|
J:196696
|
| decreased hematocrit
|
J:196696
|
| increased nucleated erythrocyte cell number
|
J:196696
|
Ccdc50tm1b(EUCOMM)Hmgu/Ccdc50tm1b(EUCOMM)Hmgu
(C57BL/6N-Ccdc50tm1b(EUCOMM)Hmgu/H)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ccdc51em1(IMPC)J/Ccdc51em1(IMPC)J
(C57BL/6NJ-Ccdc51em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ccdc57tm1a(EUCOMM)Wtsi/Ccdc57+
(B6JTyr;B6N-Ccdc57tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:175295
|
Ccdc59em1(IMPC)J/Ccdc59+
(C57BL/6NJ-Ccdc59em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
Ccdc122tm1a(KOMP)Wtsi/Ccdc122tm1a(KOMP)Wtsi
(C57BL/6N-Ccdc122tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Ccdc183em1(IMPC)Hmgu/Ccdc183em1(IMPC)Hmgu
(C57BL/6NCrl-Ccdc183em1(IMPC)Hmgu/Ieg)
|
increased hemoglobin content
|
J:211773
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol)
|
increased neutrophil cell number
|
J:118606
|
Ccl3tm1Unc/Ccl3tm1Unc
(B6.129P2-Ccl3tm1Unc/J)
|
decreased neutrophil cell number
|
J:94599
|
Ccl11tm1Mer/Ccl11tm1Mer
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
decreased eosinophil cell number
|
J:38945
|
Ccl11tm1Mer/Ccl11tm1Mer
(129S.129S6-Ccl11tm1Mer)
|
decreased eosinophil cell number
|
J:102034
|
Ccl11tm1Mer/Ccl11tm1Mer
Ccl24tm1Mer/Ccl24tm1Mer
(involves: 129S6/SvEvTac)
|
decreased eosinophil cell number
|
J:115273
|
Ccl21atm1Yout/Ccl21atm1Yout
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal negative T cell selection
|
J:244640
|
Ccl26tm1.1(KOMP)Vlcg/Ccl26tm1.1(KOMP)Vlcg
(B6N(Cg)-Ccl26tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ccna1tm1Djw/Ccna1tm1Djw
Ccna2tm1.1Pisc/Ccna2tm1.1Pisc
(involves: 129S7/SvEvBrd)
|
abnormal definitive hematopoiesis
|
J:155178
|
Ccna1tm1Djw/Ccna1tm1Djw
Ccna2tm1.1Pisc/Ccna2tm1.1Pisc
Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
decreased common myeloid progenitor cell number
|
J:155178
|
| decreased erythrocyte cell number
|
J:155178
|
| thrombocytopenia
|
J:155178
|
Ccnb2tm1Thnt/Ccnb2tm1Thnt
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:47430
|
Ccnd1tm1Dsn/Ccnd1tm1Dsn
Ccnd2tm1Wbg/Ccnd2tm1Wbg
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal common myeloid progenitor cell morphology
|
J:92563
|
| abnormal definitive hematopoiesis
|
J:92563
|
| abnormal lymphopoiesis
|
J:92563
|
| decreased erythrocyte cell number
|
J:92563
|
Ccnd2tm1b(KOMP)Mbp/Ccnd2tm1b(KOMP)Mbp
(C57BL/6N-Ccnd2tm1b(KOMP)Mbp/H)
|
increased mean corpuscular volume
|
J:211773
|
Ccnd2tm1Wbg/Ccnd2tm1Wbg
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified)
|
abnormal erythropoiesis
|
J:80994
|
| low mean erythrocyte cell number
|
J:80994
|
| macrocytosis
|
J:80994
|
Ccnd3tm1.1(Ccnd2)Iaai/Ccnd3tm1.1(Ccnd2)Iaai
(involves: 129S6/SvEvTac)
|
decreased double-positive T cell number
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
(Not Specified)
|
decreased double-positive T cell number
|
J:88120,
J:192031
|
| increased double-negative T cell number
|
J:88120
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
decreased double-positive T cell number
|
J:192031
|
Ccnd3tm1Pisc/Ccnd3tm1Pisc
Rb1tm2Brn/Rb1tm2Brn
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192031
|
Ccnd3tm2.1Pisc/Ccnd3tm2.1Pisc
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:192032
|
| decreased erythrocyte cell number
|
J:192032
|
Ccne1tm1Clur/Ccne1tm1Clur
(involves: 129S4/SvJae)
|
abnormal erythrocyte morphology
|
J:136692
|
| abnormal erythropoiesis
|
J:136692
|
| anisopoikilocytosis
|
J:136692
|
Ccne1tm1Jro/Ccne1tm1Jro
(either: 129-Ccne1tm1Jro or B6.129-Ccne1tm1Jro)
|
extramedullary hematopoiesis
|
J:99695
|
Ccne1tm1Pisc/Ccne1tm1Pisc
Ccne2tm1Pisc/Ccne2tm1Pisc
(involves: 129S2/SvPas)
|
abnormal definitive hematopoiesis
|
J:85224
|
| abnormal thrombopoiesis
|
J:85224
|
Ccnt1em1(IMPC)J/Ccnt1em1(IMPC)J
(C57BL/6NJ-Ccnt1em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ccr1tm1Gao/Ccr1tm1Gao
(involves: C57BL/6)
|
decreased mast cell number
|
J:94599
|
Ccr2em1(IMPC)H/Ccr2em1(IMPC)H
(C57BL/6N-Ccr2em1(IMPC)H/H)
|
decreased neutrophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Ccr2tm1Brv/Ccr2tm1Brv
(involves: 129S1/Sv * ICR)
|
increased eosinophil cell number
|
J:111517
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:44345
|
Ccr2tm1Mae/Ccr2tm1Mae
(involves: 129P2/OlaHsd * BALB/c)
|
decreased neutrophil cell number
|
J:162714
|
Ccr3tm1Cge/Ccr3tm1Cge
(involves: 129S4/SvJae * BALB/c)
|
abnormal eosinophil cell number
|
J:74509
|
| decreased eosinophil cell number
|
J:115273,
J:74509,
J:75347
|
| increased eosinophil cell number
|
J:74509
|
Ccr4tm1Pwr/Ccr4tm1Pwr
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased eosinophil cell number
|
J:120221
|
| increased neutrophil cell number
|
J:120221
|
Ccr6tm1Lira/Ccr6tm1Lira
(involves: 129 * C57BL/6)
|
increased double-positive T cell number
|
J:76461
|
Ccr7tm1Rfor/Ccr7tm1Rfor
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal class switch recombination
|
J:57976
|
Ccr9tm1.1Mal/Ccr9tm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:72386
|
| decreased double-positive T cell number
|
J:72386
|
| decreased pro-B cell number
|
J:72386
|
Ccr9tm1Ccb/Ccr9tm1Ccb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:94596
|
Cct3em1(IMPC)Tcp/Cct3+
(C57BL/6N-Cct3em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Cd1tm1Gru/Cd1tm1Gru
(involves: 129S2/SvPas * BALB/c)
|
abnormal eosinophil cell number
|
J:84720
|
Cd1d1em1(IMPC)H/Cd1d1em1(IMPC)H
(C57BL/6NTac-Cd1d1em1(IMPC)H/H)
|
decreased red blood cell distribution width
|
J:211773
|
| increased basophil cell number
|
J:211773
|
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
abnormal CD4-positive T cell differentiation
|
J:177038
|
Cd1d1tm1Luc/Cd1d1tm1Luc
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested T cell differentiation
|
J:125679
|
Cd3dtm1Kap/Cd3dtm1Kap
(C57BL/6-Cd3dtm1Kap)
|
arrested T cell differentiation
|
J:39925
|
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
arrested T cell differentiation
|
J:132486
|
Cd3em1Btlr/Cd3em1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd3em2Btlr/Cd3em2Btlr
(C57BL/6J-Cd3em2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274934
|
| abnormal T cell differentiation
|
J:274934
|
Cd3etm1.1Geno/Cd3etm1.1Geno
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:192604
|
| abnormal T cell differentiation
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:192604
|
| abnormal positive T cell selection
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
abnormal CD4-positive T cell differentiation
|
J:192604
|
| abnormal positive T cell selection
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Geno/Cd3etm1.1Geno
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:192604
|
| abnormal T cell differentiation
|
J:192604
|
| decreased double-positive T cell number
|
J:192604
|
| increased DN3 thymocyte number
|
J:192604
|
Cd3etm1.1Lov/Cd3etm1.1Lov
(Not Specified)
|
arrested T cell differentiation
|
J:72144
|
| decreased double-positive T cell number
|
J:72144
|
| increased double-negative T cell number
|
J:72144
|
Cd3etm1.1Lov/Cd3etm1.1Lov
Trdctm1Mal/Trdctm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
Cd3etm1Cpt/Cd3etm1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:54756
|
Cd3etm1Cpt/Cd3etm1Cpt
Tg(CD3E)26Cpt/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:54756
|
Cd3etm1Lov/Cd3etm1Lov
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:72144
|
| decreased double-positive T cell number
|
J:72144
|
| increased double-negative T cell number
|
J:72144
|
Cd3etm1Mal/Cd3etm1Mal
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:77098
|
Cd3etm1Mal/Cd3etm1Mal
(C57BL/6-Cd3etm1Mal)
|
abnormal double-negative T cell morphology
|
J:81133
|
| arrested T cell differentiation
|
J:81133
|
Cd3etm1Mal/Cd3etm1Mal
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas * C57BL/6)
|
arrested T cell differentiation
|
J:77098
|
Cd3etm1Mal/Cd3etm1Mal
Nlrp1aNeut1/Nlrp1aNeut1
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:191055
|
Cd3gtm1Amk/Cd3gtm1Amk
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77504
|
Cd4maat/Cd4maat
(C57BL/6JAnu-Cd4maat/Apb)
|
abnormal double-positive T cell morphology
|
J:104190
|
Cd4sesh/Cd4sesh
(C57BL/6JAnu-Cd4sesh/AnuApb)
|
abnormal double-positive T cell morphology
|
J:104190
|
Cd4tm1(cre/ERT2)Thbu/Cd4+
Gfm1tm1c(EUCOMM)Wtsi/Gfm1tm1c(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal T-helper 17 cell differentiation
|
J:302272
|
Cd4tm1Doi/Cd4tm1Doi
Lag3tm1Doi/Lag3tm1Doi
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
Cd4tm1Doi/Cd4tm1Litt
Lag3tm1Doi/Lag3+
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:33272
|
Cd4tm1Jrp/Cd4tm1Jrp
(either: B6.129S2-Cd4tm1Jrp or B10.Cg-Cd4tm1Jrp)
|
abnormal T cell differentiation
|
J:45168
|
| decreased double-positive T cell number
|
J:45168
|
Cd4tm1Mak/Cd4tm1Mak
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal double-negative T cell morphology
|
J:12572
|
| abnormal T cell differentiation
|
J:12572
|
| decreased double-positive T cell number
|
J:12572
|
Cd5tm1.1Chra/Cd5tm1.1Chra
(involves: C57BL/6 * FVB/N)
|
decreased double-positive T cell number
|
J:189919
|
| increased double-negative T cell number
|
J:189919
|
Cd5ltm1Nto/Cd5ltm1Nto
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:52195
|
Cd7tm1Bfh/Cd7tm1Bfh
(involves: 129 * C57BL/6)
|
increased double-positive T cell number
|
J:48758
|
Cd7tm1Bfh/Cd7tm1Bfh
(B6.129-Cd7tm1Bfh)
|
increased double-positive T cell number
|
J:48758
|
Cd8am1Btlr/Cd8am1Btlr
(C57BL/6J-Cd8am1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221492
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221492
|
Cd8atm1.1Kio/Cd8atm1.1Kio
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
abnormal CD4-positive T cell differentiation
|
J:76799
|
Cd8atm1Asin/Cd8atm1Asin
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal double-positive T cell morphology
|
J:126026
|
Cd8atm1Asin/Cd8atm1Asin
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
Cd8atm1Asin/Cd8atm1Mak
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
Cd8b1m2Btlr/Cd8b1m2Btlr
(C57BL/6J-Cd8b1m2Btlr)
|
abnormal B cell differentiation
|
J:274761
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274761
|
Cd8b1tm1Litt/Cd8b1+
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
decreased double-positive T cell number
|
J:112551
|
Cd8b1tm1Litt/Cd8b1tm1Litt
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
abnormal negative T cell selection
|
J:112551
|
| abnormal positive T cell selection
|
J:112551
|
Cd8b1tm1Wpfl/Cd8b1tm1Wpfl
(involves: 129S2/SvPas)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:19928
|
Cd9tm1Mek/Cd9tm1Mek
(involves: 129/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:83795
|
Cd19tm1(cre)Cgn/?
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sortm1(HBEGF)Awai
(involves: 129P2/OlaHsd * C57BL/6)
|
absent immature B cells
|
J:131076
|
Cd19tm1(cre)Cgn/Cd19+
Ell2tm1.1Cmil/Ell2tm1.1Cmil
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased transitional stage T1 B cell number
|
J:234692
|
| decreased transitional stage T2 B cell number
|
J:234692
|
| decreased transitional stage T3 B cell number
|
J:234692
|
| increased immature B cell number
|
J:234692
|
| increased pro-B cell number
|
J:234692
|
Cd19tm1(cre)Cgn/Cd19+
Ep300tm2Reck/Ep300+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:147840
|
| abnormal transitional stage B cell morphology
|
J:147840
|
| extramedullary hematopoiesis
|
J:147840
|
Cd19tm1(cre)Cgn/Cd19+
Faslpr/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
Cd19tm1(cre)Cgn/Cd19+
Igbp1tm1Imku/Y
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:74619
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkbtm1Cgn/Ikbkbtm1.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Ikbkgtm1.1Mpa/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:79132
|
Cd19tm1(cre)Cgn/Cd19+
Irf8tm1.1Hm/Irf8tm1.1Hm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased transitional stage B cell number
|
J:168923
|
Cd19tm1(cre)Cgn/Cd19+
Klhl6tm2Sato/Klhl6tm2Sato
(either: (involves: 129P2/OlaHsd * 129T2/SvEms) or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal B cell differentiation
|
J:101363
|
Cd19tm1(cre)Cgn/Cd19+
Mcl1tm2Sjk/Mcl1tm3Sjk
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:86906
|
| absent early pro-B cells
|
J:86906
|
| absent late pro-B cells
|
J:86906
|
| arrested B cell differentiation
|
J:86906
|
Cd19tm1(cre)Cgn/Cd19+
Notch2tm2Hhi/Notch2tm1.1Hhi
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased transitional stage B cell number
|
J:83476
|
Cd19tm1(cre)Cgn/Cd19+
Pax5tm1Mbu/Pax5tm3Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal B cell differentiation
|
J:75504
|
| abnormal class switch recombination
|
J:75504
|
| decreased immature B cell number
|
J:75504
|
Cd19tm1(cre)Cgn/Cd19+
Prdm1tm1Clme/Prdm1tm1Clme
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:101890
|
| abnormal plasma cell differentiation
|
J:101890
|
Cd19tm1(cre)Cgn/Cd19+
Ptentm1Hwu/Ptentm1Hwu
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal B cell negative selection
|
J:155314
|
| abnormal class switch recombination
|
J:114881
|
Cd19tm1(cre)Cgn/Cd19+
Ptpn6tm1Rsky/Ptpn6tm1Rsky
(involves: 129P2/OlaHsd * C57BL/6)
|
increased granulocyte number
|
J:123568
|
Cd19tm1(cre)Cgn/Cd19+
Rac1tm1Tyb/Rac1tm1Tyb
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129P2/OlaHsd * 129S/SvEv * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:86765
|
| decreased transitional stage B cell number
|
J:86765
|
Cd19tm1(cre)Cgn/Cd19+
Rbpjtm1Hon/Rbpjtm1Hon
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76240
|
Cd19tm1(cre)Cgn/Cd19+
Slc3a2tm1.1Mgin/Slc3a2tm1.1Mgin
(involves: 129 * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:148000
|
| abnormal plasma cell differentiation
|
J:148000
|
Cd19tm1(cre)Cgn/Cd19+
Tbl1xr1tm1c(EUCOMM)Hmgu/Tbl1xr1tm1c(EUCOMM)Hmgu
Tg(Vav-BCL2)69Jad/0
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
abnormal B cell differentiation
|
J:292118
|
Cd19tm1(cre)Cgn/Cd19+
Tcf3tm1Mbu/Tcf3tm1.2Mbu
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased immature B cell number
|
J:137719
|
| decreased pro-B cell number
|
J:137719
|
| decreased transitional stage B cell number
|
J:137719
|
Cd19tm1(cre)Cgn/Cd19+
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:172843
|
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:27463
|
Cd19tm1Tft/Cd19tm1Tft
(involves: 129/Sv * C57BL/6)
|
decreased neutrophil cell number
|
J:66111
|
Cd22m1Anu/Cd22m1Anu
(C57BL/6JAnu-Cd22m1Anu/AnuApb)
|
arrested B cell differentiation
|
J:104190
|
Cd22m1Btlr/Cd22m1Btlr
(C57BL/6J-Cd22m1Btlr)
|
abnormal B cell differentiation
|
J:173079
|
Cd22m1Btlr/Cd22m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
Cd22m2Btlr/Cd22m2Btlr
(C57BL/6J-Cd22m2Btlr)
|
abnormal B cell differentiation
|
J:215821
|
Cd22tm1.1(CD22)Lnit/Cd22tm1.1(CD22)Lnit
(involves: 129S4/SvJae)
|
decreased transitional stage T1 B cell number
|
J:189017
|
| decreased transitional stage T2 B cell number
|
J:189017
|
Cd22tm1Eac/Cd22+
Lyntm1Ard/Lyn+
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
Cd22tm1Eac/Cd22+
Lyntm1Ard/Lyn+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
Cd22tm1Eac/Cd22+
Ptpn6me-v/Ptpn6+
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
Cd22tm1Eac/Cd22tm1Eac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal transitional stage B cell morphology
|
J:132991
|
Cd22tm1Lam/Cd22tm1Lam
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd22tm3Lnit/Cd22tm3Lnit
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased transitional stage B cell number
|
J:198790
|
Cd24atm1Pjln/Cd24atm1Pjln
(C57BL/6-Cd24atm1Pjln)
|
abnormal B cell differentiation
|
J:76695
|
| decreased immature B cell number
|
J:76695
|
Cd27tm1Jbo/Cd27tm1Jbo
(B6.129P2-Cd27tm1Jbo)
|
abnormal leukopoiesis
|
J:97606
|
Cd28tm1Jmg/Cd28tm1Jmg
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
Cd28tm1Jmg/Cd28tm1Mak
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:124570
|
Cd28tm1Mak/Cd28+
Cd5tm1Cgn/Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal class switch recombination
|
J:14194
|
Cd28tm1Mak/Cd28tm1Mak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:123989
|
Cd28tm1Mak/Cd28tm1Mak
Cd5tm1Cgn/Cd5+
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
Cd28tm1Mak/Cd28tm1Mak
Cd5tm1Cgn/Cd5tm1Cgn
(either: (involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * DBA/1 * LP))
|
abnormal T cell clonal deletion
|
J:110925
|
Cd28tm1Mak/Cd28tm1Mak
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
increased eosinophil cell number
|
J:205692
|
Cd28tm1Mak/Cd28tm1Mak
Tg(H2-K-Cd86)7All/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:112266
|
Cd28tm1Pjl/Cd28tm1Pjl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:83722
|
Cd28tm1Pjl/Cd28tm1Pjl
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(either: B6.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk or C.Cg-Cd28tm1Pjl Tnfrsf9tm1Byk)
|
abnormal class switch recombination
|
J:83722
|
Cd33tm1Avrk/Cd33tm1Avrk
(involves: 129X1/SvJ * C57BL/6)
|
abnormal erythrocyte cell number
|
J:83728
|
Cd34tm1Lal/Cd34tm1Lal
(involves: 129S2/SvPas)
|
abnormal common myeloid progenitor cell morphology
|
J:30621
|
| abnormal definitive hematopoiesis
|
J:30621
|
Cd34tm1Szk/Cd34tm1Szk
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased eosinophil cell number
|
J:32799
|
Cd36tm1Mfe/Cd36tm1Mfe
(B6.129S1-Cd36tm1Mfe)
|
abnormal plasma cell differentiation
|
J:130897
|
| increased transitional stage B cell number
|
J:130897
|
Cd37tm1Hor/Cd37tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:63315
|
Cd40tm1Kik/Cd40tm1Kik
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased neutrophil cell number
|
J:25007
|
Cd40tm1Kik/Cd40tm1Kik
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Cd40tm1Kik Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Cd40tm1Kik/Cd40tm1Kik
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(involves: 129 * 129P2/OlaHsd * BALB/c)
|
increased transitional stage B cell number
|
J:138560
|
Cd40lgm1Btlr/Y
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd40lgm1Btlr/Cd40lgm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd40lgtm1Flv/Cd40lgtm1Flv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:25010
|
| abnormal T cell differentiation
|
J:25010
|
| decreased double-positive T cell number
|
J:25010
|
Cd40lgtm1Imx/Y
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:21137
|
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6J * BALB/c)
|
abnormal T cell clonal deletion
|
J:110925
|
Cd40lgtm1Parl/Y
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
thrombocytopenia
|
J:213459
|
Cd40lgtm1Parl/Cd40lgtm1Parl
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
thrombocytopenia
|
J:213459
|
Cd44tm1Hbg/Cd44tm1Hbg
(B6.129-Cd44tm1Hbg)
|
decreased mast cell histamine storage
|
J:146846
|
| decreased mast cell number
|
J:146846
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:72658
|
Cd47tm1Fpl/Cd47tm1Fpl
(B6.129S7-Cd47tm1Fpl)
|
thrombocytopenia
|
J:98979
|
Cd47tm1Fpl/Cd47tm1Fpl
(C.129S7-Cd47tm1Fpl)
|
thrombocytopenia
|
J:98979
|
Cd47tm1Fpl/Cd47tm1Fpl
(NOD.129S7-Cd47tm1Fpl)
|
abnormal erythropoiesis
|
J:76580
|
| decreased hematocrit
|
J:76580
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased hematocrit
|
J:134866
|
| decreased hemoglobin content
|
J:134866
|
| decreased neutrophil cell number
|
J:134866
|
Cd55btm1a(KOMP)Wtsi/Cd55btm1a(KOMP)Wtsi
(C57BL/6N-Cd55btm1a(KOMP)Wtsi/Wtsi)
|
thrombocytosis
|
J:211773
|
Cd59atm1Bpm/Cd59atm1Bpm
(B6.129-Cd59atm1Bpm)
|
increased double-positive T cell number
|
J:123582
|
| increased neutrophil cell number
|
J:123582
|
Cd59btm1Jha/Cd59btm1Jha
(involves: 129/Sv * C57BL/6)
|
anisopoikilocytosis
|
J:82330
|
| decreased erythrocyte cell number
|
J:82330
|
| decreased hematocrit
|
J:82330
|
| decreased hemoglobin content
|
J:82330
|
| echinocytosis
|
J:82330
|
| schistocytosis
|
J:82330
|
Cd69tm1Fsm/Cd69tm1Fsm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:61329
|
| increased immature B cell number
|
J:61329
|
Cd72tm1Jrp/Cd72tm1Jrp
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal B cell differentiation
|
J:76990
|
| increased immature B cell number
|
J:76990
|
| increased pro-B cell number
|
J:76990
|
Cd72tm1Jrp/Cd72tm1Jrp
Tg(BCL2)22Wehi/0
(either: (involves: 129P2/OlaHsd * C57BL/6JWehi * SJL/JWehi) or (involves: 129P2/OlaHsd * C57BL/6 * C57BL/6JWehi * SJL/JWehi))
|
increased immature B cell number
|
J:76990
|
Cd74em1(IMPC)H/Cd74em1(IMPC)H
(C57BL/6N-Cd74em1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Cd74tm1Anjm/Cd74+
Lmo2tm2(cre)Thr/Lmo2+
Smim3tm1Anjm/Smim3+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased erythrocyte cell number
|
J:155870
|
| increased mean corpuscular volume
|
J:155870
|
| thrombocytopenia
|
J:155870
|
Cd74tm1Eae/Cd74tm1Eae
(B6.129S2-Cd74tm1Eae)
|
arrested B cell differentiation
|
J:112084
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/cAn)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * BALB/c * C57BL)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv * C57BL * C57BL/10 * C57BR)
|
abnormal B cell differentiation
|
J:110927
|
| increased immature B cell number
|
J:110927
|
Cd74tm1Liz/Cd74tm1Liz
(involves: 129S/SvEv)
|
abnormal positive T cell selection
|
J:125548
|
Cd79am1Btlr/Cd79am1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Cd79atm1(cre)Reth/Cd79a+
Ctnnbl1tm1.1Crad/Ctnnbl1tm1.1Crad
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:232010
|
Cd79atm1(cre)Reth/Cd79a+
Dynll1tm1.1Jhh/Dynll1tm1.1Jhh
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth)
|
decreased immature B cell number
|
J:230105
|
Cd79atm1(cre)Reth/Cd79a+
Dynll1tm1.1Jhh/Dynll1tm1.1Jhh
Tg(IghMyc)22Bri/0
(B6.Cg-Dynll1tm1.1Jhh Cd79atm1(Cre)Reth Tg(IghMyc)22Bri)
|
decreased immature B cell number
|
J:230105
|
Cd79atm1(cre)Reth/Cd79a+
Huwe1tm1.1Mak/Y
(B6.Cg-Cd79atm1(cre)Reth Huwe1tm1.1Mak)
|
abnormal B cell differentiation
|
J:181705
|
| abnormal class switch recombination
|
J:181705
|
| decreased transitional stage B cell number
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+
Huwe1tm1.1Mak/Y
Trp53tm1Brn/Trp53tm1Brn
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal class switch recombination
|
J:181705
|
Cd79atm1(cre)Reth/Cd79a+
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:209928
|
| increased pro-B cell number
|
J:209928
|
Cd79atm1(cre)Reth/Cd79a+
Phf5atm1.1Oux/Phf5atm1.1Oux
(involves: BALB/c * C57BL/6J)
|
abnormal B cell receptor editing
|
J:345807
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:345807
|
| decreased early pro-B cell number
|
J:345807
|
| decreased immature B cell number
|
J:345807
|
| decreased late pro-B cell number
|
J:345807
|
| increased pre-pro B cell number
|
J:345807
|
Cd79atm1(cre)Reth/Cd79a+
Slc39a10tm1.1Tfk/Slc39a10tm1.1Tfk
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
decreased pro-B cell number
|
J:213935
|
Cd79atm1(cre)Reth/Cd79atm1(cre)Reth
Mzb1tm1.1Rug/Mzb1tm1.1Rug
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
increased late pro-B cell number
|
J:211639
|
| increased pro-B cell number
|
J:211639
|
Cd79atm1.1Cgn/Cd79a+
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:179254
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm1Gzmn/Cd79b+
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:179254
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:124400
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm1Gzmn/Cd79btm1Gzmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:179254
|
| increased pro-B cell number
|
J:179254
|
Cd79atm1.1Cgn/Cd79atm1.1Cgn
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:71100
|
Cd79atm1.1Rsky/Cd79atm1.1Rsky
(involves: C57BL/6)
|
increased immature B cell number
|
J:179254
|
| increased transitional stage B cell number
|
J:179254
|
| increased transitional stage T1 B cell number
|
J:179254
|
| increased transitional stage T2 B cell number
|
J:179254
|
| increased transitional stage T3 B cell number
|
J:179254
|
Cd79atm2(cre/Esr1*)Reth/Cd79a+
Rag1tm1.1Sadu/Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
Cd79atm2Cgn/Cd79atm2Cgn
(involves: C57BL/6)
|
increased pro-B cell number
|
J:66840
|
Cd79atm2Cgn/Cd79atm2Cgn
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
| decreased transitional stage B cell number
|
J:66840
|
Cd79atm2Pld/Cd79atm2Pld
(BALB/c-Cd79atm2Pld)
|
abnormal B cell differentiation
|
J:87492
|
| abnormal T cell differentiation
|
J:87492
|
| decreased double-positive T cell number
|
J:87492
|
Cd79atm4.1Cgn/Cd79atm4.1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
Cd79atm4.1Cgn/Cd79atm4.1Cgn
Ightm1.2Rsky/Igh+
(involves: BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:125719
|
Cd79atm4Cgn/Cd79atm4.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
| arrested B cell differentiation
|
J:91091
|
Cd79atm5.1Cgn/Cd79a+
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:91091
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
(involves: 129 * C57BL/6)
|
decreased immature B cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Igh+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
Cd79atm5.1Cgn/Cd79atm5.1Cgn
Ightm1.2Rsky/Ightm1.2Rsky
(involves: 129 * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:125719
|
| decreased immature B cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
Cd79atm5Cgn/Cd79atm5.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
absent immature B cells
|
J:91091
|
| arrested B cell differentiation
|
J:91091
|
Cd79atm6Cgn/Cd79atm6Cgn
(involves: C57BL/6)
|
increased transitional stage B cell number
|
J:113407
|
Cd79bm1Ghost/Cd79bm1Ghost
(B10.Cg-Ptprca Cd79bm1Ghost H2a)
|
abnormal B cell differentiation
|
J:157450
|
| arrested B cell differentiation
|
J:157450
|
Cd79btm1Mnz/Cd79btm1Mnz
(involves: 129S1/Sv)
|
abnormal pro-B cell differentiation
|
J:78601
|
| abnormal pro-B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(BCL2)22Wehi/0
Tg(IghelMD4)4Ccg/0
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(BCL2)22Wehi/0
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6JWehi * SJL/JWehi)
|
arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(IghelMD4)4Ccg/0
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:78601
|
| arrested B cell differentiation
|
J:78601
|
Cd79btm1Mnz/Cd79btm1Mnz
Tg(Rag2-Igb)1Mnz/0
(involves: 129S1/Sv)
|
arrested B cell differentiation
|
J:78601
|
Cd79btm2.1Mnz/Cd79btm2.1Mnz
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:66840
|
| decreased transitional stage B cell number
|
J:66840
|
| increased pro-B cell number
|
J:66840
|
Cd79btm3Mnz/Cd79btm3Mnz
(involves: 129/Sv * C57BL/6)
|
abnormal immature B cell morphology
|
J:128768
|
| decreased immature B cell number
|
J:128768
|
| increased pro-B cell number
|
J:128768
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm2Shr/Cd86tm2Shr
(involves: 129S4/SvJae * BALB/c)
|
decreased double-positive T cell number
|
J:112266
|
Cd81tm1Tmiy/Cd81tm1Tmiy
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:41830
|
Cd81tm1Tmiy/Cd81tm1Tmiy
Cd9tm1Mek/Cd9tm1Mek
(involves: 129/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:83795
|
Cd82tm1Kjbr/Cd82tm1Kjbr
(Not Specified)
|
abnormal macrophage differentiation
|
J:326451
|
| increased neutrophil cell number
|
J:326451
|
Cd83lcd4/Cd83lcd4
(involves: C57BL/6J)
|
abnormal CD4-positive T cell differentiation
|
J:92721
|
Cd83tm1Tft/Cd83tm1Tft
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75700
|
| arrested T cell differentiation
|
J:75700
|
Cd101tm1.1Dil/Cd101tm1.1Dil
(involves: BALB/cJ * C57BL/6 * C57BL/6NTac)
|
decreased granulocyte number
|
J:175943
|
Cd177tm1(KOMP)Vlcg/Cd177tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased neutrophil cell number
|
J:225335
|
Cd180tm1Kmiy/Cd180tm1Kmiy
Faslpr/Faslpr
(MRL.Cg-Cd180tm1Kmiy Faslpr)
|
increased double-negative T cell number
|
J:137066
|
Cd209btm1.1Cfg/Cd209btm1.1Cfg
(involves: C57BL/6)
|
increased eosinophil cell number
|
J:288225
|
Cd247tm1Lov/Cd247tm1Lov
(involves: 129S4/SvJae)
|
decreased double-positive T cell number
|
J:14170
|
Cd247tm1Mal/Cd247tm1Mal
(either: C57BL/6-Cd247tm1Mal or (involves: BALB/c * C57BL/6))
|
abnormal T cell differentiation
|
J:15272
|
| decreased double-positive T cell number
|
J:15272
|
| increased double-negative T cell number
|
J:15272
|
Cd247tm1Mal/Cd247tm1Mal
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112990,
J:110847
|
| abnormal T cell differentiation
|
J:112990
|
| decreased double-positive T cell number
|
J:110847
|
Cd247tm1Mal/Cd247tm1Mal
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:110847
|
| abnormal T cell differentiation
|
J:110847
|
| decreased double-positive T cell number
|
J:110847
|
Cd247tm1Mhu/Cd247tm1Mhu
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:15579
|
| decreased double-positive T cell number
|
J:15579
|
| increased double-negative T cell number
|
J:15579
|
Cd247tm1Tks/Cd247tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:15271
|
Cd247tm2.1Lov/Cd247tm2.1Lov
(Not Specified)
|
abnormal gamma-delta T cell differentiation
|
J:192915
|
| abnormal T cell differentiation
|
J:192915
|
| abnormal T-helper 1 cell differentiation
|
J:192915
|
Cd247tm2.1Lov/Cd247tm2.1Lov
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:192915
|
Cd274tm1Lpc/Cd274tm1Lpc
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:162539
|
Cd276tm2b(EUCOMM)Hmgu/Cd276tm2b(EUCOMM)Hmgu
(C57BL/6N-Cd276tm2b(EUCOMM)Hmgu/Orl)
|
decreased mean corpuscular volume
|
J:211773
|
Cd300atm1b(EUCOMM)Hmgu/Cd300atm1b(EUCOMM)Hmgu
(C57BL/6N-Cd300atm1b(EUCOMM)Hmgu/Bay)
|
decreased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Cd300atm1Shib/Cd300atm1Shib
(B6JJcl.C-Cd300atm1Shib)
|
increased neutrophil cell number
|
J:189144
|
Cdan1tm1b(KOMP)Wtsi/Cdan1+
(C57BL/6N-Cdan1tm1b(KOMP)Wtsi/Ucd)
|
thrombocytopenia
|
J:211773
|
Cdc7tm1.1(KOMP)Vlcg/Cdc7+
(C57BL/6N-Cdc7tm1.1(KOMP)Vlcg/Tcp)
|
decreased neutrophil cell number
|
J:211773
|
Cdc20bem1(IMPC)Wtsi/Cdc20bem1(IMPC)Wtsi
(C57BL/6N-Cdc20bem1(IMPC)Wtsi/Wtsi)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Cdc25am1Rfp/Cdc25am1Rfp
(multiple strains)
|
abnormal erythropoiesis
|
J:80142
|
Cdc42tm1Brak/Cdc42tm1Brak
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal platelet morphology
|
J:160792
|
| thrombocytopenia
|
J:160792
|
Cdc42ep5tm1(KOMP)Wtsi/Cdc42ep5tm1(KOMP)Wtsi
(C57BL/6N-Cdc42ep5tm1(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(involves: 129 * C57BL/6)
|
increased neutrophil cell number
|
J:177191
|
Cdh5tm3(Cdh5/Ctnna1)Dvst/Cdh5tm3(Cdh5/Ctnna1)Dvst
(B6.Cg-Cdh5tm3(Cdh5/Ctnna1)Dvst)
|
abnormal common myeloid progenitor cell morphology
|
J:213676
|
| abnormal definitive hematopoiesis
|
J:213676
|
Cdh10tm2b(KOMP)Wtsi/Cdh10tm2b(KOMP)Wtsi
(C57BL/6N-Cdh10tm2b(KOMP)Wtsi/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Cdh17tm1Ohn/Cdh17tm1Ohn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pro-B cell number
|
J:96738
|
Cdh23tm2b(EUCOMM)Wtsi/Cdh23tm2b(EUCOMM)Wtsi
(C57BL/6N-Cdh23tm2b(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Cdk2tm1Kald/Cdk2tm1Kald
Cdk4tm1Kiyo/Cdk4tm1Kiyo
(involves: 129S1/Sv * C57BL/6)
|
abnormal erythrocyte morphology
|
J:108720
|
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:124678
|
Cdk2tm1Sgo/Cdk2tm1Sgo
Cdk4tm2.1Bbd/Cdk4tm2.1Bbd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6 * SJL)
|
abnormal definitive hematopoiesis
|
J:125217
|
| decreased erythrocyte cell number
|
J:125217
|
Cdk2ap2em1(IMPC)J/Cdk2ap2em1(IMPC)J
(C57BL/6NJ-Cdk2ap2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Cdk4tm1b(NCOM)Mfgc/Cdk4+
(C57BL/6N-Cdk4tm1b(NCOM)Mfgc/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Cdk4tm1Bbd/Cdk4tm1Bbd
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1 * ICR)
|
abnormal erythrocyte morphology
|
J:92529
|
| decreased erythrocyte cell number
|
J:92529
|
| extramedullary hematopoiesis
|
J:92529
|
Cdk5rap2an/Cdk5rap2an
(Not Specified)
|
abnormal erythrocyte morphology
|
J:5439
|
| abnormal erythropoiesis
|
J:5439
|
| anisocytosis
|
J:5439
|
| macrocytosis
|
J:5439
|
Cdk5rap2Gt(RRO242)Byg/Cdk5rap2an
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased erythrocyte cell number
|
J:160533
|
Cdk5rap2tm1a(EUCOMM)Wtsi/Cdk5rap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cdk5rap2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
| increased mean corpuscular volume
|
J:175295
|
Cdk5rap3tm1b(EUCOMM)Hmgu/Cdk5rap3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N * FVB/N)
|
abnormal erythropoiesis
|
J:272566
|
| increased nucleated erythrocyte cell number
|
J:272566
|
Cdk5rap3tm1c(EUCOMM)Hmgu/Cdk5rap3tm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S4/SvJaeSor * C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal hemopoiesis
|
J:272566
|
Cdk6tm1b(EUCOMM)Wtsi/Cdk6tm1b(EUCOMM)Wtsi
(C57BL/6N-Cdk6tm1b(EUCOMM)Wtsi/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Cdk6tm1Bbd/Cdk6tm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal definitive hematopoiesis
|
J:92529
|
| abnormal erythrocyte morphology
|
J:92529
|
| decreased erythrocyte cell number
|
J:92529
|
| increased mean corpuscular hemoglobin concentration
|
J:92529
|
| increased mean corpuscular volume
|
J:92529
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae)
|
abnormal lymphopoiesis
|
J:144975
|
| abnormal T cell differentiation
|
J:144975
|
| decreased double-negative T cell number
|
J:144975
|
| decreased double-positive T cell number
|
J:144975
|
Cdk6tm1Phin/Cdk6tm1Phin
(involves: 129S4/SvJae * C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
Cdk6tm1Phin/Cdk6tm1Phin
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S4/SvJae)
|
abnormal T cell differentiation
|
J:144975
|
Cdk6tm2.1Phin/Cdk6tm2.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased DN4 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
| increased double-negative T cell number
|
J:174697
|
Cdk6tm3.1Phin/Cdk6tm3.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| increased DN1 thymic pro-T cell number
|
J:174697
|
Cdk6tm4.1Phin/Cdk6tm4.1Phin
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:174697
|
| decreased DN1 thymic pro-T cell number
|
J:174697
|
| decreased DN2 thymocyte number
|
J:174697
|
| decreased DN4 thymocyte number
|
J:174697
|
| decreased double-positive T cell number
|
J:174697
|
| increased DN3 thymocyte number
|
J:174697
|
Cdk12em1(IMPC)Tcp/Cdk12+
(C57BL/6NCrl-Cdk12em1(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Cdkn1atm1Led/Cdkn1atm1Led
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
| decreased basophil cell number
|
J:76041
|
| decreased eosinophil cell number
|
J:76041
|
Cdkn1atm1Led/Cdkn1atm1Led
Zbtb17tm1Cksn/Zbtb17tm1Cksn
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zbtb17tm1Cksn Cdkn1atm1Led Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Tg(MMTV-vHaras)SH1Led/0
(involves: 129S2/SvPas * C57BL/6J * CD-1 * FVB/N)
|
extramedullary hematopoiesis
|
J:66183
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:33400
|
Cdkn1ctm1Kat/Cdkn1c+
(involves: 129P2/OlaHsd * C57BL/6)
|
thrombocytopenia
|
J:102331
|
Cdkn1ctm1Kat/Cdkn1c+
(involves: 129P2/OlaHsd)
|
thrombocytopenia
|
J:102331
|
Cdkn1ctm1Kat/Cdkn1ctm1Kat
(involves: 129P2/OlaHsd)
|
thrombocytopenia
|
J:102331
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6 * SJL)
|
extramedullary hematopoiesis
|
J:53805
|
Cdkn2atm1Rdp/Cdkn2atm1Rdp
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA * SJL)
|
abnormal common myeloid progenitor cell morphology
|
J:130397
|
Cdkn2atm2.1Rdp/Cdkn2atm2.1Rdp
(involves: 129S6/SvEvTac * FVB/N)
|
increased double-positive T cell number
|
J:71394
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
extramedullary hematopoiesis
|
J:63299
|
Cdkn2btm1Bbd/Cdkn2btm1Bbd
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
extramedullary hematopoiesis
|
J:63299
|
Cdkn2btm1Wff/Cdkn2btm1Wff
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:163498
|
| myeloid hyperplasia
|
J:163498
|
Cdsntm1b(EUCOMM)Hmgu/Cdsn+
(C57BL/6N-Cdsntm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Cdx1tm1Pgr/Cdx1tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal embryonic erythropoiesis
|
J:136405
|
Cdx4tm1.1Gqda/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal embryonic erythropoiesis
|
J:136405
|
Cdx4tm1.1Gqda/Cdx4tm1.1Gqda
(involves: 129S4/SvJae * C57BL/6)
|
abnormal embryonic erythropoiesis
|
J:136405
|
Cdyl2em1(IMPC)Tcp/Cdyl2em1(IMPC)Tcp
(C57BL/6N-Cdyl2em1(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
Ceacam5em1(IMPC)Wtsi/Ceacam5em1(IMPC)Wtsi
(C57BL/6N-Ceacam5em1(IMPC)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Cebpatm1Dgt/Cebpatm1Dgt
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:94682
|
| decreased granulocyte number
|
J:94682
|
| failure of myelopoiesis
|
J:94682
|
Cebpatm1Gjd/Cebpatm1Gjd
(B6.129S7-Cebpatm1Gjd)
|
absent common myeloid progenitor cells
|
J:94682
|
| failure of myelopoiesis
|
J:94682
|
Cebpatm2Btp/Cebpatm2Btp
(B6.129P2-Cebpatm2Btp)
|
abnormal definitive hematopoiesis
|
J:187834
|
| abnormal myelopoiesis
|
J:187834
|
| decreased neutrophil cell number
|
J:187834
|
Cebpatm2Nerl/Cebpatm2Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal granulocyte morphology
|
J:72330
|
| decreased granulocyte number
|
J:72330
|
Cebpatm4Nerl/Cebpatm4Nerl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal granulocyte morphology
|
J:72330
|
| decreased granulocyte number
|
J:72330
|
Cebpatm8.1Nerl/Cebpa+
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:136134
|
Cebpatm8.1Nerl/Cebpatm8.1Nerl
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:136134
|
| abnormal definitive hematopoiesis
|
J:136134
|
| abnormal granulocyte morphology
|
J:136134
|
| decreased granulocyte number
|
J:136134
|
| decreased hematocrit
|
J:136134
|
| decreased neutrophil cell number
|
J:136134
|
| extramedullary hematopoiesis
|
J:136134
|
Cebpbtm1Vpo/Cebpbtm1Vpo
(involves: 129S/SvEv * MF1)
|
abnormal definitive hematopoiesis
|
J:25215
|
| extramedullary hematopoiesis
|
J:25215
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal common myeloid progenitor cell morphology
|
J:76024
|
| abnormal eosinophil differentiation
|
J:76024
|
| abnormal granulocyte differentiation
|
J:76024
|
| abnormal myelopoiesis
|
J:76024
|
| abnormal neutrophil differentiation
|
J:76024
|
| abnormal neutrophil morphology
|
J:76024
|
| decreased eosinophil cell number
|
J:76024
|
| decreased granulocyte number
|
J:76024
|
| extramedullary hematopoiesis
|
J:76024
|
| impaired myelopoiesis
|
J:76024
|
Cebpetm1Kgx/Cebpetm1Kgx
(involves: 129S6/SvEvTac)
|
abnormal common myeloid progenitor cell morphology
|
J:76024
|
| abnormal eosinophil differentiation
|
J:76024
|
| abnormal granulocyte differentiation
|
J:76024
|
| abnormal myelopoiesis
|
J:76024
|
| abnormal neutrophil differentiation
|
J:76024
|
| abnormal neutrophil morphology
|
J:76024
|
| decreased eosinophil cell number
|
J:76024
|
| decreased granulocyte number
|
J:76024
|
| extramedullary hematopoiesis
|
J:76024
|
| impaired myelopoiesis
|
J:76024
|
Cep15tm1b(KOMP)Wtsi/Cep15tm1b(KOMP)Wtsi
(C57BL/6N-Cep15tm1b(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Cep43tm1b(EUCOMM)Hmgu/Cep43+
(C57BL/6N-Cep43tm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Cep290em1(IMPC)Mbp/Cep290+
(C57BL/6N-Cep290em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Cerktm1Fbor/Cerktm1Fbor
(involves: BALB/c)
|
decreased granulocyte number
|
J:131522
|
| decreased neutrophil cell number
|
J:131522
|
Cers1tm1b(EUCOMM)Hmgu/Cers1+
(C57BL/6N-Cers1tm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
Cert1tm1a(KOMP)Wtsi/Cert1+
(C57BL/6N-Cert1tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ces1ftm1b(KOMP)Wtsi/Ces1ftm1b(KOMP)Wtsi
(C57BL/6N-Ces1ftm1b(KOMP)Wtsi/Nju)
|
increased mean corpuscular volume
|
J:211773
|
Ces2ftm1b(KOMP)Wtsi/Ces2ftm1b(KOMP)Wtsi
(C57BL/6N-Ces2ftm1b(KOMP)Wtsi/Nju)
|
increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Cfbtm1.1(KOMP)Wtsi/Cfbtm1.1(KOMP)Wtsi
(C57BL/6N-Cfbtm1.1(KOMP)Wtsi/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Cfhtm1.1Song/Cfhtm1.1Song
(involves: C57BL/6)
|
decreased hemoglobin content
|
J:240426
|
| thrombocytopenia
|
J:240426
|
Cfhtm1a(EUCOMM)Wtsi/Cfhtm1a(EUCOMM)Wtsi
(C57BL/6N-Cfhtm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Cfhtm1Mbo/Cfhtm1Mbo
Tg(CAG-Cfh*)#Mcp/0
(involves: 129/Sv * C57BL/6 * CBA)
|
schistocytosis
|
J:125860
|
| thrombocytopenia
|
J:125860
|
Cfitm1b(EUCOMM)Hmgu/Cfitm1b(EUCOMM)Hmgu
(C57BL/6N-Cfitm1b(EUCOMM)Hmgu/H)
|
thrombocytopenia
|
J:211773
|
Cflartm1.1Pope/Cflartm1.2Pope
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:167430
|
| abnormal erythropoiesis
|
J:167430
|
| abnormal myelopoiesis
|
J:167430
|
| increased eosinophil cell number
|
J:167430
|
| increased granulocyte number
|
J:167430
|
| increased neutrophil cell number
|
J:167430
|
| thrombocytosis
|
J:167430
|
Cftrtm2Mrc/Cftrtm2Mrc
(B6.129S6-Cftrtm2Mrc)
|
decreased neutrophil cell number
|
J:112450
|
Chcmq1C57BLKS/J/Chcmq1C57BLKS/J
(involves: C57BLKS/J * SM/J)
|
increased hemoglobin content
|
J:107220
|
Chcmq2C57BLKS/J/Chcmq2SM/J
(involves: C57BLKS/J * SM/J)
|
increased hemoglobin content
|
J:107220
|
Chcmq2SM/J/Chcmq2SM/J
(involves: C57BLKS/J * SM/J)
|
increased hemoglobin content
|
J:107220
|
Chd1tm1b(KOMP)Wtsi/Chd1+
(C57BL/6N-Chd1tm1b(KOMP)Wtsi/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Chd2Gt(RRBO46)Byg/Chd2+
(involves: 129P2/OlaHsd * C57BL/6)
|
extramedullary hematopoiesis
|
J:146743,
J:146176
|
Chd2Gt(RRBO46)Byg/Chd2Gt(RRBO46)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythropoiesis
|
J:146176
|
Chd2tm1b(EUCOMM)Hmgu/Chd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Chd2tm1b(EUCOMM)Hmgu/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean platelet volume
|
J:211773
|
Chd4tm1.1Kge/Chd4tm1.1Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * SJL)
|
arrested T cell differentiation
|
J:109547
|
| decreased double-positive T cell number
|
J:109547
|
Chd4tm1.2Kge/Chd4tm1.2Kge
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal T cell differentiation
|
J:109547
|
| decreased double-positive T cell number
|
J:109547
|
| increased double-negative T cell number
|
J:109547
|
Chd7tm2a(EUCOMM)Wtsi/Chd7+
(involves: 129S5/SvEvBrd * C57BL/6N)
|
decreased hematocrit
|
J:330596
|
| decreased hemoglobin content
|
J:330596
|
| decreased red blood cell distribution width
|
J:330596
|
Chd7Whi/Chd7+
(C3HeB/FeJ-Chd7Whi)
|
decreased hematocrit
|
J:330596
|
Chek2tm1Mak/Chek2+
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
| decreased double-negative T cell number
|
J:103922
|
Chia1tm1.1Lof/Chia1tm1.1Lof
(C57BL/6-Chia1tm1.1Lof)
|
increased neutrophil cell number
|
J:257728
|
Chmp4ctm1b(EUCOMM)Wtsi/Chmp4ctm1b(EUCOMM)Wtsi
(C57BL/6N-Chmp4ctm1b(EUCOMM)Wtsi/H)
|
decreased basophil cell number
|
J:211773
|
Chn1tm1.1(KOMP)Vlcg/Chn1tm1.1(KOMP)Vlcg
(B6N(Cg)-Chn1tm1.1(KOMP)Vlcg/J)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Chordc1em1(IMPC)Mbp/Chordc1+
(C57BL/6N-Chordc1em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Chordc1tm1Mbra/Chordc1+
(involves: 129 * C57BL/6)
|
abnormal myelopoiesis
|
J:222040
|
| anisocytosis
|
J:222040
|
| decreased hemoglobin content
|
J:222040
|
| increased nucleated erythrocyte cell number
|
J:222040
|
Chp1em1(IMPC)Tcp/Chp1+
(C57BL/6NCrl-Chp1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Chrac1tm1.1(KOMP)Vlcg/Chrac1tm1.1(KOMP)Vlcg
(C57BL/6N-Chrac1tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Chrna5em1(IMPC)H/Chrna5em1(IMPC)H
(C57BL/6N-Chrna5em1(IMPC)H/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Chrna7tm1Bay/Chrna7tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased neutrophil cell number
|
J:140280
|
Chrna10em1(IMPC)Mbp/Chrna10em1(IMPC)Mbp
(C57BL/6NCrl-Chrna10em1(IMPC)Mbp/MbpMmucd)
|
increased basophil cell number
|
J:211773
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6J)
|
myeloid hyperplasia
|
J:140280
|
Chst3tm1Tmu/Chst3tm1Tmu
(involves: 129S2/SvPas)
|
decreased neutrophil cell number
|
J:217719
|
Chst10em1(IMPC)Hmgu/Chst10em1(IMPC)Hmgu
(C57BL/6NCrl-Chst10em1(IMPC)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Chst15tm1Oh/Chst15tm1Oh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell morphology
|
J:165927
|
Chsy1em1(IMPC)Mbp/Chsy1em1(IMPC)Mbp
(C57BL/6NCrl-Chsy1em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Chsy1skt/Chsy1skt
Pde6b+/Pde6b+
(mixed)
|
decreased neutrophil cell number
|
J:286529
|
Chsy1tm1Lex/Chsy1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased red blood cell distribution width
|
J:171883
|
| increased mean corpuscular hemoglobin
|
J:171883
|
Chsy3em2(IMPC)Mbp/Chsy3em2(IMPC)Mbp
(C57BL/6NCrl-Chsy3em2(IMPC)Mbp/Mmucd)
|
increased mean platelet volume
|
J:211773
|
Chuktm2Mka/Chuktm2Mka
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma)
|
increased transitional stage B cell number
|
J:113556
|
Chuktm2Yhu/Chuktm2Yhu
Tg(Lor-CHUK)8Yhu/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased neutrophil cell number
|
J:197037
|
Ciao2atm2a(EUCOMM)Wtsi/Ciao2atm2a(EUCOMM)Wtsi
(C57BL/6N-Ciao2atm2a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
Ciao2bem1(IMPC)Ccpcz/Ciao2b+
(C57BL/6N-Ciao2bem1(IMPC)Ccpcz/Ccpcz)
|
increased neutrophil cell number
|
J:211773
|
Ciapin1tm1Yzka/Ciapin1tm1Yzka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal erythrocyte morphology
|
J:90889
|
| decreased erythrocyte cell number
|
J:90889
|
| decreased hematocrit
|
J:90889
|
| decreased hemoglobin content
|
J:90889
|
Cib1tm1b(EUCOMM)Hmgu/Cib1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cib1tm1b(EUCOMM)Hmgu/Bay)
|
decreased eosinophil cell number
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Cib2tm1b(EUCOMM)Wtsi/Cib2tm1b(EUCOMM)Wtsi
(C57BL/6N-Cib2tm1b(EUCOMM)Wtsi/H)
|
increased basophil cell number
|
J:211773
|
Cibar1tm1b(KOMP)Wtsi/Cibar1tm1b(KOMP)Wtsi
(C57BL/6N-Cibar1tm1b(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Cidectm1b(EUCOMM)Wtsi/Cidectm1b(EUCOMM)Wtsi
(C57BL/6N-Cidectm1b(EUCOMM)Wtsi/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Cigs2tm1.1Anse/Cigs2+
Il4tm1(CD2)Mmrs/Il4+
(involves: 129 * BALB/cJ * C57BL/6)
|
decreased basophil cell number
|
J:181313
|
Cigs2tm1.1Anse/Cigs2tm1.1Anse
(involves: BALB/cJ * C57BL/6)
|
abnormal class switch recombination
|
J:181313
|
Ciitam1Btlr/Ciitam1Btlr
(C57BL/6J-Ciitam1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:221483
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221483
|
Ciitatm1Ccum/Ciitatm1Ccum
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal T cell differentiation
|
J:64283
|
Ciitatm1Ccum/Ciitatm1Ccum
(NOD.129S2(B6)-Ciitatm1Ccum)
|
abnormal T cell differentiation
|
J:106081
|
Ciitatm1Jpyt/Ciitatm1Jpyt
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased double-positive T cell number
|
J:57100
|
Cilk1tm1b(KOMP)Mbp/Cilk1tm1b(KOMP)Mbp
(C57BL/6N-Cilk1tm1b(KOMP)Mbp/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Cimip2btm1(KOMP)Wtsi/Cimip2btm1(KOMP)Wtsi
(C57BL/6N-Cimip2btm1(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Cisd1em1(IMPC)Hmgu/Cisd1em1(IMPC)Hmgu
(C57BL/6N-Cisd1em1(IMPC)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Cishtm1.1Cdon/Cishtm1.1Cdon
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:204829
|
| increased eosinophil cell number
|
J:204829
|
Cishtm1.2Cdon/Cishtm1.2Cdon
(B6.129S6(Cg)-Cishtm1.2Cdon)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
| abnormal T-helper 2 cell differentiation
|
J:204829
|
| increased eosinophil cell number
|
J:204829
|
Ciz1Gt(IST13830B6)Tigm/Ciz1Gt(IST13830B6)Tigm
(B6J.B6N-Ciz1Gt(IST13830B6)Tigm)
|
increased neutrophil cell number
|
J:231433
|
Ckbtm1.1(KOMP)Wtsi/Ckbtm1.1(KOMP)Wtsi
(C57BL/6N-Ckbtm1.1(KOMP)Wtsi/Ucd)
|
decreased mean platelet volume
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Clca1tm1.1Lex/Clca1tm1.1Lex
(involves: 129S/SvEvBrd)
|
increased neutrophil cell number
|
J:125158
|
Clcc1tm1b(KOMP)Mbp/Clcc1+
(B6N(Cg)-Clcc1tm1b(KOMP)Mbp/2J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Clcn1em1(IMPC)Mbp/Clcn1em1(IMPC)Mbp
(C57BL/6NCrl-Clcn1em1(IMPC)Mbp/MbpMmucd)
|
decreased mean platelet volume
|
J:211773
|
Clcnkbem1(IMPC)Mbp/Clcnkbem1(IMPC)Mbp
(C57BL/6NCrl-Clcnkbem1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Cldn4tm1.1Jhou/Cldn4tm1.1Jhou
Tg(Aqp2-cre)1Dek/0
(B6.Cg-Cldn4tm1.1Jhou Tg(Aqp2-cre)1Dek)
|
increased hematocrit
|
J:216399
|
Cldn7tm1Yche/Cldn7tm1Yche
(involves: C57BL/6)
|
increased hematocrit
|
J:155363
|
Cldn9em1(IMPC)H/Cldn9em1(IMPC)H
(C57BL/6NTac-Cldn9em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
Cldn12tm1.1(KOMP)Vlcg/Cldn12tm1.1(KOMP)Vlcg
(B6J.B6N-Cldn12tm1.1(KOMP)Vlcg)
|
decreased erythrocyte cell number
|
J:279934
|
| increased mean corpuscular hemoglobin
|
J:279934
|
| macrocytosis
|
J:279934
|
Cldn13tm1.1(KOMP)Vlcg/Cldn13tm1.1(KOMP)Vlcg
(B6N(Cg)-Cldn13tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Cldn18tm1.1(KOMP)Vlcg/Cldn18tm1.1(KOMP)Vlcg
(C57BL/6N-Cldn18tm1.1(KOMP)Vlcg/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Clec1btm1Lex/Clec1btm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased hematocrit
|
J:161922
|
| decreased hemoglobin content
|
J:161922
|
| thrombocytopenia
|
J:161922
|
Clec4dtm1.1Cfg/Clec4dtm1.1Cfg
(involves: C57BL/6)
|
extramedullary hematopoiesis
|
J:217719
|
Clec4etm1.1Cfg/Clec4etm1.1Cfg
(B6.Cg-Clec4etm1.1Cfg)
|
decreased neutrophil cell number
|
J:136334
|
Clec4etm1Tks/Clec4etm1Tks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased neutrophil cell number
|
J:172959
|
Clec4gtm1.1Cfg/Clec4gtm1.1Cfg
(involves: C57BL/6)
|
increased erythrocyte cell number
|
J:217719
|
| thrombocytopenia
|
J:217719
|
Clec4ntm1Yiw/Clec4ntm1Yiw
(B6.129P2-Clec4ntm1Yiw)
|
abnormal CD4-positive T cell differentiation
|
J:160680
|
Clec10atm1Hed/Clec10atm1Hed
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased mean corpuscular hemoglobin
|
J:78035
|
| increased erythrocyte cell number
|
J:78035
|
| increased hematocrit
|
J:78035
|
| increased hemoglobin content
|
J:78035
|
| increased mean corpuscular volume
|
J:78035
|
| thrombocytosis
|
J:78035
|
Clic1tm1.1Breit/Clic1tm1.1Breit
(involves: 129 * C57BL/6J)
|
thrombocytosis
|
J:158394
|
Clic5jbg/Clic5jbg
(involves: C3H/HeJ * C57BL/6)
|
decreased eosinophil cell number
|
J:160186
|
| decreased neutrophil cell number
|
J:160186
|
Clk1tm1a(EUCOMM)Wtsi/Clk1tm1a(EUCOMM)Wtsi
(C57BL/6N-Clk1tm1a(EUCOMM)Wtsi/Ics)
|
decreased granulocyte number
|
J:165965
|
Clockem1(IMPC)Ccpcz/Clockem1(IMPC)Ccpcz
(C57BL/6NCrl-Clockem1(IMPC)Ccpcz/Ccpcz)
|
decreased red blood cell distribution width
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Clpptm1a(EUCOMM)Wtsi/Clpptm1a(EUCOMM)Wtsi
(C57BL/6N-Clpptm1a(EUCOMM)Wtsi/Wtsi)
|
decreased red blood cell distribution width
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Clptm1em1(IMPC)Tcp/Clptm1+
(C57BL/6NCrl-Clptm1em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Clptm1ltm1d(EUCOMM)Wtsi/Clptm1l+
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6N)
|
abnormal class switch recombination
|
J:265892
|
Clstn1tm1b(EUCOMM)Hmgu/Clstn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Clstn1tm1b(EUCOMM)Hmgu/H)
|
increased basophil cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Cltatm1.2Fmb/Cltatm1.2Fmb
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:235591
|
Cmklr1tm1Dgen/Cmklr1tm1Dgen
(B6.Cg-Cmklr1tm1Dgen)
|
abnormal definitive hematopoiesis
|
J:157190
|
| increased neutrophil cell number
|
J:157190
|
Cnga2em1(IMPC)H/Cnga2em1(IMPC)H
(C57BL/6N-Cnga2em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Cnn2tm1.2Jin/Cnn2tm1.2Jin
(B6.129X1-Cnn2tm1.2Jin)
|
decreased granulocyte number
|
J:141867
|
| decreased neutrophil cell number
|
J:141867
|
Cnn2tm1Jin/Cnn2tm1Jin
(B6.129X1-Cnn2tm1Jin)
|
decreased neutrophil cell number
|
J:141867
|
Cnot7em1(IMPC)Rbrc/Cnot7em1(IMPC)Rbrc
(C57BL/6NJcl-Cnot7em1(IMPC)Rbrc/Rbrc)
|
increased red blood cell distribution width
|
J:211773
|
Cnppd1tm1.1(KOMP)Vlcg/Cnppd1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cnppd1tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Cntd1em1(IMPC)Mbp/Cntd1em1(IMPC)Mbp
(C57BL/6NCrl-Cntd1em1(IMPC)Mbp/Mmucd)
|
increased mean corpuscular volume
|
J:211773
|
Cntnap5aem1(IMPC)J/Cntnap5aem1(IMPC)J
(C57BL/6NJ-Cntnap5aem1(IMPC)J/Mmjax)
|
decreased hematocrit
|
J:211773
|
Coasyem1(IMPC)H/Coasy+
(C57BL/6NTac-Coasyem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Cog2tm1a(KOMP)Wtsi/Cog2+
(B6JTyr;B6N-Cog2tm1a(KOMP)Wtsi/Wtsi)
|
increased hematocrit
|
J:175295
|
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased granulocyte number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Col1a1tm1(CAG-Mir22)Ppp/Col1a1tm1(CAG-Mir22)Ppp
Tg(Mx1-cre)1Cgn/0
(Not Specified)
|
abnormal erythropoiesis
|
J:199366
|
Col1a1tm1(tetO-cre)Haho/?
Gfi1btm1.1Haho/Gfi1btm1.1Haho
(involves: 129S4/SvJaeSor * C57BL/6)
|
absent platelets
|
J:207446
|
| decreased hemoglobin content
|
J:207446
|
| thrombocytopenia
|
J:207446
|
Col1a1tm1(tetO-Fos)Wag/Col1a1+
Tg(KRT5-rtTA)T2D6Sgkd/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
increased granulocyte number
|
J:201145
|
Col1a1tm1(tetO-GFP/RNAi:Rad21)Iaai/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:229031
|
| extramedullary hematopoiesis
|
J:229031
|
Col1a1tm1(tetO-Irf4)Sing/Col1a1tm1(tetO-Irf4)Sing
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Irf4tm1Mak/Irf4+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
| abnormal plasma cell differentiation
|
J:203903
|
Col1a1tm1(tetO-Irf4)Sing/Col1a1tm1(tetO-Irf4)Sing
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:203903
|
| abnormal plasma cell differentiation
|
J:203903
|
Col1a1tm1(tetO-RNAi:Rps19)Karl/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased erythrocyte cell number
|
J:179085
|
| macrocytosis
|
J:179085
|
| thrombocytosis
|
J:179085
|
Col1a1tm1(tetO-RNAi:Rps19)Karl/Col1a1tm1(tetO-RNAi:Rps19)Karl
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased erythrocyte cell number
|
J:179085
|
| decreased neutrophil cell number
|
J:179085
|
| macrocytosis
|
J:179085
|
| thrombocytopenia
|
J:179085
|
| thrombocytosis
|
J:179085
|
Col1a1tm1(tetO-U2AF1*S34F)Mjwa/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:221403
|
Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:229031
|
| extramedullary hematopoiesis
|
J:229031
|
| increased neutrophil cell number
|
J:229031
|
| myeloid hyperplasia
|
J:229031
|
| myeloid metaplasia
|
J:229031
|
Col1a1tm2(tetO-GFP/RNAi:Smc1a)Iaai/Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:229031
|
| myeloid hyperplasia
|
J:229031
|
Col1a1tm2(tetO-IDH2*R140Q)Ppp/Col1a1tm2(tetO-IDH2*R140Q)Ppp
Gt(ROSA)26Sortm1(rtTA*M2)Jae/?
(involves: 129S4/SvJae * C57BL/6)
|
extramedullary hematopoiesis
|
J:210097
|
Col1a1tm2(tetO-RNAi:Rps19)Karl/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased erythrocyte cell number
|
J:179085
|
| macrocytosis
|
J:179085
|
| thrombocytopenia
|
J:179085
|
| thrombocytosis
|
J:179085
|
Col1a1tm2(tetO-RNAi:Rps19)Karl/Col1a1tm2(tetO-RNAi:Rps19)Karl
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased erythrocyte cell number
|
J:179085
|
| decreased neutrophil cell number
|
J:179085
|
| macrocytosis
|
J:179085
|
| thrombocytopenia
|
J:179085
|
| thrombocytosis
|
J:179085
|
Col1a1tm3(tetO-GFP/RNAi:Stag2)Iaai/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:229031
|
Col1a1tm6(tetO-MSI2)Jae/Col1a1+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal erythrocyte morphology
|
J:163322
|
| abnormal myelopoiesis
|
J:163322
|
| decreased common myeloid progenitor cell number
|
J:163322
|
| decreased neutrophil cell number
|
J:163322
|
| increased erythrocyte cell number
|
J:163322
|
| increased hematocrit
|
J:163322
|
| increased mean corpuscular volume
|
J:163322
|
| thrombocytopenia
|
J:163322
|
Col1a2tm1b(EUCOMM)Wtsi/Col1a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col1a2tm1b(EUCOMM)Wtsi/BayMmucd)
|
increased neutrophil cell number
|
J:211773
|
Col4a1Acso/Col4a1+
(C3.Cg-Col4a1Acso)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1D456/Col4a1+
(C3.D2-Col4a1D456)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1ENU911/Col4a1+
(C3.Cg-Col4a1ENU911)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1ENU4004/Col4a1+
(C3.D2-Col4a1ENU4004)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1ENU6005/Col4a1+
(C3H/HeJ-Col4a1ENU6005)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1ENU6009/Col4a1+
(C3H/HeJ-Col4a1ENU6009)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1ENU6019/Col4a1+
(C3H/HeJ-Col4a1ENU6019)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1ENU6024/Col4a1+
(C3H/HeJ-Col4a1ENU6024)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a1F247/Col4a1+
(C3.Cg-Col4a1F247)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a2ENU415/Col4a2+
(C3.Cg-Col4a2ENU415)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a2ENU4003/Col4a2+
(C3.D2-Col4a2ENU4003)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a2ENU4020/Col4a2+
(C3.D2-Col4a2ENU4020)
|
decreased erythrocyte cell number
|
J:163225
|
| decreased hematocrit
|
J:163225
|
| decreased hemoglobin content
|
J:163225
|
Col4a3tm1b(EUCOMM)Wtsi/Col4a3tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a3tm1b(EUCOMM)Wtsi/H)
|
decreased basophil cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Col4a5tm1b(EUCOMM)Wtsi/Y
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| thrombocytosis
|
J:211773
|
Col4a5tm1b(EUCOMM)Wtsi/Col4a5tm1b(EUCOMM)Wtsi
(C57BL/6N-Col4a5tm1b(EUCOMM)Wtsi/Cnrm)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Col10a1tm1Bhr/Col10a1tm1Bhr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-positive T cell number
|
J:62230
|
| increased double-negative T cell number
|
J:62230
|
Col10a1tm1Ksec/Col10a1tm1Ksec
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:193886
|
Col11a2tm1b(KOMP)Wtsi/Col11a2+
(C57BL/6N-Col11a2tm1b(KOMP)Wtsi/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Col17a1tm1.1(COL17A1)Zliu/Col17a1tm1.1(COL17A1)Zliu
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased neutrophil cell number
|
J:261781
|
Col17a1tm1Tiin/Col17a1tm1Tiin
(involves: C57BL/6)
|
increased basophil cell number
|
J:220622
|
| increased eosinophil cell number
|
J:220622
|
| increased neutrophil cell number
|
J:220622
|
Col26a1em3(IMPC)Tcp/Col26a1em3(IMPC)Tcp
(C57BL/6NCrl-Col26a1em3(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Commd9tm1b(KOMP)Wtsi/Commd9+
(C57BL/6N-Commd9tm1b(KOMP)Wtsi/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Commd10Tg(Vav1-icre)A2Kio/0
Map3k7tm1.1Arte/Map3k7tm1.1Arte
(involves: C57BL/10 * C57BL/6J * C57BL/6NTac * CBA/Ca)
|
increased neutrophil cell number
|
J:332172
|
Copatm1.1Shum/Copa+
(B6(CBA)-Copatm1.1Shum)
|
decreased double-positive T cell number
|
J:288425
|
Copg1tm1a(EUCOMM)Wtsi/Copg1+
(C57BL/6N-Copg1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
| thrombocytosis
|
J:175295
|
Cops4tm1a(EUCOMM)Hmgu/Cops4+
(C57BL/6N-Cops4tm1a(EUCOMM)Hmgu/Ics)
|
increased hemoglobin content
|
J:165965
|
| increased mean corpuscular hemoglobin concentration
|
J:165965
|
Cops5tm1Rpar/Cops5tm1Rpar
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:132114
|
Coq8btm1b(EUCOMM)Hmgu/Coq8b+
(B6N(Cg)-Coq8btm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Coro1ctm1a(KOMP)Wtsi/Coro1c+
(C57BL/6N-Coro1ctm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Coro1ctm1d(KOMP)Wtsi/Coro1ctm1d(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal platelet morphology
|
J:290447
|
| thrombocytosis
|
J:290447
|
Cotl1tm1b(EUCOMM)Hmgu/Cotl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cotl1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
Cptm1b(KOMP)Wtsi/Cptm1b(KOMP)Wtsi
(B6N(Cg)-Cptm1b(KOMP)Wtsi/J)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Cpa3tm1Hrr/Cpa3tm1Hrr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell morphology
|
J:99367
|
Cpa3tm3(icre)Hrr/Cpa3+
(B6.129P2-Cpa3tm3(icre)Hrr)
|
absent mast cells
|
J:178942
|
| decreased basophil cell number
|
J:178942
|
Cpa3tm3(icre)Hrr/Cpa3+
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
absent mast cells
|
J:221184
|
Cpa3tm3(icre)Hrr/Cpa3+
Gt(ROSA)26Sortm1Hjf/?
Notch1tm1Agt/Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal dendritic cell differentiation
|
J:143731
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
Cpa3tm3(icre)Hrr/Cpa3+
Notch1tm1Agt/Notch1tm1Agt
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:143731
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:143731
|
| decreased double-negative T cell number
|
J:143731
|
| decreased double-positive T cell number
|
J:143731
|
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
(C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg)
|
increased hematocrit
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Cpeb4tm1a(EUCOMM)Wtsi/Cpeb4tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal erythropoiesis
|
J:232458
|
| abnormal fetal derived definitive erythrocyte morphology
|
J:232458
|
| decreased fetal derived definitive erythrocyte cell number
|
J:232458
|
Cplx4em1(IMPC)H/Cplx4em1(IMPC)H
(C57BL/6NTac-Cplx4em1(IMPC)H/H)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
CpoxRbc16/Cpox+
(involves: C57BL/6)
|
abnormal erythrocyte morphology
|
J:244493
|
| decreased mean corpuscular volume
|
J:244493
|
| increased red blood cell distribution width
|
J:244493
|
CpoxRgsc0129/Cpox+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Cpqem1(IMPC)Tcp/Cpqem1(IMPC)Tcp
(C57BL/6N-Cpqem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Cps1em1(IMPC)H/Cps1+
(C57BL/6NTac-Cps1em1(IMPC)H/H)
|
decreased neutrophil cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Cr2tm1Crr/Cr2tm1Crr
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased neutrophil cell number
|
J:66111
|
Cr2tm1Hmo/Cr2tm1Hmo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
| abnormal memory B cell differentiation
|
J:151991
|
Cr2tm2.1(HLA-A)Crr/Cr2tm2.1(HLA-A)Crr
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:151991
|
| abnormal memory B cell differentiation
|
J:151991
|
Crabp2em1(IMPC)Mbp/Crabp2em1(IMPC)Mbp
(C57BL/6N-Crabp2em1(IMPC)Mbp/MbpMmucd)
|
decreased erythrocyte cell number
|
J:211773
|
Crbntm1.1Ble/Crbntm1.1Ble
(involves: C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:267091
|
| decreased granulocyte number
|
J:267091
|
| thrombocytopenia
|
J:267091
|
Crebbptm1Dli/Crebbp+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:191503
|
| abnormal definitive hematopoiesis
|
J:191503,
J:60630
|
| abnormal granulocyte morphology
|
J:191503
|
| decreased common myeloid progenitor cell number
|
J:191503,
J:60630
|
| extramedullary hematopoiesis
|
J:60630
|
| increased granulocyte number
|
J:191503
|
Crebbptm1Jvd/Crebbptm1Jvd
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:105505
|
| increased double-negative T cell number
|
J:105505
|
Crebbptm1Jvd/Crebbptm1Jvd
Tg(Lck-cre)548Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:105505
|
Crebbptm1Jvd/Crebbptm1Jvd
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6 * FVB)
|
decreased double-positive T cell number
|
J:88323
|
cri/cri
(involves: DBA/2J)
|
abnormal erythrocyte cell number
|
J:5277
|
| decreased erythrocyte cell number
|
J:5277
|
| decreased neutrophil cell number
|
J:6327
|
Cripttm1.1(KOMP)Vlcg/Cript+
(B6N(Cg)-Cripttm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Crlf2em1(IMPC)Mbp/Crlf2em1(IMPC)Mbp
(C57BL/6N-Crlf2em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Crlf2tm1Wjl/Crlf2tm1Wjl
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:108209
|
Crlf3em1(IMPC)Wtsi/Crlf3em1(IMPC)Wtsi
(C57BL/6N-Crlf3em1(IMPC)Wtsi/WtsiH)
|
increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Crlf3tm1a(KOMP)Wtsi/Crlf3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Crlf3tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin concentration
|
J:175295
|
| increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin concentration
|
J:175295
|
| thrombocytopenia
|
J:165965
|
Crlf3tm1b(KOMP)Wtsi/Crlf3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Crlf3tm1b(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Crppaem1(IMPC)H/Crppa+
(C57BL/6NTac-Crppaem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Csf1op/Csf1op
(B6C3Fe a/a-Csf1op/J)
|
extramedullary hematopoiesis
|
J:26978
|
Csf1op/Csf1op
Csf2tm1Ard/Csf2tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
extramedullary hematopoiesis
|
J:19089
|
| increased hemoglobin content
|
J:19089
|
| increased neutrophil cell number
|
J:19089
|
| polycythemia
|
J:19089
|
Csf1tm1.2Sabw/Csf1tm1.2Sabw
(involves: 129S4/SvJaeSor * C57BL/6)
|
increased granulocyte number
|
J:180199
|
Csf1rtm1Ers/Csf1rtm1Ers
(involves: 129X1/SvJ * C3Heb/FeJ * C57BL/6J)
|
increased granulocyte number
|
J:73663
|
Csf1rtm1Ers/Csf1rtm1Ers
(FVB.129X1-Csf1rtm1Ers)
|
abnormal macrophage differentiation
|
J:112594
|
Csf2tm1Dran/Csf2tm1Dran
Ifngtm1Ts/Ifngtm1Ts
Il3tm1Glli/Il3tm1Glli
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased eosinophil cell number
|
J:83086
|
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(B6.129S2-Csf2tm1Dran Il3tm1Glli)
|
increased eosinophil cell number
|
J:67404
|
Csf2tm1Dran/Csf2tm1Dran
Il3tm1Glli/Il3tm1Glli
(C.129S2-Csf2tm1Dran Il3tm1Glli)
|
increased eosinophil cell number
|
J:67404
|
Csf2rbtm1Cgb/Csf2rbtm1Cgb
(involves: 129S1/Sv * C57BL/6)
|
decreased eosinophil cell number
|
J:29737
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased eosinophil cell number
|
J:35829
|
Csf2rbtm1Mur/Csf2rbtm1Mur
(involves: 129P2/OlaHsd)
|
decreased eosinophil cell number
|
J:24122
|
Csf2rbtm1Mur/Csf2rbtm1Mur
Il3tm1Tyb/Il3tm1Tyb
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased eosinophil cell number
|
J:35829
|
Csf2rbtm2b(EUCOMM)Hmgu/Csf2rb+
(C57BL/6N-Csf2rbtm2b(EUCOMM)Hmgu/Orl)
|
increased eosinophil cell number
|
J:211773
|
Csf3em1(IMPC)H/Csf3em1(IMPC)H
(C57BL/6NTac-Csf3em1(IMPC)H/H)
|
decreased eosinophil cell number
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Csf3tm1Ard/Csf3+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased neutrophil cell number
|
J:20400
|
Csf3tm1Ard/Csf3tm1Ard
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased neutrophil cell number
|
J:20400
|
| impaired myelopoiesis
|
J:20400
|
Csf3rtm1Eur/Csf3rtm1Eur
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal neutrophil differentiation
|
J:48503
|
| decreased neutrophil cell number
|
J:48503
|
Csf3rtm1Link/Csf3rtm1Link
(involves: 129X1/SvJ * NIH Black Swiss)
|
decreased neutrophil cell number
|
J:37618
|
Csf3rtm2Eur/Csf3rtm2Eur
(involves: 129P2/OlaHsd * FVB)
|
decreased neutrophil cell number
|
J:185115
|
Csf3rtm3Link/Csf3rtm3Link
(involves: 129X1/SvJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:67612
|
| decreased neutrophil cell number
|
J:67612
|
Csf3rtm4(Epor)Link/Csf3rtm4(Epor)Link
(involves: 129X1/SvJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:79825
|
| decreased granulocyte number
|
J:79825
|
| decreased neutrophil cell number
|
J:79825
|
Csf3rtm4(Epor)Link/Csf3rtm4(Epor)Link
(B6.129X1-Csf3rtm4(Epor)Link)
|
decreased neutrophil cell number
|
J:79567
|
Csktm1Sor/Csk+
Ptprcltng/Ptprctm1Mak
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
Csktm1Tara/Csktm1Tara
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CB20 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:49654
|
Csktm1Tara/Csktm2Tara
Elanetm1(cre)Roes/Elane+
(involves: 129P2/OlaHsd * CB20 * C57BL/6)
|
abnormal myelopoiesis
|
J:89716
|
Csnk1a1tm1c(KOMP)Wtsi/Csnk1a1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
decreased common myeloid progenitor cell number
|
J:216977
|
Csnk1a1tm1c(KOMP)Wtsi/Csnk1a1tm1c(KOMP)Wtsi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
abnormal blood cell morphology
|
J:216977
|
| extramedullary hematopoiesis
|
J:216977
|
Csnk1g1em1(IMPC)J/Csnk1g1em1(IMPC)J
(C57BL/6NJ-Csnk1g1em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Csnk1g2tm1b(EUCOMM)Wtsi/Csnk1g2tm1b(EUCOMM)Wtsi
(C57BL/6N-Csnk1g2tm1b(EUCOMM)Wtsi/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Csnk1g3tm1a(EUCOMM)Wtsi/Csnk1g3tm1a(EUCOMM)Wtsi
(C57BL/6N-Csnk1g3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Csnk2a2em1(IMPC)Mbp/Csnk2a2em1(IMPC)Mbp
(C57BL/6N-Csnk2a2em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Ctcftm2Gal/Ctcftm2Gal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6 * C57BL/10)
|
decreased double-positive T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
| increased double-negative T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * DBA/2J)
|
abnormal T cell differentiation
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
Ctcftm2Gal/Ctcftm2Gal
Tg(Lck-cre)1Cwi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:143271
|
| decreased double-positive T cell number
|
J:143271
|
| increased double-negative T cell number
|
J:143271
|
Ctla4tm1All/Ctla4tm1All
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:42481
|
| increased double-negative T cell number
|
J:42481
|
Ctla4tm1All/Ctla4tm1All
Tg(TcrAND)53Hed/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:119845
|
Ctla4tm1Shr/Ctla4tm1Shr
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal T cell differentiation
|
J:30393
|
| decreased double-positive T cell number
|
J:30393
|
| increased double-negative T cell number
|
J:30393
|
Ctnna2cdf/Ctnna2cdf
(C3Sn.C3-Ctnna2cdf/J)
|
increased erythrocyte cell number
|
J:38887
|
Ctnnb1tm1(Nfkbia)Rsu/Ctnnb1+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased granulocyte number
|
J:71744
|
Ctnnb1tm1Mmt/Ctnnb1+
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
extramedullary hematopoiesis
|
J:178340
|
Ctnnb1tm2(Nfkbia)Rsu/Ctnnb1+
Tg(CMV-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased granulocyte number
|
J:71744
|
Ctnnb1tm2Kem/Ctnnb1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Cdh5-cre)7Mlia/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/c * C57BL/6 * FVB/N)
|
abnormal definitive hematopoiesis
|
J:135172
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Ppargtm1.1(tTA)Jmgr/Pparg+
Tg(tetO-cre)1Jaw/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
extramedullary hematopoiesis
|
J:178340
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
cutaneous mastocytosis
|
J:204142
|
Ctnnb1tm4Wbm/Ctnnb1tm4Wbm
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd)
|
increased neutrophil cell number
|
J:202499
|
Ctnnbip1tm1b(EUCOMM)Wtsi/Ctnnbip1+
(C57BL/6N-Ctnnbip1tm1b(EUCOMM)Wtsi/H)
|
thrombocytosis
|
J:211773
|
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Ctsdtm1.1Thre/Ctsdtm1.1Thre
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6N * CBA * SJL)
|
decreased double-positive T cell number
|
J:227618
|
Ctsdtm1.1Thre/Ctsdtm1.1Thre
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased double-positive T cell number
|
J:227618
|
Ctsdtm1b(EUCOMM)Wtsi/Ctsd+
(C57BL/6N-Ctsdtm1b(EUCOMM)Wtsi/Ics)
|
decreased hematocrit
|
J:211773
|
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
decreased double-positive T cell number
|
J:28201
|
Ctsetm1Kjy/Ctsetm1Kjy
(involves: C57BL/6)
|
increased double-positive T cell number
|
J:108745
|
| increased eosinophil cell number
|
J:108745
|
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal myelopoiesis
|
J:84230,
J:86458
|
| extramedullary hematopoiesis
|
J:84230
|
| thrombocytopenia
|
J:84230
|
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:166479
|
Ctsgtm2.1(PML/RARA)Ley/Ctsg+
Elanetm1Sds/Elanetm1Sds
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6)
|
abnormal myelopoiesis
|
J:86458
|
Ctsgtm3.1(PML/RARA)Ley/Ctsg+
(involves: 129 * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:166479
|
Ctslm1Btlr/Ctslm1Btlr
(C57BL/6J-Ctslm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272869
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272869
|
| abnormal T cell differentiation
|
J:272869
|
Ctsmtm1(KOMP)Wtsi/Ctsmtm1(KOMP)Wtsi
(C57BL/6N-Ctsmtm1(KOMP)Wtsi/Nju)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ctsotm2b(KOMP)Wtsi/Ctsotm2b(KOMP)Wtsi
(C57BL/6N-Ctsotm2b(KOMP)Wtsi/Cnrm)
|
increased mean platelet volume
|
J:211773
|
Ctsstm1Hap/Ctsstm1Hap
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
increased neutrophil cell number
|
J:100854
|
Ctszem1(IMPC)H/Ctszem1(IMPC)H
(C57BL/6NTac-Ctszem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Cttnbp2tm1b(KOMP)Wtsi/Cttnbp2tm1b(KOMP)Wtsi
(C57BL/6N-Cttnbp2tm1b(KOMP)Wtsi/Wtsi)
|
decreased transitional stage T1 B cell number
|
J:211773
|
Cttnbp2nlem1(IMPC)J/Cttnbp2nlem1(IMPC)J
(C57BL/6NJ-Cttnbp2nlem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ctu2tm1(KOMP)Wtsi/Ctu2+
(C57BL/6N-Ctu2tm1(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Cuedc1em1(IMPC)J/Cuedc1em1(IMPC)J
(C57BL/6NJ-Cuedc1em1(IMPC)J/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Cul4a/Pcid2tm2Ktc/Cul4a/Pcid2tm2Ktc
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
abnormal definitive hematopoiesis
|
J:138468
|
| decreased hematocrit
|
J:138468
|
| decreased neutrophil cell number
|
J:138468
|
| thrombocytopenia
|
J:138468
|
Cul4a/Pcid2tm2Ktc/Cul4a/Pcid2tm2Ktc
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA * FVB/N)
|
abnormal definitive hematopoiesis
|
J:138468
|
| decreased hematocrit
|
J:138468
|
| decreased neutrophil cell number
|
J:138468
|
| thrombocytopenia
|
J:138468
|
Cul4atm1b(EUCOMM)Hmgu/Cul4atm1b(EUCOMM)Hmgu
(C57BL/6N-Cul4atm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Cux1tm1Rhsc/Cux1tm1Rhsc
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myelopoiesis
|
J:100055
|
| abnormal T cell differentiation
|
J:100055
|
| decreased double-positive T cell number
|
J:100055
|
Cxcl5tm1.1Mkch/Cxcl5tm1.1Mkch
(B6.129P2-Cxcl5tm1.1Mkch)
|
decreased neutrophil cell number
|
J:208901
|
Cxcl5tm1Gscw/Cxcl5tm1Gscw
(involves: 129)
|
increased granulocyte number
|
J:162629
|
Cxcl9tm1b(EUCOMM)Wtsi/Cxcl9tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl9tm1b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
Cxcl12tm1.1(KOMP)Vlcg/Cxcl12+
(C57BL/6N-Cxcl12tm1.1(KOMP)Vlcg/Ucd)
|
thrombocytopenia
|
J:211773
|
Cxcl12tm1.1Sjm/Cxcl12tm1.1Sjm
Tg(Prrx1-cre)1Cjt/?
(involves: C57BL/6 * SJL/J)
|
abnormal B cell differentiation
|
J:194748
|
Cxcl12tm1.1Ystz/Cxcl12tm1.2Ystz
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
decreased pro-B cell number
|
J:168434
|
| increased neutrophil cell number
|
J:168434
|
Cxcl12tm1Tng/Cxcl12tm1.1Link
Tg(Prrx1-cre)1Cjt/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL/J)
|
decreased common myeloid progenitor cell number
|
J:193594
|
| decreased pre-pro B cell number
|
J:193594
|
Cxcl12tm1Tng/Cxcl12tm1.1Link
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N)
|
decreased pre-pro B cell number
|
J:193594
|
Cxcl12tm1Tng/Cxcl12tm1Tng
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:34750
|
| impaired myelopoiesis
|
J:49070
|
Cxcl12tm3.1(HBEGF/EGFP)Tng/Cxcl12+
(B6.Cg-Cxcl12tm3.1(HBEGF/EGFP)Tng)
|
decreased common myeloid progenitor cell number
|
J:164657
|
| decreased pro-B cell number
|
J:164657
|
Cxcl13em2(IMPC)H/Cxcl13em2(IMPC)H
(C57BL/6NTac-Cxcl13em2(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
Cxcl15tm1Lira/Cxcl15tm1Lira
(involves: 129 * C57BL/6J)
|
decreased neutrophil cell number
|
J:67605
|
Cxcl17tm1b(EUCOMM)Wtsi/Cxcl17tm1b(EUCOMM)Wtsi
(C57BL/6N-Cxcl17tm1b(EUCOMM)Wtsi/Ucd)
|
increased mean platelet volume
|
J:211773
|
Cxcr1tm1a(EUCOMM)Wtsi/Cxcr1tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr1tm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
(involves: 129S2/SvPas * C57BL/6)
|
increased granulocyte number
|
J:113489
|
Cxcr2tm1a(EUCOMM)Wtsi/Cxcr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Cxcr2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased immature B cell number
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased pre-pro B cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased granulocyte number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal granulocyte differentiation
|
J:19570
|
| abnormal myelopoiesis
|
J:19570
|
| increased neutrophil cell number
|
J:19570
|
| myeloid hyperplasia
|
J:19570
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(involves: 129S2/SvPas * BALB/c)
|
abnormal myelopoiesis
|
J:113489
|
| extramedullary hematopoiesis
|
J:113489
|
| increased granulocyte number
|
J:113489
|
Cxcr4tm1.1Bala/Cxcr4+
(B6.129S2-Cxcr4tm1.1Bala)
|
abnormal neutrophil morphology
|
J:186735
|
| decreased immature B cell number
|
J:186735
|
Cxcr4tm1Qma/Cxcr4tm1Qma
(involves: 129X1/SvJ)
|
decreased pro-B cell number
|
J:49070
|
| impaired myelopoiesis
|
J:49070
|
Cxcr4tm1Tng/Cxcr4tm1Tng
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:69256
|
| failure of myelopoiesis
|
J:69256
|
Cxcr4tm1Tng/Cxcr4tm1Tng
(B6.Cg-Cxcr4tm1Tng)
|
abnormal T cell differentiation
|
J:82996
|
| decreased double-positive T cell number
|
J:82996
|
Cxcr4tm1Yzo/Cxcr4tm1Yzo
(Not Specified)
|
abnormal B cell differentiation
|
J:167314
|
| abnormal leukopoiesis
|
J:69255
|
| abnormal lymphopoiesis
|
J:69255
|
| impaired myelopoiesis
|
J:69255
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:94911
|
Cxcr4tm2Yzo/Cxcr4tm2Yzo
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neutrophil cell number
|
J:217569
|
Cxcr4tm2Yzo/Cxcr4tm3.1Yzo
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:167314
|
Cxcr4tm3.1Yzo/Cxcr4tm3.1Yzo
(Not Specified)
|
decreased pro-B cell number
|
J:167314
|
| impaired myelopoiesis
|
J:167314
|
Cyb561tm1a(EUCOMM)Wtsi/Cyb561tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Cyb561tm1a(EUCOMM)Wtsi/Wtsi)
|
increased erythrocyte cell number
|
J:175295
|
| increased hematocrit
|
J:175295
|
| increased hemoglobin content
|
J:175295
|
Cyb561a3tm2b(EUCOMM)Hmgu/Cyb561a3tm2b(EUCOMM)Hmgu
(C57BL/6N-Cyb561a3tm2b(EUCOMM)Hmgu/Ieg)
|
decreased mean platelet volume
|
J:211773
|
Cybatm1a(EUCOMM)Wtsi/Cybatm1a(EUCOMM)Wtsi
(C57BL/6N-Cybatm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din/J)
|
increased neutrophil cell number
|
J:235399
|
Cybbtm2b(KOMP)Wtsi/Cybbtm2b(KOMP)Wtsi
(C57BL/6N-Cybbtm2b(KOMP)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
Cyldtm1.1Awai/Cyldtm1.1Awai
(Not Specified)
|
abnormal B cell differentiation
|
J:126113
|
| abnormal class switch recombination
|
J:126113
|
| decreased immature B cell number
|
J:126113
|
| increased pro-B cell number
|
J:126113
|
Cyldtm1Awai/Cyldtm1Awai
Tg(CD19-cre/ERT2)1Cgn/?
(Not Specified)
|
decreased immature B cell number
|
J:126113
|
Cyldtm1Scs/Cyldtm1Scs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112392
|
| increased double-positive T cell number
|
J:112392
|
Cyp1a1tm1.1Dwn/Cyp1a1tm1.1Dwn
(B6.129P2-Cyp1a1tm1.1Dwn)
|
abnormal hemoglobin content
|
J:163973
|
| decreased hematocrit
|
J:163973
|
| increased hemoglobin content
|
J:163973
|
| increased neutrophil cell number
|
J:163973
|
Cyp1a1tm4.1Dwn/Cyp1a1tm4.1Dwn
(B6.129X1-Cyp1a1tm4.1Dwn)
|
abnormal hemoglobin content
|
J:163973
|
| decreased hematocrit
|
J:163973
|
| increased hemoglobin content
|
J:163973
|
| increased neutrophil cell number
|
J:163973
|
Cyp2c23tm1b(EUCOMM)Hmgu/Cyp2c23tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp2c23tm1b(EUCOMM)Hmgu/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Cyp19a1tm1b(EUCOMM)Hmgu/Cyp19a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cyp19a1tm1b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
increased granulocyte number
|
J:92438
|
Cyp27a1tm1.1(KOMP)Vlcg/Cyp27a1tm1.1(KOMP)Vlcg
(C57BL/6N-Cyp27a1tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean platelet volume
|
J:211773
|
Cyrenem1Vokh/Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
abnormal class switch recombination
|
J:306598
|
Cyrentm1.1(KOMP)Vlcg/Cyrentm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal class switch recombination
|
J:265834
|
Cyribm1Ivdi/Cyribm1Ivdi
(involves: 129S1/Sv * 129X1/SvJ * DBA/2J)
|
increased neutrophil cell number
|
J:282597
|
Cys1cpk/Cys1cpk
(B6(Cg)-Cys1cpk/J)
|
decreased hematocrit
|
J:9290
|
Cystm1tm1b(EUCOMM)Hmgu/Cystm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Cystm1tm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Cyth2tm1d(EUCOMM)Wtsi/Cyth2tm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased eosinophil cell number
|
J:307633
|
D5Ertd579eem1(IMPC)J/D5Ertd579eem1(IMPC)J
(C57BL/6NJ-D5Ertd579eem1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
D6Wsu163etm1b(EUCOMM)Wtsi/D6Wsu163etm1b(EUCOMM)Wtsi
(C57BL/6N-D6Wsu163etm1b(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
D16Ertd472etm1b(EUCOMM)Wtsi/D16Ertd472etm1b(EUCOMM)Wtsi
(C57BL/6N-D16Ertd472etm1b(EUCOMM)Wtsi/Orl)
|
decreased mean corpuscular volume
|
J:211773
|
D130043K22Riktm1b(KOMP)Wtsi/D130043K22Riktm1b(KOMP)Wtsi
(C57BL/6N-D130043K22Riktm1b(KOMP)Wtsi/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Daam2tm1b(KOMP)Wtsi/Daam2tm1b(KOMP)Wtsi
(C57BL/6N-Daam2tm1b(KOMP)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:211773
|
Dach2em1(IMPC)Ccpcz/Dach2em1(IMPC)Ccpcz
(C57BL/6NCrl-Dach2em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Dact2tm1b(EUCOMM)Wtsi/Dact2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dact2tm1b(EUCOMM)Wtsi/Bay)
|
increased mean corpuscular volume
|
J:211773
|
Dazap1em1(IMPC)Ccpcz/Dazap1+
(C57BL/6NCrl-Dazap1em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Dbn1tm1a(KOMP)Wtsi/Dbn1tm1a(KOMP)Wtsi
(C57BL/6N-Dbn1tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular volume
|
J:175295
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/Ieg)
|
decreased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Dbndd2tm1b(EUCOMM)Wtsi/Dbndd2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dbndd2tm1b(EUCOMM)Wtsi/Tcp)
|
thrombocytosis
|
J:211773
|
Dbnltm1b(KOMP)Wtsi/Dbnltm1b(KOMP)Wtsi
(C57BL/6N-Dbnltm1b(KOMP)Wtsi/Orl)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Dbr1Gt(YTA280)Byg/Dbr1+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:223318
|
Dcaf10tm1.1(KOMP)Vlcg/Dcaf10tm1.1(KOMP)Vlcg
(C57BL/6N-Dcaf10tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Dcaf11tm1a(KOMP)Wtsi/Dcaf11tm1a(KOMP)Wtsi
(C57BL/6N-Dcaf11tm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
Dcaf12em1(IMPC)Ccpcz/Dcaf12em1(IMPC)Ccpcz
(C57BL/6N-Dcaf12em1(IMPC)Ccpcz/Ccpcz)
|
increased neutrophil cell number
|
J:211773
|
DccTg(H2-Kb-Jak2*V617F)1Shmd/Dcc+
(involves: C57BL/6 * DBA/2)
|
abnormal definitive hematopoiesis
|
J:130189
|
| abnormal neutrophil morphology
|
J:130189
|
| decreased hematocrit
|
J:130189
|
| increased granulocyte number
|
J:130189
|
| myeloid hyperplasia
|
J:130189
|
| polycythemia
|
J:130189
|
| thrombocytosis
|
J:130189
|
Dcctm1b(NCOM)Mfgc/Dcc+
(C57BL/6N-Dcctm1b(NCOM)Mfgc/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Dcdc2btm1b(KOMP)Wtsi/Dcdc2btm1b(KOMP)Wtsi
(C57BL/6N-Dcdc2btm1b(KOMP)Wtsi/Wtsi)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Dckmemi/Dckmemi
(C57BL/6J-Dckmemi)
|
abnormal T cell differentiation
|
J:184080
|
Dcktm1.1Radu/Dcktm1.1Radu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal double-negative T cell morphology
|
J:158373
|
| abnormal T cell differentiation
|
J:158373
|
| decreased double-positive T cell number
|
J:158373
|
| extramedullary hematopoiesis
|
J:158373
|
| increased double-negative T cell number
|
J:158373
|
| increased pro-B cell number
|
J:158373
|
Dclre1cm1Brck/Dclre1cm1Brck
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:207533
|
| decreased DN4 thymocyte number
|
J:207533
|
| decreased double-positive T cell number
|
J:207533
|
Dclre1cm1Btlr/Dclre1cm1Btlr
(C57BL/6J-Dclre1cm1Btlr)
|
increased neutrophil cell number
|
J:217790
|
Dclre1ctm1.1Fwa/Dclre1ctm1.1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:80995
|
| arrested T cell differentiation
|
J:80995
|
Dclre1ctm1.1Jpdv/Dclre1ctm1.1Jpdv
(involves: 129P1/ReJ)
|
abnormal B cell differentiation
|
J:137743
|
| abnormal T cell receptor V(D)J recombination
|
J:194422
|
| arrested T cell differentiation
|
J:137712
|
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
absent immature B cells
|
J:80995
|
| arrested B cell differentiation
|
J:80995
|
| arrested T cell differentiation
|
J:80995
|
Dclre1ctm1Fwa/Dclre1ctm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
| arrested B cell differentiation
|
J:147864
|
| decreased double-positive T cell number
|
J:147864
|
Dclre1ctm1Jsek/Dclre1ctm1Jsek
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:147864
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:147864
|
| decreased double-positive T cell number
|
J:147864
|
| increased pro-B cell number
|
J:147864
|
Dclre1ctm2.1Jpdv/Dclre1ctm2.2Jpdv
Tg(Cr2-cre)3Cgn/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:153841
|
Dclre1ctm2.2Jpdv/Dclre1ctm2.2Jpdv
(B6.129S2-Dclre1ctm2.2Jpdv)
|
absent immature B cells
|
J:153841
|
| arrested B cell differentiation
|
J:153841
|
| arrested T cell differentiation
|
J:153841
|
| decreased double-positive T cell number
|
J:153841
|
Dclre1ctm2Mcow/Dclre1ctm2Mcow
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:96535
|
| arrested T cell differentiation
|
J:96535
|
Dctn5tm2a(KOMP)Wtsi/Dctn5+
(B6JTyr;B6N-Dctn5tm2a(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:175295
|
| increased hematocrit
|
J:175295
|
Dcun1d3em1(IMPC)Wtsi/Dcun1d3em1(IMPC)Wtsi
(C57BL/6N-Dcun1d3em1(IMPC)Wtsi/WtsiIeg)
|
increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Ddah1tm2a(EUCOMM)Wtsi/Ddah1tm2a(EUCOMM)Wtsi
(C57BL/6N-Ddah1tm2a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
Ddosttm1.1(KOMP)Vlcg/Ddost+
(C57BL/6N-Ddosttm1.1(KOMP)Vlcg/Ucd)
|
decreased hemoglobin content
|
J:211773
|
Ddrgk1em1Brle/Ddrgk1em1Brle
(C57BL/6J-Ddrgk1em1Brle)
|
decreased erythrocyte cell number
|
J:243374
|
Ddrgk1tm1b(EUCOMM)Hmgu/Ddrgk1tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal embryonic erythropoiesis
|
J:231701
|
| decreased common myeloid progenitor cell number
|
J:231701
|
| decreased erythrocyte cell number
|
J:231701
|
Ddrgk1tm1c(EUCOMM)Hmgu/Ddrgk1tm1c(EUCOMM)Hmgu
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)
|
abnormal embryonic erythropoiesis
|
J:231701
|
| decreased erythrocyte cell number
|
J:231701
|
| decreased granulocyte number
|
J:231701
|
| decreased hemoglobin content
|
J:231701
|
Ddx6em1(IMPC)Mbp/Ddx6+
(C57BL/6N-Ddx6em1(IMPC)Mbp/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ddx46em1(IMPC)Tcp/Ddx46+
(C57BL/6N-Ddx46em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ddx55tm1a(EUCOMM)Wtsi/Ddx55+
(C57BL/6N-Ddx55tm1a(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Def6Gt(OST307148)Lex/Def6Gt(OST307148)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased immature B cell number
|
J:106469
|
Defb3tm1Xen/Defb3tm1Xen
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:199719
|
Defb14tm1b(KOMP)Wtsi/Defb14tm1b(KOMP)Wtsi
(C57BL/6N-Defb14tm1b(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Del(1)1Brk/Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal erythrocyte morphology
|
J:103440
|
| anisopoikilocytosis
|
J:103440
|
| decreased hematocrit
|
J:103440
|
| decreased hemoglobin content
|
J:103440
|
| decreased mean corpuscular hemoglobin
|
J:103440
|
| decreased mean corpuscular hemoglobin concentration
|
J:103440
|
| decreased mean corpuscular volume
|
J:103440
|
| increased erythrocyte cell number
|
J:103440
|
| thrombocytosis
|
J:103440
|
Del(1)1Brk/Del(1)1Brk
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal erythrocyte morphology
|
J:100202
|
| anisocytosis
|
J:100202
|
| anisopoikilocytosis
|
J:100202
|
| decreased hematocrit
|
J:100202
|
| decreased hemoglobin content
|
J:100202
|
| decreased mean corpuscular hemoglobin
|
J:100202
|
| decreased mean corpuscular hemoglobin concentration
|
J:100202
|
| decreased mean corpuscular volume
|
J:100202
|
| microcytosis
|
J:100202
|
| polychromatophilia
|
J:100202
|
| thrombocytosis
|
J:100202
|
Del(1)1Brk/Del(1)1Brk
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal erythrocyte morphology
|
J:103440
|
| abnormal hemoglobin
|
J:103440
|
| anisopoikilocytosis
|
J:103440
|
| decreased hematocrit
|
J:103440
|
| decreased hemoglobin content
|
J:103440
|
| decreased mean corpuscular hemoglobin
|
J:103440
|
| decreased mean corpuscular hemoglobin concentration
|
J:103440
|
| decreased mean corpuscular volume
|
J:103440
|
| increased erythrocyte cell number
|
J:103440
|
| thrombocytosis
|
J:103440
|
Del(2Cd59b-Cd59a)1Jha/Del(2Cd59b-Cd59a)1Jha
(B6.129-Del(2Cd59b-Cd59a)1Jha)
|
decreased hemoglobin content
|
J:170754
|
Del(4C4-C5)1Lap/Del(4C4-C5)1Lap
(involves: 129S6/SvEvTac)
|
extramedullary hematopoiesis
|
J:158126
|
Del(9Cd3g-Cd3d)1Cpt/Del(9Cd3g-Cd3d)1Cpt
(involves: 129S4/SvJae * C57BL/6)
|
arrested T cell differentiation
|
J:76991
|
Del(10Prmt2-Col6a1)1Yah/+
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased hematocrit
|
J:167506
|
| increased red blood cell distribution width
|
J:167506
|
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal common myeloid progenitor cell morphology
|
J:83563
|
| abnormal definitive hematopoiesis
|
J:83563
|
| decreased erythrocyte cell number
|
J:83563
|
| decreased hemoglobin content
|
J:83563
|
Del(11Hoxb3-Hoxb4)1Karl/Del(11Hoxb3-Hoxb4)1Karl
Hoxa9tm1Mrc/Hoxa9tm1Mrc
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:126371
|
Del(11Jmjd6-Mettl23)1Ysfk/Del(11Jmjd6-Mettl23)1Ysfk
(involves: C57BL/6)
|
abnormal erythropoiesis
|
J:90288
|
| decreased hematocrit
|
J:90288
|
| decreased hemoglobin content
|
J:90288
|
| increased nucleated erythrocyte cell number
|
J:90288
|
Del(11Nlrp1a-Nlrp1c-ps)1Smas/Del(11Nlrp1a-Nlrp1c-ps)1Smas
(Not Specified)
|
decreased erythrocyte cell number
|
J:191055
|
| decreased neutrophil cell number
|
J:191055
|
| increased hematocrit
|
J:191055
|
Del(11Nme2-Nme1)1Zou/Del(11Nme2-Nme1)1Zou
(involves: 129 * C57BL/6)
|
anisocytosis
|
J:146219
|
| decreased erythrocyte cell number
|
J:146219
|
| decreased hematocrit
|
J:146219
|
| decreased hemoglobin content
|
J:146219
|
| extramedullary hematopoiesis
|
J:146219
|
| increased nucleated erythrocyte cell number
|
J:146219
|
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:122463
|
Del(11Stat5a-Stat5b)1Mam/Del(11Stat5a-Stat5b)1Mam
(involves: 129S6/SvEvTac * FVB/N)
|
decreased hematocrit
|
J:138904
|
| decreased mean corpuscular hemoglobin
|
J:138904
|
Del(14Trim13-Rnaseh2b)6Rdf/+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
Del(15Rr316124-Rr313939)2Fsp/+
Myctm1Atp/Myc+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased granulocyte number
|
J:257739
|
Del(15Rr316124-Rr313939)2Fsp/Del(15Rr316124-Rr313939)2Fsp
(Not Specified)
|
decreased granulocyte number
|
J:257739
|
Del(17Abcg5-Abcg8)1Hobb/Del(17Abcg5-Abcg8)1Hobb
(involves: 129S6/SvEvTac * C57BL/6)
|
increased mean platelet volume
|
J:157223
|
| thrombocytopenia
|
J:157223
|
Dennd1aem1Jgfu/Dennd1aem1Jgfu
(Not Specified)
|
abnormal embryonic hematopoiesis
|
J:276703
|
Dennd5bem1(IMPC)Tcp/Dennd5bem1(IMPC)Tcp
(C57BL/6N-Dennd5bem1(IMPC)Tcp/Tcp)
|
decreased red blood cell distribution width
|
J:211773
|
Deup1tm1.1(KOMP)Vlcg/Deup1tm1.1(KOMP)Vlcg
(C57BL/6N-Deup1tm1.1(KOMP)Vlcg/MbpMmucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Dffbtm1Osa/Dffbtm1Osa
Dnase2atm1Osa/Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:81474
|
| decreased double-positive T cell number
|
J:81474
|
| increased double-negative T cell number
|
J:81474
|
Dgkatm1Xpz/Dgkatm1Xpz
Dgkztm1Gak/Dgkztm1Gak
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:113564
|
Dh/Dh+
(Not Specified)
|
increased granulocyte number
|
J:30753
|
| thrombocytosis
|
J:30753
|
Dh/Dh+
(B6.CBA-Dh)
|
abnormal T cell differentiation
|
J:5834
|
Dh/Dh+
Foxn1nu/Foxn1nu
(involves: N:NIH(S))
|
thrombocytosis
|
J:6062
|
Dhfrorana/Dhfr+
(involves: C57BL/6JAnu)
|
abnormal hemopoiesis
|
J:236197
|
| extramedullary hematopoiesis
|
J:236197
|
Dhfrorana/Dhfrorana
(involves: C57BL/6JAnu)
|
decreased common myeloid progenitor cell number
|
J:236197
|
| decreased erythrocyte cell number
|
J:236197
|
| increased nucleated erythrocyte cell number
|
J:236197
|
Dhfrtm1b(EUCOMM)Wtsi/Dhfr+
(C57BL/6N-Dhfrtm1b(EUCOMM)Wtsi/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Dhpstm2a(EUCOMM)Wtsi/Dhps+
(C57BL/6N-Dhpstm2a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:211773
|
Dhx9Tn(pb-Act-RFP)1.071225026-HRAZhu/Dhx9+
Igs12tm1Zhu/Igs12tm1Zhu
Ptprca/Ptprcb
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/NJ * SJL/J)
|
abnormal T cell differentiation
|
J:207361
|
Dhx15em1(IMPC)Tcp/Dhx15+
(C57BL/6NCrl-Dhx15em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Dhx15tm1c(EUCOMM)Wtsi/Dhx15tm1c(EUCOMM)Wtsi
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C3H * C57BL/6N)
|
abnormal B cell differentiation
|
J:284624
|
Dhx36tm1.2Pmt/Dhx36tm1.2Pmt
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal erythropoiesis
|
J:185179
|
| decreased erythrocyte cell number
|
J:185179
|
| decreased hemoglobin content
|
J:185179
|
| increased mean corpuscular volume
|
J:185179
|
| spherocytosis
|
J:185179
|
Dhx36tm1.2Pmt/Dhx36tm1.2Pmt
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/Ola * 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal erythropoiesis
|
J:185179
|
| abnormal leukopoiesis
|
J:185179
|
Dhx38em1(IMPC)J/Dhx38+
(C57BL/6NJ-Dhx38em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Dhx40tm1b(KOMP)Wtsi/Dhx40tm1b(KOMP)Wtsi
(C57BL/6N-Dhx40tm1b(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Diaph1tm1Asal/Diaph1+
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:124319
|
Diaph1tm1Asal/Diaph1tm1Asal
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:124319
|
| echinocytosis
|
J:124319
|
| extramedullary hematopoiesis
|
J:124319
|
| increased granulocyte number
|
J:124319
|
| increased neutrophil cell number
|
J:124319
|
Diaph3tm1.1Pji/Diaph3tm1.1Pji
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * CBA/J)
|
abnormal erythropoiesis
|
J:293763
|
| anisopoikilocytosis
|
J:293763
|
| decreased erythrocyte cell number
|
J:293763
|
| decreased hematocrit
|
J:293763
|
| decreased hemoglobin content
|
J:293763
|
| extramedullary hematopoiesis
|
J:293763
|
| increased red blood cell distribution width
|
J:293763
|
| polychromatophilia
|
J:293763
|
Diaph3tm1.1Sna/Diaph3tm1.1Sna
(B6NSlc.Cg-Diaph3tm1.1Sna)
|
abnormal nucleated erythrocyte cell number
|
J:205519
|
| extramedullary hematopoiesis
|
J:205519
|
Diaph3tm1b(KOMP)Mbp/Diaph3+
(C57BL/6N-Diaph3tm1b(KOMP)Mbp/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Dicer1tm1b(EUCOMM)Wtsi/Dicer1+
(C57BL/6N-Dicer1tm1b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Dicer1tm1Mmk/Dicer1tm1.1Mmk
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
abnormal immunoglobulin V(D)J recombination
|
J:135783
|
Dicer1tm1Mmk/Dicer1tm1Mmk
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
arrested B cell differentiation
|
J:135783
|
| decreased immature B cell number
|
J:135783
|
| increased pro-B cell number
|
J:135783
|
Dicer1tm1Mmk/Dicer1tm1Mmk
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129 * C57BL/6 * CD-1)
|
abnormal granulocyte differentiation
|
J:158901
|
| abnormal neutrophil morphology
|
J:158901
|
| extramedullary hematopoiesis
|
J:158901
|
| giant platelets
|
J:158901
|
| thrombocytopenia
|
J:158901
|
Dicer1tm1Tara/Dicer1tm1Tara
Foxn1tm3(cre)Nrm/Foxn1+
(involves: 129P2/OlaHsd * C57BL/6NHsd)
|
abnormal positive T cell selection
|
J:180783
|
Dido1tm1Cmar/Dido1+
(involves: 129S1/Sv * 129X1/SvJ)
|
increased granulocyte number
|
J:101201
|
Dido1tm1Cmar/Dido1tm1Cmar
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythropoiesis
|
J:101201
|
| increased erythrocyte cell number
|
J:101201
|
| increased granulocyte number
|
J:101201
|
Dis3tm1.1Uba/Dis3tm1.1Uba
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:302856
|
Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho/Disc1del
(129S2/SvPasCrl-Disc1del Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho)
|
decreased hemoglobin content
|
J:214737
|
| increased red blood cell distribution width
|
J:214737
|
Dkc1tm1Ppp/Y
(involves: 129S1/Sv)
|
abnormal definitive hematopoiesis
|
J:81054
|
| decreased common myeloid progenitor cell number
|
J:81054
|
| decreased hemoglobin content
|
J:81054
|
| extramedullary hematopoiesis
|
J:81054
|
| thrombocytopenia
|
J:81054
|
Dkc1tm1Ppp/Dkc1+
(involves: 129S1/Sv)
|
abnormal definitive hematopoiesis
|
J:81054
|
| abnormal erythrocyte morphology
|
J:81054
|
Dkk3tm1Cni/Dkk3tm1Cni
(involves: 129X1/SvJ * C57BL/6)
|
increased hematocrit
|
J:106922
|
| increased hemoglobin content
|
J:106922
|
| increased mean corpuscular hemoglobin
|
J:106922
|
| increased mean corpuscular volume
|
J:106922
|
Dlec1tm1b(EUCOMM)Wtsi/Dlec1tm1b(EUCOMM)Wtsi
(C57BL/6N-Dlec1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Dlgap2em1(IMPC)Mhzh/Dlgap2em1(IMPC)Mhzh
(C57BL/6N-Dlgap2em1(IMPC)Mhzh/Mhzh)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Dlgap4tm1b(KOMP)Wtsi/Dlgap4+
(C57BL/6N-Dlgap4tm1b(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
Dlk1em1(IMPC)Wtsi/Dlk1em1(IMPC)Wtsi
(C57BL/6N-Dlk1em1(IMPC)Wtsi/WtsiIeg)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Dlk1tm1Srba/Dlk1tm1Srba
(involves: 129X1/SvJ * C57BL/6)
|
decreased immature B cell number
|
J:145076
|
| increased immature B cell number
|
J:145076
|
| increased transitional stage B cell number
|
J:145076
|
Dll4tm1Frad/Dll4tm1Frad
Foxn1tm3(cre)Nrm/Foxn1+
(B6.Cg-Dll4tm1Frad Foxn1tm3(cre)Nrm)
|
abnormal T cell differentiation
|
J:143472
|
| decreased double-positive T cell number
|
J:143472
|
| increased immature B cell number
|
J:143472
|
Dll4tm1Kaho/Dll4tm1Kaho
Tg(Foxn1-cre)8Ghr/0
(involves: C57BL/6 * DBA/2)
|
abnormal lymphopoiesis
|
J:143473
|
| decreased double-positive T cell number
|
J:143473
|
dm/dm
(involves: 129 * BALB/cJ * C57L/J)
|
decreased common myeloid progenitor cell number
|
J:5439
|
Dmdem1(IMPC)Hmgu/Y
(C57BL/6N-Dmdem1(IMPC)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Dmdem1(IMPC)Hmgu/Dmdem1(IMPC)Hmgu
(C57BL/6N-Dmdem1(IMPC)Hmgu/Ieg)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Dmdmdx/Y
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
decreased granulocyte number
|
J:150572
|
| decreased neutrophil cell number
|
J:150572
|
Dmdmdx/Dmdmdx
Spp1tm1Blh/Spp1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * C57BL/10ScSn)
|
decreased granulocyte number
|
J:150572
|
| decreased neutrophil cell number
|
J:150572
|
Dmgdhtm1a(KOMP)Wtsi/Dmgdhtm1a(KOMP)Wtsi
(C57BL/6N-Dmgdhtm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Dmtntm1Ahc/Dmtntm1Ahc
(involves: 129S4/SvJaeSor * C57BL/6J)
|
decreased hematocrit
|
J:76575
|
| decreased mean corpuscular volume
|
J:76575
|
| microcytosis
|
J:76575
|
| spherocytosis
|
J:76575
|
Dnaaf9tm1b(EUCOMM)Hmgu/Dnaaf9tm1b(EUCOMM)Hmgu
(C57BL/6N-Dnaaf9tm1b(EUCOMM)Hmgu/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Dnai4em1(IMPC)J/Dnai4em1(IMPC)J
(C57BL/6NJ-Dnai4em1(IMPC)J/Mmjax)
|
increased mean corpuscular volume
|
J:211773
|
Dnaja4tm1b(KOMP)Wtsi/Dnaja4tm1b(KOMP)Wtsi
(C57BL/6N-Dnaja4tm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Dnajc7tm1b(KOMP)Wtsi/Dnajc7tm1b(KOMP)Wtsi
(C57BL/6N-Dnajc7tm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Dnajc8tm1b(KOMP)Wtsi/Dnajc8+
(C57BL/6N-Dnajc8tm1b(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Dnajc10tm1a(EUCOMM)Hmgu/Dnajc10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dnajc10tm1a(EUCOMM)Hmgu/H)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Dnajc11spc/Dnajc11spc
(B6.Cg-Dnajc11spc)
|
decreased double-positive T cell number
|
J:221543
|
| decreased erythrocyte cell number
|
J:221543
|
| increased DN1 thymic pro-T cell number
|
J:221543
|
| increased double-negative T cell number
|
J:221543
|
Dnajc13em1(IMPC)J/Dnajc13+
(C57BL/6NJ-Dnajc13em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Dnal1tm1.1(KOMP)Vlcg/Dnal1+
(C57BL/6N-Dnal1tm1.1(KOMP)Vlcg/Ucd)
|
decreased eosinophil cell number
|
J:211773
|
Dnase1l2em1(IMPC)J/Dnase1l2em1(IMPC)J
(C57BL/6NJ-Dnase1l2em1(IMPC)J/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Dnase1l3em1(IMPC)Mbp/Dnase1l3em1(IMPC)Mbp
(C57BL/6NCrl-Dnase1l3em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Dnase2atm1Aea/Dnase2atm1Aea
(involves: 129 * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:89469
|
Dnase2atm1Osa/Dnase2atm1Osa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal erythropoiesis
|
J:69831
|
| decreased erythrocyte cell number
|
J:69831
|
| increased nucleated erythrocyte cell number
|
J:69831,
J:81474
|
Dnm2Rbc12/Dnm2+
(involves: C57BL/6)
|
abnormal erythrocyte morphology
|
J:330452
|
| decreased hematocrit
|
J:330452
|
| decreased hemoglobin content
|
J:330452
|
| decreased mean corpuscular hemoglobin
|
J:330452
|
Dnm2tm1.1(KOMP)Vlcg/Dnm2+
(C57BL/6N-Dnm2tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Dnmt1tm2Jae/Dnmt1tm2Jae
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113645
|
| decreased pro-B cell number
|
J:113645
|
Dnmt3atm1Trow/Dnmt3a+
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Dnmt3atm1Trow Tg(Mx1-cre)1Cgn)
|
increased common myeloid progenitor cell number
|
J:272803
|
Dnmt3btm1Enl/Dnmt3btm7Enl
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-positive T cell number
|
J:106540
|
| increased double-negative T cell number
|
J:106540
|
Dnmt3ltm1b(EUCOMM)Hmgu/Dnmt3ltm1b(EUCOMM)Hmgu
(C57BL/6N-Dnmt3ltm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Dnpeptm1e(EUCOMM)Wtsi/Dnpeptm1e(EUCOMM)Wtsi
(C57BL/6N-Dnpeptm1e(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Dntttm1Gfn/Dntttm1Gfn
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
Dnttip1em1Shmc/Dnttip1em1Shmc
(C57BL/6J-Dnttip1em1Shmc)
|
absent erythrocytes
|
J:291786
|
Dnttip1tm1b(KOMP)Wtsi/Dnttip1+
(C57BL/6N-Dnttip1tm1b(KOMP)Wtsi/J)
|
thrombocytosis
|
J:211773
|
Dock2m1Btlr/Dock2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:173592
|
| abnormal class switch recombination
|
J:185495
|
Dock2m1Hsd/Dock2m1Hsd
Irf5tm1Ttg/Irf5tm1Ttg
(B6NHsd.Cg-Irf5tm1Ttg Dock2m1Hsd)
|
abnormal B cell differentiation
|
J:182658
|
| increased immature B cell number
|
J:182658
|
Dock2m2Btlr/Dock2m2Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
| abnormal class switch recombination
|
J:185495
|
Dock2m3Btlr/Dock2m3Btlr
(C57BL/6J-Dock2m3Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:191187
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:191187
|
Dock2m4Btlr/Dock2m4Btlr
(C57BL/6J-Dock2m4Btlr)
|
abnormal B cell differentiation
|
J:221486
|
| abnormal CD4-positive T cell differentiation
|
J:221486
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221486
|
Dock2m5Btlr/Dock2+
(C57BL/6J-Dock2m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:225938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
Dock2m5Btlr/Dock2m5Btlr
(C57BL/6J-Dock2m5Btlr)
|
abnormal B cell differentiation
|
J:225938
|
| abnormal CD4-positive T cell differentiation
|
J:225938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225938
|
Dock2m7Btlr/Dock2+
(C57BL/6J-Dock2m7Btlr)
|
increased neutrophil cell number
|
J:255181
|
Dock2m7Btlr/Dock2m7Btlr
(C57BL/6J-Dock2m7Btlr)
|
increased neutrophil cell number
|
J:255181
|
Dock2m11Btlr/Dock2m11Btlr
(C57BL/6J-Dock2m11Btlr)
|
abnormal B cell differentiation
|
J:272405
|
| abnormal CD4-positive T cell differentiation
|
J:272405
|
Dock2tm1Tsas/Dock2tm1Tsas
Tg(Tcra2B4)1Mmd/?
Tg(Tcrb2B4)1Mmd/?
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:84581
|
Dock6em1(IMPC)J/Dock6+
(C57BL/6NJ-Dock6em1(IMPC)J/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Dock7m/Dock7m
(B6.D(Cg)-Dock7m)
|
decreased platelet ADP level
|
J:45425
|
Dock8m4Btlr/Dock8m4Btlr
(C57BL/6J-Dock8m4Btlr)
|
abnormal B cell differentiation
|
J:274856
|
| abnormal CD4-positive T cell differentiation
|
J:274856
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274856
|
| abnormal T cell differentiation
|
J:274856
|
Dock9em1(IMPC)J/Dock9em1(IMPC)J
(C57BL/6NJ-Dock9em1(IMPC)J/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Dock10tm1a(EUCOMM)Hmgu/Dock10tm1a(EUCOMM)Hmgu
(C57BL/6N-Dock10tm1a(EUCOMM)Hmgu/Ieg)
|
arrested B cell differentiation
|
J:236911
|
| decreased hemoglobin content
|
J:165965
|
| increased hematocrit
|
J:165965
|
| increased hemoglobin content
|
J:165965
|
Dok1tm1Ppp/Dok1tm1Ppp
Dok2tm1Ppp/Dok2tm1Ppp
(129S1/Sv-Dok1tm1Ppp Dok2tm1Ppp)
|
increased neutrophil cell number
|
J:95334
|
Dok1tm1Yyam/Dok1tm1Yyam
Dok2tm1Yyam/Dok2tm1Yyam
(B6.129-Dok1tm1Yyam Dok2tm1Yyam)
|
abnormal myelopoiesis
|
J:95335
|
| extramedullary hematopoiesis
|
J:95335
|
| increased neutrophil cell number
|
J:95335
|
Dok7tm1.1(KOMP)Vlcg/Dok7+
(C57BL/6N-Dok7tm1.1(KOMP)Vlcg/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Dop1aem1(IMPC)Tcp/Dop1aem1(IMPC)Tcp
(C57BL/6N-Dop1aem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Dot1ltm1.1Saam/Dot1ltm1.1Saam
Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:193161
|
| abnormal leukopoiesis
|
J:193161
|
| decreased common myeloid progenitor cell number
|
J:193161
|
| decreased neutrophil cell number
|
J:193161
|
Dp(16Cbr1-Fam3b)1Rhr/0
(involves: 129S6/SvEvTac)
|
abnormal common myeloid progenitor cell morphology
|
J:184564
|
| decreased erythrocyte cell number
|
J:184564
|
| thrombocytosis
|
J:184564
|
Dp(16Cbr1-Fam3b)1Rhr/0
Gata1tm8.2Sho/Y
(involves: 129S1/Sv * 129S6/SvEvTac)
|
extramedullary hematopoiesis
|
J:184564
|
| thrombocytosis
|
J:184564
|
Dph1tm1Bhr/Dph1tm1Bhr
(either: 129/Sv or (involves: 129/Sv * C57BL/6))
|
increased nucleated erythrocyte cell number
|
J:88090
|
Dph1tm2Bhr/Dph1tm2Bhr
(either: 129/Sv or (involves: 129/Sv * C57BL/6))
|
increased nucleated erythrocyte cell number
|
J:88090
|
Dph6tm1a(KOMP)Wtsi/Dph6tm1a(KOMP)Wtsi
(C57BL/6N-Dph6tm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased granulocyte number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Dpp4em1Rba/Dpp4em1Rba
(C57BL/6J-Dpp4em1Rba)
|
increased neutrophil cell number
|
J:279723
|
Dpp4tm1(DPP4)Vlcg/?
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
increased neutrophil cell number
|
J:238079
|
Dpp8em1(IMPC)J/Dpp8em1(IMPC)J
(C57BL/6NJ-Dpp8em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Dpy19l3tm1a(EUCOMM)Wtsi/Dpy19l3tm1a(EUCOMM)Wtsi
(C57BL/6N-Dpy19l3tm1a(EUCOMM)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hematocrit
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
Drg1em1(IMPC)Tcp/Drg1+
(C57BL/6NCrl-Drg1em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Droshatm1Litt/Droshatm1.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
decreased double-positive T cell number
|
J:138683
|
| increased granulocyte number
|
J:138683
|
Dsg1btm1a(KOMP)Wtsi/Dsg1btm1a(KOMP)Wtsi
(C57BL/6N-Dsg1btm1a(KOMP)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Dsg3bal/Dsg3bal
(C57BL/6J-Dsg3bal/J)
|
cutaneous mastocytosis
|
J:18223
|
Dsg3sqk/Dsg3sqk
(C57BL/6-Dsg3sqk)
|
decreased double-positive T cell number
|
J:219200
|
| decreased immature B cell number
|
J:219200
|
| decreased transitional stage B cell number
|
J:219200
|
| increased neutrophil cell number
|
J:219200
|
Dsg4hage/Dsg4hage
Faslpr/Faslpr
X/Yaa
(EOD-Dsg4hage)
|
abnormal mast cell morphology
|
J:140028
|
Dtnbp1sdy/Dtnbp1sdy
(involves: DBA/2J)
|
decreased platelet dense granule number
|
J:85123,
J:1958
|
| decreased platelet serotonin level
|
J:85123
|
| thrombocytopenia
|
J:1958
|
Dtnbp1tm1b(EUCOMM)Hmgu/Dtnbp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Dtnbp1tm1b(EUCOMM)Hmgu/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Dtx3em1(IMPC)J/Dtx3em1(IMPC)J
(C57BL/6NJ-Dtx3em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Dtx3lem1(IMPC)H/Dtx3lem1(IMPC)H
(C57BL/6N-Dtx3lem1(IMPC)H/H)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
decreased red blood cell distribution width
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Duoxa2tm1b(KOMP)Wtsi/Duoxa2tm1b(KOMP)Wtsi
(C57BL/6N-Duoxa2tm1b(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased immature B cell number
|
J:211773
|
| decreased mean platelet volume
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
| decreased transitional stage T1 B cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Dus2tm1b(EUCOMM)Wtsi/Dus2+
(C57BL/6N-Dus2tm1b(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Dusp1tm1Brv/Dusp1tm1Brv
(C3.129S2-Dusp1tm1Brv)
|
increased granulocyte number
|
J:164929
|
Dusp3tm1b(KOMP)Wtsi/Dusp3tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Dusp3tm1b(KOMP)Wtsi/Wtsi)
|
decreased red blood cell distribution width
|
J:211773
|
Dusp3tm1Srah/Dusp3tm1Srah
(involves: 129 * C57BL/6)
|
decreased hemoglobin content
|
J:235051
|
Dusp5tm1.1Achn/Dusp5tm1.1Achn
Rag2tm1.1Cgn/Rag2tm1.1Cgn
(involves: C57BL/6NCrl)
|
increased eosinophil cell number
|
J:218203
|
Dusp16em1(IMPC)Tcp/Dusp16em1(IMPC)Tcp
(C57BL/6NCrl-Dusp16em1(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Dymem1(IMPC)Tcp/Dymem1(IMPC)Tcp
(C57BL/6N-Dymem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Dync1li1em1(IMPC)Tcp/Dync1li1+
(C57BL/6NCrl-Dync1li1em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Dynlrb2tm1a(KOMP)Wtsi/Dynlrb2+
(C57BL/6N-Dynlrb2tm1a(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Dynlt4tm1e(EUCOMM)Wtsi/Dynlt4tm1e(EUCOMM)Wtsi
(C57BL/6N-Dynlt4tm1e(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Dyrk1atm1Jdc/Dyrk1atm1Jdc
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6J * C57BL/6NTac * CBA/J)
|
decreased double-positive T cell number
|
J:223138
|
| decreased immature B cell number
|
J:223138
|
Dyrk3tm1Dowo/Dyrk3tm1Dowo
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal stress erythropoiesis
|
J:144586
|
Dyrk3tm1Dowo/Dyrk3tm1Dowo
Eportm2Jni/Eportm2Jni
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal stress erythropoiesis
|
J:144586
|
E2f1tm1Meg/E2f1tm1Meg
(either: (involves: 129/Sv * 129S4/SvJae) or (involves: 129/Sv * 129S4/SvJae * C57BL/6))
|
abnormal double-positive T cell morphology
|
J:33100
|
E2f1tm1Meg/E2f1tm1Meg
(NOD.Cg-E2f1tm1Meg)
|
abnormal double-positive T cell morphology
|
J:93708
|
| decreased double-positive T cell number
|
J:93708
|
E2f2tm1Zubi/E2f2tm1Zubi
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:76318
|
E2f4tm1Jrn/E2f4tm1Jrn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:64192
|
| abnormal granulocyte morphology
|
J:64192
|
| decreased double-positive T cell number
|
J:64192
|
| decreased granulocyte number
|
J:64192
|
| decreased hematocrit
|
J:64192
|
| increased double-negative T cell number
|
J:64192
|
| increased number of Howell-Jolly bodies
|
J:64192
|
| macrocytosis
|
J:64192
|
E2f4tm1Lees/E2f4tm1Lees
(involves: 129S2/SvPas * C57BL/6)
|
abnormal stress erythropoiesis
|
J:64193
|
| anisocytosis
|
J:64193
|
| decreased erythrocyte cell number
|
J:64193
|
| decreased hematocrit
|
J:64193
|
| increased nucleated erythrocyte cell number
|
J:64193
|
| increased number of Howell-Jolly bodies
|
J:64193
|
| macrocytosis
|
J:64193
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Polr2atm1(cre/ERT2)Bbd/Polr2a+
(involves: C57BL/6 * SJL)
|
arrested B cell differentiation
|
J:182210
|
| decreased immature B cell number
|
J:182210
|
| decreased transitional stage B cell number
|
J:182210
|
Ebf1tm1.1Rug/Ebf1tm1.1Rug
Polr2atm1(cre/ERT2)Bbd/Polr2a+
Tg(BCL2)#Wehi/0
(involves: C57BL/6 * C57BL/6JWehi * SJL * SJL/JWehi)
|
decreased immature B cell number
|
J:182210
|
Ebf1tm1Rug/Ebf1tm1Rug
(involves: 129S2/SvPas)
|
arrested B cell differentiation
|
J:52607
|
| decreased pro-B cell number
|
J:52607
|
Ebi3Gt716Lex/Ebi3Gt716Lex
Tg(DO11.10)10Dlo/0
(involves: 129S5/SvEvBrd * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:134148
|
Ebna1bp2em1(IMPC)Tcp/Ebna1bp2+
(C57BL/6NCrl-Ebna1bp2em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
EbpTd-ho/Y
((CKH.Cg-EbpTd-ho x NJL)F1)
|
abnormal embryonic erythropoiesis
|
J:60400
|
| abnormal embryonic hematopoiesis
|
J:60400
|
Ecm1tm1b(EUCOMM)Hmgu/Ecm1+
(C57BL/6N-Ecm1tm1b(EUCOMM)Hmgu/H)
|
decreased neutrophil cell number
|
J:211773
|
Ecrg4tm1b(EUCOMM)Hmgu/Ecrg4tm1b(EUCOMM)Hmgu
(C57BL/6N-Ecrg4tm1b(EUCOMM)Hmgu/Orl)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Edc3em1(IMPC)Tcp/Edc3em1(IMPC)Tcp
(C57BL/6NCrl-Edc3em1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
Edc4tm1a(EUCOMM)Wtsi/Edc4+
(C57BL/6N-Edc4tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
Eddm3btm1b(KOMP)Wtsi/Eddm3btm1b(KOMP)Wtsi
(C57BL/6N-Eddm3btm1b(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Edem1em1(IMPC)Kmpc/Edem1em1(IMPC)Kmpc
(C57BL/6NTac-Edem1em1(IMPC)Kmpc/Kmpc)
|
increased mean platelet volume
|
J:211773
|
Edn2tm1Ywa/Edn2tm1Ywa
(involves: 129S6/SvEvTac)
|
increased hematocrit
|
J:201436
|
Eedtm1Sho/Eedtm1Sho
Eportm1.1(EGFP/icre)Uk/Epor+
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
abnormal erythropoiesis
|
J:154730
|
Eef1a1tm2Arge/Eef1a1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal double-positive T cell morphology
|
J:197167
|
Eef1dem1(IMPC)Mbp/Eef1d+
(C57BL/6NCrl-Eef1dem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Efcc1em1(IMPC)Tcp/Efcc1em1(IMPC)Tcp
(C57BL/6N-Efcc1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Efnb1tm1.1Jwu/Efnb1tm1.1Jwu
Efnb2tm1.1Jwu/Efnb2tm1.1Jwu
Tg(Lck-cre)I540Jxm/0
(B6.Cg-Efnb2tm1.1Jwu Efnb1tm1.1Jwu Tg(Lck-cre)I540Jxm)
|
abnormal T cell differentiation
|
J:178148
|
| abnormal T-helper 1 cell differentiation
|
J:178148
|
| abnormal T-helper 17 cell differentiation
|
J:178148
|
| decreased DN4 thymocyte number
|
J:178148
|
| decreased double-positive T cell number
|
J:178148
|
| increased DN3 thymocyte number
|
J:178148
|
| increased double-negative T cell number
|
J:178148
|
Eftud2tm1b(KOMP)Wtsi/Eftud2+
(C57BL/6N-Eftud2tm1b(KOMP)Wtsi/Ics)
|
thrombocytosis
|
J:211773
|
Egfem1em1(IMPC)J/Egfem1em1(IMPC)J
(C57BL/6NJ-Egfem1em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Egln1Gt(RRG405)Byg/Egln1Gt(RRG405)Byg
P4htmtm1Jomy/P4htmtm1Jomy
(Not Specified)
|
increased hematocrit
|
J:213191
|
| increased mean corpuscular hemoglobin concentration
|
J:213191
|
Egln1tm1.1Brei/Egln1tm1.1Brei
Egln3tm2Fong/Egln3tm2Fong
Tg(CD68-icre)1Bwlx/0
(involves: 129S6/SvEvTac * C57BL/6)
|
polycythemia
|
J:194598
|
Egln1tm1.1Brei/Egln1tm1.1Brei
Epas1tm1Mcs/Epas1tm1Mcs
Tg(CD68-icre)1Bwlx/0
(involves: 129X1/SvJ * C57BL/6)
|
decreased hematocrit
|
J:194598
|
| decreased hemoglobin content
|
J:194598
|
Egln1tm1.1Brei/Egln1tm1.1Brei
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(CD68-icre)1Bwlx/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased hematocrit
|
J:194598
|
Egln1tm1.1Brei/Egln1tm1.1Brei
Tg(CD68-icre)1Bwlx/0
(involves: C57BL/6)
|
abnormal nucleated erythrocyte cell number
|
J:194598
|
| increased hematocrit
|
J:194598
|
| polycythemia
|
J:194598
|
| thrombocytopenia
|
J:194598
|
Egln1tm1.1Fsl/Egln1+
(C57BL/6-Egln1tm1.1Fsl)
|
increased hematocrit
|
J:202737
|
| increased hemoglobin content
|
J:202737
|
| polycythemia
|
J:202737
|
Egln1tm1.1Fsl/Egln1+
Hif1atm3.1Rsjo/Hif1a+
(B6.Cg-Egln1tm1.1Fsl Hif1atm3.1Rsjo)
|
increased hematocrit
|
J:202737
|
Egln1tm1Kael/Egln1tm1Kael
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
polycythemia
|
J:132718
|
Egln1tm2.1Fsl/Egln1+
Pax3tm1(cre)Joe/Pax3+
(involves: 129 * C57BL/6)
|
increased hematocrit
|
J:202737
|
| polycythemia
|
J:202737
|
Egln1tm2.1Fsl/Egln1tm2.1Fsl
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Egln1tm2.1Fsl Commd10Tg(Vav1-icre)A2Kio)
|
increased hematocrit
|
J:202737
|
| increased hemoglobin content
|
J:202737
|
| polycythemia
|
J:202737
|
Egln1tm2.1Fsl/Egln1tm2.1Fsl
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm9(cre/ESR1)Arte Egln1tm2.1Fsl)
|
extramedullary hematopoiesis
|
J:202737
|
| increased hematocrit
|
J:202737
|
| polycythemia
|
J:202737
|
Egln1tm2.1Fsl/Egln1tm2.1Fsl
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
Hif1atm3Rsjo/Hif1atm3Rsjo
(B6.Cg-Gt(ROSA)26Sortm9(cre/ESR1)Arte Egln1tm2.1Fsl Hif1atm3Rsjo)
|
extramedullary hematopoiesis
|
J:202737
|
| increased hematocrit
|
J:202737
|
Egln1tm2.1Fsl/Egln1tm2.1Fsl
Pax3tm1(cre)Joe/Pax3+
(involves: 129 * C57BL/6)
|
increased hematocrit
|
J:202737
|
| polycythemia
|
J:202737
|
Egln1tm2.2Fsl/Egln1+
(B6.Cg-Egln1tm2.2Fsl)
|
increased hematocrit
|
J:202737
|
| increased hemoglobin content
|
J:202737
|
| polycythemia
|
J:202737
|
Egln1tm2Fong/Egln1tm2Fong
Egln2tm2Fong/Egln2tm2Fong
Egln3tm2Fong/Egln3tm2Fong
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S6/SvEvTac * C57BL/6NCr * CD-1)
|
increased hematocrit
|
J:186085
|
Egln1tm2Fong/Egln1tm2Fong
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:132720
|
| extramedullary hematopoiesis
|
J:132720
|
| increased hematocrit
|
J:132720
|
| increased hemoglobin content
|
J:132720
|
| polycythemia
|
J:132720
|
Egln2tm1Fong/Egln2tm1Fong
Egln3tm1Fong/Egln3tm1Fong
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:132720
|
| extramedullary hematopoiesis
|
J:132720
|
| increased hematocrit
|
J:132720
|
| increased hemoglobin content
|
J:132720
|
| polycythemia
|
J:132720
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
abnormal erythropoiesis
|
J:123870
|
| abnormal neutrophil morphology
|
J:123870
|
| thrombocytopenia
|
J:123870
|
Ehd1tm1a(EUCOMM)Wtsi/Ehd1+
(C57BL/6N-Ehd1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Ehfem1(IMPC)Kmpc/Ehfem1(IMPC)Kmpc
(C57BL/6NTac-Ehfem1(IMPC)Kmpc/Kmpc)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Ehmt1tm1b(EUCOMM)Hmgu/Ehmt1+
(C57BL/6N-Ehmt1tm1b(EUCOMM)Hmgu/Nju)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Eid2bem1(IMPC)J/Eid2b+
(C57BL/6NJ-Eid2bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular volume
|
J:211773
|
Eif2aem1(IMPC)Mbp/Eif2aem1(IMPC)Mbp
(C57BL/6N-Eif2aem1(IMPC)Mbp/Ucd)
|
increased mean platelet volume
|
J:211773
|
Eif2ak1tm1Jjch/Eif2ak1tm1Jjch
(Not Specified)
|
abnormal erythrocyte morphology
|
J:85896
|
| abnormal erythropoiesis
|
J:85896
|
| abnormal mean corpuscular hemoglobin
|
J:85896
|
| extramedullary hematopoiesis
|
J:85896
|
| increased mean corpuscular volume
|
J:85896
|
| increased number of Heinz bodies
|
J:85896
|
Eif2b2tm2a(KOMP)Wtsi/Eif2b2+
(C57BL/6N-Eif2b2tm2a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Eif2b3tm1b(EUCOMM)Hmgu/Eif2b3+
(C57BL/6N-Eif2b3tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
Eif2b5tm1a(EUCOMM)Wtsi/Eif2b5+
(C57BL/6N-Eif2b5tm1a(EUCOMM)Wtsi/Ics)
|
decreased mean corpuscular hemoglobin concentration
|
J:165965
|
| decreased mean corpuscular volume
|
J:165965
|
Eif2s1tm1Rjk/Eif2s1+
Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd)
|
decreased erythrocyte cell number
|
J:144954
|
Eif2s1tm1Rjk/Eif2s1tm1Rjk
Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd)
|
decreased erythrocyte cell number
|
J:144954
|
Eif4btm1.1Smoc/Eif4btm1.1Smoc
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129 * C57BL/6)
|
increased neutrophil cell number
|
J:311140
|
Eipr1em1(IMPC)J/Eipr1+
(C57BL/6NJ-Eipr1em1(IMPC)J/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Elavl1tm1b(EUCOMM)Hmgu/Elavl1+
(C57BL/6N-Elavl1tm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Elavl1tm1Dkon/Elavl1tm1Dkon
Tg(Lck-cre)I57Jxm/0
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm)
|
abnormal positive T cell selection
|
J:148866
|
| increased double-negative T cell number
|
J:148866
|
| increased double-positive T cell number
|
J:148866
|
Elavl1tm1Dkon/Elavl1tm1Dkon
Tg(Lck-cre)I57Jxm/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(B6.Cg-Elavl1tm1Dkon Tg(Lck-cre)I57Jxm Tg(TcraH-Y,TcrbH-Y)71Vbo)
|
abnormal negative T cell selection
|
J:148866
|
Elavl1tm1Thla/Elavl1tm1Thla
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129)
|
abnormal definitive hematopoiesis
|
J:155109
|
| decreased common myeloid progenitor cell number
|
J:155109
|
| decreased double-positive T cell number
|
J:155109
|
| decreased granulocyte number
|
J:155109
|
| increased granulocyte number
|
J:155109
|
Elf1tm1Jml/Elf1tm1Jml
(Not Specified)
|
abnormal B cell differentiation
|
J:100734
|
Elf4em1Hdu/Elf4em1Hdu
(C57BL/6-Elf4em1Hdu)
|
abnormal CD4-positive T cell differentiation
|
J:328935
|
Elf4tm1Nim/Elf4tm1Nim
(B6.129S1-Elf4tm1Nim)
|
abnormal definitive hematopoiesis
|
J:107070
|
| abnormal T cell differentiation
|
J:79568
|
Elfn2tm1.1(KOMP)Vlcg/Elfn2tm1.1(KOMP)Vlcg
(C57BL/6N-Elfn2tm1.1(KOMP)Vlcg/Ucd)
|
increased eosinophil cell number
|
J:211773
|
Elk4tm1a(EUCOMM)Wtsi/Elk4tm1a(EUCOMM)Wtsi
(Not Specified)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hematocrit
|
J:165965
|
Elk4tm1Rtr/Elk4tm1Rtr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal positive T cell selection
|
J:88515
|
| abnormal T cell selection
|
J:88515
|
Elk4tm1Rtr/Elk4tm1Rtr
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129/Sv * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:88515
|
Elk4tm1Rtr/Elk4tm1Rtr
Tg(TcraTcrb)425Cbn/?
(involves: 129/Sv * C57BL/6)
|
abnormal positive T cell selection
|
J:88515
|
Elk4tm1Rtr/Elk4tm1Rtr
Tg(TcrLCMV)327Sdz/?
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:88515
|
Elmo1tm1a(EUCOMM)Wtsi/Elmo1tm1a(EUCOMM)Wtsi
(C57BL/6N-Elmo1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:165965
|
| increased hemoglobin content
|
J:165965
|
| thrombocytopenia
|
J:165965
|
Elmod1tm1b(EUCOMM)Hmgu/Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H)
|
increased eosinophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Elmod2tm1b(EUCOMM)Hmgu/Elmod2+
(C57BL/6N-Elmod2tm1b(EUCOMM)Hmgu/H)
|
increased hemoglobin content
|
J:211773
|
Elovl4tm1Kzh/Elovl4tm1Kzh
(involves: C57BL/6)
|
abnormal erythrocyte morphology
|
J:124499
|
Elovl6tm1b(EUCOMM)Hmgu/Elovl6+
(C57BL/6N-Elovl6tm1b(EUCOMM)Hmgu/H)
|
increased red blood cell distribution width
|
J:211773
|
Elp1Gt(BGB184)Byg/Elp1Gt(BGB184)Byg
(B6.129P2-Gt(BGB184)Byg)
|
abnormal embryonic erythropoiesis
|
J:145561
|
Emc4tm1(KOMP)Wtsi/Emc4+
(C57BL/6N-Emc4tm1(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Emc6tm1.1(KOMP)Vlcg/Emc6+
(C57BL/6N-Emc6tm1.1(KOMP)Vlcg/Ucd)
|
increased hematocrit
|
J:211773
|
Emc8tm1b(EUCOMM)Hmgu/Emc8+
(C57BL/6N-Emc8tm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Emcnem1(IMPC)Wtsi/Emcnem1(IMPC)Wtsi
(C57BL/6N-Emcnem1(IMPC)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Eme1tm1.1(KOMP)Wtsi/Eme1tm1.1(KOMP)Wtsi
(C57BL/6N-Eme1tm1.1(KOMP)Wtsi/Bay)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Emg1tm1.1Btr/Emg1tm1.1Btr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
decreased erythrocyte cell number
|
J:230556
|
Eml1em1(IMPC)Wtsi/Eml1em1(IMPC)Wtsi
(C57BL/6N-Eml1em1(IMPC)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Eml2tm1b(EUCOMM)Wtsi/Eml2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eml2tm1b(EUCOMM)Wtsi/Bay)
|
decreased hemoglobin content
|
J:211773
|
Emsyem1(IMPC)Ccpcz/Emsy+
(C57BL/6NCrl-Emsyem1(IMPC)Ccpcz/Ccpcz)
|
increased red blood cell distribution width
|
J:211773
|
Enamabte/Enam+
(C3HeB/FeJ-Enamabte)
|
decreased erythrocyte cell number
|
J:220423
|
| decreased hematocrit
|
J:220423
|
| decreased hemoglobin concentration distribution width
|
J:220423
|
| increased mean corpuscular volume
|
J:220423
|
Engem1(IMPC)Mbp/Eng+
(C57BL/6N-Engem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Engtm1Hma/Engtm1Hma
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal embryonic hematopoiesis
|
J:73415
|
Enox1tm1.1(KOMP)Vlcg/Enox1+
(C57BL/6N-Enox1tm1.1(KOMP)Vlcg/J)
|
decreased hematocrit
|
J:211773
|
Enpp3tm1Ktak/Enpp3tm1Ktak
(either: (involves: 129S4/SvJae * C57BL/6) or (involves: 129S4/SvJae * BALB/c * C57BL/6))
|
increased basophil cell number
|
J:223825
|
| increased mast cell number
|
J:223825
|
Enpp3tm1Ktak/Enpp3tm1Ktak
P2rx7tm1Gab/P2rx7tm1Gab
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6) or (involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6))
|
increased basophil cell number
|
J:223825
|
| increased mast cell number
|
J:223825
|
Entpd1tm1Rdr/Entpd1tm1Rdr
(involves: 129S2/SvPas)
|
thrombocytopenia
|
J:57505
|
Entpd6tm1a(KOMP)Wtsi/Entpd6tm1a(KOMP)Wtsi
(C57BL/6N-Entpd6tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Entr1em1(IMPC)Mbp/Entr1em1(IMPC)Mbp
(C57BL/6N-Entr1em1(IMPC)Mbp/MbpMmucd)
|
thrombocytopenia
|
J:211773
|
Eomestm1.1Twa/?
Il15tm1Imx/Il15tm1Imx
(involves: C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1.1Twa/?
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1.1Twa/?
Tg(CD2-Tbx21)#Staka/?
(involves: C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1.1Twa/?
Tg(Itgax-TGFBR2)1Flv/?
(involves: C3H * C57BL/6 * C57BL/6N)
|
abnormal NK cell differentiation
|
J:210160
|
Eomestm1Srnr/Eomestm1Srnr
Tbx21tm1Srnr/Tbx21tm1Srnr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:137655
|
| increased neutrophil cell number
|
J:137655
|
Ep300Plt6/Ep300+
Mpltm1Wsa/Mpltm1Wsa
(involves: 129S1/Sv * C57BL/6)
|
abnormal platelet morphology
|
J:140200
|
| increased eosinophil cell number
|
J:140200
|
Ep300Plt6/Ep300Plt6
(involves: 129S1/Sv * C57BL/6)
|
decreased eosinophil cell number
|
J:140200
|
| thrombocytosis
|
J:140200
|
Ep300Plt6/Ep300Plt6
Mpltm1Wsa/Mpltm1Wsa
(involves: 129S1/Sv * C57BL/6)
|
thrombocytosis
|
J:140200
|
Ep300tm1Pkb/Ep300+
(involves: 129P2/OlaHsd * C57BL/6)
|
thrombocytosis
|
J:98329
|
Ep300tm1Pkb/Ep300+
Mybtm1Ssp/Myb+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
thrombocytosis
|
J:98329
|
Ep300tm1Pkb/Ep300tm1Pkb
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:98329
|
| anisocytosis
|
J:98329
|
| thrombocytosis
|
J:98329
|
Ep300tm2Pkb/Ep300tm2Pkb
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:105505
|
Ep400tm1Fuku/Ep400tm1Fuku
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:127131
|
| absent erythrocytes
|
J:127131
|
Ep400tm3Fuku/Ep400tm3.1Fuku
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:166397
|
Epas1tm1.1Fsl/Epas1+
(involves: C57BL/6 * C57BL/6NTac)
|
increased erythrocyte cell number
|
J:199595
|
| increased hematocrit
|
J:199595
|
| increased hemoglobin content
|
J:199595
|
Epas1tm1.1Fsl/Epas1tm1.1Fsl
(involves: C57BL/6 * C57BL/6NTac)
|
increased erythrocyte cell number
|
J:199595
|
| increased hematocrit
|
J:199595
|
| increased hemoglobin content
|
J:199595
|
Epas1tm1b(EUCOMM)Hmgu/Epas1+
(C57BL/6N-Epas1tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
Epas1tm1Mcs/Epas1tm1.1Mcs
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129X1/SvJ * FVB/N)
|
decreased erythrocyte cell number
|
J:119731
|
| decreased hematocrit
|
J:119731
|
| decreased hemoglobin content
|
J:119731
|
Epas1tm1Mcs/Epas1tm1.1Mcs
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased hematocrit
|
J:302384
|
Epas1tm1Yms/Epas1tm1Yms
Tg(Vil1-cre)20Syr/0
(B6.Cg-Epas1tm1Yms Tg(Vil1-cre)20Syr)
|
decreased erythrocyte cell number
|
J:189504
|
| decreased hematocrit
|
J:189504
|
| decreased hemoglobin content
|
J:189504
|
Epb41tm1b(KOMP)Mbp/Epb41+
(C57BL/6N-Epb41tm1b(KOMP)Mbp/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Epb41tm1Cnby/Epb41tm1Cnby
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ)
|
abnormal erythrocyte morphology
|
J:77852
|
| abnormal erythropoiesis
|
J:77852
|
| anisopoikilocytosis
|
J:77852
|
| decreased cellular hemoglobin content
|
J:77852
|
| decreased hematocrit
|
J:77852
|
| decreased mean corpuscular volume
|
J:77852
|
| extramedullary hematopoiesis
|
J:77852
|
| increased mean corpuscular hemoglobin
|
J:77852
|
| spherocytosis
|
J:77852
|
Epb41l4atm1b(KOMP)Mbp/Epb41l4atm1b(KOMP)Mbp
(C57BL/6N-Epb41l4atm1b(KOMP)Mbp/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Epb41l5tm1a(EUCOMM)Hmgu/Epb41l5+
(C57BL/6N-Epb41l5tm1a(EUCOMM)Hmgu/H)
|
increased mean corpuscular volume
|
J:165965
|
Epb42tm1Llp/Epb42tm1Llp
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:67412
|
| decreased erythrocyte cell number
|
J:67412
|
| decreased hematocrit
|
J:67412
|
| decreased hemoglobin content
|
J:67412
|
| decreased mean corpuscular volume
|
J:67412
|
| increased mean corpuscular hemoglobin concentration
|
J:67412
|
| spherocytosis
|
J:67412
|
Epc1tm1a(EUCOMM)Wtsi/Epc1+
(Not Specified)
|
increased mean corpuscular volume
|
J:175295
|
Epdr1tm1b(NCOM)Mfgc/Epdr1tm1b(NCOM)Mfgc
(C57BL/6N-Epdr1tm1b(NCOM)Mfgc/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
epi/?
(involves: CBA/J)
|
decreased hematocrit
|
J:27487
|
| increased neutrophil cell number
|
J:27487
|
Epn3tm1b(KOMP)Wtsi/Epn3tm1b(KOMP)Wtsi
(C57BL/6N-Epn3tm1b(KOMP)Wtsi/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Epotm1Jae/Epotm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal erythropoiesis
|
J:29254
|
Epotm1Knni/Epotm1Knni
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129S/Sv * C57BL/6)
|
abnormal erythropoiesis
|
J:165479
|
| decreased erythrocyte cell number
|
J:165479
|
| decreased hematocrit
|
J:165479
|
| decreased hemoglobin content
|
J:165479
|
Epotm1Knni/Epotm1Knni
Tg(EIIa-cre)C5379Lmgd/0
(involves: C57BL/6 * FVB/N)
|
decreased erythrocyte cell number
|
J:165479
|
Eportm1.2Jtp/Eportm1.2Jtp
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hematocrit
|
J:67205
|
Eportm1.4Jtp/Epor+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hematocrit
|
J:67205
|
| increased hemoglobin content
|
J:67205
|
| polycythemia
|
J:67205
|
Eportm1.4Jtp/Eportm1.4Jtp
(involves: 129P2/OlaHsd * C57BL/6)
|
anisocytosis
|
J:67205
|
| increased hematocrit
|
J:67205
|
| microcytosis
|
J:67205
|
| polycythemia
|
J:67205
|
Eportm1Cos/Eportm1Cos
(involves: 129S/SvEv * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:31156
|
| abnormal erythropoiesis
|
J:31156
|
| decreased erythrocyte cell number
|
J:31156
|
Eportm1Jae/Eportm1Jae
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal erythropoiesis
|
J:29254
|
Eportm1Jni/Eportm1Jni
(involves: 129S1/Sv * C57BL/6)
|
abnormal erythropoiesis
|
J:70036
|
| increased hematocrit
|
J:70036
|
Eportm1Lizon/Eportm1Lizon
(involves: 129S4/SvJae * C57BL/6)
|
decreased erythrocyte cell number
|
J:35594
|
Eportm2Jni/Eportm2Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythropoiesis
|
J:70036
|
| decreased hematocrit
|
J:70036
|
Eps8l1tm2b(KOMP)Wtsi/Eps8l1tm2b(KOMP)Wtsi
(C57BL/6N-Eps8l1tm2b(KOMP)Wtsi/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(B6JTyr;B6N-Eps15tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:165965
|
Eps15tm1a(KOMP)Wtsi/Eps15tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased mean corpuscular hemoglobin
|
J:213427
|
| decreased mean corpuscular hemoglobin concentration
|
J:213427
|
Eps15tm1c(KOMP)Wtsi/Eps15tm1c(KOMP)Wtsi
Eps15l1tm1.1Noff/Eps15l1tm1.1Noff
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
anisocytosis
|
J:272122
|
| decreased mean corpuscular volume
|
J:272122
|
| increased red blood cell distribution width
|
J:272122
|
Eps15tm1c(KOMP)Wtsi/Eps15tm1c(KOMP)Wtsi
Eps15l1tm2.1Noff/Eps15l1tm2.1Noff
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal erythropoiesis
|
J:272122
|
| anisopoikilocytosis
|
J:272122
|
| decreased erythrocyte cell number
|
J:272122
|
| decreased hematocrit
|
J:272122
|
| decreased hemoglobin content
|
J:272122
|
| decreased mean corpuscular volume
|
J:272122
|
| extramedullary hematopoiesis
|
J:272122
|
Eps15tm1Noff/Eps15tm1Noff
(involves: 129 * C57BL/6)
|
increased transitional stage T1 B cell number
|
J:195689
|
Eps15l1em1(IMPC)J/Eps15l1em1(IMPC)J
(C57BL/6NJ-Eps15l1em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Epsti1em1Mjnh/Epsti1em1Mjnh
(Not Specified)
|
abnormal macrophage differentiation
|
J:272013
|
Epxtm1.1(cre)Jlee/Epx+
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased eosinophil cell number
|
J:198489
|
Epxtm1Nal/Epxtm1Nal
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal eosinophil morphology
|
J:70567
|
Erap1tm1Dgen/Erap1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
extramedullary hematopoiesis
|
J:101679
|
Erap1tm2b(EUCOMM)Wtsi/Erap1tm2b(EUCOMM)Wtsi
(C57BL/6N-Erap1tm2b(EUCOMM)Wtsi/Kmpc)
|
thrombocytosis
|
J:211773
|
Erbb4tm1Grl/Erbb4tm1Grl
Tg(Myh6-ERBB4)HT2Gass/0
(involves: 129S1/Sv * 129X1/SvJ)
|
increased granulocyte number
|
J:132190
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:92471
|
Ercc1tm1Jhjh/Ercc1tm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased common myeloid progenitor cell number
|
J:206925
|
Ercc1tm1Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased common myeloid progenitor cell number
|
J:206925
|
Ercc1tm2Jhjh/Ercc1tm2Jhjh
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased common myeloid progenitor cell number
|
J:206925
|
Ercc2tm1Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal hemoglobin
|
J:48256
|
| decreased erythrocyte cell number
|
J:48256
|
| decreased hematocrit
|
J:48256
|
Ercc2tm2(ERCC2)Jhjh/Ercc2tm2(ERCC2)Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased erythrocyte cell number
|
J:76608
|
| decreased hematocrit
|
J:76608
|
| decreased hemoglobin content
|
J:76608
|
Ercc3tm1b(NCOM)Mfgc/Ercc3+
(C57BL/6N-Ercc3tm1b(NCOM)Mfgc/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ercc5tm2b(EUCOMM)Hmgu/Ercc5+
(C57BL/6N-Ercc5tm2b(EUCOMM)Hmgu/Bay)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| thrombocytosis
|
J:211773
|
Ercc6l2em1Mengf/Ercc6l2em1Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
Ercc6l2em1Mengf/Ercc6l2em1Mengf
Nhej1em1Mengf/Nhej1em1Mengf
(Not Specified)
|
abnormal T cell receptor V(D)J recombination
|
J:311900
|
Ercc6l2em2Mengf/Ercc6l2em2Mengf
(Not Specified)
|
abnormal class switch recombination
|
J:311900
|
Erfetm1Lex/Erfe+
(B6;129S5-Erfetm1Lex/Mmucd)
|
decreased hemoglobin content
|
J:211331
|
Erfetm1Lex/Erfetm1Lex
(B6;129S5-Erfetm1Lex/Mmucd)
|
decreased hematocrit
|
J:211331
|
| decreased hemoglobin content
|
J:211331
|
| decreased mean corpuscular hemoglobin
|
J:211331
|
| decreased mean corpuscular hemoglobin concentration
|
J:211331
|
| decreased mean corpuscular volume
|
J:211331
|
Erfetm1Lex/Erfetm1Lex
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S5/SvEvBrd * C57BL/6)
|
decreased mean corpuscular hemoglobin
|
J:211331
|
| decreased mean corpuscular volume
|
J:211331
|
Ergmld2/Erg+
(involves: 129S1/Sv * C57BL/6)
|
decreased transitional stage B cell number
|
J:137835
|
| thrombocytopenia
|
J:137835
|
Ergmld2/Erg+
Mpltm1Wsa/Mpltm1Wsa
(B6.Cg-Mpltm1Wsa Ergmld2)
|
thrombocytopenia
|
J:137835
|
Ergmld2/Ergmld2
(involves: 129S1/Sv * C57BL/6)
|
abnormal embryonic erythropoiesis
|
J:137835
|
Ern1tm1Rjk/Ern1tm1Rjk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:106975
|
| abnormal pro-B cell morphology
|
J:106975
|
Esdem1(IMPC)J/Esdem1(IMPC)J
(C57BL/6NJ-Esdem1(IMPC)J/Mmjax)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Espntm1a(EUCOMM)Wtsi/Espntm1a(EUCOMM)Wtsi
(C57BL/6N-Espntm1a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:82423
|
| increased double-positive T cell number
|
J:110416
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:110923
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal B cell differentiation
|
J:63462
|
| abnormal definitive hematopoiesis
|
J:63462
|
| decreased immature B cell number
|
J:63462
|
Esr1tm1Ksk/Esr1tm1Ksk
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal class switch recombination
|
J:82423
|
| increased double-positive T cell number
|
J:110416
|
Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas)
|
increased neutrophil cell number
|
J:165719
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal leukopoiesis
|
J:83617
|
| abnormal lymphopoiesis
|
J:83617
|
| increased erythrocyte cell number
|
J:83617
|
| increased granulocyte number
|
J:83617
|
| increased neutrophil cell number
|
J:83617
|
| increased pro-B cell number
|
J:83617
|
Esrratm1.1(KOMP)Vlcg/Esrratm1.1(KOMP)Vlcg
(C57BL/6N-Esrratm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Esrratm1Vgi/Esrratm1Vgi
(involves: 129S1/Sv * 129X1/SvJ)
|
extramedullary hematopoiesis
|
J:160910
|
Esyt3tm1b(EUCOMM)Wtsi/Esyt3tm1b(EUCOMM)Wtsi
(C57BL/6N-Esyt3tm1b(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ethe1tm1b(EUCOMM)Wtsi/Ethe1+
(C57BL/6N-Ethe1tm1b(EUCOMM)Wtsi/H)
|
decreased mean platelet volume
|
J:211773
|
Ets1tm1.1Dds/Ets1tm1.1Dds
(129S6/SvEvTac-Ets1tm1.1Dds)
|
abnormal lymphopoiesis
|
J:121460
|
| increased double-positive T cell number
|
J:121460
|
Ets1tm1Fwa/Ets1tm1Fwa
(B6.129S4-Ets1tm1Fwa)
|
abnormal B cell differentiation
|
J:93845
|
| decreased pro-B cell number
|
J:93845
|
| increased pro-B cell number
|
J:93845
|
Ets1tm1Jml/Ets1tm1Jml
(involves: 129S/SvEv * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125056
|
| increased double-negative T cell number
|
J:125056
|
Ets1tm1Jml/Ets1tm1Jml
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * DBA/2J)
|
increased double-negative T cell number
|
J:125056
|
Etv2tm1Dlim/Etv2tm1Dlim
(involves: C57BL/6)
|
abnormal embryonic erythropoiesis
|
J:155850
|
Etv2tm1Dlim/Etv2tm2.1Dlim
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
impaired myelopoiesis
|
J:172687
|
Etv2tm1Vkou/Etv2tm1Vkou
Tg(Pgk1-cre)1Lni/0
(involves: BALB/c * C57BL/6)
|
absent erythrocytes
|
J:194572
|
Etv6em1(IMPC)Rbrc/Etv6+
(C57BL/6NJcl-Etv6em1(IMPC)Rbrc/Rbrc)
|
decreased erythrocyte cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Etv6em3Knic/Etv6+
(involves: C57BL/6J)
|
abnormal common myeloid progenitor cell morphology
|
J:342774
|
| abnormal hemopoiesis
|
J:342774
|
| abnormal platelet shape
|
J:342774
|
Etv6tm1(RUNX1)Haho/Etv6+
Tg(Gata1-cre)1Sho/0
(involves: 129S1/Sv * C57BL/6 * CD-1 * Swiss Webster)
|
abnormal B cell differentiation
|
J:151639
|
Etv6tm1(RUNX1)Haho/Etv6+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:151639
|
| abnormal definitive hematopoiesis
|
J:151639
|
| abnormal lymphopoiesis
|
J:151639
|
| decreased neutrophil cell number
|
J:151639
|
| myeloid hyperplasia
|
J:151639
|
| thrombocytopenia
|
J:151639
|
Etv6tm1(RUNX1)Haho/Etv6+
Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:151639
|
| decreased pro-B cell number
|
J:151639
|
Etv6tm2.1Sho/Etv6tm2.1Sho
(involves: 129S1/Sv)
|
abnormal erythropoiesis
|
J:93052
|
Etv6tm2Sho/Etv6tm2Sho
Tg(Gata1-cre)1Sho/?
(involves: 129S1/Sv)
|
thrombocytopenia
|
J:93052
|
Etv6tm2Sho/Etv6tm2Sho
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased neutrophil cell number
|
J:93052
|
| thrombocytopenia
|
J:93052
|
Evltm1b(KOMP)Wtsi/Evltm1b(KOMP)Wtsi
(C57BL/6N-Evltm1b(KOMP)Wtsi/H)
|
thrombocytosis
|
J:211773
|
Ewsr1tm1Sblee/Ewsr1tm1Sblee
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased double-positive T cell number
|
J:122058
|
| decreased immature B cell number
|
J:122058
|
Exd1tm1b(EUCOMM)Hmgu/Exd1tm1b(EUCOMM)Hmgu
(C57BL/6N-Exd1tm1b(EUCOMM)Hmgu/Orl)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Exo1tm2Wed/Exo1tm2Wed
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:198719
|
| abnormal somatic hypermutation frequency
|
J:198719
|
Exoc3tm2c(EUCOMM)Hmgu/Exoc3tm2c(EUCOMM)Hmgu
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6 * C57BL/6N)
|
increased mean platelet volume
|
J:302300
|
Exoc6hbd/Exoc6hbd
(AB.Cg-Exoc6hbd)
|
anisocytosis
|
J:8251
|
| decreased hemoglobin content
|
J:8251
|
| decreased mean corpuscular hemoglobin
|
J:8251
|
| increased erythrocyte protoporphyrin level
|
J:8251
|
| microcytosis
|
J:8251
|
| poikilocytosis
|
J:8251
|
| polychromatophilia
|
J:8251
|
Exoc6hbd/Exoc6hbd
(B6.Cg-Exoc6hbd/J)
|
abnormal erythrocyte morphology
|
J:105712
|
| abnormal erythropoiesis
|
J:42436
|
| decreased hematocrit
|
J:42436,
J:105712
|
| decreased hemoglobin content
|
J:42436,
J:105712
|
| decreased mean corpuscular hemoglobin concentration
|
J:42436
|
| decreased mean corpuscular volume
|
J:42436,
J:105712
|
| increased erythrocyte protoporphyrin level
|
J:42436
|
| microcytosis
|
J:42436
|
Exoc6hbd/Exoc6hbd
(involves: STOCK Ay)
|
decreased erythrocyte cell number
|
J:5439
|
| decreased mean corpuscular hemoglobin
|
J:5439
|
| hyperchromasia
|
J:5439
|
| increased mean corpuscular volume
|
J:5439
|
| macrocytosis
|
J:5439
|
| polychromatophilia
|
J:5439
|
Exosc8tm1.1(KOMP)Vlcg/Exosc8+
(C57BL/6N-Exosc8tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ezh1tm1b(EUCOMM)Wtsi/Ezh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ezh1tm1b(EUCOMM)Wtsi/Nju)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Ezh1tm1Sgon/Ezh1tm1Sgon
Tg(VAV1-cre)1Graf/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased immature B cell number
|
J:193722
|
| decreased pro-B cell number
|
J:193722
|
Ezh2tm1a(EUCOMM)Wtsi/Ezh2+
(C57BL/6N-Ezh2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Ezh2tm1Tara/Ezh2tm1Tara
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:83216
|
| abnormal immunoglobulin V(D)J recombination
|
J:83216
|
| abnormal pro-B cell morphology
|
J:83216
|
| decreased immature B cell number
|
J:83216
|
Ezh2tm2Sho/Ezh2tm2.1Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
| increased double-negative T cell number
|
J:182211
|
Ezh2tm2Sho/Ezh2tm2Sho
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:182211
|
| increased double-negative T cell number
|
J:182211
|
f/f
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:13598
|
| decreased erythrocyte cell number
|
J:13090
|
f/f
(FL/1ReJ)
|
decreased erythrocyte cell number
|
J:24610
|
| decreased hematocrit
|
J:24610
|
| decreased mean corpuscular volume
|
J:24610
|
f/f
(involves: CBA/St)
|
decreased mean corpuscular hemoglobin
|
J:164714
|
| increased siderocyte number
|
J:14979
|
f/f
KitW/Kit+
(FL/1Re-KitW/J)
|
abnormal erythrocyte cell number
|
J:24610
|
| decreased hematocrit
|
J:24610
|
| decreased mean corpuscular volume
|
J:24610
|
F2tm1b(EUCOMM)Hmgu/F2+
(C57BL/6N-F2tm1b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular volume
|
J:211773
|
F3tm1.1Dwr/F3tm1.1Dwr
(involves: 129S1/Sv * 129X1/SvJ * MF1 * Swiss)
|
decreased neutrophil cell number
|
J:91165
|
F9tm1Dws/Y
(involves: 129P2/OlaHsd)
|
decreased hematocrit
|
J:166332
|
F9tm1Dws/F9tm1Dws
(involves: 129P2/OlaHsd)
|
decreased hematocrit
|
J:166332
|
F9tm3Dws/Y
(B6.129P2-F9tm3Dws)
|
decreased hematocrit
|
J:166332
|
F9tm3Dws/F9tm3Dws
(B6.129P2-F9tm3Dws)
|
decreased hematocrit
|
J:166332
|
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neutrophil morphology
|
J:67398
|
| anisocytosis
|
J:67398
|
| decreased neutrophil cell number
|
J:67398
|
| increased number of Howell-Jolly bodies
|
J:67398
|
Faahem1(IMPC)H/Faahem1(IMPC)H
(C57BL/6NTac-Faahem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Fabp7em1(IMPC)H/Fabp7em1(IMPC)H
(C57BL/6N-Fabp7em1(IMPC)H/H)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd)33Wnt/0
Tg(Lck-cre)I57Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA * ICR)
|
abnormal T cell differentiation
|
J:69617
|
| decreased double-positive T cell number
|
J:69617
|
| increased double-negative T cell number
|
J:69617
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd)33Wnt/0
Tg(Lck-cre)I57Jxm/0
Tg(Tcra2C,Tcrb2C)1Dlo/0
(involves: 129S4/SvJae * C57BL/6 * C57L * CBA * ICR * SJL)
|
increased double-negative T cell number
|
J:69617
|
Faddtm1Wnt/Faddtm1Wnt
Tg(Fadd/EGFP)#Jizh/?
Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal erythrocyte morphology
|
J:168722
|
Faddtm2.1Wnt/Faddtm2.1Wnt
Tg(Cd4-cre)1Cwi/?
(B6.Cg-Tg(Cd4-cre)1Cwi Faddtm2.1Wnt)
|
abnormal erythrocyte cell number
|
J:162312
|
Fam3dem1Wko/Fam3dem1Wko
(C57BL/6-Fam3dem1Wko)
|
decreased neutrophil cell number
|
J:304594
|
| increased neutrophil cell number
|
J:304594,
J:300819
|
Fam20ctm1Lex/Fam20ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
extramedullary hematopoiesis
|
J:186384
|
Fam24bem1(IMPC)J/Fam24bem1(IMPC)J
(C57BL/6NJ-Fam24bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular volume
|
J:211773
|
Fam53btm1b(EUCOMM)Hmgu/Fam53btm1b(EUCOMM)Hmgu
(C57BL/6N-Fam53btm1b(EUCOMM)Hmgu/Cnrm)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Fam72atm1.1(KOMP)Vlcg/Fam72atm1.1(KOMP)Vlcg
Msh2tm1Mak/Msh2tm1Mak
(C57BL/6NTac-Fam72atm1.1(KOMP)Vlcg Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Fam83gtm1a(EUCOMM)Wtsi/Fam83gtm1a(EUCOMM)Wtsi
(Not Specified)
|
increased erythrocyte cell number
|
J:165965
|
| increased hematocrit
|
J:165965
|
Fam107btm1a(KOMP)Wtsi/Fam107btm1a(KOMP)Wtsi
(B6JTyr;B6N-Fam107btm1a(KOMP)Wtsi/Wtsi)
|
increased erythrocyte cell number
|
J:175295
|
Fam110btm1a(EUCOMM)Wtsi/Fam110b+
(C57BL/6N-Fam110btm1a(EUCOMM)Wtsi/Cnrm)
|
increased erythrocyte cell number
|
J:165965
|
Fam135aem1(IMPC)Tcp/Fam135aem1(IMPC)Tcp
(C57BL/6NCrl-Fam135aem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Fam151btm1b(EUCOMM)Hmgu/Fam151btm1b(EUCOMM)Hmgu
(C57BL/6N-Fam151btm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
Fam163atm2b(KOMP)Wtsi/Fam163atm2b(KOMP)Wtsi
(C57BL/6N-Fam163atm2b(KOMP)Wtsi/Wtsi)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Fam193aem1(IMPC)J/Fam193a+
(C57BL/6NJ-Fam193aem1(IMPC)J/Mmjax)
|
increased mean corpuscular volume
|
J:211773
|
Fam210atm1b(EUCOMM)Wtsi/Fam210a+
(C57BL/6N-Fam210atm1b(EUCOMM)Wtsi/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Fam210btm1b(KOMP)Mbp/Fam210btm1b(KOMP)Mbp
(C57BL/6N-Fam210btm1b(KOMP)Mbp/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Fam221aem1(IMPC)Ccpcz/Fam221aem1(IMPC)Ccpcz
(C57BL/6N-Fam221aem1(IMPC)Ccpcz/Ccpcz)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Fancatm1Faw/Fancatm1Faw
(involves: 129P2/OlaHsd * FVB)
|
increased mean corpuscular volume
|
J:63742
|
| thrombocytopenia
|
J:63742
|
Fancctm1Mab/Fancctm1Mab
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased common myeloid progenitor cell number
|
J:71134
|
| thrombocytopenia
|
J:71134
|
Fancctm1Mab/Fancctm1Mab
Sod1tm1Cep/Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased common myeloid progenitor cell number
|
J:71134
|
| decreased erythrocyte cell number
|
J:71134
|
| decreased hemoglobin content
|
J:71134
|
| decreased neutrophil cell number
|
J:71134
|
| increased mean corpuscular volume
|
J:71134
|
| polychromatophilia
|
J:71134
|
Fancctm1Mgo/Fancctm1Mgo
(involves: 129S4/SvJaeSor * C57BL/6)
|
absent common myeloid progenitor cells
|
J:61512
|
Fancd2em1Tzh/Fancd2em1Tzh
(C57BL/6-Fancd2em1Tzh)
|
abnormal erythropoiesis
|
J:284566
|
| decreased erythrocyte cell number
|
J:284566
|
| decreased hemoglobin content
|
J:284566
|
Fancd2Gt(OST57859)Lex/Fancd2Gt(OST57859)Lex
(involves: 129S5/SvEvBrd)
|
thrombocytopenia
|
J:285384
|
Fancd2Gt(OST57859)Lex/Fancd2Gt(OST57859)Lex
Fancitm1.1Itl/Fancitm1.1Itl
(involves: 129S5/SvEvBrd * C57BL/6J * CBA)
|
thrombocytopenia
|
J:285384
|
Fancfem1(IMPC)J/Fancfem1(IMPC)J
(C57BL/6NJ-Fancfem1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Fancitm1.1Itl/Fancitm1.1Itl
(involves: C57BL/6J * CBA)
|
thrombocytopenia
|
J:285384
|
Fancltm1b(EUCOMM)Hmgu/Fancltm1b(EUCOMM)Hmgu
(C57BL/6N-Fancltm1b(EUCOMM)Hmgu/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Faslpr-cg/Faslpr-cg
(CBA/KlJms-Faslpr-cg/J)
|
abnormal T cell differentiation
|
J:24805
|
Faslpr/Fas+
Raf1tm1Bacc/Raf1tm1Bacc
(involves: 129/SvHsd * 129P2/OlaHsd * C57BL/6 * MRL)
|
abnormal erythropoiesis
|
J:135681
|
Faslpr/Faslpr
(MRL/Mp-Faslpr)
|
abnormal B cell receptor editing
|
J:131138
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
decreased immature B cell number
|
J:122315
|
| decreased transitional stage B cell number
|
J:122315
|
| increased neutrophil cell number
|
J:127199
|
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
|
increased immature B cell number
|
J:132217
|
| increased transitional stage B cell number
|
J:132217
|
Faslpr/Faslpr
(C3.MRL-Faslpr/J)
|
decreased eosinophil cell number
|
J:106288
|
Faslpr/Faslpr
(B6.MRL-Faslpr)
|
increased double-negative T cell number
|
J:135036
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr)
|
increased double-negative T cell number
|
J:137066
|
Faslpr/Faslpr
(involves: 129P2/OlaHsd * MRL)
|
increased double-negative T cell number
|
J:26250
|
Faslpr/Faslpr
Fcer1gtm1Tks/Fcer1gtm1Tks
(MRL.Cg-Fcer1gtm1Tks Faslpr)
|
increased double-negative T cell number
|
J:106188
|
Faslpr/Faslpr
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch Faslpr)
|
increased double-negative T cell number
|
J:186484
|
Faslpr/Faslpr
Ifngtm1Ts/Ifngtm1Ts
(involves: 129S7/SvEvBrd * DBA/1 * MRL/Mp)
|
decreased double-negative T cell number
|
J:39600
|
Faslpr/Faslpr
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(MRL.Cg-Faslpr Igh-Jtm2(3H9-VDJ*)Mwg)
|
abnormal B cell receptor editing
|
J:131138
|
Faslpr/Faslpr
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6 * MRL/Mp)
|
arrested B cell differentiation
|
J:119584
|
Faslpr/Faslpr
Itfg2Gt(OST215121)Lex/Itfg2Gt(OST215121)Lex
(involves: 129S5/SvEvBrd * C57BL/6J * MRL/Mp)
|
increased double-negative T cell number
|
J:205951
|
Faslpr/Faslpr
Raf1tm1Bacc/Raf1tm1Bacc
(involves: 129/SvHsd * 129P2/OlaHsd * C57BL/6 * MRL)
|
abnormal erythropoiesis
|
J:135681
|
Faslpr/Faslpr
Selptm1Bay/Selptm1Bay
(MRL.Cg-Selptm1Bay Faslpr)
|
increased neutrophil cell number
|
J:127199
|
Faslpr/Faslpr
Tg(CD2-Foxj1)#Stlp/0
(MRL.Cg-Faslpr Tg(CD2-Foxj1)#Stlp)
|
increased double-negative T cell number
|
J:122222
|
Faslpr/Faslpr
Tlr7tm1Flv/Y
(involves: 129S1/Sv * C57BL/6 * MRL/Mp)
|
decreased double-negative T cell number
|
J:113557
|
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(B6.Cg-Tlr9tm1Aki Faslpr)
|
increased double-negative T cell number
|
J:135036
|
Faslpr/Faslpr
Tlr9tm1Aki/Tlr9tm1Aki
(MRL.Cg-Tlr9tm1Aki Faslpr)
|
increased double-negative T cell number
|
J:113557
|
Faslpr/Faslpr
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(MRL.Cg-Tnfrsf9tm1Byk Faslpr)
|
increased double-negative T cell number
|
J:127197,
J:126929
|
Faslpr/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * MRL)
|
increased double-negative T cell number
|
J:114948
|
Fasm1Btlr/Fasm1Btlr
(C57BL/6J-Fasm1Btlr)
|
increased neutrophil cell number
|
J:216052
|
Fastm1Ach/Fastm1Ach
Tg(GZMB-cre)1Jcb/?
(involves: C57BL/6 * FVB/N)
|
increased double-positive T cell number
|
J:123556
|
Fastm1Ach/Fastm1Ach
Tg(Lck-cre)548Jxm/?
(involves: C57BL/6 * CBA)
|
increased double-positive T cell number
|
J:123556
|
Fastm1Cgn/Fastm1Cgn
Tg(Cd4-cre)1Cwi/0
(B6.Cg-Tg(Cd4-cre)1Cwi Fastm1Cgn)
|
increased double-negative T cell number
|
J:114948
|
Fastm1Osa/Fastm1Osa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell clonal deletion
|
J:32125
|
Fasldel1Hong/Fasldel1Hong
(either: (involves: 129 * BALB/c * C57BL/6) or (involves: 129X1/SvJ * C3H/HeJ * C57BL/6))
|
abnormal definitive hematopoiesis
|
J:112563
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld/J)
|
abnormal T cell differentiation
|
J:12002,
J:8267
|
| increased neutrophil cell number
|
J:7306
|
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
|
decreased granulocyte number
|
J:136745
|
Fasltm1.1Lest/Fasltm1.1Lest
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:87990
|
Fastktm1.1Andp/Fastktm1.1Andp
(B6.129S6-Fastktm1.1Andp)
|
decreased neutrophil cell number
|
J:160443
|
Fbln1tm1Tmpl/Fbln1tm1Tmpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased hematocrit
|
J:71581
|
Fbn1em1(IMPC)H/Fbn1+
(C57BL/6NTac-Fbn1em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Fbn1Tsk/Fbn1+
(B6.Cg-Fbn1Tsk)
|
increased mast cell number
|
J:8047
|
Fbn1Tsk/Fbn1+
KitW/KitW-v
(involves: C57BL/6 * C57BL/10 * DBA/2 * WB/ReJ)
|
absent mast cells
|
J:24076
|
Fbn2em1(IMPC)Rbrc/Fbn2em1(IMPC)Rbrc
(C57BL/6NJcl-Fbn2em1(IMPC)Rbrc/Rbrc)
|
thrombocytopenia
|
J:211773
|
Fbrsl1em1(IMPC)Tcp/Fbrsl1em1(IMPC)Tcp
(C57BL/6N-Fbrsl1em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Fbxl5Gt(OST386421)Lex/Fbxl5+
(129S(B6)-Fbxl5Gt(OST386421)Lex)
|
abnormal erythrocyte morphology
|
J:193752
|
Fbxl5Gt(OST386421)Lex/Fbxl5+
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:193752
|
Fbxl5tm1Kei/Fbxl5tm1Kei
Ireb2tm1Roua/Ireb2tm1Roua
(B6.129-Fbxl5tm1Kei Ireb2tm1Roua)
|
decreased hematocrit
|
J:176655
|
| decreased hemoglobin content
|
J:176655
|
| decreased mean corpuscular hemoglobin
|
J:176655
|
| decreased mean corpuscular hemoglobin concentration
|
J:176655
|
| decreased mean corpuscular volume
|
J:176655
|
| microcytosis
|
J:176655
|
Fbxl18tm1b(EUCOMM)Hmgu/Fbxl18tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxl18tm1b(EUCOMM)Hmgu/Mhzh)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Fbxl19tm1b(EUCOMM)Wtsi/Fbxl19+
(C57BL/6N-Fbxl19tm1b(EUCOMM)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Fbxl20tm1b(KOMP)Wtsi/Fbxl20+
(C57BL/6N-Fbxl20tm1b(KOMP)Wtsi/H)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Fbxo4tm1.1Jadi/Fbxo4+
(Not Specified)
|
extramedullary hematopoiesis
|
J:178645
|
| myeloid hyperplasia
|
J:178645
|
Fbxo4tm1.1Jadi/Fbxo4tm1.1Jadi
(Not Specified)
|
extramedullary hematopoiesis
|
J:178645
|
| myeloid hyperplasia
|
J:178645
|
Fbxo5em1(IMPC)Mbp/Fbxo5+
(C57BL/6NCrl-Fbxo5em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular volume
|
J:211773
|
Fbxo7tm1a(EUCOMM)Hmgu/Fbxo7tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased pro-B cell number
|
J:183053
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(C57BL/6N-Fbxo7tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Fbxo7tm1a(EUCOMM)Wtsi/Fbxo7tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal T cell differentiation
|
J:272313
|
| anisocytosis
|
J:272313
|
| decreased erythrocyte cell number
|
J:272313
|
| decreased hematocrit
|
J:272313
|
| decreased hemoglobin content
|
J:272313
|
| extramedullary hematopoiesis
|
J:272313
|
| increased double-negative T cell number
|
J:272313
|
| increased mean corpuscular hemoglobin concentration
|
J:272313
|
| increased mean corpuscular volume
|
J:272313
|
| increased red blood cell distribution width
|
J:272313
|
Fbxo9tm1b(EUCOMM)Hmgu/Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp)
|
increased basophil cell number
|
J:211773
|
Fbxo10tm1b(KOMP)Wtsi/Fbxo10tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo10tm1b(KOMP)Wtsi/Nju)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
Fbxo11tm2b(EUCOMM)Wtsi/Fbxo11+
(C57BL/6N-Fbxo11tm2b(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Fbxo21em1Smbk/Fbxo21em1Smbk
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Fbxo21em1Smbk Commd10Tg(Vav1-icre)A2Kio)
|
abnormal stress erythropoiesis
|
J:333469
|
Fbxo25em1(IMPC)Ccpcz/Fbxo25em1(IMPC)Ccpcz
(C57BL/6N-Fbxo25em1(IMPC)Ccpcz/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Fbxo28em1(IMPC)Mhzh/Fbxo28+
(C57BL/6N-Fbxo28em1(IMPC)Mhzh/Mhzh)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Fbxo36tm1b(KOMP)Wtsi/Fbxo36tm1b(KOMP)Wtsi
(C57BL/6N-Fbxo36tm1b(KOMP)Wtsi/Nju)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| decreased mean platelet volume
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Fbxo42em1(IMPC)J/Fbxo42+
(C57BL/6NJ-Fbxo42em1(IMPC)J/Mmjax)
|
thrombocytosis
|
J:211773
|
Fbxw2tm1b(EUCOMM)Hmgu/Fbxw2tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxw2tm1b(EUCOMM)Hmgu/Nju)
|
increased basophil cell number
|
J:211773
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137138
|
| decreased double-negative T cell number
|
J:137138
|
Fbxw7tm1Iaai/Fbxw7tm1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:200006
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:128523
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-positive T cell number
|
J:128523
|
Fbxw7tm1Kei/Fbxw7tm1Kei
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:128523
|
| increased double-positive T cell number
|
J:128523
|
Fbxw7tm1Sje/Fbxw7tm1Sje
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal erythrocyte cell number
|
J:88903
|
Fbxw8tm1b(EUCOMM)Hmgu/Fbxw8+
(C57BL/6N-Fbxw8tm1b(EUCOMM)Hmgu/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Fcamrtm1Shib/Fcamrtm1Shib
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal memory B cell differentiation
|
J:150824
|
| abnormal somatic hypermutation frequency
|
J:150824
|
Fcer1atm1Ftl/Fcer1atm1Ftl
(CBy.129S2-Fcer1atm1Ftl)
|
decreased eosinophil cell number
|
J:120702
|
Fcer1gtm1b(KOMP)Wtsi/Fcer1gtm1b(KOMP)Wtsi
(C57BL/6N-Fcer1gtm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased platelet calcium level
|
J:118488
|
Fcer1gtm1Rav/Fcer1gtm1Rav
(involves: 129P2/OlaHsd)
|
abnormal hemoglobin
|
J:168556
|
Fcgr1tm1Jgjw/Fcgr1tm1Jgjw
(involves: 129 * C57BL/6)
|
abnormal dendritic cell differentiation
|
J:112436
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal neutrophil morphology
|
J:191090
|
| increased double-negative T cell number
|
J:191090
|
| increased neutrophil cell number
|
J:191090
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased double-negative T cell number
|
J:191090
|
Fcgr3tm1Jsv/Fcgr3tm1Jsv
(B6.129P2-Fcgr3tm1Jsv/J)
|
increased neutrophil cell number
|
J:78297
|
Fcho2tm1b(EUCOMM)Hmgu/Fcho2+
(C57BL/6N-Fcho2tm1b(EUCOMM)Hmgu/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Fcrlatm1b(KOMP)Wtsi/Fcrlatm1b(KOMP)Wtsi
(C57BL/6N-Fcrlatm1b(KOMP)Wtsi/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Fdx2em1(IMPC)Rbrc/Fdx2em1(IMPC)Rbrc
(C57BL/6NJcl-Fdx2em1(IMPC)Rbrc/Rbrc)
|
abnormal erythrocyte cell number
|
J:211773
|
| abnormal hemoglobin content
|
J:211773
|
Fechm1Pas/Fechm1Pas
(involves: 129/Sv * BALB/c)
|
abnormal erythrocyte morphology
|
J:2021
|
| abnormal erythropoiesis
|
J:2021
|
| anisocytosis
|
J:2021
|
| decreased erythrocyte cell number
|
J:2021
|
| decreased hematocrit
|
J:2021
|
| decreased hemoglobin content
|
J:2021
|
| increased erythrocyte protoporphyrin level
|
J:2021
|
| increased red blood cell distribution width
|
J:2021
|
| leptocytosis
|
J:2021
|
| polychromatophilia
|
J:2021
|
Fechm1Pas/Fechm1Pas
hem6/hem6
(involves: 129 * BALB/c * C57BL/6)
|
decreased hemoglobin content
|
J:142791
|
| increased erythrocyte protoporphyrin level
|
J:142791
|
Fechm1Pas/Fechm1Pas
hem6/hem6+
(involves: 129 * BALB/c * C57BL/6)
|
decreased hemoglobin content
|
J:142791
|
| increased erythrocyte protoporphyrin level
|
J:142791
|
Fechm1Pas/Fechtm1.1(FECH*)Emi
(involves: 129 * BALB/cJ * C57BL/6J)
|
decreased eosinophil cell number
|
J:239515
|
| decreased erythrocyte cell number
|
J:239515
|
| decreased hematocrit
|
J:239515
|
| decreased mean corpuscular hemoglobin
|
J:239515
|
| decreased mean corpuscular hemoglobin concentration
|
J:239515
|
| decreased mean corpuscular volume
|
J:239515
|
| thrombocytosis
|
J:239515
|
Fen1tm1Bhsh/Fen1tm1Bhsh
(involves: 129S1/Sv)
|
abnormal embryonic erythropoiesis
|
J:121378
|
| abnormal embryonic hematopoiesis
|
J:121378
|
Fen1tm3.1Bhsh/Fen1+
(Not Specified)
|
extramedullary hematopoiesis
|
J:231218
|
Fen1tm3.1Bhsh/Fen1tm3.1Bhsh
(Not Specified)
|
extramedullary hematopoiesis
|
J:231218
|
Ferem1(IMPC)Tcp/Fer+
(C57BL/6N-Ferem1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Fermt3tm1.1Efp/Fermt3tm1.1Efp
(involves: C57BL/6)
|
acanthocytosis
|
J:227094
|
| decreased erythrocyte cell number
|
J:227094
|
Fermt3tm1Ref/Fermt3tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythrocyte morphology
|
J:145476
|
| anisopoikilocytosis
|
J:145476
|
| decreased erythrocyte cell number
|
J:145476
|
| increased nucleated erythrocyte cell number
|
J:145476
|
Festm1Mcs/Festm1Mcs
(involves: 129X1/SvJ)
|
increased granulocyte number
|
J:64748
|
| increased neutrophil cell number
|
J:64748
|
Festm2Pag/Festm2Pag
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal myelopoiesis
|
J:98590
|
| increased erythrocyte cell number
|
J:98590
|
| increased hematocrit
|
J:98590
|
| increased hemoglobin content
|
J:98590
|
| increased pro-B cell number
|
J:98590
|
Ffar2tm2Lex/Ffar2tm2Lex
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal neutrophil morphology
|
J:157383
|
Fgbtm1.1(KOMP)Vlcg/Fgbtm1.1(KOMP)Vlcg
(C57BL/6N-Fgbtm1.1(KOMP)Vlcg/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Fgf2tm1Doe/Fgf2tm1Doe
(involves: 129P2/OlaHsd * Black Swiss)
|
abnormal common myeloid progenitor cell morphology
|
J:45775
|
| thrombocytosis
|
J:45775
|
Fgf11tm1a(EUCOMM)Wtsi/Fgf11tm1a(EUCOMM)Wtsi
(C57BL/6N-Fgf11tm1a(EUCOMM)Wtsi/Cnrm)
|
increased mean corpuscular volume
|
J:165965
|
Fgfbp3tm1.1(KOMP)Wtsi/Fgfbp3tm1.1(KOMP)Wtsi
(C57BL/6N-Fgfbp3tm1.1(KOMP)Wtsi/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Fgfr1tm1Upir/Fgfr1tm1Upir
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(KRT5-cre)5132Jlj/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal mast cell morphology
|
J:221184
|
| increased mast cell number
|
J:221184
|
Fgfrl1tm1.1Ptew/Fgfrl1tm1.1Ptew
(B6.129-Fgfrl1tm1.1Ptew)
|
decreased erythrocyte cell number
|
J:149673
|
| decreased hematocrit
|
J:149673
|
| decreased hemoglobin content
|
J:149673
|
Fggtm1Lord/Fggtm1Lord
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hematocrit
|
J:129828
|
| decreased mean corpuscular volume
|
J:129828
|
Fhip1atm1b(EUCOMM)Wtsi/Fhip1a+
(C57BL/6N-Fhip1a1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Fhip1bem1(IMPC)Tcp/Fhip1bem1(IMPC)Tcp
(C57BL/6NCrl-Fhip1bem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Fhittm1Hbn/Fhit+
(involves: 129X1/SvJ * C57BL/6)
|
decreased granulocyte number
|
J:71303
|
Fhittm1Hbn/Fhittm1Hbn
(involves: 129X1/SvJ * C57BL/6)
|
decreased granulocyte number
|
J:71303
|
Fibptm1e(EUCOMM)Wtsi/Fibp+
(C57BL/6N-Fibptm1e(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Firrmtm1a(EUCOMM)Hmgu/Firrm+
(C57BL/6N-Firrmtm1a(EUCOMM)Hmgu/H)
|
increased mean corpuscular volume
|
J:165965
|
Fkbp4em1(IMPC)Mbp/Fkbp4em1(IMPC)Mbp
(C57BL/6N-Fkbp4em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular volume
|
J:211773
|
Fkbp5tm1b(KOMP)Wtsi/Fkbp5tm1b(KOMP)Wtsi
(C57BL/6N-Fkbp5tm1b(KOMP)Wtsi/MbpMmucd)
|
increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Fkbp6tm1b(KOMP)Wtsi/Fkbp6tm1b(KOMP)Wtsi
(C57BL/6N-Fkbp6tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Fkbp10tm2a(EUCOMM)Wtsi/Fkbp10+
(C57BL/6N-Fkbp10tm2a(EUCOMM)Wtsi/Ics)
|
decreased hemoglobin content
|
J:165965
|
| decreased mean corpuscular volume
|
J:165965
|
| increased hemoglobin content
|
J:165965
|
Flcntm1Baba/Flcntm1.1Lss
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:189078
|
Fli1tm1.1Dkw/Fli1tm1.1Dkw
(B6.129S6-Fli1tm1.1Dkw)
|
abnormal B cell differentiation
|
J:137876
|
| abnormal class switch recombination
|
J:137876
|
| increased transitional stage B cell number
|
J:137876
|
Fli1tm1Ber/Fli1tm1Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
decreased hematocrit
|
J:33052
|
Fli1tm1Dkw/Fli1+
Mpltm1Wsa/Mpltm1Wsa
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6)
|
thrombocytopenia
|
J:137835
|
Fli1tm1Morl/Fli1tm1.1Morl
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA * DBA)
|
thrombocytopenia
|
J:167426
|
Fli1tm1Morl/Fli1tm1Morl
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal erythropoiesis
|
J:167426
|
| abnormal thrombopoiesis
|
J:167426
|
| decreased granulocyte number
|
J:167426
|
| increased erythrocyte cell number
|
J:167426
|
| thrombocytopenia
|
J:167426
|
Flnbtm1b(KOMP)Wtsi/Flnb+
(C57BL/6N-Flnbtm1b(KOMP)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Flt3tm1.1Dosm/Flt3+
(B6.129(C)-Flt3tm1.1Dosm)
|
abnormal definitive hematopoiesis
|
J:205200
|
| arrested B cell differentiation
|
J:205200
|
Flt3tm1Dgg/Flt3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
| abnormal definitive hematopoiesis
|
J:126003
|
| increased granulocyte number
|
J:126003
|
Flt3tm1Dgg/Flt3+
Kmt2atm1Clgr/Kmt2a+
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6J)
|
thrombocytopenia
|
J:189096
|
Flt3tm1Dgg/Flt3tm1Dgg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:126003
|
| abnormal common myeloid progenitor cell morphology
|
J:126003
|
| abnormal definitive hematopoiesis
|
J:126003
|
| increased granulocyte number
|
J:126003
|
Flt3tm1Dosm/Flt3+
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Flt3tm1Dosm Tg(Mx1-cre)1Cgn)
|
abnormal definitive hematopoiesis
|
J:133528
|
| arrested B cell differentiation
|
J:133528
|
| decreased erythrocyte cell number
|
J:133528
|
| decreased hemoglobin content
|
J:133528
|
| decreased neutrophil cell number
|
J:133528
|
| extramedullary hematopoiesis
|
J:133528
|
| increased granulocyte number
|
J:133528
|
| increased neutrophil cell number
|
J:133528
|
| increased pro-B cell number
|
J:133528
|
Flt3tm1Irl/Flt3tm1Irl
(either: 129S/SvEv-Flt3tm1Irl or (involves: 129S/SvEv * C57BL/6J))
|
abnormal B cell differentiation
|
J:27238,
J:99149
|
| decreased pro-B cell number
|
J:27238
|
Flt3tm1Irl/Flt3tm1Irl
KitW/KitW-v
(involves: 129S/SvEv * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:27238
|
| abnormal myelopoiesis
|
J:27238
|
| decreased double-negative T cell number
|
J:27238
|
| decreased double-positive T cell number
|
J:27238
|
| decreased pro-B cell number
|
J:27238
|
Flt3tm2.1Dosm/Flt3+
(B6.129(C)-Flt3tm2.1Dosm)
|
abnormal definitive hematopoiesis
|
J:205200
|
| abnormal myelopoiesis
|
J:205200
|
| extramedullary hematopoiesis
|
J:205200
|
| increased pre-pro B cell number
|
J:205200
|
| increased pro-B cell number
|
J:205200
|
| myeloid hyperplasia
|
J:205200
|
| thrombocytosis
|
J:205200
|
Flt3ltm1Imx/Flt3ltm1Imx
(C57BL/6-Flt3ltm1Imx)
|
abnormal common myeloid progenitor cell morphology
|
J:62536
|
| abnormal immature B cell morphology
|
J:62536
|
| decreased double-negative T cell number
|
J:79569
|
| decreased pro-B cell number
|
J:79569,
J:62536
|
| impaired myelopoiesis
|
J:62536
|
| increased neutrophil cell number
|
J:62536
|
Flt3ltm1Imx/Flt3ltm1Imx
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:189122
|
Flvcr1tm1.1Jlab/Flvcr1tm1.1Jlab
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal erythropoiesis
|
J:132057
|
Fnbp1em1(IMPC)J/Fnbp1em1(IMPC)J
(C57BL/6NJ-Fnbp1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Fndc9tm1.1(KOMP)Vlcg/Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
arrested B cell differentiation
|
J:189078
|
| decreased transitional stage B cell number
|
J:189078
|
| increased pro-B cell number
|
J:189078
|
Fnip1Gt(RRM154)Byg/Fnip1Gt(RRM154)Byg
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
increased immature B cell number
|
J:189078
|
Fnip1LPAB.1/Fnip1LPAB.1
(C57BL/6J-Fnip1LPAB.1)
|
arrested B cell differentiation
|
J:187318
|
Fnip1M3Btlr/Fnip1M3Btlr
(C57BL/6J-Fnip1M3Btlr)
|
abnormal B cell differentiation
|
J:272802
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
arrested B cell differentiation
|
J:189078
|
| decreased transitional stage B cell number
|
J:189078
|
| increased pro-B cell number
|
J:189078
|
Fnip1tm1.2Baba/Fnip1tm1.2Baba
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6 * C57BL/6J * FVB/N * SJL)
|
increased immature B cell number
|
J:189078
|
Fntbtm1b(EUCOMM)Hmgu/Fntb+
(C57BL/6N-Fntbtm1b(EUCOMM)Hmgu/Nju)
|
thrombocytopenia
|
J:211773
|
Fostm1Pa/Fostm1Pa
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal lymphopoiesis
|
J:3233
|
Fostm1Wag/Fostm1Wag
(involves: 129S2/SvPas * C57BL/6)
|
decreased double-positive T cell number
|
J:3493
|
Fosbtm1b(KOMP)Wtsi/Fosbtm1b(KOMP)Wtsi
(C57BL/6N-Fosbtm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular volume
|
J:211773
|
Foxa2tm1Khk/Foxa2tm1Khk
Tg(SFTPC-rtTA)5Jaw/0
Tg(tetO-cre)1Jaw/0
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased neutrophil cell number
|
J:88601
|
Foxn1nu-str/Foxn1nu-str
(AKR/J-Foxn1nu-str/J)
|
increased eosinophil cell number
|
J:30715
|
| increased granulocyte number
|
J:30715
|
| increased neutrophil cell number
|
J:30715
|
Foxn1tm1.1Cbln/Foxn1tm1.1Cbln
(involves: 129P2/OlaHsd * C57BL/6)
|
increased DN1 thymic pro-T cell number
|
J:177992
|
| increased double-positive T cell number
|
J:177992
|
Foxn1tm1.1Dmsu/Foxn1tm1.1Dmsu
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
decreased double-positive T cell number
|
J:159773
|
Foxn1tm1Nrm/Foxn1tm1Nrm
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:86255
|
| decreased double-negative T cell number
|
J:86255
|
| decreased double-positive T cell number
|
J:86255
|
Foxo1tm1.1Stlp/Foxo1tm1.1Stlp
Tg(Lck-cre)1Cwi/0
(involves: 129S4/SvJae)
|
decreased double-positive T cell number
|
J:154205
|
Foxo1tm1b(EUCOMM)Wtsi/Foxo1+
(C57BL/6N-Foxo1tm1b(EUCOMM)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Foxo3tm1.1(KOMP)Vlcg/Foxo3tm1.1(KOMP)Vlcg
(C57BL/6N-Foxo3tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Foxo3tm1Nmt/Foxo3tm1Nmt
(involves: C57BL/6)
|
decreased erythrocyte cell number
|
J:142870
|
| increased mean corpuscular hemoglobin
|
J:142870
|
| increased mean corpuscular volume
|
J:142870
|
Foxp1tm1Rao/Foxp1tm1Rao
(B6.129-Foxp1tm1Rao)
|
abnormal B cell differentiation
|
J:112644
|
| arrested B cell differentiation
|
J:112644
|
Foxp3sf/Y
(either: 129Rl.Cg-Foxp3sf or (involves: 101/Rl * C3Hf/Rl * STOCK MR))
|
abnormal erythrocyte morphology
|
J:11262
|
| anisocytosis
|
J:11262
|
| decreased hematocrit
|
J:11262
|
| decreased hemoglobin content
|
J:11262
|
| extramedullary hematopoiesis
|
J:11262
|
| increased mean corpuscular volume
|
J:11262
|
| poikilocytosis
|
J:11262
|
| polychromatophilia
|
J:11262
|
Foxp3sf/Y
(involves: 101/H * C3H/HeH * STOCK MR)
|
abnormal erythrocyte morphology
|
J:10398
|
| decreased erythrocyte cell number
|
J:10398
|
| decreased hematocrit
|
J:10398
|
| decreased hemoglobin content
|
J:10398
|
| extramedullary hematopoiesis
|
J:10398
|
| thrombocytopenia
|
J:10398
|
Foxp3sf/Y
(B6.Cg-Foxp3sf)
|
increased mean platelet volume
|
J:167802
|
| thrombocytopenia
|
J:167802
|
Foxp3sfOtcspf/Y
(involves: 129/Rl)
|
decreased hematocrit
|
J:20865
|
Foxp3tm1.1Ayr/Foxp3tm1.1Ayr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:125405
|
| decreased double-positive T cell number
|
J:125405
|
Foxp3tm1Ayr/Foxp3tm1Ayr
Tg(Cd4-cre)1Cwi/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:125405
|
| decreased double-positive T cell number
|
J:125405
|
Foxp3tm1Kuch/?
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:123352
|
Foxp3tm1Tch/Y
(C.129X1-Foxp3tm1Tch)
|
increased eosinophil cell number
|
J:117165
|
| thrombocytopenia
|
J:117165
|
Foxp3tm1Tch/Y
(B6.129X1-Foxp3tm1Tch)
|
increased eosinophil cell number
|
J:117165
|
| thrombocytopenia
|
J:117165
|
Foxp3tm1Tch/Y
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Foxp3tm1Tch)
|
increased eosinophil cell number
|
J:117165
|
Foxp3tm2Ayr/?
Zap70rps/Zap70rps
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:211510
|
| abnormal T cell differentiation
|
J:211510
|
Foxp3tm5.2Ayr/Foxp3tm5.2Ayr
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:156942
|
Fpr3tm1b(EUCOMM)Hmgu/Fpr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Fpr3tm1b(EUCOMM)Hmgu/Ics)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Fryltm1b(KOMP)Wtsi/Fryl+
(C57BL/6N-Fryltm1b(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Frzbtm1.1Fplu/Frzbtm1.1Fplu
(involves: CD-1 * Swiss)
|
decreased hematocrit
|
J:184281
|
Fsbpem1(IMPC)J/Fsbpem1(IMPC)J
(C57BL/6NJ-Fsbpem1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Fstl1tm1b(EUCOMM)Hmgu/Fstl1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fstl1tm1b(EUCOMM)Hmgu/H)
|
decreased neutrophil cell number
|
J:211773
|
Ftl1em1(IMPC)Rbrc/Ftl1em1(IMPC)Rbrc
(C57BL/6NJcl-Ftl1em1(IMPC)Rbrc/Rbrc)
|
abnormal platelet cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Fts/Fts+
(B6.Cg-Fts)
|
abnormal CD4-positive T cell differentiation
|
J:108193
|
Fubp1tm1.1Dlev/Fubp1tm1.1Dlev
(involves: 129 * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:229985
|
Fundc2tm1Qim/Fundc2tm1Qim
(involves: C57BL/6)
|
thrombocytopenia
|
J:301633
|
Fut4tm1Jbl/Fut4tm1Jbl
(B6.129S2-Fut4tm1Jbl)
|
increased eosinophil cell number
|
J:79397
|
| increased granulocyte number
|
J:79397
|
| increased neutrophil cell number
|
J:79397
|
Fut4tm1Jbl/Fut4tm1Jbl
Fut7tm1Jbl/Fut7tm1Jbl
(B6.129S2-Fut7tm1Jbl Fut4tm1Jbl)
|
increased neutrophil cell number
|
J:79397
|
Fyb1tm1b(EUCOMM)Hmgu/Fyb1tm1b(EUCOMM)Hmgu
(C57BL/6N-Fyb1tm1b(EUCOMM)Hmgu/Cnrm)
|
thrombocytopenia
|
J:211773
|
Fyb1tm1Gak/Fyb1tm1Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
thrombocytopenia
|
J:111368
|
Fyntm1Rmp/Fyntm1Rmp
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
arrested T cell differentiation
|
J:37062,
J:37940
|
| decreased double-positive T cell number
|
J:37940
|
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal T cell clonal deletion
|
J:2242
|
Fyntm1Sor/Fyntm1Sor
Yes1tm1Sor/Yes1tm1Sor
(involves: 129S7/SvEvBrd)
|
extramedullary hematopoiesis
|
J:20346
|
| myeloid hyperplasia
|
J:20346
|
Fyntm1Yik/Fyntm1Yik
Ptk2tm1Lfr/Ptk2+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:110771
|
| decreased double-positive T cell number
|
J:110771
|
Fyttd1em1(IMPC)J/Fyttd1em1(IMPC)J
(C57BL/6NJ-Fyttd1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Fzd1em1(IMPC)Mbp/Fzd1em1(IMPC)Mbp
(C57BL/6N-Fzd1em1(IMPC)Mbp/MbpMmucd)
|
increased eosinophil cell number
|
J:211773
|
Fzd9tm1Uta/Fzd9tm1Uta
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
decreased pro-B cell number
|
J:98133
|
| increased eosinophil cell number
|
J:98133
|
| increased neutrophil cell number
|
J:98133
|
G6pc3tm1Jyc/G6pc3tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
decreased neutrophil cell number
|
J:120741
|
| increased granulocyte number
|
J:120741
|
G6pdxa-m1Neu/Y
(involves: 102/El * C3H/El * T-stock)
|
abnormal erythrocyte morphology
|
J:95754
|
| abnormal hemoglobin content
|
J:95754
|
| decreased erythrocyte cell number
|
J:95754
|
| decreased mean corpuscular hemoglobin
|
J:95754
|
Gab2tm1Hhg/Gab2tm1Hhg
(involves: 129S4/SvJae)
|
decreased mast cell number
|
J:70424
|
Gab2tm1Thir/Gab2tm1Thir
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal mast cell differentiation
|
J:75092
|
| decreased mast cell number
|
J:75092
|
Gab2tm3.1Thir/Gab2tm3.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
|
decreased mast cell number
|
J:178045
|
Gab2tm4.1Thir/Gab2tm4.1Thir
(involves: 129T/SvJcl * C57BL/6Jcl)
|
decreased mast cell number
|
J:178045
|
Gabarapl2tm1b(EUCOMM)Hmgu/Gabarapl2+
(C57BL/6N-Gabarapl2tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Gadd45atm1Ajf/Gadd45atm1Ajf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129X1/SvJ * C57BL/6))
|
abnormal lymphopoiesis
|
J:76041
|
| decreased basophil cell number
|
J:76041
|
| decreased eosinophil cell number
|
J:76041
|
Gadd45btm1Flv/Gadd45btm1Flv
(involves: 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
Gadd45btm1Flv/Gadd45btm1Flv
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
Gadd45gtm1Flv/Gadd45gtm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:87396
|
Galnt1tm1.1Jxm/Galnt1tm1.1Jxm
(B6NHsd.Cg-Galnt1tm1.1Jxm)
|
decreased basophil cell number
|
J:128982
|
| decreased eosinophil cell number
|
J:128982
|
Galnt3tm1.1Cfg/Galnt3tm1.1Cfg
(involves: C57BL/6)
|
thrombocytopenia
|
J:217719
|
Galnt18tm1b(KOMP)Wtsi/Galnt18tm1b(KOMP)Wtsi
(C57BL/6N-Galnt18tm1b(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Galr1em1(IMPC)H/Galr1em1(IMPC)H
(C57BL/6N-Galr1em1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
GapdhM6Neu/GapdhM6Neu
(C3.Cg-GapdhM6Neu)
|
abnormal hematocrit
|
J:126359
|
| decreased hemoglobin content
|
J:126359
|
Gas7em1(IMPC)J/Gas7em1(IMPC)J
(C57BL/6NJ-Gas7em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Gata1Plt13/Gata1+
(BALB/c-Gata1Plt13)
|
abnormal myelopoiesis
|
J:113720
|
| abnormal thrombopoiesis
|
J:113720
|
| extramedullary hematopoiesis
|
J:113720
|
| thrombocytopenia
|
J:113720
|
Gata1tm1.1Yen/Gata1tm1.1Yen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal erythropoiesis
|
J:200716
|
Gata1tm1Mym/Y
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal embryonic erythropoiesis
|
J:40321
|
Gata1tm1Mym/Y
Tg(Gata1*)#Mym/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:158252
|
| abnormal erythrocyte morphology
|
J:158252
|
| abnormal erythropoiesis
|
J:158252
|
| abnormal platelet morphology
|
J:158252
|
| decreased erythrocyte cell number
|
J:158252
|
| decreased hematocrit
|
J:158252
|
| decreased hemoglobin content
|
J:158252
|
| thrombocytosis
|
J:158252
|
Gata1tm1Mym/Y
Tg(Gata1*V205G)1Mym/0
(involves: C57BL/6 * DBA/2)
|
abnormal erythrocyte morphology
|
J:89054
|
| abnormal platelet morphology
|
J:89054
|
| abnormal stress erythropoiesis
|
J:89054
|
| abnormal thrombopoiesis
|
J:89054
|
| anisocytosis
|
J:89054
|
| thrombocytopenia
|
J:89054
|
Gata1tm1Mym/Gata1+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal erythropoiesis
|
J:40321
|
Gata1tm1Mym/Gata1+
(involves: 129P2/OlaHsd)
|
abnormal erythropoiesis
|
J:88685
|
| decreased hematocrit
|
J:88685
|
| extramedullary hematopoiesis
|
J:88685
|
| thrombocytopenia
|
J:88685
|
Gata1tm1Mym/Gata1tm1Mym
Tg(Gata1*)#Mym/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:158252
|
| abnormal erythrocyte morphology
|
J:158252
|
| abnormal erythropoiesis
|
J:158252
|
| abnormal platelet morphology
|
J:158252
|
| decreased erythrocyte cell number
|
J:158252
|
| decreased hematocrit
|
J:158252
|
| decreased hemoglobin content
|
J:158252
|
| thrombocytosis
|
J:158252
|
Gata1tm1Phi/Gata1+
Tg(HBB-cre)1Phi/0
(involves: FVB)
|
abnormal erythropoiesis
|
J:98277
|
Gata1tm1Phi/Gata1+
Tg(HBB-cre)1Phi/0
Tg(HBB-Gata1)G4Phi/0
(involves: FVB)
|
abnormal erythropoiesis
|
J:98277
|
Gata1tm1Phi/Gata1+
Tg(HBB-Gata1)G4Phi/0
(involves: FVB)
|
abnormal erythropoiesis
|
J:98277
|
Gata1tm1Sho/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal erythropoiesis
|
J:36249
|
Gata1tm1Sho/Y
Tg(Gata1*)#Mym/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J)
|
decreased erythrocyte cell number
|
J:158252
|
| decreased hematocrit
|
J:158252
|
| decreased hemoglobin content
|
J:158252
|
| thrombocytosis
|
J:158252
|
Gata1tm1Sho/Gata1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased eosinophil cell number
|
J:88711
|
Gata1tm1Sho/Gata1tm1Sho
Tg(Gata1*)#Mym/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J)
|
decreased erythrocyte cell number
|
J:158252
|
| decreased hematocrit
|
J:158252
|
| decreased hemoglobin content
|
J:158252
|
| thrombocytosis
|
J:158252
|
Gata1tm2.1Sho/Y
(involves: 129S4/SvJae * C57BL/6)
|
increased mean platelet volume
|
J:41605
|
| thrombocytopenia
|
J:41605
|
Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6)
|
increased mean platelet volume
|
J:41605
|
| thrombocytopenia
|
J:41605
|
Gata1tm2Sho/Y
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
abnormal common myeloid progenitor cell morphology
|
J:78348,
J:78540
|
| abnormal definitive hematopoiesis
|
J:78348
|
| abnormal hematocrit
|
J:78540
|
| abnormal platelet shape
|
J:78348,
J:78540
|
| decreased erythrocyte cell number
|
J:78348
|
| decreased hematocrit
|
J:78348
|
| extramedullary hematopoiesis
|
J:78540
|
| increased neutrophil cell number
|
J:78348
|
| increased number of Howell-Jolly bodies
|
J:78348
|
| poikilocytosis
|
J:78348
|
| polychromatophilia
|
J:78348
|
| thrombocytopenia
|
J:78348,
J:78540
|
Gata1tm2Sho/Gata1tm2Sho
(involves: 129S4/SvJae * C57BL/6 * CD-1)
|
abnormal common myeloid progenitor cell morphology
|
J:78348,
J:78540
|
| abnormal definitive hematopoiesis
|
J:78348
|
| abnormal hematocrit
|
J:78540
|
| abnormal platelet shape
|
J:78348,
J:78540
|
| decreased erythrocyte cell number
|
J:78348
|
| decreased hematocrit
|
J:78348
|
| extramedullary hematopoiesis
|
J:78540
|
| increased neutrophil cell number
|
J:78348
|
| increased number of Howell-Jolly bodies
|
J:78348
|
| poikilocytosis
|
J:78348
|
| polychromatophilia
|
J:78348
|
| thrombocytopenia
|
J:78348,
J:78540
|
Gata1tm4Sho/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythropoiesis
|
J:77724
|
Gata1tm4Sho/Y
Gata2tm2Sho/Gata2tm2Sho
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythropoiesis
|
J:77724
|
Gata1tm5(GATA3)Sho/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal erythropoiesis
|
J:47295
|
Gata1tm5(GATA3)Sho/Gata1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:47295
|
| decreased erythrocyte cell number
|
J:47295
|
Gata1tm6Sho/Y
(involves: 129S1/Sv)
|
decreased eosinophil cell number
|
J:88711
|
| decreased erythrocyte cell number
|
J:88711
|
| decreased hematocrit
|
J:88711
|
Gata1tm6Sho/Gata1tm6Sho
(involves: 129S1/Sv)
|
decreased eosinophil cell number
|
J:88711
|
Gata1tm6Sho/Gata1tm6Sho
(involves: 129S1/Sv * BALB/c)
|
decreased eosinophil cell number
|
J:115273
|
| increased neutrophil cell number
|
J:115273
|
Gata1tm7Sho/Y
(involves: 129S1/Sv * C57BL/6)
|
abnormal erythropoiesis
|
J:99310
|
Gata1tm7Sho/Gata1tm7Sho
(involves: 129S1/Sv * C57BL/6)
|
abnormal erythropoiesis
|
J:99310
|
Gata1tm8.2Sho/Y
(involves: 129S1/Sv)
|
abnormal erythropoiesis
|
J:99310
|
Gata1tm8.2Sho/Gata1tm8.2Sho
(involves: 129S1/Sv)
|
abnormal erythropoiesis
|
J:99310
|
Gata2tm1Mym/Gata2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:84836
|
Gata2tm1Mym/Gata2tm1Mym
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:106045
|
Gata2tm1Sho/Gata2tm1Sho
(involves: 129S4/SvJae * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:20316
|
Gata2tm3.1Sho/Gata2tm3.1Sho
(B6.129S1-Gata2tm3.1Sho)
|
abnormal stress erythropoiesis
|
J:165427
|
Gata2tm4.1Sho/Gata2tm4.1Sho
(Not Specified)
|
decreased common myeloid progenitor cell number
|
J:173274
|
Gata3tm1Iho/Gata3tm1Iho
Il13tm1(YFP/cre)Lky/Il13+
(involves: 129S4/SvJae)
|
decreased eosinophil cell number
|
J:178986
|
Gata3tm1Iho/Gata3tm1Iho
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:86996
|
Gata3tm1Iho/Gata3tm1Iho
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Cwi/0
(involves: BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:86996
|
| decreased double-positive T cell number
|
J:86996
|
Gata3tm1Iho/Gata3tm1Iho
Tg(Lck-cre)1Cwi/0
(involves: BALB/c)
|
arrested T cell differentiation
|
J:86996
|
| decreased double-positive T cell number
|
J:86996
|
Gata3tm1Jeng/Gata3tm1Jeng
(involves: 129S7/SvEvBrd)
|
abnormal definitive hematopoiesis
|
J:28393
|
| abnormal erythrocyte morphology
|
J:28393
|
Gata3tm1Jfz/Gata3tm1Jfz
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-cre)1Cwi/0
Tg(Tcra5CC7,Tcrb5CC7)IWep/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:141145
|
Gata3tm1Jfz/Gata3tm1Jfz
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:141145
|
Gata3tm2Jeng/Gata3tm2Jeng
(Not Specified)
|
abnormal double-positive T cell morphology
|
J:155686
|
| abnormal T cell differentiation
|
J:155686
|
| decreased double-negative T cell number
|
J:155686
|
Gata4tm1Eno/Gata4+
Gata6tm1Eno/Gata6+
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6)
|
decreased erythrocyte cell number
|
J:111824
|
Gatad2btm1b(EUCOMM)Hmgu/Gatad2b+
(C57BL/6N-Gatad2btm1b(EUCOMM)Hmgu/Ics)
|
increased mean corpuscular volume
|
J:211773
|
Gatmtm1b(KOMP)Wtsi/Gatmtm1b(KOMP)Wtsi
(C57BL/6N-Gatmtm1b(KOMP)Wtsi/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Gba1em1(IMPC)H/Gba1+
(C57BL/6N-Gba1em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Gba1tm1.1Pmis/Gba1tm1.1Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
| decreased double-positive T cell number
|
J:167081
|
| decreased hemoglobin content
|
J:167081
|
| extramedullary hematopoiesis
|
J:167081
|
Gba1tm1.1Pmis/Gba1tm1.2Pmis
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167081
|
| decreased double-positive T cell number
|
J:167081
|
| decreased hemoglobin content
|
J:167081
|
| extramedullary hematopoiesis
|
J:167081
|
Gba1tm1Karl/Gba1tm1.1Karl
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased hematocrit
|
J:113751
|
| decreased hemoglobin content
|
J:113751
|
| decreased mean corpuscular volume
|
J:113751
|
Gba1tm1Rlp/Gba1tm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
decreased erythrocyte cell number
|
J:76409
|
| decreased hematocrit
|
J:76409
|
| decreased hemoglobin content
|
J:76409
|
Gcgrtm1.1(KOMP)Vlcg/Gcgrtm1.1(KOMP)Vlcg
(C57BL/6N-Gcgrtm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
GckRgsc149/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc210/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc236/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc272/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc341/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc392/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc475/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc552/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc553/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc702/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
GckRgsc735/Gck+
(involves: C57BL/6J * DBA/2J)
|
increased glycosylated hemoglobin level
|
J:88919
|
Gcnt1tm1Jxm/Gcnt1tm1Jxm
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:86387
|
| increased neutrophil cell number
|
J:86387
|
Gcnt4tm1.1Jxm/Gcnt4tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased neutrophil cell number
|
J:149909
|
Gdatm1a(KOMP)Wtsi/Gdatm1a(KOMP)Wtsi
(C57BL/6N-Gdatm1a(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Gdap2em1(IMPC)Wtsi/Gdap2em1(IMPC)Wtsi
(C57BL/6N-Gdap2em1(IMPC)Wtsi/WtsiIeg)
|
thrombocytosis
|
J:211773
|
Gde1tm1b(EUCOMM)Hmgu/Gde1+
(C57BL/6N-Gde1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Gdf2tm1.1(KOMP)Vlcg/Gdf2tm1.1(KOMP)Vlcg
(C57BL/6N-Gdf2tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Gfi1Gen/Gfi1+
(C57BL/6J-Gfi1Gen)
|
abnormal myelopoiesis
|
J:182679
|
| abnormal NK cell differentiation
|
J:182679
|
| absent neutrophils
|
J:182679
|
Gfi1tm1.1Wep/Gfi1tm1.1Wep
(B6.129-Gfi1tm1.1Wep)
|
arrested T cell differentiation
|
J:117105
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal granulocyte differentiation
|
J:75143
|
| abnormal monocyte differentiation
|
J:75143
|
| abnormal myelopoiesis
|
J:75143
|
| abnormal T cell differentiation
|
J:75143
|
| decreased granulocyte number
|
J:75143
|
| decreased neutrophil cell number
|
J:75143
|
Gfi1tm1Tmo/Gfi1tm1Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased granulocyte number
|
J:192927
|
| decreased neutrophil cell number
|
J:192927
|
Gfi1tm1Wep/Gfi1tm1Wep
(B6.129-Gfi1tm1Wep)
|
abnormal definitive hematopoiesis
|
J:117105
|
Gfi1tm2Tmo/Gfi1tm2Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:93337
|
| decreased neutrophil cell number
|
J:93337
|
Gfi1tm3(Gfib1)Tmo/Gfi1tm3(Gfib1)Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased granulocyte number
|
J:116870
|
Gfi1tm4Tmo/Gfi1tm4Tmo
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:116870
|
| abnormal neutrophil morphology
|
J:116870
|
| abnormal T cell differentiation
|
J:116870
|
| decreased double-negative T cell number
|
J:116870
|
| decreased neutrophil cell number
|
J:116870
|
Gfi1tm5.1(GFI1*)Tmo/Gfi1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:192927
|
Gfi1tm5.1(GFI1*)Tmo/Gfi1+
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:192927
|
Gfi1tm5.1(GFI1*)Tmo/Gfi1tm5.1(GFI1*)Tmo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:192927
|
Gfi1tm5.1(GFI1*)Tmo/Gfi1tm5.1(GFI1*)Tmo
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:192927
|
Gfi1tm6.1(GFI1)Tmo/Gfi1tm6.1(GFI1)Tmo
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:192927
|
Gfi1btm1.1Haho/Gfi1btm1.1Haho
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJaeSor * C57BL/6)
|
absent platelets
|
J:207446
|
| decreased hemoglobin content
|
J:207446
|
| thrombocytopenia
|
J:207446
|
Gfi1btm1b(EUCOMM)Hmgu/Gfi1b+
(C57BL/6N-Gfi1btm1b(EUCOMM)Hmgu/H)
|
decreased neutrophil cell number
|
J:211773
|
Gfi1btm1Sho/Gfi1btm1Sho
(involves: 129S1/Sv)
|
abnormal embryonic erythropoiesis
|
J:74523
|
| abnormal erythropoiesis
|
J:74523
|
| absent erythrocytes
|
J:74523
|
Gfi1btm1Tmo/Gfi1btm1Tmo
(B6.129-Gfi1btm1Tmo)
|
abnormal erythropoiesis
|
J:141749
|
Gfi1btm2Tmo/Gfi1btm2Tmo
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:167416
|
| thrombocytopenia
|
J:167416
|
Gfpt2tm1b(EUCOMM)Wtsi/Gfpt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gfpt2tm1b(EUCOMM)Wtsi/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Gfustm1Jbl/Gfustm1Jbl
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal common myeloid progenitor cell morphology
|
J:82239
|
| abnormal definitive hematopoiesis
|
J:82239
|
| increased neutrophil cell number
|
J:82239
|
Ggcttm1.2Smoc/Ggcttm1.2Smoc
(involves: C57BL/6J)
|
abnormal erythrocyte morphology
|
J:322242
|
| decreased erythrocyte cell number
|
J:322242
|
| decreased hematocrit
|
J:322242
|
| decreased hemoglobin content
|
J:322242
|
Ggta1tm1Jbl/Ggta1+
Ightm1Jiac/Ightm1Jiac
Igktm1Jiac/Igktm1Jiac
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal B cell selection
|
J:133032
|
Ghtm1.1(KOMP)Vlcg/Ghtm1.1(KOMP)Vlcg
(C57BL/6N-Ghtm1.1(KOMP)Vlcg/Ucd)
|
thrombocytopenia
|
J:211773
|
Ghrhrtm1.1(KOMP)Vlcg/Ghrhrtm1.1(KOMP)Vlcg
(C57BL/6N-Ghrhrtm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Gigyf2tm1b(EUCOMM)Wtsi/Gigyf2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gigyf2tm1b(EUCOMM)Wtsi/Bay)
|
decreased eosinophil cell number
|
J:211773
|
| decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Gimap1tm1.1Gwb/Gimap1tm1.1Gwb
Tg(CD2-icre)4Kio/0
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased transitional stage T2 B cell number
|
J:160782
|
Gimap5m1Btlr/Gimap5m1Btlr
(involves: C57BL/6J)
|
abnormal common myeloid progenitor cell morphology
|
J:160090
|
| decreased hemoglobin content
|
J:160090
|
| extramedullary hematopoiesis
|
J:160090
|
| increased granulocyte number
|
J:160090
|
| increased neutrophil cell number
|
J:160090
|
| increased red blood cell distribution width
|
J:160090
|
| thrombocytopenia
|
J:160090
|
Gimap5m1Btlr/Gimap5m1Btlr
(either: (involves: BALB/cJ * C57BL/6J) or (involves: C3H/HeN * C57BL/6J) or (C57BL/6J * DBA/2J) or (involves: C57BL/6J * FVB/NJ) or (involves: C57BL/6J * NOD/ShiLtJ))
|
extramedullary hematopoiesis
|
J:160090
|
Gimap5tm1Wlr/Gimap5tm1Wlr
(either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:143620
|
| abnormal erythrocyte cell number
|
J:143620
|
| abnormal erythrocyte morphology
|
J:143620
|
| abnormal erythropoiesis
|
J:143620
|
| abnormal hemoglobin content
|
J:143620
|
| anisocytosis
|
J:143620
|
| decreased hematocrit
|
J:143620
|
| increased granulocyte number
|
J:143620
|
| thrombocytopenia
|
J:143620
|
Gimap6tm1b(KOMP)Wtsi/Gimap6tm1b(KOMP)Wtsi
(C57BL/6N-Gimap6tm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Gimap8tm1.1(KOMP)Vlcg/Gimap8tm1.1(KOMP)Vlcg
(C57BL/6N-Gimap8tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
Gipc3tm1b(KOMP)Wtsi/Gipc3tm1b(KOMP)Wtsi
(C57BL/6N-Gipc3tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Git2Gt(XG510)Byg/Git2Gt(XG510)Byg
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:160613
|
Git2tm1Hsb/Git2tm1Hsb
(involves: C57BL/6 * CBA)
|
abnormal neutrophil differentiation
|
J:112663
|
| extramedullary hematopoiesis
|
J:112663
|
Gjb3tm1.1(KOMP)Vlcg/Gjb3+
(C57BL/6N-Gjb3tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Gkn2tm1.1(KOMP)Vlcg/Gkn2tm1.1(KOMP)Vlcg
(C57BL/6N-Gkn2tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular volume
|
J:211773
|
Glb1tm1Jmat/Glb1tm1Jmat
(involves: C57BL/6 * CBA * ICR)
|
abnormal lymphopoiesis
|
J:43534
|
Glra2tm1b(KOMP)Wtsi/Y
(C57BL/6N-Glra2tm1b(KOMP)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Glrbem1(IMPC)Tcp/Glrb+
(C57BL/6NCrl-Glrbem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Gls2em1(IMPC)Tcp/Gls2em1(IMPC)Tcp
(C57BL/6N-Gls2em1(IMPC)Tcp/Tcp)
|
thrombocytosis
|
J:211773
|
Glyr1em1(IMPC)Tcp/Glyr1+
(C57BL/6N-Glyr1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Gm4922em1(IMPC)Tcp/Gm4922em1(IMPC)Tcp
(C57BL/6NCrl-Gm4922em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Gm5127em1(IMPC)J/Y
(C57BL/6NJ-Gm5127em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Gm36723em1Flv/Gm36723em1Flv
(C57BL/6-Gm36723em1Flv)
|
abnormal lymphopoiesis
|
J:258967
|
Gmdstm1a(KOMP)Wtsi/Gmdstm1a(KOMP)Wtsi
(C57BL/6N-Gmdstm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased transitional stage T2 B cell number
|
J:211773
|
| increased granulocyte number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Gmnntm1.1Kio/Gmnntm1.2Kio
Tg(CD2-icre)4Kio/0
(involves: 129S4/SvJae * C57BL/10 * CBA/Ca)
|
decreased DN1 thymic pro-T cell number
|
J:159657
|
| decreased DN4 thymocyte number
|
J:159657
|
| decreased double-positive T cell number
|
J:159657
|
Gmnntm1Tjm/Gmnntm1Tjm
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * C57BL/6J * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:171741
|
| decreased erythrocyte cell number
|
J:171741
|
| decreased granulocyte number
|
J:171741
|
| decreased neutrophil cell number
|
J:171741
|
| thrombocytosis
|
J:171741
|
Gna11tm1a(EUCOMM)Wtsi/Gna11tm1a(EUCOMM)Wtsi
(C57BL/6N-Gna11tm1a(EUCOMM)Wtsi/Cnrm)
|
decreased hemoglobin content
|
J:165965
|
Gna11tm1b(EUCOMM)Wtsi/Gna11tm1b(EUCOMM)Wtsi
(C57BL/6N-Gna11tm1b(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(involves: 129S7/SvEvBrd)
|
increased granulocyte number
|
J:30507
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(either: 129 or (involves: 129S7/SvEvBrd * C57BL/6J))
|
increased granulocyte number
|
J:24434
|
Gnai2tm1Lbi/Gnai2tm1Lbi
(B6.129S7-Gnai2tm1Lbi)
|
decreased eosinophil cell number
|
J:120069
|
| increased eosinophil cell number
|
J:120069
|
| increased neutrophil cell number
|
J:120069
|
Gnao1tm1b(EUCOMM)Hmgu/Gnao1+
(C57BL/6N-Gnao1tm1b(EUCOMM)Hmgu/H)
|
decreased eosinophil cell number
|
J:211773
|
| decreased erythrocyte cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Gnb1lem1(IMPC)Tcp/Gnb1l+
(C57BL/6NCrl-Gnb1lem1(IMPC)Tcp/Tcp)
|
increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Gnb2em1(IMPC)J/Gnb2em1(IMPC)J
(C57BL/6NJ-Gnb2em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Gnl1em1(IMPC)Tcp/Gnl1em1(IMPC)Tcp
(C57BL/6N-Gnl1em1(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Gnmttm1Ymac/Gnmttm1Ymac
(involves: 129 * C57BL/6)
|
decreased neutrophil cell number
|
J:147857
|
Gnpda1tm1b(KOMP)Mbp/Gnpda1+
(C57BL/6N-Gnpda1tm1b(KOMP)Mbp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Gnpda2tm1.1(KOMP)Vlcg/Gnpda2tm1.1(KOMP)Vlcg
(C57BL/6N-Gnpda2tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Gnptgem1(IMPC)Mbp/Gnptgem1(IMPC)Mbp
(C57BL/6N-Gnptgem1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Gnrh1hpg/Gnrh1hpg
(HPG/BmJ)
|
increased immature B cell number
|
J:19436
|
Golga3tm1b(EUCOMM)Hmgu/Golga3tm1b(EUCOMM)Hmgu
(C57BL/6N-Golga3tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
Golga5tm1b(KOMP)Wtsi/Golga5tm1b(KOMP)Wtsi
(C57BL/6N-Golga5tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Golph3em1(IMPC)Tcp/Golph3em1(IMPC)Tcp
(C57BL/6NCrl-Golph3em1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
Golt1atm1b(KOMP)Wtsi/Golt1atm1b(KOMP)Wtsi
(C57BL/6N-Golt1atm1b(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Golt1btm1b(EUCOMM)Wtsi/Golt1btm1b(EUCOMM)Wtsi
(C57BL/6N-Golt1btm1b(EUCOMM)Wtsi/Ieg)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Gon4ljusty/Gon4ljusty
(C3HeB/FeJ-Gon4ljusty)
|
arrested B cell differentiation
|
J:163412
|
| decreased immature B cell number
|
J:163412
|
| decreased pro-B cell number
|
J:163412
|
Got1tm1b(EUCOMM)Hmgu/Got1+
(C57BL/6N-Got1tm1b(EUCOMM)Hmgu/H)
|
decreased basophil cell number
|
J:211773
|
Gp1baPlt17/Gp1ba+
(involves: BALB/c)
|
thrombocytopenia
|
J:149205
|
Gp1batm1Ware/Gp1batm1Ware
(involves: 129S1/Sv * 129X1/SvJ)
|
giant platelets
|
J:63389
|
| thrombocytopenia
|
J:63389
|
Gp1bbtm1.1(KOMP)Vlcg/Gp1bbtm1.1(KOMP)Vlcg
(C57BL/6N-Gp1bbtm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Gp1bbtm1Frla/Gp1bbtm1Frla
(involves: 129S2/SvPas * C57BL/6)
|
abnormal platelet morphology
|
J:135065
|
| thrombocytopenia
|
J:135065
|
Gp1bbtm1Ware/Gp1bb+
(Not Specified)
|
increased mean platelet volume
|
J:93756
|
| thrombocytopenia
|
J:93756
|
Gp1bbtm1Ware/Gp1bbtm1Ware
(Not Specified)
|
increased mean platelet volume
|
J:93756
|
| thrombocytopenia
|
J:93756
|
Gp1bbtm2Frla/Gp1bbtm2Frla
(involves: 129S2/SvPas * C57BL/6)
|
abnormal platelet morphology
|
J:135065
|
| thrombocytopenia
|
J:135065
|
Gp2em1(IMPC)Mbp/Gp2em1(IMPC)Mbp
(C57BL/6N-Gp2em1(IMPC)Mbp/MbpMmucd)
|
thrombocytopenia
|
J:211773
|
Gp6tm1Beni/Gp6tm1Beni
Clec1btm1.1Arte/Clec1btm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal platelet cell number
|
J:217963
|
Gp6tm1Ware/Gp6tm1Ware
(involves: Black Swiss)
|
abnormal definitive hematopoiesis
|
J:85315
|
Gp9tm1.1(KOMP)Vlcg/Gp9tm1.1(KOMP)Vlcg
(C57BL/6N-Gp9tm1.1(KOMP)Vlcg/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Gpalpp1em1(IMPC)Hmgu/Gpalpp1em1(IMPC)Hmgu
(C57BL/6NCrl-Gpalpp1em1(IMPC)Hmgu/Ieg)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Gpc1em1(IMPC)Mbp/Gpc1em1(IMPC)Mbp
(C57BL/6N-Gpc1em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Gpc4tm2b(EUCOMM)Wtsi/Y
(C57BL/6N-Gpc4tm2b(EUCOMM)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Gpi1b-m1Neu/Gpi1b-m1Neu
(C3.Cg-Gpi1b-m1Neu)
|
abnormal erythrocyte morphology
|
J:35956
|
| decreased erythrocyte cell number
|
J:35956
|
| decreased hematocrit
|
J:35956
|
| decreased mean corpuscular hemoglobin
|
J:35956
|
| decreased mean corpuscular hemoglobin concentration
|
J:35956
|
| increased mean corpuscular volume
|
J:35956
|
Gpi1b-m2Neu/Gpi1b-m2Neu
(C3.Cg-Gpi1b-m2Neu)
|
abnormal erythrocyte morphology
|
J:35956
|
| decreased erythrocyte cell number
|
J:35956
|
| decreased hematocrit
|
J:35956
|
| decreased mean corpuscular hemoglobin
|
J:35956
|
| decreased mean corpuscular hemoglobin concentration
|
J:35956
|
| increased mean corpuscular volume
|
J:35956
|
Gpnmbtm1.1(KOMP)Vlcg/Gpnmbtm1.1(KOMP)Vlcg
(C57BL/6N-Gpnmbtm1.1(KOMP)Vlcg/Ucd)
|
increased hemoglobin content
|
J:211773
|
Gpr15em1(IMPC)J/Gpr15em1(IMPC)J
(C57BL/6NJ-Gpr15em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Gpr15tm1.1Litt/Gpr15tm1.1Litt
(B6.129P2-Gpr15tm1.1Litt)
|
decreased double-negative T cell number
|
J:199126
|
Gpr17tm1b(KOMP)Mbp/Gpr17tm1b(KOMP)Mbp
(C57BL/6N-Gpr17tm1b(KOMP)Mbp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Gpr22tm1b(KOMP)Wtsi/Gpr22tm1b(KOMP)Wtsi
(C57BL/6N-Gpr22tm1b(KOMP)Wtsi/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Gpr142tm1.1(KOMP)Vlcg/Gpr142tm1.1(KOMP)Vlcg
(C57BL/6N-Gpr142tm1.1(KOMP)Vlcg/J)
|
decreased hemoglobin content
|
J:211773
|
Gpr146em1(IMPC)H/Gpr146em1(IMPC)H
(C57BL/6NTac-Gpr146em1(IMPC)H/H)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Gpr174tm1Cys/Y
(B6.129-Gpr174tm1Cys)
|
abnormal T-helper 1 cell differentiation
|
J:222307
|
Gpr182tm2b(KOMP)Wtsi/Gpr182tm2b(KOMP)Wtsi
(C57BL/6N-Gpr182tm2b(KOMP)Wtsi/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Gpr182tm2c(KOMP)Wtsi/Gpr182tm2c(KOMP)Wtsi
Tg(Cdh5-cre/ERT2)1Rha/0
(B6.Cg-Gpr182tm2c(KOMP)Wtsi Tg(Cdh5-cre/ERT2)1Rha)
|
increased neutrophil cell number
|
J:305796
|
Gpr183tm1.1(KOMP)Vlcg/Gpr183tm1.1(KOMP)Vlcg
(C57BL/6N-Gpr183tm1.1(KOMP)Vlcg/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Gprc5ctm1Yhir/Gprc5ctm1Yhir
(B6.Cg-Gprc5ctm1Yhir)
|
decreased mean corpuscular hemoglobin concentration
|
J:176063
|
| increased basophil cell number
|
J:176063
|
| increased mean corpuscular volume
|
J:176063
|
Gprc6atm1.1(KOMP)Vlcg/Gprc6atm1.1(KOMP)Vlcg
(C57BL/6N-Gprc6atm1.1(KOMP)Vlcg/Ucd)
|
increased hemoglobin content
|
J:211773
|
Gprin1em1(IMPC)H/Gprin1em1(IMPC)H
(C57BL/6N-Gprin1em1(IMPC)H/H)
|
decreased neutrophil cell number
|
J:211773
|
Gpsm2tm1b(EUCOMM)Wtsi/Gpsm2+
(C57BL/6N-Gpsm2tm1b(EUCOMM)Wtsi/Ieg)
|
increased mean platelet volume
|
J:211773
|
Gpx7tm1.1(KOMP)Vlcg/Gpx7tm1.1(KOMP)Vlcg
(C57BL/6N-Gpx7tm1.1(KOMP)Vlcg/Ucd)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Gramd1ctm1b(KOMP)Wtsi/Gramd1ctm1b(KOMP)Wtsi
(C57BL/6N-Gramd1ctm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Gramd2bem1(IMPC)J/Gramd2bem1(IMPC)J
(C57BL/6NJ-Gramd2bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Grap2tm1Amch/Grap2tm1Amch
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:76696
|
| increased double-negative T cell number
|
J:76696
|
Grap2tm1Amch/Grap2tm1Amch
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:150304
|
| decreased double-positive T cell number
|
J:150304
|
Grap2tm1Eac/Grap2tm1Eac
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:92023
|
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(DO11.10)10Dlo/0
Tg(Lck-cre)1Jtak/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(Lck-cre)1Jtak/0
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:161294
|
| decreased double-positive T cell number
|
J:161294
|
Grb2tm1.1Hua/Grb2tm1.1Hua
Tg(Lck-cre)1Jtak/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:161294
|
| increased double-positive T cell number
|
J:161294
|
Grb2tm1Lnit/Grb2tm1Lnit
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * BALB/cJ)
|
abnormal B cell differentiation
|
J:171222
|
| decreased transitional stage T1 B cell number
|
J:171222
|
| decreased transitional stage T2 B cell number
|
J:171222
|
Gria1tm1Lex/Gria1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased glycosylated hemoglobin level
|
J:82809
|
Grin1tm1a(EUCOMM)Wtsi/Grin1+
(C57BL/6N-Grin1tm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:175295
|
Grin2btm1e.1(KOMP)Wtsi/Grin2b+
(C57BL/6N-Grin2btm1e.1(KOMP)Wtsi/Tcp)
|
increased mean platelet volume
|
J:211773
|
Grin3btm1b(KOMP)Wtsi/Grin3btm1b(KOMP)Wtsi
(C57BL/6N-Grin3btm1b(KOMP)Wtsi/H)
|
increased red blood cell distribution width
|
J:211773
|
Grm7em1(IMPC)H/Grm7em1(IMPC)H
(C57BL/6NTac-Grm7em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Grnem1(IMPC)H/Grnem1(IMPC)H
(C57BL/6NTac-Grnem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
gro20/gro20
(Not Specified)
|
polycythemia
|
J:85113
|
Gsdma3tm1(KOMP)Vlcg/Gsdma3tm1(KOMP)Vlcg
(C57BL/6N-Gsdma3tm1(KOMP)Vlcg/Nju)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Gsdmetm1b(KOMP)Wtsi/Gsdmetm1b(KOMP)Wtsi
(C57BL/6N-Gsdmetm1b(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Gse1tm1a(EUCOMM)Wtsi/Gse1+
(C57BL/6N-Gse1tm1a(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:165965
|
Gsk3atm1b(EUCOMM)Hmgu/Gsk3atm1b(EUCOMM)Hmgu
(C57BL/6N-Gsk3atm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean platelet volume
|
J:211773
|
Gsntm1Djk/Gsntm1Djk
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
increased neutrophil cell number
|
J:24346
|
Gsta4tm1b(EUCOMM)Hmgu/Gsta4tm1b(EUCOMM)Hmgu
(C57BL/6N-Gsta4tm1b(EUCOMM)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Gsto1em1(IMPC)J/Gsto1em1(IMPC)J
(C57BL/6NJ-Gsto1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Gsx1tm1Ssp/Gsx1tm1Ssp
(involves: 129P2/OlaHsd)
|
decreased neutrophil cell number
|
J:31764
|
Gt(ROSA)26Sortm1(CAG-Bcl3,-EGFP)Hoev/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:208980
|
| abnormal class switch recombination
|
J:208980
|
| abnormal transitional stage T3 B cell morphology
|
J:208980
|
| decreased immature B cell number
|
J:208980
|
| decreased transitional stage T1 B cell number
|
J:208980
|
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6NCrlj * C57BL/10 * CBA/Ca * CBA/JNCrlj)
|
decreased common myeloid progenitor cell number
|
J:203163
|
Gt(ROSA)26Sortm1(CAG-Etv2,-GFP)Hkata/Gt(ROSA)26Sor+
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * SJL)
|
abnormal definitive hematopoiesis
|
J:203163
|
Gt(ROSA)26Sortm1(CAG-NPM1*)Geno/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal platelet morphology
|
J:196690
|
| myeloid hyperplasia
|
J:196690
|
| thrombocytopenia
|
J:196690
|
Gt(ROSA)26Sortm1(CAG-NPM1*)Geno/Gt(ROSA)26Sortm1(CAG-NPM1*)Geno
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal platelet morphology
|
J:196690
|
| thrombocytopenia
|
J:196690
|
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Malt1tm1c(EUCOMM)Hmgu/Malt1tm1c(EUCOMM)Hmgu
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
increased neutrophil cell number
|
J:292094
|
Gt(ROSA)26Sortm1(CARD14*)Ribt/Gt(ROSA)26Sor+
Tg(KRT14-cre/ERT)20Efu/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
increased neutrophil cell number
|
J:292094
|
Gt(ROSA)26Sortm1(cre/ERT2)Thl/0
Picalmtm1.1Tmae/Picalmtm1.1Tmae
(involves: 129 * C57BL/6 * SJL)
|
abnormal erythropoiesis
|
J:220728
|
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sortm1(Tcfe2a/Tal1)Xhsu
(involves: 129/Sv * C57BL/6)
|
abnormal lymphopoiesis
|
J:144569
|
| abnormal myelopoiesis
|
J:144569
|
Gt(ROSA)26Sortm1(CTNNB1)Nerl/Gt(ROSA)26Sortm1(CTNNB1)Nerl
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:112660
|
| decreased double-negative T cell number
|
J:112660
|
| decreased erythrocyte cell number
|
J:112660
|
| decreased granulocyte number
|
J:112660
|
| decreased hemoglobin content
|
J:112660
|
| impaired myelopoiesis
|
J:112660
|
| thrombocytopenia
|
J:112660
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
Il13tm1(YFP/cre)Lky/Il13tm1(YFP/cre)Lky
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased eosinophil cell number
|
J:178986
|
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sortm1(DTA)Lky
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:133382
|
| abnormal T cell receptor V(D)J recombination
|
J:133382
|
| decreased double-positive T cell number
|
J:133382
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+
Cd79atm3(cre/ERT2)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal plasma cell differentiation
|
J:208904
|
Gt(ROSA)26Sortm1(ETV6/SYK)Hjum/Gt(ROSA)26Sor+
Cd79atm3(cre/ERT2)Reth/Cd79a+
Tg(BCL2)22Wehi/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6JWehi * SJL/JWehi)
|
abnormal plasma cell differentiation
|
J:208904
|
Gt(ROSA)26Sortm1(EWSR1/FLI1)Sbk/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:129039
|
| decreased erythrocyte cell number
|
J:129039
|
| decreased hematocrit
|
J:129039
|
| thrombocytosis
|
J:129039
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Rev3ltm1.1Diaz/Rev3ltm1.1Diaz
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6NTac)
|
abnormal class switch recombination
|
J:188723
|
| abnormal somatic hypermutation frequency
|
J:188723
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal plasma cell differentiation
|
J:167612
|
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:157757
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:157757
|
| increased double-positive T cell number
|
J:157757
|
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
Gt(ROSA)26Sortm1(gp80,EGFP)Eces/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6) or (involves: 129/Sv * 129P2/OlaHsd * BALB/c * C57BL/6))
|
abnormal class switch recombination
|
J:172031
|
Gt(ROSA)26Sortm1(ITK/SYK)Jrld/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:160931
|
| decreased double-positive T cell number
|
J:160931
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased hematocrit
|
J:260047
|
| increased neutrophil cell number
|
J:260047
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Tg(Itgax-cre)1-1Reiz/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased neutrophil cell number
|
J:260047
|
Gt(ROSA)26Sortm1(OVAL/fla,GFP)Vnce/Gt(ROSA)26Sor+
Tg(S100A8-cre,-EGFP)1Ilw/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased neutrophil cell number
|
J:260047
|
Gt(ROSA)26Sortm1(RNAi:Bmpr2)Dliu/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6J)
|
decreased erythrocyte cell number
|
J:145514
|
| extramedullary hematopoiesis
|
J:145514
|
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sortm1(rtTA)Awu
Xisttm1Awu/Y
(involves: 129S4/SvJae)
|
abnormal B cell differentiation
|
J:112954
|
| abnormal definitive hematopoiesis
|
J:112954
|
| abnormal erythropoiesis
|
J:112954
|
| abnormal myelopoiesis
|
J:112954
|
| abnormal T cell differentiation
|
J:112954
|
| decreased double-positive T cell number
|
J:112954
|
| decreased granulocyte number
|
J:112954
|
| decreased hematocrit
|
J:112954
|
| decreased immature B cell number
|
J:112954
|
| decreased pro-B cell number
|
J:112954
|
Gt(ROSA)26Sortm1(rtTA)Awu/Gt(ROSA)26Sortm1(rtTA)Awu
Xisttm1Awu/Xisttm1Awu
(involves: 129S4/SvJae)
|
decreased hematocrit
|
J:112954
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Col2a1-cre)1Bhr/0
Tg(tetO-Vegfa)90Ala/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N * SJL)
|
extramedullary hematopoiesis
|
J:156474
|
| thrombocytopenia
|
J:156474
|
Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv/Gt(ROSA)26Sortm1(Stat3*A661C*N663C)Sbkv
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:205858
|
Gt(ROSA)26Sortm1(tTA,tetO-Mir21)Fjsl/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6 * C57BL/6J * SJL/J)
|
decreased erythrocyte cell number
|
J:163919
|
| decreased hemoglobin content
|
J:163919
|
Gt(ROSA)26Sortm1.1(Aco1*)Mwh/Gt(ROSA)26Sortm1.1(Aco1*)Mwh
(B6.129P2(129S1)-Gt(ROSA)26Sortm1.1(Aco1*)Mwh)
|
abnormal erythropoiesis
|
J:196374
|
| decreased erythrocyte cell number
|
J:196374
|
| decreased hematocrit
|
J:196374
|
| decreased hemoglobin content
|
J:196374
|
| increased mean corpuscular hemoglobin
|
J:196374
|
| increased mean corpuscular volume
|
J:196374
|
Gt(ROSA)26Sortm1.1(PDGFB)Cbet/Gt(ROSA)26Sortm1.1(PDGFB)Cbet
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal embryonic hematopoiesis
|
J:138069
|
Gt(ROSA)26Sortm1.1(Wls/YFP)Mbtr/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
decreased neutrophil cell number
|
J:202499
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
arrested B cell differentiation
|
J:202090
|
| decreased double-positive T cell number
|
J:202090
|
| decreased pro-B cell number
|
J:202090
|
| thrombocytopenia
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
arrested B cell differentiation
|
J:202090
|
| decreased double-positive T cell number
|
J:202090
|
| decreased pro-B cell number
|
J:202090
|
| thrombocytopenia
|
J:202090
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
| decreased transitional stage T2 B cell number
|
J:179036
|
| increased transitional stage T1 B cell number
|
J:179036
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19tm1(cre)Cgn
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:179036
|
| decreased transitional stage T2 B cell number
|
J:179036
|
| increased transitional stage T1 B cell number
|
J:179036
|
Gt(ROSA)26Sortm2(CAG-Notch2*)Uzs/Gt(ROSA)26Sor+
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6J)
|
arrested B cell differentiation
|
J:179036
|
Gt(ROSA)26Sortm2(H1/tetO-RNAi:Kdm1a)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6)
|
abnormal erythropoiesis
|
J:192055
|
| abnormal granulocyte differentiation
|
J:192055
|
| abnormal monocyte differentiation
|
J:192055
|
| abnormal platelet morphology
|
J:192055
|
| increased mean platelet volume
|
J:192055
|
Gt(ROSA)26Sortm2(Lmp1/CD40)Uzs/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:137122
|
Gt(ROSA)26Sortm2.1(Mirn150)Rsky/Gt(ROSA)26Sortm2.1(Mirn150)Rsky
(involves: C57BL/6 * SJL/J)
|
arrested B cell differentiation
|
J:127234
|
| arrested T cell differentiation
|
J:127234
|
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Stat5atm2Mam Stat5btm1Mam/Del(11Stat5a-Stat5b)1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
Gt(ROSA)26Sortm3(CAG-Il17a)Awai/Gt(ROSA)26Sor+
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased granulocyte number
|
J:144710
|
Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky/Gt(ROSA)26Sortm3(CAG-MIR17-92,-EGFP)Rsky
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal T cell differentiation
|
J:133215
|
| extramedullary hematopoiesis
|
J:133215
|
Gt(ROSA)26Sortm3(HIF1A*)Kael/Gt(ROSA)26Sortm4(HIF2A*)Kael
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
increased hematocrit
|
J:144666
|
Gt(ROSA)26Sortm3.1(CAG-Il17a)Awai/Gt(ROSA)26Sor+
(involves: BALB/c * C57BL/6)
|
decreased hematocrit
|
J:144710
|
| decreased hemoglobin content
|
J:144710
|
| decreased mean corpuscular hemoglobin
|
J:144710
|
| decreased mean corpuscular volume
|
J:144710
|
| increased granulocyte number
|
J:144710
|
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:188749
|
Gt(ROSA)26Sortm4(CAG-hsb5)Nki/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
Tg(Tal1-tTA)19Dgt/0
Tg(tetO-BCR/ABL1)2Dgt/0
TgTn(pb-sb-GrOnc)#aGsva/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA/J * DBA/2 * FVB/N)
|
decreased hemoglobin content
|
J:227558
|
| increased basophil cell number
|
J:227558
|
| increased granulocyte number
|
J:227558
|
Gt(ROSA)26Sortm4(HIF2A*)Kael/Gt(ROSA)26Sor+
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * DBA)
|
increased hematocrit
|
J:144666
|
Gt(ROSA)26Sortm4(Ikbkb)Rsky/Gt(ROSA)26Sor+
Ighg1tm1(cre)Cgn/Ighg1+
Prdm1tm2Masu/Prdm1tm2Masu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:167612
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/Gt(ROSA)26Sortm13(CAG-MYC,-CD2*)Rsky
Ighg1tm1(cre)Cgn/Ighg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:191824
|
Gt(ROSA)26Sortm10(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * BALB/cJ)
|
abnormal B cell differentiation
|
J:181546
|
| increased pro-B cell number
|
J:181546
|
Gt(ROSA)26Sortm11(Lmp1)Rsky/Gt(ROSA)26Sor+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:181546
|
| increased pro-B cell number
|
J:181546
|
Gtf2e2tm1b(EUCOMM)Wtsi/Gtf2e2+
(C57BL/6N-Gtf2e2tm1b(EUCOMM)Wtsi/H)
|
increased mean platelet volume
|
J:211773
|
Gtpbp4em1(IMPC)Tcp/Gtpbp4+
(C57BL/6N-Gtpbp4em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Gtpbp10tm1b(KOMP)Mbp/Gtpbp10tm1b(KOMP)Mbp
(C57BL/6N-Gtpbp10tm1b(KOMP)Mbp/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Gulosfx/Gulosfx
(BALB/cBy-Gulosfx/J)
|
decreased hematocrit
|
J:66648
|
Gulotm1Mae/Gulotm1Mae
(involves: 129 * C57BL/6)
|
decreased erythrocyte cell number
|
J:59931
|
| decreased hematocrit
|
J:59931
|
| decreased mean corpuscular hemoglobin
|
J:59931
|
Gypatm1Skmz/Gypatm1Skmz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:89319
|
Gypcem1(IMPC)Rbrc/Gypcem1(IMPC)Rbrc
(C57BL/6NJcl-Gypcem1(IMPC)Rbrc/Rbrc)
|
decreased glycosylated hemoglobin level
|
J:211773
|
Gzf1em1(IMPC)Tcp/Gzf1+
(C57BL/6NCrl-Gzf1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
H1f10tm1.1(KOMP)Vlcg/H1f10tm1.1(KOMP)Vlcg
(C57BL/6N-H1f10tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
H2-Ab1b-tm1.1Jssh/H2-Ab1b-tm1.1Jssh
(C57BL/6-H2-Ab1b-tm1.1Jssh)
|
abnormal T cell differentiation
|
J:201198
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Tg(Ab1TL)1Gru/0
(B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:91341
|
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
H2-Ab1bm12/H2-Ab1bm12
(NZB.B6(C)-H2-Ab1bm12)
|
increased double-negative T cell number
|
J:4554
|
H2-DMatm1Lkrl/H2-DMatm1Lkrl
(involves: 129P2/OlaHsd)
|
abnormal positive T cell selection
|
J:31786
|
H2-DMatm1Luc/H2-DMatm1Luc
(involves: 129S4/SvJae)
|
abnormal positive T cell selection
|
J:125548
|
H2-Kbm1/H2-Kbm1
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:92867
|
H2-Kbm5/H2-Kbm5
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:133645
|
H2-M5tm1(KOMP)Wtsi/H2-M5tm1(KOMP)Wtsi
(C57BL/6N-H2-M5tm1(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
H2b/H2b
Itktm1Ljb/Itktm1Ljb
Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:131357
|
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
H2b/H2b
Ptcratm1Vbo/Ptcratm1Vbo
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
H2b/H2b
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
H2b/H2b
Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
H2b/H2b
Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
H2b/H2b
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
| abnormal double-positive T cell morphology
|
J:81564
|
| abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
| decreased double-positive T cell number
|
J:131357
|
H2b/H2d
((C57BL/6 x DBA/2)F1)
|
abnormal T cell differentiation
|
J:106141
|
| decreased hematocrit
|
J:106141
|
H2b/H2d
Tg(TcraTcrb)1100Mjb/?
(involves: BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:133645
|
H2b/H2d
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
H2b/H2k
Itktm1Ljb/Itktm1Ljb
Tg(TcrAND)53Hed/?
(involves: C3H/HeJ * C57BL/6 * C57BL/10)
|
abnormal positive T cell selection
|
J:123795
|
H2b/H2k
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6 * C57BL/10Sg * C57BR/c)
|
abnormal negative T cell selection
|
J:133645
|
H2b/H2s
Tg(TcraTcrb)1100Mjb/?
(involves: A/WySn * C57BL/6 * C57BL/10Sg * Swiss)
|
abnormal negative T cell selection
|
J:133645
|
H2d/H2d
(DBA/2)
|
abnormal T cell differentiation
|
J:106141
|
| decreased hematocrit
|
J:106141
|
H2d/H2d
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraN15,TcrbN15)L2Elre/?
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:133112
|
H2d/H2d
Tcra/Tcrdtm1.1(Tcra)Rsky/Tcra/Tcrdtm1.1(Tcra)Rsky
Tg(Tcrb)93Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
H2d/H2d
Tg(TcraP1.5,TcrbP1.5)29Amsv/0
Trap1atm1.1Jvde/Y
(involves: 129 * BALB/cJ * C57BL/10 * DBA/2)
|
abnormal T cell clonal deletion
|
J:180807
|
H2dlAb1-Ea/H2dlAb1-Ea
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:196156
|
H2u/H2u
Tg(TCRA)B1Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg/J)
|
decreased double-positive T cell number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
H2u/H2u
Tg(TCRA)B1Jg/?
Tg(TCRB)C14Jg/?
(involves: C57BL/6 * C57BL/10SnSg * DBA/2 * PL/J)
|
decreased double-positive T cell number
|
J:92991
|
H2u/H2u
Tg(TCRA)B1Jg/0
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRA)B1Jg Tg(TCRB)C14Jg)
|
abnormal double-negative T cell morphology
|
J:92992
|
| abnormal double-positive T cell morphology
|
J:92992
|
| decreased double-positive T cell number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
H2u/H2u
Tg(TCRB)C14Jg/0
(B10.PL-H2u H2-T18a/(73NS)Sn-Tg(TCRB)C14Jg/J)
|
abnormal double-negative T cell morphology
|
J:92992
|
| abnormal double-positive T cell morphology
|
J:92992
|
H2axtm1Fwa/H2axtm1Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:84879
|
H2axtm1Nus/H2axtm1Nus
(Not Specified)
|
abnormal class switch recombination
|
J:194603,
J:120658
|
H4c16em1(IMPC)Mbp/H4c16em1(IMPC)Mbp
(C57BL/6N-H4c16em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Haghem1(IMPC)Tcp/Haghem1(IMPC)Tcp
(C57BL/6NCrl-Haghem1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Hamptm1Svl/Hamptm1Svl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal erythrocyte morphology
|
J:119004
|
Has1tm1b(KOMP)Wtsi/Has1tm1b(KOMP)Wtsi
(C57BL/6N-Has1tm1b(KOMP)Wtsi/H)
|
decreased eosinophil cell number
|
J:211773
|
| increased basophil cell number
|
J:211773
|
Havcr1tm1Kuch/Havcr1tm1Kuch
(B6.Cg-Havcr1tm1Kuch)
|
abnormal T cell differentiation
|
J:186484
|
| increased double-negative T cell number
|
J:186484
|
Hax1tm1.1Gach/Hax1tm1.1Gach
(involves: BALB/c)
|
decreased double-positive T cell number
|
J:174159
|
| decreased immature B cell number
|
J:174159
|
| decreased pro-B cell number
|
J:174159
|
| decreased transitional stage T1 B cell number
|
J:174159
|
| decreased transitional stage T2 B cell number
|
J:174159
|
Hax1tm1Jni/Hax1tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased double-positive T cell number
|
J:132627
|
| decreased immature B cell number
|
J:132627
|
| decreased neutrophil cell number
|
J:132627
|
Hba-a1tm1Led/Hba-a1+
(involves: 129S6/SvEvTac)
|
abnormal erythrocyte morphology
|
J:41934
|
| abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
Hba-a1tm1Led/Hba-a1+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
Hba-a1tm1Led/Hba-a1+
Hba-xtm1Led/Hba-x+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
| thrombocytosis
|
J:41934
|
Hba-a1tm1Led/Hba-a1tm1Led
(involves: 129S6/SvEvTac)
|
abnormal erythrocyte morphology
|
J:41934
|
| abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
| anisocytosis
|
J:41934
|
| poikilocytosis
|
J:41934
|
| polychromatophilia
|
J:41934
|
Hba-a1tm1Led/Hba-a1tm1Led
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal erythrocyte morphology
|
J:41934
|
| abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
| thrombocytosis
|
J:41934
|
Hba-a1tm1Shs/Hba-a1+
(involves: C57BL/6CrSlc)
|
abnormal hemoglobin
|
J:81902
|
Hba-a1tm1Ywk/Hba-a1+
(involves: 129X1/SvJ * C57BL/6J)
|
decreased mean corpuscular volume
|
J:35018
|
Hba-a1tm1Ywk/Hbath-J
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:35018
|
| abnormal hemoglobin
|
J:35018
|
| anisocytosis
|
J:35018
|
| leptocytosis
|
J:35018
|
| poikilocytosis
|
J:35018
|
| polychromatophilia
|
J:35018
|
Hba-a1tm1Ywk/Hba-a1tm1Ywk
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal hemoglobin
|
J:35018
|
| decreased hemoglobin content
|
J:35018
|
| decreased mean corpuscular hemoglobin
|
J:35018
|
| decreased mean corpuscular volume
|
J:35018
|
Hba-xtm1Led/Hba-x+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
Hba-xtm1Led/Hba-xtm1Led
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal erythrocyte morphology
|
J:41934
|
| abnormal hemoglobin
|
J:41934
|
| abnormal mean corpuscular hemoglobin
|
J:41934
|
| abnormal mean corpuscular volume
|
J:41934
|
| anisocytosis
|
J:41934
|
| poikilocytosis
|
J:41934
|
| polychromatophilia
|
J:41934
|
| thrombocytosis
|
J:41934
|
Hbab2(th)/Hba+
(involves: 101/Rl * SEC/Rl)
|
abnormal hemoglobin
|
J:5686
|
Hbab2(th)/Hba+
(either: (involves: 101 * SEC) or (involves: 101 * C57BL * SEC))
|
acanthocytosis
|
J:86011
|
| anisocytosis
|
J:123943
|
| anisopoikilocytosis
|
J:86011
|
| dacryocytosis
|
J:86011
|
| decreased hematocrit
|
J:123943
|
| decreased hemoglobin content
|
J:123943
|
| decreased mean corpuscular hemoglobin
|
J:123943
|
| decreased mean corpuscular volume
|
J:123943
|
| increased erythrocyte cell number
|
J:123943
|
| leptocytosis
|
J:86011
|
| microcytosis
|
J:123943
|
| poikilocytosis
|
J:86011
|
Hbab2(th)/Hba+
(SEC-Hbab2(th))
|
abnormal fetal derived definitive erythrocyte morphology
|
J:6452
|
Hbab3(th)/Hba+
(involves: 101 * SEC)
|
abnormal hemoglobin
|
J:5686
|
Hbab3(th)/Hba+
(either: (involves: 101 * SEC) or (involves: 101 * C57BL * SEC))
|
acanthocytosis
|
J:86011
|
| anisocytosis
|
J:123943
|
| anisopoikilocytosis
|
J:86011
|
| dacryocytosis
|
J:86011
|
| decreased hematocrit
|
J:123943
|
| decreased hemoglobin content
|
J:123943
|
| decreased mean corpuscular hemoglobin
|
J:123943
|
| decreased mean corpuscular volume
|
J:123943
|
| increased erythrocyte cell number
|
J:123943
|
| leptocytosis
|
J:86011
|
| microcytosis
|
J:123943
|
| poikilocytosis
|
J:86011
|
Hbab3(th)/Hba+
(SEC-Hbab3(th))
|
abnormal fetal derived definitive erythrocyte morphology
|
J:6452
|
Hbath-J/Hba+
(involves: C57BL/6J)
|
decreased hemoglobin content
|
J:45721
|
| increased erythrocyte cell number
|
J:45721
|
| microcytosis
|
J:45721
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBB*)Tow/Hbbtm2(HBG1,HBB*)Tow
(Not Specified)
|
abnormal erythrocyte morphology
|
J:134980
|
| anisocytosis
|
J:134980
|
| decreased erythrocyte cell number
|
J:134980
|
| decreased hematocrit
|
J:134980
|
| decreased hemoglobin content
|
J:134980
|
| extramedullary hematopoiesis
|
J:134980
|
| poikilocytosis
|
J:134980
|
| polychromatophilia
|
J:134980
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm2(HBG1,HBD,HBB*)Ryan
(Not Specified)
|
anisopoikilocytosis
|
J:148521
|
| decreased hemoglobin content
|
J:148521
|
| decreased mean corpuscular volume
|
J:148521
|
| extramedullary hematopoiesis
|
J:148521
|
| low mean erythrocyte cell number
|
J:148521
|
| polychromatophilia
|
J:148521
|
| spherocytosis
|
J:148521
|
Hbatm1(HBA)Tow/Hbatm1(HBA)Tow
Hbbtm2(HBG1,HBD,HBB*)Ryan/Hbbtm3(HBG1,HBB)Tow
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:148521
|
| decreased hemoglobin content
|
J:148521
|
| decreased mean corpuscular volume
|
J:148521
|
| high mean erythrocyte cell number
|
J:148521
|
Hbatm1Ney/Hbatm1Ney
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))
|
abnormal erythrocyte morphology
|
J:86682
|
| anisopoikilocytosis
|
J:86682
|
| decreased hemoglobin content
|
J:86682
|
| decreased mean corpuscular hemoglobin
|
J:86682
|
| decreased mean corpuscular volume
|
J:86682
|
| increased erythrocyte cell number
|
J:86682
|
| leptocytosis
|
J:86682
|
| schistocytosis
|
J:86682
|
Hbatm1Paz/Hba+
(involves: 129S7/SvEvBrd)
|
decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
Hbatm1Paz/Hbatm1Paz
(involves: 129S7/SvEvBrd)
|
abnormal erythrocyte morphology
|
J:28392
|
| decreased mean corpuscular hemoglobin
|
J:28392
|
| decreased mean corpuscular volume
|
J:28392
|
Hbatm1Paz/Hbatm1Paz
Hbbtm1Tow/Hbbtm1Tow
(involves: 129S2/SvPas * 129S7/SvEvBrd)
|
abnormal embryonic erythropoiesis
|
J:204029
|
| microcytosis
|
J:204029
|
Hbatm1Paz/Hbatm1Paz
Hbbtm1Tow/Hbbtm1Tow
Tg(HBA-HBBs)41Paz/?
(involves: 129S2/SvPas * 129S7/SvEvBrd * Black Swiss * C57BL/6 * DBA/2* FVB/N)
|
abnormal erythrocyte morphology
|
J:44161
|
| abnormal hemoglobin
|
J:44161
|
| anisopoikilocytosis
|
J:44161
|
| decreased hematocrit
|
J:44161
|
| decreased mean corpuscular hemoglobin
|
J:44161
|
| decreased mean corpuscular hemoglobin concentration
|
J:44161
|
| decreased mean corpuscular volume
|
J:44161
|
Hbb-b1MommeD7/Hbb-b1+
(involves: FVB/N)
|
abnormal definitive hematopoiesis
|
J:190446
|
| anisocytosis
|
J:190446
|
| anisopoikilocytosis
|
J:190446
|
| decreased mean corpuscular hemoglobin
|
J:190446
|
| decreased mean corpuscular volume
|
J:190446
|
| extramedullary hematopoiesis
|
J:190446
|
| increased nucleated erythrocyte cell number
|
J:190446
|
| increased red blood cell distribution width
|
J:190446
|
| leptocytosis
|
J:190446
|
| poikilocytosis
|
J:190446
|
| polychromatophilia
|
J:190446
|
| schistocytosis
|
J:190446
|
| spherocytosis
|
J:190446
|
Hbb-b1MommeD7/Hbb-b1MommeD7
(involves: FVB/N)
|
decreased erythrocyte cell number
|
J:142335
|
Hbb-b1Rbc13/Hbb-b1+
(involves: BALB/c * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:190446
|
| anisocytosis
|
J:190446
|
| anisopoikilocytosis
|
J:190446
|
| decreased mean corpuscular hemoglobin
|
J:190446
|
| decreased mean corpuscular volume
|
J:190446
|
| extramedullary hematopoiesis
|
J:190446
|
| increased nucleated erythrocyte cell number
|
J:190446
|
| increased red blood cell distribution width
|
J:190446
|
| leptocytosis
|
J:190446
|
| poikilocytosis
|
J:190446
|
| polychromatophilia
|
J:190446
|
| schistocytosis
|
J:190446
|
| spherocytosis
|
J:190446
|
Hbb-b1tm1Shs/Hbb-b1+
(involves: C57BL/6CrSlc)
|
abnormal hemoglobin
|
J:81902
|
| decreased hemoglobin content
|
J:81902
|
Hbb-b1tm1Shs/Hbb-b1tm1Shs
(involves: C57BL/6)
|
abnormal erythropoiesis
|
J:78271
|
| anisopoikilocytosis
|
J:78271
|
| decreased erythrocyte cell number
|
J:78271
|
| decreased hematocrit
|
J:78271
|
| decreased mean corpuscular hemoglobin
|
J:78271
|
| decreased mean corpuscular volume
|
J:78271
|
| extramedullary hematopoiesis
|
J:78271
|
| increased number of Heinz bodies
|
J:78271
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased hematocrit
|
J:30155
|
| decreased hemoglobin content
|
J:30155
|
| increased nucleated erythrocyte cell number
|
J:30155
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased hematocrit
|
J:94421
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal erythrocyte morphology
|
J:185154
|
| abnormal erythropoiesis
|
J:185154
|
| decreased erythrocyte cell number
|
J:185154
|
| decreased hemoglobin content
|
J:185154
|
| decreased mean corpuscular volume
|
J:185154
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
(involves: 129P2/OlaHsd)
|
abnormal erythropoiesis
|
J:97548
|
| decreased erythrocyte cell number
|
J:97548
|
| decreased hematocrit
|
J:97548
|
| decreased hemoglobin content
|
J:97548
|
| decreased mean corpuscular volume
|
J:97548
|
| increased red blood cell distribution width
|
J:97548
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
Tg(HBB*)L2Pai/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythropoiesis
|
J:97548
|
| anisocytosis
|
J:97548
|
| decreased erythrocyte cell number
|
J:97548
|
| decreased hematocrit
|
J:97548
|
| decreased hemoglobin content
|
J:97548
|
| decreased mean corpuscular volume
|
J:97548
|
| increased red blood cell distribution width
|
J:97548
|
| poikilocytosis
|
J:97548
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
Tmprss6tm1Otin/Tmprss6+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal erythrocyte cell number
|
J:185154
|
| abnormal erythrocyte morphology
|
J:185154
|
| abnormal hemoglobin content
|
J:185154
|
| decreased mean corpuscular volume
|
J:185154
|
Hbb-b1tm1Unc/Hbb-b1+
Hbb-b2tm1Unc/Hbb-b2+
Tmprss6tm1Otin/Tmprss6tm1Otin
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal erythrocyte cell number
|
J:185154
|
| abnormal erythrocyte morphology
|
J:185154
|
| abnormal erythropoiesis
|
J:185154
|
| abnormal hemoglobin content
|
J:185154
|
Hbb-bh2tm1b(EUCOMM)Hmgu/Hbb-bh2tm1b(EUCOMM)Hmgu
(C57BL/6N-Hbb-bh2tm1b(EUCOMM)Hmgu/Rbrc)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Hbbd3th/Hbb+
Tg(HBB-AR-HBA2,-HBB*)58Rub/0
Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N * Swiss Webster)
|
abnormal erythrocyte morphology
|
J:94190
|
Hbbd3th/Hbb+
Tg(LCR-HBA1,LCR-HBB*)1Tow/0
(involves: C57BL/6 * DBA/2J * SJL)
|
anisopoikilocytosis
|
J:127701
|
| decreased erythrocyte cell number
|
J:127701
|
| decreased hematocrit
|
J:127701
|
| decreased hemoglobin content
|
J:127701
|
| echinocytosis
|
J:127701
|
Hbbd3th/Hbb+
Tg(LCR-HBA2,LCR-HBB*)1Cos/0
(involves: C57BL/6J * CBA/J * DBA/2J)
|
abnormal erythrocyte morphology
|
J:94193
|
| abnormal hemoglobin
|
J:94193
|
| decreased hematocrit
|
J:94193
|
| decreased mean corpuscular volume
|
J:94193
|
| increased mean corpuscular hemoglobin concentration
|
J:94193
|
Hbbd3th/Hbbd3th
(involves: C57BL/6 * DBA/2J)
|
abnormal erythrocyte morphology
|
J:7209
|
| abnormal hemoglobin
|
J:7209
|
| abnormal hemoglobin content
|
J:7209
|
| anisocytosis
|
J:7209
|
| anisopoikilocytosis
|
J:7209
|
| decreased hematocrit
|
J:7209
|
| decreased mean corpuscular hemoglobin
|
J:7209
|
| decreased mean corpuscular volume
|
J:7209
|
| hyperchromasia
|
J:7209
|
| low mean erythrocyte cell number
|
J:7209
|
| microcytosis
|
J:7209
|
| poikilocytosis
|
J:7209
|
Hbbd3th/Hbbd3th
(Not Specified)
|
decreased hematocrit
|
J:136653
|
| decreased mean corpuscular volume
|
J:136653
|
Hbbd3th/Hbbd3th
Tg(HBB-AR-HBA2,-HBB*)58Rub/0
(involves: Swiss Webster)
|
abnormal erythrocyte morphology
|
J:136653
|
| abnormal mean corpuscular volume
|
J:136653
|
Hbbd3th/Hbbd3th
Tg(HBB-AR-HBA2,-HBB*)58Rub/0
Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N * Swiss Webster)
|
abnormal erythrocyte morphology
|
J:94190
|
| abnormal hemoglobin
|
J:94190
|
| increased mean corpuscular hemoglobin
|
J:94190
|
Hbbd3th/Hbbd3th
Tg(LCR-HBA2,LCR-HBB)11Cos/0
(involves: FVB/N)
|
abnormal erythrocyte morphology
|
J:94190
|
| increased mean corpuscular hemoglobin
|
J:94190
|
Hbbd4/Hbb+
(involves: 101/H)
|
increased erythrocyte cell number
|
J:7972
|
| increased hematocrit
|
J:7972
|
| increased mean corpuscular hemoglobin concentration
|
J:7972
|
| polycythemia
|
J:7972
|
Hbbd4/Hbbd4
(involves: 101/H)
|
abnormal hemoglobin
|
J:7972
|
| increased erythrocyte cell number
|
J:7972
|
| increased hematocrit
|
J:7972
|
| increased mean corpuscular hemoglobin concentration
|
J:7972
|
| polycythemia
|
J:7972
|
Hbbtm1.1(HBG1,HBB*)Ryan/Hbb+
(involves: C57BL/6J)
|
anisopoikilocytosis
|
J:147906
|
| decreased erythrocyte cell number
|
J:147906
|
| decreased mean corpuscular hemoglobin
|
J:147906
|
| decreased mean corpuscular hemoglobin concentration
|
J:147906
|
| decreased mean corpuscular volume
|
J:147906
|
| extramedullary hematopoiesis
|
J:147906
|
| increased hemoglobin concentration distribution width
|
J:147906
|
Hbbtm1Tow/Hbb+
(involves: 129S2/SvPas * C57BL/6)
|
anisopoikilocytosis
|
J:29087
|
| decreased hemoglobin content
|
J:29087
|
Hbbtm1Unc/Hbbtm1Unc
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:4932
|
| decreased hematocrit
|
J:4932
|
| decreased mean corpuscular hemoglobin
|
J:4932
|
| poikilocytosis
|
J:4932
|
Hbbtm2Unc/Hbb+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:64295
|
| anisocytosis
|
J:64295
|
| decreased erythrocyte cell number
|
J:64295
|
| decreased hematocrit
|
J:64295
|
| decreased hemoglobin content
|
J:64295
|
| decreased mean corpuscular volume
|
J:64295
|
| extramedullary hematopoiesis
|
J:64295
|
| increased hemoglobin concentration distribution width
|
J:64295
|
| increased mean corpuscular hemoglobin concentration
|
J:64295
|
| poikilocytosis
|
J:64295
|
Hbq1atm1.1(KOMP)Vlcg/Hbq1atm1.1(KOMP)Vlcg
(C57BL/6N-Hbq1atm1.1(KOMP)Vlcg/Rbrc)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Hbs1ltm1a(KOMP)Wtsi/Hbs1ltm1a(KOMP)Wtsi
(C57BL/6N-Hbs1ltm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytosis
|
J:211773
|
Hcfc1em1Poche/Y
(C57BL/6J-Hcfc1em1Poche)
|
decreased erythrocyte cell number
|
J:317822
|
| decreased hematocrit
|
J:317822
|
| decreased hemoglobin content
|
J:317822
|
Hcktm1Ern/Hcktm1Ern
(involves: 129S1/Sv * C57BL/6)
|
increased eosinophil cell number
|
J:111432
|
Hcls1tm1Wtn/Hcls1tm1Wtn
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:28146
|
| decreased double-positive T cell number
|
J:28146
|
Hctq1NZW/LacJ/Hctq1NZW/LacJ
(involves: NZW/LacJ * SM/J)
|
increased hematocrit
|
J:107220
|
Hdac1tm1.1Mrl/Hdac1tm1.1Mrl
Hdac2tm1.1Rdp/Hdac2+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:197818
|
| thrombocytopenia
|
J:197818
|
Hdac1tm1.1Mrl/Hdac1tm1.1Mrl
Hdac2tm1.1Rdp/Hdac2tm1.1Rdp
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
decreased erythrocyte cell number
|
J:197818
|
| thrombocytopenia
|
J:197818
|
Hdac1tm1.1Pmt/Hdac1tm1.1Pmt
Hdac2tm1.1Pmt/Hdac2tm1.1Pmt
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * FVB/N)
|
arrested B cell differentiation
|
J:157903
|
| decreased pro-B cell number
|
J:157903
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2+
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
| decreased double-positive T cell number
|
J:194769
|
| increased double-negative T cell number
|
J:194769
|
| increased double-positive T cell number
|
J:194769
|
Hdac1tm1.1Shmc/Hdac1tm1.1Shmc
Hdac2tm1.1Shmc/Hdac2tm1.1Shmc
Tg(Lck-cre)1Cwi/0
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:194769
|
| decreased double-positive T cell number
|
J:194769
|
| increased double-positive T cell number
|
J:194769
|
Hdac1tm1b(EUCOMM)Wtsi/Hdac1+
(C57BL/6N-Hdac1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal mast cell morphology
|
J:70702
|
| decreased mast cell histamine storage
|
J:70702
|
| decreased mast cell number
|
J:70702
|
| decreased mast cell protease storage
|
J:70702
|
Hddc2em1(IMPC)H/Hddc2em1(IMPC)H
(C57BL/6NTac-Hddc2em1(IMPC)H/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Hectd1tm1b(EUCOMM)Hmgu/Hectd1+
(C57BL/6N-Hectd1tm1b(EUCOMM)Hmgu/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Heg1tm1.1(KOMP)Vlcg/Heg1+
(C57BL/6N-Heg1tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Hellstm1a(EUCOMM)Wtsi/Hellstm1a(EUCOMM)Wtsi
(C57BL/6N-Hellstm1a(EUCOMM)Wtsi/Ieg)
|
decreased granulocyte number
|
J:165965
|
Hellstm1Kmu/Hellstm1Kmu
(involves: 129S1/Sv)
|
increased double-negative T cell number
|
J:61948
|
hem3/hem3
(Not Specified)
|
decreased erythrocyte cell number
|
J:85113
|
| decreased hematocrit
|
J:85113
|
| decreased hemoglobin content
|
J:85113
|
hem4/hem4
(Not Specified)
|
decreased erythrocyte cell number
|
J:85113
|
| decreased hematocrit
|
J:85113
|
| decreased hemoglobin content
|
J:85113
|
hem5/hem5
(Not Specified)
|
decreased erythrocyte cell number
|
J:85113
|
| decreased hematocrit
|
J:85113
|
| decreased hemoglobin content
|
J:85113
|
hem6/hem6
(Not Specified)
|
abnormal erythrocyte cell number
|
J:89098
|
| decreased mean corpuscular hemoglobin
|
J:89098
|
hem6/hem6
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
decreased hemoglobin content
|
J:142791
|
| decreased mean corpuscular hemoglobin concentration
|
J:142791
|
| decreased mean corpuscular volume
|
J:142791
|
| high mean erythrocyte cell number
|
J:142791
|
Hemgntm1.1(KOMP)Vlcg/Hemgntm1.1(KOMP)Vlcg
(C57BL/6N-Hemgntm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Hemq1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq2C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq3C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq3DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq4DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq5C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq5DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hemq6C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
increased hematocrit
|
J:110791
|
Hephsla/Y
(involves: C57BL/6J * WB/Re)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Hephsla/Y
(B6.Cg-Hephsla)
|
decreased hemoglobin content
|
J:6052
|
Hephsla/Y
(Not Specified)
|
anisopoikilocytosis
|
J:128474
|
| decreased erythrocyte cell number
|
J:128474
|
| decreased hematocrit
|
J:128474
|
| decreased hemoglobin content
|
J:128474
|
| decreased mean corpuscular hemoglobin
|
J:128474
|
| decreased mean corpuscular volume
|
J:128474
|
| macrocytosis
|
J:128474
|
| microcytosis
|
J:128474
|
| polychromatophilia
|
J:128474
|
Hephsla/Hephsla
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:64261
|
| abnormal erythrocyte morphology
|
J:64261
|
| anisopoikilocytosis
|
J:128474
|
| decreased erythrocyte cell number
|
J:128474,
J:64261
|
| decreased hematocrit
|
J:128474
|
| decreased hemoglobin content
|
J:128474
|
| decreased mean corpuscular hemoglobin
|
J:128474
|
| decreased mean corpuscular hemoglobin concentration
|
J:64261
|
| decreased mean corpuscular volume
|
J:128474
|
| macrocytosis
|
J:128474
|
| microcytosis
|
J:128474
|
| polychromatophilia
|
J:128474
|
Hephsla/Hephsla
(B6.Cg-Hephsla)
|
decreased hemoglobin content
|
J:6052
|
Herc1em3(IMPC)Wtsi/Herc1em3(IMPC)Wtsi
(C57BL/6N-Herc1em3(IMPC)Wtsi/Wtsi)
|
increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Herc4tm1b(KOMP)Wtsi/Herc4tm1b(KOMP)Wtsi
(C57BL/6N-Herc4tm1b(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Herc6tm1b(EUCOMM)Hmgu/Herc6tm1b(EUCOMM)Hmgu
(C57BL/6N-Herc6tm1b(EUCOMM)Hmgu/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Hes1tm1.1Frad/Hes1tm1.1Frad
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:167000
|
| decreased DN1 thymic pro-T cell number
|
J:167000
|
| decreased DN2 thymocyte number
|
J:167000
|
| decreased DN3 thymocyte number
|
J:167000
|
| decreased DN4 thymocyte number
|
J:167000
|
| decreased double-positive T cell number
|
J:167000
|
| increased DN1 thymic pro-T cell number
|
J:167000
|
| increased immature B cell number
|
J:167000
|
Hexbtm1b(EUCOMM)Hmgu/Hexbtm1b(EUCOMM)Hmgu
(C57BL/6N-Hexbtm1b(EUCOMM)Hmgu/H)
|
thrombocytosis
|
J:211773
|
Hfetm2Nca/Hfetm2Nca
Slc11a2tm1Nca/Slc11a2tm1Nca
(involves: 129S6/SvEvTac * 129S6.129S4-Slc11a2tm1Nca)
|
decreased hematocrit
|
J:98088
|
Hfgi1C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
Hfgi2C57BL/6Ola/?
(involves: C57BL/6Ola * BALB/cOla)
|
abnormal lymphopoiesis
|
J:123483
|
Hgbq1C57BLKS/J/Hgbq1SM/J
(involves: C57BLKS/J * SM/J)
|
increased hemoglobin content
|
J:107220
|
Hgbq1SM/J/Hgbq1SM/J
(involves: C57BLKS/J * SM/J)
|
increased hemoglobin content
|
J:107220
|
Hgftm1Cbm/Hgftm1Cbm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased erythrocyte cell number
|
J:23170
|
Hhextm1Ngu/Hhextm1Ngu
(involves: 129/Sv * C57BL/6)
|
abnormal monocyte differentiation
|
J:65105
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129 * BALB/c * C57BL/6)
|
increased hemoglobin content
|
J:97652
|
| polycythemia
|
J:97652
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Tal1-cre/ERT)42-056Jrg/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:192126
|
| abnormal T cell differentiation
|
J:192126
|
| decreased common myeloid progenitor cell number
|
J:192126
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Vhltm1Jae/Vhltm1Jae
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * CD-1)
|
increased hematocrit
|
J:186085
|
Hif1anem1(IMPC)Mbp/Hif1anem1(IMPC)Mbp
(C57BL/6N-Hif1anem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Hint1tm1a(EUCOMM)Wtsi/Hint1tm1a(EUCOMM)Wtsi
(C57BL/6N-Hint1tm1a(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:165965
|
| increased mean corpuscular hemoglobin concentration
|
J:165965
|
Hip1tm1Tsr/Hip1tm1Tsr
(involves: 129X1/SvJ * C57BL/6)
|
absent common myeloid progenitor cells
|
J:90400
|
Hip1tm3Tsr/Hip1tm3Tsr
(involves: 129X1/SvJ * C57BL/6)
|
absent common myeloid progenitor cells
|
J:90400
|
Hip1tm4Tsr/Hip1+
Runx1tm3Dow/Runx1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:151974
|
| abnormal myelopoiesis
|
J:151974
|
| decreased common myeloid progenitor cell number
|
J:151974
|
| extramedullary hematopoiesis
|
J:151974
|
| increased granulocyte number
|
J:151974
|
| increased neutrophil cell number
|
J:151974
|
Hip1tm4Tsr/Hip1+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal myelopoiesis
|
J:151974
|
Hipk3tm1b(EUCOMM)Hmgu/Hipk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Hipk3tm1b(EUCOMM)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
| thrombocytosis
|
J:211773
|
Hirip3tm1.1(KOMP)Mbp/Hirip3tm1.1(KOMP)Mbp
(C57BL/6N-Hirip3tm1.1(KOMP)Mbp/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Hivep2tm1Sis/Hivep2tm1Sis
Tg(DO11.10)10Dlo/?
(involves: BALB/cA * C3H * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal positive T cell selection
|
J:96024
|
Hivep3tm1Lcw/Hivep3tm1Lcw
(chimera involves: 129S/SvEv * 129X1/SvJ)
|
decreased double-positive T cell number
|
J:79652
|
Hjvtm1b(KOMP)Wtsi/Hjvtm1b(KOMP)Wtsi
(C57BL/6N-Hjvtm1b(KOMP)Wtsi/J)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Hjvtm1Nca/Hjv+
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased erythrocyte cell number
|
J:160248
|
| decreased hematocrit
|
J:160248
|
| decreased hemoglobin content
|
J:160248
|
| decreased mean corpuscular hemoglobin concentration
|
J:160248
|
| decreased mean corpuscular volume
|
J:160248
|
| increased red blood cell distribution width
|
J:160248
|
Hk1dea/Hk1dea
(A/J-Hk1dea/J)
|
abnormal erythrocyte morphology
|
J:72146
|
| abnormal erythropoiesis
|
J:72146
|
| anisocytosis
|
J:72146
|
| decreased erythrocyte cell number
|
J:72146
|
| decreased hematocrit
|
J:72146
|
| decreased hemoglobin content
|
J:72146
|
| decreased mean corpuscular hemoglobin
|
J:72146
|
| hyperchromasia
|
J:72146
|
| increased mean corpuscular volume
|
J:72146
|
| polychromatophilia
|
J:72146
|
Hlb141/?
(C57BL/6J-Hlb141)
|
decreased neutrophil cell number
|
J:82961
|
hlb156/?
(C57BL/6J-hlb156/J)
|
decreased neutrophil cell number
|
J:82961
|
Hlb304/?
(C57BL/6J-Hlb304)
|
decreased hematocrit
|
J:82961
|
| decreased hemoglobin content
|
J:82961
|
Hlxtm1Rph/Hlxtm1Rph
(involves: 129P2/OlaHsd)
|
abnormal erythropoiesis
|
J:31553
|
Hmbox1em1(IMPC)Tcp/Hmbox1em1(IMPC)Tcp
(C57BL/6N-Hmbox1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Hmbstm1.1Rjde/Hmbstm1.1Rjde
(involves: 129/Sv * C57BL/6)
|
increased erythrocyte protoporphyrin level
|
J:275245
|
Hmcn2tm1b(EUCOMM)Wtsi/Hmcn2tm1b(EUCOMM)Wtsi
(C57BL/6N-Hmcn2tm1b(EUCOMM)Wtsi/Bay)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Hmga1tm1Afus/Hmga1tm1Afus
(involves: 129S7/SvEvBrd * C57BL/6)
|
myeloid hyperplasia
|
J:106702
|
Hmgb3tm1Dmb/Y
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal common myeloid progenitor cell morphology
|
J:96514
|
| abnormal definitive hematopoiesis
|
J:96514
|
| abnormal erythropoiesis
|
J:96514
|
| abnormal leukopoiesis
|
J:96514
|
| decreased mean corpuscular volume
|
J:96514
|
| increased erythrocyte cell number
|
J:96514
|
| increased hematocrit
|
J:96514
|
| increased hemoglobin content
|
J:96514
|
Hmgn5tm1.2Mbus/Y
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal erythrocyte cell number
|
J:199604
|
| decreased granulocyte number
|
J:199604
|
Hmgn5tm1.2Mbus/Hmgn5tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal erythrocyte cell number
|
J:199604
|
| decreased granulocyte number
|
J:199604
|
Hmox1tm1.1Gkl/Hmox1tm1.1Gkl
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
increased granulocyte number
|
J:148498
|
Hmox1tm1Poss/Hmox1tm1Poss
(involves: 129S2/SvPas * C57BL/6)
|
anisocytosis
|
J:79254
|
| decreased erythrocyte cell number
|
J:79254
|
| decreased hematocrit
|
J:79254
|
| decreased hemoglobin content
|
J:79254
|
| decreased mean corpuscular volume
|
J:79254
|
| extramedullary hematopoiesis
|
J:79254
|
Hmox2tm1b(EUCOMM)Hmgu/Hmox2tm1b(EUCOMM)Hmgu
(C57BL/6N-Hmox2tm1b(EUCOMM)Hmgu/H)
|
increased red blood cell distribution width
|
J:211773
|
Hnrnpdtm1b(KOMP)Wtsi/Hnrnpd+
(C57BL/6N-Hnrnpdtm1b(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Hnrnph1tm1b(KOMP)Wtsi/Hnrnph1+
(C57BL/6N-Hnrnph1tm1b(KOMP)Wtsi/Nju)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Hnrnpltm1.1Tmo/Hnrnpltm1.1Tmo
Tg(Lck-cre)548Jxm/0
(B6.Cg-Hnrnpltm1.1Tmo Tg(Lck-cre)548Jxm)
|
abnormal T cell differentiation
|
J:188749
|
| decreased double-positive T cell number
|
J:188749
|
| increased double-negative T cell number
|
J:188749
|
Hnrnpllthdr/Hnrnpllthdr
(C57BL/6JSfdAnu-Hnrnpllthdr/Anu)
|
abnormal T cell differentiation
|
J:142641
|
Hook2em1(IMPC)Tcp/Hook2em1(IMPC)Tcp
(C57BL/6N-Hook2em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Hook3tm1b(NCOM)Mfgc/Hook3tm1b(NCOM)Mfgc
(C57BL/6N-Hook3tm1b(NCOM)Mfgc/Tcp)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Hoxa9tm1Mrc/Hoxa9tm1Mrc
(B6.129S7-Hoxa9tm1Mrc)
|
abnormal common myeloid progenitor cell morphology
|
J:126371
|
Hoxb4tm1.1Karl/Hoxb4tm1.1Karl
(involves: 129 * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:90976
|
| decreased erythrocyte cell number
|
J:90976
|
| decreased hemoglobin content
|
J:90976
|
Hoxb6tm1Cka/Hoxb6tm1Cka
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:133561
|
| abnormal erythropoiesis
|
J:133561
|
Hoxc4tm2.1Mrc/Hoxc4tm2.1Mrc
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:148278
|
| abnormal somatic hypermutation frequency
|
J:148278
|
Hpf1em1(IMPC)Wtsi/Hpf1em1(IMPC)Wtsi
(C57BL/6N-Hpf1em1(IMPC)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Hprt1b-m3/Y
Impdh1tm1Bmi/Impdh1tm1Bmi
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
Hprt1tm1(ACTB-Epor)Unc/Y
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:81859
|
Hprt1tm1(ACTB-Epor)Unc/Hprt1tm1(ACTB-Epor)Unc
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:81859
|
Hprt1tm1(CUX1)Anep/Hprt1+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * FVB))
|
decreased erythrocyte cell number
|
J:113393
|
| decreased hematocrit
|
J:113393
|
| decreased mean corpuscular hemoglobin concentration
|
J:113393
|
| increased neutrophil cell number
|
J:113393
|
| myeloid hyperplasia
|
J:113393
|
Hprt1tm1(Pck1-cre)Vhh/Y
Vhltm1Jae/Vhltm1Jae
(involves: 129P2/OlaHsd * 129S4/SvJae * BALB/c * C57BL/6)
|
increased hemoglobin content
|
J:97652
|
| polycythemia
|
J:97652
|
Hprt1tm1(Rcan1)Zyga/Hprt1+
(B6.129P2-Hprt1tm1(Rcan1)Zyga)
|
thrombocytosis
|
J:197570
|
Hprt1tm1a(EUCOMM)Hmgu/Hprt1tm1a(EUCOMM)Hmgu
(C57BL/6N-Hprt1tm1a(EUCOMM)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
Hps1ep/Hps1ep
(involves: C3HeB/FeJ * C57BL/6J)
|
decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet dense granule number
|
J:42484
|
| decreased platelet serotonin level
|
J:7327
|
Hps1ep/Hps1ep
(B6.C3Fe-Hps1ep/J)
|
decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet serotonin level
|
J:7327,
J:29748
|
Hps3coa/Hps3coa
(involves: C57BL/10J)
|
decreased platelet ATP level
|
J:9300
|
| decreased platelet dense granule number
|
J:9300
|
| decreased platelet serotonin level
|
J:9300
|
Hps4le/Hps4le
(B6.C3-Pde6brd1 Hps4le)
|
abnormal platelet dense granule morphology
|
J:7327
|
| decreased platelet serotonin level
|
J:7327,
J:29748
|
Hps5ru2-mr/Hps5ru2-mr
(B6.Cg-Hps5ru2-mr/Re)
|
decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet dense granule number
|
J:7327
|
| decreased platelet serotonin level
|
J:7327,
J:29748
|
Hpsetm1.2Mdh/Hpsetm1.2Mdh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased eosinophil cell number
|
J:209913
|
Hpsetm1Jpli/Hpsetm1Jpli
(B6.129-Hpsetm1Jpli)
|
increased hemoglobin content
|
J:148281
|
Hrem1(IMPC)H/Hrem1(IMPC)H
(C57BL/6NTac-Hrem1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
HrecC57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:76791
|
HrecDBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:76791
|
Hs3st3a1tm1(KOMP)Vlcg/Hs3st3a1tm1(KOMP)Vlcg
(C57BL/6N-Hs3st3a1tm1(KOMP)Vlcg/MbpMmucd)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Hs3st3b1em2(IMPC)Mbp/Hs3st3b1em2(IMPC)Mbp
(C57BL/6N-Hs3st3b1em2(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
HscfrAKR/J/?
(involves: AKR/J * C57BL/6Ka)
|
abnormal definitive hematopoiesis
|
J:73737
|
Hsd17b1tm1.1(KOMP)Vlcg/Hsd17b1tm1.1(KOMP)Vlcg
(C57BL/6N-Hsd17b1tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Hsd17b11Gt(OST237628)Lex/Hsd17b11Gt(OST237628)Lex
(B6;129S5-Hsd17b11Gt(OST237628)Lex/Mmucd)
|
increased immature B cell number
|
J:171883
|
Hsf2bptm1a(EUCOMM)Hmgu/Hsf2bp+
(C57BL/6N-Hsf2bptm1a(EUCOMM)Hmgu/Cnrm)
|
thrombocytopenia
|
J:165965
|
Hsf2bptm1a(EUCOMM)Hmgu/Hsf2bptm1a(EUCOMM)Hmgu
(C57BL/6N-Hsf2bptm1a(EUCOMM)Hmgu/Cnrm)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Hsm1C3H/HeJ/Hsm1CAST/EiJ
(involves: C3H/HeJ-Slc4a1wan/J * CAST/EiJ)
|
decreased mean corpuscular volume
|
J:89043
|
Hsm1CAST/EiJ/Hsm1CAST/EiJ
(involves: C3H/HeJ-Slc4a1wan/J * CAST/EiJ)
|
decreased mean corpuscular volume
|
J:89043
|
Hspa13tm1.1Smoc/Hspa13tm1.1Smoc
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S * C57BL/6)
|
abnormal class switch recombination
|
J:303927
|
| abnormal somatic hypermutation frequency
|
J:303927
|
Hspb1tm1.1(KOMP)Vlcg/Hspb1tm1.1(KOMP)Vlcg
(C57BL/6N-Hspb1tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Hspd1tm1c(EUCOMM)Hmgu/Hspd1tm1c(EUCOMM)Hmgu
Tg(Tek-cre)12Flv/0
(involves: Black Swiss * C3H * C57BL/6 * C57BL/6N)
|
abnormal blood cell morphology
|
J:282096
|
| decreased erythrocyte cell number
|
J:282096
|
Htr1ftm1.1(KOMP)Vlcg/Htr1ftm1.1(KOMP)Vlcg
(C57BL/6N-Htr1ftm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular volume
|
J:211773
|
Htra2mnd2/Htra2mnd2
(involves: C57BL/6J)
|
decreased double-positive T cell number
|
J:132627
|
| decreased pro-B cell number
|
J:132627
|
hubb/hubb
(involves: ICR)
|
increased hematocrit
|
J:8170
|
Hus1tm1Led/Hus1tm1Led
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss))
|
abnormal embryonic hematopoiesis
|
J:63869
|
Hyal2tm1.1Bfla/Hyal2tm1.1Bfla
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
decreased erythrocyte cell number
|
J:146040
|
| decreased hemoglobin content
|
J:146040
|
| polychromatophilia
|
J:146040
|
| thrombocytopenia
|
J:146040
|
Hycc1em1(IMPC)Ccpcz/Hycc1em1(IMPC)Ccpcz
(C57BL/6N-Hycc1em1(IMPC)Ccpcz/Ccpcz)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Iars2em1(IMPC)Tcp/Iars2+
(C57BL/6NCrl-Iars2em1(IMPC)Tcp/Tcp)
|
increased hematocrit
|
J:211773
|
Icam1tm1Alb/Icam1tm1Alb
(B6.Cg-Icam1tm1Alb)
|
increased neutrophil cell number
|
J:100242
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased neutrophil cell number
|
J:14565
|
Icam1tm1Bay/Icam1tm1Bay
(B6.129S7-Icam1tm1Bay)
|
increased eosinophil cell number
|
J:48271
|
| increased neutrophil cell number
|
J:48271,
J:24239
|
Icam1tm1Bay/Icam1tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:112286
|
Icam1tm1Bay/Icam1tm1Bay
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:112286
|
Icam1tm1Bay/Icam1tm1Bay
Selltm1Tft/Selltm1Tft
(B6.129-Selltm1Tft Icam1tm1Bay)
|
increased eosinophil cell number
|
J:48271
|
| increased neutrophil cell number
|
J:48271
|
Icam1tm1Bay/Icam1tm1Bay
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased neutrophil cell number
|
J:24239
|
Icam1tm1Jcgr/Icam1tm1Jcgr
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
increased neutrophil cell number
|
J:18743
|
Icam1tm1Jcgr/Icam1tm1Jcgr
Ldlrtm1Her/Ldlrtm1Her
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
increased neutrophil cell number
|
J:69597
|
Icam1tm1Jcgr/Icam1tm1Jcgr
Ldlrtm1Her/Ldlrtm1Her
Vcam1tm1Dmil/Vcam1tm1Dmil
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:69597
|
Icam4tm1Jach/Icam4tm1Jach
(involves: 129 * C57BL/6)
|
abnormal erythropoiesis
|
J:138068
|
Icmttm1Hzo/Icmttm1Hzo
(involves: 129S/SvEv)
|
abnormal definitive hematopoiesis
|
J:77742
|
Icostm1.1Wks/Icostm1.1Wks
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell selection
|
J:155586
|
| abnormal class switch recombination
|
J:155586
|
Icostm1Mak/Icostm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:66702
|
Icostm1Shr/Icostm1Shr
(Not Specified)
|
abnormal T cell differentiation
|
J:87124
|
Icosltm1Cdon/Icosltm1Cdon
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:86697
|
Icosltm1Mak/Icosltm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:84668
|
| abnormal T-helper 2 cell differentiation
|
J:84668
|
Id1tm1Zhu/Id1tm1Zhu
(involves: 129S1/Sv * C57BL/6)
|
abnormal myelopoiesis
|
J:155384
|
| decreased erythrocyte cell number
|
J:119519,
J:155384
|
| increased neutrophil cell number
|
J:155384
|
| myeloid hyperplasia
|
J:155384
|
| thrombocytopenia
|
J:155384
|
Id1tm1Zhu/Id1tm1Zhu
Tcf3tm1Wein/Tcf3tm1Wein
(involves: 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
arrested B cell differentiation
|
J:44278
|
Id3em1(IMPC)Mbp/Id3em1(IMPC)Mbp
(C57BL/6N-Id3em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Id3tm1Cmu/Id3tm1Cmu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal double-positive T cell morphology
|
J:59969
|
| abnormal T cell differentiation
|
J:59969
|
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal T cell differentiation
|
J:144696
|
Id3tm2.1Zhu/Id3tm2.1Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL * SJL/J)
|
abnormal T cell differentiation
|
J:172701
|
Idd6.2NOD/Idd6.2NOD
(B6.NOD-(D6Mit259-D6Mit304))
|
abnormal T cell differentiation
|
J:120148
|
Idd7NOD/ShiLt/Idd7NOD/ShiLt
(involves: C57BL/6 * NOD/ShiLt)
|
abnormal T cell clonal deletion
|
J:131557
|
Idh1tm1Mak/Idh1tm1Mak
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal common myeloid progenitor cell morphology
|
J:186700
|
Idh1tm1Mak/Idh1tm1Mak
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:186700
|
| decreased hematocrit
|
J:186700
|
| decreased hemoglobin content
|
J:186700
|
| extramedullary hematopoiesis
|
J:186700
|
Idh1tm2Mak/Idh1tm2Mak
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal common myeloid progenitor cell morphology
|
J:186700
|
Idh1tm2Mak/Idh1tm2Mak
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:186700
|
| decreased hematocrit
|
J:186700
|
| decreased hemoglobin content
|
J:186700
|
| extramedullary hematopoiesis
|
J:186700
|
Idh2tm1b(EUCOMM)Hmgu/Idh2tm1b(EUCOMM)Hmgu
(C57BL/6N-Idh2tm1b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Ier3tm1Mxw/Ier3tm1Mxw
(involves: 129 * C57BL/6)
|
increased granulocyte number
|
J:157504
|
| increased neutrophil cell number
|
J:157504
|
Ier5lem1(IMPC)J/Ier5lem1(IMPC)J
(C57BL/6NJ-Ier5lem1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Ifi44tm1b(KOMP)Wtsi/Ifi44tm1b(KOMP)Wtsi
(C57BL/6N-Ifi44tm1b(KOMP)Wtsi/Tcp)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Ifih1Rgsc422/Ifih1+
(D2JJcl.B6JJcl-Ifih1Rgsc422)
|
increased granulocyte number
|
J:209917
|
Ifitm1tm1.1Ieg/Ifitm1tm1.1Ieg
(B6.129P2-Ifitm1tm1.1Ieg)
|
decreased granulocyte number
|
J:192287
|
Ifnar1tm1Agt/Ifnar1tm1Agt
Slamf1tm1Oono/Slamf1tm1Oono
(B6.129-Slamf1tm1Oono Ifnar1tm1Agt)
|
abnormal lymphopoiesis
|
J:117810
|
Ifnb1tm1Acgp/Ifnb1tm1Acgp
(involves: 129P2/OlaHsd)
|
decreased common myeloid progenitor cell number
|
J:86527
|
| decreased neutrophil cell number
|
J:86527
|
| decreased pro-B cell number
|
J:86527
|
Ifngtm1.1(KOMP)Vlcg/Ifng+
(C57BL/6N-Ifngtm1.1(KOMP)Vlcg/Ucd)
|
increased hematocrit
|
J:211773
|
Ifngtm1.1Hayg/Ifngtm1.1Hayg
(Not Specified)
|
abnormal B cell differentiation
|
J:220784
|
| abnormal erythropoiesis
|
J:220784
|
| decreased common myeloid progenitor cell number
|
J:220784
|
| decreased erythrocyte cell number
|
J:220784
|
| increased nucleated erythrocyte cell number
|
J:220784
|
| thrombocytopenia
|
J:220784
|
Ifngtm1Ts/Ifngtm1Ts
(B6.129S7-Ifngtm1Ts/J)
|
extramedullary hematopoiesis
|
J:47459
|
| increased granulocyte number
|
J:47459
|
Ifngtm1Ts/Ifngtm1Ts
(C.129S7(B6)-Ifngtm1Ts/J)
|
extramedullary hematopoiesis
|
J:47459
|
| increased granulocyte number
|
J:47459
|
Ifngtm1Ts/Ifngtm1Ts
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
increased eosinophil cell number
|
J:119206
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt/J)
|
abnormal lymphopoiesis
|
J:138728
|
Ifngr2tm1Pbro/Ifngr2tm1Pbro
(involves: 129S1/Sv)
|
abnormal class switch recombination
|
J:48016
|
| abnormal T-helper 1 cell differentiation
|
J:48016
|
Ift80tm1a(KOMP)Wtsi/Ift80+
(C57BL/6N-Ift80tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Igbp1tm1Imku/Y
Tg(Lck-cre)I57Jxm/?
(involves: 129P2/OlaHsd * ICR)
|
decreased double-negative T cell number
|
J:84395
|
Igf2bp3em1(IMPC)J/Igf2bp3em1(IMPC)J
(C57BL/6NJ-Igf2bp3em1(IMPC)J/Mmjax)
|
thrombocytosis
|
J:211773
|
Igf2rtm1Arge/Igf2r+
(involves: 129)
|
increased nucleated erythrocyte cell number
|
J:34584
|
Igf2rtm1Arge/Igf2rtm1Arge
(involves: 129)
|
increased nucleated erythrocyte cell number
|
J:34584
|
Igf2rtm2Arge/Igf2r+
(involves: 129)
|
increased nucleated erythrocyte cell number
|
J:34584
|
Igf2rtm2Arge/Igf2rtm2Arge
(involves: 129)
|
increased nucleated erythrocyte cell number
|
J:34584
|
Igh-7tm1Led/Igh-7tm1Led
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
increased basophil cell number
|
J:161523
|
Igh-8tm1.1Aak/Igh-8tm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
Igh-8tm1Aak/Igh-8tm1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:107063
|
Igh-8tm2(Ighg1)Aak/Igh-8tm2(Ighg1)Aak
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:130574
|
Igh-Jtm1(3H9-VDJ)Mwg/Igh-Jtm1(3H9-VDJ)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
Igh-Jtm1(CB20)Riho/Igh-J+
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
| increased immature B cell number
|
J:179456
|
Igh-Jtm1(CB20)Riho/Igh-Jtm1(CB20)Riho
(involves: C57BL/10 * DBA/1)
|
abnormal B cell differentiation
|
J:179456
|
| increased immature B cell number
|
J:179456
|
Igh-Jtm1.1Lave/Igh-J+
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
| decreased immature B cell number
|
J:155798
|
| decreased transitional stage B cell number
|
J:155798
|
| decreased transitional stage T1 B cell number
|
J:155798
|
| decreased transitional stage T2 B cell number
|
J:155798
|
| increased pro-B cell number
|
J:155798
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
(Not Specified)
|
abnormal B cell differentiation
|
J:155798
|
| arrested B cell differentiation
|
J:179317
|
| decreased immature B cell number
|
J:155798
|
| decreased transitional stage B cell number
|
J:155798
|
| decreased transitional stage T1 B cell number
|
J:155798
|
| decreased transitional stage T2 B cell number
|
J:155798
|
| increased pro-B cell number
|
J:155798
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
Igk-Jtm1.1Lave/Igk-Jtm1.1Lave
(Not Specified)
|
abnormal B cell clonal deletion
|
J:179317
|
| abnormal B cell differentiation
|
J:205708
|
| arrested B cell differentiation
|
J:205708,
J:179317
|
| decreased immature B cell number
|
J:205708
|
Igh-Jtm1.1Lave/Igh-Jtm1.1Lave
Igk-Jtm1.1Lave/Igk-Jtm1.1Lave
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:179317
|
Igh-Jtm1Cgn/Ightm11.1Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113434
|
Igh-Jtm1Cgn/Igh-J+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:64285
|
Igh-Jtm1Cgn/Ightm1Leck
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
Igh-Jtm1Cgn/Igh-Jtm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:64285
|
Igh-Jtm1Dhu/Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
Igh-Jtm1Dhu/Ightm1Tim
(involves: 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:88410
|
Igh-Jtm1Dhu/Igh-Jtm1(VDJ-17.2.25)Wabl
Igktm1Dhu/Igktm1Dhu
(Not Specified)
|
abnormal B cell differentiation
|
J:33628
|
| abnormal immature B cell morphology
|
J:89757
|
Igh-Jtm1Dhu/Igh-Jtm1Dhu
Wdr1rede/Wdr1rede
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6)
|
thrombocytopenia
|
J:134092
|
Igh-Jtm1Dim/Igh-J+
Igk-Jtm1Dim/Igk-J+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:107241
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:137738,
J:23827
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
Tg(IGK@yK2)J23.1Jkbv/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:70620
|
| abnormal immunoglobulin light chain V-J recombination
|
J:70620
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGH@yH2)J9.2Jkbv/0
Tg(IGK@yK2)J23.1Jkbv/Tg(IGK@yK2)J23.1Jkbv
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/0
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
increased late pro-B cell number
|
J:23827
|
Igh-Jtm1Jkbv/Igh-Jtm1Jkbv
Tg(IGH@yH1)2BJkbv/Tg(IGH@yH1)2BJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
| increased late pro-B cell number
|
J:137738
|
Igh-Jtm1Mcdl/Igh-Jtm1Mcdl
Igk-Jtm1Mcdl/Igk-Jtm1Mcdl
Rag1tm1Mom/Rag1tm1Mom
Tg(DO11.10)10Dlo/?
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:100072
|
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
Igh-Jtm2(3H9-VDJ*)Mwg/Igh-J+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell receptor editing
|
J:131138
|
Igh-Jtm2.1(4E10)Lave/Igh-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:205708
|
Igh-Jtm2.1(4E10)Lave/Igh-Jtm2.1(4E10)Lave
Igk-Jtm2.1(4E10)Lave/Igk-Jtm2.1(4E10)Lave
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:205708
|
| arrested B cell differentiation
|
J:205708
|
| decreased immature B cell number
|
J:205708
|
Igh-Jtm3(3H9-VDJ*)Mwg/Igh-Jtm3(3H9-VDJ*)Mwg
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal B cell receptor editing
|
J:126940
|
IghdeltaD/Igh+
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
IghdeltaD/IghdeltaD
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:95981
|
| arrested B cell differentiation
|
J:95981
|
IghdeltaD/Ightm11.1Cgn
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:113434
|
Ightm1(PAX5)Mbu/Igh+
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
| decreased double-negative T cell number
|
J:118111
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:118111
|
Ightm1(PAX5)Mbu/Igh+
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:118111
|
Ightm1(PAX5)Mbu/Ightm1(PAX5)Mbu
(B6.Cg-Ightm1(PAX5)Mbu)
|
abnormal T cell differentiation
|
J:118111
|
| decreased double-negative T cell number
|
J:118111
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:118111
|
Ightm1(VH558)Mss/Igh+
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
Ightm1(VH558)Mss/Ightm1(VH558)Mss
(involves: FVB/N)
|
abnormal B cell differentiation
|
J:130421
|
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
(involves: C57BL/6N * FVB/N)
|
decreased immature B cell number
|
J:205766
|
Ightm1.1(b12)Nemz/Ightm1.1(b12)Nemz
Igktm1.1(b12)Nemz/Igktm1.1(b12)Nemz
(involves: C57BL/6N * C57BL/6NTac * FVB/N)
|
decreased immature B cell number
|
J:205766
|
Ightm1.1(Rr361-HBB)Aak/Ightm1.1(Rr361-HBB)Aak
(129.129S2(Cg)-Ightm1.1(Rr361-HBB)Aak)
|
abnormal class switch recombination
|
J:333279
|
Ightm1.1Hmj/Ightm1.1Hmj
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:140486
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:140486
|
Ightm1.1Hws/Ightm1.1Hws
(BALB/cJ-Ightm1.1Hws)
|
decreased immature B cell number
|
J:119391
|
| increased late pro-B cell number
|
J:119391
|
Ightm1.1Hws/Ightm1.1Hws
(involves: BALB/c)
|
decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| increased early pro-B cell number
|
J:142069
|
Ightm1.1Lnit/Igh+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:119484
|
Ightm1.1Rsky/Ightm1.1Rsky
(BALB/c-Ightm1.1Rsky)
|
abnormal class switch recombination
|
J:125719
|
Ightm1.1Twin/Igh+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
increased pro-B cell number
|
J:174233
|
Ightm1.1Twin/Ightm1.1Twin
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:174233
|
| decreased immature B cell number
|
J:174233
|
| decreased transitional stage T2 B cell number
|
J:174233
|
Ightm1.1Vmd/Igh+
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
Ightm1.1Vmd/Ightm1.1Vmd
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:201147
|
Ightm1.2Rsky/Ightm1.2Rsky
(BALB/c-Ightm1.2Rsky)
|
decreased transitional stage B cell number
|
J:125719
|
| increased pro-B cell number
|
J:125719
|
Ightm1.2Rsky/Ightm1.2Rsky
Tg(CD19-cre/ERT2)1Cgn/?
(involves: BALB/c)
|
abnormal class switch recombination
|
J:125719
|
Ightm1Aak/Ightm1Aak
(Not Specified)
|
abnormal B cell differentiation
|
J:158402
|
| increased pro-B cell number
|
J:158402
|
Ightm1Cgn/Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:79556
|
Ightm1Cgn/Ightm2Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
Ightm1Cog/Ightm1Cog
(involves: 129S2/SvPas * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:80654
|
| arrested B cell differentiation
|
J:80654
|
Ightm1Kplm/Igh+
(Not Specified)
|
abnormal B cell differentiation
|
J:115292
|
Ightm1Kplm/Ightm3Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:115292
|
Ightm1Kplm/Ightm4Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
Ightm1Leck/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immature B cell morphology
|
J:144033
|
| abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
Ightm1Mnz/Ightm1Mnz
Dis3tm1.1Uba/Dis3tm1.1Uba
Aicdatm1(cre)Uba/Aicda+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:302856
|
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
(involves: C57BL/6)
|
increased immature B cell number
|
J:132538
|
Ightm1Rbr/Igh+
Tg(IgkHyHEL10)1Rbr/0
Tg(ML5sHEL)5Ccg/0
(involves: C57BL/6 * C57BL/6JSfd)
|
increased immature B cell number
|
J:132538
|
Ightm2.1Fwa/Ightm2.1Fwa
(involves: 129S/SvEv * C57BL/6)
|
abnormal class switch recombination
|
J:161437
|
| abnormal somatic hypermutation frequency
|
J:161437
|
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c * C57BL/6NCrl * DBA/2NCrl)
|
decreased transitional stage B cell number
|
J:124421
|
| increased early pro-B cell number
|
J:124421
|
Ightm2.1Hws/Ightm2.1Hws
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:142069
|
| decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| decreased transitional stage B cell number
|
J:142069
|
| increased early pro-B cell number
|
J:142069
|
Ightm2Cgn/Igh+
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
Ightm2Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal immunoglobulin light chain V-J recombination
|
J:144033
|
Ightm2Cgn/Igh+
Igktm1Rsky/Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:150435
|
Ightm2Cgn/Igh+
Igktm2Rsky/Igk+
Prkdcscid/Prkdcscid
(involves: 129P2/OlaHsd * BALB/c * C57BL/Ka)
|
abnormal class switch recombination
|
J:150435
|
Ightm2Cgn/Igh+
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:44361
|
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Ightm2Cgn/Ightm2Cgn
Igktm1Rsky/Igktm1Rsky
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Ightm2Cgn/Ightm3Cgn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * C57BL/Ka)
|
abnormal B cell differentiation
|
J:79556
|
Ightm2Cgn/Ightm4.1Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal immunoglobulin V(D)J recombination
|
J:176649
|
Ightm2Emo/Ightm2Emo
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:108098
|
Ightm2Rsky/Igh+
Igktm1Rsky/Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
Ightm2Rsky/Igh+
Igktm2Rsky/Igk+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal B cell differentiation
|
J:111431
|
Ightm3.1Cog/Ightm3.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:71300
|
Ightm3.1Tim/Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
Ightm3Cgn/Igh+
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:79556,
J:115292
|
Ightm3Cgn/Ightm3Cgn
(involves: C57BL/6)
|
decreased immature B cell number
|
J:76117
|
Ightm3Hws/Ightm3Hws
(BALB/c-Ightm3Hws)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:142068
|
Ightm3Hws/Ightm3Hws
(involves: BALB/c)
|
decreased immature B cell number
|
J:142069
|
| decreased late pro-B cell number
|
J:142069
|
| decreased transitional stage B cell number
|
J:142069
|
Ightm3Tim/Igh+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
Ightm4.1Cog/Ightm4.1Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal class switch recombination
|
J:184094
|
Ightm4.1Fwa/Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| abnormal immunoglobulin V(D)J recombination
|
J:176649
|
Ightm4.1Fwa/Ightm4.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
| abnormal immunoglobulin V(D)J recombination
|
J:176649
|
Ightm4Cgn/Igh+
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:115292
|
Ightm5.1Cgn/Ightm5.1Cgn
(BALB/c-Ightm5.1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
| decreased immature B cell number
|
J:88472
|
| increased pro-B cell number
|
J:88472
|
Ightm5.1Cog/Ightm5.1Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:164513
|
| abnormal somatic hypermutation frequency
|
J:164513,
J:333348
|
Ightm5.1Fwa/Igh+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
Ightm5.1Fwa/Ightm5.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:176649
|
Ightm5Cgn/Ightm5Cgn
(involves: BALB/c)
|
arrested B cell differentiation
|
J:88472
|
Ightm5Cgn/Ightm5Cgn
Tg(CD19-cre/ERT2)1Cgn/0
(C.Cg-Ightm5Cgn Tg(CD19-cre/ERT2)1Cgn)
|
abnormal B cell differentiation
|
J:88472
|
| increased pro-B cell number
|
J:88472
|
Ightm7(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm8(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm9(VHB1-8)Cgn/Igh+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:48835
|
Ightm11.1Cgn/Ightm11.1Cgn
(Not Specified)
|
abnormal B cell differentiation
|
J:113434
|
| decreased immature B cell number
|
J:113434
|
| increased pro-B cell number
|
J:113434
|
Ightm12Cgn/Ightm12Cgn
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:66031
|
Ighatm2Grh/Ighatm2Grh
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:72521
|
Ighdtm1Lam/Ighdtm1Lam
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukopoiesis
|
J:111020
|
Ighg1em1Wliu/Ighg1em1Wliu
(C57BL/6-Ighg1em1Wliu)
|
abnormal plasma cell differentiation
|
J:266937
|
Ighg1tm1(cre)Cgn/Ighg1+
Irf4tm1Rdf/Irf4tm1.1Rdf
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal class switch recombination
|
J:112643
|
Ighg1tm1(cre)Cgn/Ighg1+
Myd88em1.1Rsky/Myd88+
(involves: 129P2/OlaHsd * C57BL/6NTac)
|
abnormal somatic hypermutation frequency
|
J:308792
|
Ighg1tm1(cre)Cgn/Ighg1+
Tbl1xr1tm1.1Meln/Tbl1xr1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
Ighg1tm1(cre)Cgn/Ighg1+
Tbl1xr1tm1c(EUCOMM)Hmgu/Tbl1xr1tm1c(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:292118
|
Ighg1tm2Cgn/Ighg1+
((C57BL/6 x 129P2/OlaHsd)F1)
|
abnormal class switch recombination
|
J:146428
|
Ighg1tm3Cgn/Ighg1+
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal class switch recombination
|
J:166887
|
Ighmtm1.1(IGH-2)Cog/Ighmtm1.1(IGH-2)Cog
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:157575
|
| abnormal plasma cell differentiation
|
J:157575
|
| decreased transitional stage B cell number
|
J:157575
|
| increased pro-B cell number
|
J:157575
|
Ighmtm1.1Aak/Ighmtm1.1Aak
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:171251
|
| increased pro-B cell number
|
J:171251
|
Ighmtm1Cgn/Ightm3Tim
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:102308
|
Ighmtm1Cgn/Ighm+
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:70398
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:64298,
J:70398
|
| absent immature B cells
|
J:64298
|
| arrested B cell differentiation
|
J:64298
|
Ighmtm1Cgn/Ighmtm1Cgn
(B6.129S2-Ighmtm1Cgn/J)
|
arrested B cell differentiation
|
J:119584
|
Ighmtm1Cgn/Ighmtm1Cgn
(involves: 129S2/SvPas)
|
arrested B cell differentiation
|
J:118453
|
Ighmtm1Cgn/Ighmtm1Cgn
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
thrombocytopenia
|
J:174308
|
Ighmtm1Msn/Ighmtm1Msn
(involves: 129S/SvEv)
|
abnormal immature B cell morphology
|
J:49405
|
Ighmtm1Sls/Ighmtm1Sls
(Not Specified)
|
abnormal class switch recombination
|
J:99465
|
Ighmtm2.1Bgmn/Ighmtm2.1Bgmn
(involves: 129/Sv * C57BL/6 * CBA)
|
arrested B cell differentiation
|
J:118453
|
Ighmtm3Bgmn/Ighmtm3Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
Ighmtm3Bgmn/Ighmtm3Bgmn
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd * 129/Sv)
|
abnormal B cell differentiation
|
J:130864
|
Ighmtm4Bgmn/Ighmtm4Bgmn
(involves: 129)
|
decreased immature B cell number
|
J:131633
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm1Ust/Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:68144
|
Igktm1Dhu/Igktm1Dhu
Iglc1tm2Ust/Iglc1tm2Ust
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal B cell differentiation
|
J:74717
|
| decreased immature B cell number
|
J:74717
|
| decreased transitional stage T1 B cell number
|
J:74717
|
| decreased transitional stage T2 B cell number
|
J:74717
|
Igktm1Rsky/Igk+
Igll1tm1Cgn/Igll1tm1Cgn
(involves: 129P2/OlaHsd * 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:35357
|
| decreased immature B cell number
|
J:35357
|
Igktm2Ybgn/Igktm2Ybgn
(Not Specified)
|
increased immature B cell number
|
J:123344
|
Igkctm1(IGKC)Mnz/Igkc+
Igk-Jtm1(CD4*)Mss/Igk-J+
(involves: 129S4/SvJae)
|
abnormal immunoglobulin light chain V-J recombination
|
J:143876
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm1.1Bgmn/Igltm1.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm1Bgmn/Igltm1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested B cell differentiation
|
J:118712
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2.1Bgmn/Igltm2.1Bgmn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:130864
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:130864
|
Igkctm1Bgmn/Igkctm1Bgmn
Igltm2Bgmn/Igltm2Bgmn
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * CBA)
|
arrested B cell differentiation
|
J:118712
|
Igkctm1Cgn/Igkctm1Cgn
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:64287
|
| increased immature B cell number
|
J:64287
|
Igkctm1Jkbv/Igkctm1Jkbv
(Not Specified)
|
abnormal B cell differentiation
|
J:137738
|
| abnormal immunoglobulin light chain V-J recombination
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
decreased immature B cell number
|
J:137738
|
Igkctm1Jkbv/Igkctm1Jkbv
Tg(IGK@yK1)9.2CJkbv/Tg(IGK@yK1)9.2CJkbv
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:137738
|
| decreased immature B cell number
|
J:137738
|
Igkctm2(IGKC)Cgn/Igkctm2(IGKC)Cgn
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113008
|
Igkrstm1Nemz/Igkrstm1Nemz
(B6.129-Igkrstm1Nemz)
|
abnormal immunoglobulin light chain V-J recombination
|
J:132125
|
| decreased immature B cell number
|
J:132125
|
Igkrstm1Nemz/Igkrstm1Nemz
Tg(UBC-scFv)2Nemz/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal B cell clonal deletion
|
J:132125
|
| decreased immature B cell number
|
J:132125
|
Iglc1tm2Ust/Iglc1+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal immunoglobulin light chain V-J recombination
|
J:74717
|
Igll1tm1Cgn/Igll1tm1Cgn
(involves: 129S2/SvPas * C57BL/6)
|
abnormal lymphopoiesis
|
J:64284
|
| increased pro-B cell number
|
J:64284
|
Igll1tm1Cgn/Igll1tm1Cgn
Tg(Igk-V4CH27)1-2Shc/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:35357
|
Igll1tm1Shim/Igll1tm1Shim
Vpreb1atm1Shim/Vpreb1atm1Shim
Vpreb1btm1Shim/Vpreb1btm1Shim
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:76947
|
| decreased immature B cell number
|
J:76947
|
| increased late pro-B cell number
|
J:76947
|
Iigp1cem1(IMPC)Hmgu/Iigp1cem1(IMPC)Hmgu
(C57BL/6N-Iigp1cem1(IMPC)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
IkbkbM1Btlr/Ikbkb+
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
IkbkbM1Btlr/IkbkbM1Btlr
(C57BL/6J-IkbkbM1Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225271
|
Ikbkgtm1.1Mpa/Ikbkgtm1.1Mpa
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
abnormal B cell differentiation
|
J:113365
|
Ikzf1plstc/Ikzf1+
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal B cell differentiation
|
J:84569
|
| abnormal lymphopoiesis
|
J:84569
|
| abnormal T cell differentiation
|
J:84569
|
| decreased double-negative T cell number
|
J:84569
|
| decreased double-positive T cell number
|
J:84569
|
| increased pro-B cell number
|
J:84569
|
| myeloid hyperplasia
|
J:84569
|
Ikzf1plstc/Ikzf1plstc
(C57BL/6JSfdAnu-Ikzf1plstc)
|
abnormal granulocyte differentiation
|
J:84569
|
| abnormal lymphopoiesis
|
J:84569
|
| abnormal macrophage differentiation
|
J:84569
|
| abnormal myelopoiesis
|
J:84569
|
| absent pro-B cells
|
J:84569
|
| arrested B cell differentiation
|
J:84569
|
| decreased erythrocyte cell number
|
J:84569
|
| decreased fetal derived definitive erythrocyte cell number
|
J:84569
|
| decreased granulocyte number
|
J:84569
|
| decreased hematocrit
|
J:84569
|
| decreased hemoglobin content
|
J:84569
|
Ikzf1plstc/Ikzf1tm2Kge
(involves: 129S4/SvJae * C57BL/6 * C57BL/6JSfdAnu)
|
abnormal erythropoiesis
|
J:84569
|
Ikzf1tm1(Pax5)Mbu/Ikzf1tm1(Pax5)Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:80815
|
Ikzf1tm1(Pax5)Mbu/Ikzf1tm1(Pax5)Mbu
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:80815
|
| arrested T cell differentiation
|
J:80815
|
| increased early pro-B cell number
|
J:80815
|
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:80815
|
| abnormal erythropoiesis
|
J:80815
|
| decreased double-positive T cell number
|
J:118111
|
| increased pro-B cell number
|
J:80815
|
Ikzf1tm1.1(Pax5)Mbu/Ikzf1+
Tcf3tm1Mbu/Tcf3tm1Mbu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:137719
|
Ikzf1tm1.1Smale/Ikzf1tm1.1Smale
(B6.Cg-Ikzf1tm1.1Smale)
|
decreased DN1 thymic pro-T cell number
|
J:208211
|
| decreased immature B cell number
|
J:208211
|
Ikzf1tm1Kast/Ikzf1tm1Kast
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:82813
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1+
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell differentiation
|
J:29355
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:20671
|
| abnormal definitive hematopoiesis
|
J:20671
|
| abnormal eosinophil morphology
|
J:20671
|
| arrested T cell differentiation
|
J:20671
|
| extramedullary hematopoiesis
|
J:20671
|
| increased basophil cell number
|
J:20671
|
| increased nucleated erythrocyte cell number
|
J:20671
|
Ikzf1tm1Kge/Ikzf1tm1Kge
(involves: 129S4/SvJae * BALB/c)
|
abnormal common myeloid progenitor cell morphology
|
J:20671
|
| abnormal definitive hematopoiesis
|
J:20671
|
| abnormal eosinophil morphology
|
J:20671
|
| arrested T cell differentiation
|
J:20671
|
| extramedullary hematopoiesis
|
J:20671
|
| increased basophil cell number
|
J:20671
|
| increased nucleated erythrocyte cell number
|
J:20671
|
Ikzf1tm2.1Smale/Ikzf1tm2.1Smale
(B6.Cg-Ikzf1tm2.1Smale)
|
abnormal definitive hematopoiesis
|
J:208211
|
| abnormal lymphopoiesis
|
J:208211
|
| abnormal T cell differentiation
|
J:208211
|
| decreased DN2 thymocyte number
|
J:208211
|
| decreased DN3 thymocyte number
|
J:208211
|
| decreased double-negative T cell number
|
J:208211
|
| decreased double-positive T cell number
|
J:208211
|
| decreased immature B cell number
|
J:208211
|
| decreased pre-pro B cell number
|
J:208211
|
Ikzf1tm2Kge/Ikzf1tm2Kge
(involves: 129S4/SvJae)
|
abnormal erythropoiesis
|
J:37317
|
| abnormal T cell differentiation
|
J:208211,
J:37317
|
| absent pro-B cells
|
J:37317
|
| decreased double-positive T cell number
|
J:37317
|
| decreased granulocyte number
|
J:37317
|
Ikzf1tm3.1Mbu/Ikzf1tm3.1Mbu
Cd79atm1(cre)Reth/Cd79a+
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv * BALB/c * C57BL/6 * SJL)
|
decreased pro-B cell number
|
J:209928
|
Ikzf3tm1(KOMP)Vlcg/Ikzf3tm1(KOMP)Vlcg
(C57BL/6N-Ikzf3tm1(KOMP)Vlcg/Rbrc)
|
increased neutrophil cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:50626
|
Il1atm1b(EUCOMM)Wtsi/Il1atm1b(EUCOMM)Wtsi
(C57BL/6N-Il1atm1b(EUCOMM)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Il1atm1Yiw/Il1atm1Yiw
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased neutrophil cell number
|
J:191055
|
Il1r1tm1Roml/Il1r1tm1Roml
(C.Cg-Il1r1tm1Roml)
|
decreased eosinophil cell number
|
J:82863
|
Il1r1tm1Roml/Il1r1tm1Roml
(involves: 129S1/Sv)
|
decreased neutrophil cell number
|
J:193548
|
Il1r1tm1Roml/Il1r1tm1Roml
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S1/Sv * C57BL/6)
|
abnormal leukopoiesis
|
J:191055
|
| decreased eosinophil cell number
|
J:191055
|
| thrombocytopenia
|
J:191055
|
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd)
|
decreased eosinophil cell number
|
J:159464
|
Il1rl1tm1Brl/Il1rl1tm1Brl
(involves: 129S/SvEv * C57BL/6)
|
increased eosinophil cell number
|
J:63507
|
Il1rl2tm1Hblu/Il1rl2tm1Hblu
(involves: 129)
|
decreased neutrophil cell number
|
J:193548
|
Il1rntm1Sush/Il1rntm1Sush
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal dendritic cell differentiation
|
J:97684
|
Il2tm1Hor/Il2tm1Hor
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:15573
|
| abnormal T-helper 1 cell differentiation
|
J:37220
|
| decreased double-negative T cell number
|
J:15223
|
| decreased double-positive T cell number
|
J:37220
|
| increased double-negative T cell number
|
J:37220
|
| increased pro-B cell number
|
J:16662
|
Il2tm1Hor/Il2tm1Hor
(C.129P2-Il2tm1Hor)
|
decreased hematocrit
|
J:29799
|
| increased mean corpuscular hemoglobin
|
J:29799
|
| low mean erythrocyte cell number
|
J:29799
|
Il2tm1Hor/Il2tm1Hor
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
increased pro-B cell number
|
J:16662
|
Il2ratm1b(EUCOMM)Wtsi/Il2ratm1b(EUCOMM)Wtsi
(C57BL/6N-Il2ratm1b(EUCOMM)Wtsi/Orl)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Il2ratm1Dw/Il2ratm1Dw
(involves: 129S4/SvJae * C57BL/6)
|
decreased hematocrit
|
J:64279
|
Il2rbM3Btlr/Il2rbM3Btlr
(C57BL/6J-Il2rbM3Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272833
|
Il2rbtm1Mak/Il2rbtm1Mak
(either: (involves: 129P2/OlaHsd) or (involves: 129S2/SvPas))
|
abnormal common myeloid progenitor cell morphology
|
J:25940
|
| decreased double-positive T cell number
|
J:25940
|
| increased granulocyte number
|
J:25940
|
| increased neutrophil cell number
|
J:25940
|
Il2rbtm1Mak/Il2rbtm1Mak
(C.129-Il2rbtm1Mak)
|
abnormal T cell clonal deletion
|
J:113547
|
Il2rbtm1Mak/Il2rbtm1Mak
(D2.129-Il2rbtm1Mak)
|
abnormal T cell clonal deletion
|
J:113547
|
Il2rgtm1.1Flv/Il2rgtm1.1Flv
Rag2tm1.1Flv/Rag2tm1.1Flv
Thpotm1.1(TPO)Flv/Thpotm1.1(TPO)Flv
(involves: 129S4/SvJae * BALB/cAnNTac)
|
thrombocytopenia
|
J:168301
|
Il2rgtm1Cgn/Y
(involves: 129 * CB20)
|
abnormal class switch recombination
|
J:22521
|
| abnormal gamma-delta T cell differentiation
|
J:111821
|
Il2rgtm1Cgn/Il2rgtm1Cgn
(involves: 129 * CB20)
|
abnormal class switch recombination
|
J:22521
|
Il2rgtm1Cgn/Il2rgtm1Cgn
Kittm1.1Bsm/Kittm1.1Bsm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
arrested T cell differentiation
|
J:90485
|
Il2rgtm1Sug/Y
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S6/SvEvTac * C57BL/6))
|
abnormal myelopoiesis
|
J:31167
|
| arrested B cell differentiation
|
J:31167
|
| increased neutrophil cell number
|
J:31167
|
Il2rgtm1Wjl/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased double-negative T cell number
|
J:24117
|
| decreased double-positive T cell number
|
J:24117
|
| decreased immature B cell number
|
J:24117
|
Il2rgtm1Wjl/Y
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased immature B cell number
|
J:109833
|
| decreased mean corpuscular volume
|
J:109833
|
Il2rgtm1Wjl/Il2rgtm1Wjl
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid Il2rgtm1Wjl/Sz)
|
decreased immature B cell number
|
J:109833
|
| decreased mean corpuscular volume
|
J:109833
|
Il3tm1Glli/Il3tm1Glli
(either: (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal mast cell differentiation
|
J:80500
|
Il3ram1/Il3ram1
(A/J)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
| abnormal leukopoiesis
|
J:23971
|
Il3ram1/Il3ram1
(C58/J)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(AKR/J)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(RF/J)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(NZB/BlNJ)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(A/WySnJ)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(A/HeJ)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(BUB/BnJ)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(SM/J)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il3ram1/Il3ram1
(CE/J)
|
abnormal common myeloid progenitor cell morphology
|
J:24918
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased eosinophil cell number
|
J:113543
|
Il4/Il13tm3Anjm/Il4/Il13tm3Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased eosinophil cell number
|
J:113543
|
Il4tm1(CD2)Mmrs/Il4tm1(CD2)Mmrs
(involves: 129)
|
decreased basophil cell number
|
J:181313
|
Il4tm1.1Wep/Il4+
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
Il4tm1.1Wep/Il4tm1.1Wep
(C.129P2-Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
Il4tm1.1Wep/Il4tm1.1Wep
Stat6tm1Gru/Stat6tm1Gru
(C.129-Stat6tm1Gru Il4tm1.1Wep)
|
abnormal T-helper 2 cell differentiation
|
J:138827
|
Il4tm1Cgn/Il4tm1Cgn
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd)
|
increased eosinophil cell number
|
J:205692
|
| increased neutrophil cell number
|
J:205692
|
Il4tm1Kopf/Il4tm1Kopf
(involves: 129S2/SvPas)
|
decreased eosinophil cell number
|
J:113065
|
Il4tm1Kopf/Il4tm1Kopf
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
increased basophil cell number
|
J:161523
|
| increased mast cell number
|
J:161523
|
Il4tm2Nnt/Il4tm2Nnt
(BALB/c-Il4tm2Nnt/J)
|
abnormal dendritic cell differentiation
|
J:141937
|
Il4ratm2Tch/Il4ratm2Tch
(C.129X1-Il4ratm2Tch)
|
increased eosinophil cell number
|
J:152376
|
Il4ratm2Tch/Il4ratm2Tch
Tg(Scgb1a1-rtTA,tetO-Il13)1Eli/?
(B6.Cg-Il4ratm2Tch Tg(Scgb1a1-rtTA,tetO-IL13)1Eli)
|
increased eosinophil cell number
|
J:152376
|
Il5tm1Anjm/Il5tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell morphology
|
J:113543
|
| decreased eosinophil cell number
|
J:113543
|
Il5tm1Anjm/Il5tm1Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell morphology
|
J:113543
|
| decreased eosinophil cell number
|
J:113543
|
Il5tm1Kopf/Il5tm1Kopf
(C57BL/6-Il5tm1Kopf/J)
|
increased eosinophil cell number
|
J:30867
|
Il5tm1Kopf/Il5tm1Kopf
(C57BL/6-Il5tm1Kopf)
|
increased neutrophil cell number
|
J:30641
|
Il5tm2Anjm/Il5tm2Anjm
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased eosinophil cell number
|
J:113543
|
Il5ratm1Ktk/Il5ratm1Ktk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:33140
|
| abnormal eosinophil cell number
|
J:33140
|
| abnormal lymphopoiesis
|
J:33140
|
| abnormal T cell differentiation
|
J:33140
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell differentiation
|
J:17360
|
Il6tm1Kopf/Il6tm1Kopf
(B6.129S2-Il6tm1Kopf/J)
|
decreased pro-B cell number
|
J:117320
|
Il6tm1Kopf/Il6tm1Kopf
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129 * C57BL/6)
|
abnormal lymphopoiesis
|
J:117320
|
| abnormal myelopoiesis
|
J:117320
|
| decreased pro-B cell number
|
J:117320
|
Il6raem1(IMPC)Wtsi/Il6raem1(IMPC)Wtsi
(C57BL/6N-Il6raem1(IMPC)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Il6sttm1Ard/Il6sttm1Ard
(involves: 129S1/Sv * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:110742
|
| abnormal thrombopoiesis
|
J:110742
|
| thrombocytopenia
|
J:110742
|
Il6sttm1b(KOMP)Mbp/Il6st+
(C57BL/6N-Il6sttm1b(KOMP)Mbp/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Il6sttm1Ern/Il6sttm1Ern
(involves: 129S1/Sv)
|
increased neutrophil cell number
|
J:168781
|
Il6sttm1Kish/Il6sttm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:75419
|
| increased nucleated erythrocyte cell number
|
J:75419
|
Il6sttm1Thir/Il6sttm1Thir
(involves: 129 * C57BL/6)
|
abnormal T cell clonal deletion
|
J:133059
|
| decreased double-positive T cell number
|
J:133059
|
| increased double-negative T cell number
|
J:133059
|
| increased neutrophil cell number
|
J:133059
|
Il6sttm1Thir/Il6sttm1Thir
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129 * C57BL/6 * DBA)
|
abnormal negative T cell selection
|
J:133059
|
Il6sttm1Wme/Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythropoiesis
|
J:67677
|
| abnormal T cell differentiation
|
J:67677
|
| abnormal thrombopoiesis
|
J:67677
|
Il7tm1.1Mysl/Il7tm1.1Mysl
(B6.129P2(Cg)-Il7tm1.1Mysl)
|
arrested B cell differentiation
|
J:200544
|
Il7tm1Dnax/Il7tm1Dnax
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:24165
|
Il7tm2.1Iku/Il7tm2.1Iku
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * DBA)
|
abnormal B cell differentiation
|
J:190615
|
| decreased double-negative T cell number
|
J:190615
|
Il7rtm1Abra/Il7rtm1Abra
(B6.129S4-Il7rtm1Abra)
|
abnormal T cell differentiation
|
J:125360
|
| increased double-positive T cell number
|
J:125360
|
Il7rtm1Iku/Il7rtm1Iku
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:34658
|
| abnormal gamma-delta T cell differentiation
|
J:34658
|
| decreased double-positive T cell number
|
J:34658
|
| decreased immature B cell number
|
J:34658
|
| increased double-negative T cell number
|
J:34658
|
Il7rtm1Imx/Il7rtm1Imx
(involves: 129P3/J * 129S7/SvEvBrd)
|
arrested B cell differentiation
|
J:21135
|
| arrested T cell differentiation
|
J:21135
|
Il7rtm1Imx/Il7rtm1Imx
(B6.129S7-Il7rtm1Imx)
|
abnormal T cell differentiation
|
J:125360
|
| decreased double-positive T cell number
|
J:125360
|
Il7rtm2Iku/Il7rtm2Iku
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:193283
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:193283
|
Il9tm1Anjm/Il9tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal mast cell morphology
|
J:82881
|
Il10tm1Cgn/Il10tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelopoiesis
|
J:15222
|
| decreased erythrocyte cell number
|
J:15222
|
| decreased hemoglobin content
|
J:15222
|
| increased granulocyte number
|
J:35020,
J:15222
|
Il10tm1Cgn/Il10tm1Cgn
Il4tm1Cgn/Il4tm1Cgn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:111712
|
Il10tm1Cgn/Il10tm1Cgn
Il12btm1Jm/Il12btm1Jm
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:111712
|
Il10tm1Cgn/Il10tm1Cgn
Vdrtm1Mbd/Vdrtm1Mbd
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
increased neutrophil cell number
|
J:107077
|
Il10ratm1b(KOMP)Wtsi/Il10ratm1b(KOMP)Wtsi
(C57BL/6N-Il10ratm1b(KOMP)Wtsi/Orl)
|
increased neutrophil cell number
|
J:211773
|
Il10rbtm1Agt/Il10rbtm1Agt
(involves: 129S2/SvPas * C57BL/6)
|
abnormal granulocyte differentiation
|
J:45917
|
| decreased hemoglobin content
|
J:45917
|
| extramedullary hematopoiesis
|
J:45917
|
Il11ra1tm1Gos/Il11ra1tm1Gos
(involves: 129S2/SvPas * C57BL/6J * CD-1)
|
abnormal NK cell differentiation
|
J:93811
|
Il12rb1tm1b(KOMP)Wtsi/Il12rb1tm1b(KOMP)Wtsi
(C57BL/6N-Il12rb1tm1b(KOMP)Wtsi/Bay)
|
decreased hemoglobin content
|
J:211773
|
Il13tm1(YFP/cre)Lky/Il13+
Il4tm1(CD2)Mmrs/Il4+
Gt(ROSA)26Sortm1(DTA)Lky/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
decreased eosinophil cell number
|
J:178986
|
Il13tm1.1Anjm/Il13tm1.1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
Il13tm1.1Anjm/Il13tm1.1Anjm
(C.129P2-Il13tm1.1Anjm)
|
abnormal dendritic cell differentiation
|
J:141937
|
Il13tm1Anjm/Il13tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased eosinophil cell number
|
J:82881
|
Il13tm2Anjm/Il13tm2Anjm
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:67965
|
Il13tm3.1Anjm/Il13+
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased eosinophil cell number
|
J:159464
|
Il13tm3.1Anjm/Il13+
Il17rbtm1Anjm/Il17rbtm1Anjm
(involves: BALB/c * C57BL/6)
|
decreased eosinophil cell number
|
J:159464
|
Il13tm3.1Anjm/Il13+
Il17rbtm1Anjm/Il17rbtm1Anjm
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased eosinophil cell number
|
J:159464
|
Il13ra1tm1Twy/Y
(C.Cg-Il13ra1tm1Twy)
|
increased eosinophil cell number
|
J:130488
|
Il13ra1tm1Zagh/Il13ra1tm1Zagh
(involves: BALB/c * C57BL/6)
|
impaired myelopoiesis
|
J:183111
|
Il15tm1Imx/Il15tm1Imx
(C57BL/6-Il15tm1Imx/Tac)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
Il15ratm1Ama/Il15ratm2.1Ama
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
abnormal NK cell differentiation
|
J:155298
|
Il15ratm1Ama/Il15ratm2.1Ama
Tg(Itgax-cre)1-1Reiz/0
(involves: 129X1/SvJ * C57BL/6J * CBA)
|
abnormal NK cell differentiation
|
J:155298
|
Il17atm1Yiw/Il17atm1Yiw
(involves: 129P2/OlaHsd)
|
decreased neutrophil cell number
|
J:193548
|
Il17bem1Cya/Il17bem1Cya
(C57BL/6-Il17bem1Cya)
|
increased neutrophil cell number
|
J:339366
|
Il17bGt(371C12)Cmhd/Il17bGt(371C12)Cmhd
(B6.129-Il17bGt(371C12)Cmhd)
|
increased eosinophil cell number
|
J:229778
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129 * C57BL/6)
|
abnormal granulocyte differentiation
|
J:71097
|
| decreased neutrophil cell number
|
J:71097
|
Il17ratm1Koll/Il17ratm1Koll
(involves: 129)
|
abnormal T-helper 2 cell differentiation
|
J:158594
|
Il17rbtm1Anjm/Il17rbtm1Anjm
(BALB/c-Il17rbtm1Anjm)
|
decreased eosinophil cell number
|
J:159464
|
Il17rbtm1Anjm/Il17rbtm1Anjm
Il1rl1tm1Anjm/Il1rl1tm1Anjm
(involves: 129P2/OlaHsd * BALB/c)
|
decreased eosinophil cell number
|
J:159464
|
Il18tm1Aki/Il18tm1Aki
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neutrophil cell number
|
J:191055
|
Il18bptm1(KOMP)Vlcg/Il18bptm1(KOMP)Vlcg
(C57BL/6-Il18bptm1(KOMP)Vlcg)
|
abnormal NK cell differentiation
|
J:255309
|
Il18rapem1(IMPC)Wtsi/Il18rapem1(IMPC)Wtsi
(C57BL/6N-Il18rapem1(IMPC)Wtsi/WtsiCnrm)
|
decreased mean platelet volume
|
J:211773
|
Il20ratm1.1(KOMP)Vlcg/Il20ratm1.1(KOMP)Vlcg
(C57BL/6N-Il20ratm1.1(KOMP)Vlcg/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Il21tm1Lex/Il21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal T cell differentiation
|
J:123351
|
Il21tm1Llit/Il21tm1Llit
(involves: 129 * C57BL/6J)
|
abnormal class switch recombination
|
J:114783
|
Il21rtm1Day/Il21rtm1Day
(involves: BALB/c * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955,
J:123352
|
Il21rtm1Kopf/Il21rtm1Kopf
(B6.129-Il21rtm1Kopf)
|
decreased basophil cell number
|
J:137508
|
| decreased eosinophil cell number
|
J:137508
|
| decreased granulocyte number
|
J:137508
|
Il21rtm1Wjl/Il21rtm1Wjl
(NOD.Cg-Il21rtm1Wjl)
|
abnormal CD4-positive T cell differentiation
|
J:139075
|
Il22tm1.1Lex/Il22tm1.1Lex
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca)
|
increased erythrocyte cell number
|
J:305794
|
Il22tm1.1Lex/Il22tm1.1Lex
Riok2tm1c(KOMP)Wtsi/Riok2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S5/SvEvBrd * C57BL/6N * C57BL/10 * CBA/Ca)
|
increased erythrocyte cell number
|
J:305794
|
Il22tm1Jcrd/Il22tm1Jcrd
(Not Specified)
|
decreased neutrophil cell number
|
J:193548
|
Il22ra1tm1.1Koll/Il22ra1tm1.1Koll
Eportm1.1(EGFP/icre)Uk/Epor+
(involves: BALB/cJ * C57BL/6)
|
increased erythrocyte cell number
|
J:305794
|
| increased hematocrit
|
J:305794
|
Il23atm1Dnax/Il23atm1Dnax
(Not Specified)
|
decreased neutrophil cell number
|
J:193548
|
Il23rtm1Kuch/Il23rtm1Kuch
(C57BL/6-Il23rtm1Kuch)
|
abnormal CD4-positive T cell differentiation
|
J:148248
|
Il24tm1.1(KOMP)Vlcg/Il24tm1.1(KOMP)Vlcg
(C57BL/6N-Il24tm1.1(KOMP)Vlcg/J)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Il25tm1.1Cdon/Il25tm1.1Cdon
(involves: 129S6/SvEvTac)
|
decreased eosinophil cell number
|
J:229778
|
Il25tm1Anjm/Il25tm1Anjm
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased eosinophil cell number
|
J:123748
|
Il27tm1Cua/Il27tm1Cua
(C57BL/6-Il27tm1Cua)
|
abnormal CD4-positive T cell differentiation
|
J:147706
|
Il31ratm1Ngh/Il31ratm1Ngh
(C57BL/6-Il31ratm1Ngh)
|
abnormal common myeloid progenitor cell morphology
|
J:123111
|
Il33tm1Aki/Il33tm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
decreased eosinophil cell number
|
J:182160
|
Il36rntm1Kopf/Il36rntm1Kopf
(B6.129S5-Il36rntm1Kopf)
|
increased neutrophil cell number
|
J:193548
|
Immp2lTg(HLA-A/H2-D)2Enge/?
((C57BL/6 x CBA)F1)
|
abnormal negative T cell selection
|
J:31937
|
| abnormal positive T cell selection
|
J:31937
|
Impdh1tm1Bmi/Impdh1tm1Bmi
Impdh2tm1Bmi/Impdh2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:85443
|
In(7Oca2;7Sox6)100H/In(7Oca2;7Sox6)100H
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:115753
|
| increased nucleated erythrocyte cell number
|
J:115753
|
Inca1tm1Cmt/Inca1tm1Cmt
(involves: 129 * C57BL/6N)
|
extramedullary hematopoiesis
|
J:175667
|
Inf2tm1.1(KOMP)Vlcg/Inf2tm1.1(KOMP)Vlcg
(C57BL/6N-Inf2tm1.1(KOMP)Vlcg/Ucd)
|
decreased hematocrit
|
J:211773
|
Ing2tm1.1(KOMP)Vlcg/Ing2+
(C57BL/6N-Ing2tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular volume
|
J:211773
|
Ing4em1(IMPC)Tcp/Ing4em1(IMPC)Tcp
(C57BL/6NCrl-Ing4em2(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Ing5tm1.1Ttho/Ing5tm1.1Ttho
(B6.Cg-Ing5tm1.1Ttho)
|
decreased fetal derived definitive erythrocyte cell number
|
J:345308
|
Inhbatm1Zuk/Inhbatm2Zuk
(involves: 129S7/SvEvBrd)
|
decreased hematocrit
|
J:63882
|
Inhbatm2Zuk/Inhbatm2Zuk
(involves: 129S7/SvEvBrd)
|
decreased hematocrit
|
J:63882
|
Inhbbtm1b(EUCOMM)Hmgu/Inhbbtm1b(EUCOMM)Hmgu
(C57BL/6N-Inhbbtm1b(EUCOMM)Hmgu/Bay)
|
decreased erythrocyte cell number
|
J:211773
|
Inpp5del20/Inpp5del20
(B6.129-Inpp5del20)
|
abnormal erythropoiesis
|
J:173266
|
| thrombocytopenia
|
J:173266
|
Inpp5dm1Btlr/Inpp5dm1Btlr
(C57BL/6J-Inpp5dm1Btlr)
|
abnormal B cell differentiation
|
J:140987
|
Inpp5dm5Btlr/Inpp5dm5Btlr
(C57BL/6J-Inpp5dm5Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272856
|
| abnormal T cell differentiation
|
J:272856
|
Inpp5dtm1.1Wgk/Inpp5dtm1.1Wgk
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal mononuclear cell differentiation
|
J:94861
|
Inpp5dtm1Dmt/Inpp5dtm1Dmt
(B6.129P2/OlaHsd-Inpp5dtm1Dmt)
|
thrombocytopenia
|
J:173266
|
Inpp5dtm1Rav/Inpp5dtm1Rav
Cd79atm1(cre)Reth/Cd79a+
Tg(IghAb36-65)1Wys/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
abnormal B cell negative selection
|
J:178833
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:48193
|
| abnormal granulocyte differentiation
|
J:48193
|
| abnormal lymphopoiesis
|
J:48193
|
| abnormal monocyte differentiation
|
J:48193
|
| increased neutrophil cell number
|
J:48193
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myelopoiesis
|
J:117320
|
| decreased pro-B cell number
|
J:117320
|
Inpp5dtm1Rkh/Inpp5dtm1Rkh
Rag1tm1(GFP)Imku/Rag1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:117320
|
Inpp5kem1(IMPC)H/Inpp5k+
(C57BL/6NTac-Inpp5kem1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Ins2Akita/Ins2+
Prf1tm1Sdz/Prf1tm1Sdz
Rag1tm1Mom/Rag1tm1Mom
(NOD.Cg-Rag1tm1Mom Ins2Akita Prf1tm1Sdz)
|
increased erythrocyte cell number
|
J:138005
|
| increased granulocyte number
|
J:138005
|
Insig1em1(IMPC)Ccpcz/Insig1em1(IMPC)Ccpcz
(C57BL/6N-Insig1em1(IMPC)Ccpcz/Ccpcz)
|
increased mean corpuscular hemoglobin
|
J:211773
|
InsrRgsc824/Insr+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased glycosylated hemoglobin level
|
J:133634
|
Ints3em1(IMPC)J/Ints3+
(C57BL/6NJ-Ints3em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Ints8em1(IMPC)Tcp/Ints8+
(C57BL/6NCrl-Ints8em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ints9tm1b(KOMP)Wtsi/Ints9+
(C57BL/6N-Ints9tm1b(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ints12tm1b(EUCOMM)Wtsi/Ints12+
(C57BL/6N-Ints12tm1b(EUCOMM)Wtsi/H)
|
decreased red blood cell distribution width
|
J:211773
|
Ipo8tm1.1(KOMP)Vlcg/Ipo8+
(C57BL/6N-Ipo8tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Iqcetm1b(EUCOMM)Hmgu/Iqcetm1b(EUCOMM)Hmgu
(C57BL/6N-Iqcetm1b(EUCOMM)Hmgu/Ics)
|
increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Iqcjem1(IMPC)J/Iqcjem1(IMPC)J
(C57BL/6NJ-Iqcjem1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Irag1em1(IMPC)Ccpcz/Irag1em1(IMPC)Ccpcz
(C57BL/6NCrl-Irag1em1(IMPC)Ccpcz/Ccpcz)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Irak3tm1Flv/Irak3tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
increased neutrophil cell number
|
J:78189
|
Irak3tm1Flv/Irak3tm1Flv
(NOD.129S1(B6)-Irak3tm1Flv)
|
abnormal T cell differentiation
|
J:229884
|
Ireb2tm1.1Eal/Ireb2tm1.1Eal
(B6J.129-Ireb2tm1.1Eal)
|
decreased hematocrit
|
J:217335
|
| decreased hemoglobin content
|
J:217335
|
| decreased mean corpuscular hemoglobin
|
J:217335
|
| decreased mean corpuscular hemoglobin concentration
|
J:217335
|
| decreased mean corpuscular volume
|
J:217335
|
| decreased mean platelet volume
|
J:217335
|
| increased red blood cell distribution width
|
J:217335
|
| thrombocytopenia
|
J:217335
|
Ireb2tm1.2Mwh/Ireb2tm1.2Mwh
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * SJL)
|
abnormal erythrocyte morphology
|
J:103414
|
| decreased erythrocyte cell number
|
J:103414
|
| decreased hematocrit
|
J:103414
|
| decreased hemoglobin content
|
J:103414
|
| microcytosis
|
J:103414
|
Ireb2tm1Mwh/Ireb2tm1Mwh
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:105124
|
| decreased hematocrit
|
J:105124
|
| decreased hemoglobin content
|
J:105124
|
| decreased mean corpuscular volume
|
J:105124
|
| microcytosis
|
J:105124
|
Ireb2tm1Roua/Ireb2tm1Roua
(B6.Cg-Ireb2tm1Roua)
|
decreased hematocrit
|
J:176655
|
| decreased hemoglobin content
|
J:176655
|
| decreased mean corpuscular hemoglobin
|
J:176655
|
| decreased mean corpuscular hemoglobin concentration
|
J:176655
|
| decreased mean corpuscular volume
|
J:176655
|
| microcytosis
|
J:176655
|
Irf1tm1Mak/Irf1tm1Mak
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2))
|
increased double-positive T cell number
|
J:64286
|
Irf2bp2Gt(IST11591C1)Tigm/Irf2bp2Gt(IST11591C1)Tigm
(involves: C57BL/6 * C57BL/6N * FVB/N)
|
abnormal embryonic erythropoiesis
|
J:228010
|
| decreased erythrocyte cell number
|
J:228010
|
Irf4em1(IMPC)Mbp/Irf4em1(IMPC)Mbp
(C57BL/6N-Irf4em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Irf4m1Btlr/Irf4m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Irf4tm1.1Rdf/Irf4tm1.1Rdf
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal B cell differentiation
|
J:112643
|
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:42683
|
| arrested B cell differentiation
|
J:42683
|
Irf4tm1Mak/Irf4tm1Mak
(B6.129P2-Irf4tm1Mak)
|
abnormal T-helper 1 cell differentiation
|
J:78909
|
Irf8M1Btlr/Irf8M1Btlr
(C57BL/6J-Irf8M1Btlr)
|
increased neutrophil cell number
|
J:166600
|
Irf8myls/Irf8+
(involves: BXH2/TyJ * C57BL/6)
|
increased transitional stage B cell number
|
J:168923
|
Irf8myls/Irf8myls
(involves: BALB/cJ * BXH2/TyJ-Irf8myls)
|
abnormal myelopoiesis
|
J:97931
|
Irf8myls/Irf8myls
Slc11a1r/Slc11a1r
(BXH2/TyJ)
|
abnormal myelopoiesis
|
J:97931
|
Irf8tm1b(KOMP)Wtsi/Irf8tm1b(KOMP)Wtsi
(C57BL/6N-Irf8tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Irf8tm1Hor/Irf8+
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal definitive hematopoiesis
|
J:36038
|
Irf8tm1Hor/Irf8tm1Hor
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal erythropoiesis
|
J:36038
|
| increased granulocyte number
|
J:36038
|
Irf8tm1Hor/Irf8tm1Hor
Irf4tm1Mak/Irf4tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84577
|
| arrested B cell differentiation
|
J:84577
|
Irgm1em1(IMPC)Wtsi/Irgm1em1(IMPC)Wtsi
(C57BL/6N-Irgm1em1(IMPC)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Irs1em1(IMPC)H/Irs1+
(C57BL/6NTac-Irs1em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Is(14)1Rdf Is(14)5Rdf/Del(14Trim13-Rnaseh2b)6Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
Is(14)1Rdf/Is(14)1Rdf
Is(14)5Rdf/Is(14)5Rdf
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6)
|
abnormal lymphopoiesis
|
J:179879
|
Itchtm1(NCOM)Cmhd/Itch+
(C57BL/6N-Itchtm1(NCOM)Cmhd/Tcp)
|
increased mean corpuscular volume
|
J:165965
|
Itchtm1.1Alta/Itchtm1.1Alta
Foxp3tm4(YFP/icre)Ayr/Foxp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal lymphopoiesis
|
J:204685
|
| abnormal T-helper 2 cell differentiation
|
J:204685
|
| increased eosinophil cell number
|
J:204685
|
Itfg2em1(IMPC)J/Itfg2+
(C57BL/6NJ-Itfg2em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Itga2tm1.1Tkun/Itga2tm1.1Tkun
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6 * SJL)
|
decreased mean platelet volume
|
J:195799
|
Itga2btm1(GFP/cre)Emam/Itga2btm1(GFP/cre)Emam
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:84564
|
| abnormal embryonic hematopoiesis
|
J:84564
|
| thrombocytopenia
|
J:84564
|
Itga2btm1Graf/Itga2b+
(B6.Cg-Itga2btm1Graf)
|
thrombocytopenia
|
J:123159
|
Itga2btm1Tlr/Itga2btm1Tlr
(either: (involves: 129S1/Sv * 129X1/SvJ * BALB/c) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal platelet alpha-granule morphology
|
J:63961
|
| decreased erythrocyte cell number
|
J:63961
|
Itga4tm1Tpa/Itga4tm1Tpa
Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:86861
|
| abnormal definitive hematopoiesis
|
J:86861
|
Itga8tm1b(KOMP)Wtsi/Itga8+
(C57BL/6N-Itga8tm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Itgaetm1b(EUCOMM)Wtsi/Itgaetm1b(EUCOMM)Wtsi
(C57BL/6N-Itgaetm1b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
Itgaltm1Bll/Itgaltm1Bll
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased eosinophil cell number
|
J:83226
|
| increased neutrophil cell number
|
J:83226
|
Itgaltm1Bll/Itgaltm1Bll
(B6.129S7-Itgaltm1Bll)
|
increased neutrophil cell number
|
J:100242
|
Itgaltm1Hlz/Itgaltm1Hlz
(involves: 129P2/OlaHsd)
|
decreased neutrophil cell number
|
J:99286
|
Itgaltm1Mak/Itgaltm1Mak
(B6.129P2-Itgaltm1Mak)
|
thrombocytopenia
|
J:123460
|
Itgamem1(IMPC)Wtsi/Itgamem1(IMPC)Wtsi
(C57BL/6N-Itgamem1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Itgamm1Btlr/Itgam+
(C57BL/6J-Itgamm1Btlr)
|
decreased neutrophil cell number
|
J:236681
|
Itgamm1Btlr/Itgamm1Btlr
(C57BL/6J-Itgamm1Btlr)
|
decreased neutrophil cell number
|
J:236681
|
Itgamtm1Bll/Itgamtm1Bll
(B6.129S7-Itgamtm1Bll)
|
increased neutrophil cell number
|
J:100242
|
Itgamtm1Bll/Itgamtm1Bll
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased eosinophil cell number
|
J:83226
|
Itgamtm1Myd/Itgamtm1Myd
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
increased eosinophil cell number
|
J:38052
|
| increased neutrophil cell number
|
J:38052
|
Itgamtm1Myd/Itgamtm1Myd
(involves: 129S4/SvJae * C57BL/6)
|
decreased neutrophil cell number
|
J:103873
|
Itgamtm1Myd/Itgamtm1Myd
(B6.129S4-Itgamtm1Myd)
|
abnormal neutrophil morphology
|
J:113463
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Tek-cre)1Ywa/?
(involves: 129S2/SvPas * C57BL/6 * FVB * SJL)
|
abnormal dendritic cell differentiation
|
J:125508
|
Itgb1tm1Ref/Itgb1tm1Ref
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased platelet calcium level
|
J:118488
|
Itgb1tm1Ross/Itgb1tm1Ross
Tg(Hoxb7-cre)13Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased hematocrit
|
J:149831
|
Itgb2M1Btlr/Itgb2M1Btlr
(C57BL/6J-Itgb2M1Btlr)
|
abnormal NK cell differentiation
|
J:139559
|
Itgb2m3Btlr/Itgb2m3Btlr
(C57BL/6J-Itgb2m3Btlr)
|
decreased neutrophil cell number
|
J:265126
|
Itgb2M4Btlr/Itgb2M4Btlr
(C57BL/6J-Itgb2M4Btlr)
|
abnormal T cell differentiation
|
J:272843
|
Itgb2tm1.1Arte/Itgb2tm1.1Arte
(involves: C57BL/6NTac)
|
increased neutrophil cell number
|
J:202261
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd)
|
increased granulocyte number
|
J:13599
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * PL/J)
|
increased basophil cell number
|
J:32126
|
| increased eosinophil cell number
|
J:32126
|
| increased neutrophil cell number
|
J:32126
|
| myeloid hyperplasia
|
J:32126
|
| thrombocytosis
|
J:32126
|
Itgb2tm1Bay/Itgb2tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myeloid hyperplasia
|
J:13599
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal neutrophil morphology
|
J:48542
|
| increased neutrophil cell number
|
J:48542
|
| myeloid hyperplasia
|
J:48542
|
Itgb2tm2Bay/Itgb2tm2Bay
(B6.129S7-Itgb2tm2Bay)
|
increased eosinophil cell number
|
J:83226
|
| increased neutrophil cell number
|
J:83226
|
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:112286
|
Itgb3tm1Hyn/Itgb3tm1.1Wlbcr
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S2/SvPas * C57BL/6)
|
decreased hemoglobin content
|
J:224675
|
Itgb3tm1Hyn/Itgb3tm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
decreased erythrocyte cell number
|
J:52262
|
| decreased hematocrit
|
J:52262
|
| decreased hemoglobin content
|
J:52262
|
| extramedullary hematopoiesis
|
J:52262
|
Itgb3tm1Mgin/Itgb3tm1Mgin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased erythrocyte cell number
|
J:123968
|
| decreased hematocrit
|
J:123968
|
| decreased hemoglobin content
|
J:123968
|
| increased mean corpuscular hemoglobin
|
J:123968
|
| increased mean corpuscular volume
|
J:123968
|
Itgb3tm2Mgin/Itgb3tm2Mgin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
decreased erythrocyte cell number
|
J:123968
|
| increased mean corpuscular hemoglobin
|
J:123968
|
Itgb3bpem1(IMPC)J/Itgb3bpem1(IMPC)J
(C57BL/6NJ-Itgb3bpem1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Itgb5tm1a(EUCOMM)Wtsi/Itgb5tm1a(EUCOMM)Wtsi
(C57BL/6N-Itgb5tm1a(EUCOMM)Wtsi/Ics)
|
increased hematocrit
|
J:165965
|
Itgb7tm1Cgn/Itgb7tm1Cgn
(involves: C57BL/6)
|
decreased eosinophil cell number
|
J:62733
|
| decreased mast cell number
|
J:62733
|
Itktm1Litt/Itktm1Litt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111786
|
Itktm1Litt/Itktm1Litt
(B6.129S4-Itktm1Litt)
|
abnormal positive T cell selection
|
J:141390
|
| increased double-negative T cell number
|
J:141390
|
Itktm1Litt/Itktm1Litt
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:31230
|
| increased double-positive T cell number
|
J:31230
|
Itktm1Litt/Itktm1Litt
Tg(TcrAND)53Hed/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
increased double-negative T cell number
|
J:31230
|
Itktm1Litt/Itktm1Litt
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Itktm1Litt Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141390
|
| abnormal positive T cell selection
|
J:141390
|
| decreased double-positive T cell number
|
J:141390
|
Itktm1Ljb/Itktm1Ljb
(B10.129-Itktm1Ljb)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:113408
|
Itktm1Ljb/Itktm1Ljb
Rag1tm1Mom/Rag1tm1Mom
Tg(Tcra5CC7,Tcrb5CC7)IWep/?
(involves: 129 * C57BL/10)
|
abnormal CD4-positive T cell differentiation
|
J:93606
|
Itpatm1Skmi/Itpatm1Skmi
(involves: 129S/SvEv * C57BL/6J)
|
extramedullary hematopoiesis
|
J:169285
|
ItpkbT-less/ItpkbT-less
(C57BL/6-ItpkbT-less)
|
arrested T cell differentiation
|
J:89286
|
Itpkbtm1Ssch/Itpkbtm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
arrested T cell differentiation
|
J:86257
|
| increased double-positive T cell number
|
J:86257
|
Itpkbtm1Ssch/Itpkbtm1Ssch
Itpkctm1Ssch/Itpkctm1Ssch
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
arrested T cell differentiation
|
J:86257
|
Izumo1rtm2a(KOMP)Wtsi/Izumo1rtm2a(KOMP)Wtsi
(C57BL/6N-Izumo1rtm2a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Jag2tm1Grid/Jag2tm1Grid
(involves: 129S1/Sv * C57BL/6J)
|
abnormal gamma-delta T cell differentiation
|
J:46930
|
Jagn1tm1c(EUCOMM)Hmgu/Jagn1tm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal neutrophil morphology
|
J:214828
|
Jak1M1Mhda/Jak1+
(C3HeB/FeJ-Jak1M1Mhda)
|
anisocytosis
|
J:199153
|
| decreased cellular hemoglobin content
|
J:199153
|
| decreased mean corpuscular volume
|
J:199153
|
| decreased mean platelet volume
|
J:199153
|
| increased erythrocyte cell number
|
J:199153
|
| thrombocytopenia
|
J:199153
|
Jak1tm1Rds/Jak1tm1Rds
(involves: 129)
|
abnormal B cell differentiation
|
J:47300
|
| abnormal lymphopoiesis
|
J:47300
|
| abnormal T cell differentiation
|
J:47300
|
| arrested B cell differentiation
|
J:47300
|
| increased double-negative T cell number
|
J:47300
|
Jak2m1Dlbr/Jak2+
(involves: 129S1/SvImJ * C57BL/6J)
|
decreased erythrocyte cell number
|
J:207740
|
| thrombocytosis
|
J:207740
|
Jak2tm1(JAK2)Argr/Jak2+
Dppa3tm1(cre)Peli/Dppa3+
(involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
thrombocytosis
|
J:233169
|
Jak2tm1(JAK2)Argr/Jak2+
Tg(Mx1-cre)1Cgn/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:164539
|
| abnormal erythropoiesis
|
J:164539
|
| increased erythrocyte cell number
|
J:164539
|
| increased hematocrit
|
J:164539
|
| increased hemoglobin content
|
J:164539
|
| thrombocytosis
|
J:164539
|
Jak2tm1.1Ble/Jak2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal erythrocyte morphology
|
J:257910
|
| extramedullary hematopoiesis
|
J:257910
|
| increased erythrocyte cell number
|
J:257910
|
| increased granulocyte number
|
J:257910
|
| increased neutrophil cell number
|
J:257910
|
| thrombocytosis
|
J:257910
|
Jak2tm1.1Jlvl/Jak2tm1.1Jlvl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:163497
|
| abnormal erythrocyte morphology
|
J:163497
|
| anisocytosis
|
J:163497
|
| decreased mean corpuscular volume
|
J:163497
|
| extramedullary hematopoiesis
|
J:163497
|
| giant platelets
|
J:163497
|
| increased erythrocyte cell number
|
J:163497
|
| increased granulocyte number
|
J:163497
|
| increased hematocrit
|
J:163497
|
| increased mean platelet volume
|
J:163497
|
| microcytosis
|
J:163497
|
| poikilocytosis
|
J:163497
|
| polychromatophilia
|
J:163497
|
| thrombocytosis
|
J:163497
|
Jak2tm1.1Kuw/Jak2tm1.1Kuw
(involves: 129X1/SvJ)
|
abnormal erythropoiesis
|
J:90883
|
Jak2tm1.2Ble/Jak2+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal definitive hematopoiesis
|
J:160883
|
| abnormal erythropoiesis
|
J:160883
|
| extramedullary hematopoiesis
|
J:160883
|
| increased hematocrit
|
J:160883
|
Jak2tm1.2Ble/Jak2+
Picalmtm1.1Tmae/Picalm+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased mean corpuscular hemoglobin
|
J:220728
|
| decreased mean corpuscular volume
|
J:220728
|
| increased erythrocyte cell number
|
J:220728
|
| increased hematocrit
|
J:220728
|
| increased hemoglobin content
|
J:220728
|
| thrombocytosis
|
J:220728
|
Jak2tm1.2Ble/Jak2+
Picalmtm1.1Tmae/Picalmtm1.1Tmae
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased erythrocyte cell number
|
J:220728
|
| decreased hematocrit
|
J:220728
|
| decreased hemoglobin content
|
J:220728
|
| decreased mean corpuscular hemoglobin
|
J:220728
|
| decreased mean corpuscular volume
|
J:220728
|
Jak2tm1Jni/Jak2+
(involves: 129P2/OlaHsd)
|
decreased erythrocyte cell number
|
J:207740
|
| thrombocytosis
|
J:207740
|
Jak2tm1Jni/Jak2tm1Jni
(involves: 129P2/OlaHsd)
|
abnormal erythropoiesis
|
J:47299
|
| extramedullary hematopoiesis
|
J:47299
|
Jak2tm1Kf/Jak2tm1Kf
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythropoiesis
|
J:112700
|
Jak2tm1Kpf/Jak2tm1Kpf
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CD-1))
|
absent common myeloid progenitor cells
|
J:47298
|
Jak2tm1Mohi/Jak2+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:183821
|
| increased erythrocyte cell number
|
J:183821
|
| increased hematocrit
|
J:183821
|
| increased hemoglobin content
|
J:183821
|
| increased neutrophil cell number
|
J:183821
|
| microcytosis
|
J:183821
|
| myeloid hyperplasia
|
J:183821
|
| polycythemia
|
J:183821
|
| thrombocytosis
|
J:183821
|
Jak2tm1Mohi/Jak2tm1Mohi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:183821
|
| increased erythrocyte cell number
|
J:183821
|
| increased hematocrit
|
J:183821
|
| increased hemoglobin content
|
J:183821
|
| increased neutrophil cell number
|
J:183821
|
| microcytosis
|
J:183821
|
| myeloid hyperplasia
|
J:183821
|
| polycythemia
|
J:183821
|
| thrombocytosis
|
J:183821
|
Jak2tm2.1Jlvl/Jak2+
Tg(Vav1-cre)#Cgp/0
(involves: 129S2/SvPas * C57BL/6NTac)
|
abnormal definitive hematopoiesis
|
J:202234
|
| abnormal myelopoiesis
|
J:202234
|
| extramedullary hematopoiesis
|
J:202234
|
| increased erythrocyte cell number
|
J:202234
|
| increased granulocyte number
|
J:202234
|
| increased hematocrit
|
J:202234
|
| increased hemoglobin content
|
J:202234
|
| microcytosis
|
J:202234
|
| myeloid hyperplasia
|
J:202234
|
| thrombocytosis
|
J:202234
|
Jak2tm2.1Kpf/Jak2tm2.1Kpf
(involves: 129P2/OlaHsd)
|
abnormal embryonic erythropoiesis
|
J:207710
|
Jak2tm2.2Jlvl/Jak2+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * SJL)
|
polycythemia
|
J:202234
|
| thrombocytosis
|
J:202234
|
Jak3bfy/Jak3bfy
(C57BL/6JSfdAnu-Jak3bfy/AnuApb)
|
abnormal lymphopoiesis
|
J:104190
|
Jak3m1Btlr/Jak3m1Btlr
(C57BL/6J-Jak3m1Btlr)
|
increased neutrophil cell number
|
J:217795
|
Jak3m3Btlr/Jak3m3Btlr
(C57BL/6J-Jak3m3Btlr)
|
decreased immature B cell number
|
J:225935
|
Jak3M7Btlr/Jak3M7Btlr
(C57BL/6J-Jak3M7Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272401
|
Jak3tm1Flv/Jak3tm1Flv
(involves: 129S1/Sv)
|
arrested B cell differentiation
|
J:95794
|
Jak3tm1Jni/Jak3tm1Jni
Crlf2tm1Jni/Crlf2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:89031
|
Jak3tm1Ljb/Jak3+
(involves: 129S4/SvJae)
|
increased neutrophil cell number
|
J:56629
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:29722
|
| decreased immature B cell number
|
J:29722
|
Jak3tm1Ljb/Jak3tm1Ljb
(involves: 129S4/SvJae)
|
abnormal erythropoiesis
|
J:56629
|
| abnormal myelopoiesis
|
J:56629
|
| abnormal T cell differentiation
|
J:64861
|
| increased neutrophil cell number
|
J:56629
|
Jak3tm1Ljb/Jak3tm1Ljb
(B6;129S4-Jak3tm1Ljb/J)
|
abnormal dendritic cell differentiation
|
J:123902
|
Jak3tm1Tks/Jak3tm1Tks
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:31231
|
| abnormal lymphopoiesis
|
J:31231
|
Jak3wil/Jak3wil
(C57BL/6JSfdAnu-Jak3wil/Anu)
|
arrested B cell differentiation
|
J:104190
|
Jam3tm1Lex/Jam3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased neutrophil cell number
|
J:145994
|
| increased common myeloid progenitor cell number
|
J:145994
|
| increased granulocyte number
|
J:145994
|
Jam3tm1Rha/Jam3tm1Rha
(involves: 129P2/OlaHsd * C57BL/6)
|
increased granulocyte number
|
J:121841
|
Jarid2jumonji/Jarid2jumonji
(C.129P2-Jarid2jumonji)
|
abnormal definitive hematopoiesis
|
J:51843
|
| abnormal erythropoiesis
|
J:51843
|
| decreased fetal derived definitive erythrocyte cell number
|
J:51843
|
Jmjd4em1(IMPC)Wtsi/Jmjd4em1(IMPC)Wtsi
(C57BL/6N-Jmjd4em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Jmjd6tm1b(EUCOMM)Wtsi/Jmjd6+
(C57BL/6N-Jmjd6tm1b(EUCOMM)Wtsi/Ieg)
|
decreased mean platelet volume
|
J:211773
|
Jmjd6tm1Gbf/Jmjd6tm1Gbf
(C57BL/6-Ptdsrtm1Gbf)
|
abnormal erythropoiesis
|
J:98905
|
Juntm1Wag/Juntm1Wag
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))
|
increased nucleated erythrocyte cell number
|
J:14538
|
Juptm1.1(KOMP)Vlcg/Jup+
(C57BL/6N-Juptm1.1(KOMP)Vlcg/J)
|
increased hemoglobin content
|
J:211773
|
Kat2bem1(IMPC)Wtsi/Kat2bem1(IMPC)Wtsi
(C57BL/6N-Kat2bem1(IMPC)Wtsi/WtsiIeg)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Kat6atm1.1Glac/Kat6atm1.1Glac
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:148955
|
| decreased common myeloid progenitor cell number
|
J:148955
|
| decreased immature B cell number
|
J:148955
|
| decreased pro-B cell number
|
J:148955
|
Kat6atm1Avo/Kat6a+
(involves: 129 * BALB/c * FVB/N)
|
abnormal definitive hematopoiesis
|
J:108453
|
Kat6atm1Avo/Kat6atm1Avo
(involves: 129/Sv * BALB/c * FVB/N)
|
abnormal erythropoiesis
|
J:108453
|
| decreased double-negative T cell number
|
J:108453
|
| increased nucleated erythrocyte cell number
|
J:108453
|
Kat6atm1Iki/Kat6atm1Iki
(Not Specified)
|
abnormal erythropoiesis
|
J:108699
|
| abnormal myelopoiesis
|
J:108699
|
| absent common myeloid progenitor cells
|
J:108699
|
Kat14tm1a(KOMP)Wtsi/Kat14tm1a(KOMP)Wtsi
(B6JTyr;B6N-Kat14tm1a(KOMP)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:165965
|
Katnal1em1(IMPC)Tcp/Katnal1+
(C57BL/6NCrl-Katnal1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Katnb1tm1a(EUCOMM)Hmgu/Katnb1tm1a(EUCOMM)Hmgu
(C57BL/6-Katnb1tm1a(EUCOMM)Hmgu)
|
abnormal erythropoiesis
|
J:220901
|
Kbtbd3em1(IMPC)Ccpcz/Kbtbd3em1(IMPC)Ccpcz
(C57BL/6NCrl-Kbtbd3em1(IMPC)Ccpcz/Ccpcz)
|
increased neutrophil cell number
|
J:211773
|
Kbtbd8em1(IMPC)Tcp/Kbtbd8em1(IMPC)Tcp
(C57BL/6N-Kbtbd8em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Kcna2em1(IMPC)H/Kcna2+
(C57BL/6NTac-Kcna2em1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Kcnb1tm1b(EUCOMM)Hmgu/Kcnb1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcnb1tm1b(EUCOMM)Hmgu/H)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Kcnb2em1(IMPC)J/Kcnb2em1(IMPC)J
(C57BL/6NJ-Kcnb2em1(IMPC)J/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Kcnc1em4(IMPC)H/Kcnc1em4(IMPC)H
(C57BL/6NTac-Kcnc1em4(IMPC)H/H)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Kcne1tm1b(EUCOMM)Hmgu/Kcne1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcne1tm1b(EUCOMM)Hmgu/Ics)
|
increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Kcne1tm1Sfh/Kcne1tm1Sfh
(involves: 129S1/Sv)
|
increased hematocrit
|
J:77288
|
Kcne2tm1a(EUCOMM)Wtsi/Kcne2tm1a(EUCOMM)Wtsi
(C57BL/6N-Kcne2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:175295
|
Kcne2tm1a(EUCOMM)Wtsi/Kcne2tm1a(EUCOMM)Wtsi
(C57BL/6N-Kcne2tm1a(EUCOMM)Wtsi)
|
decreased erythrocyte cell number
|
J:230226
|
| decreased hematocrit
|
J:230226
|
| decreased hemoglobin content
|
J:230226
|
| decreased mean corpuscular hemoglobin
|
J:230226
|
| decreased mean corpuscular volume
|
J:230226
|
| increased red blood cell distribution width
|
J:230226
|
| thrombocytosis
|
J:230226
|
Kcnh3tm1.1(KOMP)Vlcg/Kcnh3tm1.1(KOMP)Vlcg
(C57BL/6N-Kcnh3tm1.1(KOMP)Vlcg/J)
|
increased hemoglobin content
|
J:211773
|
Kcnip1em1(IMPC)H/Kcnip1em1(IMPC)H
(C57BL/6N-Kcnip1em1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
Kcnip4tm1a(KOMP)Wtsi/Kcnip4tm1a(KOMP)Wtsi
(C57BL/6N-Kcnip4tm1a(KOMP)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Kcnj1tm1Ges/Kcnj1tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
increased hematocrit
|
J:79354
|
Kcnj9tm1b(EUCOMM)Hmgu/Kcnj9tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcnj9tm1b(EUCOMM)Hmgu/H)
|
increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Kcnj10tm1b(KOMP)Wtsi/Kcnj10+
(C57BL/6N-Kcnj10tm1b(KOMP)Wtsi/H)
|
decreased basophil cell number
|
J:211773
|
| decreased mean platelet volume
|
J:211773
|
Kcnj11tm1b(EUCOMM)Wtsi/Kcnj11tm1b(EUCOMM)Wtsi
(C57BL/6N-Kcnj11tm1b(EUCOMM)Wtsi/H)
|
decreased hemoglobin content
|
J:211773
|
Kcnk13em1(IMPC)H/Kcnk13em1(IMPC)H
(C57BL/6N-Kcnk13em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Kcnn1tm1b(KOMP)Wtsi/Kcnn1tm1b(KOMP)Wtsi
(C57BL/6N-Kcnn1tm1b(KOMP)Wtsi/H)
|
increased red blood cell distribution width
|
J:211773
|
Kcnn4em1(IMPC)Ccpcz/Kcnn4em1(IMPC)Ccpcz
(C57BL/6NCrl-Kcnn4em1(IMPC)Ccpcz/Ccpcz)
|
decreased erythrocyte cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Kcnn4tm1Rklr/Kcnn4tm1Rklr
(involves: 129S/SvEv * C57BL/6)
|
abnormal red blood cell deformability
|
J:148910
|
| increased hematocrit
|
J:148910
|
| increased hemoglobin concentration distribution width
|
J:148910
|
| increased mean corpuscular volume
|
J:148910
|
| macrocytosis
|
J:148910
|
Kctd1em1(IMPC)J/Kctd1em1(IMPC)J
(C57BL/6NJ-Kctd1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Kctd1Mhdahst014/Kctd1+
(C3HeB/FeJ-Kctd1Mhdahst014)
|
decreased erythrocyte cell number
|
J:250423
|
| decreased hematocrit
|
J:250423
|
| decreased hemoglobin content
|
J:250423
|
| decreased mean corpuscular hemoglobin
|
J:250423
|
| decreased mean corpuscular volume
|
J:250423
|
Kctd2em1(IMPC)Hmgu/Kctd2em1(IMPC)Hmgu
(C57BL/6NCrl-Kctd2em1(IMPC)Hmgu/Ieg)
|
thrombocytopenia
|
J:211773
|
Kctd3em1(IMPC)Tcp/Kctd3+
(C57BL/6N-Kctd3em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Kctd9em1(IMPC)J/Kctd9em1(IMPC)J
(C57BL/6NJ-Kctd9em1(IMPC)J/J)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Kctd9em1Beij/Kctd9em1Beij
(BALB/c-Kctd9em1Beij)
|
abnormal NK cell differentiation
|
J:281803
|
Kctd11em1(IMPC)J/Kctd11em1(IMPC)J
(C57BL/6NJ-Kctd11em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Kdelr1m1Btlr/Kdelr1m1Btlr
(C57BL/6J-Kdelr1m1Btlr)
|
abnormal T cell differentiation
|
J:224970
|
| decreased transitional stage T1 B cell number
|
J:224970
|
| decreased transitional stage T2 B cell number
|
J:224970
|
Kdm1atm1(NCOM)Mfgc/Kdm1a+
(C57BL/6N-Kdm1atm1(NCOM)Mfgc/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Kdm1atm1.1Sho/Kdm1atm1.1Sho
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal definitive hematopoiesis
|
J:201572
|
| decreased common myeloid progenitor cell number
|
J:201572
|
| decreased erythrocyte cell number
|
J:201572
|
| thrombocytopenia
|
J:201572
|
Kdm1atm1.1Sho/Kdm1atm1.1Sho
Eportm1.1(EGFP/icre)Uk/Epor+
(involves: 129 * BALB/cJ)
|
abnormal erythropoiesis
|
J:201572
|
| decreased fetal derived definitive erythrocyte cell number
|
J:201572
|
Kdm1atm1.1Sho/Kdm1atm1.1Sho
Tg(Mx1-cre)1Cgn/?
(involves: 129 * C57BL/6 * CBA/Ca)
|
abnormal common myeloid progenitor cell morphology
|
J:201572
|
| abnormal definitive hematopoiesis
|
J:201572
|
| decreased common myeloid progenitor cell number
|
J:201572
|
| decreased granulocyte number
|
J:201572
|
| decreased neutrophil cell number
|
J:201572
|
Kdm3bem1(IMPC)Tcp/Kdm3b+
(C57BL/6NCrl-Kdm3bem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Kdm5atm1.1Kael/Kdm5atm1.1Kael
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
abnormal definitive hematopoiesis
|
J:137185
|
| increased neutrophil cell number
|
J:137185
|
Kdm6atm1.1Afst/Kdm6atm1.1Afst
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6NTac)
|
abnormal erythropoiesis
|
J:196401
|
| abnormal granulocyte morphology
|
J:196401
|
| decreased common myeloid progenitor cell number
|
J:196401
|
| decreased erythrocyte cell number
|
J:196401
|
| decreased hemoglobin content
|
J:196401
|
| decreased mean corpuscular volume
|
J:196401
|
| extramedullary hematopoiesis
|
J:196401
|
| thrombocytopenia
|
J:196401
|
Kdm6atm1Cdcn/Y
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J * CBA)
|
decreased erythrocyte cell number
|
J:263565
|
| extramedullary hematopoiesis
|
J:263565
|
| increased granulocyte number
|
J:263565
|
| increased neutrophil cell number
|
J:263565
|
| increased nucleated erythrocyte cell number
|
J:263565
|
| thrombocytopenia
|
J:263565
|
Kdm6atm1Cdcn/Y
Tg(CAG-cre/Esr1*)5Amc/0
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6J * CBA * FVB/N)
|
decreased erythrocyte cell number
|
J:263565
|
| increased neutrophil cell number
|
J:263565
|
| thrombocytopenia
|
J:263565
|
Kdm6atm1Cdcn/Kdm6atm1Cdcn
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6J * CBA)
|
decreased erythrocyte cell number
|
J:263565
|
| extramedullary hematopoiesis
|
J:263565
|
| increased granulocyte number
|
J:263565
|
| increased neutrophil cell number
|
J:263565
|
| increased nucleated erythrocyte cell number
|
J:263565
|
| thrombocytopenia
|
J:263565
|
Kdrtm1Jrt/Kdrtm1Jrt
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal definitive hematopoiesis
|
J:26846
|
Keg1tm1b(KOMP)Mbp/Keg1tm1b(KOMP)Mbp
(C57BL/6N-Keg1tm1b(KOMP)Mbp/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Keltm1Slee/Keltm1Slee
(B6.129X1-Keltm1Slee)
|
abnormal cellular hemoglobin content
|
J:212529
|
| decreased erythrocyte magnesium level
|
J:212528
|
| decreased erythrocyte potassium level
|
J:212528
|
| decreased mean corpuscular hemoglobin concentration
|
J:212528
|
| increased hemoglobin concentration distribution width
|
J:212528,
J:212529
|
| increased mean corpuscular hemoglobin
|
J:212529
|
| increased mean corpuscular hemoglobin concentration
|
J:212529
|
| increased mean corpuscular volume
|
J:212528,
J:212529
|
Keltm1Slee/Keltm1Slee
Xktm1Ariv/Y
(B6.Cg-Keltm1Slee Xktm1Ariv)
|
abnormal erythrocyte ion content
|
J:212528
|
| decreased mean corpuscular hemoglobin concentration
|
J:212528
|
| increased erythrocyte sodium level
|
J:212528
|
| increased mean corpuscular volume
|
J:212528
|
Keratm1Cyl/Keratm1Cyl
(involves: 129S6/SvEvTac)
|
decreased neutrophil cell number
|
J:128992
|
Khsrpem1(IMPC)Mbp/Khsrpem1(IMPC)Mbp
(C57BL/6NCrl-Khsrpem1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Kif1btm1b(KOMP)Wtsi/Kif1b+
(C57BL/6N-Kif1btm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Kif5ctm1dIcs/Kif5c+
(C57BL/6N-Kif5ctm1dIcs/Ics)
|
increased eosinophil cell number
|
J:211773
|
Kif20atm1b(EUCOMM)Hmgu/Kif20a+
(C57BL/6N-Kif20atm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Kiss1rtm1.1Lex/Kiss1r+
(involves: 129S4/SvJae)
|
decreased eosinophil cell number
|
J:181650
|
Kiss1rtm1.1Lex/Kiss1rtm1.1Lex
(involves: 129S4/SvJae)
|
decreased basophil cell number
|
J:181650
|
| decreased neutrophil cell number
|
J:181650
|
| thrombocytopenia
|
J:181650
|
KitM1Hmgu/Kit+
(C3HeB/FeJ-KitM1Hmgu)
|
decreased mean corpuscular hemoglobin
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
| increased erythrocyte cell number
|
J:186868
|
| increased hematocrit
|
J:186868
|
KitMhdasco1/KitMhdasco1
(C3HeB/FeJ-KitMhdasco1)
|
abnormal erythrocyte morphology
|
J:125831
|
| decreased erythrocyte cell number
|
J:125831
|
| decreased hematocrit
|
J:125831
|
| increased hemoglobin content
|
J:125831
|
| increased mean corpuscular volume
|
J:125831
|
KitMhdasco5/KitMhdasco5
(C3HeB/FeJ-KitMhdasco5)
|
abnormal erythrocyte morphology
|
J:125831
|
| decreased erythrocyte cell number
|
J:125831
|
| decreased hematocrit
|
J:125831
|
| increased hemoglobin content
|
J:125831
|
| increased mean corpuscular volume
|
J:125831
|
Kittm1.1Bsm/Kittm1.1Bsm
(involves: 129S1/Sv * BALB/c * C57BL/6J * FVB/N)
|
decreased mast cell number
|
J:61141
|
Kittm1Ber/Kittm1Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased mast cell number
|
J:89602
|
Kittm1Bpr/Kittm1Bpr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
decreased mast cell number
|
J:100778
|
Kittm1Bsm/Kittm1Bsm
(involves: 129S1/Sv * C57BL/6J)
|
decreased mast cell number
|
J:61141
|
Kittm2Ber/Kittm2Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased mast cell number
|
J:89602
|
Kittm2Bsm/Kit+
(involves: 129X1/SvJ * C57BL/6J)
|
increased mast cell number
|
J:83616
|
Kittm3.1Bsm/Kittm3.1Bsm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:90485
|
| abnormal T cell differentiation
|
J:90485
|
| decreased mast cell number
|
J:90485
|
Kittm3.1Bsm/Kittm3.1Bsm
(B6.129S1-Kittm3.1Bsm)
|
abnormal stress erythropoiesis
|
J:146561
|
| decreased erythrocyte cell number
|
J:146561
|
| decreased hematocrit
|
J:146561
|
| increased mean corpuscular volume
|
J:146561
|
Kittm3Ber/Kittm3Ber
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
arrested B cell differentiation
|
J:89602
|
| decreased mast cell number
|
J:89602
|
Kittm4.1Bsm/Kit+
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
abnormal erythrocyte morphology
|
J:188434
|
| decreased mean corpuscular volume
|
J:188434
|
| increased erythrocyte cell number
|
J:188434
|
| increased hematocrit
|
J:188434
|
| increased mast cell number
|
J:188434
|
| increased mean platelet volume
|
J:188434
|
| polycythemia
|
J:188434
|
Kittm5.1Bsm/Kit+
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased mean corpuscular volume
|
J:188434
|
KitW-3Bao/KitW-3Bao
(involves: C57BL/6J)
|
decreased erythrocyte cell number
|
J:163026
|
| decreased hematocrit
|
J:163026
|
| decreased hemoglobin content
|
J:163026
|
| increased mean corpuscular hemoglobin
|
J:163026
|
| increased mean corpuscular hemoglobin concentration
|
J:163026
|
| macrocytosis
|
J:163026
|
KitW-34J/Kit+
(C57BL/6J-KitW-34J/J)
|
polycythemia
|
J:6571
|
KitW-35J/Kit+
(C57BL/6J-KitW-35J/J)
|
polycythemia
|
J:6571
|
KitW-37J/Kit+
(C57BL/6J-KitW-37J/J)
|
polycythemia
|
J:6571
|
KitW-37J/Kit+
(involves: C57BL/6 * C57BL/6J)
|
decreased mast cell number
|
J:27513
|
KitW-37J/KitW
(involves: C57BL/6 * C57BL/6J * WB)
|
decreased mast cell number
|
J:27513
|
KitW-38J/Kit+
(involves: C57BL/6J)
|
polycythemia
|
J:6571
|
KitW-40J/Kit+
(C57BL/6J-KitW-40J/J)
|
polycythemia
|
J:6571
|
KitW-42J/Kit+
(involves: C57BL/6 * C57BL/6J * WB)
|
decreased erythrocyte cell number
|
J:27513
|
| decreased mast cell number
|
J:27513
|
KitW-42J/KitW
(involves: C57BL/6 * C57BL/6J * WB)
|
decreased mast cell number
|
J:27513
|
KitW-43J/Kit+
(C57BL/6J-KitW-43J/J)
|
polycythemia
|
J:6571
|
KitW-Btlr/KitW-Btlr
(C57BL/6J-KitW-Btlr)
|
decreased mast cell number
|
J:133270
|
KitW-f/KitW-f
(involves: C3H/HePas)
|
decreased erythrocyte cell number
|
J:27513
|
| decreased mast cell number
|
J:27513
|
KitW-Jic/Kit+
(involves: C57BL/6)
|
decreased erythrocyte cell number
|
J:27513
|
| decreased mast cell number
|
J:27513
|
KitW-Jic/KitW
(involves: C57BL/6 * WB)
|
decreased mast cell number
|
J:27513
|
KitW-n/KitW-n
(Not Specified)
|
decreased mast cell number
|
J:12107
|
KitW-n/KitW
(involves: WB)
|
decreased mast cell number
|
J:27513
|
KitW-sh/KitW-sh
(involves: 101/H * C3H/HeH)
|
abnormal definitive hematopoiesis
|
J:6857
|
| abnormal erythrocyte cell number
|
J:6857
|
| decreased erythrocyte cell number
|
J:6857
|
| decreased mast cell number
|
J:145444
|
KitW-sh/KitW-sh
Lyntm1Ard/Lyntm1Ard
(involves: 101 * 129P2/OlaHsd * C3H/HeH)
|
increased basophil cell number
|
J:161523
|
KitW-sh/KitW-v
(involves: 101/H * C3H/HeH)
|
abnormal definitive hematopoiesis
|
J:6857
|
| abnormal erythrocyte cell number
|
J:6857
|
| decreased erythrocyte cell number
|
J:6857
|
KitW-v/Kit+
(involves: C57BL * C57BL/6)
|
decreased erythrocyte cell number
|
J:27513
|
| decreased mast cell number
|
J:27513
|
KitW-v/KitW-v
Ly6atm1Pmf/Ly6atm1Pmf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:81387
|
KitW-vkd/KitW-vkd
(involves: 129P2/OlaHsd * BALB/c * C57BL/6 * WB)
|
abnormal B cell differentiation
|
J:79128
|
| abnormal T cell differentiation
|
J:79128
|
| low mean erythrocyte cell number
|
J:79128
|
KitW/Kit+
(FL/1Re-KitW/J)
|
high mean erythrocyte cell number
|
J:24610
|
| increased hematocrit
|
J:24610
|
KitW/Kit+
Tg(PGK1-KITLG*220)441Daw/0
(involves: C3H/HeJ)
|
decreased mast cell number
|
J:32600
|
KitW/KitW-v
((WB/ReJ x C57BL/6J-KitW-v/J)F1-KitW/KitW-v/J)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
KitW/KitW-v
(involves: C57BL/6)
|
decreased basophil cell number
|
J:178942
|
| decreased mast cell number
|
J:178942
|
KitW/KitW
Tg(PDGFB-EPO)321Zbz/?
(involves: C3H * C57BL/6)
|
abnormal B cell differentiation
|
J:79128
|
| abnormal T cell differentiation
|
J:79128
|
KitWads/Kit+
(C57BL/6J-KitWads)
|
increased mean platelet volume
|
J:96391
|
KitWads/KitWads
(C57BL/6J-KitWads)
|
decreased erythrocyte cell number
|
J:96391
|
| decreased mast cell number
|
J:96391
|
| increased mean corpuscular volume
|
J:96391
|
| increased mean platelet volume
|
J:96391
|
| thrombocytosis
|
J:96391
|
KitWhc1/KitWhc1
(involves: C3HeB/Fe * C57BL/6)
|
abnormal erythrocyte morphology
|
J:125831
|
| decreased erythrocyte cell number
|
J:125831
|
| decreased hematocrit
|
J:125831
|
| increased hemoglobin content
|
J:125831
|
| increased mean corpuscular volume
|
J:125831
|
KitlSl-1Neu/Kitl+
(involves: 102/El * C3H/El)
|
decreased erythrocyte cell number
|
J:37172
|
| decreased hematocrit
|
J:37172
|
| decreased hemoglobin content
|
J:37172
|
| decreased mean corpuscular hemoglobin concentration
|
J:37172
|
| increased mean corpuscular hemoglobin
|
J:37172
|
| increased mean corpuscular volume
|
J:37172
|
KitlSl-1Neu/KitlSl-1Neu
(involves: 102/El * C3H/El)
|
decreased erythrocyte cell number
|
J:37172
|
| decreased hematocrit
|
J:37172
|
| decreased hemoglobin content
|
J:37172
|
| decreased mean corpuscular hemoglobin concentration
|
J:37172
|
| increased mean corpuscular hemoglobin
|
J:37172
|
| increased mean corpuscular volume
|
J:37172
|
KitlSl-2Neu/Kitl+
(involves: 102/El * C3H/El)
|
decreased hematocrit
|
J:37172
|
| decreased hemoglobin content
|
J:37172
|
KitlSl-2Neu/KitlSl-2Neu
(involves: 102/El * C3H/El)
|
decreased hematocrit
|
J:37172
|
| decreased hemoglobin content
|
J:37172
|
KitlSl-5R/Kitl+
(C3.Cg-KitlSl-5R)
|
decreased erythrocyte cell number
|
J:82263
|
KitlSl-5R/KitlSl-5R
(C3.Cg-KitlSl-5R)
|
low mean erythrocyte cell number
|
J:82263
|
KitlSl-18R/Kitl+
(C3.Cg-KitlSl-18R)
|
decreased erythrocyte cell number
|
J:82263
|
KitlSl-18R/KitlSl-18R
(C3.Cg-KitlSl-18R)
|
low mean erythrocyte cell number
|
J:82263
|
KitlSl-20J/KitlSl-20J
(C57BL/6J-KitlSl-20J/J)
|
abnormal erythropoiesis
|
J:86436
|
KitlSl-22R/Kitl+
(C3H-KitlSl-22R)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
KitlSl-22R/KitlSl-22R
(C3H-KitlSl-22R)
|
low mean erythrocyte cell number
|
J:79293
|
KitlSl-28R/Kitl+
(C3.101Rl-KitlSl-28R)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
KitlSl-28R/KitlSl-28R
(C3.101Rl-KitlSl-28R)
|
low mean erythrocyte cell number
|
J:79293
|
KitlSl-30R/Kitl+
(C3.101Rl-KitlSl-30R)
|
decreased hematocrit
|
J:79293
|
| increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
KitlSl-30R/KitlSl-30R
(C3.101Rl-KitlSl-30R)
|
low mean erythrocyte cell number
|
J:79293
|
KitlSl-31R/Kitl+
(C3H-KitlSl-31R)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
KitlSl-31R/KitlSl-31R
(C3H-KitlSl-31R)
|
low mean erythrocyte cell number
|
J:79293
|
KitlSl-36R/Kitl+
(C3H-KitlSl-36R)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
| low mean erythrocyte cell number
|
J:79293
|
KitlSl-36R/KitlSl-36R
(C3H-KitlSl-36R)
|
decreased hematocrit
|
J:79293
|
| increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular hemoglobin concentration
|
J:79293
|
| low mean erythrocyte cell number
|
J:79293
|
KitlSl-39R/Kitl+
(C3.B10Rl-KitlSl-39R)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
| low mean erythrocyte cell number
|
J:79293
|
KitlSl-39R/KitlSl-39R
(C3.B10Rl-KitlSl-39R)
|
decreased hematocrit
|
J:79293
|
| increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular hemoglobin concentration
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
| low mean erythrocyte cell number
|
J:79293
|
KitlSl-42R/Kitl+
(C3.101Rl-KitlSl-42R)
|
decreased hematocrit
|
J:79293
|
| increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
KitlSl-42R/KitlSl-42R
(C3.101Rl-KitlSl-42R)
|
low mean erythrocyte cell number
|
J:79293
|
KitlSl-con/KitlSl-con
(either: (involves: C3H/HeJ) or (involves: C3H/HeN))
|
increased mast cell number
|
J:23593
|
KitlSl-d/Kitl+
(either: (involves: C57BL/6 * DBA/2J) or (involves: C3H * C57BL/6 * DBA/2J * WC))
|
decreased mast cell number
|
J:6084
|
KitlSl-d/Kitl+
(C3.D2-KitlSl-d)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
| low mean erythrocyte cell number
|
J:79293
|
KitlSl-d/KitlSl-d
(C3.D2-KitlSl-d)
|
decreased hematocrit
|
J:79293
|
| increased mean corpuscular hemoglobin concentration
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
| low mean erythrocyte cell number
|
J:79293
|
KitlSl-gb/Kitl+
(C3.Cg-KitlSl-gb)
|
increased mean corpuscular hemoglobin
|
J:79293
|
| increased mean corpuscular volume
|
J:79293
|
KitlSl-gb/KitlSl-gb
(C3.Cg-KitlSl-gb)
|
low mean erythrocyte cell number
|
J:79293
|
KitlSl/Kitl+
(involves: C3H)
|
decreased erythrocyte cell number
|
J:3399
|
KitlSl/Kitl+
(either: (involves: C3H * WC) or (involves: C3H * C57BL/6 * DBA/2J * WC))
|
decreased mast cell number
|
J:6084
|
KitlSl/Kitl+
Tg(PGK1-KITLG*220)441Daw/0
(involves: C3H)
|
decreased mast cell number
|
J:32600
|
KitlSl/KitlSl-d
(involves: C57BL/6 * WC)
|
decreased hematocrit
|
J:27511
|
KitlSl/KitlSl-d
(involves: C3H * C57BL/6 * DBA/2J * WC)
|
decreased mast cell number
|
J:6084
|
KitlSl/KitlSl-d
((WC/ReJ KitlSl x B6.D2-KitlSl-d/J)F1-KitlSl/KitlSl-d/J)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Kitltm1.1Sjm/Kitltm1.1Sjm
(BKa.129S6-Kitltm1.1Sjm)
|
decreased erythrocyte cell number
|
J:180431
|
Kitltm1.1Sjm/Kitltm2.1Sjm
Leprtm2(cre)Rck/Lepr+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/Ka * SJL)
|
extramedullary hematopoiesis
|
J:180431
|
Kitltm1Pbes/Kitltm1Pbes
(involves: 129S1/Sv * C57BL/6J)
|
decreased mast cell number
|
J:50150
|
Kitltm2.1Pbes/Kitltm2.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:157170
|
| increased mast cell number
|
J:157170
|
Kitltm2.1Sjm/Kitltm2.1Sjm
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6 * C57BL/Ka * SJL)
|
decreased erythrocyte cell number
|
J:180431
|
Kitltm3.1Pbes/Kitltm3.1Pbes
(involves: 129S1/Sv * C57BL/6J * FVB/N)
|
decreased double-negative T cell number
|
J:157170
|
| decreased double-positive T cell number
|
J:157170
|
| decreased erythrocyte cell number
|
J:157170
|
| decreased mast cell number
|
J:157170
|
| increased mean corpuscular volume
|
J:157170
|
Klm1Anu/Klm1Anu
(C57BL/6NCrlAnu-Klm1Anu)
|
abnormal definitive hematopoiesis
|
J:104190
|
Klf1Nan/Klf1+
(either: B6.Cg-Klf1Nan or WB.Cg-Klf1Nan)
|
abnormal erythrocyte morphology
|
J:162530
|
| anisocytosis
|
J:162530
|
| decreased erythrocyte cell number
|
J:162530
|
| decreased hematocrit
|
J:162530
|
| decreased hemoglobin content
|
J:162530
|
| decreased mean corpuscular hemoglobin
|
J:162530
|
| poikilocytosis
|
J:162530
|
| polychromatophilia
|
J:162530
|
Klf1Nan/Klf1+
(involves: 101/H * C3H/HeH * PT)
|
anisocytosis
|
J:13933
|
| decreased erythrocyte cell number
|
J:13933
|
| increased nucleated erythrocyte cell number
|
J:13933
|
Klf1tm1Nimr/Klf1tm1Nimr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * CBA) or (involves: 129P2/OlaHsd * FVB))
|
abnormal erythropoiesis
|
J:25650
|
| decreased hemoglobin content
|
J:25650
|
Klf1tm1Sho/Klf1tm1Sho
(involves: 129S4/SvJae * C57BL/6)
|
abnormal erythrocyte morphology
|
J:25651
|
| abnormal erythropoiesis
|
J:25651
|
Klf2tm1Ling/Klf2tm1Ling
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased nucleated erythrocyte cell number
|
J:51402
|
Klf2tm2Ling/Klf2tm2Ling
Tg(Cd4-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:151604
|
Klf3Gt(CH0516)Wtsi/Klf3Gt(CH0516)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased red blood cell distribution width
|
J:206507
|
Klf3Gt(XS0187)Wtsi/Klf3Gt(XS0187)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased red blood cell distribution width
|
J:206507
|
Klf3m1Cmhd/Klf3+
(involves: C3H/HeJ * C57BL/6J)
|
decreased erythrocyte cell number
|
J:206507
|
| decreased hemoglobin content
|
J:206507
|
Klf6tm1Fdmn/Klf6+
(involves: C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:122926
|
Klf7tm1b(EUCOMM)Hmgu/Klf7+
(C57BL/6N-Klf7tm1b(EUCOMM)Hmgu/H)
|
increased mean platelet volume
|
J:211773
|
Klf13tm1Coll/Klf13tm1Coll
(involves: 129S/SvEv)
|
abnormal erythropoiesis
|
J:136545
|
| decreased erythrocyte cell number
|
J:136545
|
| increased mean corpuscular hemoglobin
|
J:136545
|
| increased mean corpuscular volume
|
J:136545
|
| increased red blood cell distribution width
|
J:136545
|
Klf13tm1Kren/Klf13tm1Kren
(B6.129-Klf13tm1Kren)
|
increased double-positive T cell number
|
J:145839
|
Klf14tm1.1(KOMP)Vlcg/Klf14tm1.1(KOMP)Vlcg
(C57BL/6N-Klf14tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Klf16em1(IMPC)J/Klf16+
(C57BL/6NJ-Klf16em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Klhdc2tm1b(EUCOMM)Hmgu/Klhdc2+
(C57BL/6N-Klhdc2tm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
Klhdc7bem1(IMPC)H/Klhdc7bem1(IMPC)H
(C57BL/6N-Klhdc7bem1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
Klhl2em1(IMPC)J/Klhl2em1(IMPC)J
(C57BL/6NJ-Klhl2em1(IMPC)J/J)
|
increased mean corpuscular volume
|
J:211773
|
Klhl3tm1b(KOMP)Wtsi/Klhl3tm1b(KOMP)Wtsi
(C57BL/6N-Klhl3tm1b(KOMP)Wtsi/H)
|
decreased hemoglobin content
|
J:211773
|
Klhl6m1Anu/Klhl6m1Anu
(C57BL/6JAnu-Klhl6m1Anu)
|
increased immature B cell number
|
J:104190
|
Klhl6M7Btlr/Klhl6M7Btlr
(C57BL/6J-Klhl6M7Btlr)
|
abnormal B cell differentiation
|
J:272397
|
Klhl6tm1Sato/Klhl6tm1Sato
(either: (involves: 129T2/SvEms) or (involves: BALB/c) or (involves: CD-1))
|
abnormal B cell differentiation
|
J:101363
|
Klhl18tm1a(KOMP)Wtsi/Klhl18tm1a(KOMP)Wtsi
(C57BL/6N-Klhl18tm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Klhl42tm1b(EUCOMM)Hmgu/Klhl42tm1b(EUCOMM)Hmgu
(C57BL/6N-Klhl42tm1b(EUCOMM)Hmgu/Wtsi)
|
thrombocytosis
|
J:211773
|
Klk4tm1.1(KOMP)Vlcg/Klk4tm1.1(KOMP)Vlcg
(C57BL/6N-Klk4tm1.1(KOMP)Vlcg/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Klk5tm2b(KOMP)Wtsi/Klk5tm2b(KOMP)Wtsi
(C57BL/6N-Klk5tm2b(KOMP)Wtsi/Ccpcz)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Klrk1tm1.1Bpol/Klrk1tm1.1Bpol
(C57BL/6-Klrk1tm1.1Bpol)
|
abnormal NK cell differentiation
|
J:151878
|
Klrk1tm2.1Bpol/Klrk1tm2.1Bpol
(Not Specified)
|
abnormal NK cell differentiation
|
J:215590
|
Kmt2atm1(AFF1)Ksy/Kmt2a+
(involves: 129S1/Sv * C57BL/6 * FVB)
|
increased neutrophil cell number
|
J:110241
|
| increased pro-B cell number
|
J:110241
|
| myeloid hyperplasia
|
J:110241
|
Kmt2atm1(MLL1/ERT)Divo/?
(involves: 129S4/SvJae * C57BL/6)
|
myeloid hyperplasia
|
J:189329
|
Kmt2atm1.1(Sh3gl1)Lcc/Kmt2a+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
myeloid hyperplasia
|
J:205605
|
Kmt2atm1.1Brad/Kmt2atm1.1Brad
(involves: 129S4/SvJae * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:149811
|
Kmt2atm1.1Erns/Kmt2atm1.1Erns
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal definitive hematopoiesis
|
J:147265
|
| decreased common myeloid progenitor cell number
|
J:147265
|
Kmt2atm1.1Erns/Kmt2atm1.1Erns
Tg(Mx1-cre)1Cgn/0
(involves: 129S2/SvPas * C57BL/6 * CBA * SJL)
|
abnormal definitive hematopoiesis
|
J:147265
|
| decreased common myeloid progenitor cell number
|
J:147265
|
Kmt2atm1.1Mlc/Kmt2atm1.1Mlc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:183048
|
Kmt2atm1Brad/Kmt2atm1Brad
Commd10Tg(Vav1-icre)A2Kio/?
(involves: 129S4/SvJae * C57BL/6 * C57BL/10 * CBA/Ca)
|
decreased common myeloid progenitor cell number
|
J:149811
|
Kmt2atm1Clgr/Kmt2a+
(B6.129-Kmt2atm1Clgr)
|
abnormal common myeloid progenitor cell morphology
|
J:115001
|
| abnormal myelopoiesis
|
J:115001
|
Kmt2atm1Sjk/Kmt2a+
(involves: 129S2/SvPas * C3H * C57BL/6)
|
decreased erythrocyte cell number
|
J:29958
|
| decreased hemoglobin content
|
J:29958
|
| thrombocytopenia
|
J:29958
|
Kmt2atm2(MLLT3)Thr/Kmt2a+
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:56340
|
Kmt2atm2(MLLT3)Thr/Kmt2atm2(MLLT3)Thr
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal definitive hematopoiesis
|
J:110241
|
| increased neutrophil cell number
|
J:110241
|
| increased pro-B cell number
|
J:110241
|
Kmt2atm2Sjk/Kmt2a+
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
myeloid hyperplasia
|
J:95914
|
| thrombocytopenia
|
J:95914
|
Kmt2dtm1.1Kaig/Kmt2dtm1.1Kaig
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:228913
|
Kmt2etm1.1Hjf/Kmt2etm1.1Hjf
(B6.129P2-Kmtetm1.1Hjf)
|
abnormal lymphopoiesis
|
J:145579
|
| decreased common myeloid progenitor cell number
|
J:145579
|
| decreased double-negative T cell number
|
J:145579
|
| decreased double-positive T cell number
|
J:145579
|
| decreased erythrocyte cell number
|
J:145579
|
| decreased hematocrit
|
J:145579
|
| decreased pro-B cell number
|
J:145579
|
| thrombocytopenia
|
J:145579
|
Kmt2etm1Apa/Kmt2etm1Apa
(129S6/SvEvTac-Kmt2etm1Apa)
|
abnormal definitive hematopoiesis
|
J:145445
|
| abnormal granulocyte differentiation
|
J:145445
|
| abnormal neutrophil differentiation
|
J:145445
|
| decreased hematocrit
|
J:145445
|
| decreased hemoglobin content
|
J:145445
|
| increased hemoglobin concentration distribution width
|
J:145445
|
| low mean erythrocyte cell number
|
J:145445
|
Kmt2etm1Nik/Kmt2etm1Nik
(B6.Cg-Kmtetm1Nik)
|
abnormal definitive hematopoiesis
|
J:145449
|
| increased neutrophil cell number
|
J:145449
|
Kmt5btm1Jnw/Kmt5btm1Jnw
Kmt5ctm1.1Jnw/Kmt5ctm1.1Jnw
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129/Sv * C57BL/6J * C57BL/10 * CBA/Ca)
|
abnormal class switch recombination
|
J:139510
|
| abnormal lymphopoiesis
|
J:139510
|
| decreased double-positive T cell number
|
J:139510
|
Knstrntm1b(KOMP)Wtsi/Knstrntm1b(KOMP)Wtsi
(C57BL/6N-Knstrntm1b(KOMP)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Kpna1tm1.2Yyo/Kpna1tm1.2Yyo
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
thrombocytopenia
|
J:188099
|
Krastm1.1Khai/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA/J)
|
decreased hemoglobin content
|
J:276349
|
Krastm1Tyj/Kras+
Nrastm1Rak/Nrastm1Rak
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:43433
|
| abnormal erythropoiesis
|
J:43433
|
Krastm1Tyj/Krastm1Tyj
(involves: 129S2/SvPas)
|
abnormal definitive hematopoiesis
|
J:43433
|
Krastm4.1Bbd/Krastm4.1Bbd
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:223433
|
| extramedullary hematopoiesis
|
J:223433
|
| increased basophil cell number
|
J:223433
|
| increased eosinophil cell number
|
J:223433
|
| increased neutrophil cell number
|
J:223433
|
| thrombocytopenia
|
J:223433
|
Krastm4Tyj/Kras+
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
Tg(Flt3-cre)#Ccb/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
decreased double-negative T cell number
|
J:247853
|
| decreased double-positive T cell number
|
J:247853
|
| thrombocytopenia
|
J:247853
|
Krastm4Tyj/Kras+
Meox2tm1(cre)Sor/Meox2+
(involves: 129S4/SvJae * 129S4/SvJaeSor)
|
abnormal embryonic erythropoiesis
|
J:119477
|
Krastm4Tyj/Kras+
Pggt1btm1Mbrg/Pggt1b+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:122107
|
| increased neutrophil cell number
|
J:122107
|
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:88163
|
| abnormal erythrocyte morphology
|
J:88163
|
| abnormal myelopoiesis
|
J:88163
|
| decreased hematocrit
|
J:88163
|
| extramedullary hematopoiesis
|
J:88163
|
| increased granulocyte number
|
J:88163
|
| myeloid hyperplasia
|
J:88163
|
Krastm4Tyj/Kras+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal erythropoiesis
|
J:87429,
J:115071
|
| abnormal myelopoiesis
|
J:87429
|
| anisopoikilocytosis
|
J:115071
|
| decreased mean corpuscular hemoglobin
|
J:115071
|
| myeloid hyperplasia
|
J:87429
|
| polychromatophilia
|
J:115071
|
Krt8tm1b(EUCOMM)Hmgu/Krt8+
(C57BL/6N-Krt8tm1b(EUCOMM)Hmgu/Ics)
|
increased neutrophil cell number
|
J:211773
|
Krt8tm1Rgo/Krt8tm1Rgo
(involves: 129S2/SvPas * C57BL/6)
|
extramedullary hematopoiesis
|
J:12899
|
Krt17tm1.1(KOMP)Vlcg/Krt17+
(C57BL/6N-Krt17tm1.1(KOMP)Vlcg/J)
|
decreased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Krt32em1(IMPC)Kmpc/Krt32em1(IMPC)Kmpc
(C57BL/6NTac-Krt32em1(IMPC)Kmpc/Kmpc)
|
increased hemoglobin content
|
J:211773
|
Krt33bem1(IMPC)Ccpcz/Krt33bem1(IMPC)Ccpcz
(C57BL/6N-Krt33bem1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Ksr1tm1Shaw/Ksr1tm1Shaw
Tg(DO11.10)10Dlo/0
(involves: BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:75739
|
Kxd1tm1Wli/Kxd1tm1Wli
(involves: 129 * C57BL/6J)
|
decreased platelet dense granule number
|
J:192646
|
L3mbtl3tm1Tmiy/L3mbtl3tm1Tmiy
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:98498
|
Lage3em1(IMPC)Tcp/Lage3em1(IMPC)Tcp
(C57BL/6N-Lage3em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Lair1tm1.1Jco/Lair1tm1.1Jco
(involves: C57BL/6)
|
increased eosinophil cell number
|
J:180203
|
| thrombocytosis
|
J:180203
|
Lama2tm1Stk/Lama2tm1Stk
(involves: 129P2/OlaHsd * BALB/c)
|
decreased double-positive T cell number
|
J:61802
|
Lama4tm1.1(KOMP)Vlcg/Lama4tm1.1(KOMP)Vlcg
(C57BL/6N-Lama4tm1.1(KOMP)Vlcg/Ucd)
|
increased basophil cell number
|
J:211773
|
Lama4tm1Ktry/Lama4tm1Ktry
(either: B6.129X1-Lama4tm1Ktry or (involves: 129X1/SvJ * C57BL/6))
|
decreased erythrocyte cell number
|
J:74287
|
| decreased hematocrit
|
J:74287
|
| decreased hemoglobin content
|
J:74287
|
Lama5tm1Lsor/Lama5tm1Lsor
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
decreased transitional stage T2 B cell number
|
J:198783
|
| increased transitional stage T1 B cell number
|
J:198783
|
Lamc3tm1a(KOMP)Wtsi/Lamc3tm1a(KOMP)Wtsi
(C57BL/6N-Lamc3tm1a(KOMP)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Laptm5tm1a(EUCOMM)Wtsi/Laptm5tm1a(EUCOMM)Wtsi
(C57BL/6N-Laptm5tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Larp4bem1(IMPC)Wtsi/Larp4bem1(IMPC)Wtsi
(C57BL/6N-Larp4bem1(IMPC)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Lattm1.1Lov/Lattm1.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:77099
|
| abnormal T cell differentiation
|
J:77099
|
| decreased double-positive T cell number
|
J:77099
|
Lattm1.1Mal/Lattm1.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:77098
|
| abnormal T cell selection
|
J:77098
|
| decreased double-positive T cell number
|
J:77098
|
| increased eosinophil cell number
|
J:77098
|
Lattm1Bpay/Lattm1Bpay
(involves: 129S2/SvPas)
|
abnormal T cell differentiation
|
J:103904
|
| arrested T cell differentiation
|
J:103904
|
| decreased double-negative T cell number
|
J:103904
|
Lattm1Les/Lattm1.1Wz
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:147946
|
| increased double-positive T cell number
|
J:147946
|
Lattm1Les/Lattm1.2Wz
(involves: C57BL/6 * FVB/N)
|
arrested T cell differentiation
|
J:147946
|
Lattm1Les/Lattm1Les
(Not Specified)
|
arrested T cell differentiation
|
J:116964,
J:54059
|
| decreased double-negative T cell number
|
J:54059
|
Lattm1Les/Lattm1Les
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
| decreased double-positive T cell number
|
J:147721
|
Lattm1Les/Lattm1Les
Tg(CD2-LAT2)1Wz/0
(Not Specified)
|
abnormal T cell differentiation
|
J:116964
|
| decreased double-positive T cell number
|
J:116964
|
Lattm2.1Lov/Lattm2.1Lov
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:77695
|
Lattm2.1Mal/Lattm2.1Mal
(involves: 129S2/SvPas)
|
abnormal B cell differentiation
|
J:94074
|
| abnormal gamma-delta T cell differentiation
|
J:94074
|
| abnormal lymphopoiesis
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
Lattm3.1Mal/Lattm3.1Mal
(involves: 129S2/SvPas)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
(involves: 129P2/OlaHsd)
|
abnormal gamma-delta T cell differentiation
|
J:94074
|
| arrested T cell differentiation
|
J:94074
|
| decreased double-positive T cell number
|
J:94074
|
Lattm4.1Mal/Lattm4.1Mal
Trdctm1Mal/Trdctm1Mal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112658
|
Lattm5.1Mal/Lattm5.1Mal
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:152363
|
Lattm8.1(CD2,-ECFP)Mal/Lattm8.1(CD2,-ECFP)Mal
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:152149
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:152149
|
| arrested T cell differentiation
|
J:152149
|
| increased double-negative T cell number
|
J:152149
|
Lattm9Mal/Lattm9Mal
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:205441
|
Lats1em1(IMPC)H/Lats1em1(IMPC)H
(C57BL/6NTac-Lats1em1(IMPC)H/H)
|
decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Lbrem1(IMPC)Tcp/Lbrem1(IMPC)Tcp
(C57BL/6N-Lbrem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
LbrGt(XE569)Byg/LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
abnormal granulocyte differentiation
|
J:138854
|
| abnormal granulocyte morphology
|
J:138854
|
| abnormal neutrophil morphology
|
J:138854
|
Lbric-J/Lbr+
(C57BL/6J-Lbric-J)
|
abnormal granulocyte morphology
|
J:80915
|
Lbric-J/Lbr+
((NZW/LacJ x C57BL/6J-Lbric-J/J)F1)
|
abnormal neutrophil morphology
|
J:234168
|
Lbric-J/Lbric-J
(C57BL/6J-Lbric-J)
|
abnormal eosinophil morphology
|
J:80915
|
| abnormal neutrophil morphology
|
J:80915
|
Lbric-J/Lbric-J
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil differentiation
|
J:143838
|
Lbric-J/Lbric-J
Tm7sf2tm1Fdp/Tm7sf2+
(involves: 129S4/SvJae * C57BL/6)
|
extramedullary hematopoiesis
|
J:143838
|
Lbrlym3/Lbr+
(C57BL/6-Lbrlym3)
|
abnormal neutrophil morphology
|
J:180355
|
Lbrlym3/Lbrlym3
(C57BL/6-Lbrlym3)
|
abnormal neutrophil morphology
|
J:180355
|
Lca5lem1(IMPC)Ics/Lca5lem1(IMPC)Ics
(C57BL/6N-Lca5lem1(IMPC)Ics/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Lckm1Btlr/Lckm1Btlr
(C57BL/6J-Lckm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:144695
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:144695
|
Lcktm1Dbs/Lcktm1Dbs
(involves: C3H * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:114660
|
| abnormal T cell differentiation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C3H * C57BL/6 * DBA/2J)
|
abnormal positive T cell selection
|
J:114660
|
| abnormal T cell differentiation
|
J:114660
|
| arrested T cell differentiation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraTcrb)425Cbn/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
| arrested T cell differentiation
|
J:114660
|
Lcktm1Dbs/Lcktm1Dbs
Tg(TcraTcrb)1100Mjb/0
(involves: C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:114660
|
Lcktm1Mak/Lcktm1Mak
(involves: 129S2/SvPas)
|
abnormal double-negative T cell morphology
|
J:110847
|
| decreased double-positive T cell number
|
J:1119,
J:110847
|
Lcktm1Mak/Lcktm1Mak
(B6.129S2-Lcktm1Mak)
|
abnormal T cell differentiation
|
J:111646
|
Lcktm1Mak/Lcktm1Mak
Rag1tm1Mom/Rag1+
Tg(Lck-Fyn*Y528F)5525Cjg/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:37062
|
Lclat1em1(IMPC)Mbp/Lclat1em1(IMPC)Mbp
(C57BL/6N-Lclat1em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Lcn2tm1b(KOMP)Wtsi/Lcn2tm1b(KOMP)Wtsi
(C57BL/6N-Lcn2tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular volume
|
J:211773
|
Lcn2tm1Mrgr/Lcn2tm1Mrgr
(129(B6)-Lcn2tm1Mrgr)
|
abnormal erythropoiesis
|
J:173490
|
| abnormal myelopoiesis
|
J:173490
|
| increased erythrocyte cell number
|
J:173490
|
| increased hematocrit
|
J:173490
|
| increased mean corpuscular hemoglobin
|
J:173490
|
| increased neutrophil cell number
|
J:173490
|
| myeloid hyperplasia
|
J:173490
|
| thrombocytopenia
|
J:173490
|
Lcp1tm1e.1(KOMP)Wtsi/Lcp1+
(C57BL/6N-Lcp1tm1e.1(KOMP)Wtsi/J)
|
decreased hematocrit
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
(B6.Cg-Lcp2tm1.1Wz)
|
abnormal T cell differentiation
|
J:150304
|
| decreased double-negative T cell number
|
J:150304
|
| increased double-negative T cell number
|
J:150304
|
Lcp2tm1.1Wz/Lcp2tm1.1Wz
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:150304
|
Lcp2tm3Gak/Lcp2tm3Gak
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:132995
|
| abnormal negative T cell selection
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2J)
|
abnormal negative T cell selection
|
J:132995
|
| increased double-positive T cell number
|
J:132995
|
Lcp2tm3Gak/Lcp2tm3Gak
Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal double-negative T cell morphology
|
J:132995
|
| abnormal negative T cell selection
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal negative T cell selection
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S6/SvEvTac * C57BL/6 * DBA * FVB/N)
|
abnormal negative T cell selection
|
J:132995
|
| increased double-positive T cell number
|
J:132995
|
Lcp2tm4Gak/Lcp2tm4Gak
Tg(TcrAND)53Hed/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:132995
|
Lcp2tm5(Lat/Lcp2)Gak/Lcp2tm5(Lat/Lcp2)Gak
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:147721
|
| decreased double-positive T cell number
|
J:147721
|
Lcp2twm/Lcp2twm
(C57BL/6JSfdAnu-Lcp2twm/Anu)
|
abnormal double-positive T cell morphology
|
J:104190
|
| abnormal negative T cell selection
|
J:104190
|
| abnormal positive T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
Ldb1tm1.1Gsv/Ldb1tm1.1Gsv
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
abnormal embryonic erythropoiesis
|
J:196469
|
Ldb3tm2b(EUCOMM)Hmgu/Ldb3+
(C57BL/6N-Ldb3tm2b(EUCOMM)Hmgu/Bay)
|
increased basophil cell number
|
J:211773
|
Ldhaa-m1Neu/Ldhaa-m1Neu
(C3.Cg-Ldhaa-m1Neu)
|
decreased erythrocyte cell number
|
J:14326
|
| decreased hematocrit
|
J:14326
|
| decreased hemoglobin content
|
J:14326
|
Ldhaa-m1Neu/Ldhaa-m1Neu
(involves: 101/El * C3H/El)
|
abnormal common myeloid progenitor cell morphology
|
J:132674
|
| abnormal erythrocyte morphology
|
J:132674
|
| decreased erythrocyte cell number
|
J:132674
|
| decreased hematocrit
|
J:132674
|
| decreased hemoglobin content
|
J:132674
|
| increased mean corpuscular volume
|
J:132674
|
| increased neutrophil cell number
|
J:132674
|
Ldhaa-m3Neu/Ldhaa-m3Neu
(C3.Cg-Ldhaa-m3Neu)
|
decreased hemoglobin content
|
J:1072
|
Ldlrtm1b(EUCOMM)Wtsi/Ldlrtm1b(EUCOMM)Wtsi
(C57BL/6N-Ldlrtm1b(EUCOMM)Wtsi/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Leprdb-Nokl/Leprdb-Nokl
(C57BL/6N-Leprdb-Nokl)
|
increased glycosylated hemoglobin level
|
J:313303
|
Leprdb/Leprdb-Nokl
(B6NTac.Cg-Leprdb Leprdb-Nokl)
|
increased glycosylated hemoglobin level
|
J:313303
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
increased glycosylated hemoglobin level
|
J:104790
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
increased neutrophil cell number
|
J:115772
|
Leprdb/Leprdb
(B6NTac.BKS(D)-Leprdb)
|
increased glycosylated hemoglobin level
|
J:313303
|
Leprtm1b(EUCOMM)Wtsi/Leprtm1b(EUCOMM)Wtsi
(C57BL/6N-Leprtm1b(EUCOMM)Wtsi/H)
|
increased eosinophil cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Leprottm2a(KOMP)Wtsi/Leprottm2a(KOMP)Wtsi
(C57BL/6N-Leprottm2a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Lfngtm1Rjo/Lfngtm1Rjo
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:146621
|
Lfngtm1Rjo/Lfngtm1Rjo
Mfngtm1Cjg/Mfngtm1Cjg
(B6.Cg-Lfngtm1Rjo Mfngtm1Cjg)
|
abnormal embryonic hematopoiesis
|
J:146621
|
Lgals2tm1.1Cfg/Lgals2tm1.1Cfg
(involves: C57BL/6)
|
decreased neutrophil cell number
|
J:217719
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(involves: 129S2/SvPas * C57BL/6)
|
increased eosinophil cell number
|
J:60741
|
Lgals3tm1Poi/Lgals3tm1Poi
(involves: 129/Sv * C57BL/6 * MF1 * SJL)
|
decreased granulocyte number
|
J:110422
|
Lgals9tm1.1Cfg/Lgals9tm1.1Cfg
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:217719
|
Lgmntm1Ihn/Lgmntm1Ihn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:143886
|
| decreased erythrocyte cell number
|
J:143886
|
| decreased hematocrit
|
J:143886
|
| decreased hemoglobin content
|
J:143886
|
| decreased mean corpuscular hemoglobin
|
J:143886
|
| decreased mean corpuscular hemoglobin concentration
|
J:143886
|
| extramedullary hematopoiesis
|
J:143886
|
Lhcgrtm1(KOMP)Vlcg/Lhcgrtm1(KOMP)Vlcg
(C57BL/6N-Lhcgrtm1(KOMP)Vlcg/Nju)
|
decreased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Lhx2tm1Dra/Lhx2tm1Dra
(involves: 129S4/SvJae)
|
abnormal erythropoiesis
|
J:64676
|
| decreased hematocrit
|
J:64676
|
Liftm1Cgre/Liftm1Cgre
(involves: MF1)
|
increased eosinophil cell number
|
J:96965
|
Liftm1Phb/Liftm1Phb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
decreased common myeloid progenitor cell number
|
J:77410
|
Liftm1Stw/Liftm1Stw
(involves: 129S1/Sv * BALB/c)
|
thrombocytopenia
|
J:136940
|
Lig1m1Anu/Lig1m1Anu
(involves: C3H/HeH * C57BL/6JAnu)
|
increased nucleated erythrocyte cell number
|
J:199856
|
Lig1tm1Dwm/Lig1tm1Dwm
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal erythropoiesis
|
J:76371
|
| absent erythrocytes
|
J:76371
|
| anisocytosis
|
J:76371
|
| poikilocytosis
|
J:76371
|
Lig1tm1Dwm/Lig1tm1Dwm
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:75962
|
| decreased hematocrit
|
J:75962
|
| macrocytosis
|
J:75962
|
Lig1tm2Dwm/Lig1tm2Dwm
(involves: 129P2/OlaHsd)
|
abnormal erythropoiesis
|
J:75962
|
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:50865
|
| abnormal lymphopoiesis
|
J:50865
|
| abnormal T cell differentiation
|
J:63078
|
| arrested B cell differentiation
|
J:63078
|
| arrested T cell differentiation
|
J:50865
|
Lig4tm1Fwa/Lig4tm1Fwa
Tg(Cr2-cre)3Cgn/0
Xrcc4tm2Fwa/Xrcc4tm2Fwa
(involves: 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:126758
|
Lig4tm2.1Fwa/Lig4tm2.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:157574
|
| abnormal T cell differentiation
|
J:157574
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:157574
|
| abnormal T cell receptor V(D)J recombination
|
J:157574
|
| decreased double-negative T cell number
|
J:157574
|
| decreased double-positive T cell number
|
J:157574
|
Lig4tm3.1Fwa/Lig4tm3.1Fwa
Tg(Cr2-cre)3Cgn/0
(Not Specified)
|
abnormal class switch recombination
|
J:157537
|
Limd1em1(IMPC)H/Limd1em1(IMPC)H
(C57BL/6NTac-Limd1em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Lime1tm1.1Mal/Lime1tm1.1Mal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(B6.Cg-Rag2tm1Fwa Lime1tm1.1Mal Tg(TcraH-Y,TcrbH-Y)1Pas)
|
abnormal CD4-positive T cell differentiation
|
J:126321
|
Lin52em1(IMPC)J/Lin52+
(C57BL/6NJ-Lin52em1(IMPC)J/Mmjax)
|
increased mean corpuscular volume
|
J:211773
|
Lman1tm1c(KOMP)Wtsi/Lman1tm1c(KOMP)Wtsi
Tg(Tek-cre)12Flv/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
abnormal platelet morphology
|
J:213133
|
Lmb1C57BL/6Scr/Lmb1C57BL/6Scr
(MRL.Cg-Lmb1C57BL/6Scr Faslpr)
|
increased double-negative T cell number
|
J:125557
|
Lmb2MRL/MpScr/Lmb2MRL/MpScr
(B6.MRL-Lmb2MRL/MpScr Faslpr)
|
decreased double-negative T cell number
|
J:125557
|
Lmbr1lem1Btlr/Lmbr1lem1Btlr
(C57BL/6J-Lmbr1lem1Btlr)
|
abnormal B cell differentiation
|
J:274568
|
Lmbr1lm1Btlr/Lmbr1lm1Btlr
(C57BL/6J-Lmbr1lm1Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274568
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274568
|
| abnormal T cell differentiation
|
J:274568
|
| increased neutrophil cell number
|
J:274568
|
Lmbrd1tm1b(EUCOMM)Hmgu/Lmbrd1+
(C57BL/6N-Lmbrd1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Lmnb1tm1a(EUCOMM)Wtsi/Lmnb1+
(B6Dnk;B6Brd;B6N-Tyrc-Brd Lmnb1tm1a(EUCOMM)Wtsi/WtsiH)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Lmo2tm1Thr/Lmo2tm1Thr
(either: (involves: 129P2/OlaHsd * MF1) or (involves: 129/Sv * 129P2/OlaHsd))
|
abnormal embryonic hematopoiesis
|
J:19175
|
Lmo2tm2(cre)Thr/Lmo2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:155870
|
| decreased erythrocyte cell number
|
J:155870
|
| decreased granulocyte number
|
J:155870
|
| decreased hemoglobin content
|
J:155870
|
| increased mean corpuscular volume
|
J:155870
|
| thrombocytopenia
|
J:155870
|
Lmo4tm1Slp/Lmo4tm1Slp
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
Lmo4tm1Slp/Lmo4tm1Slp
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S1/Sv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
Lmod3em1(IMPC)Mbp/Lmod3+
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Lpcat2em1(IMPC)J/Lpcat2em1(IMPC)J
(C57BL/6NJ-Lpcat2em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Lpin2tm1b(KOMP)Wtsi/Lpin2tm1b(KOMP)Wtsi
(C57BL/6N-Lpin2tm1b(KOMP)Wtsi/Tcp)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Lpin2tm1Reue/Lpin2tm1Reue
(involves: C57BL/6J)
|
abnormal erythrocyte morphology
|
J:189894
|
| decreased hemoglobin content
|
J:189894
|
| increased red blood cell distribution width
|
J:189894
|
Lpin3tm1b(KOMP)Wtsi/Lpin3tm1b(KOMP)Wtsi
(C57BL/6N-Lpin3tm1b(KOMP)Wtsi/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Lpxntm1b(EUCOMM)Hmgu/Lpxntm1b(EUCOMM)Hmgu
(C57BL/6N-Lpxntm1b(EUCOMM)Hmgu/Wtsi)
|
abnormal plasma cell differentiation
|
J:305662
|
Lratd2em1(IMPC)Ccpcz/Lratd2em1(IMPC)Ccpcz
(C57BL/6N-Lratd2em1(IMPC)Ccpcz/Ccpcz)
|
decreased eosinophil cell number
|
J:211773
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2+
(involves: C57BL/10 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:125805
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2+
Tg(H2-K-Myc)1Brn/?
(involves: C57BL/10 * CBA * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:125805
|
| abnormal erythropoiesis
|
J:125805
|
| extramedullary hematopoiesis
|
J:125805
|
Lrfn2Tg(CD2-Myb/en)5Kmw/Lrfn2Tg(CD2-Myb/en)5Kmw
(involves: C57BL/10 * CBA)
|
decreased double-negative T cell number
|
J:126456
|
Lrfn2tm1.1Jaru/Lrfn2tm1.1Jaru
(B6.129P2(Cg)-Lrfn2tm1.1Jaru)
|
abnormal erythropoiesis
|
J:301285
|
| decreased granulocyte number
|
J:301285
|
| decreased hematocrit
|
J:301285
|
| decreased mean corpuscular hemoglobin
|
J:301285
|
| increased erythrocyte cell number
|
J:301285
|
| increased hemoglobin content
|
J:301285
|
Lrif1em1(IMPC)J/Lrif1em1(IMPC)J
(C57BL/6NJ-Lrif1em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Lrpprctm1a(KOMP)Wtsi/Lrpprc+
(C57BL/6N-Lrpprctm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Lrrc4bem1(IMPC)J/Lrrc4bem1(IMPC)J
(C57BL/6NJ-Lrrc4bem1(IMPC)J/Mmjax)
|
increased hematocrit
|
J:211773
|
Lrrc8atm1.1Geha/Lrrc8atm1.1Geha
(B6.129S1(Cg)-Lrrc8atm1.1Geha)
|
abnormal B cell differentiation
|
J:211308
|
| abnormal T cell differentiation
|
J:211308
|
| abnormal T cell selection
|
J:211308
|
| decreased DN2 thymocyte number
|
J:211308
|
| decreased DN3 thymocyte number
|
J:211308
|
| decreased DN4 thymocyte number
|
J:211308
|
| decreased double-negative T cell number
|
J:211308
|
| decreased double-positive T cell number
|
J:211308
|
| decreased immature B cell number
|
J:211308
|
| decreased transitional stage B cell number
|
J:211308
|
| increased pro-B cell number
|
J:211308
|
Lrrc30em1(IMPC)Rbrc/Lrrc30em1(IMPC)Rbrc
(C57BL/6NJcl-Lrrc30em1(IMPC)Rbrc/Rbrc)
|
abnormal mean corpuscular hemoglobin
|
J:211773
|
Lrrc38em1(IMPC)Tcp/Lrrc38em1(IMPC)Tcp
(C57BL/6NCrl-Lrrc38em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Lrrcc1tm1b(EUCOMM)Wtsi/Lrrcc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Lrrcc1tm1b(EUCOMM)Wtsi/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
Lrrk1tm1b(KOMP)Wtsi/Lrrk1tm1b(KOMP)Wtsi
(C57BL/6N-Lrrk1tm1b(KOMP)Wtsi/H)
|
decreased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Lskcn2DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:92256
|
Lsm1tm1b(EUCOMM)Hmgu/Lsm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Lsm1tm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Lsm11tm1a(KOMP)Wtsi/Lsm11+
(C57BL/6N-Lsm11tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Lsm14atm1b(KOMP)Wtsi/Lsm14a+
(C57BL/6N-Lsm14atm1b(KOMP)Wtsi/Nju)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased basophil cell number
|
J:211773
|
Lsm14btm1b(KOMP)Mbp/Lsm14btm1b(KOMP)Mbp
(C57BL/6N-Lsm14btm1b(KOMP)Mbp/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Lsp1tm1Jejb/Lsp1tm1Jejb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal lymphopoiesis
|
J:64219
|
Ltahlb382/Ltahlb382
(C57BL/6J-Ltahlb382/J)
|
decreased transitional stage B cell number
|
J:134498
|
Ltatm1.1(KOMP)Vlcg/Ltatm1.1(KOMP)Vlcg
(C57BL/6N-Ltatm1.1(KOMP)Vlcg/Ucd)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Ltatm1.1Sned/Ltatm1.1Sned
(B6.129-Ltatm1.1Sned)
|
abnormal class switch recombination
|
J:109621
|
| abnormal lymphopoiesis
|
J:109621
|
Ltatm1Dch/Ltatm1Dch
(B6.129S2-Ltatm1Dch)
|
abnormal class switch recombination
|
J:80616
|
Ltatm1Dch/Ltatm1Dch
(involves: 129S2/SvPas * C57BL/6)
|
abnormal class switch recombination
|
J:109621
|
Ltb4r1tm1Tksh/Ltb4r1tm1Tksh
(B6.Cg-Ltb4r1tm1Tksh)
|
decreased eosinophil cell number
|
J:118995
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
Ltb/Tnf/Ltatm1Dvk/Ltb/Tnf/Ltatm1Dvk
(B6.Cg-Ltb/Tnf/Ltatm1Dvk)
|
abnormal class switch recombination
|
J:80616
|
Ltbtm1Kpf/Ltbtm1Kpf
(B6.129P2-Ltbtm1Kpf)
|
abnormal class switch recombination
|
J:80616
|
Ltbp1tm1a(EUCOMM)Wtsi/Ltbp1tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Ltbp1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Ltbrtm1Avt/Ltbrtm1Avt
Tg(Rorc-cre)1Litt/0
(Not Specified)
|
decreased neutrophil cell number
|
J:158663
|
Ltbrtm1Avt/Ltbrtm1Avt
Tg(Vil1-cre)997Gum/0
(involves: C57BL/6J * SJL)
|
decreased neutrophil cell number
|
J:158663
|
Ltbrtm1Kpf/Ltbrtm1Kpf
(B6.129P2-Ltbrtm1Kpf)
|
decreased neutrophil cell number
|
J:158663
|
Ltn1tm1b(EUCOMM)Hmgu/Ltn1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ltn1tm1b(EUCOMM)Hmgu/Ccpcz)
|
increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Luc7l3em1(IMPC)J/Luc7l3+
(C57BL/6NJ-Luc7l3em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
Luc7lem1(IMPC)Mbp/Luc7lem1(IMPC)Mbp
(C57BL/6N-Luc7lem1(IMPC)Mbp/MbpMmucd)
|
increased erythrocyte cell number
|
J:211773
|
Lumtm1Wwk/Lumtm1Wwk
(involves: 129P2/OlaHsd)
|
decreased neutrophil cell number
|
J:128992
|
Ly6atm1Pmf/Ly6atm1Pmf
(B6.129P2-Ly6atm1Pmf)
|
abnormal common myeloid progenitor cell morphology
|
J:81387
|
| abnormal definitive hematopoiesis
|
J:81387
|
| decreased granulocyte number
|
J:81387
|
| thrombocytopenia
|
J:81387
|
Ly6atm1Pmf/Ly6atm1Pmf
(C.129P2-Ly6atm1Pmf)
|
abnormal common myeloid progenitor cell morphology
|
J:83409
|
Ly6atm2(RUNX1)Grau/Ly6a+
(involves: 129X1/SvJ * C57BL/6J)
|
absent common myeloid progenitor cells
|
J:93408
|
| extramedullary hematopoiesis
|
J:93408
|
| increased neutrophil cell number
|
J:93408
|
| myeloid hyperplasia
|
J:93408
|
| polychromatophilia
|
J:93408
|
Ly6etm1c(EUCOMM)Hmgu/Ly6etm1c(EUCOMM)Hmgu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Ly6etm1c(EUCOMM)Hmgu Commd10Tg(Vav1-icre)A2Kio)
|
decreased neutrophil cell number
|
J:291868
|
Ly6g6dtm1b(EUCOMM)Hmgu/Ly6g6dtm1b(EUCOMM)Hmgu
(C57BL/6N-Ly6g6dtm1b(EUCOMM)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Lyl1tm1Fsky/Lyl1tm1Fsky
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:116300
|
| arrested B cell differentiation
|
J:116300
|
| decreased pro-B cell number
|
J:116300
|
| thrombocytopenia
|
J:173665
|
Lyl1tm1Mago/Lyl1tm1Mago
(B6.129S7-Lyl1tm1Mago)
|
thrombocytopenia
|
J:173665
|
LynM1Btlr/Lyn+
(C57BL/6J-LynM1Btlr)
|
increased neutrophil cell number
|
J:214511
|
LynM1Btlr/LynM1Btlr
(C57BL/6J-LynM1Btlr)
|
increased neutrophil cell number
|
J:214511
|
Lynm2Anu/Lynm2Anu
(C57B/6JAnu-Lynm2Anu/AnuApb)
|
increased immature B cell number
|
J:104190
|
Lynmld4/Lynmld4
(involves: C57BL/6)
|
abnormal myelopoiesis
|
J:144799
|
| decreased transitional stage B cell number
|
J:144799
|
| increased neutrophil cell number
|
J:144799
|
Lynmld4/Lynmld4
Mpltm1Wsa/Mpltm1Wsa
(B6.129S1-Mpltm1Wsa)
|
decreased erythrocyte cell number
|
J:144799
|
| thrombocytopenia
|
J:144799
|
Lyntm1.1Calo/Lyntm1.1Calo
Tg(Itgax-cre)1-1Reiz/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased granulocyte number
|
J:200745
|
| myeloid hyperplasia
|
J:200745
|
Lyntm1Ard/Lyntm1Ard
(involves: 129P2/OlaHsd)
|
extramedullary hematopoiesis
|
J:72269
|
| increased basophil cell number
|
J:161523
|
| increased mast cell number
|
J:161523
|
| increased neutrophil cell number
|
J:72269
|
| thrombocytopenia
|
J:72269
|
Lyntm1Ard/Lyntm1Ard
(B6.129P2-Lyntm1Ard)
|
abnormal myelopoiesis
|
J:144799
|
| decreased transitional stage B cell number
|
J:144799
|
Lyntm1Ard/Lyntm1Ard
Tg(IghelMD4)4Ccg/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell negative selection
|
J:110531
|
Lyntm1b(EUCOMM)Hmgu/Lyntm1b(EUCOMM)Hmgu
(C57BL/6N-Lyntm1b(EUCOMM)Hmgu/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Lyntm1Mhi/Lyntm1Mhi
(involves: 129S1/Sv)
|
increased neutrophil cell number
|
J:72269
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
decreased transitional stage B cell number
|
J:146161
|
| myeloid hyperplasia
|
J:146161
|
Lyntm1Tya/Lyntm1Tya
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:29751
|
Lynweeb/Lynweeb
(C57BL/6-Lynweeb)
|
decreased transitional stage B cell number
|
J:146161
|
Lyplal1tm1b(KOMP)Wtsi/Lyplal1tm1b(KOMP)Wtsi
(C57BL/6N-Lyplal1tm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular volume
|
J:211773
|
| increased hematocrit
|
J:211773
|
Lystbg-grey/Lystbg-grey
(C57BL/6-Lystbg-grey)
|
abnormal dermal mast cell morphology
|
J:106442
|
Lystbg-J/Lystbg-J
(C57BL/6J-Lystbg-J/J)
|
abnormal granulocyte morphology
|
J:34814
|
| abnormal neutrophil morphology
|
J:34814
|
| decreased platelet ADP level
|
J:7327
|
| decreased platelet ATP level
|
J:7327
|
| decreased platelet serotonin level
|
J:7327
|
Lystbg-J/Lystbg-J
Prkdcscid/Prkdcscid
(B6.Cg-Lystbg-J Prkdcscid/Sz)
|
abnormal granulocyte morphology
|
J:34814
|
| abnormal neutrophil morphology
|
J:34814
|
| increased eosinophil cell number
|
J:34814
|
| increased granulocyte number
|
J:34814
|
| increased neutrophil cell number
|
J:34814
|
Lystbg/Lystbg
(B6.C3Rl-Lystbg)
|
abnormal eosinophil morphology
|
J:5078
|
| abnormal neutrophil morphology
|
J:5078
|
Lysttm1b(EUCOMM)Wtsi/Lysttm1b(EUCOMM)Wtsi
(C57BL/6N-Lysttm1b(EUCOMM)Wtsi/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Lyz2tm1(cre)Ifo/Lyz2+
Pdcd10tm1Wami/Pdcd10tm1Wami
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil morphology
|
J:256076
|
Lyz2tm1(cre)Ifo/Lyz2+
Pikfyvetm1b(EUCOMM)Hmgu/Pikfyvetm1b(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased eosinophil cell number
|
J:244776
|
Lztr1tm1a(EUCOMM)Wtsi/Lztr1+
(C57BL/6N-Lztr1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
X/m1Nish
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:204833
|
| abnormal NK cell differentiation
|
J:204833
|
| decreased immature B cell number
|
J:204833
|
M7321Wlst/M7321Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:189491
|
| thrombocytosis
|
J:189491
|
M7323Wlst/M7323Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
thrombocytosis
|
J:189491
|
M7324Wlst/M7324Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:189491
|
| thrombocytopenia
|
J:189491
|
M7325Wlst/M7325Wlst+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:189491
|
| thrombocytosis
|
J:189491
|
Macrod2tm1.1(KOMP)Vlcg/Macrod2tm1.1(KOMP)Vlcg
(C57BL/6N-Macrod2tm1.1(KOMP)Vlcg/J)
|
increased hemoglobin content
|
J:211773
|
Macroh2a1tm1.1Oxbo/Macroh2a1tm1.1Oxbo
(B6.Cg-Macroh2a1tm1.1Oxbo)
|
decreased hematocrit
|
J:293382
|
| decreased neutrophil cell number
|
J:293382
|
| increased eosinophil cell number
|
J:293382
|
MaeaGt(XG702)Byg/MaeaGt(XG702)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythropoiesis
|
J:114865
|
| increased nucleated erythrocyte cell number
|
J:114865
|
Mafgtm1Jeng/Mafgtm1Jeng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
thrombocytopenia
|
J:78982
|
Mafgtm1Jeng/Mafgtm1Jeng
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
thrombocytopenia
|
J:78982
|
Mafgtm1Jeng/Mafgtm1Jeng
Mafktm1Jeng/Mafk+
(involves: 129S1/Sv * 129X1/SvJ)
|
thrombocytopenia
|
J:61142
|
Mafgtm1Jeng/Mafgtm1Jeng
Mafktm1Jeng/Mafktm1Jeng
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythrocyte morphology
|
J:61142
|
| extramedullary hematopoiesis
|
J:61142
|
| thrombocytopenia
|
J:61142
|
Magixem1(IMPC)Hmgu/Y
(C57BL/6NCrl-Magixem1(IMPC)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Magixem1(IMPC)Hmgu/Magixem1(IMPC)Hmgu
(C57BL/6NCrl-Magixem1(IMPC)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Malt1tm1Vmd/Malt1tm1Vmd
(involves: C57BL/6N)
|
abnormal B cell differentiation
|
J:86770
|
| abnormal double-negative T cell morphology
|
J:86770
|
| abnormal T cell differentiation
|
J:86770
|
Maml1tm1Mkit/Maml1tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:122286
|
Man2a1em1(IMPC)Hmgu/Man2a1em1(IMPC)Hmgu
(C57BL/6N-Man2a1em1(IMPC)Hmgu/Ieg)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Man2a1tm1Jxm/Man2a1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal erythrocyte morphology
|
J:41621
|
| anisocytosis
|
J:41621
|
Man2b2tm1b(KOMP)Wtsi/Man2b2tm1b(KOMP)Wtsi
(C57BL/6N-Man2b2tm1b(KOMP)Wtsi/Tcp)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Manealtm1a(KOMP)Wtsi/Manealtm1a(KOMP)Wtsi
(C57BL/6N-Manealtm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Map3k1tm1a(KOMP)Wtsi/Map3k1+
(C57BL/6N-Map3k1tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Map3k3tm1Kuro/Map3k3tm1Kuro
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:147103
|
| increased double-negative T cell number
|
J:147103
|
Map3k9em1(IMPC)Mbp/Map3k9em1(IMPC)Mbp
(C57BL/6N-Map3k9em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Map3k14aly/Map3k14aly
(involves: C57BL/6J)
|
decreased mast cell number
|
J:135748
|
| increased eosinophil cell number
|
J:135748
|
Map3k14aly/Map3k14aly
(involves: AEJ/GnRk * C57BL/6J)
|
abnormal lymphopoiesis
|
J:16865
|
Map3k14m1Btlr/Map3k14m1Btlr
(C57BL/6J-Map3k14m1Btlr)
|
arrested B cell differentiation
|
J:152065
|
Map3k14m1Btlr/Map3k14m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| arrested B cell differentiation
|
J:185495
|
Map3k14tm1.2Gne/Map3k14tm1.2Gne
(B6(Cg)-Map3k14tm1.2Gne)
|
decreased transitional stage T1 B cell number
|
J:240453
|
| decreased transitional stage T2 B cell number
|
J:240453
|
Map3k14tm1Rds/Map3k14tm1Rds
(involves: 129)
|
abnormal class switch recombination
|
J:188560
|
Map4k3Gt(RRO270)Byg/Map4k3Gt(RRO270)Byg
(involves: 129P2/OlaHsd)
|
abnormal T-helper 1 cell differentiation
|
J:177642
|
| abnormal T-helper 2 cell differentiation
|
J:177642
|
| abnormal T-helper 17 cell differentiation
|
J:177642
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Cd4-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Cd4-cre)1Cwi/0
Tg(TcrAND)53Hed/0
(involves: 129/Sv * C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Lck-cre)1Cwi/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:113280
|
| increased double-positive T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(Lck-cre)1Cwi/0
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal positive T cell selection
|
J:113280
|
Mapk1tm1Hed/Mapk1tm1Hed
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal double-positive T cell morphology
|
J:113280
|
| abnormal positive T cell selection
|
J:113280
|
Mapk1tm2Moga/Mapk1tm2Moga
Mapk3tm1Gpg/Mapk3tm1Gpg
Tg(Mx1-cre)1Cgn/?
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal pro-B cell differentiation
|
J:134528
|
| abnormal pro-B cell morphology
|
J:134528
|
Mapk8tm1Flv/Mapk8tm1Flv
(involves: 129S1/Sv)
|
abnormal T-helper 1 cell differentiation
|
J:51510
|
Mapk8tm1Rjd/Mapk8tm1Rjd
Mapk9tm2.1Rjd/Mapk9tm2.1Rjd
Lyz2tm1(cre)Ifo/Lyz2+
(B6J.Cg-Lyz2tm1(cre)Ifo Mapk9tm2.1Rjd Mapk8tm1Rjd)
|
abnormal macrophage differentiation
|
J:192551
|
Mapk9tm1Flv/Mapk9tm1Flv
(involves: 129S2/SvPas)
|
abnormal T-helper 1 cell differentiation
|
J:50628
|
Mapk11tm1Jda/Mapk11tm1Jda
Mapk14tm1Jda/Mapk14tm1Jda
(involves: 129 * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:165966
|
| abnormal T-helper 2 cell differentiation
|
J:165966
|
| abnormal T-helper 17 cell differentiation
|
J:165966
|
Mapk14tm1Jda/Mapk14tm1Jda
(B6.Cg-Mapk14tm1Jda)
|
increased double-negative T cell number
|
J:146088
|
Mapk14tm1Mka/Mapk14tm1Mka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal erythropoiesis
|
J:63425
|
Mapk15tm1b(EUCOMM)Hmgu/Mapk15tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapk15tm1b(EUCOMM)Hmgu/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Mapkapk2tm1b(EUCOMM)Hmgu/Mapkapk2tm1b(EUCOMM)Hmgu
(C57BL/6N-Mapkapk2tm1b(EUCOMM)Hmgu/H)
|
increased eosinophil cell number
|
J:211773
|
Mapre3tm1a(EUCOMM)Wtsi/Mapre3+
(C57BL/6N-Mapre3tm1a(EUCOMM)Wtsi/Ics)
|
increased hematocrit
|
J:165965
|
Mar1tm1Wtg/Mar1+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
Mar1tm1Wtg/Mar1tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:68024
|
Marchf1tm1.1Sish/Marchf1tm1.1Sish
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:201198
|
Marchf6tm1b(EUCOMM)Hmgu/Marchf6tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf6tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Marchf8em2(IMPC)Ccpcz/Marchf8em2(IMPC)Ccpcz
(C57BL/6N-Marchf8em2(IMPC)Ccpcz/Ccpcz)
|
decreased eosinophil cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Matn1tm1Ref/Matn1tm1Ref
Matn2tm1Asz/Matn2tm1Asz
Matn3tm1Asz/Matn3tm1Asz
Matn4tm1.1Asz/Matn4tm1.1Asz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-positive T cell number
|
J:237230
|
| decreased erythrocyte cell number
|
J:237230
|
| increased granulocyte number
|
J:237230
|
Mbtm1Jsc/Mbtm1Jsc
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
increased hematocrit
|
J:57481
|
| increased hemoglobin content
|
J:57481
|
Mbd1em1(IMPC)Wtsi/Mbd1em1(IMPC)Wtsi
(C57BL/6N-Mbd1em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Mcattm1.1Ssmi/Mcattm1.1Ssmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
abnormal myelopoiesis
|
J:192213
|
| decreased erythrocyte cell number
|
J:192213
|
| decreased hematocrit
|
J:192213
|
| decreased hemoglobin content
|
J:192213
|
| extramedullary hematopoiesis
|
J:192213
|
| increased mean corpuscular volume
|
J:192213
|
| increased red blood cell distribution width
|
J:192213
|
Mccc2em1(IMPC)J/Mccc2+
(C57BL/6NJ-Mccc2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Mcemp1em1Jngj/Mcemp1em1Jngj
(C57BL/6-Mcemp1em1Jngj)
|
abnormal mast cell differentiation
|
J:335318
|
Mchq1SM/J/Mchq1SM/J
(involves: C57BLKS/J * SM/J)
|
increased mean corpuscular hemoglobin
|
J:107220
|
Mcl1em1(IMPC)Mbp/Mcl1+
(C57BL/6N-Mcl1em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Mcl1tm1Dmta/Mcl1tm1Dmta
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Mcl1tm1Dmta Gt(ROSA)26Sortm9(cre/ESR1)Arte)
|
abnormal B cell differentiation
|
J:166069
|
Mcl1tm1Yen/Mcl1tm1Yen
(B6.129-Mcl1tm1Yen)
|
abnormal double-positive T cell morphology
|
J:146246
|
| decreased double-negative T cell number
|
J:146246
|
Mcl1tm1Yen/Mcl1tm1Yen
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal double-positive T cell morphology
|
J:146246
|
Mcl1tm1Yen/Mcl1tm1Yen
Tg(TcraTcrb)425Cbn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:146246
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased granulocyte number
|
J:137502
|
| decreased neutrophil cell number
|
J:137502
|
| increased eosinophil cell number
|
J:137502
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Cd4-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
increased double-positive T cell number
|
J:137400
|
Mcl1tm1Ywh/Mcl1tm1Ywh
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:137400
|
| decreased double-negative T cell number
|
J:137400
|
| decreased double-positive T cell number
|
J:137400
|
Mcl1tm2Sjk/Mcl1tm3Sjk
Tg(Lck-cre)1Cwi/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:86906
|
| decreased double-negative T cell number
|
J:86906
|
| decreased double-positive T cell number
|
J:86906
|
Mcl1tm3Sjk/Mcl1tm3Sjk
Tg(Cpa3-cre)3Glli/0
(involves: 129X1/Sv * C57BL/6)
|
decreased basophil cell number
|
J:179080
|
| decreased erythrocyte cell number
|
J:179080
|
| decreased hematocrit
|
J:179080
|
| decreased mast cell number
|
J:179080
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4Gt(RRE056)Byg/Mcm4+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4Gt(RRE056)Byg/Mcm4+
Mcm6Gt(YHD248)Byg/Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4Gt(RRE056)Byg/Mcm4+
Mcm6Gt(YHD248)Byg/Mcm6+
Mcm7Gt(YTA285)Byg/Mcm7+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm6Gt(YHD248)Byg/Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm6Gt(YHD248)Byg/Mcm6+
Mcm7Gt(YTA285)Byg/Mcm7+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm4chaos3/Mcm4chaos3
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm4Gt(RRE056)Byg/Mcm4+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2Gt(AB0178)Wtsi/Mcm2+
Mcm4Gt(RRE056)Byg/Mcm4+
Mcm6Gt(YHD248)Byg/Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm2tm1(cre/ERT2)Scpr/Mcm2tm1(cre/ERT2)Scpr
(involves: 129S6/SvEvTac)
|
abnormal erythrocyte morphology
|
J:141493
|
Mcm3Gt(RRR002)Byg/Mcm3+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4Gt(RRE056)Byg/Mcm4+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm3Gt(RRR002)Byg/Mcm3+
Mcm4Gt(RRE056)Byg/Mcm4+
Mcm6Gt(YHD248)Byg/Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm3tm1.1Geno/Mcm3tm1.1Geno
(involves: 129S2/SvPas * C57BL/6)
|
abnormal erythrocyte morphology
|
J:227638
|
| abnormal erythropoiesis
|
J:227638
|
| decreased fetal derived definitive erythrocyte cell number
|
J:227638
|
| decreased hematocrit
|
J:227638
|
| decreased hemoglobin content
|
J:227638
|
Mcm4chaos3/Mcm4chaos3
(involves: C57BL/6J)
|
abnormal erythrocyte morphology
|
J:117494,
J:165667
|
Mcm4chaos3/Mcm4chaos3
Mcm7Gt(YTA285)Byg/Mcm7+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm4Gt(RRE056)Byg/Mcm4+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm4Sdla/Mcm4+
(involves: C57BL/6)
|
decreased DN1 thymic pro-T cell number
|
J:194117
|
Mcm6Gt(YHD248)Byg/Mcm6+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm7Gt(YTA285)Byg/Mcm7+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal erythrocyte morphology
|
J:165667
|
Mcm9Gt(XG743)Byg/Mcm9Gt(XG743)Byg
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
abnormal definitive hematopoiesis
|
J:177420
|
Mcmbpem1(IMPC)J/Mcmbp+
(C57BL/6NJ-Mcmbpem1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Mcpt1tm1Hrpm/Mcpt1tm1Hrpm
(involves: 129P2/OlaHsd * MF1)
|
abnormal mast cell morphology
|
J:93795
|
Mcpt8tm1.1(HBEGF)Hkar/Mcpt8tm1.1(HBEGF)Hkar
(B6.Cg-Mcpt8tm1.1(HBEGF)Hkar)
|
decreased basophil cell number
|
J:163761
|
McrC57BL/10J/McrNC
(involves: C57BL/10J * NC)
|
cutaneous mastocytosis
|
J:8804
|
McrNC/McrNC
(involves: C57BL/10J * NC)
|
cutaneous mastocytosis
|
J:8804
|
Mcvq1SM/J/Mcvq1SM/J
(involves: C57BLKS/J * NZW/LacJ * SM/J)
|
increased mean corpuscular volume
|
J:107220
|
Mcvq2NZW/LacJ/Mcvq2SM/J
(involves: NZW/LacJ * SM/J)
|
decreased mean corpuscular volume
|
J:107220
|
Mcvq3SM/J/Mcvq3SM/J
(involves: C57BLKS/J * SM/J)
|
increased mean corpuscular volume
|
J:107220
|
Mdc1Gt(OST441263)Lex/Mdc1Gt(OST441263)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:137341
|
Mdktm1.1(KOMP)Mbp/Mdktm1.1(KOMP)Mbp
(C57BL/6N-Mdktm1.1(KOMP)Mbp/J)
|
decreased mean corpuscular volume
|
J:211773
|
Mdm2tm1Bay/Mdm2tm1Mep
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal B cell differentiation
|
J:81065
|
| decreased double-negative T cell number
|
J:81065
|
| decreased double-positive T cell number
|
J:81065
|
| decreased erythrocyte cell number
|
J:81065
|
| decreased granulocyte number
|
J:81065
|
| decreased immature B cell number
|
J:81065
|
| decreased neutrophil cell number
|
J:81065
|
Mdm2tm1Glo/Mdm2+
Mdm4tm1Glo/Mdm4+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:123661
|
| decreased erythrocyte cell number
|
J:123661
|
| decreased hemoglobin content
|
J:123661
|
| thrombocytopenia
|
J:123661
|
Mdm2tm1Glo/Mdm2+
Trp53tm2Wahl/Trp53tm2Wahl
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6)
|
decreased erythrocyte cell number
|
J:174375
|
| thrombocytopenia
|
J:174375
|
Mdm4tm1.1Wahl/Mdm4tm1.1Wahl
(involves: 129S/Sv * C57BL/6)
|
increased erythrocyte cell number
|
J:150341
|
| thrombocytosis
|
J:150341
|
Mecomem1(IMPC)J/Mecom+
(C57BL/6NJ-Mecomem1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
MecomJbo/Mecom+
(C3N.C-MecomJbo)
|
abnormal neutrophil differentiation
|
J:113445
|
Mecomtm1.1Miku/Mecom+
(B6.Cg-Mecomtm1.1Miku)
|
abnormal platelet morphology
|
J:149794
|
Mecomtm1Aspe/Mecomtm1Aspe
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:178429
|
| thrombocytopenia
|
J:178429
|
Mecomtm1Aspe/Mecomtm2.1Aspe
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/SvImJ * C57BL/6 * C57BL/6J * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:178429
|
| decreased common myeloid progenitor cell number
|
J:178429
|
Mecomtm1Miku/Mecomtm1Miku
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal platelet morphology
|
J:149794
|
| thrombocytopenia
|
J:149794
|
Mecomtm2.1Aspe/Mecomtm2.1Aspe
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/SvImJ * C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:178429
|
| decreased common myeloid progenitor cell number
|
J:178429
|
Mecomtm2.2Aspe/Mecomtm2.2Aspe
(involves: 129 * C57BL/6J * FVB/N)
|
thrombocytopenia
|
J:213829
|
Med1tm1.1Mpk/Med1tm1.1Mpk
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased nucleated erythrocyte cell number
|
J:86857
|
Med1tm1Jkr/Med1tm1Jkr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:74328
|
Med1tm1Mpk/Med1tm1Mpk
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased nucleated erythrocyte cell number
|
J:86857
|
Med10em1(IMPC)J/Med10+
(C57BL/6NJ-Med10em1(IMPC)J/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Med23em1(IMPC)Wtsi/Med23+
(C57BL/6N-Med23em1(IMPC)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Med24tm1Rgr/Med24tm1Rgr
(involves: 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal embryonic erythropoiesis
|
J:77765
|
Med25tm1b(KOMP)Wtsi/Med25+
(C57BL/6N-Med25tm1b(KOMP)Wtsi/Ics)
|
decreased mean corpuscular volume
|
J:211773
|
Mef2ctm1Eno/Mef2ctm1Eno
(involves: 129S7/SvEvBrd)
|
abnormal definitive hematopoiesis
|
J:56426
|
Mef2ctm1Jjs/Mef2ctm1Jjs
Mir223tm1Fcam/Mir223tm1Fcam
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129 * C57BL/6)
|
abnormal neutrophil differentiation
|
J:140009
|
| increased neutrophil cell number
|
J:140009
|
Mefvtm5.1(MEFV)Chae/Mefvtm5.1(MEFV)Chae
(B6.129S6-Mefvtm5.1(MEFV)Chae)
|
increased granulocyte number
|
J:172117
|
| increased neutrophil cell number
|
J:172117
|
Meis1tm1Mtor/Meis1tm1Mtor
(involves: CD-1)
|
absent common myeloid progenitor cells
|
J:98307
|
| absent platelets
|
J:98307
|
Meis1tm1Ngc/Meis1tm1Ngc
(involves: 129 * C57BL/6NCr)
|
decreased common myeloid progenitor cell number
|
J:87890
|
Meis1tm2Ngc/Meis1tm2Ngc
Tg(Tal1-cre/ERT)42-056Jrg/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J)
|
decreased common myeloid progenitor cell number
|
J:192126
|
Meox2tm1(cre)Sor/Meox2+
Procrtm2Cte/Procrtm2Cte
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * Black Swiss * C57BL/6)
|
thrombocytopenia
|
J:119529
|
Meox2tm1(cre)Sor/Meox2+
Slc40a1tm2Nca/Slc40a1tm2Nca
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal erythrocyte morphology
|
J:129846
|
| anisocytosis
|
J:129846
|
| decreased hemoglobin content
|
J:129846
|
| decreased mean corpuscular hemoglobin
|
J:129846
|
| decreased mean corpuscular volume
|
J:129846
|
| poikilocytosis
|
J:129846
|
Mertktm1Gkm/Mertktm1Gkm
Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/0
(NOD.Cg-Mertktm1Gkm Tg(TcraBDC2.5,TcrbBDC2.5)1Doi)
|
decreased double-positive T cell number
|
J:147153
|
Metrnem1(IMPC)Mbp/Metrnem1(IMPC)Mbp
(C57BL/6NCrl-Metrnem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Mettl5em1(IMPC)Hmgu/Mettl5+
(C57BL/6N-Mettl5em1(IMPC)Hmgu/Ieg)
|
increased hematocrit
|
J:211773
|
Mettl5em1(IMPC)Hmgu/Mettl5em1(IMPC)Hmgu
(C57BL/6N-Mettl5em1(IMPC)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Mettl16tm1b(KOMP)Mbp/Mettl16+
(C57BL/6N-Mettl16tm1b(KOMP)Mbp/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Mettl23em1(IMPC)Hmgu/Mettl23em1(IMPC)Hmgu
(C57BL/6NCrl-Mettl23em1(IMPC)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Mettl24tm1a(KOMP)Wtsi/Mettl24tm1a(KOMP)Wtsi
(C57BL/6N-Mettl24tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Mfap2tm1a(KOMP)Wtsi/Mfap2tm1a(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal hemopoiesis
|
J:236092
|
| decreased neutrophil cell number
|
J:236092
|
Mfap2tm1Mech/Mfap2tm1Mech
(B6.129X1-Mfap2tm1Mech)
|
thrombocytopenia
|
J:134343
|
Mfap2tm1Mech/Mfap2tm1Mech
Mfap5tm1Mech/Mfap5tm1Mech
(involves: 129X1/SvJ)
|
decreased neutrophil cell number
|
J:203960
|
Mfap5tm1Mech/Mfap5tm1Mech
(Not Specified)
|
decreased neutrophil cell number
|
J:203960
|
Mfngtm1.1Cfg/Mfngtm1.1Cfg
(involves: C57BL/6)
|
decreased neutrophil cell number
|
J:217719
|
Mfsd1em1(IMPC)Tcp/Mfsd1em1(IMPC)Tcp
(C57BL/6N-Mfsd1em1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(B6JTyr;B6N-Mfsd2btm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Mfsd2btm1a(KOMP)Wtsi/Mfsd2btm1a(KOMP)Wtsi
(C57BL/6-Mfsd2btm1a(KOMP)Wtsi)
|
abnormal mean corpuscular volume
|
J:250123
|
| abnormal stress erythropoiesis
|
J:250123
|
| decreased erythrocyte cell number
|
J:250123
|
| stomatocytosis
|
J:250123
|
Mgat1tm1b(EUCOMM)Hmgu/Mgat1+
(C57BL/6N-Mgat1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased mean corpuscular volume
|
J:80661
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal B cell differentiation
|
J:80661
|
Mgat4btm1.1Jxm/Mgat4btm1.1Jxm
(B6.129-Mgat4btm1.1Jxm)
|
decreased neutrophil cell number
|
J:212313
|
| decreased red blood cell distribution width
|
J:212313
|
| increased mean corpuscular hemoglobin
|
J:212313
|
| increased mean corpuscular volume
|
J:212313
|
Mgllem1(IMPC)Hmgu/Mgllem1(IMPC)Hmgu
(C57BL/6N-Mgllem1(IMPC)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Mgme1em1(IMPC)J/Mgme1em1(IMPC)J
(C57BL/6NJ-Mgme1em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Mgme1tm1.2Lrsn/Mgme1tm1.2Lrsn
(involves: C57BL/6NTac)
|
decreased hemoglobin content
|
J:259702
|
Mgrn1em1(IMPC)Tcp/Mgrn1+
(C57BL/6NCrl-Mgrn1em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Mgrn1em1(IMPC)Tcp/Mgrn1em1(IMPC)Tcp
(C57BL/6NCrl-Mgrn1em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Mgst3tm1a(KOMP)Wtsi/Mgst3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Mgst3tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular volume
|
J:175295
|
| increased mean corpuscular volume
|
J:175295
|
Mhstq2M. macedonius/Mhstq2M. macedonius
(involves: C57BL/6J * M. macedonius)
|
thrombocytopenia
|
J:94029
|
Mib1tm1Kong/Mib1tm1Kong
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:137915
|
Mib1tm2Kong/Mib1tm2Kong
Tg(Tek-cre)12Flv/0
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:137915
|
Mical3em1(IMPC)J/Mical3em1(IMPC)J
(C57BL/6NJ-Mical3em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Micu2tm1a(EUCOMM)Wtsi/Micu2tm1a(EUCOMM)Wtsi
(C57BL/6N-Micu2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Mideasem1Shmc/Mideasem1Shmc
(C57BL/6J-Mideasem1Shmc)
|
absent erythrocytes
|
J:291786
|
Miftm1Mky/Miftm1Mky
(C.129-Miftm1Mky)
|
decreased eosinophil cell number
|
J:106380
|
Miga2tm1a(KOMP)Wtsi/Miga2tm1a(KOMP)Wtsi
(B6JTyr;B6N-Miga2tm1a(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:175295
|
| decreased hemoglobin content
|
J:175295
|
Mindy1tm1a(EUCOMM)Wtsi/Mindy1tm1a(EUCOMM)Wtsi
(C57BL/6N-Mindy1tm1a(EUCOMM)Wtsi/Ics)
|
increased hemoglobin content
|
J:165965
|
Mindy3em1(IMPC)H/Mindy3em1(IMPC)H
(C57BL/6NTac-Mindy3em1(IMPC)H/H)
|
decreased mean corpuscular volume
|
J:211773
|
Mir122tm1.2Kgh/Mir122tm1.2Kgh
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
increased neutrophil cell number
|
J:190067
|
Mir142tm1.1Sbel/Mir142tm1.1Sbel
(involves: C57BL/6N)
|
decreased eosinophil cell number
|
J:227228
|
| increased mean platelet volume
|
J:227228
|
| thrombocytopenia
|
J:227228
|
Mir142hgGt(IST11580H2)Tigm/Mir142hgGt(IST11580H2)Tigm
(involves: C57BL/6N)
|
abnormal definitive hematopoiesis
|
J:207516
|
| abnormal dendritic cell differentiation
|
J:207516
|
| increased neutrophil cell number
|
J:207516
|
Mir144/Mir451atm1.1Mjwe/Mir144/Mir451atm1.1Mjwe
(Not Specified)
|
decreased hemoglobin content
|
J:163250
|
| decreased mean corpuscular hemoglobin
|
J:163250
|
| decreased mean corpuscular volume
|
J:163250
|
| increased number of Heinz bodies
|
J:163250
|
| increased red blood cell distribution width
|
J:163250
|
| polychromatophilia
|
J:163250
|
Mir144/Mir451atm1.1Mjwe/Mir144/Mir451atm1.1Mjwe
(Not Specified)
|
decreased hemoglobin content
|
J:163250
|
| decreased mean corpuscular hemoglobin
|
J:163250
|
| decreased mean corpuscular volume
|
J:163250
|
| increased number of Heinz bodies
|
J:163250
|
| increased red blood cell distribution width
|
J:163250
|
| polychromatophilia
|
J:163250
|
Mir144/Mir451atm1.2Doca/Mir144/Mir451atm1.2Doca
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)
|
abnormal erythropoiesis
|
J:163418
|
| anisocytosis
|
J:163418
|
| decreased erythrocyte cell number
|
J:163418
|
| decreased hematocrit
|
J:163418
|
| decreased hemoglobin content
|
J:163418
|
| increased red blood cell distribution width
|
J:163418
|
Mir144/Mir451atm1.2Doca/Mir144/Mir451atm1.2Doca
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)
|
abnormal erythropoiesis
|
J:163418
|
| anisocytosis
|
J:163418
|
| decreased erythrocyte cell number
|
J:163418
|
| decreased hematocrit
|
J:163418
|
| decreased hemoglobin content
|
J:163418
|
| increased red blood cell distribution width
|
J:163418
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:167922
|
| decreased erythrocyte cell number
|
J:173230
|
| decreased hematocrit
|
J:173230
|
| decreased hemoglobin content
|
J:173230
|
| extramedullary hematopoiesis
|
J:173230
|
| myeloid hyperplasia
|
J:167922,
J:173230
|
| thrombocytopenia
|
J:173230
|
Mir146tm1.1Bal/Mir146tm1.1Bal
(involves: C57BL/6 * FVB/N)
|
myeloid hyperplasia
|
J:173671
|
Mir146tm1.1Bal/Mir146tm1.1Bal
Tifabtm1.1Dsta/Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased neutrophil cell number
|
J:229024
|
Mir146tm2.1Bal/Mir146tm2.1Bal
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
decreased hematocrit
|
J:173671
|
| decreased hemoglobin content
|
J:173671
|
| extramedullary hematopoiesis
|
J:173671
|
| myeloid hyperplasia
|
J:173671
|
| thrombocytopenia
|
J:173671
|
Mir155tm1.1Rsky/Mir155tm1.1Rsky
(B6.Cg-Mir155tm1Rsky/J)
|
abnormal T-helper 17 cell differentiation
|
J:226678
|
Mir155tm1Brd/Mir155tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal class switch recombination
|
J:121095
|
Mir155tm1Rsky/Mir155tm1Rsky
(involves: 129 * C57BL/6)
|
abnormal class switch recombination
|
J:136224
|
Mir223tm1Fcam/Mir223tm1Fcam
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neutrophil differentiation
|
J:140009
|
| increased granulocyte number
|
J:140009
|
| increased neutrophil cell number
|
J:140009
|
Mir451atm1.2Doca/Mir451atm1.2Doca
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * BALB/cJ)
|
decreased erythrocyte cell number
|
J:163418
|
| decreased hematocrit
|
J:163418
|
| increased red blood cell distribution width
|
J:163418
|
Mir451atm1Eno/Mir451a+
(involves: C57BL/6)
|
abnormal erythrocyte cell number
|
J:163251
|
Mir451atm1Eno/Mir451atm1Eno
(involves: C57BL/6)
|
abnormal fetal derived definitive erythrocyte cell number
|
J:163251
|
Mirc1tm1.1Aven/Mirc1tm1.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased pro-B cell number
|
J:223213
|
Mirc1tm1.2Tyj/Mirc1tm1.2Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)
|
abnormal B cell differentiation
|
J:134861
|
Mirc1tm1.3Tyj/Mirc1tm1.3Tyj
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:134861
|
Mirc1tm1Tyj/Mirc1tm1Tyj
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA * SJL)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:134861
|
Mirc1tm3.1Aven/Mirc1tm3.1Aven
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased pro-B cell number
|
J:223213
|
Mirc11tm1Rdhl/Mirc11tm1Rdhl
(B6.129-Mirc11tm1Rdhl)
|
abnormal B cell differentiation
|
J:243248
|
| decreased common myeloid progenitor cell number
|
J:243248
|
| impaired myelopoiesis
|
J:243248
|
| increased immature B cell number
|
J:243248
|
| increased pre-pro B cell number
|
J:243248
|
| increased pro-B cell number
|
J:243248
|
| increased transitional stage T1 B cell number
|
J:243248
|
Mirc14tm1.1Ankr/Mirc14tm1.1Ankr
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:196134
|
| decreased double-positive T cell number
|
J:196134
|
Mirc14tm1.1Czc/Mirc14tm1.1Czc
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(either: (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S4/SvJae * 129S4/SvJaeSor * C57BL/6))
|
decreased double-positive T cell number
|
J:188125
|
Mirc14tm1.2Czc/Mirc14tm1.2Czc
(either: (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor) or (involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6))
|
decreased DN3 thymocyte number
|
J:188125
|
| decreased double-positive T cell number
|
J:188125
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal T cell differentiation
|
J:203157
|
| abnormal T cell receptor V(D)J recombination
|
J:203157
|
| decreased DN1 thymic pro-T cell number
|
J:203157
|
| decreased double-positive T cell number
|
J:203157
|
Mirc14tm1.2Flv/Mirc14tm1.2Flv
Mirc15tm1.2Flv/Mirc15tm1.2Flv
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
decreased immature B cell number
|
J:203157
|
| increased pro-B cell number
|
J:203157
|
Mirc30em1Hhzg/Mirc30em1Hhzg
Tg(Vav1-cre)#Cgp/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6NRj)
|
increased pro-B cell number
|
J:320883
|
Mirc55tm1.1Eno/Mirc55tm1.1Eno
(Not Specified)
|
increased erythrocyte cell number
|
J:139708
|
MitfMi/MitfMi
(Not Specified)
|
decreased mast cell number
|
J:6889
|
Mkrn2em1(IMPC)Wtsi/Mkrn2em1(IMPC)Wtsi
(C57BL/6N-Mkrn2em1(IMPC)Wtsi/WtsiOulu)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Mllt3tm1b(EUCOMM)Hmgu/Mllt3+
(C57BL/6N-Mllt3tm1b(EUCOMM)Hmgu/Cnrm)
|
thrombocytopenia
|
J:211773
|
Mllt6em1(IMPC)Tcp/Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Mllt10em1(IMPC)Mbp/Mllt10+
(C57BL/6N-Mllt10em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Mlxtm1.1(KOMP)Vlcg/Mlxtm1.1(KOMP)Vlcg
(C57BL/6N-Mlxtm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Mmaaem1(IMPC)J/Mmaaem1(IMPC)J
(C57BL/6NJ-Mmaaem1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Mmdtm1Beij/Mmdtm1Beij
(Not Specified)
|
abnormal macrophage differentiation
|
J:304637
|
Mmgt2tm1b(EUCOMM)Wtsi/Mmgt2tm1b(EUCOMM)Wtsi
(C57BL/6N-Mmgt2tm1b(EUCOMM)Wtsi/Bay)
|
increased basophil cell number
|
J:211773
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * CD-1)
|
impaired myelopoiesis
|
J:149957
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6)
|
increased eosinophil cell number
|
J:88065
|
Mmp11tm1b(EUCOMM)Hmgu/Mmp11tm1b(EUCOMM)Hmgu
(C57BL/6N-Mmp11tm1b(EUCOMM)Hmgu/Ics)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Mmp19tm1Rase/Mmp19tm1Rase
(B6.129P2-Mmp19tm1Rase)
|
abnormal T cell differentiation
|
J:137128
|
| increased double-positive T cell number
|
J:137128
|
Mnek1aCAST/Ei/Mnek1aCAST/Ei
(involves: C57BL/6J-Nek1kat-2J/+ * CAST/Ei)
|
decreased hematocrit
|
J:55632
|
Mnek1bC57BL/6J/Mnek1bC57BL/6J
(involves: C57BL/6J-Nek1kat-2J/+ * CAST/Ei)
|
decreased hematocrit
|
J:55632
|
Mnek1bC57BL/6J/Mnek1bCAST/Ei
(involves: C57BL/6J-Nek1kat-2J/+ * CAST/Ei)
|
decreased hematocrit
|
J:55632
|
Mocosem2(IMPC)Ics/Mocosem2(IMPC)Ics
(involves: C57BL/6N)
|
decreased erythrocyte cell number
|
J:336718
|
| decreased hematocrit
|
J:336718
|
| decreased hemoglobin content
|
J:336718
|
Mon1bem1(IMPC)J/Mon1bem1(IMPC)J
(C57BL/6NJ-Mon1bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Morc3tm1b(EUCOMM)Hmgu/Morc3+
(C57BL/6N-Morc3tm1b(EUCOMM)Hmgu/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Morn3em1(IMPC)J/Morn3em1(IMPC)J
(C57BL/6NJ-Morn3em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
Morrbidem1Flv/Morrbid+
(C57BL/6N-Morrbidem1Flv)
|
decreased eosinophil cell number
|
J:236609
|
| decreased neutrophil cell number
|
J:236609
|
Morrbidem1Flv/Morrbidem1Flv
(C57BL/6N-Morrbidem1Flv)
|
abnormal myelopoiesis
|
J:236609
|
| decreased eosinophil cell number
|
J:236609
|
| decreased neutrophil cell number
|
J:236609
|
Mospd1tm1a(KOMP)Wtsi/Y
(C57BL/6N-Mospd1tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Mov10em1(IMPC)Tcp/Mov10em1(IMPC)Tcp
(C57BL/6NCrl-Mov10em1(IMPC)Tcp/Tcp)
|
increased erythrocyte cell number
|
J:211773
|
Mpig6btm1.1(KOMP)Vlcg/Mpig6btm1.1(KOMP)Vlcg
(C57BL/6N-Mpig6btm1.1(KOMP)Vlcg/Ucd)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Mpig6btm1.1Arte/Mpig6btm1.1Arte
(involves: C57BL/6NTac)
|
decreased platelet ATP level
|
J:201266
|
| extramedullary hematopoiesis
|
J:201266
|
| increased mean platelet volume
|
J:201266
|
| thrombocytopenia
|
J:201266
|
Mpig6btm1.1Arte/Mpig6btm1.1Arte
Gp6tm1Ware/Gp6tm1Ware
(involves: C57BL/6 * C57BL/6NTac)
|
thrombocytopenia
|
J:201266
|
Mplhlb219/Mpl+
(C57BL/6J-Mplhlb219/J)
|
abnormal definitive hematopoiesis
|
J:146577
|
| decreased erythrocyte cell number
|
J:146577
|
| decreased hemoglobin content
|
J:146577
|
| thrombocytosis
|
J:146577
|
Mplhlb219/Mplhlb219
(C57BL/6J-Mplhlb219/J)
|
abnormal definitive hematopoiesis
|
J:146577
|
| decreased common myeloid progenitor cell number
|
J:146577
|
| decreased erythrocyte cell number
|
J:146577
|
| decreased hematocrit
|
J:146577
|
| decreased hemoglobin content
|
J:146577
|
| thrombocytopenia
|
J:146577,
J:82961
|
Mpltm1Fjs/Mpltm1Fjs
(involves: 129 * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:87416
|
Mpltm1Mwm/Mpltm1Mwm
(B6;129S2)
|
increased mean platelet volume
|
J:83264
|
| thrombocytopenia
|
J:83264
|
Mpltm1Wsa/Mpltm1Wsa
(involves: 129S1/Sv * C57BL/6)
|
thrombocytopenia
|
J:32131
|
Mpltm1Wsa/Mpltm1Wsa
(involves: 129S1/Sv)
|
thrombocytopenia
|
J:162629
|
Mpltm1Wsa/Mpltm1Wsa
MybPlt3/Myb+
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:89601
|
| abnormal thrombopoiesis
|
J:89601
|
| thrombocytosis
|
J:89601
|
Mpltm1Wsa/Mpltm1Wsa
MybPlt3/MybPlt3
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:89601
|
| abnormal definitive hematopoiesis
|
J:89601
|
| abnormal erythropoiesis
|
J:89601
|
| abnormal thrombopoiesis
|
J:89601
|
| thrombocytosis
|
J:89601
|
Mpltm1Wsa/Mpltm1Wsa
MybPlt4/Myb+
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:89601
|
| abnormal thrombopoiesis
|
J:89601
|
| thrombocytosis
|
J:89601
|
Mpltm1Wsa/Mpltm1Wsa
MybPlt4/MybPlt4
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:89601
|
| abnormal erythropoiesis
|
J:89601
|
| abnormal thrombopoiesis
|
J:89601
|
| thrombocytosis
|
J:89601
|
Mpltm1Wsa/Mpltm1Wsa
Suz12Gt(Betageo)1Khe/Suz12+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:136262
|
| thrombocytopenia
|
J:136262
|
Mpltm1Wsa/Mpltm1Wsa
Suz12Plt8/Suz12+
(B6.Cg-Mpltm1Wsa Suz12Plt8)
|
abnormal thrombopoiesis
|
J:136262
|
| thrombocytopenia
|
J:136262
|
Mpltm2.1Wsa/Mpltm2.1Wsa
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:208120
|
| thrombocytosis
|
J:208120
|
Mpltm2.2Wsa/Mpltm2.2Wsa
(involves: BALB/cJ * C57BL/6)
|
thrombocytopenia
|
J:208120
|
Mpv17/Mpv17
(CFW-Mpv17/J)
|
decreased erythrocyte cell number
|
J:10661
|
| decreased hemoglobin content
|
J:10661
|
Mpv17em1(IMPC)J/Mpv17em1(IMPC)J
(C57BL/6NJ-Mpv17em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Mpvq1NZW/LacJ/Mpvq1SM/J
(involves: NZW/LacJ * SM/J)
|
increased mean platelet volume
|
J:102636
|
Mpvq1SM/J/Mpvq1SM/J
(involves: C57BLKS/J * SM/J)
|
increased mean platelet volume
|
J:102636
|
Mpvq1SM/J/Mpvq1SM/J
(involves: NZW/LacJ * SM/J)
|
increased mean platelet volume
|
J:102636
|
Mpvq2SM/J/Mpvq2SM/J
(involves: C57BLKS/J * SM/J)
|
increased mean platelet volume
|
J:102636
|
Mpzem1(IMPC)Tcp/Mpzem1(IMPC)Tcp
(C57BL/6NCrl-Mpzem1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Mpzl2tm1b(EUCOMM)Hmgu/Mpzl2+
(C57BL/6N-Mpzl2tm1b(EUCOMM)Hmgu/Bay)
|
increased red blood cell distribution width
|
J:211773
|
Mrap2tm1a(EUCOMM)Wtsi/Mrap2tm1a(EUCOMM)Wtsi
(C57BL/6N-Mrap2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Mrc1tm1Mnz/Mrc1tm1Mnz
(B6.129P2-Mrc1tm1Mnz)
|
increased granulocyte number
|
J:194065
|
Mre11atm1.1Rchd/Mre11atm1.1Rchd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:184053
|
Mrpl3em1(IMPC)J/Mrpl3+
(C57BL/6NJ-Mrpl3em1(IMPC)J/J)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Mrpl58tm1b(EUCOMM)Hmgu/Mrpl58+
(C57BL/6N-Mrpl58tm1b(EUCOMM)Hmgu/J)
|
decreased hematocrit
|
J:211773
|
Mrps18ctm1.1(KOMP)Vlcg/Mrps18c+
(C57BL/6N-Mrps18ctm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Mrps22tm1.1(KOMP)Vlcg/Mrps22+
(C57BL/6N-Mrps22tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ms4a1tm1Tft/Ms4a1tm1Tft
(involves: 129 * C57BL/6)
|
increased transitional stage B cell number
|
J:88933
|
Ms4a4aem1Wwz/Ms4a4aem1Wwz
(C57BL/6NCrl-Ms4a4aem1Wwz)
|
decreased eosinophil cell number
|
J:296429
|
Msh2tm1Htr/Msh2tm1Htr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:80893
|
| abnormal somatic hypermutation frequency
|
J:155454
|
Msh2tm1Htr/Msh2tm1Htr
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
Msh2tm1Mak/Msh2tm1Mak
(C57BL/6NTac-Msh2tm1Mak)
|
abnormal class switch recombination
|
J:326431
|
| abnormal somatic hypermutation frequency
|
J:326431
|
Msh2tm1Rak/Msh2tm1Rak
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:56764
|
Msh2tm1Wed/Msh2tm1Wed
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:86278
|
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:79016
|
Msh2tm1Whl/Msh2tm1Whl
Rb1tm1Brd/Rb1tm1Brd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:79016
|
Msi2em1(IMPC)Mbp/Msi2em1(IMPC)Mbp
(C57BL/6N-Msi2em1(IMPC)Mbp/MbpMmucd)
|
decreased neutrophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Msi2Gt(E035H03)Wrst/Msi2Gt(E035H03)Wrst
(B6.129P2-Msi2Gt(E035H03)Wrst)
|
decreased common myeloid progenitor cell number
|
J:174870
|
| decreased DN2 thymocyte number
|
J:174870
|
| decreased DN3 thymocyte number
|
J:174870
|
| decreased double-negative T cell number
|
J:174870
|
| decreased double-positive T cell number
|
J:174870
|
| decreased erythrocyte cell number
|
J:174870
|
| decreased granulocyte number
|
J:174870
|
| decreased immature B cell number
|
J:174870
|
Msmpem1Jzx/Msmpem1Jzx
(C57BL/6-Msmpem1Jzx)
|
abnormal macrophage differentiation
|
J:311042
|
Msntm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Msntm1b(EUCOMM)Hmgu/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Msntm1b(EUCOMM)Hmgu/Msntm1b(EUCOMM)Hmgu
(C57BL/6N-Msntm1b(EUCOMM)Hmgu/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Msntm1Sts/Y
(involves: 129S4/SvJae * C57BL/6)
|
decreased eosinophil cell number
|
J:189837
|
| decreased neutrophil cell number
|
J:189837
|
Mst1tm1(KOMP)Wtsi/Mst1tm1(KOMP)Wtsi
(C57BL/6N-Mst1tm1(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
increased neutrophil cell number
|
J:120196
|
Mta1tm1a(EUCOMM)Wtsi/Mta1tm1a(EUCOMM)Wtsi
(129S/SvEvBrd-Mta1tm1a(EUCOMM)Wtsi/WtsiH)
|
thrombocytopenia
|
J:175295
|
Mta3tm3a(KOMP)Wtsi/Mta3tm3a(KOMP)Wtsi
(Not Specified)
|
decreased erythrocyte cell number
|
J:165965
|
Mthfd1tm1.1Rzn/Mthfd1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
decreased neutrophil cell number
|
J:199578
|
Mtmr1tm2b(KOMP)Wtsi/Y
(C57BL/6N-Mtmr1tm2b(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Mtmr2em1(IMPC)Hmgu/Mtmr2em1(IMPC)Hmgu
(C57BL/6NCrl-Mtmr2em1(IMPC)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Mtmr3tm1b(EUCOMM)Hmgu/Mtmr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Mtmr3tm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Mtmr7em1(IMPC)Mbp/Mtmr7em1(IMPC)Mbp
(C57BL/6N-Mtmr7em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Mtortm1.2Koz/Mtortm1.2Koz
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:150108
|
Mtortm1a(EUCOMM)Wtsi/Mtor+
(C57BL/6N-Mtortm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Mtortm1Lgm/Mtortm1Lgm
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:168600
|
| decreased double-positive T cell number
|
J:168600
|
| decreased neutrophil cell number
|
J:168600
|
| decreased transitional stage T1 B cell number
|
J:168600
|
Mtpaptm1.1(KOMP)Vlcg/Mtpap+
(C57BL/6N-Mtpaptm1.1(KOMP)Vlcg/Ucd)
|
increased erythrocyte cell number
|
J:211773
|
Mtss1Gt(CSC156)Byg/Mtss1Gt(CSC156)Byg
(B6.129P2-Mtss1Gt(CSC156)Byg)
|
abnormal B cell differentiation
|
J:186118
|
| decreased immature B cell number
|
J:186118
|
Mttptm1Sgy/Mttptm1Sgy
(involves: 129S4/SvJae)
|
decreased erythrocyte cell number
|
J:48934
|
Mtus1Gt(RRA048)Byg/Mtus1Gt(RRA048)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased erythrocyte cell number
|
J:212144
|
| decreased hematocrit
|
J:212144
|
| decreased hemoglobin content
|
J:212144
|
| thrombocytopenia
|
J:212144
|
Muc2wnn/Muc2+
(C57BL/6-Muc2wnn)
|
decreased hematocrit
|
J:194148
|
Muc2wnn/Muc2wnn
(C57BL/6-Muc2wnn)
|
decreased hematocrit
|
J:194148
|
Muc13tm1.1Mamg/Muc13tm1.1Mamg
(involves: 129 * C57BL/6)
|
decreased hematocrit
|
J:313870
|
Mul1em1(IMPC)H/Mul1em1(IMPC)H
(C57BL/6N-Mul1em1(IMPC)H/H)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Mvd003/Mvd003+
(C3HeB/FeJ-Mvd003)
|
decreased mean corpuscular volume
|
J:186868
|
Mvd005/Mvd005+
(C3HeB/FeJ-Mvd005)
|
decreased mean corpuscular hemoglobin
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
Mvd007/Mvd007+
(C3HeB/FeJ-Mvd007)
|
decreased mean corpuscular volume
|
J:186868
|
Mvd009/Mvd009+
(C3HeB/FeJ-Mvd009)
|
decreased mean corpuscular volume
|
J:186868
|
Mvd016/Mvd016+
(C3HeB/FeJ-Mvd016)
|
decreased mean corpuscular hemoglobin
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
| increased erythrocyte cell number
|
J:186868
|
Mvd017/Mvd017+
(C3HeB/FeJ-Mvd017)
|
decreased mean corpuscular hemoglobin
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
Mvd018/Mvd018+
(C3HeB/FeJ-Mvd018)
|
decreased mean corpuscular hemoglobin
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
Mvd019/Mvd019+
(C3HeB/FeJ-Mvd019)
|
decreased mean corpuscular volume
|
J:186868
|
Mvd021/Mvd021+
(C3HeB/FeJ-Mvd021)
|
decreased mean corpuscular volume
|
J:186868
|
Mvd023/Mvd023+
(C3HeB/FeJ-Mvd023)
|
decreased hematocrit
|
J:186868
|
| decreased hemoglobin content
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
mvu008/mvu008
(C3HeB/FeJ-mvu008)
|
increased mean corpuscular hemoglobin
|
J:186868
|
| increased mean corpuscular volume
|
J:186868
|
Mxd1tm1Rne/Mxd1tm1Rne
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:45945
|
| increased granulocyte number
|
J:45945
|
Mybboo/Mybboo
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:167270
|
| abnormal definitive hematopoiesis
|
J:167270
|
| abnormal embryonic erythropoiesis
|
J:167270
|
| abnormal erythrocyte morphology
|
J:167270
|
| abnormal erythropoiesis
|
J:167270
|
| decreased neutrophil cell number
|
J:167270
|
| increased nucleated erythrocyte cell number
|
J:167270
|
| increased number of Howell-Jolly bodies
|
J:167270
|
| polychromatophilia
|
J:167270
|
| thrombocytosis
|
J:167270
|
MybM303V/MybM303V
(involves: 129S1/SvlmJ * C57BL/6)
|
abnormal platelet shape
|
J:96507
|
| absent common myeloid progenitor cells
|
J:96507
|
| arrested B cell differentiation
|
J:96507
|
| arrested T cell differentiation
|
J:96507
|
| decreased eosinophil cell number
|
J:96507
|
| decreased erythrocyte cell number
|
J:96507
|
| macrocytosis
|
J:96507
|
| thrombocytosis
|
J:96507
|
Mybtm1.1Cgn/Myb+
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:127234
|
Mybtm1Cgn/Mybtm1.1Cgn
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:91122
|
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:91122
|
| decreased double-negative T cell number
|
J:91122
|
| decreased double-positive T cell number
|
J:91122
|
Mybtm1Cgn/Mybtm1Cgn
Tg(Lck-cre)548Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:91122
|
Mybtm1Epr/Mybtm1Epr
Tg(Cd4-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:93481
|
| decreased double-positive T cell number
|
J:93481
|
Mybtm1Epr/Mybtm1Epr
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal double-negative T cell morphology
|
J:93481
|
| abnormal T cell differentiation
|
J:93481
|
| decreased double-positive T cell number
|
J:93481
|
Mybtm1Jof/Mybtm1Jof
(involves: 129/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:85344
|
| abnormal definitive hematopoiesis
|
J:85344
|
| abnormal double-negative T cell morphology
|
J:85344
|
| abnormal erythropoiesis
|
J:85344
|
| abnormal T cell differentiation
|
J:85344
|
Mybtm1Jof/Mybtm1Ssp
(involves: 129/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:85344
|
| abnormal erythropoiesis
|
J:85344
|
| abnormal T cell differentiation
|
J:85344
|
Mybtm1Ssp/Mybtm1Ssp
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
abnormal erythropoiesis
|
J:43747
|
| decreased common myeloid progenitor cell number
|
J:43747
|
| decreased hematocrit
|
J:43747
|
| increased nucleated erythrocyte cell number
|
J:43747
|
Mybtm1Ssp/Mybtm1Ssp
(involves: 129S2/SvPas)
|
abnormal definitive hematopoiesis
|
J:63424
|
| abnormal erythropoiesis
|
J:63424
|
Mybbp1atm1b(EUCOMM)Hmgu/Mybbp1a+
(C57BL/6N-Mybbp1atm1b(EUCOMM)Hmgu/Ieg)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| thrombocytosis
|
J:211773
|
Mybl2tm1.1Epr/Mybl2tm1.1Epr
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA * FVB/N)
|
abnormal myelopoiesis
|
J:206816
|
| decreased common myeloid progenitor cell number
|
J:206816
|
| decreased neutrophil cell number
|
J:206816
|
| thrombocytopenia
|
J:206816
|
Mybl2tm1.1Jof/Mybl2+
Tg(Zp3-cre)3Mrt/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
abnormal erythrocyte morphology
|
J:196804
|
| abnormal myelopoiesis
|
J:196804
|
| anisocytosis
|
J:196804
|
| decreased erythrocyte cell number
|
J:196804
|
| decreased neutrophil cell number
|
J:196804
|
| increased granulocyte number
|
J:196804
|
| increased number of Howell-Jolly bodies
|
J:196804
|
| myeloid hyperplasia
|
J:196804
|
| poikilocytosis
|
J:196804
|
| thrombocytopenia
|
J:196804
|
| thrombocytosis
|
J:196804
|
Myctm1Atp/Myctm1Atp
(involves: 129P2/OlaHsd * FVB/N)
|
absent common myeloid progenitor cells
|
J:73369
|
Myctm1Jlc/Myctm1Jlc
(involves: 129S7/SvEvBrd)
|
abnormal embryonic erythropoiesis
|
J:79427
|
| decreased common myeloid progenitor cell number
|
J:79427
|
Myctm2.1Atp/Myctm2.1Atp
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:137630
|
Myctm3(Tcrb)Fwa/Myc+
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
Myct1em1(IMPC)Mbp/Myct1em1(IMPC)Mbp
(C57BL/6N-Myct1em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Myd88tm1.1Defr/Myd88tm1.1Defr
(B6.129P2(SJL)-Myd88tm1.1Defr)
|
decreased neutrophil cell number
|
J:224849
|
Myd88tm1a(EUCOMM)Wtsi/Myd88tm1a(EUCOMM)Wtsi
(C57BL/6N-Myd88tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular volume
|
J:175295
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
abnormal dendritic cell differentiation
|
J:139001
|
Myd88tm1Defr/Myd88tm1Defr
Tg(Itgax-cre)1-1Reiz/0
(B6.Cg-Myd88tm1Defr Tg(Itgax-cre)1-1Reiz)
|
abnormal dendritic cell differentiation
|
J:139001
|
| abnormal T-helper 1 cell differentiation
|
J:139001
|
Myd88tm1Hlz/Myd88tm1Hlz
(B6.129P2-Myd88tm1Hlz)
|
decreased neutrophil cell number
|
J:188968
|
Myh1tm1b(KOMP)Wtsi/Myh1tm1b(KOMP)Wtsi
(C57BL/6N-Myh1tm1b(KOMP)Wtsi/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Myh7btm1a(KOMP)Wtsi/Myh7btm1a(KOMP)Wtsi
(C57BL/6N-Myh7btm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Myh8em1(IMPC)Tcp/Myh8+
(C57BL/6N-Myh8em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
Myh9tm1.1(MYH9*)Mjk/Myh9+
(B6.Cg-Myh9tm1.1(MYH9*)Mjk)
|
abnormal neutrophil morphology
|
J:175367
|
| abnormal platelet morphology
|
J:175367
|
| thrombocytopenia
|
J:175367
|
Myh9tm1.1(MYH9*)Mjk/Myh9tm1.1(MYH9*)Mjk
(B6.129-Myh9tm1.1(MYH9*)Mjk)
|
abnormal neutrophil morphology
|
J:175367
|
| abnormal platelet morphology
|
J:175367
|
| thrombocytopenia
|
J:175367
|
Myh9tm1.1Dash/Myh9+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
abnormal platelet morphology
|
J:204923
|
| abnormal thrombopoiesis
|
J:204923
|
| thrombocytopenia
|
J:204923
|
Myh9tm1.1Gac/Myh9tm1.1Gac
Tg(Pf4-icre)Q3Rsko/0
(involves: 129 * C57BL/6)
|
abnormal platelet morphology
|
J:148233
|
| abnormal platelet shape
|
J:148233
|
| thrombocytopenia
|
J:148233
|
Myh9tm6.1(EGFP/MYH9*)Rsad/Myh9+
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
abnormal neutrophil morphology
|
J:175367
|
| abnormal platelet morphology
|
J:175367
|
| thrombocytopenia
|
J:175367
|
Myh9tm7.1Rsad/Myh9+
(involves: BALB/cJ)
|
abnormal neutrophil morphology
|
J:175367
|
| abnormal platelet morphology
|
J:175367
|
| thrombocytopenia
|
J:175367
|
Myh9tm7.1Rsad/Myh9tm7.1Rsad
(involves: BALB/cJ)
|
abnormal neutrophil morphology
|
J:175367
|
| abnormal platelet morphology
|
J:175367
|
| thrombocytopenia
|
J:175367
|
Myl2tm1b(EUCOMM)Hmgu/Myl2+
(C57BL/6N-Myl2tm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Myl12btm1a(EUCOMM)Wtsi/Myl12btm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Myl12btm1a(EUCOMM)Wtsi/Wtsi)
|
decreased hematocrit
|
J:175295
|
| decreased hemoglobin content
|
J:175295
|
| decreased mean corpuscular hemoglobin
|
J:175295
|
Myliptm1.1(KOMP)Vlcg/Myliptm1.1(KOMP)Vlcg
(C57BL/6N-Myliptm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Myo1ctm1.1Biat/Myo1ctm1.1Biat
(B6N.129S2-Myo1ctm1.1Biat)
|
decreased erythrocyte cell number
|
J:200573
|
| decreased mean corpuscular hemoglobin concentration
|
J:200573
|
| increased mean corpuscular hemoglobin
|
J:200573
|
| increased mean corpuscular volume
|
J:200573
|
| macrocytosis
|
J:200573
|
Myo1eGt(ROSA)74Sor/Myo1eGt(ROSA)74Sor
(involves: 129S4/SvJaeSor)
|
decreased erythrocyte cell number
|
J:117491
|
| decreased hematocrit
|
J:117491
|
| decreased hemoglobin content
|
J:117491
|
| polychromatophilia
|
J:117491
|
Myo6em1(IMPC)Tcp/Myo6em1(IMPC)Tcp
(C57BL/6N-Myo6em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Mysm1tm1a(KOMP)Wtsi/Mysm1+
(Not Specified)
|
increased mean corpuscular volume
|
J:165965
|
Mysm1tm1a(KOMP)Wtsi/Mysm1tm1a(KOMP)Wtsi
(Not Specified)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hematocrit
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
| increased granulocyte number
|
J:165965
|
| increased mean corpuscular hemoglobin concentration
|
J:165965
|
| increased mean corpuscular volume
|
J:165965
|
| thrombocytosis
|
J:165965
|
Mysm1tm1b(KOMP)Wtsi/Mysm1tm1b(KOMP)Wtsi
Tg(MMTV-cre)4Mam/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal T cell differentiation
|
J:179287
|
| arrested B cell differentiation
|
J:179287
|
| decreased immature B cell number
|
J:179287
|
| decreased pro-B cell number
|
J:179287
|
Mzb1tm1.2Rug/Mzb1tm1.2Rug
(involves: 129S2/SvPas * BALB/cJ * C57BL/6 * SJL)
|
increased pro-B cell number
|
J:211639
|
Mzf1tm1Ppp/Mzf1tm1Ppp
(involves: 129)
|
abnormal myelopoiesis
|
J:70407
|
| extramedullary hematopoiesis
|
J:70407
|
Naaatm1a(KOMP)Wtsi/Naaatm1a(KOMP)Wtsi
(C57BL/6N-Naaatm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Nacc1em1(IMPC)Hmgu/Nacc1em1(IMPC)Hmgu
(C57BL/6N-Nacc1em1(IMPC)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Nadk2em1(IMPC)J/Nadk2+
(C57BL/6NJ-Nadk2em1(IMPC)J/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Nae1tm1b(EUCOMM)Wtsi/Nae1+
(C57BL/6N-Nae1tm1b(EUCOMM)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Nagktm1b(EUCOMM)Hmgu/Nagktm1b(EUCOMM)Hmgu
(C57BL/6N-Nagktm1b(EUCOMM)Hmgu/H)
|
increased neutrophil cell number
|
J:211773
|
Nalcnem1(IMPC)Mbp/Nalcn+
(C57BL/6N-Nalcnem1(IMPC)Mbp/Ucd)
|
increased neutrophil cell number
|
J:211773
|
NamptGt(RRR084)Byg/Nampt+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased neutrophil cell number
|
J:194883
|
Nampttm1Oleo/Nampttm1Oleo
Tg(CD2-icre)4Kio/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/10 * CBA/Ca)
|
decreased double-negative T cell number
|
J:141448
|
Natd1tm1b(EUCOMM)Wtsi/Natd1tm1b(EUCOMM)Wtsi
(C57BL/6N-Natd1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Nav2em1(IMPC)Tcp/Nav2em1(IMPC)Tcp
(C57BL/6NCrl-Nav2em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Nbeal2gps/Nbeal2gps
(129S1/SvImJ-Nbeal2gps)
|
decreased neutrophil cell number
|
J:236370
|
| decreased platelet alpha-granule number
|
J:236370
|
| thrombocytopenia
|
J:236370
|
Nbeal2tm1a(EUCOMM)Wtsi/Nbeal2tm1a(EUCOMM)Wtsi
(C57BL/6N-Nbeal2tm1a(EUCOMM)Wtsi/Wtsi)
|
abnormal platelet morphology
|
J:220801
|
| abnormal platelet shape
|
J:220801
|
| decreased platelet alpha-granule number
|
J:220801
|
| increased mean platelet volume
|
J:220801,
J:211773
|
| thrombocytopenia
|
J:220801,
J:211773
|
Nbeal2tm1Lex/Nbeal2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal platelet morphology
|
J:201413
|
| decreased platelet alpha-granule number
|
J:201413
|
| thrombocytopenia
|
J:201413
|
Nbnem7Jpt/Nbntm2Zqw
Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
decreased erythrocyte cell number
|
J:277750
|
| increased pro-B cell number
|
J:277750
|
| thrombocytosis
|
J:277750
|
Nbntm2Zqw/Nbntm2Zqw
Tg(VAV1-cre)1Graf/0
(involves: 129P2/OlaHsd)
|
decreased erythrocyte cell number
|
J:251434
|
Nbr1tm1.1Jmos/Nbr1tm1.1Jmos
Tnfrsf4tm2(cre)Nik/Tnfrsf4+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:165438
|
| abnormal T-helper 2 cell differentiation
|
J:165438
|
Ncam2tm1b(EUCOMM)Hmgu/Ncam2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncam2tm1b(EUCOMM)Hmgu/Orl)
|
increased eosinophil cell number
|
J:211773
|
Ncaph2nes/Ncaph2nes
(C57BL/6JSfdAnu-Ncaph2nes/Anu)
|
abnormal double-negative T cell morphology
|
J:123300
|
| decreased double-negative T cell number
|
J:123300
|
| decreased double-positive T cell number
|
J:123300
|
Ncaph2nes/Ncaph2nes
Tg(TcrHEL3A9)1Mmd/0
(C57BL/6-Ncaph2nes Tg(TcrHEL3A9)1Mmd)
|
abnormal double-negative T cell morphology
|
J:123300
|
| decreased double-positive T cell number
|
J:123300
|
Ncf2tm1a(EUCOMM)Wtsi/Ncf2tm1a(EUCOMM)Wtsi
(C57BL/6N-Ncf2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Nckap1lm1Iri/Nckap1lm1Iri
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:141377
|
| abnormal common myeloid progenitor cell morphology
|
J:141377
|
| abnormal lymphopoiesis
|
J:141377
|
| acanthocytosis
|
J:141377
|
| dacryocytosis
|
J:141377
|
| decreased double-positive T cell number
|
J:141377
|
| decreased hematocrit
|
J:141377
|
| decreased mean corpuscular volume
|
J:141377
|
| extramedullary hematopoiesis
|
J:141377
|
| increased double-negative T cell number
|
J:141377
|
| increased neutrophil cell number
|
J:141377
|
| poikilocytosis
|
J:141377
|
| schistocytosis
|
J:141377
|
Ncoa2em1(IMPC)Mbp/Ncoa2+
(C57BL/6N-Ncoa2em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Ncoa3tm1Jxu/Ncoa3tm1Jxu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal lymphopoiesis
|
J:109522
|
| thrombocytopenia
|
J:109522
|
Ncoa5tm1.1(KOMP)Mbp/Ncoa5+
(C57BL/6N-Ncoa5tm1.1(KOMP)Mbp/Tcp)
|
increased eosinophil cell number
|
J:211773
|
Ncoa6tm1.1Jkr/Ncoa6tm1.1Jkr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal embryonic hematopoiesis
|
J:81217
|
Ncor1tm1Rsd/Ncor1tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal erythropoiesis
|
J:65417
|
| abnormal hematocrit
|
J:65417
|
| arrested T cell differentiation
|
J:65417
|
| decreased erythrocyte cell number
|
J:65417
|
| decreased hematocrit
|
J:65417
|
| increased nucleated erythrocyte cell number
|
J:65417
|
Ncor2tm1Rev/Ncor2tm1Rev
(involves: 129/Sv * C57BL/6)
|
extramedullary hematopoiesis
|
J:202976
|
Ncstntm1.1Akli/Ncstntm1.1Akli
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:196407
|
| myeloid hyperplasia
|
J:196407
|
Ncstntm1.1Akli/Ncstntm1.1Akli
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA * SJL)
|
abnormal definitive hematopoiesis
|
J:172442
|
Ncstntm1.1Akli/Ncstntm1.1Akli
Tg(VAV1-cre)1Graf/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal definitive hematopoiesis
|
J:172442
|
Ndfip1Gt(RRD002)Byg/Ndfip1Gt(RRD002)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
extramedullary hematopoiesis
|
J:116617
|
Ndfip1tm1.1Pmo/Ndfip1tm1.1Pmo
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
increased eosinophil cell number
|
J:205692
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rnpc3tm1c(EUCOMM)Wtsi/Rnpc3tm1c(EUCOMM)Wtsi
(involves: 129S/SvEv * C57BL/6 * C57BL/6N)
|
decreased erythrocyte cell number
|
J:267519
|
| thrombocytopenia
|
J:267519
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rpl11tm1.1Srn/Rpl11+
(involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
abnormal erythropoiesis
|
J:292575
|
| decreased erythrocyte cell number
|
J:292575
|
| decreased hemoglobin content
|
J:292575
|
| macrocytosis
|
J:292575
|
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
Rragatm2Dmsa/Rragatm2Dmsa
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
myeloid hyperplasia
|
J:213516
|
Ndst2tm1Lkj/Ndst2tm1Lkj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal mast cell morphology
|
J:57121
|
| decreased mast cell histamine storage
|
J:57121
|
| decreased mast cell number
|
J:57121
|
| decreased mast cell protease storage
|
J:57121
|
Ndst2tm1Rls/Ndst2tm1Rls
(Not Specified)
|
decreased mast cell histamine storage
|
J:57120
|
| decreased mast cell protease storage
|
J:57120
|
Ndst2tm1Rls/Ndst2tm1Rls
(B6.Cg-Ndst2tm1Rls)
|
abnormal mast cell differentiation
|
J:142880
|
Ndufs3tm1a(EUCOMM)Wtsi/Ndufs3+
(B6JTyr;B6N-Ndufs3tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:175295
|
Ndufs7tm1b(EUCOMM)Hmgu/Ndufs7+
(C57BL/6N-Ndufs7tm1b(EUCOMM)Hmgu/Bay)
|
decreased hemoglobin content
|
J:211773
|
Ndufv1tm1.1(KOMP)Vlcg/Ndufv1+
(C57BL/6N-Ndufv1tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Necap2em1(IMPC)J/Necap2em1(IMPC)J
(C57BL/6NJ-Necap2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Nedd4ltm1Shkr/Nedd4ltm1Shkr
(involves: C57BL/6 * C57BL/6J)
|
increased neutrophil cell number
|
J:205657
|
Nefhtm1.1(KOMP)Vlcg/Nefhtm1.1(KOMP)Vlcg
(C57BL/6N-Nefhtm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Neil2tm1.1Tkhz/Neil2tm1.1Tkhz
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
increased neutrophil cell number
|
J:225791
|
Nek1kat-2J/Nek1kat-2J
(C57BL/6J-Nek1kat-2J/J)
|
poikilocytosis
|
J:59839
|
Nelfaem1(IMPC)Tcp/Nelfa+
(C57BL/6NCrl-Nelfaem1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Nell1em1(IMPC)Mbp/Nell1em1(IMPC)Mbp
(C57BL/6N-Nell1em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Nemp1em1(IMPC)Mbp/Nemp1em1(IMPC)Mbp
(C57BL/6NCrl-Nemp1em1(IMPC)Mbp/Mmucd)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
extramedullary hematopoiesis
|
J:76937
|
Neurl4em1(IMPC)Mbp/Neurl4em1(IMPC)Mbp
(C57BL/6NCrl-Neurl4em1(IMPC)Mbp/Mmucd)
|
decreased neutrophil cell number
|
J:211773
|
Nexmifem1(IMPC)Tcp/Y
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Nexmifem1(IMPC)Tcp/Nexmif+
(C57BL/6N-Nexmifem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Nf1tm1Fcr/Nf1+
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Nf1tm1Fcr Ptentm1Hwu)
|
abnormal hemopoiesis
|
J:232645
|
| decreased hemoglobin content
|
J:232645
|
| increased granulocyte number
|
J:232645
|
| thrombocytosis
|
J:232645
|
Nf1tm1Par/Nf1tm1Par
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:90973
|
| abnormal definitive hematopoiesis
|
J:90973
|
| abnormal myelopoiesis
|
J:90973
|
| increased granulocyte number
|
J:90973
|
| increased neutrophil cell number
|
J:90973
|
Nfat5tm1b(KOMP)Wtsi/Nfat5+
(C57BL/6N-Nfat5tm1b(KOMP)Wtsi/J)
|
decreased hematocrit
|
J:211773
|
Nfatc1tm1Glm/Nfatc1tm2Glm
(chimera involves: 129S2/SvPas)
|
decreased double-positive T cell number
|
J:78376
|
| increased double-negative T cell number
|
J:78376
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c)
|
abnormal class switch recombination
|
J:177319
|
Nfatc1tm1Rao/Nfatc1tm1Rao
Tg(Fcer2a-cre)5Mbu/0
(involves: C57BL/6 * CBA)
|
abnormal class switch recombination
|
J:177319
|
Nfatc2tm1Rao/Nfatc2tm1Rao
Nfatc3tm1Grc/Nfatc3tm1Grc
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal double-negative T cell morphology
|
J:141917
|
| abnormal T cell differentiation
|
J:141917
|
Nfatc2ipem1(IMPC)Ics/Nfatc2ipem1(IMPC)Ics
(C57BL/6N-Nfatc2ipem1(IMPC)Ics/Ics)
|
increased eosinophil cell number
|
J:211773
|
Nfatc2iptm1.1Glm/Nfatc2iptm1.1Glm
(either: B6.129-Nfatc2iptm1.1Glm or C.129-Nfatc2iptm1.1Glm)
|
decreased mast cell number
|
J:157559
|
Nfatc3tm1Glm/Nfatc3tm1Glm
Tg(DO11.10)10Dlo/?
(involves: 129S2/SvPas * BALB/c * C3H * C57BL/6)
|
decreased double-positive T cell number
|
J:50124
|
| increased double-negative T cell number
|
J:50124
|
Nfatc3tm1Grc/Nfatc3tm1Grc
Tg(Lck-cre)I57Jxm/0
(involves: ICR)
|
abnormal T cell differentiation
|
J:141917
|
| increased double-negative T cell number
|
J:141917
|
Nfe2tm1Sho/Nfe2tm1Sho
(involves: 129/Sv * 129S4/SvJae)
|
absent platelets
|
J:20132
|
| decreased hemoglobin content
|
J:20132
|
| microcytosis
|
J:20132
|
| thrombocytopenia
|
J:106670
|
Nfe2tm1Sho/Nfe2tm1Sho
(involves: 129S4/SvJae * C57BL/6J)
|
absent platelets
|
J:20132
|
| decreased hemoglobin content
|
J:20132
|
| microcytosis
|
J:20132
|
Nfe2tm1Sho/Nfe2tm1Sho
Nfe2l2tm1Ney/Nfe2l2tm1Ney
(involves: 129/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
thrombocytopenia
|
J:47440
|
Nfe2l1tm1Ywk/Nfe2l1tm1Ywk
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal erythropoiesis
|
J:46990
|
| decreased hematocrit
|
J:46990
|
| increased nucleated erythrocyte cell number
|
J:46990
|
Nfe2l2em1(IMPC)Ccpcz/Nfe2l2em1(IMPC)Ccpcz
(C57BL/6NCrl-Nfe2l2em1(IMPC)Ccpcz/Ccpcz)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Nfe2l2tm1Ywk/Nfe2l2tm1Ywk
(involves: 129X1/SvJ)
|
acanthocytosis
|
J:91407
|
| anisocytosis
|
J:91407
|
| decreased erythrocyte cell number
|
J:91407
|
| decreased hematocrit
|
J:91407
|
| decreased hemoglobin content
|
J:91407
|
| increased number of Howell-Jolly bodies
|
J:91407
|
| poikilocytosis
|
J:91407
|
| schistocytosis
|
J:91407
|
| thrombocytopenia
|
J:91407
|
Nfil3tm1.1Brad/Nfil3tm1.1Brad
(B6.Cg-Nfil3tm1.1Brad)
|
abnormal NK cell differentiation
|
J:152774
|
Nfil3tm1Look/Nfil3tm1Look
(B6.129X1-Nfil3tm1Look)
|
abnormal NK cell differentiation
|
J:155677
|
Nfil3tm1Pbro/Nfil3tm1Pbro
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:156521
|
Nfkb1tm1a(KOMP)Wtsi/Nfkb1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Nfkb1tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin concentration
|
J:175295
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:30268
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
arrested B cell differentiation
|
J:45119
|
| decreased double-positive T cell number
|
J:45119
|
| increased granulocyte number
|
J:45119
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Relatm1Bal/Relatm1Bal
(involves: 129P2/OlaHsd * 129S4/SvJae)
|
abnormal dendritic cell differentiation
|
J:113514
|
Nfkb1tm1Bal/Nfkb1tm1Bal
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Nfkb1tm1Bal Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
| increased transitional stage B cell number
|
J:113556
|
Nfkb1tm1Brv/Nfkb1tm1Brv
(involves: 129S1/Sv)
|
decreased erythrocyte cell number
|
J:46912
|
| extramedullary hematopoiesis
|
J:46912
|
| myeloid hyperplasia
|
J:46912
|
Nfkb2Lym1/Nfkb2+
(involves: BALB/c)
|
abnormal B cell differentiation
|
J:188560
|
Nfkb2Lym1/Nfkb2Lym1
(involves: BALB/c)
|
abnormal class switch recombination
|
J:154812
|
| abnormal plasma cell differentiation
|
J:154812
|
| abnormal T cell differentiation
|
J:154812
|
| decreased transitional stage B cell number
|
J:154812
|
| extramedullary hematopoiesis
|
J:154812
|
| increased double-negative T cell number
|
J:154812
|
| increased double-positive T cell number
|
J:154812
|
| increased transitional stage B cell number
|
J:154812
|
Nfkb2m3Btlr/Nfkb2m3Btlr
(C57BL/6J-Nfkb2m3Btlr)
|
abnormal B cell differentiation
|
J:274960
|
| abnormal CD4-positive T cell differentiation
|
J:274960
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274960
|
| abnormal T cell differentiation
|
J:274960
|
Nfkb2tm1Brv/Nfkb2tm1Brv
(involves: 129S1/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:43469
|
| decreased double-positive T cell number
|
J:43469
|
| increased granulocyte number
|
J:43469
|
Nfkb2tm1Sbn/Nfkb2tm1Sbn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:45437
|
Nfkb2xdr/Nfkb2xdr
(C57BL/6JSfdAnu-Nfkb2xdr/Anu)
|
decreased transitional stage T2 B cell number
|
J:79725
|
Nfkbiatm1.1Kbp/Nfkbiatm1.1Kbp
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythropoiesis
|
J:97945
|
| abnormal granulocyte morphology
|
J:97945
|
| increased granulocyte number
|
J:97945
|
Nfkbiatm1.1Pjc/Nfkbiatm1.1Pjc
(involves: C57BL/6)
|
increased double-positive T cell number
|
J:163686
|
Nfkbiatm1.1Smiy/Nfkbia+
(B6.129-Nfkbiatm1.1Smiy)
|
decreased transitional stage T2 B cell number
|
J:168977
|
| increased pro-B cell number
|
J:168977
|
Nfkbiatm1.1Smiy/Nfkbiatm1.1Smiy
(B6.129-Nfkbiatm1.1Smiy)
|
abnormal B cell differentiation
|
J:168977
|
| decreased transitional stage T2 B cell number
|
J:168977
|
| increased immature B cell number
|
J:168977
|
| increased pro-B cell number
|
J:168977
|
Nfkbiatm1Bal/Nfkbiatm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal granulocyte differentiation
|
J:30058
|
| decreased double-positive T cell number
|
J:30058
|
Nfkbiatm1Bal/Nfkbiatm1Bal
Nfkbietm1Syme/Nfkbietm1Syme
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:88142
|
| abnormal T cell differentiation
|
J:88142
|
| decreased immature B cell number
|
J:88142
|
Nfkbiatm1Fey/Nfkbiatm1Fey
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:110817
|
| decreased double-negative T cell number
|
J:110817
|
Nfkbiatm1Stw/Nfkbiatm1Stw
(involves: 129S1/Sv)
|
abnormal erythropoiesis
|
J:32527
|
| abnormal myelopoiesis
|
J:32527
|
| extramedullary hematopoiesis
|
J:32527
|
Nfkbidm1Btlr/Nfkbidm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Nfkbidtm1a(EUCOMM)Wtsi/Nfkbidtm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:185495
|
Nfkbietm1Syme/Nfkbietm1Syme
(either: (involves: 129P2/OlaHsd * C57BL/6 * DBA/2) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal double-negative T cell morphology
|
J:88538
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
(involves: 129 * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
Nhej1tm1.1Ics/Nhej1tm1.1Ics
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal T cell receptor V(D)J recombination
|
J:194422
|
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129)
|
abnormal class switch recombination
|
J:138774
|
Nherf1em1(IMPC)H/Nherf1em1(IMPC)H
(C57BL/6NTac-Nherf1em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
Nherf2tm2a(EUCOMM)Hmgu/Nherf2tm2a(EUCOMM)Hmgu
(C57BL/6N-Nherf2tm2a(EUCOMM)Hmgu/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Nhlh2tm1b(KOMP)Mbp/Nhlh2tm1b(KOMP)Mbp
(C57BL/6N-Nhlh2tm1b(KOMP)Mbp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Nhp2tm1a(KOMP)Wtsi/Nhp2+
(C57BL/6N-Nhp2tm1a(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Niban3tm1Jyw/Niban3tm1Jyw
(B6.Cg-Niban3tm1Jyw)
|
abnormal B cell differentiation
|
J:282961
|
| abnormal class switch recombination
|
J:282961
|
| abnormal transitional stage B cell morphology
|
J:282961
|
| increased transitional stage T2 B cell number
|
J:282961
|
Nidd3kKK/TaJcl/Nidd3kKK/TaJcl
(involves: KK * PWK)
|
increased glycosylated hemoglobin level
|
J:76775
|
Ninj2tm1a(KOMP)Wtsi/Ninj2tm1a(KOMP)Wtsi
(C57BL/6N-Ninj2tm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Nipsnap1tm1a(EUCOMM)Wtsi/Nipsnap1tm1a(EUCOMM)Wtsi
(Not Specified)
|
increased mean corpuscular volume
|
J:165965
|
Nkaptm1.1Viss/Y
Tg(Lck-cre)1Cwi/0
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested T cell differentiation
|
J:165961
|
| decreased DN4 thymocyte number
|
J:165961
|
| decreased double-positive T cell number
|
J:165961
|
| increased DN3 thymocyte number
|
J:165961
|
Nkg7tm1.1(KOMP)Vlcg/Nkg7tm1.1(KOMP)Vlcg
(C57BL/6N-Nkg7tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Nktcn1C57BL/6J/Nktcn1C57BL/6J
(NOD.B6-(D1Mit369-D1Mit155)(D6Mit105-D6Mit135))
|
abnormal T cell differentiation
|
J:137521
|
Nkx2-5tm1Siz/Nkx2-5tm1Siz
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal embryonic hematopoiesis
|
J:52597
|
Nle1tm1Cba/Nle1tm1.1Cota
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased common myeloid progenitor cell number
|
J:204063
|
| decreased granulocyte number
|
J:204063
|
Nlgn3em1(IMPC)Rbrc/Y
(C57BL/6NJcl-Nlgn3em1(IMPC)Rbrc/Rbrc)
|
abnormal eosinophil cell number
|
J:211773
|
| abnormal hematocrit
|
J:211773
|
| abnormal hemoglobin content
|
J:211773
|
| abnormal red blood cell distribution width
|
J:211773
|
Nlgn3em1(IMPC)Rbrc/Nlgn3em1(IMPC)Rbrc
(C57BL/6NJcl-Nlgn3em1(IMPC)Rbrc/Rbrc)
|
abnormal neutrophil cell number
|
J:211773
|
Nlktm1Tbo/Nlktm1Tbo
(129S1/Sv-Nlktm1Tbo)
|
abnormal definitive hematopoiesis
|
J:73353
|
| decreased double-positive T cell number
|
J:73353
|
| decreased pro-B cell number
|
J:73353
|
| impaired myelopoiesis
|
J:73353
|
Nlrp1am2Btlr/Nlrp1am2Btlr
(C57BL/6J-Nlrp1am2Btlr)
|
increased neutrophil cell number
|
J:265174
|
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1)
|
increased neutrophil cell number
|
J:191055
|
Nlrp1aNeut1/Nlrp1aNeut1
Pycardtm1Vmd/Pycardtm1Vmd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased neutrophil cell number
|
J:191055
|
Nlrp3tm1Hhf/Nlrp3+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased neutrophil cell number
|
J:150054
|
| thrombocytosis
|
J:150054
|
Nlrp3tm1Hhf/Nlrp3+
Tg(Zp3-cre)3Mrt/?
(involves: 129/Sv * FVB/N)
|
increased neutrophil cell number
|
J:150054
|
| thrombocytosis
|
J:150054
|
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129)
|
decreased erythrocyte cell number
|
J:202147
|
| increased granulocyte number
|
J:202147
|
| increased neutrophil cell number
|
J:202147
|
| thrombocytosis
|
J:202147
|
Nlrp12tm1Jpyt/Nlrp12tm1Jpyt
(B6.Cg-Nlrp12tm1Jpyt)
|
decreased neutrophil cell number
|
J:164725
|
Nmnat1tm1a(EUCOMM)Wtsi/Nmnat1+
(C57BL/6N-Nmnat1tm1a(EUCOMM)Wtsi/Cnrm)
|
increased mean corpuscular volume
|
J:165965
|
Nmnat3Gt(3020)Tgen/Nmnat3Gt(3020)Tgen
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal erythrocyte morphology
|
J:214107
|
| abnormal erythropoiesis
|
J:214107
|
| acanthocytosis
|
J:214107
|
| decreased erythrocyte cell number
|
J:214107
|
| decreased hematocrit
|
J:214107
|
| decreased hemoglobin content
|
J:214107
|
| echinocytosis
|
J:214107
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased DN4 thymocyte number
|
J:226234
|
| decreased double-positive T cell number
|
J:226234
|
| increased double-negative T cell number
|
J:226234
|
Nmt1tm1.1Poru/Nmt1tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased double-positive T cell number
|
J:226234
|
Nmt2tm1.1Poru/Nmt2tm1.1Poru
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
decreased double-positive T cell number
|
J:226234
|
Noa/Noa+
(NOA)
|
cutaneous mastocytosis
|
J:43274
|
Noc2ltm1.1Arte/Noc2ltm1.1Arte
Tg(CD2-icre)4Kio/0
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
arrested T cell differentiation
|
J:216490
|
| decreased DN3 thymocyte number
|
J:216490
|
| decreased DN4 thymocyte number
|
J:216490
|
| decreased double-positive T cell number
|
J:216490
|
| decreased immature B cell number
|
J:216490
|
| decreased pro-B cell number
|
J:216490
|
Nod2tm1Flv/Nod2tm1Flv
(involves: 129S1/Sv)
|
increased neutrophil cell number
|
J:147177
|
Nod2tm1Jhgt/Nod2tm1Jhgt
(B6.Cg-Nod2tm1Jhgt)
|
increased double-negative T cell number
|
J:124575
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd)
|
abnormal eosinophil cell number
|
J:51635
|
| decreased eosinophil cell number
|
J:51635
|
Nos3em1(IMPC)Mbp/Nos3em1(IMPC)Mbp
(C57BL/6N-Nos3em1(IMPC)Mbp/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Notch1tm1Agt/Notch1tm1Agt
Notch2tm1Frad/Notch2tm1Frad
Tg(Mx1-cre)1Cgn/0
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:125373
|
| arrested T cell differentiation
|
J:125373
|
Notch1tm1Agt/Notch1tm1Agt
Tg(Mx1-cre)1Cgn/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
| abnormal T cell differentiation
|
J:125373,
J:55400
|
| decreased double-negative T cell number
|
J:55400
|
| decreased double-positive T cell number
|
J:55400
|
| increased immature B cell number
|
J:143472
|
Notch1tm2Pst/Notch1tm2Pst
(B6.Cg-Notch1tm2Pst)
|
abnormal T cell differentiation
|
J:131563
|
| decreased double-negative T cell number
|
J:131563
|
Notch1tm2Rko/Notch1tm2Rko
Notch2tm1Rko/Notch2tm1Rko
Notch3Gt(PST033)Byg/Notch3+
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
extramedullary hematopoiesis
|
J:172442
|
Notch1tm2Rko/Notch1tm2Rko
Notch2tm1Rko/Notch2tm1Rko
Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:172442
|
| extramedullary hematopoiesis
|
J:172442
|
Notch1tm2Rko/Notch1tm3(cre)Rko
(involves: 129X1/SvJ * C57BL/6)
|
extramedullary hematopoiesis
|
J:171829
|
Notch2tm1Frad/Notch2tm1Frad
Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:125373
|
Notch3tm1.1(KOMP)Vlcg/Notch3tm1.1(KOMP)Vlcg
(C57BL/6N-Notch3tm1.1(KOMP)Vlcg/Ucd)
|
increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Npas2em1(IMPC)Mbp/Npas2em1(IMPC)Mbp
(C57BL/6N-Npas2em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Npeppsem1(IMPC)Hmgu/Npeppsem1(IMPC)Hmgu
(C57BL/6N-Npeppsem1(IMPC)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Npm1tm1Gsva/Npm1+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:172071
|
| increased granulocyte number
|
J:172071
|
| increased mean corpuscular volume
|
J:172071
|
| increased mean platelet volume
|
J:172071
|
Npm1tm1Hft/Npm1+
(involves: 129)
|
abnormal common myeloid progenitor cell morphology
|
J:194999
|
| abnormal granulocyte differentiation
|
J:194999
|
| extramedullary hematopoiesis
|
J:194999
|
| increased granulocyte number
|
J:194999
|
| myeloid hyperplasia
|
J:194999
|
| thrombocytosis
|
J:194999
|
Npm1tm1Ppp/Npm1+
(involves: 129S1/Sv * C57BL/6)
|
abnormal thrombopoiesis
|
J:101494
|
| anisocytosis
|
J:101494
|
| increased mean corpuscular volume
|
J:101494
|
Npm1tm1Ppp/Npm1tm1Ppp
(involves: 129S1/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:101494
|
Npm1tm2Ppp/Npm1tm2Ppp
(involves: 129S1/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:101494
|
Nppatm1Unc/Nppatm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hematocrit
|
J:76312
|
Npr3tm1Unc/Npr3+
(involves: 129 * C57BL/6)
|
increased erythrocyte cell number
|
J:56058
|
| increased hematocrit
|
J:56058
|
| increased hemoglobin content
|
J:56058
|
Npr3tm1Unc/Npr3tm1Unc
(involves: 129 * C57BL/6)
|
increased erythrocyte cell number
|
J:56058
|
| increased hematocrit
|
J:56058
|
| increased hemoglobin content
|
J:56058
|
Nprl2tm1.2Bpt/Nprl2tm1.2Bpt
(involves: C57BL/6)
|
abnormal erythropoiesis
|
J:224837
|
Npsr1tm1b(KOMP)Wtsi/Npsr1tm1b(KOMP)Wtsi
(C57BL/6N-Npsr1tm1b(KOMP)Wtsi/Rbrc)
|
increased eosinophil cell number
|
J:211773
|
Nptntm1b(EUCOMM)Hmgu/Nptntm1b(EUCOMM)Hmgu
(C57BL/6N-Nptntm1b(EUCOMM)Hmgu/H)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Npy1rtm1.1Wpg/Npy1rtm1.1Wpg
(involves: 129X1/SvJ * C57BL/6)
|
decreased transitional stage B cell number
|
J:118850
|
Nqo2tm1Akj/Nqo2tm1Akj
(Not Specified)
|
abnormal lymphopoiesis
|
J:80549
|
| increased granulocyte number
|
J:80549
|
| thrombocytosis
|
J:80549
|
Nr0b1em2(IMPC)Wtsi/Y
(C57BL/6N-Nr0b1em2(IMPC)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:211773
|
Nr2c1tm1Chc/Nr2c1tm1Chc
(involves: 129S5/SvEvBrd)
|
abnormal hemoglobin
|
J:121628
|
Nr2c2tm1Chc/Nr2c2tm1Chc
(Not Specified)
|
abnormal hemoglobin
|
J:121628
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(Lck-cre)548Jxm/0
Tg(TcrAND)53Hed/0
(B6.Cg-Rag2tm1.1Cgn Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm Tg(TcrAND)53Hed)
|
decreased double-positive T cell number
|
J:189951
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tcratm1Mom/Tcratm1Mom
Tg(Lck-cre)548Jxm/0
(B6.Cg-Tcratm1Mom Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased double-positive T cell number
|
J:189951
|
Nr3c1tm1.1Jda/Nr3c1tm1.1Jda
Tg(Lck-cre)548Jxm/0
(B6.Cg-Nr3c1tm1.1Jda Tg(Lck-cre)548Jxm)
|
decreased double-positive T cell number
|
J:189951
|
Nr3c2tm1Gsc/Nr3c2tm1Gsc
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hematocrit
|
J:77285
|
Nr4a1tm1Jmi/Nr4a1tm1Jmi
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:121903
|
| abnormal leukopoiesis
|
J:121903
|
| abnormal myelopoiesis
|
J:121903
|
| increased eosinophil cell number
|
J:121903
|
| increased granulocyte number
|
J:121903
|
| increased neutrophil cell number
|
J:121903
|
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T-helper 1 cell differentiation
|
J:205658
|
| abnormal T-helper 17 cell differentiation
|
J:205658
|
Nr4a2tm1.1Pcn/Nr4a2tm1.1Pcn
Tg(Lck-cre)1Jtak/0
(Not Specified)
|
abnormal T-helper 1 cell differentiation
|
J:205658
|
| abnormal T-helper 17 cell differentiation
|
J:205658
|
Nrastm1.1Emfu/Nrastm1.1Emfu
(involves: 129S1/Sv * FVB/N)
|
abnormal granulocyte differentiation
|
J:189834
|
| increased granulocyte number
|
J:189834
|
Nrastm1Tyj/Nras+
Meox2tm1(cre)Sor/Meox2+
(B6.Cg-Nrastm1Tyj Meox2tm1(cre)Sor)
|
abnormal definitive hematopoiesis
|
J:305401
|
Nrastm1Tyj/Nrastm1Tyj
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:204263
|
| abnormal myelopoiesis
|
J:174880
|
| increased neutrophil cell number
|
J:204263
|
| myeloid hyperplasia
|
J:204263
|
Nrsn2em1(IMPC)Kmpc/Nrsn2em1(IMPC)Kmpc
(C57BL/6NTac-Nrsn2em1(IMPC)Kmpc/Kmpc)
|
increased red blood cell distribution width
|
J:211773
|
Nsftm1b(KOMP)Mbp/Nsf+
(C57BL/6N-Nsftm1b(KOMP)Mbp/J)
|
increased hemoglobin content
|
J:211773
|
Nsg1tm1.1(KOMP)Vlcg/Nsg1tm1.1(KOMP)Vlcg
(C57BL/6N-Nsg1tm1.1(KOMP)Vlcg/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Nsmftm1a(KOMP)Wtsi/Nsmftm1a(KOMP)Wtsi
(C57BL/6N-Nsmftm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2+
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular volume
|
J:165965
|
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased mean corpuscular hemoglobin
|
J:213427
|
| decreased mean corpuscular volume
|
J:213427
|
| increased erythrocyte cell number
|
J:213427
|
Nsun5tm2b(EUCOMM)Wtsi/Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6N-Nsun5tm2b(EUCOMM)Wtsi/J)
|
increased neutrophil cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Nsun5tm2b(EUCOMM)Wtsi/Nsun5tm2b(EUCOMM)Wtsi
(C57BL/6NJ-Nsun5tm2b(EUCOMM)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Nt5c1btm1b(KOMP)Wtsi/Nt5c1btm1b(KOMP)Wtsi
(C57BL/6N-Nt5c1btm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Nt5c3em1(IMPC)Tcp/Nt5c3em1(IMPC)Tcp
(C57BL/6NCrl-Nt5c3em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Ntaq1tm1.1(KOMP)Vlcg/Ntaq1tm1.1(KOMP)Vlcg
(C57BL/6N-Ntaq1tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Ntf5tm1b(EUCOMM)Hmgu/Ntf5tm1b(EUCOMM)Hmgu
(C57BL/6N-Ntf5tm1b(EUCOMM)Hmgu/Ics)
|
decreased mean corpuscular volume
|
J:211773
|
Ntn4tm1b(KOMP)Wtsi/Ntn4tm1b(KOMP)Wtsi
(C57BL/6N-Ntn4tm1b(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Ntrk1tm1b(EUCOMM)Wtsi/Ntrk1+
(C57BL/6N-Ntrk1tm1b(EUCOMM)Wtsi/H)
|
increased basophil cell number
|
J:211773
|
Nucb1em1(IMPC)Mbp/Nucb1em1(IMPC)Mbp
(C57BL/6NCrl-Nucb1em1(IMPC)Mbp/Mmucd)
|
thrombocytopenia
|
J:211773
|
Nudcd3em1(IMPC)Wtsi/Nudcd3em1(IMPC)Wtsi
(C57BL/6N-Nudcd3em1(IMPC)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Nudt15em1Maska/Nudt15+
(C57BL/6-Nudt15em1Maska)
|
decreased neutrophil cell number
|
J:285800
|
Nudt15em1Maska/Nudt15em1Maska
(C57BL/6-Nudt15em1Maska)
|
decreased neutrophil cell number
|
J:285800
|
Nudt19tm1.1(KOMP)Vlcg/Nudt19tm1.1(KOMP)Vlcg
(C57BL/6N-Nudt19tm1.1(KOMP)Vlcg/Ucd)
|
increased mean platelet volume
|
J:211773
|
Nufip2em1(IMPC)J/Nufip2+
(C57BL/6NJ-Nufip2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Nuggctm1Diaz/Nuggctm1Diaz
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal somatic hypermutation frequency
|
J:190402
|
Nutm1tm1b(KOMP)Wtsi/Nutm1tm1b(KOMP)Wtsi
(C57BL/6N-Nutm1tm1b(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Nxnem1(IMPC)J/Nxn+
(C57BL/6NJ-Nxnem1(IMPC)J/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Nxpe5tm1a(EUCOMM)Wtsi/Nxpe5tm1a(EUCOMM)Wtsi
(C57BL/6N-Nxpe5tm1a(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:165965
|
Oaz2em1(IMPC)J/Oaz2em1(IMPC)J
(C57BL/6NJ-Oaz2em1(IMPC)J/J)
|
increased mean corpuscular volume
|
J:211773
|
Ociad1tm1.1Msin/Ociad1+
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal platelet cell number
|
J:279239
|
| increased erythrocyte cell number
|
J:279239
|
Ociad1tm1.1Msin/Ociad1tm1.1Msin
(involves: BALB/cJ * C57BL/6NCrlj * CBA/JNCrlj)
|
increased granulocyte number
|
J:279239
|
| increased neutrophil cell number
|
J:279239
|
oed/oed
(STOCK pc-oed)
|
increased granulocyte number
|
J:5609
|
Ofcc1em1(IMPC)J/Ofcc1em1(IMPC)J
(C57BL/6NJ-Ofcc1em1(IMPC)J/J)
|
thrombocytopenia
|
J:211773
|
Ogdhtm1e(KOMP)Wtsi/Ogdh+
(C57BL/6N-Ogdhtm1e(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Ogttm1Gwh/Y
Tg(Lck-cre)548Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:93112
|
oh/oh
(Not Specified)
|
increased erythrocyte cell number
|
J:5300
|
Ola1Gt(OST312288)Lex/Ola1Gt(OST312288)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:236306
|
Olahtm1b(KOMP)Wtsi/Olahtm1b(KOMP)Wtsi
(C57BL/6N-Olahtm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Oplahtm1b(KOMP)Wtsi/Oplahtm1b(KOMP)Wtsi
(C57BL/6N-Oplahtm1b(KOMP)Wtsi/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
Opn3em1(IMPC)Mbp/Opn3em1(IMPC)Mbp
(C57BL/6NCrl-Opn3em1(IMPC)Mbp/Mmucd)
|
increased basophil cell number
|
J:211773
|
Oprl1em1(IMPC)Mbp/Oprl1em1(IMPC)Mbp
(C57BL/6N-Oprl1em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Oprm1tm1Lyu/Oprm1tm1Lyu
(involves: Black Swiss)
|
abnormal common myeloid progenitor cell morphology
|
J:39864
|
Or2l13bem1Scjc/Or2l13bem1Scjc
(FVB/NTac-Or2l13bem1Scjc)
|
abnormal platelet morphology
|
J:324598
|
Orai1tm1Fesk/Orai1tm1Fesk
(C57BL/6-Orai1tm1Fesk)
|
decreased platelet calcium level
|
J:144861
|
Osbpem1(IMPC)Tcp/Osbp+
(C57BL/6NCrl-Osbpem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Osbpl8em1(IMPC)Tcp/Osbpl8em1(IMPC)Tcp
(C57BL/6NCrl-Osbpl8em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Oscp1tm1b(EUCOMM)Hmgu/Oscp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Oscp1tm1b(EUCOMM)Hmgu/Ieg)
|
increased hematocrit
|
J:211773
|
Osmtm1b(KOMP)Wtsi/Osmtm1b(KOMP)Wtsi
(C57BL/6N-Osmtm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Osmrtm1Mtan/Osmrtm1Mtan
(B6.129S-Osmrtm1Mtan)
|
abnormal common myeloid progenitor cell morphology
|
J:86261
|
| abnormal definitive hematopoiesis
|
J:86261
|
| decreased erythrocyte cell number
|
J:86261
|
| decreased hematocrit
|
J:86261
|
| thrombocytopenia
|
J:86261
|
Ostm1om/Ostm1om
(C3HeB/FeJ-Ostm1om)
|
decreased hemoglobin content
|
J:195249
|
Otoatm1.1(KOMP)Vlcg/Otoatm1.1(KOMP)Vlcg
(C57BL/6N-Otoatm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Otptm1b(EUCOMM)Wtsi/Otp+
(C57BL/6N-Otptm1b(EUCOMM)Wtsi/H)
|
decreased mean platelet volume
|
J:211773
|
Otub1tm1c(EUCOMM)Hmgu/Otub1tm1c(EUCOMM)Hmgu
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
decreased immature B cell number
|
J:280549
|
Otud5tm1Vmd/Otud5tm1Vmd
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
Otud5tm1Vmd/Otud5tm1Vmd
Tg(Vav1-cre)#Cgp/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:219495
|
Otud6atm1(KOMP)Vlcg/Otud6atm1(KOMP)Vlcg
(C57BL/6N-Otud6atm1(KOMP)Vlcg/Nju)
|
increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Otud6btm1b(EUCOMM)Wtsi/Otud6b+
(C57BL/6N-Otud6btm1b(EUCOMM)Wtsi/Wtsi)
|
increased basophil cell number
|
J:211773
|
Ovol1tm1b(KOMP)Wtsi/Ovol1+
(C57BL/6N-Ovol1tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Oxr1tm1a(EUCOMM)Wtsi/Oxr1+
(C57BL/6N-Oxr1tm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
P2rx4tm1b(EUCOMM)Wtsi/P2rx4tm1b(EUCOMM)Wtsi
(C57BL/6N-P2rx4tm1b(EUCOMM)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
P2ry6tm1Jabo/P2ry6tm1Jabo
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: 129 * C57BL/6 * C57BL/6NTac)
|
increased eosinophil cell number
|
J:179177
|
| increased neutrophil cell number
|
J:179177
|
P2ry6tm1Jabo/P2ry6tm1Jabo
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(B6.Cg-Gt(ROSA)26Sortm9(cre/ESR1)Arte P2ry6tm1Jabo)
|
increased eosinophil cell number
|
J:179177
|
| increased neutrophil cell number
|
J:179177
|
P3h3tm1.1(KOMP)Vlcg/P3h3tm1.1(KOMP)Vlcg
(C57BL/6N-P3h3tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
P4hbtm1.1Geno/P4hbtm1.2Geno
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd)
|
decreased neutrophil cell number
|
J:197556
|
Pa2g4tm1a(EUCOMM)Wtsi/Pa2g4+
(Not Specified)
|
increased mean corpuscular volume
|
J:165965
|
Pabpc1ltm1a(EUCOMM)Wtsi/Pabpc1ltm1a(EUCOMM)Wtsi
(C57BL/6N-Pabpc1ltm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Pacsin2tm1b(EUCOMM)Hmgu/Pacsin2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pacsin2tm1b(EUCOMM)Hmgu/J)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| thrombocytosis
|
J:211773
|
Padi4em1(IMPC)Mbp/Padi4em1(IMPC)Mbp
(C57BL/6N-Padi4em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Paip1em1(IMPC)Tcp/Paip1em1(IMPC)Tcp
(C57BL/6NCrl-Paip1em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Pak2em1(IMPC)H/Pak2+
(C57BL/6NTac-Pak2em1(IMPC)H/H)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Pan2tm1b(KOMP)Wtsi/Pan2tm1b(KOMP)Wtsi
(C57BL/6N-Pan2tm1b(KOMP)Wtsi/Mhzh)
|
increased eosinophil cell number
|
J:211773
|
Pan3em1(IMPC)Tcp/Pan3+
(C57BL/6N-Pan3em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Pank3tm1b(KOMP)Mbp/Pank3tm1b(KOMP)Mbp
(C57BL/6N-Pank3tm1b(KOMP)Mbp/Bay)
|
decreased erythrocyte cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Panx1tm1b(KOMP)Wtsi/Panx1tm1b(KOMP)Wtsi
(C57BL/6N-Panx1tm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Paoxtm1.1(KOMP)Wtsi/Paoxtm1.1(KOMP)Wtsi
(C57BL/6N-Paoxtm1.1(KOMP)Wtsi/Ieg)
|
thrombocytopenia
|
J:211773
|
Pard3tm1b(KOMP)Wtsi/Pard3+
(C57BL/6N-Pard3tm1b(KOMP)Wtsi/H)
|
decreased basophil cell number
|
J:211773
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased double-positive T cell number
|
J:116017
|
Parltm1a(EUCOMM)Hmgu/Parl+
(C57BL/6N-Parltm1a(EUCOMM)Hmgu/H)
|
increased mean corpuscular volume
|
J:165965
|
Parp12tm1.1(KOMP)Vlcg/Parp12tm1.1(KOMP)Vlcg
(C57BL/6N-Parp12tm1.1(KOMP)Vlcg/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Pate4tm1.1(KOMP)Mbp/Pate4tm1.1(KOMP)Mbp
(C57BL/6N-Pate4tm1.1(KOMP)Mbp/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Patz1tm1.2Welm/Patz1tm1.2Welm
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Patz1tm1.2Welm Commd10Tg(Vav1-icre)A2Kio)
|
abnormal mast cell differentiation
|
J:209168
|
Pax1un-i/Pax1un-i
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6J))
|
decreased double-negative T cell number
|
J:100951
|
| decreased double-positive T cell number
|
J:100951
|
| increased double-negative T cell number
|
J:100951
|
Pax1un/Pax1+
Tcf3tm1Cmu/Tcf3tm1Cmu
(involves: 129P2/OlaHsd * C3H * C57BL/6)
|
abnormal T cell differentiation
|
J:103567
|
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:38813
|
| abnormal lymphopoiesis
|
J:38813
|
| arrested B cell differentiation
|
J:113076
|
| decreased immature B cell number
|
J:113076
|
Pax5tm1Mbu/Pax5tm1Mbu
(involves: 129S2/SvPas)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:139510
|
| arrested B cell differentiation
|
J:75504
|
Pax5tm1Mbu/Pax5tm1Mbu
(either: 129 or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal late pro-B cell
|
J:21935
|
| abnormal lymphopoiesis
|
J:21935
|
| absent late pro-B cells
|
J:21935
|
| arrested B cell differentiation
|
J:21935
|
Pax5tm3.1Mbu/Pax5tm3.1Mbu
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:75504
|
Pax5tm3Mbu/Pax5+
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:226241
|
| arrested B cell differentiation
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
Paxxem1Spj/Paxxem1Spj
(C57BL/6NTac-Paxxem1Spj)
|
decreased transitional stage B cell number
|
J:236776
|
Pbat1BXSB/Slc/Pbat1BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
|
thrombocytopenia
|
J:49899
|
Pbat1BXSB/Slc/Pbat1NZW/Slc
(involves: BXSB/Slc * NZW/Slc)
|
thrombocytopenia
|
J:49899
|
Pbat2BXSB/Slc/Pbat2BXSB/Slc
(involves: BXSB/Slc * NZW/Slc)
|
thrombocytopenia
|
J:49899
|
Pbat2BXSB/Slc/Pbat2NZW/Slc
(involves: BXSB/Slc * NZW/Slc)
|
thrombocytopenia
|
J:49899
|
Pbrbc1CBA/HOla/Pbrbc1CBA/HOla
(involves: C57BL/6Ola * CBA/HOla)
|
increased erythrocyte cell number
|
J:118313
|
Pbrbc2A/J/?
(involves: A/J * C57BL/6J)
|
increased erythrocyte cell number
|
J:118313
|
Pbrbc3C57BL/6J/?
(involves: A/J * C57BL/6J)
|
increased erythrocyte cell number
|
J:118313
|
Pbrbc4C57BL/6J/?
(involves: A/J * C57BL/6J)
|
increased erythrocyte cell number
|
J:118313
|
Pbrgcsf1C57BL/6J/Pbrgcsf1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:87464
|
Pbrgcsf1C57BL/6J/Pbrgcsf1DBA/2J
Pbrgcsf2C57BL/6J/Pbrgcsf2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:87464
|
Pbrgcsf2C57BL/6J/Pbrgcsf2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:87464
|
Pbrgcsf2DBA/2J/Pbrgcsf2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:87464
|
Pbrm1tm1b(EUCOMM)Wtsi/Pbrm1+
(C57BL/6N-Pbrm1tm1b(EUCOMM)Wtsi/Ieg)
|
increased mean platelet volume
|
J:211773
|
Pbrm1tm1Zhwa/Pbrm1tm1Zhwa
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T-helper 2 cell differentiation
|
J:236906
|
Pbx1tm1Mlc/Pbx1tm1Mlc
(involves: 129S6/SvEvTac * C57BL/6)
|
absent common myeloid progenitor cells
|
J:70684
|
| decreased hematocrit
|
J:70684
|
| low mean erythrocyte cell number
|
J:70684
|
Pbx1tm1Mlc/Pbx1tm3.1Mlc
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:149799
|
Pbx1tm1Mlc/Pbx1tm3.1Mlc
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal definitive hematopoiesis
|
J:149799
|
| decreased common myeloid progenitor cell number
|
J:149799
|
| decreased double-negative T cell number
|
J:149799
|
| decreased pro-B cell number
|
J:149799
|
Pcbp2tm1.2Salr/Pcbp2+
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal platelet cell number
|
J:235912
|
Pcdhb10em1(IMPC)Tcp/Pcdhb10em1(IMPC)Tcp
(C57BL/6N-Pcdhb10em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Pcdhb13em1(IMPC)Tcp/Pcdhb13em1(IMPC)Tcp
(C57BL/6N-Pcdhb13em1(IMPC)Tcp/Tcp)
|
decreased basophil cell number
|
J:211773
|
Pcdhb22tm1.1(KOMP)Vlcg/Pcdhb22tm1.1(KOMP)Vlcg
(C57BL/6N-Pcdhb22tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Pcgf6tm1.2Hko/Pcgf6tm1.2Hko
(involves: 129 * C57BL/6)
|
decreased nucleated erythrocyte cell number
|
J:258919
|
Pclaftm1.1Lkd/Pclaftm1.1Lkd
(involves: C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:177782
|
Pclaftm1a(EUCOMM)Wtsi/Pclaftm1a(EUCOMM)Wtsi
(C57BL/6N-Pclaftm1a(EUCOMM)Wtsi/Wtsi)
|
increased pro-B cell number
|
J:211773
|
Pcnatm1.1Mdsc/Pcnatm1.1Mdsc
Tg(Pcna*K164R)1Mdsc/0
(involves: FVB/N)
|
abnormal class switch recombination
|
J:141098
|
| abnormal somatic hypermutation frequency
|
J:141098
|
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:125916
|
Pcnatm1Jcbs/Pcnatm1Jcbs
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454,
J:177630
|
Pcnatm1Jcbs/Pcnatm1Jcbs
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal somatic hypermutation frequency
|
J:155454
|
Pcsk1tm1Dfs/Pcsk1tm1Dfs
(involves: 129 * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:184882
|
Pcsk2em1(IMPC)H/Pcsk2em1(IMPC)H
(C57BL/6NTac-Pcsk2em1(IMPC)H/H)
|
increased mean corpuscular volume
|
J:211773
|
Pdap1em1Rkuhn/Pdap1em1Rkuhn
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N)
|
abnormal class switch recombination
|
J:298705
|
| abnormal somatic hypermutation frequency
|
J:298705
|
Pdcd1tm1Hon/Pdcd1tm1Hon
(involves: 129S2/SvPas * C57BL/6)
|
abnormal leukopoiesis
|
J:50688
|
| abnormal myelopoiesis
|
J:50688
|
Pdcd6ipem1(IMPC)Mbp/Pdcd6ipem1(IMPC)Mbp
(C57BL/6NCrl-Pdcd6ipem1(IMPC)Mbp/Mmucd)
|
increased mean platelet volume
|
J:211773
|
Pdcd7em1(IMPC)Mbp/Pdcd7+
(C57BL/6N-Pdcd7em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Pde1btm1b(EUCOMM)Wtsi/Pde1btm1b(EUCOMM)Wtsi
(C57BL/6N-Pde1btm1b(EUCOMM)Wtsi/Bay)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Pde2aem1(IMPC)H/Pde2a+
(C57BL/6NTac-Pde2aem1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Pde4diptm1b(KOMP)Wtsi/Pde4dip+
(C57BL/6N-Pde4diptm1b(KOMP)Wtsi/Bay)
|
increased hemoglobin content
|
J:211773
|
Pde10aem1(IMPC)H/Pde10aem1(IMPC)H
(C57BL/6NTac-Pde10aem1(IMPC)H/H)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Pdgfbtm1Cbet/Pdgfbtm1Cbet
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hematocrit
|
J:20017
|
| decreased hemoglobin content
|
J:20017
|
| increased mean corpuscular volume
|
J:20017
|
| thrombocytopenia
|
J:20017
|
Pdgfctm1b(EUCOMM)Hmgu/Pdgfc+
(C57BL/6N-Pdgfctm1b(EUCOMM)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| increased granulocyte number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Pdgfrbtm1Rheu/Pdgfrbtm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:138069
|
Pdgfrbtm1Sor/Pdgfrbtm1Sor
(either: 129S7/SvEvBrd-Pdgfrbtm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal erythrocyte morphology
|
J:20016
|
| anisocytosis
|
J:20016
|
| increased nucleated erythrocyte cell number
|
J:20016
|
| poikilocytosis
|
J:20016
|
| polychromatophilia
|
J:20016
|
| schistocytosis
|
J:20016
|
| thrombocytopenia
|
J:20016
|
Pdgfrbtm2Sor/Pdgfrbtm2Sor
(either: 129S7/SvEvBrd-Pdgfrbtm2Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
abnormal erythrocyte morphology
|
J:20016
|
| anisocytosis
|
J:20016
|
| increased nucleated erythrocyte cell number
|
J:20016
|
| poikilocytosis
|
J:20016
|
| polychromatophilia
|
J:20016
|
| schistocytosis
|
J:20016
|
| thrombocytopenia
|
J:20016
|
Pdgfrlem1(IMPC)J/Pdgfrlem1(IMPC)J
(C57BL/6NJ-Pdgfrlem1(IMPC)J/J)
|
increased hemoglobin content
|
J:211773
|
Pdia4tm1b(EUCOMM)Wtsi/Pdia4tm1b(EUCOMM)Wtsi
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6N)
|
decreased platelet ATP level
|
J:244748
|
Pdia6em1Btlr/Pdia6m1Btlr
(involves: C57BL/6J)
|
decreased common myeloid progenitor cell number
|
J:288824
|
| decreased double-negative T cell number
|
J:288824
|
| decreased double-positive T cell number
|
J:288824
|
| decreased transitional stage B cell number
|
J:288824
|
| thrombocytopenia
|
J:288824
|
Pdik1lem1(IMPC)Mbp/Pdik1lem1(IMPC)Mbp
(C57BL/6NCrl-Pdik1lem1(IMPC)Mbp/Mmucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Pdlim1Gt(XC262)Byg/Pdlim1Gt(XC262)Byg
(involves: 129P2/OlaHsd)
|
increased mean platelet volume
|
J:212221
|
Pdlim7em1(IMPC)Mbp/Pdlim7em1(IMPC)Mbp
(C57BL/6N-Pdlim7em1(IMPC)Mbp/MbpMmucd)
|
increased mean platelet volume
|
J:211773
|
Pdpk1tm1Mlw/Pdpk1tm1Mlw
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:165626
|
Pdprtm1b(EUCOMM)Wtsi/Pdprtm1b(EUCOMM)Wtsi
(C57BL/6N-Pdprtm1b(EUCOMM)Wtsi/Ics)
|
increased hematocrit
|
J:211773
|
Pdss2tm1b(EUCOMM)Hmgu/Pdss2+
(C57BL/6N-Pdss2tm1b(EUCOMM)Hmgu/H)
|
thrombocytopenia
|
J:211773
|
Pdynem1(IMPC)Rbrc/Pdynem1(IMPC)Rbrc
(C57BL/6NJcl-Pdynem1(IMPC)Rbrc/Rbrc)
|
abnormal platelet cell number
|
J:211773
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8+
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Peak1em1(IMPC)J/Peak1em1(IMPC)J
(C57BL/6NJ-Peak1em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Pebp1em1(IMPC)Tcp/Pebp1em1(IMPC)Tcp
(C57BL/6NCrl-Pebp1em1(IMPC)Tcp/Tcp)
|
decreased eosinophil cell number
|
J:211773
|
Peds1tm1a(KOMP)Wtsi/Peds1tm1a(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Peds1tm1a(KOMP)Wtsi Tyrc-Brd/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Peli1tm1b(EUCOMM)Wtsi/Peli1tm1b(EUCOMM)Wtsi
(C57BL/6N-Peli1tm1b(EUCOMM)Wtsi/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Pepdtm1a(KOMP)Wtsi/Pepdtm1a(KOMP)Wtsi
(C57BL/6N-Pepdtm1a(KOMP)Wtsi/Ucd)
|
decreased immature B cell number
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased transitional stage T1 B cell number
|
J:211773
|
Pepdtm1b(KOMP)Wtsi/Pepdtm1b(KOMP)Wtsi
(C57BL/6N-Pepdtm1b(KOMP)Wtsi/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Pes1tm1b(EUCOMM)Wtsi/Pes1+
(C57BL/6N-Pes1tm1b(EUCOMM)Wtsi/Bay)
|
increased mean platelet volume
|
J:211773
|
Pex3tm1a(EUCOMM)Wtsi/Pex3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pex3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Pex6em1(IMPC)Tcp/Pex6+
(C57BL/6N-Pex6em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Pf4tm1Mako/Pf4+
(B6.129X1-Pf4tm1Mako)
|
thrombocytosis
|
J:94900
|
Pf4tm1Mako/Pf4tm1Mako
(B6.129X1-Pf4tm1Mako)
|
thrombocytosis
|
J:94900
|
PfasSofa-2J/Pfas+
(B6(Cg)-PfasSofa-2J/GrsrJ)
|
abnormal transitional stage B cell morphology
|
J:223062
|
Pfdn1Gt(GTR1.3)1Rul/Pfdn1Gt(GTR1.3)1Rul
(involves: 129)
|
abnormal B cell differentiation
|
J:137415
|
| abnormal erythrocyte morphology
|
J:137415
|
| abnormal neutrophil morphology
|
J:137415
|
| decreased erythrocyte cell number
|
J:137415
|
Pfdn6tm1.1(KOMP)Vlcg/Pfdn6+
(C57BL/6N-Pfdn6tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Pfkfb2tm1b(KOMP)Wtsi/Pfkfb2tm1b(KOMP)Wtsi
(C57BL/6N-Pfkfb2tm1b(KOMP)Wtsi/Nju)
|
decreased neutrophil cell number
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Pfkmtm1Fbos/Pfkmtm1Fbos
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased hematocrit
|
J:152153
|
Pgam1tm1.1Hiko/Pgam1tm1.1Hiko
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:293746
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:293746
|
Pgam5tm1b(EUCOMM)Wtsi/Pgam5tm1b(EUCOMM)Wtsi
(C57BL/6N-Pgam5tm1b(EUCOMM)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Pgap3tm1.1Ymra/Pgap3tm1.1Ymra
(B6.Cg-Pgap3tm1.1Ymra)
|
abnormal T-helper 2 cell differentiation
|
J:203443
|
Pgcem1Hcz/Pgcem1Hcz
(Not Specified)
|
decreased erythrocyte cell number
|
J:338079
|
| decreased hemoglobin content
|
J:338079
|
Pgdtm1.1Pse/Pgdtm1.1Pse
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:306553
|
Pgm3Gt(W037B08)Wrst/Pgm3mld1
(involves: 129S1/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:125094
|
| decreased erythrocyte cell number
|
J:125094
|
| decreased hematocrit
|
J:125094
|
| increased pro-B cell number
|
J:125094
|
| thrombocytopenia
|
J:125094
|
Pgm3mld1/Pgm3mld1
(C57BL/6-Pgm3mld1)
|
abnormal erythropoiesis
|
J:125094
|
| abnormal thrombopoiesis
|
J:125094
|
| decreased erythrocyte cell number
|
J:125094
|
| decreased hematocrit
|
J:125094
|
| extramedullary hematopoiesis
|
J:125094
|
| increased pro-B cell number
|
J:125094
|
| thrombocytopenia
|
J:125094
|
Phb1em1(IMPC)H/Phb1+
(C57BL/6NTac-Phb1em1(IMPC)H/H)
|
decreased red blood cell distribution width
|
J:211773
|
Phc1tm1Os/Phc1tm1Os
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:75707
|
| extramedullary hematopoiesis
|
J:75707
|
Phf6em1Wencc/Y
Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
decreased double-negative T cell number
|
J:278804
|
| extramedullary hematopoiesis
|
J:278804
|
| increased pro-B cell number
|
J:278804
|
| thrombocytopenia
|
J:278804
|
Phf6em1Wencc/Phf6em1Wencc
Tg(Vav1-cre)#Cgp/0
(Not Specified)
|
decreased double-negative T cell number
|
J:278804
|
| extramedullary hematopoiesis
|
J:278804
|
| increased pro-B cell number
|
J:278804
|
| thrombocytopenia
|
J:278804
|
Phf6tm1.1Avo/Y
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:276228
|
| decreased DN2 thymocyte number
|
J:276228
|
Phf8em2(IMPC)Wtsi/Y
(C57BL/6N-Phf8em2(IMPC)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Phf8em2(IMPC)Wtsi/Phf8em2(IMPC)Wtsi
(C57BL/6N-Phf8em2(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Phf8tm1dIcs/Phf8tm1dIcs
(C57BL/6N-Phf8tm1dIcs/Ics)
|
increased neutrophil cell number
|
J:211773
|
Phf20Gt(XN131)Byg/Phf20Gt(XN131)Byg
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:228714
|
| decreased double-positive T cell number
|
J:228714
|
| increased double-negative T cell number
|
J:228714
|
Phf20l1em1(IMPC)Tcp/Phf20l1em1(IMPC)Tcp
(C57BL/6N-Phf20l1em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Phkg2tm1.1(KOMP)Vlcg/Phkg2+
(C57BL/6N-Phkg2tm1.1(KOMP)Vlcg/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Phldb1em1(IMPC)J/Phldb1em1(IMPC)J
(C57BL/6NJ-Phldb1em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Phldb2em1(IMPC)H/Phldb2em1(IMPC)H
(C57BL/6NTac-Phldb2em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
Phyhtm1b(EUCOMM)Wtsi/Phyhtm1b(EUCOMM)Wtsi
(C57BL/6N-Phyhtm1b(EUCOMM)Wtsi/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Pi4katm1b(EUCOMM)Wtsi/Pi4ka+
(C57BL/6N-Pi4katm1b(EUCOMM)Wtsi/Tcp)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Pias4tm1Rug/Pias4tm1Rug
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myelopoiesis
|
J:94291
|
Picalmtm1.1Tmae/Picalmtm1.1Tmae
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/10 * CBA * SJL)
|
decreased erythrocyte cell number
|
J:220728
|
| decreased mean corpuscular hemoglobin
|
J:220728
|
| decreased mean corpuscular volume
|
J:220728
|
Picalmtm1.1Tmae/Picalmtm1.1Tmae
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL)
|
abnormal erythrocyte morphology
|
J:220728
|
| abnormal erythropoiesis
|
J:220728
|
| decreased erythrocyte cell number
|
J:220728
|
| decreased hematocrit
|
J:220728
|
| decreased hemoglobin content
|
J:220728
|
| decreased mean corpuscular hemoglobin
|
J:220728
|
| decreased mean corpuscular volume
|
J:220728
|
| increased red blood cell distribution width
|
J:220728
|
Picalmtm1.2Tmae/Picalmtm1.2Tmae
(involves: C57BL/6 * FVB/N)
|
abnormal erythropoiesis
|
J:220728
|
Picalmtm1Towa/Picalmtm1Towa
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal B cell differentiation
|
J:185312
|
| abnormal erythropoiesis
|
J:185312
|
| decreased erythrocyte cell number
|
J:185312
|
| decreased hemoglobin content
|
J:185312
|
| decreased mean corpuscular hemoglobin
|
J:185312
|
Piezo1tm2.1Apat/Piezo1tm2.1Apat
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA)
|
decreased erythrocyte cell number
|
J:229436
|
| decreased hematocrit
|
J:229436
|
| decreased mean corpuscular hemoglobin concentration
|
J:229436
|
| increased mean corpuscular hemoglobin
|
J:229436
|
| increased mean corpuscular volume
|
J:229436
|
| increased red blood cell distribution width
|
J:229436
|
| macrocytosis
|
J:229436
|
Pigatm1Bsl/Piga+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S1/Sv * FVB/NJ)
|
abnormal definitive hematopoiesis
|
J:75506
|
| abnormal erythrocyte morphology
|
J:75506
|
Pigcem1(IMPC)J/Pigc+
(C57BL/6NJ-Pigcem1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Pik3ap1m1Btlr/Pik3ap1m1Btlr
(involves: C57BL/6J)
|
arrested B cell differentiation
|
J:185495
|
Pik3ap1tm1b(KOMP)Wtsi/Pik3ap1tm1b(KOMP)Wtsi
(C57BL/6N-Pik3ap1tm1b(KOMP)Wtsi/Orl)
|
increased neutrophil cell number
|
J:211773
|
Pik3ap1tm1Kuro/Pik3ap1tm1Kuro
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:75075
|
Pik3c2aGt(OST288105)Lex/Pik3c2aGt(OST288105)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased erythrocyte cell number
|
J:169710
|
| decreased hematocrit
|
J:169710
|
| decreased hemoglobin content
|
J:169710
|
| increased granulocyte number
|
J:169710
|
| increased mean platelet volume
|
J:169710
|
| increased neutrophil cell number
|
J:169710
|
| thrombocytosis
|
J:169710
|
Pik3c2atm1b(EUCOMM)Hmgu/Pik3c2a+
(C57BL/6N-Pik3c2atm1b(EUCOMM)Hmgu/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Pik3c2atm1Bvan/Pik3c2a+
(involves: C57BL/6)
|
abnormal platelet alpha-granule morphology
|
J:226344
|
| abnormal platelet morphology
|
J:226344
|
| abnormal platelet shape
|
J:226344
|
| abnormal thrombopoiesis
|
J:226344
|
| decreased platelet alpha-granule number
|
J:226344
|
| increased hematocrit
|
J:226344
|
Pik3cbtm1a(EUCOMM)Wtsi/Pik3cb+
(B6JTyr;B6N-Pik3cbtm1a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Pik3cbtm1a(EUCOMM)Wtsi/Pik3cbtm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Pik3cbtm1a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Pik3cdtm1.1Bvan/Pik3cdtm1.1Bvan
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal B cell differentiation
|
J:78412
|
| increased neutrophil cell number
|
J:78412
|
Pik3cdtm1Jni/Pik3cdtm1Jni
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:124330
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:125791
|
| decreased double-positive T cell number
|
J:125791
|
Pik3cdtm1Tnr/Pik3cdtm1Tnr
Ptentm2.1Ppp/Ptentm2.1Ppp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal class switch recombination
|
J:130950
|
Pik3cgtm1Dwu/Pik3cgtm1Dwu
(B6.Cg-Pik3cgtm1Dwu)
|
decreased platelet calcium level
|
J:107460
|
Pik3cgtm1Pngr/Pik3cgtm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:60347
|
| abnormal NK cell differentiation
|
J:124330
|
| abnormal T cell differentiation
|
J:60347
|
| increased eosinophil cell number
|
J:60347
|
| increased neutrophil cell number
|
J:60347
|
Pik3cgtm1Wym/Pik3cgtm1Wym
(either: 129/Sv-Pik3cgtm1Wym or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased neutrophil cell number
|
J:60349
|
Pik3cgtm2Ehi/Pik3cgtm2Ehi
(Not Specified)
|
decreased neutrophil cell number
|
J:124856
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:52229
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
| decreased immature B cell number
|
J:104166
|
| increased pro-B cell number
|
J:104166
|
Pik3r1tm1Dfr/Pik3r1tm1Dfr
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:104166
|
| arrested B cell differentiation
|
J:104166
|
| decreased immature B cell number
|
J:104166
|
Pik3r1tm1Tka/Pik3r1tm1Tka
(involves: C57BL/6 * CBA)
|
decreased pro-B cell number
|
J:52228
|
Pik3r1tm2Dfr/Pik3r1tm2Dfr
(either: C.129S6-Pik3r1tm2Dfr or (involves: 129S6/SvEvTac * BALB/c * C57BL/6))
|
abnormal B cell differentiation
|
J:94077
|
| abnormal erythropoiesis
|
J:94077
|
Pik3r5tm1Lste/Pik3r5tm1Lste
(involves: 129P2/OlaHsd)
|
increased neutrophil cell number
|
J:238900
|
Pik3r6tm1.1Lste/Pik3r6tm1.1Lste
(Not Specified)
|
decreased granulocyte number
|
J:238900
|
| increased neutrophil cell number
|
J:238900
|
Pilratm1Osb/Pilratm1Osb
(B6.129-Pilratm1Osb)
|
increased neutrophil cell number
|
J:191085
|
Pim1tm1Pwl/Pim1tm1Pwl
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal erythropoiesis
|
J:15268
|
| abnormal hemoglobin
|
J:15268
|
| decreased mean corpuscular volume
|
J:15268
|
Pim1tm1Pwl/Pim1tm1Pwl
Pim2tm1Brn/Pim2tm1Brn
Pim3tm1Brn/Pim3tm1Brn
(involves: 129P/Ola * FVB/N)
|
decreased mean corpuscular volume
|
J:91592
|
| decreased pro-B cell number
|
J:91592
|
| increased early pro-B cell number
|
J:91592
|
| increased erythrocyte cell number
|
J:91592
|
Pink1tm1b(EUCOMM)Wtsi/Pink1tm1b(EUCOMM)Wtsi
(C57BL/6N-Pink1tm1b(EUCOMM)Wtsi/H)
|
decreased mean platelet volume
|
J:211773
|
Pirbtm1Ttk/Pirbtm1Ttk
(involves: 129X1/SvJ)
|
abnormal dendritic cell differentiation
|
J:76770
|
Pitpnm1tm1a(EUCOMM)Wtsi/Pitpnm1tm1a(EUCOMM)Wtsi
(C57BL/6N-Pitpnm1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Pitx3eyl/Pitx3eyl
(involves: C3H/He * C57BL/6)
|
increased granulocyte number
|
J:156878
|
| thrombocytopenia
|
J:156878
|
Pkd1tm1b(EUCOMM)Hmgu/Pkd1+
(C57BL/6N-Pkd1tm1b(EUCOMM)Hmgu/Bay)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Pklrchar4/Pklrchar4
(involves: A/J * C57BL/6)
|
abnormal erythrocyte morphology
|
J:86735
|
| abnormal erythropoiesis
|
J:141722
|
| decreased hemoglobin content
|
J:141722
|
Pklrslc/Pklrslc
(CBA/NSlc-Pklrslc)
|
abnormal common myeloid progenitor cell morphology
|
J:30035
|
| abnormal erythropoiesis
|
J:141722,
J:30035
|
| decreased erythrocyte cell number
|
J:30035
|
| decreased hematocrit
|
J:30035
|
| decreased hemoglobin content
|
J:141722,
J:30035
|
| increased mean corpuscular volume
|
J:30035
|
| increased nucleated erythrocyte cell number
|
J:30035
|
Pklrslc/Pklrslc
(involves: CBA/NSlc)
|
abnormal erythrocyte morphology
|
J:203909
|
Pkn1tm1b(KOMP)Wtsi/Pkn1tm1b(KOMP)Wtsi
(C57BL/6N-Pkn1tm1b(KOMP)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Pkn1tm1Kik/Pkn1tm1Kik
(B6.129P2-Pkn1tm1Kik)
|
abnormal somatic hypermutation frequency
|
J:193187
|
Pkn3tm1.1Mrl/Pkn3+
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
extramedullary hematopoiesis
|
J:216983
|
Pkn3tm1.1Mrl/Pkn3tm1.1Mrl
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
extramedullary hematopoiesis
|
J:216983
|
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased double-negative T cell number
|
J:103769
|
Pknox1Gt(OST71835)Lex/Pknox1Gt(OST71835)Lex
(B6.129S5-Pknox1Gt(OST71835)Lex)
|
abnormal erythropoiesis
|
J:111418
|
| decreased hematocrit
|
J:111418
|
| increased nucleated erythrocyte cell number
|
J:111418
|
Pknox1tm2.1Fbla/Pknox1tm2.1Fbla
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd)
|
increased pro-B cell number
|
J:192251
|
Pla2g2etm1b(EUCOMM)Wtsi/Pla2g2etm1b(EUCOMM)Wtsi
(C57BL/6N-Pla2g2etm1b(EUCOMM)Wtsi/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Pla2g2fem1(IMPC)Ccpcz/Pla2g2fem1(IMPC)Ccpcz
(C57BL/6NCrl-Pla2g2fem1(IMPC)Ccpcz/Ccpcz)
|
increased mean platelet volume
|
J:211773
|
Pla2g3tm1Murm/Pla2g3tm1Murm
(involves: 129S/SvEv * C57BL/6)
|
abnormal mast cell differentiation
|
J:197334
|
| abnormal mast cell morphology
|
J:197334
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
abnormal mast cell differentiation
|
J:54619
|
| polycythemia
|
J:76813
|
Pla2g6m1Sein/Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
decreased double-positive T cell number
|
J:155328
|
Pla2g10Gt712Lex/Pla2g10Gt712Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased eosinophil cell number
|
J:125607
|
Pla2g10tm1Kiku/Pla2g10tm1Kiku
(B6.129P2-Pla2g10tm1Kiku)
|
decreased neutrophil cell number
|
J:155082
|
Plaat3em1(IMPC)Tcp/Plaat3em1(IMPC)Tcp
(C57BL/6NCrl-Plaat3em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Plaat5em1(IMPC)Tcp/Plaat5em1(IMPC)Tcp
(C57BL/6N-Plaat5em1(IMPC)Tcp/Tcp)
|
increased eosinophil cell number
|
J:211773
|
Plac8tm1Bhk/Plac8tm1Bhk
(129S/SvEv-Plac8tm1Bhk)
|
increased neutrophil cell number
|
J:145277
|
Plac9tm1b(EUCOMM)Hmgu/Plac9tm1b(EUCOMM)Hmgu
(C57BL/6N-Plac9tm1b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular volume
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Plag1em1(IMPC)Hmgu/Plag1em1(IMPC)Hmgu
(C57BL/6N-Plag1em1(IMPC)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Plautm1b(EUCOMM)Wtsi/Plautm1b(EUCOMM)Wtsi
(C57BL/6N-Plautm1b(EUCOMM)Wtsi/H)
|
increased neutrophil cell number
|
J:211773
|
Plbd2em1(IMPC)J/Plbd2em1(IMPC)J
(C57BL/6NJ-Plbd2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Plcb2tm1Dwu/Plcb2tm1Dwu
Plcb3tm1Dwu/Plcb3tm1Dwu
(involves: 129S1/Sv * CD-1)
|
decreased platelet calcium level
|
J:60348
|
| increased platelet ATP level
|
J:60348
|
Plcd1tm1.1Kfu/Plcd1tm1.1Kfu
Tg(KRT14-cre)1Amc/0
(involves: C57BL/6 * C57BL/6JJcl * CBA)
|
decreased erythrocyte cell number
|
J:205633
|
| increased granulocyte number
|
J:205633
|
Plcd1tm1Tta/Plcd1tm1Tta
(involves: 129P2/OlaHsd)
|
abnormal common myeloid progenitor cell morphology
|
J:205633
|
| abnormal granulocyte differentiation
|
J:205633
|
| decreased erythrocyte cell number
|
J:205633
|
| increased granulocyte number
|
J:205633
|
Plce1em1(IMPC)Mbp/Plce1em1(IMPC)Mbp
(C57BL/6N-Plce1em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Plcg1tm1Gcrp/Plcg1tm1Rwen
Tg(Cd4-cre)1Cwi/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased double-negative T cell number
|
J:157757
|
| increased double-positive T cell number
|
J:157757
|
Plcg1tm1Ine/Plcg1tm1Ine
(involves: 129P2/OlaHsd)
|
abnormal embryonic hematopoiesis
|
J:73254
|
Plcg1tm2Gcrp/Plcg1tm2Gcrp
(involves: 129/Sv * CD-1)
|
abnormal embryonic hematopoiesis
|
J:75316
|
Plcg2Ali5/Plcg2Ali5
(involves: C57BL/6J * C3HeB/FeJ-Plcg2Ali5)
|
decreased transitional stage B cell number
|
J:97930
|
Plcg2m1Btlr/Plcg2m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
Plcg2tm1.1Kuro/Plcg2tm1.1Kuro
(Not Specified)
|
abnormal B cell differentiation
|
J:131161
|
| increased pro-B cell number
|
J:131161
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd)
|
arrested B cell differentiation
|
J:86373
|
| increased pro-B cell number
|
J:104166
|
| increased transitional stage T2 B cell number
|
J:86373
|
Plcg2tm1Jni/Plcg2tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:117023
|
Plcg2tm1Kuro/Plcg2tm1Kuro
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
increased immature B cell number
|
J:63744
|
| increased pro-B cell number
|
J:63744
|
Plcz1em1(IMPC)H/Plcz1em1(IMPC)H
(C57BL/6N-Plcz1em1(IMPC)H/H)
|
decreased mean platelet volume
|
J:211773
|
Pld1tm3Mafr/Pld1tm3Mafr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased mean platelet volume
|
J:211547
|
Pld3tm1e(EUCOMM)Wtsi/Pld3tm1e(EUCOMM)Wtsi
(C57BL/6N-Pld3tm1e(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Pld4tm1.2Nemz/Pld4tm1.2Nemz
(B6.129(Cg)-Pld4tm1.1Nemz)
|
thrombocytopenia
|
J:281205
|
Pld5tm1b(KOMP)Wtsi/Pld5tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Pld5tm1b(KOMP)Wtsi Tyrc-Brd/Wtsi)
|
decreased mean platelet volume
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Plek2tm1Pji/Plek2tm1Pji
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal erythropoiesis
|
J:257910
|
| abnormal granulocyte differentiation
|
J:257910
|
Plek2tm1Pji/Plek2tm1Pji
Jak2tm1.1Ble/Jak2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129 * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal granulocyte differentiation
|
J:257910
|
| extramedullary hematopoiesis
|
J:257910
|
Plektm1Csab/Plektm1Csab
(involves: 129P2/OlaHsd * C57BL/6J)
|
thrombocytopenia
|
J:148429
|
Plekha1tm1b(EUCOMM)Hmgu/Plekha1tm1b(EUCOMM)Hmgu
(C57BL/6N-Plekha1tm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Plekha5em1(IMPC)Tcp/Plekha5em1(IMPC)Tcp
(C57BL/6NCrl-Plekha5em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Plekhf2em1(IMPC)Wtsi/Plekhf2em1(IMPC)Wtsi
(C57BL/6NCrl-Plekhf2em1(IMPC)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Plekhm2tm1a(EUCOMM)Wtsi/Plekhm2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Plekhm2tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased hematocrit
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
Plpp3tm1b(EUCOMM)Hmgu/Plpp3+
(C57BL/6N-Plpp3tm1b(EUCOMM)Hmgu/Cnrm)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Plpp6tm1.1(KOMP)Vlcg/Plpp6tm1.1(KOMP)Vlcg
(C57BL/6N-Plpp6tm1.1(KOMP)Vlcg/Ucd)
|
increased mean platelet volume
|
J:211773
|
Plppr5em1(IMPC)H/Plppr5em1(IMPC)H
(C57BL/6NTac-Plppr5em1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Pls3tm1a(EUCOMM)Wtsi/Pls3tm1a(EUCOMM)Wtsi
(C57BL/6N-Pls3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Plscr1tm1Lex/Plscr1tm1Lex
(129S/SvEvBrd-Plscr1tm1Lex)
|
abnormal granulocyte differentiation
|
J:76790
|
| abnormal myelopoiesis
|
J:76790
|
| abnormal neutrophil differentiation
|
J:76790
|
| decreased granulocyte number
|
J:76790
|
| decreased neutrophil cell number
|
J:76790
|
Plscr1tm1Lex/Plscr1tm1Lex
Plscr3tm1Sims/Plscr3tm1Sims
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal myelopoiesis
|
J:92404
|
Plt001/Plt001+
(C3HeB/FeJ-Plt001)
|
thrombocytosis
|
J:186868
|
plt005/plt005
(C3HeB/FeJ-plt005)
|
thrombocytosis
|
J:186868
|
plt008/plt008
(C3HeB/FeJ-plt008)
|
thrombocytopenia
|
J:186868
|
plt009/plt009
(C3HeB/FeJ-plt009)
|
thrombocytosis
|
J:186868
|
Plt18/Plt18+
(involves: BALB/c)
|
thrombocytopenia
|
J:149205
|
Plt21/Plt21+
(involves: BALB/c)
|
thrombocytopenia
|
J:149205
|
Pltct1QSi5/Ianm/?
(involves: CBA/CaH * QSi5)
|
thrombocytopenia
|
J:93967
|
Pltct2QSi5/Ianm/?
(involves: CBA/CaH * QSi5)
|
thrombocytosis
|
J:93967
|
Pltq1SM/J/Pltq1SM/J
(involves: NZW/LacJ * SM/J)
|
thrombocytosis
|
J:102636
|
Pltq2NZW/LacJ/Pltq2NZW/LacJ
(involves: NZW/LacJ * SM/J)
|
thrombocytosis
|
J:102636
|
Pltq2NZW/LacJ/Pltq2SM/J
(involves: NZW/LacJ * SM/J)
|
thrombocytosis
|
J:102636
|
Pltq3NZW/LacJ/Pltq3NZW/LacJ
(involves: NZW/LacJ * SM/J)
|
thrombocytosis
|
J:102636
|
Pltq3NZW/LacJ/Pltq3SM/J
(involves: NZW/LacJ * SM/J)
|
thrombocytosis
|
J:102636
|
Plvaptm1e(EUCOMM)Hmgu/Plvaptm1e(EUCOMM)Hmgu
(C57BL/6N-Plvaptm1e(EUCOMM)Hmgu)
|
abnormal erythrocyte morphology
|
J:203907
|
| increased nucleated erythrocyte cell number
|
J:203907
|
Plxna2tm1a(EUCOMM)Wtsi/Plxna2tm1a(EUCOMM)Wtsi
(C57BL/6N-Plxna2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Pm20d1em1(IMPC)H/Pm20d1em1(IMPC)H
(C57BL/6NTac-Pm20d1em1(IMPC)H/H)
|
increased hematocrit
|
J:211773
|
Pmltm1.1Ews/Pmltm1.1Ews
Tg(PML-RARA)556Kog/0
(FVB.Cg-Pmltm1.1Ews Tg(PML-RARA)556Kog)
|
thrombocytosis
|
J:262172
|
Pmltm1Ppp/Pml+
Trp53tm3.1Glo/Trp53+
(B6.129S7(Cg)-Pmltm1Ppp Trp53tm3.1Glo)
|
extramedullary hematopoiesis
|
J:317504
|
Pmltm1Ppp/Pmltm1Ppp
(involves: 129S7/SvEvBrd)
|
abnormal myelopoiesis
|
J:46381
|
| decreased granulocyte number
|
J:46381
|
Pms2tm1.1Wed/Pms2tm1.1Wed
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal class switch recombination
|
J:162378
|
Pms2tm1Lisk/Pms2tm1Lisk
(involves: 129S2/SvPas)
|
abnormal class switch recombination
|
J:162378
|
Pnpf/Pnpf
(involves: C3H/HeHa * C57BL/6J)
|
increased double-negative T cell number
|
J:522
|
Pnpf/Pnpf
(C57BL/6J-Pnpf)
|
decreased double-positive T cell number
|
J:39328
|
Pnpg/Pnpg
(involves: C57BL/6 * DBA/2J)
|
decreased double-positive T cell number
|
J:39328
|
| increased double-negative T cell number
|
J:39328
|
Pnptm1Cmr/Pnptm1Cmr
(involves: 129)
|
abnormal myelopoiesis
|
J:62870
|
| decreased double-positive T cell number
|
J:62870
|
| increased double-negative T cell number
|
J:62870
|
Pnpt1tm1a(KOMP)Wtsi/Pnpt1+
(B6JTyr;B6N-Pnpt1tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:165965
|
| increased mean corpuscular volume
|
J:165965
|
Podxl2tm1.1(KOMP)Vlcg/Podxl2tm1.1(KOMP)Vlcg
(C57BL/6N-Podxl2tm1.1(KOMP)Vlcg/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Pofut2Gt(RST434)Byg/Pofut2Gt(RST434)Byg
(involves: 129P2/OlaHsd)
|
abnormal embryonic erythropoiesis
|
J:165751
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:206872
|
| abnormal somatic hypermutation frequency
|
J:206872
|
Polbtm1a(KOMP)Wtsi/Polb+
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Pole3em3Tbo/Pole3em3Tbo
(FVB-Pole3em3Tbo)
|
decreased DN4 thymocyte number
|
J:298827
|
| decreased double-positive T cell number
|
J:298827
|
| decreased immature B cell number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
Pole3em4Tbo/Pole3em4Tbo
(FVB-Pole3em4Tbo)
|
decreased DN4 thymocyte number
|
J:298827
|
| decreased immature B cell number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
Pole3tm1(KOMP)Vlcg/Pole3tm1(KOMP)Vlcg
(involves: C57BL/6NTac * FVB)
|
decreased DN4 thymocyte number
|
J:298827
|
| increased DN3 thymocyte number
|
J:298827
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
abnormal B cell differentiation
|
J:261973
|
| abnormal T cell differentiation
|
J:261973
|
| arrested B cell differentiation
|
J:261973
|
| increased double-negative T cell number
|
J:261973
|
| increased granulocyte number
|
J:261973
|
| thrombocytosis
|
J:261973
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
Trp53tm1Brd/Trp53+
(involves: C57BL/6J * C57BL/6NTac)
|
increased granulocyte number
|
J:261973
|
Polgtm1.1Lrsn/Polgtm1.1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased hemoglobin content
|
J:91077
|
Polgtm1Prol/Polgtm1Prol
(involves: 129S7/SvEvBrd * C57BL/6J * ICR)
|
decreased erythrocyte cell number
|
J:99764
|
Polgtm1Prol/Polgtm1Prol
(B6J.129S7-Polgtm1Prol)
|
abnormal lymphopoiesis
|
J:154187
|
| decreased double-positive T cell number
|
J:154187
|
| decreased hemoglobin content
|
J:154187
|
| decreased immature B cell number
|
J:154187
|
| decreased pro-B cell number
|
J:154187
|
| increased mean corpuscular volume
|
J:154187
|
| macrocytosis
|
J:154187
|
Politm1b(EUCOMM)Hmgu/Politm1b(EUCOMM)Hmgu
(C57BL/6N-Politm1b(EUCOMM)Hmgu/BayMmucd)
|
decreased hematocrit
|
J:211773
|
Polltm1Crey/Polltm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
Polltm1Crey/Polltm1Crey
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:113406
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:113406
|
| abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
Polmtm1Crey/Polmtm1Crey
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin light chain V-J recombination
|
J:113406
|
Polqtm1Jcs/Polqtm1Jcs
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal somatic hypermutation frequency
|
J:103365
|
Polqtm1Jow/Polqtm1Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal somatic hypermutation frequency
|
J:101409
|
Polqtm2Jow/Polqtm2Jow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:115989
|
Polr2atm1(cre/ERT2)Bbd/Polr2a+
Rnf2tm1Mvi/Rnf2tm1Mvi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * SJL)
|
abnormal common myeloid progenitor cell morphology
|
J:130397
|
Polr3aem2(IMPC)Tcp/Polr3a+
(C57BL/6NCrl-Polr3aem2(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
Polr3dem1(IMPC)Tcp/Polr3d+
(C57BL/6N-Polr3dem1(IMPC)Tcp/Tcp)
|
decreased mean platelet volume
|
J:211773
|
Pomkem1(IMPC)Hmgu/Pomk+
(C57BL/6NCrl-Pomkem1(IMPC)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Pomt1Gt(OST194127)Lex/Pomt1+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
increased neutrophil cell number
|
J:103485
|
Pon2tm1b(EUCOMM)Hmgu/Pon2tm1b(EUCOMM)Hmgu
(C57BL/6N-Pon2tm1b(EUCOMM)Hmgu/H)
|
decreased neutrophil cell number
|
J:211773
|
Postntm1.1(KOMP)Vlcg/Postntm1.1(KOMP)Vlcg
(C57BL/6N-Postntm1.1(KOMP)Vlcg/J)
|
thrombocytosis
|
J:211773
|
Pot1btm1.1Schg/Pot1btm1.1Schg
Terctm1Rdp/Terc+
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal definitive hematopoiesis
|
J:144553
|
| abnormal granulocyte morphology
|
J:144553
|
| decreased erythrocyte cell number
|
J:144553
|
| decreased granulocyte number
|
J:144553
|
| thrombocytopenia
|
J:144553
|
Pot1btm1.1Schg/Pot1btm1.1Schg
Terctm1Rdp/Terctm1Rdp
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal erythrocyte morphology
|
J:144553
|
| abnormal granulocyte morphology
|
J:144553
|
Pou2af1tm1b(KOMP)Wtsi/Pou2af1tm1b(KOMP)Wtsi
(C57BL/6N-Pou2af1tm1b(KOMP)Wtsi/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Pou2af1tm1Pjln/Pou2af1tm1Pjln
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:67362
|
| decreased immature B cell number
|
J:67362
|
Pou2af1tm1Pmt/Pou2af1tm1Pmt
Ikzf3tm1Kge/Ikzf3tm1Kge
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
arrested B cell differentiation
|
J:81805
|
Pou2af1tm1Rgr/Pou2af1tm1Rgr
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv))
|
abnormal B cell differentiation
|
J:114816,
J:35785
|
| arrested B cell differentiation
|
J:114816
|
Pou2af3tm1b(NCOM)Mfgc/Pou2af3tm1b(NCOM)Mfgc
(C57BL/6N-Pou2af3tm1b(NCOM)Mfgc/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Pou2f1tm1Shrp/Pou2f1tm1Shrp
(involves: 129S4/SvJae * C57BL/6)
|
abnormal erythropoiesis
|
J:87664
|
Pou2f2tm1Bal/Pou2f2tm1Bal
(involves: 129S2/SvPas * C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
Pou2f2tm1Lmc/Pou2f2tm1Lmc
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:88240
|
Ppargtm1.1Gonz/Ppargtm1.1Gonz
Tg(Aqp2-cre)1Dek/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal hematocrit
|
J:99873
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Cd4-cre)1Cwi/?
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T-helper 17 cell differentiation
|
J:153358
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)1Ywa/?
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
extramedullary hematopoiesis
|
J:130475
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Tek-cre)12Flv/?
(B6.Cg-Ppargtm2Rev Tg(Tek-cre)12Flv)
|
decreased hematocrit
|
J:154216
|
Ppargc1atm1Aztc/Ppargc1a+
(C57BL/6-Ppargc1atm1Aztc)
|
thrombocytopenia
|
J:82809
|
Ppatem1(IMPC)Tcp/Ppat+
(C57BL/6NCrl-Ppatem1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ppbptm1.1(KOMP)Vlcg/Ppbptm1.1(KOMP)Vlcg
(C57BL/6N-Ppbptm1.1(KOMP)Vlcg/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Ppiaem1(IMPC)Mbp/Ppiaem1(IMPC)Mbp
(C57BL/6NCrl-Ppiaem1(IMPC)Mbp/MbpMmucd)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Ppicem1Igc/Ppicem1Igc
(C57BL/6-Ppicem1Igc)
|
increased transitional stage T1 B cell number
|
J:321155
|
| increased transitional stage T2 B cell number
|
J:321155
|
Ppieem1(IMPC)Tcp/Ppie+
(C57BL/6N-Ppieem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Ppm1dtm1Lad/Ppm1dtm1Lad
(involves: 129S7/SvEvBrd * C57BL/6)
|
myeloid hyperplasia
|
J:74284
|
Ppm1nem1(IMPC)Mbp/Ppm1nem1(IMPC)Mbp
(C57BL/6N-Ppm1nem1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Ppp1ccem1(IMPC)Wtsi/Ppp1ccem1(IMPC)Wtsi
(C57BL/6N-Ppp1ccem1(IMPC)Wtsi/WtsiOulu)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ppp1r14dtm1b(KOMP)Wtsi/Ppp1r14dtm1b(KOMP)Wtsi
(C57BL/6N-Ppp1r14dtm1b(KOMP)Wtsi/Nju)
|
decreased red blood cell distribution width
|
J:211773
|
Ppp1r15aem2(IMPC)H/Ppp1r15aem2(IMPC)H
(C57BL/6NTac-Ppp1r15aem2(IMPC)H/H)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Ppp1r15atm1.1Ajf/Ppp1r15atm1.1Ajf
(involves: 129 * C57BL/6)
|
abnormal erythrocyte morphology
|
J:106905
|
| abnormal erythropoiesis
|
J:106905
|
| acanthocytosis
|
J:106905
|
| anisopoikilocytosis
|
J:106905
|
| decreased hemoglobin content
|
J:106905
|
| decreased mean corpuscular hemoglobin
|
J:106905
|
| decreased mean corpuscular volume
|
J:106905
|
| increased number of Howell-Jolly bodies
|
J:106905
|
| leptocytosis
|
J:106905
|
| microcytosis
|
J:106905
|
Ppp1r15btm1Dron/Ppp1r15btm1Dron
(involves: 129P2/OlaHsd)
|
abnormal erythrocyte morphology
|
J:144954
|
| decreased erythrocyte cell number
|
J:144954
|
| decreased hematocrit
|
J:144954
|
| decreased hemoglobin content
|
J:144954
|
| decreased mean corpuscular hemoglobin concentration
|
J:144954
|
| decreased mean corpuscular volume
|
J:144954
|
| echinocytosis
|
J:144954
|
Ppp1r17em1(IMPC)H/Ppp1r17em1(IMPC)H
(C57BL/6NTac-Ppp1r17em1(IMPC)H/H)
|
decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Ppp1r18em1Mgin/Ppp1r18em1Mgin
(B6J.B6N-Ppp1r18em1Mgin)
|
increased neutrophil cell number
|
J:331428
|
Ppp1r18em3Mgin/Ppp1r18em3Mgin
(B6J.B6N-Ppp1r18em3Mgin)
|
increased neutrophil cell number
|
J:331428
|
Ppp2catm1.1Nju/Ppp2catm1.1Nju
Tg(Tek-cre)12Flv/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythropoiesis
|
J:171578
|
| decreased fetal derived definitive erythrocyte cell number
|
J:171578
|
Ppp2r2btm1a(KOMP)Wtsi/Ppp2r2btm1a(KOMP)Wtsi
(C57BL/6N-Ppp2r2btm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:175295
|
| decreased mean corpuscular volume
|
J:175295
|
| thrombocytopenia
|
J:175295
|
Ppp2r3cem1(IMPC)H/Ppp2r3c+
(C57BL/6NTac-Ppp2r3cem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Ppp2r3ctm1Imku/Ppp2r3ctm1Imku
Tg(CD19-cre/ERT2)1Cgn/?
(involves: C57BL/6)
|
decreased immature B cell number
|
J:100706
|
| decreased transitional stage B cell number
|
J:100706
|
| increased pro-B cell number
|
J:100706
|
| increased transitional stage B cell number
|
J:100706
|
Ppp2r5aGt(IST13127C10)Tigm/Ppp2r5aGt(IST13127C10)Tigm
(C57BL/6N-Ppp2r5aGt(IST13127C10)Tigm)
|
extramedullary hematopoiesis
|
J:254808
|
Ppp2r5cem1(IMPC)Mbp/Ppp2r5cem1(IMPC)Mbp
(C57BL/6N-Ppp2r5cem1(IMPC)Mbp/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Ppp3cbtm1Jmk/Ppp3cbtm1Jmk
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell differentiation
|
J:77729
|
Ppp3cctm1b(EUCOMM)Hmgu/Ppp3cctm1b(EUCOMM)Hmgu
(C57BL/6N-Ppp3cctm1b(EUCOMM)Hmgu/H)
|
decreased mean platelet volume
|
J:211773
|
Ppp3r1tm2Grc/Ppp3r1tm2.1Grc
Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:89771
|
Ppp3r2tm1.1(KOMP)Vlcg/Ppp3r2tm1.1(KOMP)Vlcg
(C57BL/6N-Ppp3r2tm1.1(KOMP)Vlcg/Ucd)
|
increased red blood cell distribution width
|
J:211773
|
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
| abnormal T cell differentiation
|
J:117684
|
| decreased double-positive T cell number
|
J:117684
|
| increased double-negative T cell number
|
J:117684
|
Ppp4ctm1Tht/Ppp4ctm1Tht
Tg(Lck-cre)548Jxm/0
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:117684
|
| decreased double-positive T cell number
|
J:117684
|
Ppp4r1em1(IMPC)Rbrc/Ppp4r1em1(IMPC)Rbrc
(C57BL/6N-Ppp4r1em1(IMPC)Rbrc/Rbrc)
|
thrombocytosis
|
J:211773
|
Ppp5ctm1a(EUCOMM)Wtsi/Ppp5ctm1a(EUCOMM)Wtsi
(B6Dnk;B6Brd;B6N-Ppp5ctm1a(EUCOMM)Wtsi Tyrc-Brd/WtsiH)
|
decreased mean corpuscular hemoglobin concentration
|
J:175295
|
Ppp6ctm1b(EUCOMM)Hmgu/Ppp6c+
(C57BL/6N-Ppp6ctm1b(EUCOMM)Hmgu/Ics)
|
increased mean corpuscular volume
|
J:211773
|
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
extramedullary hematopoiesis
|
J:86202
|
Prdm1tm1Clme/Prdm1tm1Clme
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal T follicular helper cell differentiation
|
J:178876
|
Prdm11tm1.1Ahl/Prdm11tm1.1Ahl
(B6.129(C)-Prdm11tm1.1Ahl)
|
decreased neutrophil cell number
|
J:233986
|
Prdx1flro/Prdx1flro
(C57BL/10JAnu-Prdx1flro/AnuApb)
|
abnormal erythrocyte morphology
|
J:104190
|
Prdx1tm1Rave/Prdx1tm1Rave
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythrocyte morphology
|
J:84677
|
| anisocytosis
|
J:84677
|
| decreased hematocrit
|
J:84677
|
| decreased hemoglobin content
|
J:84677
|
| extramedullary hematopoiesis
|
J:84677
|
| increased hemoglobin concentration distribution width
|
J:84677
|
| microcytosis
|
J:84677
|
| poikilocytosis
|
J:84677
|
| polychromatophilia
|
J:84677
|
Prdx2tm1Yu/Prdx2tm1Yu
(involves: 129S4/SvJae)
|
abnormal erythrocyte morphology
|
J:84271
|
| abnormal erythropoiesis
|
J:84271
|
| decreased hematocrit
|
J:84271
|
| decreased hemoglobin content
|
J:84271
|
| echinocytosis
|
J:84271
|
| increased number of Heinz bodies
|
J:84271
|
| schistocytosis
|
J:84271
|
| spherocytosis
|
J:84271
|
Prex1tm1Hcew/Prex1tm1Hcew
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neutrophil cell number
|
J:102214
|
Prf1tm1.1(KOMP)Vlcg/Prf1tm1.1(KOMP)Vlcg
(C57BL/6N-Prf1tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
decreased erythrocyte cell number
|
J:193137
|
| decreased neutrophil cell number
|
J:193137
|
| thrombocytopenia
|
J:193137
|
Prg2tm1Nal/Prg2tm1Nal
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
abnormal eosinophil morphology
|
J:65655
|
Primpolem1Nki/Primpolem1Nki
(C57BL/6-Primpolem1Nki)
|
abnormal somatic hypermutation frequency
|
J:242620
|
Prkaa1tm1Sbj/Prkaa1tm1Sbj
(involves: 129)
|
decreased hematocrit
|
J:147215
|
| decreased mean corpuscular hemoglobin
|
J:147215
|
| increased red blood cell distribution width
|
J:147215
|
| low mean erythrocyte cell number
|
J:147215
|
Prkab1em1(IMPC)J/Prkab1em1(IMPC)J
(C57BL/6NJ-Prkab1em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Prkab1em2(IMPC)Mbp/Prkab1em2(IMPC)Mbp
(C57BL/6N-Prkab1em2(IMPC)Mbp/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab1tm1a(KOMP)Wtsi/Prkab1tm1a(KOMP)Wtsi
(C57BL/6N-Prkab1tm1a(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:175295
|
| decreased hematocrit
|
J:175295
|
| decreased hemoglobin content
|
J:175295
|
| decreased mean corpuscular hemoglobin
|
J:175295
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/H)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Rbrc)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased glycosylated hemoglobin level
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(B6N(Cg)-Prkab1tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Orl)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal erythrocyte morphology
|
J:236972
|
| abnormal erythropoiesis
|
J:236972
|
| acanthocytosis
|
J:236972
|
| anisocytosis
|
J:236972
|
| decreased erythrocyte cell number
|
J:236972
|
| decreased hematocrit
|
J:236972
|
| decreased hemoglobin content
|
J:236972
|
| decreased mean corpuscular hemoglobin concentration
|
J:236972
|
| echinocytosis
|
J:236972
|
| extramedullary hematopoiesis
|
J:236972
|
| increased mean platelet volume
|
J:236972
|
| increased red blood cell distribution width
|
J:236972
|
| microcytosis
|
J:236972
|
| schistocytosis
|
J:236972
|
| stomatocytosis
|
J:236972
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/MbpMmucd)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab1tm1b(KOMP)Wtsi/Prkab1tm1b(KOMP)Wtsi
(C57BL/6N-Prkab1tm1b(KOMP)Wtsi/Ccpcz)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Prkab2tm1b(EUCOMM)Hmgu/Prkab2+
(C57BL/6N-Prkab2tm1b(EUCOMM)Hmgu/H)
|
decreased mean platelet volume
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Prkag1tm1.2Mfor/Prkag1tm1.2Mfor
(involves: 129S2/SvPas * C57BL/6 * C57BL/6NTac * FVB/N)
|
abnormal erythrocyte morphology
|
J:167779
|
| abnormal red blood cell deformability
|
J:167779
|
| anisocytosis
|
J:167779
|
| decreased erythrocyte cell number
|
J:167779
|
| decreased hematocrit
|
J:167779
|
| decreased hemoglobin content
|
J:167779
|
| decreased mean corpuscular hemoglobin
|
J:167779
|
| decreased mean corpuscular hemoglobin concentration
|
J:167779
|
| decreased mean corpuscular volume
|
J:167779
|
| extramedullary hematopoiesis
|
J:167779
|
| increased red blood cell distribution width
|
J:167779
|
| macrocytosis
|
J:167779
|
| microcytosis
|
J:167779
|
Prkar1atm2Gsm/Prkar1atm2Gsm
Tg(Cr2-cre)3Cgn/0
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147785
|
Prkcdtm1Kin/Prkcdtm1Kin
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal plasma cell differentiation
|
J:143854
|
| increased transitional stage B cell number
|
J:143854
|
Prkcdtm1Msg/Prkcdtm1Msg
(involves: 129X1/SvJ * C57BL/6J)
|
decreased neutrophil cell number
|
J:91377
|
Prkcdtm1Qxu/Prkcdtm1Qxu
(involves: 129P2/OlaHsd * C57BL/6)
|
increased erythrocyte cell number
|
J:76134
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
(involves: C57BL/6 * FVB/N * SJL)
|
decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased DN4 thymocyte number
|
J:186080
|
| decreased double-positive T cell number
|
J:186080
|
Prkchtm1.2Gasc/Prkchtm1.2Gasc
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal positive T cell selection
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
| decreased DN4 thymocyte number
|
J:186080
|
| decreased double-negative T cell number
|
J:186080
|
| decreased double-positive T cell number
|
J:186080
|
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
abnormal T-helper 1 cell differentiation
|
J:94285
|
Prkcqtm1Litt/Prkcqtm1Litt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal positive T cell selection
|
J:186080
|
| decreased DN1 thymic pro-T cell number
|
J:186080
|
Prkd1em2(IMPC)Wtsi/Prkd1+
(C57BL/6N-Prkd1em2(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Prkd2tm1.1Shoy/Prkd2tm1.1Shoy
Prkd3tm1.1Shoy/Prkd3tm1.1Shoy
Tg(Lck-cre)1Jtak/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: 129 * C57BL/6 * C57BL/6J * DBA/2J)
|
increased double-positive T cell number
|
J:236298
|
Prkdcem2(IMPC)Ics/Prkdcem2(IMPC)Ics
(C57BL/6N-Prkdcem2(IMPC)Ics/Ics)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Prkdchanky/Prkdchanky
(either: C57BL/6JAnu or (involves: C57BL/6JAnu * CBA/CaJ))
|
myeloid hyperplasia
|
J:104190
|
Prkdcm1Btlr/Prkdcm1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Prkdcm4Btlr/Prkdcm4Btlr
(C57BL/6J-Prkdcm4Btlr)
|
increased neutrophil cell number
|
J:255217
|
Prkdcm14Btlr/Prkdcm14Btlr
(C57BL/6J-Prkdcm14Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272442
|
PrkdcM16Btlr/PrkdcM16Btlr
(C57BL/6J-PrkdcM16Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272520
|
Prkdcm18Btlr/Prkdcm18Btlr
(C57BL/6J-Prkdcm18Btlr)
|
abnormal B cell differentiation
|
J:274730
|
| abnormal CD4-positive T cell differentiation
|
J:274730
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274730
|
| abnormal T cell differentiation
|
J:274730
|
Prkdcm19Btlr/Prkdcm19Btlr
(C57BL/6J-Prkdcm19Btlr)
|
abnormal B cell differentiation
|
J:274763
|
| abnormal CD4-positive T cell differentiation
|
J:274763
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274763
|
| abnormal T cell differentiation
|
J:274763
|
Prkdcscid/Prkdcscid
(NOD.Cg-Prkdcscid)
|
decreased erythrocyte cell number
|
J:22026
|
| increased granulocyte number
|
J:22026
|
| increased mean corpuscular volume
|
J:22026
|
Prkdcscid/Prkdcscid
(B6.Cg-Prkdcscid/Sz)
|
increased eosinophil cell number
|
J:34814
|
| increased granulocyte number
|
J:34814
|
| increased neutrophil cell number
|
J:34814
|
Prkdcscid/Prkdcscid
Tg(Tcrb)93Vbo/0
(involves: Balb/c * C57BL/Ka * C57BL/Lia * CBA/BrA)
|
abnormal double-positive T cell morphology
|
J:111476
|
| abnormal T cell differentiation
|
J:111476
|
Prkdctm1.1Bpcc/Prkdctm1.1Bpcc
(involves: 129 * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:171351
|
| arrested B cell differentiation
|
J:171351
|
| decreased double-negative T cell number
|
J:171351
|
| decreased double-positive T cell number
|
J:171351
|
| decreased erythrocyte cell number
|
J:171351
|
| decreased granulocyte number
|
J:171351
|
| thrombocytopenia
|
J:171351
|
Prkdctm1Fwa/Prkdctm1Fwa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:50221
|
| abnormal T cell receptor V(D)J recombination
|
J:50221
|
| arrested B cell differentiation
|
J:50221
|
| arrested T cell differentiation
|
J:50221
|
| decreased double-positive T cell number
|
J:50221
|
Prkdctm1Gcl/Prkdctm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:53765
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:53765
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:53765
|
| arrested B cell differentiation
|
J:53765
|
Prkdctm1Get/Prkdctm1Get
(involves: 129S4/SvJae * Black Swiss)
|
abnormal B cell differentiation
|
J:50222
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:50222
|
| abnormal immunoglobulin light chain V-J recombination
|
J:50222
|
| abnormal T cell differentiation
|
J:50222
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:50222
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:50222
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:50222
|
| arrested B cell differentiation
|
J:50222
|
| arrested T cell differentiation
|
J:50222
|
| increased double-negative T cell number
|
J:50222
|
| increased double-positive T cell number
|
J:50222
|
Prkg1tm2.1Naw/Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythrocyte morphology
|
J:134639
|
| decreased erythrocyte cell number
|
J:134639
|
| decreased hematocrit
|
J:134639
|
| increased mean corpuscular hemoglobin
|
J:134639
|
| increased mean corpuscular volume
|
J:134639
|
| increased red blood cell distribution width
|
J:134639
|
Prmt7tm1a(EUCOMM)Wtsi/Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:175295
|
Prmt9em1(IMPC)J/Prmt9em1(IMPC)J
(C57BL/6NJ-Prmt9em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp)a20Cwe/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:129512
|
| decreased DN2 thymocyte number
|
J:129512
|
| decreased DN4 thymocyte number
|
J:129512
|
| decreased double-positive T cell number
|
J:129512
|
| increased DN3 thymocyte number
|
J:129512
|
| increased double-negative T cell number
|
J:129512
|
Procrtm1.1Pcl/Procrtm1.1Pcl
(involves: 129S2/SvPas * C57BL/6)
|
extramedullary hematopoiesis
|
J:225914
|
| thrombocytopenia
|
J:225914
|
Procrtm1Cte/Procr+
(B6.129S7-Procrtm1Cte)
|
thrombocytopenia
|
J:144388
|
Prom2tm1.1(KOMP)Vlcg/Prom2tm1.1(KOMP)Vlcg
(C57BL/6N-Prom2tm1.1(KOMP)Vlcg/J)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Prom2tm1Lex/Prom2tm1Lex
(B6;129S5-Prom2tm1Lex/Mmucd)
|
decreased erythrocyte cell number
|
J:171883
|
| decreased hematocrit
|
J:171883
|
| decreased mean corpuscular hemoglobin
|
J:171883
|
Pros1tm1.1Ansc/Pros1tm1.1Ansc
(involves: 129/Sv * C57BL/6J * FVB/N)
|
thrombocytopenia
|
J:152423
|
Prpf3tm1b(KOMP)Wtsi/Prpf3+
(C57BL/6N-Prpf3tm1b(KOMP)Wtsi/Bay)
|
increased neutrophil cell number
|
J:211773
|
Prpf6tm1.1(KOMP)Vlcg/Prpf6+
(C57BL/6N-Prpf6tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Prpf39em1(IMPC)Tcp/Prpf39+
(C57BL/6NCrl-Prpf39em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Prpf40aem1(IMPC)J/Prpf40a+
(C57BL/6NJ-Prpf40aem1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Prss8tm1b(EUCOMM)Hmgu/Prss8+
(C57BL/6N-Prss8tm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Prss16tm1.1Mal/Prss16+
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
Prss16tm1.1Mal/Prss16tm1.1Mal
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcraH-Y,TcrbH-Y)1Pas/?
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal positive T cell selection
|
J:148034
|
| decreased double-positive T cell number
|
J:148034
|
Prss57tm1.1Gne/Prss57tm1.1Gne
(C57BL/6N-Prss57tm1.1Gne)
|
abnormal mast cell morphology
|
J:301479
|
| decreased mast cell histamine storage
|
J:301479
|
Prtn3tm1.1Hrlu/Prtn3tm1.1Hrlu
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:217636
|
Prxl2btm1b(EUCOMM)Hmgu/Prxl2btm1b(EUCOMM)Hmgu
(C57BL/6N-Prxl2btm1b(EUCOMM)Hmgu/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Psen2em1(IMPC)Ccpcz/Psen2em1(IMPC)Ccpcz
(C57BL/6NCrl-Psen2em1(IMPC)Ccpcz/Ccpcz)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Psmb10tm1Mgro/Psmb10Tub6
(involves: 129S2/SvPas * C3HeB/FeJ)
|
increased granulocyte number
|
J:261081
|
Psmb10Tub6/Psmb10Tub6
(C3HeB/FeJ-Psmb10Tub6)
|
increased granulocyte number
|
J:261081
|
Psmb10Tub6/Psmb10Tub6
(B6.C3Fe-Psmb10Tub6)
|
increased granulocyte number
|
J:261081
|
Psmb10Tub6/Psmb10Tub6
(C.C3Fe-Psmb10Tub6)
|
increased granulocyte number
|
J:261081
|
Psmb11tm1(Psmb8)Khog/Psmb11tm1(Psmb8)Khog
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:196156
|
| abnormal T cell receptor V(D)J recombination
|
J:196156
|
Psmb11tm1.1(Psmb8)Khog/Psmb11tm1.1(Psmb8)Khog
Psmb8tm1Hjf/Psmb8tm1Hjf
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6NTac)
|
abnormal T cell receptor V(D)J recombination
|
J:196156
|
Psme3tm1Jjm/Psme3tm1Jjm
(B6.129X1-Psme3tm1Jjm)
|
decreased double-positive T cell number
|
J:88626
|
Psphtm1.1(KOMP)Vlcg/Psph+
(C57BL/6N-Psphtm1.1(KOMP)Vlcg/Ucd)
|
thrombocytopenia
|
J:211773
|
Pstpip2cmo/Pstpip2cmo
(C.Cg-Pstpip2cmo/J)
|
extramedullary hematopoiesis
|
J:104476
|
Pstpip2em1(IMPC)Tcp/Pstpip2em1(IMPC)Tcp
(C57BL/6NCrl-Pstpip2em1(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
Ptcd3tm1.1(KOMP)Vlcg/Ptcd3+
(C57BL/6N-Ptcd3tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ptch1tm1Hahn/Ptch1tm1Hahn
Gt(ROSA)26Sortm2(cre/ERT2)Brn/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:127207
|
| decreased double-positive T cell number
|
J:127207
|
| decreased immature B cell number
|
J:127207
|
| decreased transitional stage B cell number
|
J:127207
|
| increased double-negative T cell number
|
J:127207
|
| increased neutrophil cell number
|
J:127207
|
Ptch2tm1Dgen/Ptch2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:101679
|
| decreased hematocrit
|
J:101679
|
| decreased hemoglobin content
|
J:101679
|
| extramedullary hematopoiesis
|
J:101679
|
| increased neutrophil cell number
|
J:101679
|
Ptch2tm3b(EUCOMM)Hmgu/Ptch2tm3b(EUCOMM)Hmgu
(C57BL/6N-Ptch2tm3b(EUCOMM)Hmgu/Bay)
|
increased neutrophil cell number
|
J:211773
|
Ptchd1tm1b(KOMP)IcsOrl/Ptchd1tm1b(KOMP)IcsOrl
(C57BL/6N-Ptchd1tm1b(KOMP)IcsOrl/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
Ptcratm1(icre)Hjf/Ptcratm1(icre)Hjf
(B6.129P2-Ptcratm1(icre)Hjf)
|
decreased DN4 thymocyte number
|
J:197923
|
| decreased double-positive T cell number
|
J:197923
|
Ptcratm1.1Shoy/Ptcratm1.1Shoy
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:166147
|
| increased DN3 thymocyte number
|
J:166147
|
Ptcratm1Bjf/Ptcra+
(involves: 129X1/SvJ)
|
abnormal T cell differentiation
|
J:94338
|
| decreased double-negative T cell number
|
J:94338
|
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested T cell differentiation
|
J:91542
|
| increased double-negative T cell number
|
J:91542
|
Ptcratm1Vbo/Ptcratm1Vbo
(involves: 129P2/OlaHsd)
|
abnormal double-positive T cell morphology
|
J:123569
|
| decreased DN4 thymocyte number
|
J:123569
|
| increased DN3 thymocyte number
|
J:123569
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Cdh5-cre)7Mlia/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N)
|
abnormal definitive hematopoiesis
|
J:135172
|
| increased neutrophil cell number
|
J:135172
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(BKS.Cg-Ptprcb Thy1a Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
extramedullary hematopoiesis
|
J:109085
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * C57BL/6J * CBA)
|
thrombocytosis
|
J:165893
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Tg(Mx1-cre)1Cgn Ptentm1Hwu)
|
increased granulocyte number
|
J:232645
|
| thrombocytosis
|
J:232645
|
Ptgdr2tm1Byl/Ptgdr2tm1Byl
(involves: C57BL/6J)
|
increased eosinophil cell number
|
J:107519
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(B6.129P2-Ptgdrtm1Sna/Sna)
|
abnormal dermal mast cell morphology
|
J:197334
|
| decreased mast cell histamine storage
|
J:197334
|
Ptgdstm1Ohy/Ptgdstm1Ohy
(B6.129P2-Ptgdstm1Ohy)
|
abnormal dermal mast cell morphology
|
J:197334
|
| decreased mast cell histamine storage
|
J:197334
|
Ptger1tm1Sna/Ptger1tm1Sna
(B6CrSlc.129P2-Ptger1tm1Sna/Sna)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:128435
|
| abnormal T-helper 1 cell differentiation
|
J:128435
|
Ptges2tm1a(EUCOMM)Wtsi/Ptges2tm1a(EUCOMM)Wtsi
(C57BL/6N-Ptges2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:165965
|
Ptgisem1(IMPC)Mbp/Ptgisem1(IMPC)Mbp
(C57BL/6N-Ptgisem1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(D1.129P2(B6J)-Ptgs2tm1Unc)
|
decreased hematocrit
|
J:102777
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
decreased platelet calcium level
|
J:124756
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hematocrit
|
J:60668
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal class switch recombination
|
J:140698
|
| abnormal memory B cell differentiation
|
J:140698
|
Ptgs2ostm1Scrp/Ptgs2ostm1Scrp
(Not Specified)
|
decreased neutrophil cell number
|
J:325487
|
Ptp4a2em1(IMPC)Tcp/Ptp4a2em1(IMPC)Tcp
(C57BL/6N-Ptp4a2em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Ptpmt1tm2.1Ckq/Ptpmt1tm2.1Ckq
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
decreased common myeloid progenitor cell number
|
J:194929
|
Ptpn2tm1a(EUCOMM)Wtsi/Ptpn2+
(C57BL/6N-Ptpn2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(involves: 129S4/SvJae * BALB/c)
|
abnormal erythropoiesis
|
J:42595
|
| decreased double-positive T cell number
|
J:42595
|
| decreased hematocrit
|
J:42595
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(C.129S4-Ptpn2tm1Mtr)
|
abnormal negative T cell selection
|
J:186843
|
| abnormal positive T cell selection
|
J:186843
|
| abnormal T cell differentiation
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased erythrocyte cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
Ptpn2tm1Mtr/Ptpn2tm1Mtr
(B6.129S4(C)-Ptpn2tm1Mtr)
|
decreased double-positive T cell number
|
J:186843
|
| decreased erythrocyte cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
Ptpn2tm2.1Ttig/Ptpn2tm2.1Ttig
(B6.Cg-Ptpn2tm2.1Ttig)
|
abnormal negative T cell selection
|
J:186843
|
| abnormal positive T cell selection
|
J:186843
|
| abnormal T cell differentiation
|
J:186843
|
| decreased double-positive T cell number
|
J:186843
|
| decreased erythrocyte cell number
|
J:186843
|
| decreased immature B cell number
|
J:186843
|
Ptpn6m1Btlr/Ptpn6m1Btlr
(C57BL/6J-Ptpn6m1Btlr/Mmucd)
|
increased neutrophil cell number
|
J:142845
|
Ptpn6m3Btlr/Ptpn6+
(C57BL/6J-Ptpn6m3Btlr)
|
decreased immature B cell number
|
J:234259
|
Ptpn6m3Btlr/Ptpn6m3Btlr
(C57BL/6J-Ptpn6m3Btlr)
|
decreased immature B cell number
|
J:234259
|
Ptpn6m6Btlr/Ptpn6m6Btlr
(C57BL/6J-Ptpn6m6Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272439
|
| abnormal T cell differentiation
|
J:272439
|
Ptpn6m7Btlr/Ptpn6m7Btlr
(C57BL/6J-Ptpn6m7Btlr)
|
abnormal T cell differentiation
|
J:272440
|
Ptpn6me-B2/Ptpn6me-B2
(involves: BALB/c)
|
increased neutrophil cell number
|
J:169850
|
Ptpn6me/Ptpn6me
(C57BL/6J-Ptpn6me/J)
|
abnormal granulocyte morphology
|
J:5579
|
| increased granulocyte number
|
J:5579
|
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
abnormal T cell differentiation
|
J:118880
|
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6J)
|
increased neutrophil cell number
|
J:91609
|
| myeloid hyperplasia
|
J:91609
|
Ptpn11tm1Bgn/Ptpn11+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:147154
|
Ptpn11tm1Ckq/Ptpn11+
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J)
|
myeloid hyperplasia
|
J:177285
|
Ptpn11tm1Ckq/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
arrested B cell differentiation
|
J:177285
|
| decreased common myeloid progenitor cell number
|
J:177285
|
| extramedullary hematopoiesis
|
J:177285
|
| increased neutrophil cell number
|
J:177285
|
| myeloid hyperplasia
|
J:177285
|
Ptpn11tm6Bgn/Ptpn11+
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:148430
|
| abnormal leukopoiesis
|
J:148430
|
Ptpn11tm6Bgn/Ptpn11+
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:148430
|
| abnormal erythropoiesis
|
J:148430
|
| abnormal leukopoiesis
|
J:148430
|
| decreased common myeloid progenitor cell number
|
J:148430
|
| extramedullary hematopoiesis
|
J:148430
|
| increased granulocyte number
|
J:148430
|
Ptpn11tm7Bgn/Ptpn11+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:147154
|
Ptpn11tm7Bgn/Ptpn11tm7Bgn
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:147154
|
Ptpn18em1(IMPC)J/Ptpn18+
(C57BL/6NJ-Ptpn18em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
Ptpn22tm1.1Draw/Ptpn22+
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
| increased double-positive T cell number
|
J:201448
|
| increased transitional stage T1 B cell number
|
J:201448
|
Ptpn22tm1.1Draw/Ptpn22tm1.1Draw
(involves: 129 * C57BL/6)
|
abnormal B cell differentiation
|
J:201448
|
| abnormal T cell differentiation
|
J:201448
|
| increased double-positive T cell number
|
J:201448
|
| increased transitional stage T1 B cell number
|
J:201448
|
Ptpn22tm2Achn/Ptpn22tm2Achn
(B6.Cg-Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
Ptpn22tm2Achn/Ptpn22tm2Achn
Ptprctm1Weis/Ptprctm1Weis
(B6.Cg-Ptprctm1Weis Ptpn22tm2Achn)
|
abnormal double-positive T cell morphology
|
J:147129
|
| increased transitional stage B cell number
|
J:147129
|
Ptpratm1b(EUCOMM)Hmgu/Ptpratm1b(EUCOMM)Hmgu
(C57BL/6N-Ptpratm1b(EUCOMM)Hmgu/Orl)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Ptprcloc/Ptprcloc
(C57BL/6JSfdAnu-Ptprcloc/AnuApb)
|
abnormal double-positive T cell morphology
|
J:104190
|
| abnormal T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
| decreased double-positive T cell number
|
J:104190
|
Ptprcltng/Ptprcltng
(C57BL/6-Ptprcltng)
|
abnormal T cell differentiation
|
J:158876
|
| decreased double-positive T cell number
|
J:158876
|
Ptprcltng/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
| decreased double-positive T cell number
|
J:158876
|
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
abnormal CD4-positive T cell differentiation
|
J:214487
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214487
|
| decreased DN4 thymocyte number
|
J:214487
|
| increased DN3 thymocyte number
|
J:214487
|
| increased double-negative T cell number
|
J:214487
|
Ptprcm2Btlr/Ptprcm2Btlr
(C57BL/6J-Ptprcm2Btlr)
|
increased neutrophil cell number
|
J:216796
|
PtprcM9Btlr/PtprcM9Btlr
(C57BL/6J-PtprcM9Btlr)
|
abnormal B cell differentiation
|
J:272745
|
PtprcM11Btlr/PtprcM11Btlr
(C57BL/6J-PtprcM11Btlr)
|
abnormal B cell differentiation
|
J:274863
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274863
|
Ptprctm1Holm/Ptprctm1Holm
(involves: 129/Sv * C57BL/6)
|
abnormal lymphopoiesis
|
J:33466
|
| abnormal T cell differentiation
|
J:33466
|
| decreased double-positive T cell number
|
J:33466
|
| increased double-negative T cell number
|
J:33466
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129/Sv * C57BL/6)
|
arrested T cell differentiation
|
J:158876
|
| increased double-negative T cell number
|
J:13163
|
Ptprctm1Mak/Ptprctm1Mak
(B6.Cg-Ptprctm1Mak)
|
abnormal T cell differentiation
|
J:111646
|
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(involves: 129/Sv * 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal myelopoiesis
|
J:131736
|
Ptprctm1Mak/Ptprctm1Mak
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(B6.Cg-Ptprctm1Mak Ptprjtm1.2Weis)
|
abnormal B cell differentiation
|
J:131736
|
| abnormal myelopoiesis
|
J:131736
|
| abnormal transitional stage B cell morphology
|
J:131736
|
| decreased immature B cell number
|
J:131736
|
| extramedullary hematopoiesis
|
J:131736
|
Ptprctm1Tyb/Ptprctm1Tyb
(C.129S2-Ptprctm1Tyb)
|
abnormal positive T cell selection
|
J:57681
|
| abnormal T cell differentiation
|
J:57681
|
| decreased double-positive T cell number
|
J:57681
|
| increased double-negative T cell number
|
J:57681
|
Ptprctm1Weis/Ptprctm1Weis
(involves: 129X1/SvJ * C57BL/6)
|
abnormal erythropoiesis
|
J:66501
|
| abnormal granulocyte differentiation
|
J:66501
|
| extramedullary hematopoiesis
|
J:66501
|
Ptprctm1Weis/Ptprctm1Weis
(B6.129X1-Ptprctm1Weis)
|
abnormal double-positive T cell morphology
|
J:147129
|
| increased transitional stage B cell number
|
J:147129
|
Ptprjtm1.2Weis/Ptprjtm1.2Weis
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal B cell differentiation
|
J:131736
|
Ptprstm1b(KOMP)Mbp/Ptprs+
(C57BL/6N-Ptprstm1b(KOMP)Mbp/Tcp)
|
increased mean platelet volume
|
J:211773
|
Ptrh2tm1.1Eruo/Ptrh2tm1.1Eruo
(C57BL/6-Ptrh2tm1.1Eruo)
|
decreased neutrophil cell number
|
J:131853
|
Pttg1tm1Sme/Pttg1tm1Sme
(involves: 129S4/SvJae * C57BL/6)
|
thrombocytopenia
|
J:72267
|
Puf60tm1.1Kmtsu/Puf60+
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * C57BL/6NCrSlc * CBA/JNCrlj)
|
decreased erythrocyte cell number
|
J:233347
|
| thrombocytopenia
|
J:233347
|
Pum2tm1b(KOMP)Wtsi/Pum2tm1b(KOMP)Wtsi
(C57BL/6N-Pum2tm1b(KOMP)Wtsi/Tcp)
|
increased mean platelet volume
|
J:211773
|
Pwwp3aem1(IMPC)Tcp/Pwwp3aem1(IMPC)Tcp
(C57BL/6NCrl-Pwwp3aem1(IMPC)Tcp/Tcp)
|
thrombocytosis
|
J:211773
|
Pxdc1tm1e.1(KOMP)Wtsi/Pxdc1tm1e.1(KOMP)Wtsi
(C57BL/6N-Pxdc1tm1e.1(KOMP)Wtsi/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Pxkem1(IMPC)Tcp/Pxkem1(IMPC)Tcp
(C57BL/6N-Pxkem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Pxylp1tm1a(KOMP)Wtsi/Pxylp1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Pxylp1tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:175295
|
Pycr2m1J/Pycr2m1J
(involves: C3H/HeJ * C57BL/6J)
|
decreased basophil cell number
|
J:308336
|
Pycr2tm1a(EUCOMM)Wtsi/Pycr2tm1a(EUCOMM)Wtsi
(C57BL/6N-Pycr2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
R3hcc1ltm1b(KOMP)Wtsi/R3hcc1ltm1b(KOMP)Wtsi
(C57BL/6N-R3hcc1ltm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Rab2aem2(IMPC)Tcp/Rab2a+
(C57BL/6NCrl-Rab2aem2(IMPC)Tcp/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Rab3ctm1b(EUCOMM)Wtsi/Rab3ctm1b(EUCOMM)Wtsi
(C57BL/6N-Rab3ctm1b(EUCOMM)Wtsi/J)
|
increased erythrocyte cell number
|
J:211773
|
Rab3gap1em1(IMPC)J/Rab3gap1em1(IMPC)J
(C57BL/6NJ-Rab3gap1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Rab3gap2tm1b(KOMP)Wtsi/Rab3gap2tm1b(KOMP)Wtsi
(C57BL/6N-Rab3gap2tm1b(KOMP)Wtsi/J)
|
decreased hematocrit
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Rab3iptm1.1(KOMP)Vlcg/Rab3iptm1.1(KOMP)Vlcg
(C57BL/6N-Rab3iptm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Rab5atm1b(KOMP)Wtsi/Rab5atm1b(KOMP)Wtsi
(C57BL/6N-Rab5atm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Rab10em1(IMPC)J/Rab10+
(C57BL/6NJ-Rab10em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Rab11bem1(IMPC)J/Rab11bem1(IMPC)J
(C57BL/6NJ-Rab11bem1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Rab19tm1b(EUCOMM)Hmgu/Rab19tm1b(EUCOMM)Hmgu
(C57BL/6N-Rab19tm1b(EUCOMM)Hmgu/Ics)
|
increased eosinophil cell number
|
J:211773
|
Rab23tm1b(EUCOMM)Wtsi/Rab23+
(C57BL/6N-Rab23tm1b(EUCOMM)Wtsi/H)
|
increased mean platelet volume
|
J:211773
|
Rab27aash/Rab27aash
(involves: C3H/HeDiSn)
|
decreased platelet dense granule number
|
J:63231
|
| decreased platelet serotonin level
|
J:63231
|
Rab27aash/Rab27aash
(C3H/HeSn-Rab27aash/JRos)
|
decreased platelet serotonin level
|
J:137593
|
Rab27aash/Rab27aash
(B6.C3Sn-Rab27aash)
|
decreased erythrocyte cell number
|
J:193137
|
| decreased neutrophil cell number
|
J:193137
|
| thrombocytopenia
|
J:193137
|
Rab27aash/Rab27aash
(C3H/HeSn-Rab27aash/J)
|
abnormal platelet dense granule morphology
|
J:77395
|
| decreased platelet ADP level
|
J:77395
|
| decreased platelet ATP level
|
J:77395
|
| decreased platelet dense granule number
|
J:77395
|
| decreased platelet serotonin level
|
J:77395
|
Rab27aash/Rab27aash
Rab27btm1.2Seab/Rab27btm1.2Seab
(involves: 129X1/SvJ * C3H/HeSn * C57BL/6J)
|
decreased platelet dense granule number
|
J:120307
|
| decreased platelet serotonin level
|
J:120307
|
Rab27btm1.2Seab/Rab27btm1.2Seab
(involves: 129X1/SvJ * C57BL/6J)
|
decreased platelet dense granule number
|
J:120307
|
| decreased platelet serotonin level
|
J:120307
|
Rab32tm1b(KOMP)Wtsi/Rab32+
Rab38tm1.1Ics/Rab38tm1.1Ics
(involves: C57BL/6N * C57BL/6NTac)
|
decreased platelet ADP level
|
J:293385
|
| decreased platelet ATP level
|
J:293385
|
| decreased platelet serotonin level
|
J:293385
|
Rab32tm1b(KOMP)Wtsi/Rab32tm1b(KOMP)Wtsi
Rab38tm1.1Ics/Rab38+
(involves: C57BL/6N * C57BL/6NTac)
|
decreased platelet ADP level
|
J:293385
|
| decreased platelet ATP level
|
J:293385
|
| decreased platelet serotonin level
|
J:293385
|
Rab32tm1b(KOMP)Wtsi/Rab32tm1b(KOMP)Wtsi
Rab38tm1.1Ics/Rab38tm1.1Ics
(involves: C57BL/6N * C57BL/6NTac)
|
abnormal platelet dense granule morphology
|
J:293385
|
| decreased platelet ADP level
|
J:293385
|
| decreased platelet ATP level
|
J:293385
|
| decreased platelet dense granule number
|
J:293385
|
| decreased platelet serotonin level
|
J:293385
|
Rab32tm1c(KOMP)Wtsi/Rab32tm1c(KOMP)Wtsi
Tg(Itgax-cre)1-1Reiz/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * CBA)
|
increased neutrophil cell number
|
J:267497
|
Rab36tm1b(KOMP)Wtsi/Rab36tm1b(KOMP)Wtsi
(C57BL/6N-Rab36tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rab40bem1(IMPC)J/Rab40bem1(IMPC)J
(C57BL/6NJ-Rab40bem1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Rab40ctm1b(KOMP)Wtsi/Rab40c+
(C57BL/6N-Rab40ctm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Rab43tm1.1(KOMP)Vlcg/Rab43tm1.1(KOMP)Vlcg
(C57BL/6N-Rab43tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rabgef1tm1Glli/Rabgef1tm1Glli
(either: (involves: 129P2/OlaHsd * 129S/SvEv) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal mast cell morphology
|
J:91790
|
| cutaneous mastocytosis
|
J:91790
|
Rabggtagm/Rabggtagm
(C57BL/6J-Rabggtagm)
|
abnormal platelet alpha-granule morphology
|
J:12434
|
| decreased platelet dense granule number
|
J:12434
|
| decreased platelet serotonin level
|
J:12434
|
| increased mean platelet volume
|
J:12434
|
| thrombocytopenia
|
J:12434
|
Rabggtatm1.1(KOMP)Vlcg/Rabggta+
(C57BL/6N-Rabggtatm1.1(KOMP)Vlcg/Nju)
|
decreased neutrophil cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Rac1em1(IMPC)Mbp/Rac1+
(C57BL/6N-Rac1em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Rac1tm1Djk/Rac1tm1.1Djk
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
decreased neutrophil cell number
|
J:83457
|
Rac2em1Shl/Rac2+
(involves: C57BL/6)
|
abnormal neutrophil morphology
|
J:276213
|
| increased neutrophil cell number
|
J:276213
|
Rac2m3Btlr/Rac2m3Btlr
(C57BL/6J-Rac2m3Btlr)
|
increased neutrophil cell number
|
J:236680
|
Rac2tm1Mddw/Rac2tm1Mddw
(involves: 129S/SvEv * C57BL/6)
|
abnormal granulocyte differentiation
|
J:53362
|
| decreased neutrophil cell number
|
J:53362
|
| increased neutrophil cell number
|
J:53362
|
Racgap1tm1Mahi/Racgap1tm1Mahi
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:137760
|
| abnormal definitive hematopoiesis
|
J:137760
|
| abnormal erythrocyte morphology
|
J:137760
|
| abnormal myelopoiesis
|
J:137760
|
| decreased pro-B cell number
|
J:137760
|
| decreased transitional stage B cell number
|
J:137760
|
Rad1tm1b(KOMP)Wtsi/Rad1+
(C57BL/6N-Rad1tm1b(KOMP)Wtsi/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Rad18tm1a(EUCOMM)Wtsi/Rad18tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Rad18tm1a(EUCOMM)Wtsi/Wtsi)
|
increased hematocrit
|
J:165965
|
| increased mean corpuscular hemoglobin concentration
|
J:175295
|
| increased mean corpuscular volume
|
J:165965
|
Rad21tm1.1Mmk/Rad21tm1.1Mmk
Tg(Cd4-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:175827
|
| decreased double-positive T cell number
|
J:175827
|
Rad50tm2Jpt/Rad50tm2Jpt
(either: (involves: 129S6/SvEvTac * 129S7/SvEvBrd) or (involves: 129S7/SvEvBrd * C57BL/6))
|
decreased immature B cell number
|
J:78820
|
| increased late pro-B cell number
|
J:78820
|
Rad50tm2Jpt/Rad50tm2Jpt
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased double-negative T cell number
|
J:103922
|
| decreased pro-B cell number
|
J:103922
|
| thrombocytopenia
|
J:103922
|
Rad50tm2Jpt/Rad50tm2Jpt
Smc1atm1Mbk/Smc1atm1Mbk
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal pro-B cell morphology
|
J:103922
|
| decreased double-negative T cell number
|
J:103922
|
Rad52tm1Aps/Rad52tm1Aps
Rad54ltm1Jhjh/Rad54ltm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:101697
|
Rad54btm1Roka/Rad54btm1Roka
Rad54ltm1Jhjh/Rad54ltm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:105544
|
Rad54l2em1(IMPC)Tcp/Rad54l2+
(C57BL/6NCrl-Rad54l2em1(IMPC)Tcp/Tcp)
|
thrombocytosis
|
J:211773
|
Rad54ltm1Jhjh/Rad54ltm1Jhjh
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:101697
|
Raf1tm1.1Bgn/Raf1+
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal common myeloid progenitor cell morphology
|
J:172034
|
| increased neutrophil cell number
|
J:172034
|
Rag1/Rag2tm1Mnz/Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
| abnormal double-positive T cell morphology
|
J:90487
|
Rag1/Rag2tm1Mnz/Rag1/Rag2tm1Mnz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:90487
|
| abnormal double-positive T cell morphology
|
J:90487
|
Rag1em2Mvw/Rag1em2Mvw
(A/J-Rag1em2Mvw/MvwJ)
|
arrested B cell differentiation
|
J:332675
|
| arrested T cell differentiation
|
J:332675
|
Rag1em3Mvw/Rag1em3Mvw
(129S1/SvImJ-Rag1em3Mvw/Mvw)
|
arrested B cell differentiation
|
J:332675
|
| arrested T cell differentiation
|
J:332675
|
Rag1m1Btlr/Rag1m1Btlr
(C57BL/6J-Rag1m1Btlr)
|
absent late pro-B cells
|
J:150635
|
Rag1m2Btlr/Rag1m2Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Rag1m4Btlr/Rag1m4Btlr
(C57BL/6J-Rag1m4Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272094
|
| abnormal T cell differentiation
|
J:272094
|
Rag1tm1(cre)Thr/Rag1tm1(cre)Thr
(Not Specified)
|
abnormal lymphopoiesis
|
J:86869
|
Rag1tm1(GFP)Imku/?
Zfp335blt/Zfp335blt
(involves: C57BL/6 * CBA)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
Rag1tm1(GFP)Imku/Rag1tm1(GFP)Imku
(involves: C57BL/6 * CBA)
|
abnormal immunoglobulin V(D)J recombination
|
J:79416
|
Rag1tm1.1Sadu/Rag1tm1.1Sadu
(involves: BALB/c)
|
arrested B cell differentiation
|
J:155473
|
Rag1tm1Bal/Rag1tm1Bal
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
arrested T cell differentiation
|
J:113270
|
Rag1tm1Fwa/Rag1tm1Fwa
(involves: 129)
|
abnormal B cell differentiation
|
J:86464
|
| abnormal T cell differentiation
|
J:86464
|
| increased double-negative T cell number
|
J:86464
|
Rag1tm1Jsek/Rag1+
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:146912
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
| abnormal T cell differentiation
|
J:146912
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
| decreased double-positive T cell number
|
J:146912
|
Rag1tm1Jsek/Rag1tm1Jsek
(involves: 129S6/SvEvTac)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:146912
|
| abnormal lymphopoiesis
|
J:146912
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:146912
|
| abnormal T cell receptor V(D)J recombination
|
J:146912
|
| absent immature B cells
|
J:146912
|
| arrested B cell differentiation
|
J:146912
|
| arrested T cell differentiation
|
J:146912
|
| decreased double-positive T cell number
|
J:146912
|
| increased double-negative T cell number
|
J:146912
|
| increased pro-B cell number
|
J:146912
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * CD-1)
|
abnormal B cell differentiation
|
J:1934
|
| abnormal immunoglobulin V(D)J recombination
|
J:1934
|
| abnormal T cell differentiation
|
J:1934
|
| abnormal T cell receptor V(D)J recombination
|
J:1934
|
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Rag1tm1Mom)
|
increased eosinophil cell number
|
J:111828
|
Rag1tm1Mom/Rag1tm1Mom
(NOD.129S7(B6)-Rag1tm1Mom)
|
increased granulocyte number
|
J:109843
|
| increased immature B cell number
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased neutrophil cell number
|
J:119344
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal double-negative T cell morphology
|
J:112990
|
Rag1tm1Mom/Rag1tm1Mom
Prf1tm1Sdz/Prf1tm1Sdz
(NOD.Cg-Rag1tm1Mom Prf1tm1Sdz/Sz)
|
increased granulocyte number
|
J:109843
|
| increased immature B cell number
|
J:109843
|
Rag1tm1Mom/Rag1tm1Mom
Slc46a2tm1Moki/Slc46a2+
Tg(TcraB12,TcrbB12)1Rest/0
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:140121
|
| decreased double-positive T cell number
|
J:140121
|
Rag1tm1Mom/Rag1tm1Mom
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S7/SvEvBrd * C3H/He * C57BL/6)
|
increased double-positive T cell number
|
J:135903
|
Rag1tm1Mom/Rag1tm1Mom
Tg(LPV-TAg1135)11Tvd/0
(involves: 129/Sv * C57BL/6 * DBA/2)
|
abnormal T cell receptor V(D)J recombination
|
J:47667
|
Rag1tm1Mom/Rag1tm1Mom
Tg(Tcra,Tcrb)HRCAll/0
(B6.Cg-Rag1tm1Mom Tg(Tcra,Tcrb)HRCAll)
|
abnormal T cell differentiation
|
J:131347
|
Rag1tm1Mom/Rag1tm1Mom
Tg(TcraBDC12-4.1)10Jos/0
Tg(TcrbBDC12-4.1)82Gse/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB * NOD)
|
increased double-positive T cell number
|
J:111874
|
Rag1tm1Mom/Rag1tm1Mom
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
abnormal T cell differentiation
|
J:84536
|
Rag1tm1Mom/Rag1tm1Mom
Vtcn1tm1Lpc/Vtcn1tm1Lpc
(involves: 129S/SvEvBrd * 129S7/SvEvBrd * C57BL/6)
|
abnormal neutrophil differentiation
|
J:145712
|
| increased neutrophil cell number
|
J:145712
|
Rag2tm1.1Cgn/Rag2tm1.1Cgn
(C57BL/6-Rag2tm1.1Cgn)
|
arrested B cell differentiation
|
J:72214
|
| arrested T cell differentiation
|
J:72214
|
Rag2tm1.1Desi/Rag2tm1.1Desi
(involves: 129X1/SvJ * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
Rag2tm1.1Mss/Rag2tm1.1Mss
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:171970
|
| increased DN3 thymocyte number
|
J:171970
|
Rag2tm1Avla/Rag2tm1Avla
(involves: 129/Sv * C57BL/6)
|
arrested B cell differentiation
|
J:122108
|
| arrested T cell differentiation
|
J:122108
|
| decreased double-positive T cell number
|
J:122108
|
Rag2tm1Cgn/Rag2tm1.1Cgn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
absent immature B cells
|
J:72214
|
| arrested B cell differentiation
|
J:72214
|
| arrested T cell differentiation
|
J:72214
|
Rag2tm1Cgn/Rag2tm1Cgn
Xrcc4tm1Fwa/Xrcc4tm2Fwa
Tg(Cr2-cre)3Cgn/?
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6)
|
abnormal class switch recombination
|
J:150339
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * MF1)
|
abnormal immunoglobulin V(D)J recombination
|
J:1935
|
| abnormal T cell receptor V(D)J recombination
|
J:1935
|
| arrested B cell differentiation
|
J:1935
|
| arrested T cell differentiation
|
J:1935
|
| decreased double-positive T cell number
|
J:1935
|
| increased granulocyte number
|
J:1935
|
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:91542
|
| decreased double-negative T cell number
|
J:81133,
J:91542
|
| increased double-negative T cell number
|
J:91542
|
Rag2tm1Fwa/Rag2tm1Fwa
Rr299391tm1.1Fwa/Rr299391tm1.1Fwa
(involves: 129P2/OlaHsd * 129S/SvEv)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:149413
|
Rag2tm1Fwa/Rag2tm1Fwa
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:174536
|
Rag2tm1Fwa/Rag2tm1Fwa
Tbatatm1Faf/Tbatatm1Faf
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
abnormal T cell differentiation
|
J:166065
|
Rag2tm1Fwa/Rag2tm1Fwa
TcraLn3Jae/Tcra+
TcrbLn3Jae/Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
Rag2tm1Fwa/Rag2tm1Fwa
TcrbLn3Jae/Tcrb+
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143006
|
| increased double-positive T cell number
|
J:143006
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: 129S/SvEv * C57BL/6 * Swiss Webster)
|
increased DN3 thymocyte number
|
J:235890
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(EmuSR-tTa)83Bop/0
Tg(tetO-Nfatct1*)1Grc/0
(involves: 129S/SvEv * C57BL/6J * CBA/J * FVB/N)
|
abnormal double-positive T cell morphology
|
J:141917
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Lck-Akt1*)M-1Pnt/0
(involves: 129S/SvEv * C3H/He * C57BL/6)
|
increased double-positive T cell number
|
J:135903
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra5CC7,Tcrb5CC7)IWep/?
Themis5AT161/Themis5AT161
(involves: 129S/SvEv * C57BL/6)
|
arrested T cell differentiation
|
J:151076
|
| increased double-positive T cell number
|
J:151076
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6NTac * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125548
|
| abnormal positive T cell selection
|
J:125548
|
| increased double-positive T cell number
|
J:125548
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Fwa
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: 129S/SvEv * C57BL/6)
|
decreased double-positive T cell number
|
J:78309
|
Rag2tm1Fwa/Rag2tm1Fwa
Wdr1rede/Wdr1rede
(involves: 129S/SvEv * C57BL/6)
|
thrombocytopenia
|
J:134092
|
Rag2tm1Fwa/Rag2tm1Mao
(involves: 129S/SvEv * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:81837
|
| arrested B cell differentiation
|
J:81837
|
| arrested T cell differentiation
|
J:81837
|
| decreased double-negative T cell number
|
J:81837
|
| decreased immature B cell number
|
J:81837
|
| increased immature B cell number
|
J:81837
|
Rag2tm1Libo/Rag2tm1Libo
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal B cell differentiation
|
J:84563
|
Rag2tm1Mao/Rag2tm1Mao
(involves: 129 * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:81837
|
| arrested B cell differentiation
|
J:81837
|
| arrested T cell differentiation
|
J:81837
|
| decreased double-negative T cell number
|
J:81837
|
| decreased immature B cell number
|
J:81837
|
| increased immature B cell number
|
J:81837
|
Rag2tm1Tgi/Rag2tm1Tgi
(involves: 129S1/Sv * 129X1/SvJ)
|
arrested B cell differentiation
|
J:113641
|
| arrested T cell differentiation
|
J:113641
|
| decreased double-positive T cell number
|
J:113641
|
Rai14em1(IMPC)J/Rai14+
(C57BL/6NJ-Rai14em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ralgps1em1(IMPC)J/Ralgps1em1(IMPC)J
(C57BL/6NJ-Ralgps1em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Ramp1tm1b(EUCOMM)Wtsi/Ramp1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ramp1tm1b(EUCOMM)Wtsi/H)
|
increased basophil cell number
|
J:211773
|
Ranbp10Gt(RRZ226)Byg/Ranbp10Gt(RRZ226)Byg
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal platelet shape
|
J:193236
|
| decreased erythrocyte cell number
|
J:193236
|
| increased mean corpuscular volume
|
J:193236
|
Rap1gapem1(IMPC)H/Rap1gapem1(IMPC)H
(C57BL/6NTac-Rap1gapem1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Rapgef2tm1.1Hous/Rapgef2tm1.1Hous
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:165879
|
Rapgef2tm1.1Tkat/Rapgef2tm1.1Tkat
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased erythrocyte cell number
|
J:125199
|
Rapgef2tm1.2Hous/Rapgef2tm1.2Hous
(involves: 129S1/Sv)
|
abnormal embryonic hematopoiesis
|
J:165879
|
| abnormal erythropoiesis
|
J:165879
|
| absent erythrocytes
|
J:165879
|
| decreased common myeloid progenitor cell number
|
J:165879
|
Rapgef4em1(IMPC)H/Rapgef4+
(C57BL/6NTac-Rapgef4em1(IMPC)H/H)
|
increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Raratm1.1Ybe/Raratm1.1Ybe
(involves: C57BL/6N)
|
abnormal lymphopoiesis
|
J:207485
|
Rarres1tm1.2Mhl/Rarres1tm1.2Mhl
(involves: 129S1/SvImJ * C57BL/6 * FVB/N * NIH Black Swiss)
|
abnormal B cell differentiation
|
J:324270
|
| abnormal plasma cell differentiation
|
J:324270
|
| extramedullary hematopoiesis
|
J:324270
|
Rasa1tm1b(EUCOMM)Hmgu/Rasa1+
(C57BL/6N-Rasa1tm1b(EUCOMM)Hmgu/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Rasa3hlb381/?
(C57BL/6J-Rasa3hlb381/J)
|
thrombocytopenia
|
J:82961
|
Rasa3hlb381/Rasa3hlb381
(C57BL/6J-Rasa3hlb381/J)
|
increased mean platelet volume
|
J:221899
|
| thrombocytopenia
|
J:301035,
J:221899
|
Rasa3hlb381/Rasa3hlb381
Rasgrp2tm1Amg/Rasgrp2tm1Amg
(involves: C57BL/6J)
|
abnormal platelet cell number
|
J:221899
|
Rasa3scat/Rasa3scat
(involves: BALB/cBy)
|
abnormal erythropoiesis
|
J:186485
|
| anisocytosis
|
J:186485
|
| decreased mean corpuscular hemoglobin
|
J:186485
|
| poikilocytosis
|
J:186485
|
| polychromatophilia
|
J:186485
|
| thrombocytopenia
|
J:186485
|
Rasa3scat/Rasa3scat
(involves: BALB/cBy * BALB/cByJ)
|
abnormal erythropoiesis
|
J:281271
|
| decreased erythrocyte cell number
|
J:301035
|
| decreased hematocrit
|
J:301035
|
| decreased hemoglobin content
|
J:301035
|
| decreased mean corpuscular hemoglobin concentration
|
J:301035
|
| increased hemoglobin concentration distribution width
|
J:301035
|
| increased mean corpuscular volume
|
J:301035
|
| increased mean platelet volume
|
J:301035
|
| increased red blood cell distribution width
|
J:301035
|
| thrombocytopenia
|
J:301035
|
Rasa3tm1.1Llp/Rasa3tm1.1Llp
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/SvImJ * C57BL/6J * CBA/J)
|
abnormal erythropoiesis
|
J:301035
|
| anisocytosis
|
J:301035
|
| decreased erythrocyte cell number
|
J:301035
|
| decreased hematocrit
|
J:301035
|
| decreased hemoglobin content
|
J:301035
|
| increased mean corpuscular volume
|
J:301035
|
| increased mean platelet volume
|
J:301035
|
| increased red blood cell distribution width
|
J:301035
|
| poikilocytosis
|
J:301035
|
| thrombocytopenia
|
J:301035
|
Rasa3tm1.1Llp/Rasa3tm1.1Llp
Tg(Tek-cre)1Ywa/?
(involves: 129S1/SvImJ * C57BL/6J * SJL/J)
|
abnormal embryonic hematopoiesis
|
J:301035
|
Rasa3tm1.1Llp/Rasa3tm1.1Llp
Tg(Vav1-cre)1Cgp/?
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal embryonic hematopoiesis
|
J:301035
|
Rasal3tm1.1Fuj/Rasal3tm1.1Fuj
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
increased granulocyte number
|
J:229641
|
Rasal3tm1b(EUCOMM)Hmgu/Rasal3tm1b(EUCOMM)Hmgu
(C57BL/6N-Rasal3tm1b(EUCOMM)Hmgu/Orl)
|
increased eosinophil cell number
|
J:211773
|
Rasgrp1lag/Rasgrp1lag
(involves: 129 * C57BL/6)
|
abnormal positive T cell selection
|
J:85189
|
Rasgrp1m1Anu/Rasgrp1m1Anu
(C57BL/6JSfdAnu-Rasgrp1m1Anu)
|
abnormal T cell differentiation
|
J:104190
|
Rasgrp1m3Btlr/Rasgrp1m3Btlr
(C57BL/6J-Rasgrp1m3Btlr)
|
increased neutrophil cell number
|
J:265255
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
(B6.Cg-Rasgrp1tm1.1Wz)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:225109
|
| abnormal T cell differentiation
|
J:225109
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * DBA/2J)
|
increased double-positive T cell number
|
J:225109
|
Rasgrp1tm1.1Wz/Rasgrp1tm1.1Wz
Tg(TcraTcrb)425Cbn/?
(involves: C57BL/6 * BALB/c)
|
abnormal CD4-positive T cell differentiation
|
J:225109
|
Rasgrp1tm1Jstn/Rasgrp1tm1Jstn
(involves: 129P3/J)
|
abnormal double-positive T cell morphology
|
J:207898
|
Rasgrp3em1(IMPC)Wtsi/Rasgrp3em1(IMPC)Wtsi
(C57BL/6N-Rasgrp3em1(IMPC)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean platelet volume
|
J:211773
|
Rasgrp4tm2a(KOMP)Wtsi/Rasgrp4tm2a(KOMP)Wtsi
(C57BL/6N-Rasgrp4tm2a(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Rassf2tm1Dlim/Rassf2tm1Dlim
(B6.Cg-Rassf2tm1Dlim)
|
decreased common myeloid progenitor cell number
|
J:181952
|
| decreased erythrocyte cell number
|
J:181952
|
Rassf5tm1Kina/Rassf5tm1Kina
(involves: C57BL/6 * CBA * ICR)
|
abnormal B cell differentiation
|
J:92670
|
Rb1tm1Brd/Rb1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal erythrocyte morphology
|
J:2516
|
| increased nucleated erythrocyte cell number
|
J:2516
|
Rb1tm1Dwg/Rb1tm1Dwg
(involves: 129/Sv * C57BL/6)
|
abnormal erythropoiesis
|
J:105548
|
Rb1tm1Dwg/Rb1tm1Tyj
(involves: 129/Sv * 129S2/SvPas * C57BL/6)
|
abnormal erythropoiesis
|
J:105548
|
Rb1tm1Mlh/Rb1tm1Mlh
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal definitive hematopoiesis
|
J:2498
|
| abnormal erythrocyte morphology
|
J:2498
|
| abnormal erythropoiesis
|
J:20542,
J:2498
|
| abnormal myelopoiesis
|
J:2498
|
| decreased erythrocyte cell number
|
J:2498
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas)
|
abnormal erythropoiesis
|
J:105548
|
| abnormal macrophage differentiation
|
J:105548
|
| increased nucleated erythrocyte cell number
|
J:81643
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal erythrocyte morphology
|
J:2511
|
| abnormal erythropoiesis
|
J:2511
|
| low mean erythrocyte cell number
|
J:2511
|
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
(involves: 129S2/SvPas * C57BL/6)
|
abnormal erythropoiesis
|
J:37145
|
Rb1tm2Mlh/Rb1tm2Mlh
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal definitive hematopoiesis
|
J:2498
|
| abnormal erythrocyte morphology
|
J:2498
|
| abnormal erythropoiesis
|
J:20542,
J:2498
|
| abnormal myelopoiesis
|
J:2498
|
| decreased erythrocyte cell number
|
J:2498
|
Rb1cc1tm1.1Guan/Rb1cc1tm1.1Guan
Tg(Tek-cre)12Flv/0
(B6.Cg-Rb1cc1tm1.1Guan Tg(Tek-cre)12Flv)
|
abnormal erythropoiesis
|
J:167258
|
| abnormal myelopoiesis
|
J:167258
|
| decreased erythrocyte cell number
|
J:167258
|
| decreased hematocrit
|
J:167258
|
| decreased hemoglobin content
|
J:167258
|
| increased neutrophil cell number
|
J:167258
|
| increased red blood cell distribution width
|
J:167258
|
Rbcq1SM/J/Rbcq1SM/J
(involves: NZW/LacJ * SM/J)
|
increased erythrocyte cell number
|
J:107220
|
Rbcq2SM/J/Rbcq2SM/J
(involves: NZW/LacJ * SM/J)
|
increased erythrocyte cell number
|
J:107220
|
Rbcq3NZW/LacJ/Rbcq3SM/J
(involves: NZW/LacJ * SM/J)
|
increased erythrocyte cell number
|
J:107220
|
Rbcq3SM/J/Rbcq3SM/J
(involves: NZW/LacJ * SM/J)
|
increased erythrocyte cell number
|
J:107220
|
Rbcq4C57BLKS/J/Rbcq4C57BLKS/J
(involves: C57BLKS/J * SM/J)
|
increased erythrocyte cell number
|
J:107220
|
Rbcq4C57BLKS/J/Rbcq4SM/J
(involves: C57BLKS/J * SM/J)
|
increased erythrocyte cell number
|
J:107220
|
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
abnormal common myeloid progenitor cell morphology
|
J:51060
|
| abnormal definitive hematopoiesis
|
J:51060
|
| extramedullary hematopoiesis
|
J:51060
|
Rbm15tm1.1(MAL)Dgg/Rbm15tm1.1(MAL)Dgg
(B6.129-Rbm15tm1.1(MAL)Dgg)
|
abnormal common myeloid progenitor cell morphology
|
J:149622
|
| extramedullary hematopoiesis
|
J:149622
|
Rbm15tm1Dgg/Rbm15tm1.1Dgg
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA * FVB/N)
|
abnormal B cell differentiation
|
J:120321
|
Rbm15tm1Swm/Rbm15tm1Swm
Tg(Mx1-cre)1Cgn/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal definitive hematopoiesis
|
J:152262
|
| decreased hemoglobin content
|
J:152262
|
| decreased neutrophil cell number
|
J:152262
|
Rbm22em1(IMPC)Mbp/Rbm22+
(C57BL/6NCrl-Rbm22em1(IMPC)Mbp/Mmucd)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Rbm38tm1.1Xch/Rbm38tm1.1Xch
(involves: C57BL/6 * FVB/N)
|
abnormal erythrocyte morphology
|
J:216929
|
| decreased hematocrit
|
J:216929
|
| decreased hemoglobin content
|
J:216929
|
| extramedullary hematopoiesis
|
J:216929
|
Rbp1tm1Ipc/Rbp1tm1Ipc
(involves: 129S2/SvPas)
|
increased granulocyte number
|
J:67762
|
| increased neutrophil cell number
|
J:67762
|
Rbp4tm1.1(KOMP)Vlcg/Rbp4tm1.1(KOMP)Vlcg
(C57BL/6N-Rbp4tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
abnormal T-helper 2 cell differentiation
|
J:90018
|
Rbpjtm1Hon/Rbpjtm1Hon
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:99747
|
| abnormal lymphopoiesis
|
J:99747
|
| arrested T cell differentiation
|
J:125869,
J:99747
|
| decreased double-positive T cell number
|
J:99747
|
| increased double-negative T cell number
|
J:99747
|
Rc3h1san/Rc3h1san
(either: C57BL/6JSfdAnu-Rc3h1san/Anu or (involves: C57BL/6JSfdAnu * CBA/Ca))
|
abnormal T cell differentiation
|
J:98938
|
| thrombocytopenia
|
J:98938
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6 * NZB * SJL)
|
increased eosinophil cell number
|
J:177784
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca * NZB * SJL)
|
abnormal B cell differentiation
|
J:177784
|
| decreased immature B cell number
|
J:177784
|
| increased eosinophil cell number
|
J:177784
|
Rc3h1tm1.1Mass/Rc3h1tm1.1Mass
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * NZB * SJL)
|
increased eosinophil cell number
|
J:177784
|
Rcc2tm1b(EUCOMM)Wtsi/Rcc2tm1b(EUCOMM)Wtsi
(C57BL/6N-Rcc2tm1b(EUCOMM)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
Rcor1tm2.2Gman/Rcor1tm2.2Gman
(B6.129S1(SJL)-Rcor1tm2.2Gman)
|
abnormal embryonic erythropoiesis
|
J:211681
|
Rcor3em1(IMPC)J/Rcor3em1(IMPC)J
(C57BL/6NJ-Rcor3em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Rd3em1(IMPC)Bay/Rd3em1(IMPC)Bay
(C57BL/6N-Rd3em1(IMPC)Bay/BayMmucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased hematocrit
|
J:211773
|
Rdxtm1.1(KOMP)Vlcg/Rdx+
(C57BL/6N-Rdxtm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rec8tm1b(KOMP)Wtsi/Rec8tm1b(KOMP)Wtsi
(C57BL/6N-Rec8tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Reg4tm1b(EUCOMM)Hmgu/Reg4tm1b(EUCOMM)Hmgu
(C57BL/6NTac-Reg4tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
RelM2Btlr/RelM2Btlr
(C57BL/6J-RelM2Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272778
|
| abnormal T cell differentiation
|
J:272778
|
Reltm1Brv/Reltm1Brv
(involves: 129S1/Sv)
|
extramedullary hematopoiesis
|
J:46911
|
Reltm1Grd/Reltm1Grd
Relatm1Bal/Relatm1Bal
(B6.129S-Reltm1Grd Relatm1Bal)
|
abnormal erythropoiesis
|
J:111325
|
| abnormal monocyte differentiation
|
J:111325
|
| decreased common myeloid progenitor cell number
|
J:111325
|
| hyperchromasia
|
J:111325
|
| increased granulocyte number
|
J:111325
|
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:79107
|
| increased eosinophil cell number
|
J:58987
|
Relatm1Bal/Relatm1Bal
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(involves: 129S4/SvJae * C57BL/6)
|
extramedullary hematopoiesis
|
J:60742
|
Relatm1Yuo/Relatm1Yuo
(involves: 129S/SvEv)
|
decreased double-positive T cell number
|
J:63099
|
Relatm2.1Gho/Relatm2.1Gho
(involves: 129S6/SvEvTac * C57BL/6)
|
extramedullary hematopoiesis
|
J:163663
|
| increased neutrophil cell number
|
J:163663
|
RelbTg(H2-K1/GH1)106Bri/RelbTg(H2-K1/GH1)106Bri
(C57BL/6-RelbTg(H2-K1/GH1)106Bri)
|
increased granulocyte number
|
J:23081,
J:76450
|
Relbtm1Brv/Relbtm1Brv
(involves: 129S2/SvPas * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:22675
|
| abnormal erythropoiesis
|
J:22675
|
| extramedullary hematopoiesis
|
J:22675
|
| myeloid hyperplasia
|
J:22675
|
Relbtm1Brv/Relbtm1Brv
(either: (involves: 129S2/SvPas) or (involves: C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
increased eosinophil cell number
|
J:63950
|
Relchem1(IMPC)J/Relchem1(IMPC)J
(C57BL/6NJ-Relchem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
decreased hematocrit
|
J:169129
|
Resttm2b(EUCOMM)Wtsi/Rest+
(C57BL/6N-Resttm2b(EUCOMM)Wtsi/Ieg)
|
decreased mean platelet volume
|
J:211773
|
Retnlbtm1Lex/Retnlbtm1Lex
(FVB.129S5-Retnlbtm1Lex)
|
increased neutrophil cell number
|
J:235058
|
Retnlgem1(IMPC)J/Retnlgem1(IMPC)J
(C57BL/6NJ-Retnlgem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Retreg3tm2a(EUCOMM)Wtsi/Retreg3tm2a(EUCOMM)Wtsi
(C57BL/6N-Retreg3tm2a(EUCOMM)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:165965
|
Retreg3tm2b(EUCOMM)Wtsi/Retreg3tm2b(EUCOMM)Wtsi
(C57BL/6N-Fam134ctm2b(EUCOMM)Wtsi/Wtsi)
|
increased neutrophil cell number
|
J:211773
|
Rev1tm1.1Jow/Rev1tm1.1Jow
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:151700
|
Rev1tm1Ndew/Rev1tm1Ndew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:119176
|
Rev3ltm1.1Kunk/Rev3ltm1.1Kunk
(involves: C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:188723
|
Rev3ltm1b(EUCOMM)Hmgu/Rev3l+
(C57BL/6N-Rev3ltm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Rev3ltm1Rsky/Rev3ltm1.1Rsky
Tg(Cr2-cre)3Cgn/?
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:146453
|
| abnormal somatic hypermutation frequency
|
J:146453
|
Rexo2tm1b(EUCOMM)Wtsi/Rexo2+
(C57BL/6N-Rexo2tm1b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
Rfc1tm1b(KOMP)Mbp/Rfc1+
(B6N(Cg)-Rfc1tm1b(KOMP)Mbp/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Rft1tm1b(KOMP)Wtsi/Rft1+
(C57BL/6N-Rft1tm1b(KOMP)Wtsi/Bay)
|
decreased erythrocyte cell number
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Rftn1tm1Ayos/Rftn1tm1Ayos
(B6.Cg-Rftn1tm1Ayos)
|
abnormal CD4-positive T cell differentiation
|
J:150299
|
Rgl1em1(IMPC)Mbp/Rgl1+
(C57BL/6N-Rgl1em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Rgs4em1(IMPC)H/Rgs4em1(IMPC)H
(C57BL/6N-Rgs4em1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Rgs13tm1.1Jhk/Rgs13tm1.1Jhk
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:199530
|
Rgs18tm1.1Ics/Rgs18tm1.1Ics
(involves: 129S2/SvPas * C57BL/6J)
|
thrombocytopenia
|
J:225296
|
Rgsc16/Rgsc16+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
| increased red blood cell distribution width
|
J:133634
|
Rgsc278/Rgsc278+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| increased hemoglobin concentration distribution width
|
J:133634
|
Rgsc279/Rgsc279+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
| decreased hemoglobin content
|
J:133634
|
Rgsc344/Rgsc344+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
| increased mean corpuscular hemoglobin
|
J:133634
|
Rgsc350/Rgsc350+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc375/Rgsc375+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc393/Rgsc393+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| increased hemoglobin concentration distribution width
|
J:133634
|
Rgsc411/Rgsc411+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc460/Rgsc460+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc461/Rgsc461+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc471/Rgsc471+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc485/Rgsc485+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc486/Rgsc486+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| increased hemoglobin concentration distribution width
|
J:133634
|
Rgsc530/Rgsc530+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc538/Rgsc538+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc546/Rgsc546+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular hemoglobin
|
J:133634
|
Rgsc548/Rgsc548+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc630/Rgsc630+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc649/Rgsc649+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
thrombocytopenia
|
J:133634
|
Rgsc669/Rgsc669+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
| increased mean corpuscular hemoglobin
|
J:133634
|
| increased mean corpuscular volume
|
J:133634
|
Rgsc710/Rgsc710+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
| increased mean corpuscular hemoglobin
|
J:133634
|
Rgsc719/Rgsc719+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
| increased hemoglobin concentration distribution width
|
J:133634
|
Rgsc747/Rgsc747+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
Rgsc758/Rgsc758+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc859/Rgsc859+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
anisocytosis
|
J:133634
|
| decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
| increased erythrocyte cell number
|
J:133634
|
| increased hemoglobin concentration distribution width
|
J:133634
|
Rgsc861/Rgsc861+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
Rgsc900/Rgsc900+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc919/Rgsc919+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
abnormal erythrocyte morphology
|
J:133634
|
| anisocytosis
|
J:133634
|
| decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
| increased erythrocyte cell number
|
J:133634
|
| increased hemoglobin concentration distribution width
|
J:133634
|
Rgsc930/Rgsc930+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
abnormal erythrocyte morphology
|
J:133634
|
| anisocytosis
|
J:133634
|
| decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc933/Rgsc933+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
Rgsc1088/Rgsc1088+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc1142/Rgsc1142+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased mean corpuscular hemoglobin
|
J:133634
|
| decreased mean corpuscular volume
|
J:133634
|
Rgsc1175/Rgsc1175+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased erythrocyte cell number
|
J:133634
|
| increased mean corpuscular hemoglobin
|
J:133634
|
Rgsc1177/Rgsc1177+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
decreased mean corpuscular volume
|
J:133634
|
Rgsc1471/Rgsc1471+
(involves: C3H * C57BL/6JJcl)
|
thrombocytopenia
|
J:133634
|
Rgsc1605/Rgsc1605+
(involves: C3H * C57BL/6JJcl)
|
decreased mean corpuscular volume
|
J:133634
|
| increased erythrocyte cell number
|
J:133634
|
Rgsc1686/Rgsc1686+
(involves: C3H * C57BL/6JJcl)
|
increased mean corpuscular hemoglobin
|
J:133634
|
Rgsc1700/Rgsc1700+
(involves: C3H * C57BL/6JJcl)
|
thrombocytopenia
|
J:133634
|
Rgsc1701/Rgsc1701+
(involves: C3H * C57BL/6JJcl)
|
thrombocytopenia
|
J:133634
|
Rgsc1716/Rgsc1716+
(involves: C3H * C57BL/6JJcl)
|
thrombocytosis
|
J:133634
|
Rhagem1(IMPC)Ccpcz/Rhagem1(IMPC)Ccpcz
(C57BL/6NCrl-Rhagem1(IMPC)Ccpcz/Ccpcz)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Rhbdf1/Hbatm1(RHBDF1/HBA)Ajhs/Rhbdf1/Hbatm1(RHBDF1/HBA)Ajhs
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
anisopoikilocytosis
|
J:117887
|
| decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
| microcytosis
|
J:117887
|
Rhbdf1/Hbatm1(RHBDF1/HBA)Ajhs/Rhbdf1+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
anisopoikilocytosis
|
J:117887
|
Rhbdf1/Hbatm1(RHBDF1/HBA)Ajhs/Hba+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
anisopoikilocytosis
|
J:117887
|
Rhbdf1/Hbatm1(RHBDF1/HBA)Ajhs/Rhbdf1/Hbatm1(RHBDF1/HBA)Ajhs
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
anisopoikilocytosis
|
J:117887
|
| decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
| microcytosis
|
J:117887
|
Rhbdf1/Hbatm1.1(RHBDF1/HBA)Ajhs/Rhbdf1/Hbatm1.1(RHBDF1/HBA)Ajhs
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
Rhbdf1/Hbatm1.1(RHBDF1/HBA)Ajhs/Rhbdf1/Hbatm1.1(RHBDF1/HBA)Ajhs
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
Rhbdf1/Hbatm2.1Ajhs/Hba+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
Rhbdf1/Hbatm2.1Ajhs/Rhbdf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
Rhbdf1/Hbatm2Ajhs/Hba+
(involves: 129P2/OlaHsd * C57BL/6)
|
anisopoikilocytosis
|
J:117887
|
| decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
| microcytosis
|
J:117887
|
Rhbdf1/Hbatm2Ajhs/Rhbdf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
anisopoikilocytosis
|
J:117887
|
| decreased hemoglobin content
|
J:117887
|
| decreased mean corpuscular hemoglobin
|
J:117887
|
| decreased mean corpuscular volume
|
J:117887
|
| microcytosis
|
J:117887
|
Rhbdf2em1(IMPC)Wtsi/Rhbdf2em1(IMPC)Wtsi
(C57BL/6N-Rhbdf2em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rhbdl2tm1b(KOMP)Wtsi/Rhbdl2tm1b(KOMP)Wtsi
(C57BL/6N-Rhbdl2tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Rhdtm1a(EUCOMM)Wtsi/Rhdtm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Rhdtm1a(EUCOMM)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:175295
|
| decreased mean corpuscular hemoglobin concentration
|
J:175295
|
| decreased mean corpuscular volume
|
J:175295
|
Rhoatm1Csab/Rhoatm1Csab
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
increased mean platelet volume
|
J:204459
|
| thrombocytopenia
|
J:204459
|
Rhobtb3tm1a(KOMP)Wtsi/Rhobtb3tm1a(KOMP)Wtsi
(B6JTyr;B6N-Rhobtb3tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular volume
|
J:175295
|
Rhoftm1.2Tac/Rhoftm1.2Tac
(involves: C57BL/6)
|
thrombocytopenia
|
J:195926
|
Rhohtm1Brak/Rhohtm1Brak
(involves: 129/Sv * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:143161
|
| decreased double-positive T cell number
|
J:143161
|
| increased double-negative T cell number
|
J:143161
|
Rhohtm1Brak/Rhohtm1Brak
Itgb2tm2Bay/Itgb2tm2Bay
(involves: 129/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:143161
|
| increased double-negative T cell number
|
J:143161
|
Rhohtm1Daw/Rhohtm1Daw
(involves: 129 * C57BL/6)
|
arrested T cell differentiation
|
J:113565
|
| decreased double-positive T cell number
|
J:113565
|
Rhoutm1a(KOMP)Wtsi/Rhoutm1a(KOMP)Wtsi
(C57BL/6N-Rhoutm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular volume
|
J:175295
|
Rhpn1tm1b(KOMP)Wtsi/Rhpn1tm1b(KOMP)Wtsi
(C57BL/6N-Rhpn1tm1b(KOMP)Wtsi/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Ric1tm1a(EUCOMM)Hmgu/Ric1tm1a(EUCOMM)Hmgu
(C57BL/6N-Ric1tm1a(EUCOMM)Hmgu/H)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hematocrit
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
| increased mean corpuscular volume
|
J:165965
|
Ric8btm1b(EUCOMM)Hmgu/Ric8b+
(C57BL/6N-Ric8btm1b(EUCOMM)Hmgu/Cnrm)
|
increased basophil cell number
|
J:211773
|
Rictortm1.1Klg/Rictortm1.1Klg
Tg(Mx1-cre)1Cgn/0
(B6.Cg-Rictortm1.1Klg Tg(Mx1-cre)1Cgn)
|
abnormal double-negative T cell morphology
|
J:189736
|
| decreased DN1 thymic pro-T cell number
|
J:189736
|
| decreased DN2 thymocyte number
|
J:189736
|
| decreased DN3 thymocyte number
|
J:189736
|
| decreased DN4 thymocyte number
|
J:189736
|
| decreased double-positive T cell number
|
J:189736
|
| increased double-negative T cell number
|
J:189736
|
Ridatm1a(KOMP)Wtsi/Ridatm1a(KOMP)Wtsi
(C57BL/6N-Ridatm1a(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:211773
|
Rif1Gt(XT0278)Wtsi/Rif1Gt(XT0278)Wtsi
(involves: 129P2/OlaHsd * CD-1 * MF1)
|
abnormal class switch recombination
|
J:195061
|
Rigitm1Zgwg/Rigitm1Zgwg
(involves: 129S1/Sv)
|
abnormal B cell differentiation
|
J:139016
|
| abnormal granulocyte morphology
|
J:139016
|
| extramedullary hematopoiesis
|
J:139016
|
| increased granulocyte number
|
J:139016
|
Rimklbtm1.1(KOMP)Vlcg/Rimklbtm1.1(KOMP)Vlcg
(C57BL/6N-Rimklbtm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rinlem1(IMPC)Mbp/Rinlem1(IMPC)Mbp
(C57BL/6NCrl-Rinlem1(IMPC)Mbp/Mmucd)
|
increased red blood cell distribution width
|
J:211773
|
Riok2tm1c(KOMP)Wtsi/Riok2+
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6N * C57BL/10 * CBA/Ca)
|
abnormal erythropoiesis
|
J:305794
|
| decreased erythrocyte cell number
|
J:305794
|
| decreased hematocrit
|
J:305794
|
| decreased hemoglobin content
|
J:305794
|
| decreased neutrophil cell number
|
J:305794
|
Riok2tm1c(KOMP)Wtsi/Riok2+
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6 * C57BL/6N)
|
decreased erythrocyte cell number
|
J:305794
|
| decreased hematocrit
|
J:305794
|
| decreased hemoglobin content
|
J:305794
|
Riok2tm1c(KOMP)Wtsi/Riok2+
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
decreased erythrocyte cell number
|
J:305794
|
| decreased hematocrit
|
J:305794
|
| decreased hemoglobin content
|
J:305794
|
Riox2tm1Mtsun/Riox2tm1Mtsun
(B6CrSlc.Cg-Riox2tm1Mtsun)
|
decreased eosinophil cell number
|
J:201871
|
| decreased neutrophil cell number
|
J:201871
|
Ripply3tm1a(EUCOMM)Wtsi/Ripply3tm1a(EUCOMM)Wtsi
(C57BL/6N-Ripply3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:165965
|
Rit1em1(IMPC)Mbp/Rit1em1(IMPC)Mbp
(C57BL/6N-Rit1em1(IMPC)Mbp/MbpMmucd)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Rlimem1(IMPC)Rbrc/Y
(C57BL/6NJcl-Rlimem1(IMPC)Rbrc/Rbrc)
|
abnormal mean corpuscular hemoglobin
|
J:211773
|
| abnormal mean corpuscular volume
|
J:211773
|
Rln3tm1(KOMP)Mbp/Rln3tm1(KOMP)Mbp
(C57BL/6N-Rln3tm1(KOMP)Mbp/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Rnaseh2aem1(IMPC)Tcp/Rnaseh2a+
(C57BL/6NCrl-Rnaseh2aem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytosis
|
J:211773
|
Rnf2tm1Mvi/Rnf2tm1Mvi
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/10 * CBA)
|
abnormal B cell differentiation
|
J:130397
|
| abnormal common myeloid progenitor cell morphology
|
J:130397
|
| decreased erythrocyte cell number
|
J:130397
|
| thrombocytosis
|
J:130397
|
Rnf8Gt(AS0574)Wtsi/Rnf8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
Rnf8Gt(AS0574)Wtsi/Rnf8Gt(AS0574)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased double-negative T cell number
|
J:161240
|
| decreased double-positive T cell number
|
J:161240
|
| decreased immature B cell number
|
J:161240
|
| decreased pro-B cell number
|
J:161240
|
Rnf8Gt(RRR260)Byg/Rnf8Gt(RRR260)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:161240
|
| decreased double-negative T cell number
|
J:161240
|
| decreased double-positive T cell number
|
J:161240
|
| decreased immature B cell number
|
J:161240
|
| decreased pro-B cell number
|
J:161240
|
Rnf10em1(IMPC)J/Rnf10em1(IMPC)J
(C57BL/6NJ-Rnf10em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/H)
|
decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Rbrc)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Rnf13tm1.1(KOMP)Vlcg/Rnf13tm1.1(KOMP)Vlcg
(C57BL/6N-Rnf13tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rnf19bem1(IMPC)Ccpcz/Rnf19b+
(C57BL/6N-Rnf19bem1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Rnf24em1(IMPC)J/Rnf24em1(IMPC)J
(C57BL/6NJ-Rnf24em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Rnf25tm1.1(KOMP)Vlcg/Rnf25tm1.1(KOMP)Vlcg
(C57BL/6N-Rnf25tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular volume
|
J:211773
|
Rnf43em1(IMPC)Tcp/Rnf43em1(IMPC)Tcp
(C57BL/6NCrl-Rnf43em1(IMPC)Tcp/Tcp)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Rnf43em2Mage/Rnf43em2Mage
(Not Specified)
|
hyperchromasia
|
J:285428
|
Rnf114em1(IMPC)Wtsi/Rnf114em1(IMPC)Wtsi
(C57BL/6N-Rnf114em1(IMPC)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Rnf123em1Nmea/Rnf123em1Nmea
(NC/Jic-Rnf123em1Nmea)
|
decreased mean corpuscular volume
|
J:327312
|
| increased mean corpuscular hemoglobin concentration
|
J:327312
|
Rnf123em2Nmea/Rnf123em2Nmea
(NC/Jic-Rnf123em2Nmea)
|
decreased mean corpuscular volume
|
J:327312
|
| increased mean corpuscular hemoglobin concentration
|
J:327312
|
Rnf168Gt(156B6)Cmhd/Rnf168Gt(156B6)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
| increased DN3 thymocyte number
|
J:198260
|
| increased double-negative T cell number
|
J:198260
|
Rnf168Gt(405F11)Cmhd/Rnf168Gt(405F11)Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:198260
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:198260
|
| increased DN3 thymocyte number
|
J:198260
|
| increased double-negative T cell number
|
J:198260
|
Rnf168tm2b(EUCOMM)Hmgu/Rnf168tm2b(EUCOMM)Hmgu
(C57BL/6N-Rnf168tm2b(EUCOMM)Hmgu/Ccpcz)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Rnf180em1(IMPC)J/Rnf180em1(IMPC)J
(C57BL/6NJ-Rnf180em1(IMPC)J/Mmjax)
|
increased mean corpuscular volume
|
J:211773
|
Rnf208em1(IMPC)Ccpcz/Rnf208em1(IMPC)Ccpcz
(C57BL/6N-Rnf208em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Rnf214em1(IMPC)J/Rnf214em1(IMPC)J
(C57BL/6NJ-Rnf214em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Rnh1tm1Rall/Rnh1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal erythropoiesis
|
J:261784
|
Rnh1tm1Rall/Rnh1tm1Rall
(involves: 129S/SvEv * C57BL/6)
|
abnormal embryonic erythropoiesis
|
J:261784
|
Rorctm1.1Zsun/Rorctm1.1Zsun
(B6(129S4)-Rorctm1.1Zsun)
|
abnormal T-helper 17 cell differentiation
|
J:248565
|
Rorctm1Amj/Rorctm1Amj
(either: (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * C57BL/6 * DBA/2))
|
decreased double-positive T cell number
|
J:64381
|
| increased double-negative T cell number
|
J:64381
|
Rorctm1Litt/Rorctm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:248565
|
| abnormal T cell differentiation
|
J:128344,
J:248565
|
| abnormal T-helper 17 cell differentiation
|
J:248565
|
| decreased double-positive T cell number
|
J:248565
|
Rorctm1Litt/Rorctm1Litt
Tcra-Jtm3.1Krg/Tcra-Jtm3.1Krg
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
Rorctm2Litt/Rorctm2Litt
(involves: 129P2/OlaHsd)
|
decreased double-negative T cell number
|
J:91566
|
| decreased double-positive T cell number
|
J:87395
|
Rpa1tm1b(KOMP)Wtsi/Rpa1+
(C57BL/6N-Rpa1tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Rpa1tm1Wed/Rpa1+
(involves: 129/Sv * C57BL/6J * SJL)
|
abnormal definitive hematopoiesis
|
J:99303
|
Rpl5Skax23-Jus/Rpl5+
(129S6.B6-Rpl5Skax23-Jus)
|
decreased hemoglobin content
|
J:330162
|
| thrombocytopenia
|
J:330162
|
Rpl22Gt(GST000137)Lex/Rpl22Gt(GST000137)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:123569
|
| arrested T cell differentiation
|
J:123569
|
| decreased double-negative T cell number
|
J:123569
|
Rpl27aSfa/Rpl27a+
(C57BL/6J-Rpl27aSfa)
|
decreased erythrocyte cell number
|
J:174216
|
| thrombocytopenia
|
J:174216
|
Rpl32tm1b(EUCOMM)Hmgu/Rpl32tm1b(EUCOMM)Hmgu
(C57BL/6N-Rpl32tm1b(EUCOMM)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Rpl38Ts/Rpl38+
(TSJ/Le)
|
abnormal embryonic erythropoiesis
|
J:6184
|
Rprd1btm1a(EUCOMM)Hmgu/Rprd1b+
(C57BL/6N-Rprd1btm1a(EUCOMM)Hmgu/H)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Rps7Mtu/Rps7+
(involves: BALB/cOlaHsd * C3H/HeH)
|
increased mean corpuscular volume
|
J:195156
|
Rps7Zma/Rps7+
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
abnormal erythropoiesis
|
J:195156
|
Rps9tm1.1Geno/Rps9tm1.1Geno
(involves: C57BL/6)
|
extramedullary hematopoiesis
|
J:329922
|
Rps12em1.1Nbakr/Rps12+
(involves: C57BL/6J * FVB/N)
|
abnormal erythropoiesis
|
J:338970
|
| decreased erythrocyte cell number
|
J:338970
|
| increased mean corpuscular volume
|
J:338970
|
Rps14tm1.1Ble/Rps14+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6NTac * CBA/J)
|
abnormal platelet shape
|
J:233322
|
| thrombocytosis
|
J:233322
|
Rps19Mhdadsk3/Rps19+
(C3HeB/FeJ-Rps19Mhdadsk3/Ieg)
|
decreased erythrocyte cell number
|
J:139244
|
Rps27lGt(IST11658B7)Tigm/Rps27lGt(IST11658B7)Tigm
(C57BL/6-Rps27lGt(IST11658B7)Tigm)
|
decreased common myeloid progenitor cell number
|
J:223276
|
Rpsatm1Ells/Rpsa+
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased mean corpuscular hemoglobin concentration
|
J:138267
|
Rr38tm1.2Aafo/Rr38tm1.2Aafo
(involves: 129S4/SvJaeSor * BALB/cJ * C57BL/6)
|
decreased double-positive T cell number
|
J:227747
|
| increased DN3 thymocyte number
|
J:227747
|
Rr94tm3.1Litt/Rr94+
Tg(Cd4-cre)1Cwi/0
Rr112tm4.1Litt/Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
Rr94tm3.1Litt/Rr94tm3.1Litt
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
Rr94tm3.2Litt/Rr94+
Rr112tm4.1Litt/Rr112+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * FVB/N)
|
abnormal T cell differentiation
|
J:158962
|
Rr94tm3.2Litt/Rr94tm3.2Litt
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal double-positive T cell morphology
|
J:158962
|
| abnormal T cell differentiation
|
J:158962
|
| decreased double-positive T cell number
|
J:158962
|
Rr96tm1.1Tich/Rr96+
Gt(ROSA)26Sortm1(cre/ERT2)Thl/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
Rr96tm1.1Tich/Rr96+
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sor+
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:191711
|
Rr96tm1.1Tich/Rr96tm1.1Tich
Gt(ROSA)26Sortm1(rtTA*M2)Jae/Gt(ROSA)26Sortm1(rtTA*M2)Jae
(involves: 129 * 129S4/SvJae * C57BL/6)
|
abnormal T cell differentiation
|
J:191711
|
Rr96tm1.1Tich/Rr96tm1.1Tich
Tg(ACTB-tTS)1Mllo/?
(involves: 129 * C57BL/6)
|
decreased double-positive T cell number
|
J:191711
|
Rr96tm1.1Yzo/Rr96tm1.1Yzo
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:130559
|
| increased double-positive T cell number
|
J:130559
|
Rr96tm1.1Yzo/Rr96tm1.1Yzo
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal T cell differentiation
|
J:130559
|
Rr96tm1Yzo/Rr96tm1Yzo
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:130559
|
| increased double-positive T cell number
|
J:130559
|
Rr96tm1Yzo/Rr96tm1Yzo
Tg(Cd8a-cre,-GFP)1Yzo/?
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:130559
|
Rr96tm2Litt/Rr96+
Zbtb7btm1Itan/Zbtb7btm1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:141142
|
Rr96tm2Litt/Rr96+
Zbtb7btm1Tani/Zbtb7btm1Tani
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
Rr96tm2Litt/Rr96tm2Litt
Tfap4tm1.1Litt/Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
Rr97tm3Welm/Rr97tm3Welm
(involves: 129 * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:126027
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:126027
|
| abnormal double-positive T cell morphology
|
J:126027
|
| abnormal T cell differentiation
|
J:126027
|
Rr100tm2.1Welm/Rr100+
(involves: 129P2/OlaHsd * AKR.1 * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
Rr100tm2.1Welm/Rr100tm2.1Welm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:113136
|
| decreased double-positive T cell number
|
J:113136
|
Rr100tm2.1Welm/Rr100tm2.1Welm
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:158947
|
| decreased double-positive T cell number
|
J:158947
|
Rr104tm1.2Mym/Rr104tm1.2Mym
(Not Specified)
|
abnormal erythropoiesis
|
J:175070
|
| decreased fetal derived definitive erythrocyte cell number
|
J:175070
|
| decreased hematocrit
|
J:175070
|
Rr104tm1.2Mym/Rr104tm1.2Mym
Tg(Epo*)458Mym/0
(involves: C57BL/6 * DBA/2)
|
decreased hematocrit
|
J:231255
|
Rr148tm1.1Fwa/Rr148tm1.1Fwa
(involves: 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
| arrested B cell differentiation
|
J:101400
|
| decreased immature B cell number
|
J:101400
|
Rr148tm1.1Fwa/Rr148tm1.1Fwa
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
Rr148tm1Anbo/Rr148tm1Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
| decreased immature B cell number
|
J:136307
|
Rr148tm1Fwa/Rr148tm1Fwa
(129S6/SvEvTac-Rr148tm1Fwa)
|
abnormal immature B cell morphology
|
J:101400
|
| arrested B cell differentiation
|
J:101400
|
Rr148tm1Fwa/Rr148tm1Fwa
Rag2tm1Fwa/Rag2tm1Fwa
(involves: 129S/SvEv * 129S6/SvEvTac)
|
abnormal B cell differentiation
|
J:101400
|
Rr148tm2Anbo/Rr148tm2Anbo
(involves: 129/Sv * C57BL/6 * FVB/N)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:136307
|
| decreased immature B cell number
|
J:136307
|
Rr158tm1(Igh)Xu/Rr158tm1(Igh)Xu
(Not Specified)
|
decreased immature B cell number
|
J:124407
|
Rr158tm1Cgn/Rr158tm1Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574,
J:64287
|
Rr158tm2Cgn/Rr158tm2Cgn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal B cell differentiation
|
J:12574
|
Rr159tm1.1Fwa/Rr159+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
Rr159tm1.1Fwa/Rr159tm1.1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
Rr159tm1Fwa/Rr159tm1Fwa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:113715
|
Rr160tm1Wtg/Rr160tm1Wtg
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal somatic hypermutation frequency
|
J:134885
|
| increased transitional stage B cell number
|
J:134885
|
Rr161tm2.2Wtg/Rr161tm2.2Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:167472
|
| abnormal immunoglobulin V(D)J recombination
|
J:167472
|
| decreased pro-B cell number
|
J:167472
|
Rr162tm3.1Wtg/Rr162tm3.1Wtg
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal immunoglobulin V(D)J recombination
|
J:172855
|
Rr166tm4.1Wtg/Rr166tm4.1Wtg
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal B cell differentiation
|
J:193015
|
| abnormal immunoglobulin light chain V-J recombination
|
J:193015
|
Rr169tm2Rao/Rr169+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
Rr169tm2Rao/Rr169tm2Rao
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal T-helper 1 cell differentiation
|
J:94039
|
Rr185tm3Cog/Rr185tm3Cog
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:71300
|
Rr249tm1.1Ebres/Rr249+
(involves: 129 * BALB/cJ * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:191756
|
Rr249tm1.1Ebres/Rr249tm1.1Ebres
(involves: 129 * BALB/cJ * C57BL/6)
|
decreased common myeloid progenitor cell number
|
J:191756
|
Rr250em1Ebres/Rr250em1Ebres
(C57BL/6N-Rr250em1Ebres)
|
decreased erythrocyte cell number
|
J:270526
|
| decreased hematocrit
|
J:270526
|
Rr253em1Kmm/Rr253em1Kmm
(C57BL/6-Rr253em1Kmm)
|
abnormal class switch recombination
|
J:316113
|
| increased neutrophil cell number
|
J:316113
|
Rr253em6Kmm/Rr253em6Kmm
(C57BL/6J-Rr253em6Kmm)
|
abnormal common myeloid progenitor cell morphology
|
J:334296
|
Rr308tm1.1Fwa/Rr308tm1.1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616,
J:82395
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
Rr308tm1Fwa/Rr308tm1Fwa
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:82616
|
| abnormal T cell receptor alpha chain V-J recombination
|
J:82616
|
Rr308tm2Fwa/Rr308tm2Fwa
(Not Specified)
|
abnormal T cell differentiation
|
J:82395
|
Rr320tm1Ley/Rr320tm1Ley
(involves: 129X1/SvJ * C57BL/6)
|
decreased hematocrit
|
J:33053
|
| decreased mean corpuscular hemoglobin concentration
|
J:33053
|
| decreased mean corpuscular volume
|
J:33053
|
Rr320tm2Mkg/Rr320+
(involves: 129S4/SvJaeSor)
|
anisopoikilocytosis
|
J:28981
|
Rr320tm2Mkg/Rr320tm2Mkg
(involves: 129S4/SvJaeSor)
|
abnormal erythropoiesis
|
J:28981
|
| anisopoikilocytosis
|
J:28981
|
Rr338em1Jeng/Rr338em1Jeng
(Not Specified)
|
abnormal T cell differentiation
|
J:232438
|
Rr348tm1.1Drhi/Rr348+
Rr349tm1.1Wgw/Rr349+
(Not Specified)
|
decreased mean corpuscular hemoglobin
|
J:259286
|
| decreased mean corpuscular volume
|
J:259286
|
Rr349tm1.1Wgw/Rr349+
(involves: 129P2/OlaHsd * CD-1)
|
decreased mean corpuscular hemoglobin
|
J:80121
|
| decreased mean corpuscular volume
|
J:80121
|
Rr349tm1.1Wgw/Rr349tm1.1Wgw
(involves: 129P2/OlaHsd * CD-1)
|
abnormal erythropoiesis
|
J:80121
|
| abnormal hemoglobin
|
J:80121
|
| decreased mean corpuscular hemoglobin
|
J:80121
|
| decreased mean corpuscular volume
|
J:80121
|
Rr349tm1Wgw/Rr349+
(involves: 129P2/OlaHsd)
|
abnormal hemoglobin
|
J:80121
|
| anisocytosis
|
J:80121
|
| decreased hemoglobin content
|
J:80121
|
| decreased mean corpuscular hemoglobin
|
J:80121
|
| decreased mean corpuscular volume
|
J:80121
|
| poikilocytosis
|
J:80121
|
Rr349tm1Wgw/Rr349tm1Wgw
(involves: 129P2/OlaHsd)
|
abnormal erythrocyte morphology
|
J:80121
|
| abnormal hemoglobin
|
J:80121
|
Rr364tm1.1Aak/Rr364tm1.1Aak
(129.129S2(Cg)-Rr364tm1.1Aak)
|
abnormal class switch recombination
|
J:242276
|
Rr394em1Bhao/Rr394em1Bhao
(Not Specified)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:333961
|
| increased DN3 thymocyte number
|
J:333961
|
Rr395em1Bhao/Rr395em1Bhao
(Not Specified)
|
decreased double-positive T cell number
|
J:333961
|
| increased DN4 thymocyte number
|
J:333961
|
Rr149356tm1.1Pf/Rr149356tm1.1Pf
(either: 129P2/OlaHsd-Rr149356tm1.1Pf or (involves: 129P2/OlaHsd * BALB/c))
|
abnormal T cell differentiation
|
J:34311
|
| arrested T cell differentiation
|
J:34311
|
| decreased double-positive T cell number
|
J:34311
|
| increased double-negative T cell number
|
J:34311
|
Rr149356tm1Abnd/Rr149356tm1Abnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:137580
|
| arrested T cell differentiation
|
J:137580
|
| decreased double-positive T cell number
|
J:137580
|
| increased double-negative T cell number
|
J:137580
|
Rr149356tm1Che/Rr149356tm1Che
(involves: 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246,
J:107306
|
| abnormal double-positive T cell morphology
|
J:106246,
J:107306
|
Rr149356tm1Che/Rr149356tm1Che
Tcrdtm1Mom/Tcrdtm1Mom
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
Rr149356tm1Che/Rr149356tm1Che
Trp53tm1Tyj/Trp53tm1Tyj
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106246
|
| abnormal double-positive T cell morphology
|
J:106246
|
Rr275254tm2.1Dhr/Rr275254tm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Rr275254tm2Dhr/Rr275254tm2Dhr
(involves: 129S4/SvJae)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Rr282726tm1Dhr/Rr282726tm1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Rr282729tm1.1Iku/Rr282729tm1.1Iku
(C57BL/6J-Rr316tm1.1Iku)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:288442
|
Rradtm1.1(KOMP)Vlcg/Rradtm1.1(KOMP)Vlcg
(C57BL/6N-Rradtm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Rragcem1Efe/Rragc+
(Not Specified)
|
abnormal class switch recombination
|
J:320567
|
Rrbp1em1(IMPC)J/Rrbp1em1(IMPC)J
(C57BL/6NJ-Rrbp1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Rreb1tm1b(EUCOMM)Wtsi/Rreb1+
(C57BL/6N-Rreb1tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Rrm2bGt(OST85254)Lex/Rrm2bGt(OST85254)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased hematocrit
|
J:186071
|
| decreased hemoglobin content
|
J:186071
|
| thrombocytosis
|
J:186071
|
Rsad2tm1Kchc/Rsad2tm1Kchc
(B6.129-Rsad2tm1Kchc)
|
abnormal T-helper 2 cell differentiation
|
J:148305
|
Rtbdntm1a(EUCOMM)Wtsi/Rtbdntm1a(EUCOMM)Wtsi
(C57BL/6N-Rtbdntm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytosis
|
J:211773
|
Rthyd1NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rthyd2B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rthyd3B10.Br/SgSnJ/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rthyd5NOD/MrkTac/?
(involves: B10.Br/SgSnJ * NOD-H2k)
|
abnormal T cell clonal deletion
|
J:94684
|
Rtn4em1(IMPC)Hmgu/Rtn4em1(IMPC)Hmgu
(C57BL/6NCrl-Rtn4em1(IMPC)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Rtn4rl2em1(IMPC)Mbp/Rtn4rl2em1(IMPC)Mbp
(C57BL/6NCrl-Rtn4rl2em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Rtraftm1b(EUCOMM)Hmgu/Rtraf+
(C57BL/6N-Rtraftm1b(EUCOMM)Hmgu/H)
|
increased eosinophil cell number
|
J:211773
|
Rubcnem1Dgre/Rubcnem1Dgre
(involves: C57BL/6 * C57BL/6N)
|
increased neutrophil cell number
|
J:235399
|
Runx1tm1(RUNX1)Gcg/Runx1tm1(RUNX1)Gcg
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal granulocyte differentiation
|
J:106800
|
| abnormal myelopoiesis
|
J:106801
|
| abnormal T cell differentiation
|
J:106800
|
| decreased double-positive T cell number
|
J:106800
|
Runx1tm1(RUNX1/EVI1)Kmit/Runx1+
(involves: C57BL/6 * CBA)
|
abnormal embryonic hematopoiesis
|
J:118892
|
| abnormal myelopoiesis
|
J:118892
|
| decreased erythrocyte cell number
|
J:118892
|
Runx1tm1.1(RUNX1*)Homy/Runx1tm1.1(RUNX1*)Homy
(B6.129P2-Runx1tm1.1(RUNX1*)Homy)
|
abnormal common myeloid progenitor cell morphology
|
J:164806
|
Runx1tm1.1Gss/Runx1tm1.1Gss
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:157660
|
Runx1tm1Dow/Runx1tm1Dow
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:31130
|
Runx1tm1Sata/Runx1tm1Sata
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:50937,
J:63424
|
| abnormal erythropoiesis
|
J:63424
|
Runx1tm1Soga/Runx1tm1.1Soga
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:88511
|
| abnormal common myeloid progenitor cell morphology
|
J:88511
|
| abnormal definitive hematopoiesis
|
J:88511
|
| abnormal T cell differentiation
|
J:88511
|
| thrombocytopenia
|
J:88511
|
Runx1tm1Soga/Runx1tm1Soga
Stag2tm1.1Soga/Y
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
increased mean corpuscular volume
|
J:289000
|
| increased red blood cell distribution width
|
J:289000
|
Runx1tm1Spe/Runx1+
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm1Spe/Runx1tm1Spe
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal erythropoiesis
|
J:35115
|
| impaired myelopoiesis
|
J:35115
|
| increased nucleated erythrocyte cell number
|
J:35115
|
Runx1tm1Spe/Runx1tm2Spe
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal embryonic hematopoiesis
|
J:56184
|
Runx1tm1Tani/Runx1tm1Tani
Tg(Cd4-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:125959
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125959
|
| abnormal double-positive T cell morphology
|
J:125959
|
Runx1tm1Tani/Runx1tm1Tani
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd)
|
arrested T cell differentiation
|
J:125959
|
| decreased double-positive T cell number
|
J:125959
|
| increased double-negative T cell number
|
J:125959
|
Runx1tm1Yg/Runx1tm1Yg
(either: (involves: 129/Sv * 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal definitive hematopoiesis
|
J:125830
|
| abnormal leukopoiesis
|
J:125830
|
| abnormal T cell differentiation
|
J:125830
|
| increased double-positive T cell number
|
J:125830
|
Runx1tm2.1Gss/Runx1tm2.1Gss
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:214025
|
| abnormal erythrocyte morphology
|
J:214025
|
| abnormal erythropoiesis
|
J:214025
|
| decreased hematocrit
|
J:214025
|
| decreased immature B cell number
|
J:214025
|
| decreased mean corpuscular volume
|
J:214025
|
| decreased pre-pro B cell number
|
J:214025
|
| increased erythrocyte cell number
|
J:214025
|
| increased granulocyte number
|
J:214025
|
| increased hemoglobin content
|
J:214025
|
| increased mean platelet volume
|
J:214025
|
| increased pro-B cell number
|
J:214025
|
| increased red blood cell distribution width
|
J:214025
|
| myeloid hyperplasia
|
J:214025
|
| thrombocytosis
|
J:214025
|
Runx1tm2Buch/Runx1tm2Buch
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:105709
|
| decreased double-positive T cell number
|
J:105709
|
| impaired myelopoiesis
|
J:105709
|
| increased mast cell number
|
J:105709
|
| increased neutrophil cell number
|
J:105709
|
| increased number of Howell-Jolly bodies
|
J:105709
|
| thrombocytopenia
|
J:105709
|
Runx1tm2Dow/Runx1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:79160
|
Runx1tm3Itan/Runx1tm3Itan
(involves: 129P2/OlaHsd * C57BL/6)
|
thrombocytopenia
|
J:160791
|
Runx1tm3Spe/Runx1tm3Spe
Spi1tm2.1Dgt/Spi1tm2.1Dgt
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
increased granulocyte number
|
J:131217
|
Runx1tm3Spe/Runx1tm3Spe
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
arrested T cell differentiation
|
J:131217
|
| decreased double-negative T cell number
|
J:131217
|
| increased double-negative T cell number
|
J:131217
|
| thrombocytopenia
|
J:131217
|
Runx1tm3Spe/Runx1tm3Spe
Tg(VAV1-cre)1Graf/0
(involves: 129S4/SvJae)
|
abnormal common myeloid progenitor cell morphology
|
J:145700
|
| abnormal platelet morphology
|
J:145700
|
| decreased double-positive T cell number
|
J:145700
|
| increased granulocyte number
|
J:145700
|
Runx1tm3Spe/Runx1tm3Spe
U2af1tm1.1Hev/U2af1+
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * 129S6/SvEvTac * BALB/c * C57BL/6 * CBA/J)
|
abnormal blood cell morphology
|
J:267082
|
| thrombocytopenia
|
J:267082
|
Runx1tm4Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm4Spe/Runx1tm4Spe
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
| thrombocytopenia
|
J:120100
|
Runx1tm5Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm5Spe/Runx1tm5Spe
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm6Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm6Spe/Runx1tm6Spe
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm7Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm7Spe/Runx1tm7Spe
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm8Spe/Runx1+
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx1tm8Spe/Runx1tm8Spe
(involves: 129/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:120100
|
Runx2tm1Kish/Runx2tm1Kish
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:53069
|
| extramedullary hematopoiesis
|
J:53069
|
| increased granulocyte number
|
J:53069
|
| increased nucleated erythrocyte cell number
|
J:53069
|
Runx2tm1Mjo/Runx2tm1Mjo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased nucleated erythrocyte cell number
|
J:40784
|
Runx3tm1Itan/Runx3tm1Itan
Tg(Cd4-cre)1Cwi/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:125953
|
Runx3tm1Litt/Runx3tm1Litt
(involves: 129P2/OlaHsd)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:141144
|
| abnormal double-positive T cell morphology
|
J:141144
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal dendritic cell differentiation
|
J:88424
|
Runx3tm2Yg/Runx3tm2Yg
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6 * ICR)
|
abnormal dendritic cell differentiation
|
J:109584
|
Rusc1em1(IMPC)J/Rusc1em1(IMPC)J
(C57BL/6NJ-Rusc1em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ruvbl1tm1.1Oxbk/Ruvbl1tm1.1Oxbk
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA/J * SJL)
|
abnormal definitive hematopoiesis
|
J:220926
|
Ruvbl2M1Btlr/Ruvbl2+
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
| decreased double-positive T cell number
|
J:185495
|
Rwdd1tm1b(KOMP)Wtsi/Rwdd1tm1b(KOMP)Wtsi
(C57BL/6N-Rwdd1tm1b(KOMP)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Rxfp2tm1b(EUCOMM)Wtsi/Rxfp2tm1b(EUCOMM)Wtsi
(C57BL/6N-Rxfp2tm1b(EUCOMM)Wtsi/Ieg)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Rxfp4tm1.1(KOMP)Vlcg/Rxfp4tm1.1(KOMP)Vlcg
(C57BL/6N-Rxfp4tm1.1(KOMP)Vlcg/J)
|
thrombocytopenia
|
J:211773
|
S1pr1tm1Rlp/S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
abnormal NK cell differentiation
|
J:154069
|
S1pr4tm1Lipp/S1pr4tm1Lipp
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal thrombopoiesis
|
J:179199
|
S1pr5tm1Jch/S1pr5tm1Jch
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal NK cell differentiation
|
J:154069
|
S100a9tm1Hogg/S100a9tm1Hogg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neutrophil morphology
|
J:82513
|
Sac3d1tm1Hnaka/Sac3d1+
(involves: 129P2/OlaHsd)
|
abnormal common myeloid progenitor cell morphology
|
J:144601
|
Sac3d1tm1Hnaka/Sac3d1tm1Hnaka
(involves: 129P2/OlaHsd)
|
abnormal common myeloid progenitor cell morphology
|
J:144601
|
Sacsem1(IMPC)Tcp/Sacs+
(C57BL/6NCrl-Sacsem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Sacsem1(IMPC)Tcp/Sacsem1(IMPC)Tcp
(C57BL/6NCrl-Sacsem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Safbtm1So/Safbtm1So
(involves: 129 * C57BL/6J)
|
abnormal erythropoiesis
|
J:97633
|
Samd1tm1Pfi/Samd1tm1Pfi
(involves: C57BL/6J * C57BL/6N)
|
decreased erythrocyte cell number
|
J:333561
|
Samd3tm1.1(HBEGF)Wfkr/Samd3+
(C57BL/6J-Samd3tm1.1(HBEGF)Wfkr)
|
abnormal NK cell differentiation
|
J:322359
|
Samd9ltm1Homy/Samd9l+
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:202604
|
| abnormal erythropoiesis
|
J:202604
|
| abnormal myelopoiesis
|
J:202604
|
| abnormal neutrophil morphology
|
J:202604
|
| anisopoikilocytosis
|
J:202604
|
| decreased neutrophil cell number
|
J:202604
|
| giant platelets
|
J:202604
|
| increased number of Howell-Jolly bodies
|
J:202604
|
| polychromatophilia
|
J:202604
|
Samd9ltm1Homy/Samd9ltm1Homy
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:202604
|
| abnormal erythropoiesis
|
J:202604
|
| abnormal myelopoiesis
|
J:202604
|
| abnormal neutrophil morphology
|
J:202604
|
| anisopoikilocytosis
|
J:202604
|
| decreased neutrophil cell number
|
J:202604
|
| giant platelets
|
J:202604
|
| increased number of Howell-Jolly bodies
|
J:202604
|
| polychromatophilia
|
J:202604
|
Sap30em1(IMPC)J/Sap30em1(IMPC)J
(C57BL/6NJ-Sap30em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Sar1btm1a(EUCOMM)Wtsi/Sar1b+
(C57BL/6N-Sar1btm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Sarnptm1b(EUCOMM)Hmgu/Sarnp+
(C57BL/6N-Sarnptm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Sart3tm1.1Hbro/Sart3+
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
abnormal common myeloid progenitor cell morphology
|
J:173259
|
| abnormal definitive hematopoiesis
|
J:173259
|
Sash3tm1Hlz/Sash3tm1Hlz
(B6.129P2-Sash3tm1Hlz)
|
abnormal CD4-positive T cell differentiation
|
J:102171
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:102171
|
| decreased double-positive T cell number
|
J:102171
|
Satb1tm1Kos/Satb1tm1Kos
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:61085
|
| arrested T cell differentiation
|
J:61085
|
Satb2em3(IMPC)Tcp/Satb2+
(C57BL/6NCrl-Satb2em3(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Saxo1tm1b(EUCOMM)Hmgu/Saxo1tm1b(EUCOMM)Hmgu
(C57BL/6N-Saxo1tm1b(EUCOMM)Hmgu/Ics)
|
increased eosinophil cell number
|
J:211773
|
Sbdstm1Dats/Sbdstm1Dats
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: C57BL/6 * CD-1)
|
abnormal neutrophil morphology
|
J:158901
|
Sbf1em1(IMPC)Mbp/Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Sbno1tm1b(EUCOMM)Hmgu/Sbno1+
(C57BL/6N-Sbno1tm1b(EUCOMM)Hmgu/H)
|
increased red blood cell distribution width
|
J:211773
|
Scand1em1(IMPC)H/Scand1em1(IMPC)H
(C57BL/6NTac-Scand1em1(IMPC)H/H)
|
decreased red blood cell distribution width
|
J:211773
|
Scarb1tm1Kri/Scarb1tm1Kri
(involves: 129S2/SvPas * C57BL/6)
|
abnormal erythrocyte morphology
|
J:75090
|
| macrocytosis
|
J:75090
|
| poikilocytosis
|
J:75090
|
Scarb2em2(IMPC)Tcp/Scarb2em2(IMPC)Tcp
(C57BL/6NCrl-Scarb2em2(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Scfd1em1(IMPC)Tcp/Scfd1+
(C57BL/6N-Scfd1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Scg5em1(IMPC)Mbp/Scg5em1(IMPC)Mbp
(C57BL/6NCrl-Scg5em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Scmh1tm1Yota/Scmh1tm1Yota
(involves: 129X1/SvJ * C57BL/6)
|
myeloid hyperplasia
|
J:194424
|
Scn2atm1Mml/Scn2atm1Mml
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal hemoglobin
|
J:76457
|
Scn4atm2b(KOMP)Wtsi/Scn4a+
(C57BL/6N-Scn4atm2b(KOMP)Wtsi/H)
|
decreased mean platelet volume
|
J:211773
|
Scpro1DBA/2/?
(involves: C57BL/6 * DBA/2)
|
abnormal definitive hematopoiesis
|
J:54115
|
Scpro2DBA/2/?
(involves: C57BL/6 * DBA/2)
|
abnormal definitive hematopoiesis
|
J:78926,
J:54115
|
Scpro4C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro5C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro5DBA/2J/Scpro5DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:97354
|
Scpro6C57BL/6J/Scpro6C57BL/6J
(D2.B6-Scpro6C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:118331
|
Scpro6DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro6DBA/2J/Scpro6DBA/2J
(B6.D2-Scpro6DBA/2J)
|
abnormal definitive hematopoiesis
|
J:118331
|
Scpro7DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro8DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro9DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro10DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Scpro11C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:98123
|
Sdc1em1(IMPC)H/Sdc1em1(IMPC)H
(C57BL/6NTac-Sdc1em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Sdc2tm1b(KOMP)Wtsi/Sdc2tm1b(KOMP)Wtsi
(C57BL/6N-Sdc2tm1b(KOMP)Wtsi/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
Sdc4tm2b(KOMP)Wtsi/Sdc4tm2b(KOMP)Wtsi
(C57BL/6N-Sdc4tm2b(KOMP)Wtsi/H)
|
decreased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
SdhbGt(AP0532)Wtsi/Sdhb+
SdhcGt(BA0521)Wtsi/Sdhc+
(B6;129P2-SdhcGt(BA0521)Wtsi SdhbGt(AP0532)Wtsi)
|
abnormal hemoglobin content
|
J:242046
|
SdhbGt(AP0532)Wtsi/Sdhb+
SdhcGt(BA0521)Wtsi/Sdhc+
Sdhdtm1Jlob/Sdhd+
(involves: 129P2/OlaHsd)
|
abnormal hemoglobin content
|
J:242046
|
Sdhbtm1b(EUCOMM)Hmgu/Sdhb+
(C57BL/6N-Sdhbtm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
Sec63tm1b(EUCOMM)Hmgu/Sec63+
(C57BL/6N-Sec63tm1b(EUCOMM)Hmgu/Bay)
|
increased neutrophil cell number
|
J:211773
|
Secisbp2lem1(IMPC)J/Secisbp2lem1(IMPC)J
(C57BL/6NJ-Secisbp2lem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Seletm1Alb/Seletm1Alb
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:112286
|
Seletm1Hyn/Seletm1Hyn
Selltm1Hyn/Selltm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased eosinophil cell number
|
J:57973
|
| increased neutrophil cell number
|
J:57973
|
Seletm1Hyn/Seletm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
abnormal common myeloid progenitor cell morphology
|
J:31626
|
| abnormal definitive hematopoiesis
|
J:31626
|
| abnormal erythropoiesis
|
J:31626
|
| abnormal granulocyte differentiation
|
J:31626
|
| abnormal myelopoiesis
|
J:31626
|
| extramedullary hematopoiesis
|
J:31626
|
| increased eosinophil cell number
|
J:31626
|
| increased neutrophil cell number
|
J:31626
|
Seletm1Hyn/Seletm1Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased eosinophil cell number
|
J:57973
|
| increased neutrophil cell number
|
J:57973
|
Seletm2Alb/Seletm2Alb
Selltm2Alb/Selltm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
extramedullary hematopoiesis
|
J:70682
|
| increased eosinophil cell number
|
J:70682
|
| increased neutrophil cell number
|
J:106550,
J:70682
|
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased neutrophil cell number
|
J:101979
|
Seletm2Alb/Seletm2Alb
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
extramedullary hematopoiesis
|
J:70682
|
| increased eosinophil cell number
|
J:70682
|
| increased neutrophil cell number
|
J:70682,
J:112286
|
Seletm2Hyn/Seletm2Hyn
(B6.129S2-Seletm2Hyn)
|
decreased mast cell number
|
J:121083
|
| increased mast cell number
|
J:121083
|
Selenbp1tm1b(KOMP)Wtsi/Selenbp1tm1b(KOMP)Wtsi
(C57BL/6N-Selenbp1tm1b(KOMP)Wtsi/Ucd)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Selenoktm1a(EUCOMM)Wtsi/Selenoktm1a(EUCOMM)Wtsi
(C57BL/6N-Selenoktm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean platelet volume
|
J:211773
|
Selltm1Alb/Selltm1Alb
(involves: 129S7/SvEvBrd * C57BL/6)
|
extramedullary hematopoiesis
|
J:70682
|
Selltm3Hyn/Selltm3Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased eosinophil cell number
|
J:57973
|
| increased neutrophil cell number
|
J:57973
|
Selltm4Hyn/Selltm4Hyn
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased eosinophil cell number
|
J:57973
|
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased neutrophil cell number
|
J:101979,
J:24239
|
Selptm1Bay/Selptm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:112286
|
Selptm1Bay/Selptm1Bay
(B6.129S7-Selptm1Bay)
|
decreased mast cell number
|
J:121083
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6J)
|
increased neutrophil cell number
|
J:77329
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas)
|
increased neutrophil cell number
|
J:29814
|
Selptm1Hyn/Selptm1Hyn
(involves: 129S2/SvPas * C57BL/6)
|
increased eosinophil cell number
|
J:57973
|
| increased neutrophil cell number
|
J:57973
|
Selplgtm1Fur/Selplgtm1Fur
(involves: 129/Sv * C57BL/6J * SJL)
|
increased eosinophil cell number
|
J:75412
|
| increased neutrophil cell number
|
J:75412
|
Selplgtm1Rpmc/Selplgtm1Rpmc
(involves: 129S1/Sv * C57BL/6J)
|
increased eosinophil cell number
|
J:75829
|
| increased neutrophil cell number
|
J:75829
|
Sema3eem1(IMPC)H/Sema3eem1(IMPC)H
(C57BL/6NTac-Sema3eem1(IMPC)H/H)
|
decreased mean corpuscular volume
|
J:211773
|
Sema4atm1Kik/Sema4atm1Kik
(either: B6.Cg-Sema4atm1Kik or C.Cg-Sema4atm1Kik)
|
abnormal T-helper 1 cell differentiation
|
J:97027
|
Senp1Gt(XG001)Byg/Senp1Gt(XG001)Byg
(involves: 129P2/OlaHsd)
|
abnormal erythropoiesis
|
J:141453
|
| decreased erythrocyte cell number
|
J:141453
|
Senp1tm1.1Wami/Senp1tm1.1Wami
(involves: 129 * C57BL/6)
|
abnormal erythropoiesis
|
J:163428
|
| abnormal granulocyte differentiation
|
J:163428
|
| abnormal hemoglobin content
|
J:163428
|
| abnormal monocyte differentiation
|
J:163428
|
Sepsecsem1(IMPC)Tcp/Sepsecs+
(C57BL/6N-Sepsecsem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Septin5tm1b(EUCOMM)Hmgu/Septin5+
(C57BL/6N-Septin5tm1b(EUCOMM)Hmgu/Rbrc)
|
thrombocytopenia
|
J:211773
|
Septin8tm1a(EUCOMM)Wtsi/Septin8tm1a(EUCOMM)Wtsi
(C57BL/6N-Septin8tm1a(EUCOMM)Wtsi/Ics)
|
decreased mean corpuscular volume
|
J:165965
|
Septin9tm2.1Emfu/Septin9tm2.1Emfu
Tg(Lck-cre)548Jxm/0
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:205027
|
| decreased DN4 thymocyte number
|
J:205027
|
| increased DN3 thymocyte number
|
J:205027
|
| increased double-negative T cell number
|
J:205027
|
Septin14em1(IMPC)Tcp/Septin14em1(IMPC)Tcp
(C57BL/6NCrl-Septin14em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Serpina5em1(IMPC)Mbp/Serpina5em1(IMPC)Mbp
(C57BL/6N-Serpina5em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Serpinb1atm1.1Cben/Serpinb1atm1.1Cben
(129S6/SvEvTac-Serpinb1atm1.1Cben)
|
decreased neutrophil cell number
|
J:125918
|
Serpinb2tm1Dgi/Serpinb2tm1Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
decreased neutrophil cell number
|
J:52283
|
| thrombocytopenia
|
J:52283
|
Serpinb2tm2Dgi/Serpinb2tm2Dgi
(involves: 129S2/SvPas * C57BL/6J * DBA/2J)
|
decreased neutrophil cell number
|
J:52283
|
| thrombocytopenia
|
J:52283
|
Serpine1tm1Mlg/Serpine1tm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
increased granulocyte number
|
J:133227
|
Serpinf1tm1e.1(KOMP)Wtsi/Serpinf1tm1e.1(KOMP)Wtsi
(C57BL/6N-Serpinf1tm1e.1(KOMP)Wtsi/Bay)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Serpini2pq/Serpini2pq
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:115744
|
| abnormal pro-B cell morphology
|
J:115744
|
| decreased immature B cell number
|
J:115744
|
| decreased pro-B cell number
|
J:115744
|
Sesn1tm1a(EUCOMM)Wtsi/Sesn1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal class switch recombination
|
J:240602
|
Sesn1tm1b(EUCOMM)Wtsi/Sesn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sesn1tm1b(EUCOMM)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Setd6tm1.1(KOMP)Mbp/Setd6tm1.1(KOMP)Mbp
(C57BL/6N-Setd6tm1.1(KOMP)Mbp/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Setdb2tm1a(KOMP)Wtsi/Setdb2tm1a(KOMP)Wtsi
(C57BL/6N-Setdb2tm1a(KOMP)Wtsi/Ieg)
|
thrombocytopenia
|
J:165965
|
Setdb2tm1Desr/Setdb2tm1Desr
(B6.Cg-Setdb2tm1Desr)
|
increased neutrophil cell number
|
J:222611
|
Setxtm1b(EUCOMM)Wtsi/Setxtm1b(EUCOMM)Wtsi
(C57BL/6N-Setxtm1b(EUCOMM)Wtsi/Ics)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Sf3b1tm1.1Mdf/Sf3b1+
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(Mx1-cre)1Cgn/?
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA/J)
|
abnormal erythropoiesis
|
J:234976
|
| abnormal myelopoiesis
|
J:234976
|
| increased granulocyte number
|
J:234976
|
| increased mean corpuscular volume
|
J:234976
|
| macrocytosis
|
J:234976
|
Sf3b1tm1.1Mdf/Sf3b1+
Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
abnormal erythropoiesis
|
J:234976
|
| abnormal myelopoiesis
|
J:234976
|
| decreased erythrocyte cell number
|
J:234976
|
| increased mean corpuscular volume
|
J:234976
|
| macrocytosis
|
J:234976
|
Sf3b1tm1Hko/Sf3b1+
(Not Specified)
|
decreased erythrocyte cell number
|
J:324276
|
| decreased hemoglobin content
|
J:324276
|
| extramedullary hematopoiesis
|
J:324276
|
| increased mean corpuscular volume
|
J:324276
|
| thrombocytosis
|
J:324276
|
Sfntm1Mak/Sfntm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:168328
|
Sfrp1tm1Bsk/Sfrp1tm1Bsk
(involves: 129S5/SvEvBrd * C57BL/6)
|
decreased neutrophil cell number
|
J:89547
|
Sftpdtm1Jhf/Sftpdtm1Jhf
(involves: 129P2/OlaHsd * Black Swiss)
|
increased neutrophil cell number
|
J:72681
|
Sfxn1tm1b(EUCOMM)Wtsi/Sfxn1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sfxn1tm1b(EUCOMM)Wtsi/J)
|
thrombocytosis
|
J:211773
|
Sgms1tm1a(EUCOMM)Wtsi/Sgms1tm1a(EUCOMM)Wtsi
(C57BL/6N-Sgms1tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Sgpl1Gt(OST58278)Lex/Sgpl1Gt(OST58278)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:145159
|
| abnormal lymphopoiesis
|
J:145159
|
| decreased double-positive T cell number
|
J:145159
|
| decreased neutrophil cell number
|
J:145159
|
| increased granulocyte number
|
J:145159
|
Sgpl1Gt(ROSA)78Sor/Sgpl1Gt(ROSA)78Sor
(involves: 129S4/SvJaeSor)
|
decreased erythrocyte cell number
|
J:117491
|
| decreased hematocrit
|
J:117491
|
| decreased hemoglobin content
|
J:117491
|
| polychromatophilia
|
J:117491
|
Sgshem3(IMPC)Tcp/Sgshem3(IMPC)Tcp
(C57BL/6NCrl-Sgshem3(IMPC)Tcp/Tcp)
|
thrombocytosis
|
J:211773
|
Sgsm1tm1b(EUCOMM)Wtsi/Sgsm1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sgsm1tm1b(EUCOMM)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Sgtatm1b(KOMP)Mbp/Sgtatm1b(KOMP)Mbp
(C57BL/6N-Sgtatm1b(KOMP)Mbp/J)
|
decreased hematocrit
|
J:211773
|
Sh2b2tm1Yeb/Sh2b2tm1Yeb
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:88527
|
Sh2b3tm1Paw/Sh2b3tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal granulocyte differentiation
|
J:77248
|
| abnormal monocyte differentiation
|
J:77248
|
| extramedullary hematopoiesis
|
J:77248
|
| thrombocytosis
|
J:77248
|
Sh2b3tm1Paw/Sh2b3tm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
extramedullary hematopoiesis
|
J:161643
|
| increased granulocyte number
|
J:161643
|
| increased neutrophil cell number
|
J:161643
|
| myeloid hyperplasia
|
J:161643
|
| thrombocytosis
|
J:161643
|
Sh2d1atm1Cpt/Sh2d1atm1Cpt
(B6.129S4-Sh2d1atm1Cpt)
|
decreased transitional stage B cell number
|
J:97690
|
Sh3bp2tm1Rtpl/Sh3bp2tm1Rtpl
(B6.129P2-Sh3bp2tm1Rtpl)
|
decreased pro-B cell number
|
J:121380
|
| decreased transitional stage B cell number
|
J:121380
|
Sh3kbp1tm1Kuro/Sh3kbp1tm1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6 * NZB)
|
decreased immature B cell number
|
J:176805
|
| decreased transitional stage T2 B cell number
|
J:176805
|
| decreased transitional stage T3 B cell number
|
J:176805
|
Sh3tc1tm1b(EUCOMM)Hmgu/Sh3tc1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sh3tc1tm1b(EUCOMM)Hmgu/Orl)
|
increased neutrophil cell number
|
J:211773
|
Shank2em2(IMPC)Rbrc/Shank2em2(IMPC)Rbrc
(C57BL/6NJcl-Shank2em2(IMPC)Rbrc/Rbrc)
|
abnormal neutrophil cell number
|
J:211773
|
| decreased erythrocyte cell number
|
J:211773
|
Sharpincpdm/Sharpincpdm
(C57BL/KaLawRij-Sharpincpdm)
|
cutaneous mastocytosis
|
J:31745,
J:14539
|
| extramedullary hematopoiesis
|
J:31745,
J:14539,
J:53575
|
| increased eosinophil cell number
|
J:31745,
J:14539
|
Shc1tm1Ravi/Shc1tm1Ravi
Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
| decreased double-positive T cell number
|
J:78180
|
Shisa6em1(IMPC)Tcp/Shisa6em1(IMPC)Tcp
(C57BL/6N-Shisa6em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Shld1em1(IMPC)Wtsi/Shld1em1(IMPC)Wtsi
(C57BL/6N-Shld1em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Shld1em1Nus/Shld1em1Nus
(involves: C57BL/6NCrl)
|
abnormal class switch recombination
|
J:307190
|
Shmt1tm1b(KOMP)Wtsi/Shmt1tm1b(KOMP)Wtsi
(C57BL/6N-Shmt1tm1b(KOMP)Wtsi/H)
|
increased mean platelet volume
|
J:211773
|
Shprhem1(IMPC)Tcp/Shprhem1(IMPC)Tcp
(C57BL/6NCrl-Shprhem1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Sidt2em1(IMPC)Wtsi/Sidt2em1(IMPC)Wtsi
(C57BL/6N-Sidt2em1(IMPC)Wtsi/Wtsi)
|
thrombocytosis
|
J:211773
|
Siglecftm1.2Avrk/Siglecftm1.2Avrk
(B6.129(FVB)-Siglecftm1.2Avrk)
|
abnormal eosinophil differentiation
|
J:204811
|
| increased eosinophil cell number
|
J:204811
|
Siglecgtm1Lnit/Siglecgtm1Lnit
(involves: BALB/c)
|
abnormal plasma cell differentiation
|
J:123353
|
Sik3tm1a(EUCOMM)Hmgu/Sik3tm1a(EUCOMM)Hmgu
(C57BL/6N-Sik3tm1a(EUCOMM)Hmgu/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased granulocyte number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Sim1Rgsc646/Sim1+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
increased glycosylated hemoglobin level
|
J:133634
|
Sin3btm1.2Rdp/Sin3btm1.2Rdp
(involves: 129 * C57BL/6 * FVB/N * SJL)
|
abnormal erythrocyte morphology
|
J:154855
|
| abnormal granulocyte differentiation
|
J:154855
|
| decreased erythrocyte cell number
|
J:154855
|
| decreased granulocyte number
|
J:154855
|
| decreased hemoglobin content
|
J:154855
|
| increased nucleated erythrocyte cell number
|
J:154855
|
| increased number of Howell-Jolly bodies
|
J:154855
|
Sipa1tm1Nm/Sipa1+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased erythrocyte cell number
|
J:97239
|
Sipa1tm1Nm/Sipa1tm1Nm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:97239
|
| extramedullary hematopoiesis
|
J:97239
|
| increased granulocyte number
|
J:97239
|
Sirpatm1Nog/Sirpatm1Nog
(involves: 129P2/OlaHsd * C57BL/6)
|
thrombocytopenia
|
J:79592
|
Sirt1tm1b(EUCOMM)Wtsi/Sirt1+
(C57BL/6N-Sirt1tm1b(EUCOMM)Wtsi/H)
|
increased basophil cell number
|
J:211773
|
Sirt6tm1a(EUCOMM)Wtsi/Sirt6+
(C57BL/6N-Sirt6tm1a(EUCOMM)Wtsi/H)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Sirt6tm1Fwa/Sirt6tm1Fwa
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:112817
|
| abnormal lymphopoiesis
|
J:112817
|
| decreased double-positive T cell number
|
J:112817
|
Sirt7tm1Evbo/Sirt7tm1Evbo
(involves: 129/Sv * C57BL/6)
|
increased granulocyte number
|
J:147652
|
Sit1tm1Lsmn/Sit1tm1Lsmn
(B6.Cg-Sit1tm1Lsmn)
|
abnormal T cell differentiation
|
J:100408
|
| abnormal T-helper 1 cell differentiation
|
J:100408
|
| increased double-positive T cell number
|
J:100408
|
Sit1tm1Lsmn/Sit1tm1Lsmn
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:100408
|
| abnormal T cell differentiation
|
J:100408
|
Sit1tm1Lsmn/Sit1tm1Lsmn
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:100408
|
| abnormal T cell selection
|
J:100408
|
Ska2tm1b(KOMP)Wtsi/Ska2+
(C57BL/6N-Ska2tm1b(KOMP)Wtsi/J)
|
thrombocytopenia
|
J:211773
|
Skic3em1(IMPC)Tcp/Skic3+
(C57BL/6NCrl-Skic3em1(IMPC)Tcp/Tcp)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Skida1tm1(KOMP)Wtsi/Skida1+
(C57BL/6N-Skida1tm1(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Skint1m1Tac/Skint1m1Tac
(FVB/NTac)
|
abnormal T cell differentiation
|
J:139711
|
Skp2tm1Kin/Skp2tm1Kin
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin V(D)J recombination
|
J:168974
|
Slatm1Weis/Slatm1Weis
(involves: 129 * C57BL/6)
|
abnormal double-positive T cell morphology
|
J:71804
|
Slatm1Weis/Slatm1Weis
Sla2tm1Amch/Sla2tm1Amch
(involves: 129)
|
abnormal dendritic cell differentiation
|
J:169170
|
Slatm1Weis/Slatm1Weis
Tg(DO11.10)10Dlo/0
(involves: 129 * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:71804
|
| abnormal T cell differentiation
|
J:71804
|
Slatm1Weis/Slatm1Weis
Zap70tm1Weis/Zap70tm1Weis
(involves: 129 * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:71804
|
Slbptm1.1(KOMP)Vlcg/Slbp+
(C57BL/6N-Slbptm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Slc1a4tm1e(KOMP)Wtsi/Slc1a4tm1e(KOMP)Wtsi
(C57BL/6N-Slc1a4tm1e(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Slc1a5tm1Tac/Slc1a5tm1Tac
(involves: 129S/SvEv * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:254980
|
| abnormal T-helper 2 cell differentiation
|
J:254980
|
| abnormal T-helper 17 cell differentiation
|
J:254980
|
Slc2a2tm1b(KOMP)Wtsi/Slc2a2+
(C57BL/6N-Slc2a2tm1b(KOMP)Wtsi/Rbrc)
|
increased glycosylated hemoglobin level
|
J:211773
|
Slc3a1tm1.1(KOMP)Vlcg/Slc3a1tm1.1(KOMP)Vlcg
(C57BL/6N-Slc3a1tm1.1(KOMP)Vlcg/Ucd)
|
decreased mean corpuscular volume
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Slc3a2tm1.1Yait/Slc3a2tm1.1Yait
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6NCrSlc)
|
abnormal macrophage differentiation
|
J:188365
|
Slc4a1l11Jus51/Slc4a1l11Jus51
(involves: C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:85113
|
| abnormal erythrocyte cell number
|
J:85113
|
| abnormal erythrocyte morphology
|
J:85113
|
| abnormal hemoglobin
|
J:85113
|
| decreased erythrocyte cell number
|
J:85113
|
| decreased hematocrit
|
J:85113
|
| decreased hemoglobin content
|
J:85113
|
| increased nucleated erythrocyte cell number
|
J:85113
|
Slc4a1tm1Ahc/Slc4a1tm1Ahc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:35637
|
| abnormal hemoglobin
|
J:35637
|
| abnormal mean corpuscular volume
|
J:35637
|
| decreased erythrocyte cell number
|
J:35637
|
| decreased hematocrit
|
J:35637
|
| decreased hemoglobin content
|
J:35637
|
| decreased mean corpuscular volume
|
J:35637
|
| microcytosis
|
J:35637
|
| spherocytosis
|
J:35637
|
Slc4a1tm1Dmb/Slc4a1tm1Dmb
(involves: 129S6/SvEvTac)
|
abnormal erythrocyte morphology
|
J:145243
|
| poikilocytosis
|
J:145243
|
| stomatocytosis
|
J:145243
|
Slc4a1tm1Llp/Slc4a1tm1Llp
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:35487
|
| abnormal erythrocyte morphology
|
J:35487
|
| abnormal mean corpuscular hemoglobin
|
J:35487
|
| decreased erythrocyte cell number
|
J:35487
|
| decreased hematocrit
|
J:35487,
J:148154
|
| decreased hemoglobin content
|
J:35487
|
| decreased mean corpuscular volume
|
J:35487
|
| hyperchromasia
|
J:35487
|
| increased nucleated erythrocyte cell number
|
J:35487
|
| microcytosis
|
J:35487
|
| poikilocytosis
|
J:35487
|
| polychromatophilia
|
J:35487
|
| spherocytosis
|
J:35487
|
Slc4a1tm1Llp/Slc4a1tm1Llp
(B6;129S4-Slc4a1tm1Llp/J)
|
decreased hematocrit
|
J:120610
|
| spherocytosis
|
J:120610
|
Slc4a1tm1Phsl/Slc4a1tm1Phsl
(involves: 129 * 129S6/SvEvTac * Black Swiss)
|
abnormal erythrocyte morphology
|
J:152245
|
| decreased hematocrit
|
J:152245
|
| decreased hemoglobin content
|
J:152245
|
| increased mean corpuscular volume
|
J:152245
|
| increased nucleated erythrocyte cell number
|
J:152245
|
| low mean erythrocyte cell number
|
J:152245
|
| thrombocytopenia
|
J:152245
|
Slc4a1wan/Slc4a1wan
(C3H/HeJ-Slc4a1wan/J)
|
decreased erythrocyte cell number
|
J:85321
|
| decreased hematocrit
|
J:85321
|
| decreased hemoglobin content
|
J:85321
|
| decreased mean corpuscular volume
|
J:85321
|
| spherocytosis
|
J:85321
|
Slc4a4tm1.1Slin/Slc4a4tm1.1Slin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased hemoglobin content
|
J:186877
|
Slc4a4tm1Ges/Slc4a4tm1Ges
(involves: 129S6/SvEvTac * Black Swiss)
|
decreased hematocrit
|
J:120867
|
| increased nucleated erythrocyte cell number
|
J:120867
|
Slc4a10tm1b(KOMP)Wtsi/Slc4a10tm1b(KOMP)Wtsi
(C57BL/6N-Slc4a10tm1b(KOMP)Wtsi/H)
|
increased hemoglobin content
|
J:211773
|
Slc6a2tm1b(EUCOMM)Hmgu/Slc6a2+
(C57BL/6N-Slc6a2tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
Slc6a5tm1.1(KOMP)Vlcg/Slc6a5+
(C57BL/6N-Slc6a5tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Slc6a6em1(IMPC)Mbp/Slc6a6em1(IMPC)Mbp
(C57BL/6N-Slc6a6em1(IMPC)Mbp/MbpMmucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Slc6a14tm1b(KOMP)Wtsi/Slc6a14tm1b(KOMP)Wtsi
(C57BL/6N-Slc6a14tm1b(KOMP)Wtsi/Tcp)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Slc7a1tm1Rbmn/Slc7a1tm1Rbmn
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: C57BL/6))
|
anisopoikilocytosis
|
J:39649
|
| decreased erythrocyte cell number
|
J:39649
|
| decreased hemoglobin content
|
J:39649
|
| decreased mean corpuscular hemoglobin
|
J:39649
|
| increased nucleated erythrocyte cell number
|
J:39649
|
Slc7a5em1(IMPC)H/Slc7a5+
(C57BL/6NTac-Slc7a5em1(IMPC)H/H)
|
increased basophil cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Slc7a7em1Lbu/Slc7a7em1Lbu
(involves: 129/SvEv * C57BL/6)
|
increased neutrophil cell number
|
J:293773
|
Slc7a11sut/Slc7a11sut
(C3H/HeSnJ-Slc7a11sut/J)
|
decreased platelet serotonin level
|
J:31616
|
Slc9a5em1(IMPC)J/Slc9a5em1(IMPC)J
(C57BL/6NJ-Slc9a5em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Slc11a1em1(IMPC)Mbp/Slc11a1em1(IMPC)Mbp
(C57BL/6N-Slc11a1em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Slc11a2mk/Slc11a2mk
(MK/ReJ)
|
anisocytosis
|
J:162917
|
| decreased cellular hemoglobin content
|
J:5167
|
| decreased hematocrit
|
J:5167
|
| decreased hemoglobin content
|
J:162917,
J:5167
|
| decreased mean corpuscular hemoglobin
|
J:5167
|
| high mean erythrocyte cell number
|
J:5167
|
| microcytosis
|
J:5167
|
Slc11a2mk/Slc11a2mk
(involves: C57BL/6J * DBA/2J * WB/Re)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Slc11a2mk/Slc11a2mk
(SEC.Cg-Slc11a2mk)
|
anisocytosis
|
J:162917
|
| decreased cellular hemoglobin content
|
J:5167
|
| decreased hematocrit
|
J:5167
|
| decreased hemoglobin content
|
J:162917,
J:5167
|
| decreased mean corpuscular hemoglobin
|
J:5167
|
| high mean erythrocyte cell number
|
J:5167
|
| microcytosis
|
J:5167
|
Slc11a2tm1Nca/Slc11a2tm1Nca
(129S6.129S4-Slc11a2tm1Nca)
|
abnormal erythrocyte morphology
|
J:98088
|
| anisocytosis
|
J:98088
|
| decreased erythrocyte cell number
|
J:98088
|
| decreased hematocrit
|
J:98088
|
| decreased hemoglobin content
|
J:98088
|
| decreased mean corpuscular hemoglobin concentration
|
J:98088
|
| decreased mean corpuscular volume
|
J:98088
|
| poikilocytosis
|
J:98088
|
Slc11a2tm2Nca/Slc11a2tm2Nca
Tg(Vil1-cre)20Syr/?
(involves: 129S6.129S4-Slc11a2tm2Nca * C57BL/6 * DBA/2)
|
abnormal erythrocyte morphology
|
J:98088
|
| extramedullary hematopoiesis
|
J:98088
|
Slc12a1tm1Tkh/Slc12a1tm1Tkh
(involves: 129S6/SvEvTac)
|
increased hematocrit
|
J:62224
|
Slc12a4Rbc10/Slc12a4+
(involves: BALB/c * C57BL/6J)
|
microcytosis
|
J:227339
|
Slc12a4Rbc10/Slc12a4Rbc10
(involves: BALB/c * C57BL/6J)
|
microcytosis
|
J:227339
|
Slc13a3tm1b(KOMP)Wtsi/Slc13a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc13a3tm1b(KOMP)Wtsi/Ucd)
|
increased neutrophil cell number
|
J:211773
|
Slc15a3tm1b(KOMP)Wtsi/Slc15a3tm1b(KOMP)Wtsi
(C57BL/6N-Slc15a3tm1b(KOMP)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Slc19a1tm1Gold/Slc19a1tm1Gold
(involves: 129/Sv * C57BL/6 * SJL)
|
abnormal erythropoiesis
|
J:68666
|
| abnormal lymphopoiesis
|
J:68666
|
Slc19a2tm1Ejn/Slc19a2tm1Ejn
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal erythropoiesis
|
J:101675
|
| decreased erythrocyte cell number
|
J:101675
|
| thrombocytosis
|
J:101675
|
Slc19a2tm1Gelb/Slc19a2tm1Gelb
(involves: 129X1/SvJ)
|
abnormal definitive hematopoiesis
|
J:79974
|
| abnormal erythropoiesis
|
J:79974
|
| abnormal myelopoiesis
|
J:79974
|
Slc20a1tm1.1Lbek/Slc20a1tm1.1Lbek
Tg(Mx1-cre)1Cgn/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * CBA)
|
abnormal definitive hematopoiesis
|
J:194198
|
| decreased erythrocyte cell number
|
J:194198
|
Slc20a1tm1.2Lbek/Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J)
|
abnormal erythropoiesis
|
J:157997
|
| decreased common myeloid progenitor cell number
|
J:157997
|
Slc20a1tm1Lbek/Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J)
|
increased nucleated erythrocyte cell number
|
J:157997
|
Slc20a1tm1Lbek/Slc20a1tm1.2Lbek
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal erythropoiesis
|
J:194198
|
Slc20a1tm1Lbek/Slc20a1tm1Lbek
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:194198
|
| abnormal erythrocyte morphology
|
J:157997
|
| abnormal erythropoiesis
|
J:194198
|
| decreased erythrocyte cell number
|
J:157997,
J:194198
|
| decreased hematocrit
|
J:157997
|
| decreased hemoglobin content
|
J:157997,
J:194198
|
| decreased mean corpuscular hemoglobin
|
J:157997
|
| echinocytosis
|
J:157997
|
| schistocytosis
|
J:157997
|
| spherocytosis
|
J:157997
|
Slc24a3em1(IMPC)Kmpc/Slc24a3em1(IMPC)Kmpc
(C57BL/6NTac-Slc24a3em1(IMPC)Kmpc/Kmpc)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Slc24a4tm1b(KOMP)Wtsi/Slc24a4+
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H)
|
decreased red blood cell distribution width
|
J:211773
|
Slc25a21tm1d(KOMP)Wtsi/Slc25a21tm1d(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Slc25a21tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Slc25a37tm1.1Kapl/Slc25a37tm1.2Kapl
Tg(Mx1-cre)1Cgn/?
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr * CBA)
|
abnormal definitive hematopoiesis
|
J:173284
|
| abnormal erythropoiesis
|
J:173284
|
| decreased erythrocyte cell number
|
J:173284
|
| decreased hematocrit
|
J:173284
|
| decreased hemoglobin content
|
J:173284
|
| decreased mean corpuscular volume
|
J:173284
|
Slc25a37tm1.2Kapl/Slc25a37tm1.2Kapl
(involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * C57BL/6NCr)
|
decreased cellular hemoglobin content
|
J:173284
|
Slc29a1tm2b(NCOM)Mfgc/Slc29a1tm2b(NCOM)Mfgc
(C57BL/6N-Slc29a1tm2b(NCOM)Mfgc/Tcp)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Slc29a3em1(IMPC)Wtsi/Slc29a3em1(IMPC)Wtsi
(C57BL/6N-Slc29a3em1(IMPC)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Slc29a3tm1Lex/Slc29a3tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
extramedullary hematopoiesis
|
J:179286
|
| myeloid hyperplasia
|
J:179286
|
Slc30a8tm1a(KOMP)Wtsi/Slc30a8tm1a(KOMP)Wtsi
(C57BL/6N-Slc30a8tm1a(KOMP)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neutrophil cell number
|
J:211266
|
Slc35c1tm1Cknr/Slc35c1tm1Cknr
(involves: 129/Sv * 129P2/OlaHsd * C57BL/6)
|
increased eosinophil cell number
|
J:121151
|
| increased neutrophil cell number
|
J:121151
|
Slc35d3IAP/Slc35d3IAP
(involves: C3H/HeSn * C3H/HeSnJ * C57BL/6J)
|
decreased platelet serotonin level
|
J:137593
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myelopoiesis
|
J:86005
|
| decreased neutrophil cell number
|
J:86005
|
Slc38a2tm1a(KOMP)Wtsi/Slc38a2+
(C57BL/6N-Slc38a2tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Slc38a10tm1a(EUCOMM)Wtsi/Slc38a10tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Slc38a10tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:175295
|
| decreased hemoglobin content
|
J:175295
|
Slc38a10tm2a(EUCOMM)Wtsi/Slc38a10tm2a(EUCOMM)Wtsi
(C57BL/6N-Slc38a10tm2a(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:165965
|
| decreased hemoglobin content
|
J:165965
|
| increased mean corpuscular hemoglobin concentration
|
J:165965
|
| thrombocytopenia
|
J:165965
|
Slc39a3tm1Gka/Slc39a3tm1Gka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-positive T cell number
|
J:99161
|
Slc40a1ffe/Slc40a1+
(either: (involves: 129X1/SvJ * C57BL/6J) or (involves: C3H/HeJ * C57BL/6J))
|
abnormal erythrocyte morphology
|
J:118592
|
| anisocytosis
|
J:118592
|
| decreased mean corpuscular hemoglobin
|
J:118592
|
| leptocytosis
|
J:118592
|
Slc40a1Pcm/Slc40a1+
(involves: 101/H * C3H/HeH)
|
polycythemia
|
J:30568
|
Slc40a1Pcm/Slc40a1+
(A.Cg-Slc40a1Pcm)
|
polycythemia
|
J:89185
|
Slc40a1tm1.1Mmfe/Slc40a1tm1.1Mmfe
(involves: 129P2/OlaHsd * C57BL/6)
|
increased erythrocyte cell number
|
J:215585
|
| increased hematocrit
|
J:215585
|
| increased hemoglobin content
|
J:215585
|
| increased mean corpuscular volume
|
J:215585
|
Slc40a1tm1Nca/Slc40a1+
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased hemoglobin content
|
J:129846
|
| decreased mean corpuscular volume
|
J:129846
|
Slc40a1tm2Nca/Slc40a1tm2Nca
Tg(Vil1-cre/ERT2)23Syr/0
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased hematocrit
|
J:129846
|
| decreased hemoglobin content
|
J:129846
|
Slc44a5tm1a(KOMP)Wtsi/Slc44a5tm1a(KOMP)Wtsi
(C57BL/6N-Slc44a5tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular volume
|
J:175295
|
Slc46a3tm1.1(KOMP)Vlcg/Slc46a3tm1.1(KOMP)Vlcg
(C57BL/6N-Slc46a3tm1.1(KOMP)Vlcg/J)
|
thrombocytosis
|
J:211773
|
Slc48a1em1Ih/Slc48a1em1Ih
(involves: 129 * C57BL/6J)
|
abnormal stress erythropoiesis
|
J:282829
|
| decreased hematocrit
|
J:282829
|
| extramedullary hematopoiesis
|
J:282829
|
Slc51bem1(IMPC)Mbp/Slc51bem1(IMPC)Mbp
(C57BL/6NCrl-Slc51bem1(IMPC)Mbp/Mmucd)
|
increased red blood cell distribution width
|
J:211773
|
Slco1b2em1(IMPC)Mbp/Slco1b2em1(IMPC)Mbp
(C57BL/6NCrl-Slco1b2em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Slfn1tm1.1(KOMP)Vlcg/Slfn1tm1.1(KOMP)Vlcg
(C57BL/6NCrl-Slfn1tm1.1(KOMP)Vlcg/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Slfn2m1Btlr/Slfn2m1Btlr
(C57BL/6J-Slfn2m1Btlr)
|
increased neutrophil cell number
|
J:158985
|
Slfn14em1(IMPC)Tcp/Slfn14em1(IMPC)Tcp
(C57BL/6NCrl-Slfn14em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Slfn14em1Nvm/Slfn14+
(C57BL/6J-Slfn14em1Nvm)
|
abnormal erythropoiesis
|
J:325381
|
| abnormal platelet morphology
|
J:325381
|
| decreased hemoglobin content
|
J:325381
|
| extramedullary hematopoiesis
|
J:325381
|
| increased erythrocyte cell number
|
J:325381
|
| increased mean platelet volume
|
J:325381
|
| microcytosis
|
J:325381
|
Slx4tm1a(EUCOMM)Wtsi/Slx4tm1a(EUCOMM)Wtsi
(C57BL/6N-Slx4tm1a(EUCOMM)Wtsi)
|
abnormal lymphopoiesis
|
J:168567
|
| decreased common myeloid progenitor cell number
|
J:168567
|
| increased erythrocyte cell number
|
J:168567
|
| thrombocytopenia
|
J:168567
|
Slx4tm1a(EUCOMM)Wtsi/Slx4tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Slx4tm1a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:165965
|
Smad2tm1Cxd/Smad2+
Smad3tm1Cxd/Smad3+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
increased erythrocyte cell number
|
J:70388
|
Smad3tm1Cxd/Smad3tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
extramedullary hematopoiesis
|
J:53510
|
| increased neutrophil cell number
|
J:53510
|
Smad3tm1Cxd/Smad3tm1Cxd
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:136955
|
Smad4tm2.1Cxd/Smad4tm2.1Cxd
Kdrtm1(cre)Sato/Kdr+
(involves: 129S1/Sv * 129S6/SvEvTac)
|
abnormal embryonic hematopoiesis
|
J:112269
|
Smad5tm1.1Huy/Smad5tm1.1Huy
(involves: 129P2/OlaHsd)
|
abnormal definitive hematopoiesis
|
J:86157
|
Smad5tm1Cxd/Smad5tm1Cxd
(either: (involves: 129S6/SvEvTac * C57BL/6) or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal embryonic hematopoiesis
|
J:53289
|
Smad7tm1.1Ink/Smad7tm1.1Ink
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
Smad7tm1Rheu/Smad7tm1Rheu
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal class switch recombination
|
J:120714
|
Smap1tm1.1Sata/Smap1tm1.1Sata
(B6.Cg-Smap1tm1.1Sata)
|
abnormal erythrocyte morphology
|
J:196385
|
| abnormal myelopoiesis
|
J:196385
|
| abnormal neutrophil morphology
|
J:196385
|
| abnormal platelet morphology
|
J:196385
|
| decreased hematocrit
|
J:196385
|
| decreased hemoglobin content
|
J:196385
|
| increased erythrocyte cell number
|
J:196385
|
| increased mean corpuscular volume
|
J:196385
|
| increased neutrophil cell number
|
J:196385
|
| increased number of Howell-Jolly bodies
|
J:196385
|
| polychromatophilia
|
J:196385
|
| thrombocytopenia
|
J:196385
|
Smarca4enu1/Smarca4tm1Mag
(involves: 129S/Sv * C57BL/10 * CBA/Cbi)
|
abnormal erythrocyte morphology
|
J:103896
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Lck-cre)1Cwi/0
(Not Specified)
|
decreased double-negative T cell number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1.2Pcn
Tg(Lck-cre)1Cwi/0
Tg(LCKprBCL2L1)12Sjk/0
(Not Specified)
|
decreased double-positive T cell number
|
J:144072
|
| increased double-negative T cell number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1Mag
Tg(Lck-cre)1Cwi/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:85191
|
| arrested T cell differentiation
|
J:85191
|
| decreased double-negative T cell number
|
J:85191
|
| decreased double-positive T cell number
|
J:85191
|
Smarca4tm1.2Pcn/Smarca4tm1Mag
Tg(Lck-cre)1Cwi/?
Tg(LCKprBCL2)36Sjk/?
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
arrested T cell differentiation
|
J:85191
|
Smarca4tm1.2Pcn/Smarca4tm1Tich
Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased double-negative T cell number
|
J:144072
|
Smarca4tm1.2Pcn/Smarca4tm1Tich
Tg(Lck-cre)1Cwi/0
Tg(LCKprBCL2L1)12Sjk/0
(involves: 129)
|
decreased double-positive T cell number
|
J:144072
|
| increased double-negative T cell number
|
J:144072
|
Smarca4tm1Tich/Smarca4+
Tg(Lck-cre)1Cwi/0
(involves: 129)
|
decreased double-negative T cell number
|
J:144072
|
| decreased double-positive T cell number
|
J:144072
|
Smarcal1tm1a(EUCOMM)Wtsi/Smarcal1tm1a(EUCOMM)Wtsi
(C57BL/6N-Smarcal1tm1a(EUCOMM)Wtsi/Wtsi)
|
increased hemoglobin content
|
J:175295
|
| increased mean corpuscular hemoglobin
|
J:175295
|
Smarcb1tm1Sho/Smarcb1tm3Sho
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6 * CBA)
|
increased eosinophil cell number
|
J:80224
|
Smarcc1tm2.1Rhs/Smarcc1tm2.1Rhs
Tg(Mx1-cre)1Cgn/0
(involves: BALB/c * C57BL/6 * CBA)
|
abnormal immature B cell morphology
|
J:184060
|
| abnormal immunoglobulin heavy chain V(D)J recombination
|
J:184060
|
| abnormal pro-B cell morphology
|
J:184060
|
| arrested B cell differentiation
|
J:184060
|
| decreased early pro-B cell number
|
J:184060
|
| decreased late pro-B cell number
|
J:184060
|
| decreased pro-B cell number
|
J:184060
|
Smarcc2em1(IMPC)J/Smarcc2+
(C57BL/6NJ-Smarcc2em1(IMPC)J/Mmjax)
|
increased mean corpuscular volume
|
J:211773
|
Smarcd2tm1.1(KOMP)Vlcg/Smarcd2+
(C57BL/6N-Smarcd2tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Smarce1em1(IMPC)J/Smarce1+
(C57BL/6NJ-Smarce1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Smc3tm1a(EUCOMM)Wtsi/Smc3+
(B6Dnk;B6Brd;B6N-Tyrc-Brd Smc3tm1a(EUCOMM)Wtsi/WtsiH)
|
decreased mean corpuscular hemoglobin
|
J:175295
|
Smc5tm1b(KOMP)Wtsi/Smc5+
(C57BL/6N-Smc5tm1b(KOMP)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Smc6tm1.1Arln/Smc6tm1.1Arln
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
macrocytosis
|
J:220422
|
| thrombocytosis
|
J:220422
|
Smg6em1(IMPC)Mbp/Smg6+
(C57BL/6NCrl-Smg6em1(IMPC)Mbp/Mmucd)
|
decreased hematocrit
|
J:211773
|
Smg9em1(IMPC)J/Smg9+
(C57BL/6NJ-Smg9em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Smim3tm1Anjm/Smim3+
Cd74tm1Anjm/Cd74+
Lmo2tm2(cre)Thr/Lmo2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood cell morphology
|
J:155870
|
| abnormal common myeloid progenitor cell morphology
|
J:155870
|
| abnormal erythropoiesis
|
J:155870
|
| abnormal mast cell morphology
|
J:155870
|
| decreased erythrocyte cell number
|
J:155870
|
| decreased granulocyte number
|
J:155870
|
| decreased hemoglobin content
|
J:155870
|
| increased mean corpuscular volume
|
J:155870
|
| increased red blood cell distribution width
|
J:155870
|
| macrocytosis
|
J:155870
|
| thrombocytopenia
|
J:155870
|
Smim3tm1Anjm/Smim3+
Cd74tm1Anjm/Cd74+
Lmo2tm2(cre)Thr/Lmo2+
Trp53tm1Brd/Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6)
|
decreased erythrocyte cell number
|
J:155870
|
| increased mean corpuscular volume
|
J:155870
|
| thrombocytopenia
|
J:155870
|
Smoc1tm1b(EUCOMM)Wtsi/Smoc1+
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
decreased erythrocyte cell number
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Smoc1tm1b(EUCOMM)Wtsi/Smoc1tm1b(EUCOMM)Wtsi
(C57BL/6N-Smoc1tm1b(EUCOMM)Wtsi/H)
|
increased neutrophil cell number
|
J:211773
|
Smpdl3btm1a(EUCOMM)Wtsi/Smpdl3btm1a(EUCOMM)Wtsi
(C57BL/6-Smpdl3btm1a(EUCOMM)Wtsi)
|
increased neutrophil cell number
|
J:224870
|
Snai2tm2Grid/Snai2tm2Grid
(involves: 129S1/Sv)
|
abnormal T cell differentiation
|
J:78323
|
| decreased hematocrit
|
J:78323
|
| decreased hemoglobin content
|
J:78323
|
| increased mean corpuscular volume
|
J:78323
|
| thrombocytopenia
|
J:78323
|
Snai2tm2Grid/Snai2tm2Grid
Snai3tm1.2Jhws/Snai3+
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
increased neutrophil cell number
|
J:204710
|
Snai2tm2Grid/Snai2tm2Grid
Snai3tm1.2Jhws/Snai3tm1.2Jhws
(involves: 129/Sv * 129S1/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:204710
|
| increased neutrophil cell number
|
J:204710
|
Sncaem1(IMPC)H/Sncaem1(IMPC)H
(C57BL/6NTac-Sncaem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Snd1em1(IMPC)Tcp/Snd1+
(C57BL/6NCrl-Snd1em1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Snrnp40em1Btlr/Snrnp40swp
(C57BL/6J-Snrnp40em1Btlr/Snrnp40swp)
|
decreased DN1 thymic pro-T cell number
|
J:282417
|
| decreased DN4 thymocyte number
|
J:282417
|
| decreased erythrocyte cell number
|
J:282417
|
| decreased hematocrit
|
J:282417
|
| decreased hemoglobin content
|
J:282417
|
| increased red blood cell distribution width
|
J:282417
|
| thrombocytosis
|
J:282417
|
Snx5tm1a(KOMP)Wtsi/Snx5tm1a(KOMP)Wtsi
(B6JTyr;B6N-Snx5tm1a(KOMP)Wtsi/Wtsi)
|
increased hematocrit
|
J:175295
|
Snx8tm2a(EUCOMM)Hmgu/Snx8tm2a(EUCOMM)Hmgu
(C57BL/6N-Snx8tm2a(EUCOMM)Hmgu/Wtsi)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Snx13tm1b(EUCOMM)Hmgu/Snx13+
(C57BL/6N-Snx13tm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Snx14em1(IMPC)H/Snx14+
(C57BL/6NTac-Snx14em1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
Snx27tm1b(KOMP)Wtsi/Snx27+
(C57BL/6N-Snx27tm1b(KOMP)Wtsi/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Socs1tm1Ayos/Socs1tm1Ayos
Tg(Lck-cre)1Jtak/0
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
Socs1tm1Jni/Socs1tm1Jni
(Not Specified)
|
abnormal T cell differentiation
|
J:57475
|
Socs1tm1Wehi/Socs1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
decreased eosinophil cell number
|
J:51281
|
| decreased hematocrit
|
J:51281
|
| thrombocytopenia
|
J:51281
|
Socs1tm1Wehi/Socs1tm3Wehi
Tg(Lck-cre)I57Jxm/0
(involves: 129P2/OlaHsd * C57BL/6 * ICR)
|
abnormal T cell differentiation
|
J:83009
|
Socs1tm2Wehi/Socs1tm2Wehi
(C57BL/6-Socs1tm2Wehi)
|
extramedullary hematopoiesis
|
J:72528
|
Socs3tm1Jni/Socs3tm1Jni
(involves: 129P2/OlaHsd)
|
abnormal embryonic erythropoiesis
|
J:57476
|
| increased erythrocyte cell number
|
J:57476
|
| increased nucleated erythrocyte cell number
|
J:57476
|
Socs3tm1Robb/Socs3tm1Robb
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:145513
|
Socs3tm1Wsa/Socs3tm2Wsa
Tg(Vav1-cre)1Awr/0
(involves: C57BL/6)
|
abnormal definitive hematopoiesis
|
J:89785
|
| abnormal erythropoiesis
|
J:89785
|
| abnormal granulocyte differentiation
|
J:89785
|
| abnormal myelopoiesis
|
J:89785
|
| extramedullary hematopoiesis
|
J:89785
|
| increased neutrophil cell number
|
J:89785
|
Sod1tm1Cep/Sod1tm1Cep
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased common myeloid progenitor cell number
|
J:71134
|
| decreased erythrocyte cell number
|
J:71134
|
| decreased hemoglobin content
|
J:71134
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * CD-1)
|
decreased hematocrit
|
J:29899
|
Sod2tm1Leb/Sod2tm1Leb
(B6.129S7-Sod2tm1Leb/J)
|
impaired myelopoiesis
|
J:36148
|
Sonem1(IMPC)Wtsi/Sonem1(IMPC)Wtsi
(C57BL/6N-Sonem1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Sos1tm1.1Les/Sos1tm1.1Les
Tg(Lck-cre)1Cwi/0
(involves: 129 * C57BL/6)
|
decreased DN4 thymocyte number
|
J:174536
|
| decreased double-negative T cell number
|
J:174536
|
| decreased double-positive T cell number
|
J:174536
|
Sos1tm1.2Rak/Sos1+
(involves: 129S/Sv * C57BL/6 * FVB/N * SJL)
|
abnormal common myeloid progenitor cell morphology
|
J:171873
|
| abnormal erythropoiesis
|
J:171873
|
| extramedullary hematopoiesis
|
J:171873
|
| increased neutrophil cell number
|
J:171873
|
Sox4tm1Cle/Sox4tm1Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
| decreased pro-B cell number
|
J:32741
|
Sox4tm2Cle/Sox4tm2Cle
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:32741
|
| decreased pro-B cell number
|
J:32741
|
Sox13tm1a(EUCOMM)Wtsi/Sox13tm1a(EUCOMM)Wtsi
(C57BL/6N-Sox13tm1a(EUCOMM)Wtsi/Ics)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
| increased mean corpuscular volume
|
J:165965
|
Sox17tm1Sjm/Sox17tm1Sjm
(BKa.129-Sox17tm1Sjm)
|
abnormal embryonic hematopoiesis
|
J:123050
|
Sox17tm1Sjm/Sox17tm2Sjm
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C3H * C57BL/6 * C57BL/Ka * CBA)
|
thrombocytopenia
|
J:123050
|
Sox17tm1Sjm/Sox17tm2Sjm
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6 * C57BL/Ka)
|
abnormal embryonic hematopoiesis
|
J:123050
|
Sox18tm1.1(KOMP)Vlcg/Sox18tm1.1(KOMP)Vlcg
(C57BL/6N-Sox18tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Sox21em1(IMPC)Mbp/Sox21em1(IMPC)Mbp
(C57BL/6NCrl-Sox21em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Sp1tm1Phi/Sp1+
Sp3tm1Sus/Sp3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal erythropoiesis
|
J:123073
|
Sp3tm1Sus/Sp3tm1Sus
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:84837
|
| abnormal erythropoiesis
|
J:84837
|
Sp5tm1b(KOMP)Wtsi/Sp5tm1b(KOMP)Wtsi
(C57BL/6N-Sp5tm1b(KOMP)Wtsi/J)
|
decreased hematocrit
|
J:211773
|
Sparctm1a(EUCOMM)Wtsi/Sparctm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Sparctm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin concentration
|
J:175295
|
Spata2tm1.1(KOMP)Vlcg/Spata2tm1.1(KOMP)Vlcg
(C57BL/6N-Spata2tm1.1(KOMP)Vlcg/Ucd)
|
increased eosinophil cell number
|
J:211773
|
Spata24tm1b(EUCOMM)Wtsi/Spata24tm1b(EUCOMM)Wtsi
(C57BL/6N-Spata24tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased neutrophil cell number
|
J:211773
|
Spegtm1b(KOMP)Wtsi/Speg+
(C57BL/6N-Spegtm1b(KOMP)Wtsi/Nju)
|
increased basophil cell number
|
J:211773
|
Spentm1Hon/Spentm1Hon
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal B cell differentiation
|
J:82332
|
Sphk1tm1.1Cgh/Sphk1tm2Cgh
Sphk2tm1.1Cgh/Sphk2tm1.1Cgh
Tg(Mx1-cre)1Cgn/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal NK cell differentiation
|
J:154069
|
| abnormal T cell differentiation
|
J:120783
|
Spi1tm1.1Dgt/Spi1tm1.1Dgt
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal definitive hematopoiesis
|
J:90331
|
| abnormal erythrocyte cell number
|
J:90331
|
Spi1tm1.1Nutt/Spi1tm1.1Nutt
(involves: C57BL/6 * BALB/cJ)
|
absent common myeloid progenitor cells
|
J:98188
|
Spi1tm1.1Rpd/Spi1tm1.1Rpd
(involves: 129/Sv * Black Swiss * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:138501
|
Spi1tm1.2Nutt/Spi1tm1.2Nutt
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal granulocyte differentiation
|
J:98188
|
| absent common myeloid progenitor cells
|
J:98188
|
| absent erythrocytes
|
J:98188
|
| extramedullary hematopoiesis
|
J:98188
|
| increased granulocyte number
|
J:98188
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:106040
|
| arrested B cell differentiation
|
J:106040
|
| decreased granulocyte number
|
J:106040
|
| decreased pro-B cell number
|
J:106040
|
Spi1tm1.3Dgt/Spi1tm1.3Dgt
(involves: 129 * BALB/c * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:90331
|
| increased neutrophil cell number
|
J:90331
|
Spi1tm1.3Nutt/Spi1tm1.3Nutt
(C57BL/6-Sfpi1tm1.3Nutt)
|
absent common myeloid progenitor cells
|
J:98188
|
Spi1tm1Kast/Spi1+
(B6.129S2-Spi1tm1Kast)
|
abnormal erythropoiesis
|
J:90543
|
Spi1tm1Kast/Spi1tm1Kast
(B6.129S2-Spi1tm1Kast)
|
abnormal erythropoiesis
|
J:90543
|
| abnormal fetal derived definitive erythrocyte cell number
|
J:90543
|
| failure of myelopoiesis
|
J:90543
|
Spi1tm1Ram/Spi1tm1Ram
(involves: 129S2/SvPas * C57BL/6)
|
abnormal macrophage differentiation
|
J:36473
|
| abnormal neutrophil differentiation
|
J:36473
|
| abnormal T cell differentiation
|
J:36473
|
| decreased double-positive T cell number
|
J:36473
|
| decreased neutrophil cell number
|
J:36473
|
Spi1tm1Rpd/Spi1tm1Rpd
(involves: 129/Sv * C57BL/6 * Black Swiss)
|
abnormal common myeloid progenitor cell morphology
|
J:123079
|
| abnormal myelopoiesis
|
J:123079
|
| arrested B cell differentiation
|
J:123079
|
| impaired myelopoiesis
|
J:123079
|
Spi1tm1Rpd/Spi1tm1Rpd
(involves: 129)
|
abnormal common myeloid progenitor cell morphology
|
J:138501
|
Spi1tm1Sing/Spi1+
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S/SvEv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:88257
|
| abnormal immature B cell morphology
|
J:88257
|
Spi1tm1Sing/Spi1tm1Sing
(involves: 129S/SvEv)
|
abnormal B cell differentiation
|
J:20348
|
| abnormal common myeloid progenitor cell morphology
|
J:138501
|
| abnormal erythropoiesis
|
J:20348
|
| abnormal granulocyte morphology
|
J:20348
|
| abnormal leukopoiesis
|
J:20348
|
| abnormal T cell differentiation
|
J:20348
|
| decreased hematocrit
|
J:20348
|
Spi1tm2b(EUCOMM)Wtsi/Spi1+
(C57BL/6N-Spi1tm2b(EUCOMM)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Spi1tm3Dgt/Spi1tm3Dgt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased double-negative T cell number
|
J:131217
|
| increased double-negative T cell number
|
J:131217
|
| increased granulocyte number
|
J:131217
|
Spibtm1Mcs/Spibtm1Mcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal immature B cell morphology
|
J:88257
|
Spice1tm1b(EUCOMM)Hmgu/Spice1tm1b(EUCOMM)Hmgu
(C57BL/6N-Spice1tm1b(EUCOMM)Hmgu/H)
|
increased red blood cell distribution width
|
J:211773
|
Spink2tm1.1(KOMP)Vlcg/Spink2tm1.1(KOMP)Vlcg
(C57BL/6N-Spink2tm1.1(KOMP)Vlcg/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| increased basophil cell number
|
J:211773
|
Spink5m1Btlr/Spink5m1Btlr
(involves: C57BL/6J)
|
increased neutrophil cell number
|
J:183755
|
Spink12em1(IMPC)J/Spink12em1(IMPC)J
(C57BL/6NJ-Spink12em1(IMPC)J/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Spns2tm1.2Nmoc/Spns2tm1.2Nmoc
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
decreased immature B cell number
|
J:184558
|
| decreased transitional stage T1 B cell number
|
J:184558
|
Spns2tm1a(KOMP)Wtsi/Spns2tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased granulocyte number
|
J:213427
|
Spns2tm1b(KOMP)Wtsi/Spns2tm1b(KOMP)Wtsi
(B6Brd;B6Dnk;B6N-Tyrc-Brd Spns2tm1b(KOMP)Wtsi/WtsiH)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Spns3em1(IMPC)Tcp/Spns3em1(IMPC)Tcp
(C57BL/6NCrl-Spns3em1(IMPC)Tcp/Tcp)
|
increased eosinophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6(Cg)-Spp1tm1Blh/J)
|
decreased hematocrit
|
J:133795
|
| decreased hemoglobin content
|
J:133795
|
Sppl2achompB/Sppl2achompB
(involves: C57BL/6)
|
abnormal class switch recombination
|
J:194595
|
| decreased transitional stage T2 B cell number
|
J:194595
|
Sppl2am1Anu/Sppl2am1Anu
(involves: C57BL/6JAnu)
|
abnormal transitional stage B cell morphology
|
J:194663
|
| decreased transitional stage T2 B cell number
|
J:194663
|
| decreased transitional stage T3 B cell number
|
J:194663
|
Sppl2am1Anu/Sppl2am1Anu
Tg(Vav-BCL2)69Jad/?
(involves: C57BL/6JAnu)
|
decreased double-negative T cell number
|
J:194663
|
Sppl2atm1Basc/Sppl2atm1Basc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
arrested B cell differentiation
|
J:194664
|
| decreased transitional stage T2 B cell number
|
J:194664
|
Sppl2atm1Dgen/Sppl2atm1Dgen
(B6.129P2-Sppl2atm1Dgen)
|
decreased transitional stage T2 B cell number
|
J:194595
|
Sppl3tm1Itl/Sppl3em1Pomz
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: 129S/SvEv * C57BL/6 * C57BL/6J)
|
abnormal NK cell differentiation
|
J:280182
|
Sppl3tm1Itl/Sppl3tm1Itl
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129S/SvEv * C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal NK cell differentiation
|
J:280182
|
Sppl3tm1Itl/Sppl3tm1Itl
Ncr1tm1.1(icre)Viv/Ncr1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal NK cell differentiation
|
J:280182
|
Sprem1(IMPC)H/Spr+
(C57BL/6N-Sprem1(IMPC)H/H)
|
increased hematocrit
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Spred1em1(IMPC)Ccpcz/Spred1em1(IMPC)Ccpcz
(C57BL/6N-Spred1em1(IMPC)Ccpcz/Ccpcz)
|
increased neutrophil cell number
|
J:211773
|
Spred1tm1.1Ayos/Spred1tm1.1Ayos
(involves: 129 * C57BL/6 * SJL)
|
increased mast cell number
|
J:186742
|
Spred1tm1Hiin/Spred1tm1Hiin
(involves: C57BL/6)
|
increased eosinophil cell number
|
J:95263
|
Spred2em1(IMPC)Mbp/Spred2em1(IMPC)Mbp
(C57BL/6N-Spred2em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Spred2tm1Taga/Spred2tm1Taga
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:90463
|
Spryd3tm1b(EUCOMM)Hmgu/Spryd3tm1b(EUCOMM)Hmgu
(C57BL/6N-Spryd3tm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Spsb2tm1Nch/Spsb2tm1Nch
(involves: C57BL/6)
|
thrombocytopenia
|
J:99226
|
Spta1ihj/Spta1ihj
(involves: HRS/J * LAH)
|
anisocytosis
|
J:105409
|
| microcytosis
|
J:105409
|
| poikilocytosis
|
J:105409
|
| polychromatophilia
|
J:105409
|
| spherocytosis
|
J:105409
|
Spta1sph-2Bc/Spta1sph-2Bc
(involves: SELH)
|
abnormal erythrocyte morphology
|
J:7048,
J:7501
|
| anisocytosis
|
J:7048
|
| decreased hematocrit
|
J:7048
|
| decreased hemoglobin content
|
J:7048
|
| extramedullary hematopoiesis
|
J:7048
|
| poikilocytosis
|
J:7048
|
| schistocytosis
|
J:7048
|
| spherocytosis
|
J:7048
|
Spta1sph-2Bc/Spta1sph-2Bc
((WB.Cg-Spta1sph-2Bc/Brk x B6.Cg-Spta1sph-2Bc/Brk)F1)
|
abnormal erythrocyte morphology
|
J:62355
|
| abnormal red blood cell deformability
|
J:81125
|
| microcytosis
|
J:62355
|
Spta1sph-3J/Spta1sph-3J
(NOD.Cg-H2b Spta1sph-3J)
|
abnormal erythrocyte morphology
|
J:157766
|
| anisocytosis
|
J:157766
|
| anisopoikilocytosis
|
J:157766
|
| decreased erythrocyte cell number
|
J:157766
|
| decreased hematocrit
|
J:157766
|
| decreased hemoglobin content
|
J:157766
|
| decreased mean corpuscular hemoglobin concentration
|
J:157766
|
| elliptocytosis
|
J:157766
|
| extramedullary hematopoiesis
|
J:157766
|
| poikilocytosis
|
J:157766
|
| polychromatophilia
|
J:157766
|
| spherocytosis
|
J:157766
|
Spta1sph-4J/Spta1sph-4J
(C57BL/6J-Spta1sph-4J/Llp)
|
abnormal erythrocyte morphology
|
J:157766
|
| anisocytosis
|
J:157766
|
| anisopoikilocytosis
|
J:157766
|
| decreased erythrocyte cell number
|
J:157766
|
| decreased hematocrit
|
J:157766
|
| decreased hemoglobin content
|
J:157766
|
| decreased mean corpuscular hemoglobin concentration
|
J:157766
|
| extramedullary hematopoiesis
|
J:157766
|
| increased mean corpuscular volume
|
J:157766
|
| poikilocytosis
|
J:157766
|
| polychromatophilia
|
J:157766
|
| spherocytosis
|
J:157766
|
Spta1sph-Dem/Spta1sph-Dem
(CcS3/Dem-Spta1sph-Dem)
|
abnormal erythrocyte morphology
|
J:62355
|
| elliptocytosis
|
J:62355,
J:66966
|
| microcytosis
|
J:62355
|
Spta1sph-ha/Spta1+
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Spta1sph-ha/Spta1sph-ha
(involves: DBA/1J)
|
abnormal erythrocyte morphology
|
J:30699
|
| decreased hematocrit
|
J:24829
|
| decreased hemoglobin content
|
J:24829
|
| decreased mean corpuscular volume
|
J:24829
|
| microcytosis
|
J:24729
|
Spta1sph-ha/Spta1sph-ha
(either: (B6.D1-Spta1sph-ha x WB.D1-Spta1sph-ha)F1 or (WB.D1-Spta1sph-ha x B6.D1-Spta1sph-ha)F1)
|
abnormal erythropoiesis
|
J:6695
|
| decreased hematocrit
|
J:6695
|
| extramedullary hematopoiesis
|
J:12830
|
| increased erythrocyte protoporphyrin level
|
J:5985,
J:6695
|
| increased neutrophil cell number
|
J:12830
|
| macrocytosis
|
J:6695
|
| microcytosis
|
J:6695
|
| spherocytosis
|
J:6695
|
Spta1sph-ha/Spta1sph-ha
((WB.D1-Spta1sph-ha/Brk x B6.D1-Spta1sph-ha/Brk)F1)
|
abnormal erythrocyte morphology
|
J:62355
|
| abnormal red blood cell deformability
|
J:81125
|
| anisopoikilocytosis
|
J:162532
|
| decreased hematocrit
|
J:162532
|
| decreased hemoglobin content
|
J:162532
|
| extramedullary hematopoiesis
|
J:162532
|
| increased mean corpuscular volume
|
J:162532
|
| increased nucleated erythrocyte cell number
|
J:162532
|
| low mean erythrocyte cell number
|
J:162532
|
| microcytosis
|
J:62355
|
| poikilocytosis
|
J:162532
|
| schistocytosis
|
J:162532
|
Spta1sph/Spta1+
(either: (B6.C3-Spta1sph x WB.C3-Spta1sph)F1 or (WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Spta1sph/Spta1sph
(involves: C3H)
|
decreased hematocrit
|
J:12276
|
| decreased hemoglobin content
|
J:12276
|
| poikilocytosis
|
J:12276
|
| spherocytosis
|
J:12276
|
Spta1sph/Spta1sph
(either: (B6.C3-Spta1sph x WB.C3-Spta1sph)F1 or (WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
abnormal erythropoiesis
|
J:6695
|
| decreased hematocrit
|
J:6695
|
| increased erythrocyte protoporphyrin level
|
J:5985,
J:111131
|
| macrocytosis
|
J:6695
|
| microcytosis
|
J:6695
|
| spherocytosis
|
J:6695
|
Spta1sph/Spta1sph
((WB.C3-Spta1sph x B6.C3-Spta1sph)F1)
|
abnormal erythrocyte morphology
|
J:62355
|
| anisopoikilocytosis
|
J:162532
|
| decreased cellular hemoglobin content
|
J:44313
|
| decreased erythrocyte cell number
|
J:44313
|
| decreased hematocrit
|
J:162532,
J:44313
|
| decreased hemoglobin content
|
J:162532,
J:44313
|
| extramedullary hematopoiesis
|
J:162532
|
| increased mean corpuscular volume
|
J:162532
|
| increased nucleated erythrocyte cell number
|
J:162532
|
| low mean erythrocyte cell number
|
J:162532
|
| microcytosis
|
J:62355
|
| poikilocytosis
|
J:162532
|
| schistocytosis
|
J:162532
|
Sptbem1(IMPC)J/Sptb+
(C57BL/6NJ-Sptbem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Sptbja/Sptb+
(129/Sv-Sptbja)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Sptbja/Sptb+
(involves: 129/Sv * C57BL/6J * WB/Re)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Sptbja/Sptbja
(129/Sv-Sptbja)
|
anisocytosis
|
J:305
|
| poikilocytosis
|
J:305
|
Sptbja/Sptbja
(involves: 129/Sv * C57BL/6J * WB/Re)
|
increased erythrocyte protoporphyrin level
|
J:5985
|
Sptbja/Sptbja
((WB.129-Sptbja/J x B6.129-Sptbja/J)F1)
|
abnormal erythrocyte morphology
|
J:62355
|
| anisopoikilocytosis
|
J:162532
|
| decreased cellular hemoglobin content
|
J:44313
|
| decreased erythrocyte cell number
|
J:44313
|
| decreased hematocrit
|
J:162532,
J:44313
|
| decreased hemoglobin content
|
J:162532,
J:44313
|
| extramedullary hematopoiesis
|
J:162532
|
| increased nucleated erythrocyte cell number
|
J:162532
|
| low mean erythrocyte cell number
|
J:162532
|
| microcytosis
|
J:62355
|
| poikilocytosis
|
J:162532
|
| schistocytosis
|
J:162532
|
Sptbm1Jus/Sptbm1Jus
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythrocyte morphology
|
J:159750
|
| acanthocytosis
|
J:159750
|
| spherocytosis
|
J:159750
|
Sptbn2tm1b(EUCOMM)Hmgu/Sptbn2tm1b(EUCOMM)Hmgu
(C57BL/6N-Sptbn2tm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
Sptlc2tm1Yhir/Sptlc2tm1Yhir
Gt(ROSA)26Sortm9(cre/ESR1)Arte/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6NTac)
|
increased erythrocyte cell number
|
J:202954
|
| increased hematocrit
|
J:202954
|
| increased hemoglobin content
|
J:202954
|
| increased neutrophil cell number
|
J:202954
|
Spz1em1(IMPC)Mbp/Spz1em1(IMPC)Mbp
(C57BL/6N-Spz1em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Sqstm1tm1a(KOMP)Wtsi/Sqstm1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Sqstm1tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:175295
|
Srcapem1(IMPC)Wtsi/Srcap+
(C57BL/6N-Srcapem1(IMPC)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Srgntm1Mabr/Srgntm1Mabr
(involves: 129X1/SvJ)
|
abnormal mast cell morphology
|
J:93338
|
| decreased mast cell number
|
J:93338
|
Srprbtm2b(EUCOMM)Hmgu/Srprb+
(C57BL/6N-Srprbtm2b(EUCOMM)Hmgu/Bay)
|
decreased mean corpuscular volume
|
J:211773
|
Srsf2tm1.1Oaw/Srsf2+
Tg(Mx1-cre)1Cgn/?
(B6.Cg-Tg(Mx1-cre)1Cgn Srsf2tm1.1Oaw)
|
abnormal erythropoiesis
|
J:221404
|
| abnormal myelopoiesis
|
J:221404
|
| abnormal neutrophil morphology
|
J:221404
|
| failure of myelopoiesis
|
J:221404
|
Srsf2tm1Xdfu/Srsf2tm1Xdfu
Tg(Lck-cre)I57Jxm/?
(involves: 129S4/SvJae * 129X1/SvJ * ICR)
|
abnormal T cell differentiation
|
J:88668
|
| decreased double-positive T cell number
|
J:88668
|
| increased double-negative T cell number
|
J:88668
|
Srsf3tm1Pjln/Srsf3tm1Pjln
Cd79atm1(cre)Reth/Cd79a+
(involves: 129P2/OlaHsd * BALB/c)
|
decreased pro-B cell number
|
J:113645
|
Srsf9em1(IMPC)J/Srsf9+
(C57BL/6NJ-Srsf9em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Ssbtm1Rjma/Ssbtm2.1Rjma
Cd79atm1(cre)Reth/Cd79a+
(involves: 129S/SvEv * BALB/c)
|
arrested B cell differentiation
|
J:207687
|
Ssc5dem1(IMPC)Wtsi/Ssc5dem1(IMPC)Wtsi
(C57BL/6N-Ssc5dem1(IMPC)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Sspntm1b(EUCOMM)Hmgu/Sspntm1b(EUCOMM)Hmgu
(C57BL/6N-Sspntm1b(EUCOMM)Hmgu/Ieg)
|
increased hematocrit
|
J:211773
|
Sstr4tm1Szo/Sstr4tm1Szo
(B6.129P2-Sstr4tm1Szo)
|
abnormal granulocyte morphology
|
J:152015
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(B6.129-St3gal4tm1.1Jxm)
|
thrombocytopenia
|
J:136946
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
increased mean platelet volume
|
J:189086
|
| thrombocytopenia
|
J:189086
|
St3gal4tm1.1Jxm/St3gal4tm1.1Jxm
St3gal6tm1.1Jxm/St3gal6tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased mean platelet volume
|
J:189086
|
| increased neutrophil cell number
|
J:189086
|
| thrombocytopenia
|
J:189086
|
St6gal1tm1Jlau/St6gal1tm1Jlau
(B6.129S4-St6gal1tm1Jlau)
|
abnormal myelopoiesis
|
J:140547
|
| increased neutrophil cell number
|
J:140547
|
St6gal1tm1Jxm/St6gal1tm1Jxm
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased transitional stage B cell number
|
J:132991
|
| increased neutrophil cell number
|
J:140547
|
St6galnac2tm1.1Cfg/St6galnac2tm1.1Cfg
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythropoiesis
|
J:217719
|
St7em1(IMPC)J/St7em1(IMPC)J
(C57BL/6NJ-St7em1(IMPC)J/Mmjax)
|
decreased mean corpuscular volume
|
J:211773
|
St14tm1Bug/St14tm1Bug
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased double-positive T cell number
|
J:87125
|
Stag1Gt(P099A04)Wrst/Stag1Gt(P099A04)Wrst
(involves: 129S2/SvPas)
|
abnormal definitive hematopoiesis
|
J:184719
|
Stag2tm1.1Soga/Y
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
extramedullary hematopoiesis
|
J:289000
|
| increased common myeloid progenitor cell number
|
J:289000
|
| increased granulocyte number
|
J:289000
|
| increased red blood cell distribution width
|
J:289000
|
Stard10tm1b(KOMP)Wtsi/Stard10tm1b(KOMP)Wtsi
(C57BL/6N-Stard10tm1b(KOMP)Wtsi/H)
|
increased mean platelet volume
|
J:211773
|
Stard13tm1a(KOMP)Wtsi/Stard13tm1a(KOMP)Wtsi
(B6JTyr;B6N-Stard13tm1a(KOMP)Wtsi/Wtsi)
|
decreased hematocrit
|
J:175295
|
Stard13tm1a(KOMP)Wtsi/Stard13tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
decreased hematocrit
|
J:213427
|
| decreased hemoglobin content
|
J:213427
|
Stat1m5Btlr/Stat1m5Btlr
(C57BL/6J-Stat1m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274938
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274938
|
| abnormal T cell differentiation
|
J:274938
|
Stat1tm1Rds/Stat1tm1Rds
(involves: 129)
|
abnormal common myeloid progenitor cell morphology
|
J:109408
|
Stat1tm2b(EUCOMM)Wtsi/Stat1tm2b(EUCOMM)Wtsi
(C57BL/6N-Stat1tm2b(EUCOMM)Wtsi/Orl)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Stat2tm1Shnd/Stat2tm1Shnd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal T cell differentiation
|
J:66564
|
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Cd4-cre)1Cwi/?
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal CD4-positive T cell differentiation
|
J:124293
|
Stat3tm1Dlv/Stat3tm1Dlv
Tg(Csf1r-icre)1Jwp/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
increased granulocyte number
|
J:156593
|
Stat3tm1Xyfu/Stat3tm1.1Xyfu
Tg(Ttr-cre)10-3Xyfu/?
(involves: 129S1/Sv * C57BL/6)
|
increased neutrophil cell number
|
J:128719
|
Stat4tm1Gru/Stat4tm1Gru
(C.129S2-Stat4tm1Gru)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
Stat5atm1.1Wjl/Stat5atm1.1Wjl
Stat5btm2.1Wjl/Stat5btm2.1Wjl
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
decreased erythrocyte cell number
|
J:187325
|
| decreased hematocrit
|
J:187325
|
| decreased hemoglobin content
|
J:187325
|
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(either: (involves: 129P2/OlaHsd) or (involves: 129X1/SvJ))
|
abnormal myelopoiesis
|
J:77412
|
| increased neutrophil cell number
|
J:77412
|
Stat5atm1Jni/Stat5atm1Jni
Stat5btm2Jni/Stat5btm2Jni
(involves: 129 * C57BL/6)
|
abnormal mast cell differentiation
|
J:84889
|
| absent mast cells
|
J:84889
|
Stat5atm1Mam/Stat5atm1Mam
(C.129S6-Stat5atm1Mam)
|
abnormal mast cell differentiation
|
J:101855
|
| abnormal mast cell morphology
|
J:101855
|
| decreased mast cell number
|
J:101855
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5b+
(involves: 129S6/SvEvTac)
|
abnormal lymphopoiesis
|
J:258967
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:155489
|
| abnormal neutrophil differentiation
|
J:155489
|
| decreased erythrocyte cell number
|
J:155489
|
| decreased hematocrit
|
J:155489
|
| decreased hemoglobin content
|
J:155489
|
| decreased neutrophil cell number
|
J:155489
|
Stat5atm2Mam/Stat5atm2Mam
Stat5btm1Mam/Stat5btm1Mam
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
anisocytosis
|
J:138904
|
| decreased erythrocyte cell number
|
J:138904
|
| decreased hematocrit
|
J:138904
|
| decreased mean corpuscular hemoglobin
|
J:138904
|
| increased red blood cell distribution width
|
J:138904
|
| microcytosis
|
J:138904
|
| poikilocytosis
|
J:138904
|
Stat5btm1Hwd/Stat5btm1Hwd
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:112035
|
Stat5btm1Mam/Stat5btm1Mam
Tg(Mx1-cre)1Cgn/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
abnormal leukopoiesis
|
J:155489
|
| abnormal neutrophil differentiation
|
J:155489
|
| decreased erythrocyte cell number
|
J:155489
|
| decreased hematocrit
|
J:155489
|
| decreased hemoglobin content
|
J:155489
|
| decreased neutrophil cell number
|
J:155489
|
Stat5btm1Mam/Stat5btm1Mam
Tg(Tek-cre)1Ywa/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
anisocytosis
|
J:138904
|
| decreased erythrocyte cell number
|
J:138904
|
| decreased hematocrit
|
J:138904
|
| decreased mean corpuscular hemoglobin
|
J:138904
|
| increased red blood cell distribution width
|
J:138904
|
| microcytosis
|
J:138904
|
| poikilocytosis
|
J:138904
|
Stat6tm1Gru/Stat6tm1Gru
(C.129S2-Stat6tm1Gru/J)
|
abnormal CD4-positive T cell differentiation
|
J:204829
|
Stat6tm1Gru/Stat6tm1Gru
(129S2/SvPas-Stat6tm1Gru)
|
abnormal T-helper 2 cell differentiation
|
J:31932
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv)
|
abnormal class switch recombination
|
J:32607
|
| abnormal T-helper 1 cell differentiation
|
J:32607
|
| abnormal T-helper 2 cell differentiation
|
J:32607
|
Stat6tm1Jni/Stat6tm1Jni
(involves: 129S/SvEv * C57BL/6)
|
abnormal mast cell morphology
|
J:110429
|
| abnormal T-helper 1 cell differentiation
|
J:51096
|
Stau2em1(IMPC)Mbp/Stau2em1(IMPC)Mbp
(C57BL/6N-Stau2em1(IMPC)Mbp/MbpMmucd)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Steap3fred/Steap3fred
(C57BL/6-Steap3fred)
|
anisopoikilocytosis
|
J:145194
|
| decreased hemoglobin content
|
J:145194
|
| leptocytosis
|
J:145194
|
| polychromatophilia
|
J:145194
|
Steap3tm1.1Atel/Steap3tm1.1Atel
(involves: C57BL/6)
|
abnormal erythropoiesis
|
J:154356
|
| anisopoikilocytosis
|
J:154356
|
| decreased mean corpuscular hemoglobin
|
J:154356
|
| decreased mean corpuscular volume
|
J:154356
|
| extramedullary hematopoiesis
|
J:154356
|
| increased erythrocyte cell number
|
J:154356
|
| thrombocytosis
|
J:154356
|
Steap3tm1.1Mdf/Steap3tm1.1Mdf
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal erythrocyte morphology
|
J:103440
|
| anisopoikilocytosis
|
J:103440
|
| decreased hematocrit
|
J:103440
|
| decreased hemoglobin content
|
J:103440
|
| decreased mean corpuscular hemoglobin
|
J:103440
|
| decreased mean corpuscular hemoglobin concentration
|
J:103440
|
| decreased mean corpuscular volume
|
J:103440
|
| increased erythrocyte cell number
|
J:103440
|
| thrombocytosis
|
J:103440
|
Stim1em1(IMPC)Mbp/Stim1+
(C57BL/6N-Stim1em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Stim1Sax/Stim1+
(involves: C3HeB/FeJ * C57BL/6)
|
abnormal thrombopoiesis
|
J:127381
|
| thrombocytopenia
|
J:127381
|
Stim1tm1.1Pg/Stim1+
(involves: C57BL/6)
|
thrombocytopenia
|
J:285187
|
Stim1tm1Rao/Stim1tm1Rao
Stim2tm1Rao/Stim2tm1Rao
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal B cell differentiation
|
J:133262
|
| abnormal granulocyte morphology
|
J:133262
|
| abnormal T cell differentiation
|
J:133262
|
Stk3tm1Dlim/Stk3tm1Dlim
Stk4tm1Dlim/Stk4tm1Dlim
(Not Specified)
|
abnormal embryonic hematopoiesis
|
J:155001
|
Stk4Gt(AJ0315)Wtsi/Stk4Gt(AJ0315)Wtsi
(B6.129P2-Stk4Gt(AJ0315)Wtsi)
|
abnormal T cell differentiation
|
J:142674
|
Stk4m1Btlr/Stk4m1Btlr
(C57BL/6J-Stk4m1Btlr)
|
increased neutrophil cell number
|
J:265233
|
Stk4m2Btlr/Stk4m2Btlr
(C57BL/6J-Stk4m2Btlr)
|
increased neutrophil cell number
|
J:265237
|
Stk4m5Btlr/Stk4m5Btlr
(C57BL/6J-Stk4m5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272743
|
| abnormal T cell differentiation
|
J:272743
|
Stk11tm1.1Sjm/Stk11tm1.1Sjm
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA * SJL)
|
decreased erythrocyte cell number
|
J:165090
|
| thrombocytopenia
|
J:165090
|
Stk16tm1.1(KOMP)Vlcg/Stk16tm1.1(KOMP)Vlcg
(C57BL/6N-Stk16tm1.1(KOMP)Vlcg/J)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Stk17btm1Hed/Stk17btm1Hed
(B6.129X1-Stk17btm1Hed)
|
decreased double-positive T cell number
|
J:94685
|
Stk24Gt(AM0826)Wtsi/Stk24Gt(AM0826)Wtsi
(B6.129P2-Stk24Gt(AM0826)Wtsi)
|
abnormal neutrophil morphology
|
J:256076
|
Stk26tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Stk26tm1b(EUCOMM)Hmgu/Stk26tm1b(EUCOMM)Hmgu
(C57BL/6N-Stk26tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased mean platelet volume
|
J:211773
|
Stk33em1(IMPC)J/Stk33em1(IMPC)J
(C57BL/6NJ-Stk33em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Stk35em1(IMPC)J/Stk35em1(IMPC)J
(C57BL/6N-Stk35em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Stk38tm1b(KOMP)Wtsi/Stk38+
(C57BL/6N-Stk38tm1b(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Stk39tm1Pawe/Stk39tm1Pawe
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased hematocrit
|
J:287773
|
Stk39tm1Pawe/Stk39tm1Pawe
Pvalbtm1(cre)Arbr/Pvalb+
(B6.129-Stk39tm1Pawe Pvalbtm1(cre)Arbr)
|
decreased hematocrit
|
J:287773
|
Stmn3em1(IMPC)J/Stmn3em1(IMPC)J
(C57BL/6NJ-Stmn3em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Stox2tm2b(EUCOMM)Hmgu/Stox2+
(C57BL/6N-Stox2tm2b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Stra6ltm1b(KOMP)Wtsi/Stra6ltm1b(KOMP)Wtsi
(C57BL/6N-Stra6ltm1b(KOMP)Wtsi/Ucd)
|
increased basophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Stradbtm1b(KOMP)Wtsi/Stradbtm1b(KOMP)Wtsi
(C57BL/6N-Stradbtm1b(KOMP)Wtsi/Ics)
|
decreased mean corpuscular volume
|
J:211773
|
Strbpem1(IMPC)Hmgu/Strbpem1(IMPC)Hmgu
(C57BL/6N-Strbpem1(IMPC)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Strn4tm1b(EUCOMM)Hmgu/Strn4+
(C57BL/6NCrl-Strn4tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Stt3bem1(IMPC)J/Stt3b+
(C57BL/6NJ-Stt3bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Stx2tm1b(EUCOMM)Wtsi/Stx2tm1b(EUCOMM)Wtsi
(C57BL/6N-Stx2tm1b(EUCOMM)Wtsi/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Stx5atm1b(EUCOMM)Hmgu/Stx5a+
(C57BL/6N-Stx5atm1b(EUCOMM)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Stx11tm1.2Ics/Stx11tm1.2Ics
(involves: C57BL/6NTac)
|
decreased erythrocyte cell number
|
J:193137
|
| decreased neutrophil cell number
|
J:193137
|
| thrombocytopenia
|
J:193137
|
Stxbp1tm1b(EUCOMM)Hmgu/Stxbp1+
(C57BL/6N-Stxbp1tm1b(EUCOMM)Hmgu/J)
|
decreased hematocrit
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Sun1tm1b(EUCOMM)Wtsi/Sun1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sun1tm1b(EUCOMM)Wtsi/Orl)
|
increased neutrophil cell number
|
J:211773
|
Sun5em1(IMPC)Mbp/Sun5em1(IMPC)Mbp
(C57BL/6N-Sun5em1(IMPC)Mbp/MbpMmucd)
|
thrombocytopenia
|
J:211773
|
Supt4atm1b(EUCOMM)Hmgu/Supt4a+
(C57BL/6N-Supt4atm1b(EUCOMM)Hmgu/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Supv3l1tm2.1Jkl/Supv3l1tm2.2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:144991
|
| decreased double-negative T cell number
|
J:144991
|
| decreased double-positive T cell number
|
J:144991
|
Supv3l1tm2Jkl/Supv3l1tm2Jkl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:144991
|
| decreased double-negative T cell number
|
J:144991
|
| decreased double-positive T cell number
|
J:144991
|
Susd1em1(IMPC)H/Susd1em1(IMPC)H
(C57BL/6NTac-Susd1em1(IMPC)H/H)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Susd6tm1b(KOMP)Wtsi/Susd6tm1b(KOMP)Wtsi
(C57BL/6N-Susd6tm1b(KOMP)Wtsi/Bay)
|
decreased neutrophil cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Suz12Plt8/Suz12+
(involves: 129 * C57BL/6)
|
thrombocytosis
|
J:136262
|
Svep1tm1b(EUCOMM)Hmgu/Svep1+
(C57BL/6N-Svep1tm1b(EUCOMM)Hmgu/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
SvilGt(RRF043)Byg/SvilGt(RRF043)Byg
(B6.129P2-SvilGt(RRF043)Byg)
|
abnormal platelet morphology
|
J:198612
|
Svopem1(IMPC)H/Svopem1(IMPC)H
(C57BL/6N-Svopem1(IMPC)H/H)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Swap70tm1Jess/Swap70tm1Jess
(involves: 129T2/SvEms * 129X1/SvJ)
|
abnormal class switch recombination
|
J:71160
|
Sykm1Btlr/Sykm1Btlr
(involves: C57BL/6J)
|
increased neutrophil cell number
|
J:199281
|
SykM2Btlr/Syk+
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
SykM2Btlr/SykM2Btlr
(C57BL/6J-SykM2Btlr)
|
abnormal NK cell differentiation
|
J:231803
|
Syktm1.1Tara/Syktm1.1Tara
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:115080
|
Syktm1Kuro/Syktm1Kuro
Zap70tm1Dlo/Zap70tm1Dlo
Cd79atm1(cre)Reth/?
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:134528
|
Syktm1Paw/Syktm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal B cell differentiation
|
J:29797
|
| decreased late pro-B cell number
|
J:29797
|
Syktm1Tyb/Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
arrested B cell differentiation
|
J:29796
|
Syktm2.1(ZAP70)Fkfr/Syktm2.1(ZAP70)Fkfr
(B6.129-Syktm2.1(ZAP70)Fkfr)
|
arrested B cell differentiation
|
J:188422
|
| decreased DN1 thymic pro-T cell number
|
J:188422
|
| decreased transitional stage B cell number
|
J:188422
|
| decreased transitional stage T1 B cell number
|
J:188422
|
| decreased transitional stage T2 B cell number
|
J:188422
|
| increased DN3 thymocyte number
|
J:188422
|
Syn3tm1.1(KOMP)Vlcg/Syn3tm1.1(KOMP)Vlcg
(C57BL/6N-Syn3tm1.1(KOMP)Vlcg/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Syncriptm1b(EUCOMM)Hmgu/Syncrip+
(C57BL/6N-Syncriptm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean platelet volume
|
J:211773
|
Syne2em1(IMPC)J/Syne2em1(IMPC)J
(C57BL/6N-Syne2em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
Synj1tm1b(EUCOMM)Wtsi/Synj1+
(C57BL/6N-Synj1tm1b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Synpo2tm1b(EUCOMM)Wtsi/Synpo2+
(C57BL/6N-Synpo2tm1b(EUCOMM)Wtsi/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Syt9em1(IMPC)Tcp/Syt9em1(IMPC)Tcp
(C57BL/6N-Syt9em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Syt17tm1b(KOMP)Wtsi/Syt17tm1b(KOMP)Wtsi
(C57BL/6N-Syt17tm1b(KOMP)Wtsi/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(B6JTyr;B6N-Sytl1tm1a(KOMP)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:175295
|
| increased hematocrit
|
J:175295
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased mean platelet volume
|
J:213427
|
tAE5/tAE5
(Not Specified)
|
increased mast cell number
|
J:83862
|
Tac4tm1Albe/Tac4tm1Albe
(B6.129P2-Tac4tm1Albe)
|
increased pro-B cell number
|
J:166471
|
Tacc3tm1Jni/Tacc3tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:74762
|
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Cd8a*-cre)B8Asin/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
| decreased double-positive T cell number
|
J:185745
|
Taf7tm1.1Dss/Taf7tm1.2Dss
Tg(Lck-cre)1Cwi/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:185745
|
| decreased double-positive T cell number
|
J:185745
|
| increased double-negative T cell number
|
J:185745
|
Tafa4em1(IMPC)Mbp/Tafa4em1(IMPC)Mbp
(C57BL/6N-Tafa4em1(IMPC)Mbp/MbpMmucd)
|
increased hematocrit
|
J:211773
|
Tagln2em1(IMPC)Tcp/Tagln2em1(IMPC)Tcp
(C57BL/6N-Tagln2em1(IMPC)Tcp/Tcp)
|
increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tal1Hpt/Tal1+
(HPT/Le)
|
abnormal erythropoiesis
|
J:1780
|
Tal1tm1Por/Tal1tm1Por
(involves: 129P2/OlaHsd)
|
abnormal embryonic erythropoiesis
|
J:139179
|
| abnormal erythropoiesis
|
J:139179
|
| anisocytosis
|
J:139179
|
| decreased hematocrit
|
J:139179
|
| decreased hemoglobin content
|
J:139179
|
| decreased mean corpuscular hemoglobin concentration
|
J:139179
|
| decreased mean corpuscular volume
|
J:139179
|
| extramedullary hematopoiesis
|
J:139179
|
| increased red blood cell distribution width
|
J:139179
|
Tal1tm1Sho/Tal1tm1Sho
(involves: 129S4/SvJae)
|
abnormal embryonic hematopoiesis
|
J:23061
|
| absent common myeloid progenitor cells
|
J:23061
|
Tal1tm1Wehi/Tal1tm1Wehi
(involves: 129S1/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:27458
|
Tal1tm2Sho/Tal1tm2Sho
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
thrombocytopenia
|
J:83215
|
Tal1tm2Wehi/Tal1tm2Wehi
(involves: 129S1/Sv * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:58825
|
Tal1tm3Wehi/Tal1tm2Wehi
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal erythropoiesis
|
J:81826
|
| thrombocytopenia
|
J:81826
|
Tap1tm1Arp/Tap1tm1Arp
(involves: 129S2/SvPas * C57BL/6)
|
decreased double-negative T cell number
|
J:3524
|
Tapbptm1Luc/Tapbptm1Luc
Tg(TcraTcrb)1100Mjb/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal negative T cell selection
|
J:64177
|
| abnormal positive T cell selection
|
J:64177
|
Tardbptm1b(EUCOMM)Wtsi/Tardbp+
(C57BL/6N-Tardbptm1b(EUCOMM)Wtsi/H)
|
decreased mean platelet volume
|
J:211773
|
Tarm1tm1Yiw/Tarm1tm1Yiw
(involves: C57BL/6 * C57BL/6NSlc)
|
abnormal dendritic cell differentiation
|
J:301164
|
Tasp1tm1Jjdh/Tasp1tm1Jjdh
Tg(Mx1-cre)1Cgn/?
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
decreased double-positive T cell number
|
J:112159
|
Tb2r1DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal definitive hematopoiesis
|
J:87437
|
Tb2r1DBA/2J/Tb2r1DBA/2J
(B6.D2-(D4Mit37-tel))
|
abnormal definitive hematopoiesis
|
J:140749
|
Tbatatm1Faf/Tbatatm1Faf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-negative T cell number
|
J:166065
|
Tbc1d4tm1b(EUCOMM)Hmgu/Tbc1d4tm1b(EUCOMM)Hmgu
(C57BL/6N-Tbc1d4tm1b(EUCOMM)Hmgu/J)
|
increased hematocrit
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Tbc1d9bem1(IMPC)J/Tbc1d9bem1(IMPC)J
(C57BL/6NJ-Tbc1d9bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Tbc1d20em1(IMPC)Mbp/Tbc1d20+
(C57BL/6N-Tbc1d20em1(IMPC)Mbp/MbpMmucd)
|
increased red blood cell distribution width
|
J:211773
|
Tbc1d22atm1b(KOMP)Wtsi/Tbc1d22atm1b(KOMP)Wtsi
(C57BL/6N-Tbc1d22atm1b(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Tbk1tm1.1Lex/Tbk1+
(involves: 129S4/SvJae * 129S5/SvEvBrd)
|
decreased basophil cell number
|
J:166476
|
| decreased eosinophil cell number
|
J:166476
|
Tbk1tm1Arte/Tbk1tm1Arte
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal class switch recombination
|
J:188560
|
Tbk1tm1Arte/Tbk1tm1Arte
Map3k14tm1Rds/Map3k14tm1Rds
Cd19tm1(cre)Cgn/Cd19+
(involves: 129/SvEv * 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:188560
|
Tbx20em1(IMPC)Mbp/Tbx20+
(C57BL/6N-Tbx20em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Tbx21duane/Tbx21duane
(C57BL/6-Tbx21duane)
|
abnormal NK cell differentiation
|
J:154069
|
Tbx21tm1Glm/Tbx21tm1Glm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:73833
|
Tbx21tm1Glm/Tbx21tm1Glm
(B6.129S6-Tbx21tm1Glm)
|
abnormal CD4-positive T cell differentiation
|
J:143729
|
Tbx22tm1.1(KOMP)Vlcg/Tbx22tm1.1(KOMP)Vlcg
(C57BL/6N-Tbx22tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Tcaf2em1(IMPC)Ccpcz/Tcaf2em1(IMPC)Ccpcz
(C57BL/6NCrl-Tcaf2em1(IMPC)Ccpcz/Ccpcz)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Tcaimtm1b(EUCOMM)Wtsi/Tcaimtm1b(EUCOMM)Wtsi
(C57BL/6N-Tcaimtm1b(EUCOMM)Wtsi/H)
|
increased neutrophil cell number
|
J:211773
|
Tcdel1C57BL/6/Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcdel1NOD/ShiLtDoi/Tcdel1NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcdel2C57BL/6/Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcdel2NOD/ShiLtDoi/Tcdel2NOD/ShiLtDoi
(involves: C57BL/6 * NOD/ShLtDoi * SJL)
|
decreased double-negative T cell number
|
J:97046
|
| increased double-positive T cell number
|
J:97046
|
Tcea1tm1Skmz/Tcea1tm1Skmz
(involves: 129P2/OlaHsd * C57BL/6JJcl)
|
abnormal erythropoiesis
|
J:107421
|
Tceal9tm1a(KOMP)Wtsi/Y
(C57BL/6N-Tceal9tm1a(KOMP)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:226241
|
| abnormal pro-B cell morphology
|
J:226241
|
| arrested B cell differentiation
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
| thrombocytopenia
|
J:226241
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
arrested B cell differentiation
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
| thrombocytopenia
|
J:226241
|
Tcf3tm1(PBX1)Mlc/Tcf3+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * CBA/J)
|
arrested B cell differentiation
|
J:226241
|
| decreased immature B cell number
|
J:226241
|
| thrombocytopenia
|
J:226241
|
Tcf3tm1(TCF3/HLF)Homy/Tcf3+
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:160392
|
Tcf3tm1.1Mbu/Tcf3+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:137719
|
Tcf3tm1Cmu/Tcf3tm1Cmu
(either: 129P2/OlaHsd-Tcf3tm1Cmu or (involves: 129P2/OlaHsd * FVB/N))
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:67011
|
| abnormal immunoglobulin V(D)J recombination
|
J:67011
|
Tcf3tm1Mbu/Tcf3tm1Mbu
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: 129P2/OlaHsd * C57BL/10 * CBA/Ca)
|
decreased pro-B cell number
|
J:137719
|
Tcf3tm1Wein/Tcf3tm3Zhu
(involves: 129/Sv * 129S4/SvJaeSor * C57BL/6)
|
decreased pro-B cell number
|
J:47671
|
Tcf3tm1Zhu/Tcf3tm1Zhu
(involves: 129 * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
Tcf3tm2Cmu/Tcf3tm2Cmu
(involves: 129P2/OlaHsd)
|
abnormal lymphopoiesis
|
J:118827
|
| absent pro-B cells
|
J:118827
|
Tcf3tm2Zhu/Tcf3tm2Zhu
(involves: 129 * C57BL/6)
|
decreased pro-B cell number
|
J:47671
|
Tcf3tm3.1Cmu/Tcf3tm3.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal B cell differentiation
|
J:153423
|
| abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
Tcf3tm4.1Cmu/Tcf3tm4.1Cmu
(involves: 129S/SvEv * FVB/N)
|
abnormal immunoglobulin light chain V-J recombination
|
J:153423
|
| arrested B cell differentiation
|
J:153423
|
| decreased pro-B cell number
|
J:153423
|
Tcf3tm6(Esr1*)Zhu/Tcf3tm6(Esr1*)Zhu
(involves: 129/Sv * C57BL/6)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:154788
|
| arrested B cell differentiation
|
J:154788
|
Tcf4tm1.1Hmb/Tcf4+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased double-negative T cell number
|
J:136143
|
Tcf4tm1.1Hmb/Tcf4tm1.1Hmb
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal T cell differentiation
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
Tcf4tm1Hmb/Tcf4tm1Zhu
Tg(Kit-cre)143Hmb/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:65236
|
| decreased double-positive T cell number
|
J:65236
|
Tcf4tm1Zhu/Tcf4+
Tcf3tm1Wein/Tcf3+
(involves: 129P2/OlaHsd)
|
decreased pro-B cell number
|
J:43324
|
Tcf4tm1Zhu/Tcf4tm1Zhu
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
Tcf7tm1Cle/Tcf7tm1Cle
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:23255
|
| decreased double-positive T cell number
|
J:23255
|
Tcf7tm2Cle/Tcf7tm2Cle
(involves: 129P2/OlaHsd)
|
decreased double-positive T cell number
|
J:23255
|
Tcf7l2tm1a(EUCOMM)Wtsi/Tcf7l2+
(C57BL/6N-Tcf7l2tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tcf12tm1Zhu/Tcf12+
Tcf3tm1Wein/Tcf3+
(involves: 129S4/SvJaeSor)
|
decreased pro-B cell number
|
J:43324
|
Tcf12tm1Zhu/Tcf12+
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:75746
|
| increased double-negative T cell number
|
J:75746
|
Tcf12tm1Zhu/Tcf12+
Tcf4tm1Zhu/Tcf4+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
decreased pro-B cell number
|
J:43324
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129/Sv * C57BL/6)
|
decreased pro-B cell number
|
J:43324
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
Tcf12tm1Zhu/Tcf12tm1Zhu
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased double-positive T cell number
|
J:136143
|
| increased double-negative T cell number
|
J:136143
|
Tcf12tm1Zhu/Tcf12tm2Zhu
(involves: 129S7/SvEvBrd)
|
arrested T cell differentiation
|
J:120411
|
Tcf12tm2Zhu/Tcf12tm2Zhu
(Not Specified)
|
abnormal B cell differentiation
|
J:120411
|
| abnormal T cell differentiation
|
J:120411
|
| arrested T cell differentiation
|
J:120411
|
| decreased double-positive T cell number
|
J:120411
|
| decreased immature B cell number
|
J:120411
|
| decreased pro-B cell number
|
J:120411
|
| increased double-negative T cell number
|
J:120411
|
Tcf12tm2Zhu/Tcf12tm2Zhu
Tg(TcrAND)53Hed/0
(involves: C57BL/6 * SJL)
|
arrested T cell differentiation
|
J:120411
|
Tcf12tm3Zhu/Tcf12tm3Zhu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Cd4-cre)1Cwi/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:129171
|
Tcf12tm3Zhu/Tcf12tm3Zhu
Tcf3tm4Zhu/Tcf3tm4Zhu
Tg(Lck-cre)#Zhu/0
(involves: 129S4/SvJae * C57BL/6 * SJL/J)
|
decreased double-positive T cell number
|
J:129570
|
| increased double-negative T cell number
|
J:129570
|
Tcf25em1(IMPC)Mbp/Tcf25em1(IMPC)Mbp
(C57BL/6NCrl-Tcf25em1(IMPC)Mbp/Mmucd)
|
thrombocytopenia
|
J:211773
|
Tcimtm1Icle/Tcimtm1Icle
(B6.129-Tcimtm1Icle)
|
abnormal erythrocyte morphology
|
J:217318
|
| abnormal hemopoiesis
|
J:217318
|
| decreased mean corpuscular hemoglobin
|
J:217318
|
| decreased mean corpuscular volume
|
J:217318
|
| increased common myeloid progenitor cell number
|
J:217318
|
| increased eosinophil cell number
|
J:217318
|
| increased erythrocyte cell number
|
J:217318
|
| increased neutrophil cell number
|
J:217318
|
| increased red blood cell distribution width
|
J:217318
|
| myeloid hyperplasia
|
J:217318
|
Tcirg1oc/Tcirg1oc
(B6C3Fe a/a-Tcirg1oc/J)
|
extramedullary hematopoiesis
|
J:7870
|
Tcirg1tm1Utku/Tcirg1tm1Utku
(involves: 129X1/SvJ * C57BL/6)
|
increased granulocyte number
|
J:92730
|
Tcra-Jtm1Jpdv/Tcra-Jtm1Jpdv
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:77518
|
Tcra-Jtm1Kgwa/Tcra-Jtm1Kgwa
Tg(Tcrb2B4)1Mmd/0
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:50143
|
| increased double-positive T cell number
|
J:50143
|
Tcra-Jtm1Slek/Tcra-Jtm1Slek
(involves: 129P2/OlaHsd)
|
abnormal T cell differentiation
|
J:101398
|
| decreased double-positive T cell number
|
J:101398
|
| increased double-negative T cell number
|
J:101398
|
Tcra-Jtm1Tgi/Tcra-Jtm1Tgi
(involves: 129S1/Sv * 129X1/SvJ * BALB/c)
|
abnormal eosinophil cell number
|
J:84720
|
Tcra-Jtm2.3Krg/Tcra-Jtm2.3Krg
(involves: 129S/SvEv * C57BL/6)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
Tcra-Jtm3.1Krg/Tcra-Jtm3.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell differentiation
|
J:128344
|
Tcra-Jtm4.1Krg/Tcra-Jtm4.1Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
Tcra-Jtm5Krg/Tcra-Jtm5Krg
(involves: 129S6/SvEvTac)
|
abnormal T cell receptor alpha chain V-J recombination
|
J:147326
|
TcraLn3Jae/Tcra+
(B6.Cg-TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| decreased double-positive T cell number
|
J:143006
|
TcraLn3Jae/Tcra+
TcrbLn3Jae/Tcrb+
(B6.Cg-TcrbLn3Jae TcraLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
| abnormal T cell differentiation
|
J:143006
|
| decreased double-positive T cell number
|
J:143006
|
Tcratm1Mass/Tcra+
Tg(Nes-cre)Wme/0
(involves: C57BL/6 * CBA)
|
abnormal positive T cell selection
|
J:201417
|
| increased double-negative T cell number
|
J:201417
|
Tcratm1Mass/Tcratm1Mass
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:201417
|
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
H2b/H2b
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:131357
|
| abnormal double-positive T cell morphology
|
J:81564
|
| abnormal negative T cell selection
|
J:81564
|
| abnormal T cell differentiation
|
J:81564
|
| decreased double-positive T cell number
|
J:131357
|
Tcratm1Mom/Tcra/Tcrdtm1.1(Tcra)Rsky
H2d/H2d
Ptcratm1Vbo/Ptcratm1Vbo
Tg(Tcrb)93Vbo/?
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:131357
|
Tcratm1Mom/Tcratm1Mom
(involves: 129S2/SvPas * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
Tcratm1Mom/Tcratm1Mom
Tcra-Jtm1Kgwa/Tcra-Jtm1Kgwa
(involves: 129P2/OlaHsd * 129S2/SvPas * C3H/HeJ * C57BL/6J)
|
increased double-negative T cell number
|
J:50143
|
Tcratm1Mom/Tcratm1Mom
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
Tcratm1Mom/Tcratm1Mom
Tg(Lck-Akt1*E40K)E-3Pnt/0
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
arrested T cell differentiation
|
J:135903
|
TcrbLn3Jae/Tcrb+
(B6.Cg-TcrbLn3Jae)
|
abnormal double-negative T cell morphology
|
J:143006
|
Tcrbtm1(Tcrb)Chb/Tcrbtm1(Tcrb)Chb
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
Tcrbtm1(Tcrb)Chb/Tcrbtm1Slek
(Not Specified)
|
abnormal double-negative T cell morphology
|
J:147947
|
| abnormal T cell receptor beta chain V(D)J recombination
|
J:147947
|
Tcrbtm1(Tcrb)Fwa/Tcrbtm1(Tcrb)Fwa
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:131995
|
Tcrbtm1Mom/Tcrbtm1Mom
(involves: 129P2/OlaHsd * BALB/c)
|
arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(B6.129P2-Tcrbtm1Mom Tcrdtm1Mom/J)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| increased immature B cell number
|
J:187766
|
| increased transitional stage T2 B cell number
|
J:187766
|
| increased transitional stage T3 B cell number
|
J:187766
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
(involves: 129 * BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:3206
|
| decreased double-positive T cell number
|
J:3206
|
Tcrbtm1Mom/Tcrbtm1Mom
Tcrdtm1Mom/Tcrdtm1Mom
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Tcrbtm1Mom Traf3ip2tm1.1Lix Tcrdtm1Mom)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| increased immature B cell number
|
J:187766
|
Tcrbtm1Mom/Tcrbtm1Mom
Tg(H2-K-Cd86)7All/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:112475
|
Tcrbtm1Slek/Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm1Slek/Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm2(Tcrb)Fwa/Tcrbtm3Slek
(involves: 129)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:132446
|
Tcrbtm2Slek/Tcrbtm2Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
Tcrbtm2Slek/Tcrbtm2Slek
Trbv13-2tm1(CD2)Zhu/Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
Tcrbtm3Slek/Tcrbtm3Slek
(Not Specified)
|
arrested T cell differentiation
|
J:119552
|
Tcrbtm5Slek/Tcrbtm5Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm6Slek/Tcrbtm6Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrbtm7Slek/Tcrbtm7Slek
(Not Specified)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:143738
|
Tcrd-V1tm1Kjk/Tcrd-V1tm1Kjk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:64863
|
| abnormal T cell receptor delta chain V(D)J recombination
|
J:64863
|
Tcrd-V1tm1Kjk/Tcrd-V1tm1Kjk
(B6.129P2-Tcrd-V1tm1Kjk)
|
abnormal T cell receptor delta chain V(D)J recombination
|
J:128525
|
Tcrdtm1Mom/Tcrdtm1Mom
(either: (involves: 129P2/OlaHsd * BALB/cJ) or (involves: 129P2/OlaHsd * C57BL/6))
|
abnormal gamma-delta T cell differentiation
|
J:3865
|
Tcrdtm1Mom/Tcrdtm1Mom
Tcrgtm2.1Dhr/Tcrgtm2.1Dhr
(involves: 129 * C57BL/6)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Tcrgtm1.1Dhr/Tcrgtm1.1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
Tcrgtm1Dhr/Tcrgtm1Dhr
(involves: 129)
|
abnormal T cell receptor gamma chain V-J recombination
|
J:133974
|
Tcrgtm2.1Dhr/Tcrgtm2.1Dhr
(involves: 129S4/SvJae * C57BL/6)
|
abnormal gamma-delta T cell differentiation
|
J:75624
|
| abnormal T cell receptor gamma chain V-J recombination
|
J:75624
|
Tdp1em1(IMPC)Tcp/Tdp1em1(IMPC)Tcp
(C57BL/6NCrl-Tdp1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tdp2tm1.1Huy/Tdp2tm1.1Huy
(involves: 129P2/OlaHsd * CD-1)
|
abnormal immature B cell morphology
|
J:195301
|
| abnormal lymphopoiesis
|
J:195301
|
| decreased double-positive T cell number
|
J:195301
|
Tdrd3Gt(RRK474)Byg/Tdrd3Gt(RRK474)Byg
(involves: 129P2/OlaHsd)
|
abnormal B cell differentiation
|
J:210647
|
Tektm1Ber/Tektm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal definitive hematopoiesis
|
J:99096
|
Tektm1Dmt/Tektm1Dmt
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal definitive hematopoiesis
|
J:99096
|
Tenm1em1(IMPC)Tcp/Y
(C57BL/6NCrl-Tenm1em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Tenm1em1(IMPC)Tcp/Tenm1em1(IMPC)Tcp
(C57BL/6NCrl-Tenm1em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Tent5aem1(IMPC)Ccpcz/Tent5aem1(IMPC)Ccpcz
(C57BL/6N-Tent5aem1(IMPC)Ccpcz/Ccpcz)
|
increased granulocyte number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Tent5cem1Adki/Tent5cem1Adki
(involves: C57BL/6J * CBA)
|
decreased hemoglobin content
|
J:252302
|
| decreased mean corpuscular hemoglobin concentration
|
J:252302
|
| decreased mean corpuscular volume
|
J:252302
|
| increased erythrocyte cell number
|
J:252302
|
Tent5cem1Hncs/Tent5cem1Hncs
(involves: C57BL/6J * DBA)
|
decreased hematocrit
|
J:277640
|
| decreased hemoglobin content
|
J:277640
|
| decreased mean corpuscular hemoglobin
|
J:277640
|
| decreased mean corpuscular hemoglobin concentration
|
J:277640
|
| decreased mean corpuscular volume
|
J:277640
|
| increased erythrocyte cell number
|
J:277640
|
| thrombocytosis
|
J:277640
|
Tent5ctm1b(KOMP)Wtsi/Tent5c+
(C57BL/6N-Tent5ctm1b(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Terf2ipem1(IMPC)Mbp/Terf2ipem1(IMPC)Mbp
(C57BL/6N-Terf2ipem1(IMPC)Mbp/MbpMmucd)
|
decreased red blood cell distribution width
|
J:211773
|
Tespa1tm1Smoc/Tespa1tm1Smoc
(B6.129-Tespa1tmSmoc)
|
abnormal T cell differentiation
|
J:186446
|
Tespa1tm1Smoc/Tespa1tm1Smoc
Tg(TcraTcrb)425Cbn/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)425Cbn)
|
abnormal T cell differentiation
|
J:186446
|
Tespa1tm1Smoc/Tespa1tm1Smoc
Tg(TcraTcrb)1100Mjb/0
(B6.Cg-Tespa1tm1Smoc Tg(TcraTcrb)1100Mjb)
|
abnormal T cell differentiation
|
J:186446
|
Tet1tm1.1Jae/Tet1tm1.1Jae
(involves: 129S4/SvJae * C57BL/6)
|
decreased neutrophil cell number
|
J:175858
|
Tet2Gt(AN0709)Wtsi/Tet2+
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
abnormal monocyte differentiation
|
J:174052
|
| decreased erythrocyte cell number
|
J:174052
|
| thrombocytopenia
|
J:174052
|
Tet2Gt(AN0709)Wtsi/Tet2Gt(AN0709)Wtsi
(B6.129P2-Tet2Gt(AN0709)Wtsi)
|
abnormal common myeloid progenitor cell morphology
|
J:174052
|
| abnormal monocyte differentiation
|
J:174052
|
| decreased erythrocyte cell number
|
J:174052
|
| decreased pro-B cell number
|
J:174052
|
| extramedullary hematopoiesis
|
J:174052
|
| increased DN1 thymic pro-T cell number
|
J:174052
|
| increased double-negative T cell number
|
J:174052
|
| thrombocytopenia
|
J:174052
|
Tet2tm1.1Iaai/Tet2+
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
extramedullary hematopoiesis
|
J:174053
|
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(Mx1-cre)1Cgn/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal erythropoiesis
|
J:234976
|
| abnormal myelopoiesis
|
J:234976
|
| increased granulocyte number
|
J:234976
|
Tet2tm1.1Iaai/Tet2tm1.1Iaai
Tg(VAV1-cre)1Graf/0
(involves: 129S/SvEv * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:174053
|
| extramedullary hematopoiesis
|
J:174053
|
| myeloid hyperplasia
|
J:174053
|
Tet2tm1.1Mjxu/Tet2+
(involves: 129 * C57BL/6)
|
myeloid hyperplasia
|
J:178415
|
Tet2tm1.1Mjxu/Tet2tm1.1Mjxu
(involves: 129 * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:178415
|
| increased erythrocyte cell number
|
J:178415
|
| increased hemoglobin content
|
J:178415
|
| increased neutrophil cell number
|
J:178415
|
| myeloid hyperplasia
|
J:178415
|
Tet2tm1.2Rao/Tet2tm1.2Rao
(involves: C57BL/6NTac)
|
abnormal definitive hematopoiesis
|
J:175222
|
| abnormal myelopoiesis
|
J:175222
|
Tet2tm1Ics/Tet2tm1Ics
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal common myeloid progenitor cell morphology
|
J:174052
|
| decreased erythrocyte cell number
|
J:174052
|
| decreased pro-B cell number
|
J:174052
|
| extramedullary hematopoiesis
|
J:174052
|
| increased DN1 thymic pro-T cell number
|
J:174052
|
| increased double-negative T cell number
|
J:174052
|
| thrombocytopenia
|
J:174052
|
Tex2tm1.1(KOMP)Vlcg/Tex2+
(C57BL/6N-Tex2tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Tex2tm1.1(KOMP)Vlcg/Tex2tm1.1(KOMP)Vlcg
(C57BL/6N-Tex2tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Tex21em1(IMPC)J/Tex21em1(IMPC)J
(C57BL/6NJ-Tex21em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Tex261tm1b(EUCOMM)Wtsi/Tex261tm1b(EUCOMM)Wtsi
(C57BL/6N-Tex261tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tfap4tm1.1(KOMP)Vlcg/Tfap4tm1.1(KOMP)Vlcg
(C57BL/6N-Tfap4tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tfap4tm1.1Litt/Tfap4tm1.1Litt
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal T cell differentiation
|
J:176461
|
Tfebtm1a(EUCOMM)Wtsi/Tfeb+
(C57BL/6N-Tfebtm1a(EUCOMM)Wtsi/Bay)
|
decreased hemoglobin content
|
J:211773
|
Tfr2em1(IMPC)Rbrc/Tfr2em1(IMPC)Rbrc
(C57BL/6N-Tfr2em1(IMPC)Rbrc/Rbrc)
|
abnormal erythrocyte cell number
|
J:211773
|
| abnormal hemoglobin content
|
J:211773
|
| abnormal mean corpuscular hemoglobin
|
J:211773
|
| abnormal mean corpuscular hemoglobin concentration
|
J:211773
|
| abnormal mean corpuscular volume
|
J:211773
|
| decreased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Tfr2tm1.1Anro/Tfr2tm1.1Anro
(129.Cg-Tfr2tm1.1Anro)
|
increased cellular hemoglobin content
|
J:160785
|
| increased hemoglobin content
|
J:160785
|
Tfrcem1(IMPC)H/Tfrc+
(C57BL/6N-Tfrcem1(IMPC)H/H)
|
decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
TfrcMvd001/Tfrc+
(C3HeB/FeJ-TfrcMvd001)
|
decreased mean corpuscular hemoglobin
|
J:186868
|
| decreased mean corpuscular volume
|
J:186868
|
| increased erythrocyte cell number
|
J:186868
|
TfrcRbc6/Tfrc+
(involves: C57BL/6)
|
decreased hematocrit
|
J:330452
|
| decreased hemoglobin content
|
J:330452
|
| decreased mean corpuscular hemoglobin
|
J:330452
|
| decreased mean corpuscular volume
|
J:330452
|
| increased erythrocyte cell number
|
J:330452
|
| increased red blood cell distribution width
|
J:330452
|
Tfrctm1Nca/Tfrc+
(either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal erythropoiesis
|
J:54107
|
| decreased mean corpuscular hemoglobin
|
J:54107
|
| decreased mean corpuscular volume
|
J:54107
|
| increased erythrocyte cell number
|
J:54107
|
| microcytosis
|
J:54107
|
Tfrctm1Nca/Tfrctm1Nca
(either: (involves: 129S4/SvJae * 129S6/SvEvTac) or (involves: 129S4/SvJae * C57BL/6))
|
abnormal embryonic erythropoiesis
|
J:54107
|
Tg(ACTB-Mgat3)2Nta/0
(involves: C57BL/6 * DBA/2)
|
abnormal definitive hematopoiesis
|
J:80227
|
| decreased erythrocyte cell number
|
J:80227
|
| decreased hemoglobin content
|
J:80227
|
| decreased neutrophil cell number
|
J:80227
|
| thrombocytopenia
|
J:80227
|
Tg(ACTB-TNFRSF6B)754Jwu/?
(B6.Cg-Tg(Actb-TNFRSF6B)754Jwu)
|
thrombocytopenia
|
J:148162
|
Tg(B19-RNAi:Il3)241Ckn/?
(involves: BALB/cJ * C57BL/6J * FVB/N)
|
abnormal B cell differentiation
|
J:107618
|
Tg(BCL2)22Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:93111
|
Tg(BCL2)25Wehi/0
(involves: C57BL/6JWehi * SJL/JWehi)
|
abnormal B cell differentiation
|
J:131912
|
| abnormal plasma cell differentiation
|
J:131912
|
Tg(BCL2/IGH)1Tjd/?
(involves: C3H/He * C57BL/6)
|
abnormal mononuclear cell differentiation
|
J:81147
|
Tg(BCL2/IGH)M23Tjd/?
(involves: C3H/He * C57BL/6)
|
abnormal mononuclear cell differentiation
|
J:81147
|
Tg(CAG-Ptafr)1Tksh/0
(B6;D2-Tg(CAG-Ptafr)1Tksh/TkshRbrc)
|
increased mast cell number
|
J:38639
|
Tg(CAG-RPS19*R62W)#Dmb/0
Tg(Prnp-GFP/cre)1Blw/0
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal erythropoiesis
|
J:165876
|
| decreased erythrocyte cell number
|
J:165876
|
| decreased hematocrit
|
J:165876
|
| decreased hemoglobin content
|
J:165876
|
Tg(CD2-Ifngr2)1Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)1Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
Tg(CD2-Ifngr2)2Pbro/?
(B6.Cg-Tg(CD2-Ifngr2)2Pbro)
|
abnormal T-helper 1 cell differentiation
|
J:134448
|
Tg(CD2-Mir181d)38Oers/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:212571
|
Tg(CD2-Myb/en)2Kmw/?
(involves: C57BL/10 * CBA)
|
increased double-negative T cell number
|
J:126456
|
Tg(CD2-Myb/en)2Kmw/Tg(CD2-Myb/en)2Kmw
(involves: C57BL/10 * CBA)
|
decreased double-positive T cell number
|
J:126456
|
| increased double-negative T cell number
|
J:126456
|
Tg(CD2-Nfat5)1Snh/0
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:80066
|
Tg(CD2-Ppp2ca)#Gct/0
(involves: C57BL/6J)
|
increased neutrophil cell number
|
J:184067
|
Tg(Cd2-Smad7)#Chbe/0
(involves: C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:184670
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
(involves: C57BL/10)
|
abnormal positive T cell selection
|
J:113713
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/10 * FVB/N)
|
abnormal positive T cell selection
|
J:126026
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(CD2-TcraF5,CD2-TcrbF5)1Kio/0
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(CD2-Zbtb7b)C8Rbo/?
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(CD2-Zbtb7b)C8Rbo/?
Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(CD2-Zbtb7b)C8Rbo/?
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal T cell differentiation
|
J:151075
|
Tg(Cd3d-Il5)NJ.1638Nal/?
(involves: C57BL/6J * CBA/J)
|
abnormal eosinophil differentiation
|
J:123440
|
| increased eosinophil cell number
|
J:123440
|
| increased neutrophil cell number
|
J:123440
|
Tg(CD3E)26Cpt/Tg(CD3E)26Cpt
(involves: C57BL/6J * CBA/J)
|
arrested T cell differentiation
|
J:81711
|
| decreased double-positive T cell number
|
J:54756
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6)
|
abnormal T cell clonal deletion
|
J:217939
|
| decreased double-positive T cell number
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(Cd4-BCL2*G101A*D102A*D103A)AWnt/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(Cd4-cre)1Cwi/0
Trmt61aem1Hbgl/Trmt61aem1Hbgl
(involves: C57BL/6 * DBA/2J)
|
abnormal CD4-positive T cell differentiation
|
J:336736
|
Tg(Cd4-Il17rb)#Cdon/?
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:158594
|
| increased eosinophil cell number
|
J:158594
|
Tg(Cd4-NPM/ALK)N1Ingh/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal T cell differentiation
|
J:235890
|
| increased DN3 thymocyte number
|
J:235890
|
Tg(Cd4-NPM/ALK)N1Ingh/0
Tg(TcraTcrb)1100Mjb/0
(involves: C57BL/6 * Swiss Webster)
|
abnormal double-negative T cell morphology
|
J:235890
|
Tg(Cd8aCd8b)3Erob/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
| abnormal double-positive T cell morphology
|
J:93004
|
| decreased double-negative T cell number
|
J:93004
|
Tg(Cd8aCd8b)3Erob/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93004
|
Tg(CD19)1Tft/Tg(CD19)1Tft
(involves: C57BL/6 * C57BL/6J * SJL)
|
decreased immature B cell number
|
J:27236
|
Tg(CD19-Tnfsf7)#Rvl/0
(involves: C57BL/6)
|
decreased transitional stage B cell number
|
J:88620
|
Tg(Cd74-Nlrc4*)1Kyas/0
(involves: C57BL/6N)
|
increased neutrophil cell number
|
J:219652
|
Tg(Cma1-cre)ARoer/0
Tg(Kit*D814V)1Roer/0
(involves: C57BL/6)
|
increased mast cell number
|
J:169611
|
Tg(Cma1-cre)ARoer/0
Tg(Kit*D814V)3Roer/0
(involves: C57BL/6)
|
increased mast cell number
|
J:169611
|
Tg(CMV-cre)1Cgn/0
Tg(Kit*D814V)1Roer/0
(involves: BALB/cJ * C57BL/6)
|
abnormal erythropoiesis
|
J:169611
|
| increased mast cell number
|
J:169611
|
| increased nucleated erythrocyte cell number
|
J:169611
|
Tg(CMV-cre)1Cgn/0
Tg(Kit*D814V)3Roer/0
(involves: BALB/cJ * C57BL/6)
|
abnormal erythropoiesis
|
J:169611
|
| increased mast cell number
|
J:169611
|
| increased nucleated erythrocyte cell number
|
J:169611
|
Tg(CMV-SALL4_iB)#Chai/?
(Not Specified)
|
abnormal erythrocyte morphology
|
J:115037
|
| abnormal myelopoiesis
|
J:115037
|
| abnormal neutrophil morphology
|
J:115037
|
| decreased neutrophil cell number
|
J:115037
|
| giant platelets
|
J:115037
|
| increased nucleated erythrocyte cell number
|
J:115037
|
| myeloid hyperplasia
|
J:115037
|
Tg(CMV-SART3)#Hbro/0
(Not Specified)
|
abnormal common myeloid progenitor cell morphology
|
J:173259
|
| abnormal definitive hematopoiesis
|
J:173259
|
Tg(Cnp-EGFR)10Nrat/0
(involves: C57BL/6 * SJL)
|
increased mast cell number
|
J:95933
|
Tg(Col1a1-Dkk1)1Hmk/?
(B6.FVB-Tg(Col1a1-Dkk1)1Hmk)
|
abnormal definitive hematopoiesis
|
J:238121
|
Tg(Cr2-cre)3Cgn/?
Xrcc4tm1Fwa/Xrcc4tm2Fwa
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal class switch recombination
|
J:150339
|
Tg(CTSG-NUMA1/RARA)#Skr/0
(involves: C57BL/6)
|
abnormal definitive hematopoiesis
|
J:88103
|
| decreased common myeloid progenitor cell number
|
J:88103
|
| increased granulocyte number
|
J:88103
|
| increased neutrophil cell number
|
J:88103
|
| thrombocytopenia
|
J:88103
|
Tg(CTSG-PML/RARA)135Ley/?
(Not Specified)
|
thrombocytopenia
|
J:77881
|
Tg(CTSG-PML/RARA)135Ley/?
(involves: C3H * C57BL/6)
|
thrombocytopenia
|
J:59080
|
Tg(CTSG-PML/RARA)135Ley/0
Tg(CTSG-RARA/PML)#Ley/0
(involves: C3H * C57BL/6)
|
thrombocytopenia
|
J:59080
|
Tg(CTSG-PML/RARA)6179Ppp/0
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:40373
|
| abnormal myelopoiesis
|
J:40373
|
| increased granulocyte number
|
J:40373
|
Tg(CTSG-PML/RARA)#Ppp/0
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:40373
|
| abnormal myelopoiesis
|
J:78201,
J:40373
|
| increased granulocyte number
|
J:40373
|
Tg(CTSG-RARA/ZBTB16)#Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:65878
|
| myeloid hyperplasia
|
J:65878
|
| thrombocytopenia
|
J:65878
|
Tg(CTSG-RARA/ZBTB16)#Ppp/0
Tg(CTSG-ZBTB16/RARA)#Ppp/0
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:65878
|
| abnormal myelopoiesis
|
J:65878
|
| thrombocytopenia
|
J:65878
|
Tg(CTSG-ZBTB16/RARA)#Ppp/0
(Not Specified)
|
abnormal myelopoiesis
|
J:78201
|
Tg(CTSG-ZBTB16/RARA)#Sjch/0
(involves: C57BL/6)
|
abnormal myelopoiesis
|
J:55196
|
| myeloid hyperplasia
|
J:55196
|
Tg(DO11.10)10Dlo/?
(involves: BALB/c * C3H * C57BL/6)
|
decreased double-positive T cell number
|
J:70572
|
Tg(DO11.10)10Dlo/?
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S/Sv * BALB/c * C3H * C57BL/6)
|
arrested T cell differentiation
|
J:131287
|
Tg(EEF1A1-SHC1*)1Ravi/?
Tg(Lck-cre)1Cwi/?
(involves: 129 * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:78180
|
| decreased double-positive T cell number
|
J:78180
|
Tg(EIF1AX-Il31ra)1Jagr/0
(involves: C3H * C57BL/6)
|
abnormal leukopoiesis
|
J:91124
|
| cutaneous mastocytosis
|
J:91124
|
Tg(Emu-Zfp521)1Homy/0
(Not Specified)
|
abnormal B cell differentiation
|
J:160392
|
Tg(EPO33)72Ptc/0
(involves: C57BL/6J * SJL/J)
|
increased hematocrit
|
J:92650
|
Tg(Fabp2-Arg1)1Wla/Tg(Fabp2-Arg1)1Wla
(involves: FVB)
|
abnormal B cell differentiation
|
J:80204
|
| decreased transitional stage B cell number
|
J:80204
|
Tg(FCGR2A)11Mkz/0
(involves: C57BL/6 * SJL)
|
abnormal platelet morphology
|
J:93244
|
Tg(FCGR2A)11Mkz/0
Tg(PF4)#Zcy/0
(involves: C57BL/6 * SJL)
|
thrombocytopenia
|
J:72220
|
Tg(Gata1-Dyrk3)FND-IDowo/0
(involves: C57BL/6 * DBA/2)
|
abnormal erythropoiesis
|
J:144586
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
decreased erythrocyte cell number
|
J:104241
|
| increased neutrophil cell number
|
J:104241
|
| increased nucleated erythrocyte cell number
|
J:104241
|
Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6)
|
abnormal double-negative T cell morphology
|
J:81133
|
Tg(H2-Ea-Il7)10Rhdr/0
(involves: C57BL/6 * DBA/2)
|
increased pro-B cell number
|
J:171924
|
Tg(H2-Ea-Tnfsf9)16Lpc/0
(involves: C57BL/6)
|
increased granulocyte number
|
J:132372
|
Tg(H2-K-Cd86)7All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
Tg(H2-K-Cd86)27All/0
(involves: C57BL/6J * CBA)
|
abnormal B cell differentiation
|
J:112475
|
Tg(H2-K-DUSP5)21Wjl/0
(involves: C57BL/6J * CBA)
|
increased double-positive T cell number
|
J:138077
|
Tg(H2-K-Fosl1)1Wag/0
(involves: C57BL/6 * CBA)
|
extramedullary hematopoiesis
|
J:64494
|
Tg(H2-K-IL6)2Srj/0
(B6.Cg-Tg(H2-K-IL6)2Srj)
|
abnormal definitive hematopoiesis
|
J:185153
|
| abnormal granulocyte morphology
|
J:185153
|
| extramedullary hematopoiesis
|
J:185153
|
Tg(H2-K-MC159/EGFP)13Fkmc/0
(involves: C57BL/6)
|
abnormal lymphopoiesis
|
J:138050
|
Tg(H2-K-MC159/EGFP)13Fkmc/Tg(H2-K-MC159/EGFP)13Fkmc
(involves: C57BL/6)
|
increased double-negative T cell number
|
J:138050
|
Tg(H2-K-TcrbP14)128Mak/?
(involves: C57BL/6 * C57L * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:111265
|
| abnormal T cell clonal deletion
|
J:111265
|
| abnormal T cell differentiation
|
J:111265
|
Tg(H2-Kb-IL21)5Wjl/0
(involves: 129)
|
abnormal B cell differentiation
|
J:93740
|
| abnormal class switch recombination
|
J:93740
|
| decreased transitional stage T2 B cell number
|
J:93740
|
| increased immature B cell number
|
J:93740
|
| increased transitional stage T1 B cell number
|
J:93740
|
Tg(H2-Kb-Jak2*V617F)2Shmd/0
(involves: C57BL/6 * DBA/2)
|
abnormal definitive hematopoiesis
|
J:130189
|
| decreased erythrocyte cell number
|
J:130189
|
| decreased hematocrit
|
J:130189
|
| decreased hemoglobin content
|
J:130189
|
| giant platelets
|
J:130189
|
| increased neutrophil cell number
|
J:130189
|
| increased number of Howell-Jolly bodies
|
J:130189
|
| myeloid hyperplasia
|
J:130189
|
| polychromatophilia
|
J:130189
|
| thrombocytosis
|
J:130189
|
Tg(H2-L-IL6)1Kish/Tg(H2-L-IL6)1Kish
(C57BL/6-Tg(H2-L-IL6)1Kish)
|
abnormal definitive hematopoiesis
|
J:128016
|
| abnormal myelopoiesis
|
J:128016
|
| decreased erythrocyte cell number
|
J:128016
|
| decreased hemoglobin content
|
J:128016
|
| increased neutrophil cell number
|
J:128016
|
| thrombocytosis
|
J:128016
|
Tg(H2KmPCC)2939Stoe/0
Tg(Tcra2B4)1Mmd/0
Tg(Tcrb2B4)1Mmd/0
(involves: C3H/HeJ * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:50143
|
Tg(HBB-Gata1)G4Phi/Y
(involves: 129P2/OlaHsd * FVB)
|
abnormal erythropoiesis
|
J:63773
|
Tg(HBB-Gata1)G4Phi/Y
(involves: FVB)
|
abnormal erythropoiesis
|
J:98277
|
Tg(HBB-Myc)#Cos/0
(involves: C57BL/6J * CBA/J)
|
decreased hematocrit
|
J:276641
|
Tg(HBVX*,-Myc)#Skp/Tg(HBVX*,-Myc)#Skp
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:81098
|
Tg(Igh3H9)41Mwg/?
(involves: C57BL/6 * SJL)
|
abnormal B cell differentiation
|
J:119625
|
Tg(Igh*-Mir125b-1)5Toki/0
(Not Specified)
|
decreased hemoglobin content
|
J:178816
|
Tg(Igh*-Mir125b-1)116Toki/0
(Not Specified)
|
decreased hemoglobin content
|
J:178816
|
Tg(Igh-6-Cd80)1Gjf/0
(NOD.FVB-Tg(Igh-6-Cd80)1Gjf/JbsJ)
|
decreased immature B cell number
|
J:131077
|
Tg(Igh-HOX11)11Idd/0
(CD-1)
|
abnormal immunoglobulin V(D)J recombination
|
J:52782
|
| myeloid hyperplasia
|
J:52782
|
Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro/0
(FVB/N-Tg(Igh-Mir29a,-Mir29b-1,-hrGFP)#Cro)
|
abnormal lymphopoiesis
|
J:162077
|
Tg(Igh-Mir155)8Cro/0
(involves: FVB/N)
|
abnormal lymphopoiesis
|
J:109591
|
| extramedullary hematopoiesis
|
J:109591
|
Tg(Igh-Mir210)#aKgcs/Tg(Igh-Mir210)#aKgcs
(B6.Cg-Tg(Igh-Mir210)#aKgcs)
|
abnormal class switch recombination
|
J:205868
|
| decreased pro-B cell number
|
J:205868
|
Tg(IGH@yH1)2BJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin heavy chain V(D)J recombination
|
J:23827
|
Tg(IghelMD4)4Ccg/0
(involves: C3H/HeJ * C57BL/6)
|
decreased pro-B cell number
|
J:115059
|
Tg(IghelMD4)4Ccg/0
(involves: C57BL/6)
|
decreased pro-B cell number
|
J:115059
|
Tg(IghelMD4)4Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg)
|
abnormal immature B cell morphology
|
J:109923
|
| abnormal pro-B cell morphology
|
J:109923
|
| increased immature B cell number
|
J:78308,
J:132538
|
Tg(IghelMD4)4Ccg/?
Tg(KLK4mHEL)6Ccg/?
(involves: C57BL/6)
|
arrested B cell differentiation
|
J:78307
|
| increased immature B cell number
|
J:78307
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(NOD.B6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg/Dvs)
|
abnormal B cell clonal deletion
|
J:89156
|
Tg(IghelMD4)4Ccg/0
Tg(ML5sHEL)5Ccg/0
(C57BL/6-Tg(IghelMD4)4Ccg Tg(ML5sHEL)5Ccg)
|
abnormal immature B cell morphology
|
J:109923
|
| abnormal pro-B cell morphology
|
J:109923
|
Tg(IghelMD4)4Ccg/Tg(IghelMD4)4Ccg
(involves: C57BL/6)
|
decreased pro-B cell number
|
J:171924
|
Tg(IghMyc)22Bri/0
(involves: C57BL/6 * SJL)
|
abnormal lymphopoiesis
|
J:78177
|
Tg(IghMyc)22Bri/0
Tg(Igk-V21-Bax)1967Bvn/0
(involves: C57BL/6 * FVB/N)
|
increased transitional stage B cell number
|
J:89049
|
Tg(Igk-Eik-H2-Ead)1Flv/0
Tg(Tcra1H3.1,Tcrb1H3.1)1Vire/0
(involves: C57BL/6 * SJL)
|
decreased double-positive T cell number
|
J:124574
|
Tg(Igk-V21-Bax)1967Bvn/0
(involves: FVB/N)
|
increased transitional stage B cell number
|
J:89049
|
Tg(IGK@yK1)9.2CJkbv/0
(involves: 129P2/OlaHsd)
|
abnormal immunoglobulin light chain V-J recombination
|
J:23827
|
Tg(Igkv3-5*-MYC)24Plbe/0
(C57BL/6J-Tg(Igkv3-5*-MYC)DLoxP4Plbe/PlbeMmmh)
|
abnormal hemoglobin
|
J:131912
|
| abnormal plasma cell differentiation
|
J:131912
|
Tg(Igl-2MOPC315)1275Ust/?
(C57BL/6-Tg(Igl-2MOPC315)1275Ust)
|
decreased immature B cell number
|
J:134666
|
Tg(Ins2-GP)#Psoh/0
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell selection
|
J:81285
|
Tg(Ins2-TFRC/OVA)296Wehi/0
Tg(TcraTcrb)425Cbn/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased double-positive T cell number
|
J:135154
|
Tg(ITGAL-Hhex)2Hro/0
(C3HeB/FeJ-Tg(ITGAL-Hhex)2Hro)
|
abnormal common myeloid progenitor cell morphology
|
J:80777
|
| abnormal definitive hematopoiesis
|
J:80777
|
| abnormal double-negative T cell morphology
|
J:80777
|
| decreased double-positive T cell number
|
J:80777
|
Tg(ITGAL-Ptprc)FWcr/Tg(ITGAL-Ptprc)FWcr
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:158876
|
Tg(ITGAM-HBEGF/EGFP)34Lan/0
(involves: FVB/N)
|
increased neutrophil cell number
|
J:95141
|
Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh/0
(C57BL/6-Tg(Itgax-EGFP,-cre,-HBEGF,-luc)2Gjh)
|
increased neutrophil cell number
|
J:194800
|
Tg(Itgax-HBEGF/OVA/EGFP)1Garbi/0
(C57BL/6-Tg(Itgax-HBEGF/OVA/EGFP)1Garbi)
|
increased neutrophil cell number
|
J:194800
|
Tg(Itgax-TGFBR2)1Flv/0
(C.Cg-Tg(Itgax-TGFBR2)1Flv)
|
abnormal NK cell differentiation
|
J:98953
|
Tg(JAK2*V617F)FF1Rsko/0
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal common myeloid progenitor cell morphology
|
J:134364
|
| abnormal erythropoiesis
|
J:134364
|
| abnormal myelopoiesis
|
J:134364
|
| decreased hemoglobin content
|
J:134364
|
| extramedullary hematopoiesis
|
J:134364
|
| increased neutrophil cell number
|
J:134364
|
| thrombocytosis
|
J:134364
|
Tg(JAK2*V617F)FF1Rsko/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal erythropoiesis
|
J:134364
|
| abnormal myelopoiesis
|
J:134364
|
| decreased mean corpuscular volume
|
J:134364
|
| extramedullary hematopoiesis
|
J:134364
|
| increased erythrocyte cell number
|
J:134364
|
| increased hemoglobin content
|
J:134364
|
| increased neutrophil cell number
|
J:134364
|
| thrombocytosis
|
J:134364
|
Tg(JAK2*V617F)FF1Rsko/0
Tg(Tek-cre)1Arnd/0
(involves: C57BL/6 * CBA * DBA/2)
|
abnormal common myeloid progenitor cell morphology
|
J:206659
|
| abnormal erythropoiesis
|
J:206659
|
| increased neutrophil cell number
|
J:206659
|
| increased red blood cell distribution width
|
J:206659
|
| thrombocytosis
|
J:206659
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
increased neutrophil cell number
|
J:294084,
J:300960,
J:302313
|
Tg(Kit*D814V)1Roer/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal mast cell morphology
|
J:169611
|
| increased mast cell number
|
J:169611
|
Tg(Kit*D814V)2Roer/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal mast cell morphology
|
J:169611
|
| increased mast cell number
|
J:169611
|
Tg(Kit*D814V)3Roer/0
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
abnormal mast cell morphology
|
J:169611
|
| increased mast cell number
|
J:169611
|
Tg(KLK4mHEL)6Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
Tg(KRT5-rtTA)1Glk/0
Tg(tetO/CMV-Tslp)#Sfz/0
(C.Cg-Tg(KRT5-rtTA)1Glk Tg(tetO/CMV-Tslp)#Sfz)
|
decreased hematocrit
|
J:182756
|
Tg(KRT5-rtTA)#Glk/0
Tg(tetO-cre)1Jaw/0
Wlstm1.1Lan/Wlstm1.1Lan
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
cutaneous mastocytosis
|
J:204142
|
Tg(KRT5-TGFB1)F2020Xjw/0
(involves: C57BL/6 * DBA/2 * ICR)
|
cutaneous mastocytosis
|
J:90118
|
Tg(KRT5-tTA)1216Glk/0
Tg(tetO-Il13)1Tazh/0
(B6.Cg-Tg(KRT5-tTA)1216Glk Tg(tetO-Il13)1Tazh)
|
cutaneous mastocytosis
|
J:150232
|
Tg(KRT14-CASP1)1Miz/0
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:78602
|
Tg(KRT14-Il18)#Knak/0
(C57BL/6-Tg(KRT14-Il18)#Knak)
|
increased neutrophil cell number
|
J:78602
|
Tg(KRT14-Vegfa)3Dtm/0
(FVB/N-Tg(KRT14-Vegfa)3Dtm)
|
increased mast cell number
|
J:104245
|
Tg(LANA,vFLIP,vCYC)801Dtmr/?
(involves: C57BL/6)
|
abnormal B cell differentiation
|
J:196403
|
| extramedullary hematopoiesis
|
J:196403
|
Tg(Lck-Akt1*)M-1Pnt/0
(involves: C3H/He * C57BL/6)
|
increased double-negative T cell number
|
J:135903
|
Tg(Lck-Akt1*E40K)E-3Pnt/0
(Not Specified)
|
abnormal T cell differentiation
|
J:144975
|
Tg(Lck-cre)548Jxm/?
Upf2tm1Btp/Upf2tm1Btp
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:134765
|
| decreased double-positive T cell number
|
J:134765
|
Tg(Lck-FADD)1Hed/0
(involves: BALB/c * C57BL/6)
|
arrested T cell differentiation
|
J:100451
|
Tg(Lck-FADD)1Hed/Tg(Lck-FADD)1Hed
(involves: BALB/c * C57BL/6)
|
abnormal T cell differentiation
|
J:100451
|
Tg(Lck-Hhex)1Hro/0
(C3HeB/FeJ-Tg(Lck-Hhex)1Hro)
|
abnormal double-negative T cell morphology
|
J:80777
|
| decreased double-positive T cell number
|
J:80777
|
Tg(Lck-Il31)1Jagr/0
(involves: C3H * C57BL/6)
|
abnormal leukopoiesis
|
J:91124
|
| cutaneous mastocytosis
|
J:91124
|
Tg(Lck-LMO1)11Sjk/0
Tg(STIL-TAL1)A5(3)Alpa/0
(involves: C3H * C3H/HeRos * C57BL/6 * C57BL/10Ros)
|
decreased erythrocyte cell number
|
J:40868
|
| thrombocytopenia
|
J:40868
|
Tg(LCK-NFKBIA)5Dwb/0
(involves: C57BL/6 * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93003
|
Tg(Lck-Notch3)#Issc/0
(involves: C57BL/6 * DBA/2)
|
abnormal T cell differentiation
|
J:63300
|
| increased double-negative T cell number
|
J:63300
|
Tg(Lck-Socs3)1Kubo/0
(Not Specified)
|
abnormal CD4-positive T cell differentiation
|
J:132905
|
Tg(Lck-Sox13)#Jskg/0
(involves: C57BL/6)
|
decreased double-positive T cell number
|
J:117301
|
Tg(Lck-Stk17b)26.1Wals/?
(B6.Cg-Tg(Lck-Stk17b)26.1Wals)
|
increased double-positive T cell number
|
J:149973
|
Tg(Lck-Stk17b)26.1Wals/?
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * C57BL/10)
|
abnormal T cell differentiation
|
J:149973
|
Tg(Lck-Tnfsf14)24Yxf/?
(C57BL/6-Tg(Lck-Tnfsf14)24Yxf)
|
extramedullary hematopoiesis
|
J:129951
|
Tg(Lck-VIPR2)1Ejg/0
(C57BL/6-Tg(Lck-VIPR2)1Ejg)
|
increased eosinophil cell number
|
J:127974
|
Tg(LckIl4)1315Dbl/0
(involves: C57BL/6J * DBA/2J)
|
abnormal T cell differentiation
|
J:92453
|
| decreased double-positive T cell number
|
J:92453
|
| increased double-negative T cell number
|
J:92453
|
Tg(LckNotch1)9Erob/?
(involves: C57BL/6 * CBA/J)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:93005
|
Tg(LCKprBCL2)36Sjk/0
(involves: C57BL/6 * CBA/J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
Tg(Nr4a1-EGFP/cre)820Khog/0
(involves: C57BL/6 * C57BL/6J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(LCKprBCL2)36Sjk/0
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: C57BL/6 * C57BL/6J * DBA/2J)
|
abnormal T cell clonal deletion
|
J:217939
|
Tg(LCR-HBA2,LCR-HBB*)1Cos/0
(involves: C57BL/6J * CBA/J)
|
abnormal erythrocyte morphology
|
J:94193
|
| decreased hematocrit
|
J:94193
|
| increased mean corpuscular hemoglobin concentration
|
J:94193
|
Tg(Ly6a-BCR/ABL1)IS1AIsg/0
(involves: C57BL/6J * CBA)
|
increased neutrophil cell number
|
J:144382
|
Tg(Ly6a-BCR/ABL1)IS1BIsg/0
(involves: C57BL/6J * CBA)
|
increased neutrophil cell number
|
J:144382
|
Tg(Ly6a-SET/NUP214)2969Gcg/0
(involves: FVB/NJ)
|
abnormal B cell differentiation
|
J:142938
|
| abnormal common myeloid progenitor cell morphology
|
J:142938
|
| abnormal definitive hematopoiesis
|
J:142938
|
| decreased pro-B cell number
|
J:142938
|
Tg(Ly6a-TK,-BCR/ABL1)IS9AIsg/0
(involves: C57BL/6J * CBA)
|
increased neutrophil cell number
|
J:144382
|
Tg(Ly6e-MALT1)#Isg/0
(involves: C57BL/6 * CBA)
|
increased pro-B cell number
|
J:185590
|
Tg(MCL1)8Caig/0
(involves: C57BL/6 * SJL)
|
abnormal common myeloid progenitor cell morphology
|
J:50604,
J:69755
|
| abnormal immature B cell morphology
|
J:50604
|
| abnormal mast cell differentiation
|
J:50604
|
| abnormal monocyte differentiation
|
J:50604
|
| extramedullary hematopoiesis
|
J:50604
|
Tg(Mcpt8-cre)1Voeh/0
(involves: C57BL/6)
|
decreased basophil cell number
|
J:164432
|
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
Tg(ML5sHEL)5Ccg/0
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6JSfd * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
increased mast cell number
|
J:182703
|
| increased neutrophil cell number
|
J:182703
|
Tg(Mt1-IL6)28Gci/0
(involves: C57BL/6 * DBA/2)
|
extramedullary hematopoiesis
|
J:177825
|
| increased granulocyte number
|
J:177825
|
| increased mean platelet volume
|
J:18424
|
| increased neutrophil cell number
|
J:18424
|
Tg(Mx1-cre)1Cgn/0
Tg(Tal1-tTA)19Dgt/0
Tg(tetO-BCR/ABL1)2Dgt/0
TgTn(pb-sb-GrOnc)#aGsva/0
(involves: C57BL/6 * CBA/J * DBA/2 * FVB/N)
|
increased granulocyte number
|
J:227558
|
Tg(Mx1-cre)1Cgn/0
Thoc5tm1Tate/Thoc5tm1Tate
(involves: C57BL/6 * CBA)
|
abnormal lymphopoiesis
|
J:169944
|
| decreased common myeloid progenitor cell number
|
J:169944
|
| decreased erythrocyte cell number
|
J:169944
|
| decreased hematocrit
|
J:169944
|
| decreased hemoglobin content
|
J:169944
|
| thrombocytopenia
|
J:169944
|
Tg(Mx1-cre)1Cgn/0
Tnfrsf13ctm2.1Mass/Tnfrsf13ctm2.1Mass
(involves: C57BL/6 * CBA)
|
increased immature B cell number
|
J:170519
|
| increased pro-B cell number
|
J:170519
|
Tg(Mx1-cre)1Cgn/0
U2af1tm1.1Hev/U2af1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6J * CBA/J)
|
decreased erythrocyte cell number
|
J:267082
|
| decreased hematocrit
|
J:267082
|
| decreased hemoglobin content
|
J:267082
|
| increased mean corpuscular volume
|
J:267082
|
Tg(Mx1-cre)1Cgn/0
U2af1tm1Mohi/U2af1tm1Mohi
(involves: C57BL/6J * CBA/J)
|
decreased common myeloid progenitor cell number
|
J:308564
|
| decreased erythrocyte cell number
|
J:308564
|
| decreased hemoglobin content
|
J:308564
|
| decreased neutrophil cell number
|
J:308564
|
| thrombocytopenia
|
J:308564
|
Tg(PF4-tTA/VP16)42Kra/0
Tg(tetO-Aurkb,lacZ)41Kra/0
(FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra)
|
abnormal thrombopoiesis
|
J:104239
|
Tg(Pgk1-HA)1.1Vbo/?
Tg(Tcra/Tcrb)1Vbo/?
(involves: 129 * BALB/c * C57BL/6J * DBA/2J)
|
increased double-positive T cell number
|
J:125750
|
Tg(Pkd1)6Mtru/0
(involves: C57BL/6J * CBA/J)
|
decreased hematocrit
|
J:157952
|
Tg(Pkd1)18Mtru/0
(involves: C57BL/6J * CBA/J)
|
decreased hematocrit
|
J:157952
|
Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J)
|
decreased hematocrit
|
J:157952
|
Tg(Pkd1*)39Mtru/0
(involves: C57BL/6J * CBA/J)
|
decreased hematocrit
|
J:198147
|
Tg(PML-RARA)556Kog/?
(involves: FVB/N)
|
abnormal neutrophil differentiation
|
J:39327
|
| thrombocytopenia
|
J:39327
|
Tg(PML-RARA)556Kog/0
(FVB/N-Tg(PML-RARA)556Kog)
|
thrombocytosis
|
J:262172
|
Tg(Scgb1a1-rtTA,tetO-Ifng)14Eli/0
(involves: C57BL/6 * CBA)
|
increased neutrophil cell number
|
J:100854
|
Tg(SERPINA1-IGHG1/Il1rl1)423Zbz/?
(involves: C3H * C57BL/6)
|
increased eosinophil cell number
|
J:63507
|
Tg(SERPINC1-SV40)A1Pbr/0
(involves: C57BL/6 * DBA/2)
|
anisocytosis
|
J:101541
|
Tg(SFTPC-rtTA,tetO-Tnf)320-1Gwho/0
(involves: C57BL/6 * SJL)
|
increased neutrophil cell number
|
J:97297
|
Tg(SFTPC-Tnf)2Pva/0
(involves: C57BL/6 * DBA/2)
|
abnormal platelet cell number
|
J:28120
|
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
decreased eosinophil cell number
|
J:129215
|
| increased basophil cell number
|
J:129215
|
Tg(Stat3*)9199Alau/0
(involves: C57BL/6)
|
abnormal T-helper 17 cell differentiation
|
J:210877
|
| increased neutrophil cell number
|
J:210877
|
Tg(SV40-Ahr)1Poe/0
(involves: C57BL/6 * CBA)
|
increased pro-B cell number
|
J:82428
|
Tg(SV40-Igh-64C8)H3Hon/0
Tg(SV40-Igk4C8)L1Hon/0
(involves: C57BL/6)
|
abnormal B cell clonal deletion
|
J:139864
|
| decreased hematocrit
|
J:139864
|
Tg(Tagln-rtTA)E1Jwst/0
Tg(tetO-BMPR2*T504)1Jwst/0
(involves: FVB/N)
|
increased hematocrit
|
J:98898
|
Tg(TCF3/HLF)1Mlc/0
(involves: FVB/N)
|
arrested T cell differentiation
|
J:55022
|
| decreased double-positive T cell number
|
J:55022
|
Tg(Tcra2B4)1Mmd/?
(involves: C3H/HeJ * C57BL/6)
|
decreased double-positive T cell number
|
J:92992
|
| increased double-negative T cell number
|
J:92992
|
Tg(Tcra51-11.5,Tcrb51-11.5)AR206Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
Tg(Tcra,Tcrb)3Ayr/0
(involves: C57BL/6 * DBA/2)
|
abnormal positive T cell selection
|
J:125548
|
Tg(Tcra,Tcrb)24Efro/0
(D1.Cg-Tg(Tcra,Tcrb)24Efro)
|
abnormal T cell differentiation
|
J:104243
|
Tg(TcraCl4,TcrbCl4)1Shrm/?
(B10.Cg-H2d Tg(TcraCl4,TcrbCl4)1Shrm)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:99756
|
Tg(TcraDN32D3)#Alhn/0
(involves: NOD)
|
increased double-negative T cell number
|
J:201417
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6J * C57L/J * DBA/2J)
|
abnormal double-negative T cell morphology
|
J:79738
|
| abnormal T cell differentiation
|
J:79738,
J:90776
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151074
|
| abnormal positive T cell selection
|
J:151074
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
Themistm1Lov/Themistm1Lov
(involves: 129 * C57BL/6 * DBA/2)
|
abnormal negative T cell selection
|
J:151075
|
| abnormal positive T cell selection
|
J:151075
|
| increased double-positive T cell number
|
J:151075
|
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd * C57BL/6J * DBA/2J)
|
abnormal negative T cell selection
|
J:84536
|
Tg(TcrAND)53Hed/?
(involves: A/WySnSg * C57BL/6 * C57BL/10SnSg * SJL)
|
abnormal positive T cell selection
|
J:85777
|
| abnormal T cell differentiation
|
J:85777
|
| decreased double-positive T cell number
|
J:85777
|
Tg(TcrAND)53Hed/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
Tg(TcrAND)53Hed/?
Themistm1Lov/Themistm1Lov
(involves: 129 * C57BL/6 * SJL)
|
abnormal positive T cell selection
|
J:151075
|
| increased double-positive T cell number
|
J:151075
|
Tg(TcrAND)53Hed/?
Zbtb7btm1.1Rbo/Zbtb7btm1.1Rbo
(involves: C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:141145
|
Tg(TcraR28,TcrbR28)KRNDim/0
(involves: C57BL/6 * NOD * SJL)
|
abnormal T cell clonal deletion
|
J:36815
|
Tg(TcraTcrb)425Cbn/0
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:125548
|
Tg(TcraTcrb)425Cbn/?
(involves: BALB/c * C57BL/6)
|
abnormal positive T cell selection
|
J:87876
|
Tg(TcraTcrb)1100Mjb/?
(involves: C57BL/6)
|
abnormal positive T cell selection
|
J:92867,
J:133645
|
| abnormal T cell clonal deletion
|
J:92867
|
Tg(TcraTcrb)1100Mjb/?
Themistm1Gasc/Themistm1Gasc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
Tg(Tcrb)93Vbo/0
(involves: C57BL/LiA * CBA/BrA)
|
abnormal T cell receptor beta chain V(D)J recombination
|
J:93247
|
Tg(Tcrb)93Vbo/0
(involves: C57BL/6 * C57BL/LiA * CBA/BrA)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:66565
|
| abnormal T cell clonal deletion
|
J:66565
|
Tg(TcrHEL3A9)1Mmd/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
abnormal double-positive T cell morphology
|
J:78309
|
Tg(TcrHEL3A9)1Mmd/0
Tg(TLK2mHEL)2Ccg/0
(involves: C57BL/6 * C57BL/10 * C57BR/cd)
|
decreased double-positive T cell number
|
J:78309
|
Tg(TcrLCMV)1Aox/?
(C57BL/6-Tg(TcrLCMV)1Aox)
|
decreased double-positive T cell number
|
J:92228
|
| increased double-negative T cell number
|
J:92228
|
Tg(TcrLCMV)2Aox/?
(C57BL/6-Tg(TcrLCMV)2Aox)
|
decreased double-positive T cell number
|
J:92228
|
| increased double-negative T cell number
|
J:92228
|
Tg(TcrLCMV)327Sdz/0
(involves: C57BL/6 * DBA/2)
|
decreased double-positive T cell number
|
J:77696
|
Tg(TcrLCMV)327Sdz/?
(involves: C57BL/6 * DBA/2J)
|
abnormal T cell differentiation
|
J:97610
|
Tg(Tek-cre)1Ywa/0
Thbdtm2Rdr/Thbdtm2Wlr
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
thrombocytopenia
|
J:71269
|
Tg(Tek-tTA)1Dmt/0
Tg(tetO-Tek)1Dmt/0
(involves: CD-1)
|
increased eosinophil cell number
|
J:137745
|
Tg(tetO-BCR/ABL1)2Dgt/0
Tg(MMTVtTA)1Mam/0
(involves: C57BL/6 * FVB/N * SJL)
|
thrombocytopenia
|
J:72377
|
Tg(tetO-BCR/ABL1)2Dgt/0
Tg(Tal1-tTA)19Dgt/0
(involves: C57BL/6 * DBA/2 * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:96511
|
| abnormal definitive hematopoiesis
|
J:96511
|
| abnormal lymphopoiesis
|
J:96511
|
| increased neutrophil cell number
|
J:96511
|
Tg(tetO-BCR/ABL1)27Dgt/0
Tg(MMTVtTA)1Mam/0
(involves: C57BL/6 * FVB/N * SJL)
|
thrombocytopenia
|
J:72377
|
Tg(Thy1-Fcer2a)2431Putt/?
(involves: BALB/c * C57BL/6)
|
increased eosinophil cell number
|
J:20421
|
Tg(Thy1/THY1)T6Gsv/0
(involves: C57BL/10 * CBA)
|
increased neutrophil cell number
|
J:294621
|
Tg(Tlr7)1Boll/0
(involves: C57BL/6)
|
extramedullary hematopoiesis
|
J:127600
|
| thrombocytopenia
|
J:127600
|
Tg(Tnfsf13b)1Fma/0
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
abnormal B cell differentiation
|
J:73711
|
Tg(Tnfsf13b)1Fma/0
(involves: C57BL/6J * DBA/2J)
|
abnormal B cell differentiation
|
J:115788
|
Tg(Tnfsf13b)1Fma/?
(B6.Cg-Tg(Tnfsf13b)1Fma)
|
increased transitional stage B cell number
|
J:113556
|
Tg(Tnfsf13b)1Fma/?
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(B6.Cg-Tnfrsf13btm1Rjb Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Tg(Tnfsf13b)1Fma/?
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(B6.Cg-Tnfrsf13ctm1Mass Tg(Tnfsf13b)1Fma)
|
abnormal class switch recombination
|
J:113556
|
Tg(Tnfsf13b)1Fma/Tg(Tnfsf13b)1Fma
(involves: C57BL/6 * DBA/2)
|
increased transitional stage T2 B cell number
|
J:178227
|
Tg(UBC-scFv)2Nemz/0
(involves: C57BL/6 * DBA/2)
|
abnormal B cell differentiation
|
J:96759
|
| abnormal B cell receptor editing
|
J:96759
|
Tg(Vav1-Asxl1*Y588X)#Fcy/0
(C57BL/6-Tg(Vav1-Asxl1*Y588X)#Fcy)
|
abnormal definitive hematopoiesis
|
J:257690
|
| abnormal neutrophil morphology
|
J:257690
|
| decreased erythrocyte cell number
|
J:257690
|
| decreased hemoglobin content
|
J:257690
|
| increased neutrophil cell number
|
J:257690
|
| increased number of Howell-Jolly bodies
|
J:257690
|
| thrombocytosis
|
J:257690
|
Tg(Vav1-JAK2*V617F)AZjz/0
(involves: C57BL/6 * DBA/2)
|
abnormal definitive hematopoiesis
|
J:135993
|
| giant platelets
|
J:135993
|
| increased erythrocyte cell number
|
J:135993
|
| increased granulocyte number
|
J:135993
|
| increased hematocrit
|
J:135993
|
| increased hemoglobin content
|
J:135993
|
| microcytosis
|
J:135993
|
| thrombocytosis
|
J:135993
|
Tg(Vav1-Lin28b)C3Apla/0
(involves: C57BL/6)
|
abnormal T cell differentiation
|
J:189197
|
| decreased double-positive T cell number
|
J:189197
|
| increased eosinophil cell number
|
J:189197
|
| increased neutrophil cell number
|
J:189197
|
Tg(Vav1-NUP98/HOXD13)C1Apla/0
(FVB/N-Tg(Vav1-NUP98/HOXD13)C1Apla)
|
abnormal definitive hematopoiesis
|
J:107446
|
| abnormal neutrophil morphology
|
J:107446
|
| anisocytosis
|
J:107446
|
| giant platelets
|
J:107446
|
| increased mean corpuscular volume
|
J:107446
|
| increased nucleated erythrocyte cell number
|
J:107446
|
| poikilocytosis
|
J:107446
|
| polychromatophilia
|
J:107446
|
Tg(Vav1-NUP98/HOXD13)G2Apla/0
(C57BL/6-Tg(Vav1-NUP98/HOXD13)G2Apla)
|
abnormal definitive hematopoiesis
|
J:107446
|
| abnormal neutrophil morphology
|
J:107446
|
| anisocytosis
|
J:107446
|
| decreased neutrophil cell number
|
J:107446
|
| increased nucleated erythrocyte cell number
|
J:107446
|
| poikilocytosis
|
J:107446
|
| polychromatophilia
|
J:107446
|
Tg(Vav1-STAT5B*N642H)726Biat/0
(C57BL/6NCrl-Tg(Vav1-STAT5B*N642H)726Biat)
|
increased common myeloid progenitor cell number
|
J:257519
|
Tg(Vav-BCL2)69Jad/0
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:88565
|
| abnormal somatic hypermutation frequency
|
J:88565
|
Tg(VIM-Tag)3Pau/0
(involves: C57BL/6 * SJL/J)
|
increased double-negative T cell number
|
J:91542
|
Tgcog/Tgcog
(involves: AKR/J * C57BL/6By)
|
decreased hematocrit
|
J:8567
|
Tgfb1tm1N/Tgfb1tm1N
(involves: 129S/SvEv * C57BL/6J * NIH/Ola)
|
abnormal embryonic erythropoiesis
|
J:26913
|
| abnormal embryonic hematopoiesis
|
J:26913
|
Tgfbr2tm1.1Karl/Tgfbr2tm1.1Karl
(involves: 129/Sv * C57BL/6)
|
abnormal erythropoiesis
|
J:77844
|
Tgfbr2tm1Mmt/Tgfbr2tm1Mmt
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal embryonic hematopoiesis
|
J:73414
|
Tgfbr3tm1Stv/Tgfbr3tm1Stv
(involves: 129/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:83727
|
Tgm2tm1Gml/Tgm2tm1Gml
(involves: 129X1/SvJ * C57BL/6)
|
decreased erythrocyte cell number
|
J:75566
|
| decreased hematocrit
|
J:75566
|
Thap11em1Poche/Thap11em1Poche
(C57BL/6J-Thap11em1Poche)
|
decreased erythrocyte cell number
|
J:317822
|
| decreased hematocrit
|
J:317822
|
| decreased hemoglobin content
|
J:317822
|
| thrombocytopenia
|
J:317822
|
Thbs1tm1Hyn/Thbs1tm1Hyn
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * C57BL/6))
|
increased eosinophil cell number
|
J:46182
|
| increased neutrophil cell number
|
J:46182
|
Thbs2tm1Bst/Thbs2tm1Bst
(either: (involves: 129S4/SvJae * 129X1/SvJ) or (involves: 129X1/SvJ))
|
thrombocytosis
|
J:45509
|
Themism5Btlr/Themism5Btlr
(C57BL/6J-Themism5Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:274716
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274716
|
| abnormal T cell differentiation
|
J:274716
|
ThemisSpotr/ThemisSpotr
(C57BL/6-ThemisSpotr)
|
abnormal T cell differentiation
|
J:152601
|
Themistm1Gasc/Themistm1Gasc
(B6.129S-Themistm1Gasc)
|
abnormal positive T cell selection
|
J:151074
|
| increased double-positive T cell number
|
J:151074
|
Themistm1Hasu/Themistm1Hasu
(involves: C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:153235
|
Themistm1Lov/Themistm1Lov
(involves: 129)
|
abnormal negative T cell selection
|
J:151075
|
| abnormal T cell differentiation
|
J:151075
|
Thoc1em1(IMPC)Ccpcz/Thoc1+
(C57BL/6NCrl-Thoc1em1(IMPC)Ccpcz/Ccpcz)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Thoc7em1(IMPC)J/Thoc7+
(C57BL/6NJ-Thoc7em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
increased granulocyte number
|
J:290567
|
| thrombocytopenia
|
J:290567
|
Thpotm1.1(KOMP)Vlcg/Thpotm1.1(KOMP)Vlcg
(C57BL/6N-Thpotm1.1(KOMP)Vlcg/Ucd)
|
increased mean platelet volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Thpotm1Mwm/Thpo+
(involves: 129S2/SvPas * C57BL/6)
|
thrombocytopenia
|
J:83262
|
Thpotm1Mwm/Thpotm1Mwm
(involves: 129S2/SvPas * C57BL/6)
|
increased mean platelet volume
|
J:83262
|
| thrombocytopenia
|
J:83262
|
Thraem1Ffla/Thra+
(C57BL/6-Thraem1Ffla)
|
decreased hemoglobin content
|
J:268664
|
Thraem2Ffla/Thra+
(C57BL/6-Thraem2Ffla)
|
decreased hemoglobin content
|
J:268664
|
Thratm1b(EUCOMM)Wtsi/Thra+
(C57BL/6N-Thratm1b(EUCOMM)Wtsi/Ics)
|
increased hematocrit
|
J:211773
|
Thrbtm2a(EUCOMM)Wtsi/Thrbtm2a(EUCOMM)Wtsi
(C57BL/6N-Thrbtm2a(EUCOMM)Wtsi/H)
|
decreased hemoglobin content
|
J:165965
|
Thsd1tm1.1(KOMP)Vlcg/Thsd1tm1.1(KOMP)Vlcg
(C57BL/6N-Thsd1tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Tia1tm1Andp/Tia1tm1Andp
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Tia1tm1Andp Zfp36tm1Pjb)
|
increased neutrophil cell number
|
J:88443
|
Tial1tm1b(EUCOMM)Wtsi/Tial1+
(C57BL/6N-Tial1tm1b(EUCOMM)Wtsi/Wtsi)
|
thrombocytosis
|
J:211773
|
Ticam1Lps2/Ticam1Lps2
(C57BL/6J-Ticam1Lps2/J)
|
increased neutrophil cell number
|
J:288471
|
Tifabtm1.1Dsta/Tifabtm1.1Dsta
(involves: 129 * C57BL/6 * C57BL/6J)
|
abnormal neutrophil morphology
|
J:229024
|
| decreased neutrophil cell number
|
J:229024
|
Timd2tm1(GAL4)Pdre/Timd2tm1(GAL4)Pdre
(C.129S4-Timd2tm1(GAL4)Pdre)
|
increased eosinophil cell number
|
J:125054
|
Timd6tm1b(KOMP)Wtsi/Timd6+
(C57BL/6N-Timd6tm1b(KOMP)Wtsi/H)
|
increased neutrophil cell number
|
J:211773
|
Timm8a1em1(IMPC)Tcp/Timm8a1em1(IMPC)Tcp
(C57BL/6NCrl-Timm8a1em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Timp1tm1Pds/Timp1tm1Pds
(involves: 129S4/SvJae * C57BL/6)
|
increased neutrophil cell number
|
J:112941
|
Timp2em1(IMPC)Hmgu/Timp2em1(IMPC)Hmgu
(C57BL/6N-Timp2em1(IMPC)Hmgu/Ieg)
|
decreased mean corpuscular volume
|
J:211773
|
Timp2tm1Pds/Timp2tm1Pds
(involves: 129S4/SvJae * C57BL/6)
|
increased neutrophil cell number
|
J:112941
|
Timp3tm1.1(KOMP)Vlcg/Timp3tm1.1(KOMP)Vlcg
(C57BL/6N-Timp3tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular volume
|
J:211773
|
Timp3tm1Rkho/Timp3tm1Rkho
Tnftm1Gkl/Tnftm1Gkl
(involves: 129 * 129S/SvEv * C57BL/6)
|
increased neutrophil cell number
|
J:112033
|
Tinf2tm2.2Tdl/Tinf2+
(involves: BALB/cJ * C57BL/6)
|
myeloid hyperplasia
|
J:207367
|
TiparpGt(ROSA)79Sor/TiparpGt(ROSA)79Sor
(involves: 129S4/SvJaeSor)
|
decreased erythrocyte cell number
|
J:117491
|
| decreased hematocrit
|
J:117491
|
| decreased hemoglobin content
|
J:117491
|
| polychromatophilia
|
J:117491
|
Tlcd5tm1.1(KOMP)Vlcg/Tlcd5tm1.1(KOMP)Vlcg
(C57BL/6N-Tlcd5tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Tle4tm1.2Dasw/Tle4tm1.2Dasw
(B6.129S6(Cg)-Tle4tm1.2Dasw)
|
abnormal lymphopoiesis
|
J:219243
|
| decreased common myeloid progenitor cell number
|
J:219243
|
| decreased DN2 thymocyte number
|
J:219243
|
| decreased double-positive T cell number
|
J:219243
|
| decreased pre-pro B cell number
|
J:219243
|
Tlk1tm1b(EUCOMM)Hmgu/Tlk1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tlk1tm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Tln1tm4.1Crit/Tln1tm4.1Crit
Tg(Mx1-cre)1Cgn/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal platelet morphology
|
J:129708
|
| abnormal platelet shape
|
J:129708
|
Tln1tm4.1Crit/Tln1tm4.1Crit
Tg(Pf4-icre)Q3Rsko/?
(involves: 129P2/OlaHsd)
|
decreased hematocrit
|
J:129707
|
| decreased hemoglobin content
|
J:129707
|
| low mean erythrocyte cell number
|
J:129707
|
| thrombocytopenia
|
J:129707
|
Tlr4tm1Aki/Tlr4tm1Aki
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased hemoglobin content
|
J:98224
|
Tlr5tm1Flv/Tlr5tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased neutrophil cell number
|
J:111778
|
Tlr7em2Anu/Tlr7+
(C57BL/6NCrl-Tlr7em2Anu)
|
thrombocytopenia
|
J:324448
|
Tlr9tm1Aki/Tlr9tm1Aki
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
thrombocytopenia
|
J:174308
|
Tlx1tm1Sjk/Tlx1tm1Sjk
(involves: 129S2/SvPas)
|
increased neutrophil cell number
|
J:17695
|
| increased number of Howell-Jolly bodies
|
J:17695
|
Tm2d1em1(IMPC)Bay/Tm2d1+
(C57BL/6N-Tm2d1em1(IMPC)Bay/Bay)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased hematocrit
|
J:211773
|
Tm7sf2tm1b(KOMP)Wtsi/Tm7sf2tm1b(KOMP)Wtsi
(C57BL/6N-Tm7sf2tm1b(KOMP)Wtsi/Orl)
|
increased eosinophil cell number
|
J:211773
|
Tm9sf2em1(IMPC)Tcp/Tm9sf2+
(C57BL/6N-Tm9sf2em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Tmcc2em1Tar/Tmcc2em1Tar
(involves: C57BL/6JTar * CBA/WTar)
|
abnormal erythrocyte morphology
|
J:325992
|
| abnormal erythropoiesis
|
J:325992
|
| decreased erythrocyte cell number
|
J:325992
|
| decreased hematocrit
|
J:325992
|
| decreased hemoglobin content
|
J:325992
|
| decreased mean corpuscular hemoglobin concentration
|
J:325992
|
| extramedullary hematopoiesis
|
J:325992
|
| increased erythrocyte cell number
|
J:325992
|
| increased hematocrit
|
J:325992
|
| increased hemoglobin content
|
J:325992
|
| increased mean corpuscular volume
|
J:325992
|
| increased nucleated erythrocyte cell number
|
J:325992
|
Tmem8bem1(IMPC)Tcp/Tmem8b+
(C57BL/6N-Tmem8bem1(IMPC)Tcp/Tcp)
|
increased basophil cell number
|
J:211773
|
Tmem9bem1(IMPC)J/Tmem9bem1(IMPC)J
(C57BL/6NJ-Tmem9bem1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
Tmem11em1(IMPC)Tcp/Tmem11em1(IMPC)Tcp
(C57BL/6N-Tmem11em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Tmem14cGt(E295C12)Wrst/Tmem14cGt(E295C12)Wrst
(B6;129P2-Tmem14cGt(E295C12)Wrst/Llp)
|
abnormal erythropoiesis
|
J:212530
|
| abnormal hemoglobin
|
J:212530
|
| decreased cellular hemoglobin content
|
J:212530
|
Tmem72tm1b(KOMP)Wtsi/Tmem72tm1b(KOMP)Wtsi
(C57BL/6N-Tmem72tm1b(KOMP)Wtsi/Kmpc)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Tmem79tm1.1(KOMP)Wtsi/Tmem79tm1.1(KOMP)Wtsi
(C57BL/6N-Tmem79tm1.1(KOMP)Wtsi/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Tmem94tm1a(EUCOMM)Wtsi/Tmem94+
(C57BL/6N-Tmem94tm1a(EUCOMM)Wtsi/Ics)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Tmem97tm1.1(KOMP)Vlcg/Tmem97tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem97tm1.1(KOMP)Vlcg/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Tmem121bem1(IMPC)Tcp/Tmem121bem1(IMPC)Tcp
(C57BL/6NCrl-Tmem121bem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Tmem127tm1(KOMP)Wtsi/Tmem127tm1(KOMP)Wtsi
(C57BL/6N-Tmem127tm1(KOMP)Wtsi/Wtsi)
|
decreased neutrophil cell number
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Tmem129tm1.1(KOMP)Vlcg/Tmem129tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem129tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Tmem150bem1(IMPC)Ccpcz/Tmem150bem1(IMPC)Ccpcz
(C57BL/6N-Tmem150bem1(IMPC)Ccpcz/Ccpcz)
|
decreased eosinophil cell number
|
J:211773
|
Tmem163em1Lwbch/Tmem163em1Lwbch
(C57BL/6J-Tmem163em1Lwbch)
|
decreased platelet dense granule number
|
J:323340
|
Tmem165tm1e(EUCOMM)Wtsi/Tmem165tm1e(EUCOMM)Wtsi
(B6JTyr;B6N-Tmem165tm1e(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular volume
|
J:175295
|
Tmem203em1(IMPC)H/Tmem203em1(IMPC)H
(C57BL/6N-Tmem203em1(IMPC)H/H)
|
increased mean corpuscular volume
|
J:211773
|
Tmem212em1(IMPC)J/Tmem212em1(IMPC)J
(C57BL/6NJ-Tmem212em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Tmem219tm1(KOMP)Vlcg/Tmem219tm1(KOMP)Vlcg
(B6J.B6N-Tmem219tm1(KOMP)Vlcg)
|
increased eosinophil cell number
|
J:236976
|
Tmem248tm1.1(KOMP)Vlcg/Tmem248tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem248tm1.1(KOMP)Vlcg/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Tmem256tm1.1(KOMP)Vlcg/Tmem256tm1.1(KOMP)Vlcg
(C57BL/6N-Tmem256tm1.1(KOMP)Vlcg/Ucd)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
Tmigd3Tg(H2-K-CALR*)del52Shmd/0
(involves: C57BL/6 * DBA/2)
|
increased common myeloid progenitor cell number
|
J:241724
|
| thrombocytosis
|
J:241724
|
Tmod1tm1Sung/Tmod1tm1Sung
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythrocyte morphology
|
J:89956
|
Tmod2tm1b(KOMP)Wtsi/Tmod2tm1b(KOMP)Wtsi
(C57BL/6N-Tmod2tm1b(KOMP)Wtsi/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Tmod3Gt(RRF004)Byg/Tmod3Gt(RRF004)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythropoiesis
|
J:208725
|
| decreased erythrocyte cell number
|
J:208725
|
| increased nucleated erythrocyte cell number
|
J:208725
|
Tmpotm1.1Foi/Tmpotm1.1Foi
(involves: 129S1/Sv * C57BL/6)
|
increased hematocrit
|
J:145628
|
Tmprss6hem8/Tmprss6hem8
(C57BL/6J-Tmprss6hem8)
|
decreased mean corpuscular hemoglobin
|
J:237155
|
| decreased mean corpuscular volume
|
J:237155
|
Tmprss6hem8/Tmprss6tm1Dgen
(involves: C57BL/6 * C57BL/6J)
|
decreased mean corpuscular hemoglobin
|
J:237155
|
| decreased mean corpuscular volume
|
J:237155
|
Tmprss6msk/Tmprss6msk
(C57BL/6J-Tmprss6msk)
|
decreased hemoglobin content
|
J:134446
|
| decreased mean corpuscular volume
|
J:134446
|
Tmprss6tm1b(EUCOMM)Wtsi/Tmprss6tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics)
|
decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Tmprss6tm1Dgen/Tmprss6+
(B6.129P2-Tmprss6tm1Dgen/Crl)
|
decreased mean corpuscular hemoglobin concentration
|
J:160248
|
| decreased mean corpuscular volume
|
J:160248
|
Tmprss6tm1Dgen/Tmprss6+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased mean corpuscular hemoglobin concentration
|
J:160248
|
| decreased mean corpuscular volume
|
J:160248
|
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(B6.129P2-Tmprss6tm1Dgen/Crl)
|
abnormal erythrocyte morphology
|
J:160248
|
| decreased erythrocyte cell number
|
J:160248
|
| decreased hematocrit
|
J:160248
|
| decreased hemoglobin content
|
J:160248
|
| decreased mean corpuscular hemoglobin
|
J:237155
|
| decreased mean corpuscular hemoglobin concentration
|
J:160248
|
| decreased mean corpuscular volume
|
J:237155,
J:160248
|
| extramedullary hematopoiesis
|
J:160248
|
| increased red blood cell distribution width
|
J:160248
|
Tmprss6tm1Dgen/Tmprss6tm1Dgen
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
decreased erythrocyte cell number
|
J:160248
|
| decreased hematocrit
|
J:160248
|
| decreased hemoglobin content
|
J:160248
|
| decreased mean corpuscular hemoglobin concentration
|
J:160248
|
| decreased mean corpuscular volume
|
J:160248
|
| increased red blood cell distribution width
|
J:160248
|
Tmprss6tm1Otin/Tmprss6tm1Otin
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal erythrocyte morphology
|
J:138734
|
| anisopoikilocytosis
|
J:138734
|
Tmprss6tm1Otin/Tmprss6tm1Otin
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hemoglobin content
|
J:185154
|
| microcytosis
|
J:185154
|
Tmprss15tm1a(KOMP)Wtsi/Tmprss15tm1a(KOMP)Wtsi
(C57BL/6N-Tmprss15tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Tmub2tm1b(KOMP)Wtsi/Tmub2tm1b(KOMP)Wtsi
(C57BL/6N-Tmub2tm1b(KOMP)Wtsi/Tcp)
|
increased eosinophil cell number
|
J:211773
|
Tnftm1Gkl/Tnftm1Gkl
(either: B6.129-Tnftm1Gkl or (involves: 129 * C57BL/6))
|
increased neutrophil cell number
|
J:97783
|
Tnftm1Ljo/Tnftm1Ljo
(either: B6.129-Tnftm1Ljo or (involves: 129 * C57BL/6))
|
increased neutrophil cell number
|
J:97783
|
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * C57BL/6)
|
increased neutrophil cell number
|
J:127028
|
Tnftm2Gkl/Tnf+
(involves: 129S/SvEv * C57BL/6J)
|
abnormal myelopoiesis
|
J:108572
|
Tnftm3Gkl/Tnftm3Gkl
Zfp36tm1Pjb/Zfp36tm1Pjb
(involves: 129S/SvEv * C57BL/6)
|
myeloid hyperplasia
|
J:114740
|
Tnfaip3tm1Ama/Tnfaip3tm1Ama
(Not Specified)
|
increased granulocyte number
|
J:92931
|
Tnfaip3tm1Homy/Tnfaip3tm1Homy
Tg(Mx1-cre)1Cgn/?
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal myelopoiesis
|
J:212681
|
Tnfaip3tm2Ama/Tnfaip3tm2Ama
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased immature B cell number
|
J:163917
|
Tnfaip3tm3.1Ama/Tnfaip3tm3.1Ama
(C57BL/6J-Tnfaip3tm3.1Ama)
|
myeloid hyperplasia
|
J:203160
|
Tnfaip3tm4.1Ama/Tnfaip3tm4.1Ama
(C57BL/6J-Tnfaip3tm4.1Ama)
|
myeloid hyperplasia
|
J:203160
|
Tnfaip8Gt(IST13629C1)Tigm/Tnfaip8Gt(IST13629C1)Tigm
(involves: C57BL/6N)
|
increased neutrophil cell number
|
J:223320
|
Tnfrsf1aem1(IMPC)Ccpcz/Tnfrsf1aem1(IMPC)Ccpcz
(C57BL/6NCrl-Tnfrsf1aem1(IMPC)Ccpcz/Ccpcz)
|
increased neutrophil cell number
|
J:211773
|
Tnfrsf1atm1Mak/Tnfrsf1atm1Mak
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
decreased hemoglobin content
|
J:180054
|
| increased neutrophil cell number
|
J:180054
|
Tnfrsf1atm2b(EUCOMM)Wtsi/Tnfrsf1atm2b(EUCOMM)Wtsi
(C57BL/6N-Tnfrsf1atm2b(EUCOMM)Wtsi/H)
|
decreased neutrophil cell number
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(B6.Cg-Tnfrsf9tm1Byk)
|
abnormal common myeloid progenitor cell morphology
|
J:83996
|
Tnfrsf9tm1Byk/Tnfrsf9tm1Byk
(C.Cg-Tnfrsf9tm1Byk)
|
abnormal common myeloid progenitor cell morphology
|
J:83996
|
Tnfrsf11adel8/Tnfrsf11adel8
(involves: 129)
|
extramedullary hematopoiesis
|
J:111512
|
Tnfrsf11atm1Imx/Tnfrsf11atm1Imx
(involves: 129 * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:57899
|
| extramedullary hematopoiesis
|
J:57899
|
| increased granulocyte number
|
J:57899
|
| increased neutrophil cell number
|
J:57899
|
Tnfrsf11atm1Imx/Tnfrsf11atm1Imx
(involves: 129)
|
abnormal negative T cell selection
|
J:125864
|
Tnfrsf11btm1Eac/Tnfrsf11btm1Eac
(involves: 129S4/SvJaeSor)
|
abnormal pro-B cell differentiation
|
J:67105
|
| increased immature B cell number
|
J:67105
|
| increased pro-B cell number
|
J:67105
|
Tnfrsf13btm1Rjb/Tnfrsf13btm1Rjb
(involves: 129X1/SvJ)
|
abnormal class switch recombination
|
J:95288
|
Tnfrsf13btm1Vmd/Tnfrsf13btm1Vmd
(involves: C57BL/6)
|
increased transitional stage B cell number
|
J:70172
|
Tnfrsf13ctm1Mass/Tnfrsf13ctm1Mass
(C57BL/6-Tnfrsf13ctm1Mass)
|
arrested B cell differentiation
|
J:92732
|
Tnfrsf13ctm1Msc/Tnfrsf13ctm1Msc
(involves: 129P2/OlaHsd * C57BL/6)
|
absent transitional stage B cells
|
J:92676
|
Tnfrsf25tm1Mjo/Tnfrsf25tm1Mjo
(involves: 129P2/OlaHsd)
|
abnormal negative T cell selection
|
J:84536
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(C.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
Tnfsf10tm1Mjs/Tnfsf10tm1Mjs
(B6.129-Tnfsf10tm1Mjs)
|
abnormal negative T cell selection
|
J:82145
|
Tnfsf11tm1Pngr/Tnfsf11tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pro-B cell differentiation
|
J:52369
|
| arrested T cell differentiation
|
J:52369
|
| decreased immature B cell number
|
J:52369
|
| extramedullary hematopoiesis
|
J:52369
|
Tnfsf11tm1Ywc/Tnfsf11tm1Ywc
(involves: 129P2/OlaHsd)
|
extramedullary hematopoiesis
|
J:233265
|
Tnfsf12tm1Ash/Tnfsf12tm1Ash
(B6.129-Tnfsf12tm1Ash)
|
increased double-positive T cell number
|
J:104801
|
Tnfsf13tm1Geha/Tnfsf13tm1Geha
(involves: 129S4/SvJae)
|
abnormal class switch recombination
|
J:88910
|
Tnfsf13bm1Anu/Tnfsf13bm1Anu
(C57BL/6JAnu-Tnfsf13bm1Anu/AnuApb)
|
abnormal B cell differentiation
|
J:104190
|
| increased immature B cell number
|
J:104190
|
Tnfsf13btm1Cleg/Tnfsf13btm1Cleg
(involves: 129S5/SvEvBrd)
|
abnormal B cell differentiation
|
J:71301
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas * C57BL/6)
|
abnormal B cell differentiation
|
J:71681
|
| arrested B cell differentiation
|
J:71681
|
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129S2/SvPas)
|
decreased transitional stage B cell number
|
J:138560
|
Tnfsf15tm1Cdon/Tnfsf15tm1Cdon
(B6.129-Tnfsf15tm1Cdon)
|
abnormal dendritic cell differentiation
|
J:136280
|
Tnfsf18tm1.1(KOMP)Vlcg/Tnfsf18tm1.1(KOMP)Vlcg
(C57BL/6N-Tnfsf18tm1.1(KOMP)Vlcg/J)
|
increased hematocrit
|
J:211773
|
Tnip1Gt(E059E05)Wrst/Tnip1Gt(E059E05)Wrst
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased hemoglobin content
|
J:180054
|
| increased neutrophil cell number
|
J:180054
|
Tnip1tm1.1Ama/Tnip1tm1.1Ama
(involves: C57BL/6J)
|
decreased hematocrit
|
J:145539
|
Tnip1tm1.1Pcoh/Tnip1tm1.1Pcoh
(involves: 129P2/OlaHsd * C57BL/6)
|
increased granulocyte number
|
J:176826
|
Tnip1tm1b(EUCOMM)Hmgu/Tnip1tm1b(EUCOMM)Hmgu
(C57BL/6N-Tnip1tm1b(EUCOMM)Hmgu/H)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Tnksem1(IMPC)Hmgu/Tnksem1(IMPC)Hmgu
(C57BL/6N-Tnksem1(IMPC)Hmgu/Ieg)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Tnrc6aGt(XE786)Byg/Tnrc6aGt(XE786)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased erythrocyte cell number
|
J:182447
|
Tns2nph/Tns2nph
(involves: ICR)
|
decreased hematocrit
|
J:24698
|
Tom1l2Gt(XG909)Byg/Tom1l2Gt(XG909)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
thrombocytopenia
|
J:133892
|
Tomm5Gt(OST44663)Lex/Tomm5Gt(OST44663)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased eosinophil cell number
|
J:186382
|
Tomm22em1(IMPC)J/Tomm22+
(C57BL/6NJ-Tomm22em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Tomm40em1(IMPC)J/Tomm40+
(C57BL/6NJ-Tomm40em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Top2aem2(IMPC)Tcp/Top2a+
(C57BL/6NCrl-Top2aem2(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Tox2em1(IMPC)H/Tox2em1(IMPC)H
(C57BL/6NTac-Tox2em1(IMPC)H/H)
|
decreased mean platelet volume
|
J:211773
|
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:131287
|
Toxtm1.1Kay/Toxtm1.1Kay
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal positive T cell selection
|
J:164687
|
Toxtm1Kay/Toxtm1Kay
Tg(Lck-cre)1Cwi/0
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:164687
|
Tpcn1tm1.1(KOMP)Vlcg/Tpcn1tm1.1(KOMP)Vlcg
(C57BL/6N-Tpcn1tm1.1(KOMP)Vlcg/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Tpcn2tm1b(EUCOMM)Hmgu/Tpcn2tm1b(EUCOMM)Hmgu
(C57BL/6N-Tpcn2tm1b(EUCOMM)Hmgu/H)
|
increased eosinophil cell number
|
J:211773
|
Tph2em1(IMPC)Mbp/Tph2em1(IMPC)Mbp
(C57BL/6N-Tph2em1(IMPC)Mbp/MbpMmucd)
|
increased eosinophil cell number
|
J:211773
|
Tpi1a-m6Neu/Tpi1a-m6Neu
(involves: 101/El * C3H/El)
|
decreased hematocrit
|
J:163223
|
| decreased hemoglobin content
|
J:163223
|
| decreased mean corpuscular hemoglobin concentration
|
J:163223
|
| increased mean corpuscular volume
|
J:163223
|
Tpi1rbc19/Tpi1rbc19
(SJL-Tpi1rbc19)
|
abnormal erythropoiesis
|
J:263104
|
| decreased erythrocyte cell number
|
J:263104
|
| decreased hematocrit
|
J:263104
|
| increased mean corpuscular hemoglobin
|
J:263104
|
| macrocytosis
|
J:263104
|
| polychromatophilia
|
J:263104
|
Tpmttm1Rlng/Tpmt+
(involves: 129P2/OlaHsd * C57BL/6 * NMRI)
|
thrombocytosis
|
J:121737
|
Tpmttm1Rlng/Tpmttm1Rlng
(involves: 129P2/OlaHsd * C57BL/6 * NMRI)
|
thrombocytosis
|
J:121737
|
Tpoem1(IMPC)H/Tpo+
(C57BL/6NTac-Tpoem1(IMPC)H/H)
|
increased mean platelet volume
|
J:211773
|
TpoR479C/TpoR479C
(involves: ICR)
|
decreased erythrocyte cell number
|
J:112930
|
| decreased hematocrit
|
J:112930
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased double-positive T cell number
|
J:133572
|
| extramedullary hematopoiesis
|
J:133572
|
| increased double-negative T cell number
|
J:133572
|
Tpp2tm1.1Gnie/Tpp2tm1.1Gnie
(involves: 129S6/SvEvTac)
|
abnormal CD4-positive T cell differentiation
|
J:221205
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:221205
|
Tppptm1.1(KOMP)Vlcg/Tppptm1.1(KOMP)Vlcg
(C57BL/6N-Tppptm1.1(KOMP)Vlcg/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Tpsab1m1/Tpsab1m1
(involves: C57BL/6J)
|
abnormal mast cell differentiation
|
J:142880
|
Tpsab1m1/Tpsab1m1
Tpsb2tm1(cre)Adch/Tpsb2tm1(cre)Adch
(B6.Cg-Tpsb2tm1(cre)Adch Tpsab1m1)
|
abnormal mast cell differentiation
|
J:142880
|
Tpsb2tm1.1Mfg/Tpsb2tm1.1Mfg
(B6.129-Tpsb2tm1.1Mfg)
|
abnormal mast cell differentiation
|
J:142880
|
Tra2atm2b(EUCOMM)Hmgu/Tra2a+
(C57BL/6N-Tra2atm2b(EUCOMM)Hmgu/Bay)
|
increased basophil cell number
|
J:211773
|
Traf2tm1Mak/Traf2tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * BALB/c * C57BL/6J))
|
decreased double-positive T cell number
|
J:44360
|
| decreased immature B cell number
|
J:44360
|
| increased granulocyte number
|
J:44360
|
Traf3tm1Bal/Traf3tm1Bal
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal B cell differentiation
|
J:37065
|
| decreased double-positive T cell number
|
J:37065
|
Traf3tm1Bshp/Traf3tm1Bshp
Cd19tm1(cre)Cgn/Cd19+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
increased transitional stage B cell number
|
J:124329
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(C.129-Traf3ip2tm1.1Lix)
|
increased transitional stage B cell number
|
J:138560
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
(B6.129-Traf3ip2tm1.1Lix)
|
abnormal transitional stage B cell morphology
|
J:187766
|
| increased immature B cell number
|
J:187766
|
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix
Tnfsf13btm1Msc/Tnfsf13btm1Msc
(involves: 129 * 129S2/SvPas * BALB/c)
|
decreased transitional stage B cell number
|
J:138560
|
Traf3ip3tm1b(KOMP)Wtsi/Traf3ip3tm1b(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
abnormal T cell differentiation
|
J:226431
|
| increased double-positive T cell number
|
J:226431
|
Traf6tm1Jino/Traf6tm1Jino
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased immature B cell number
|
J:77453
|
Traf6tm1Ywc/Traf6tm1Ywc
(Not Specified)
|
abnormal dendritic cell differentiation
|
J:85808
|
Trank1em1(IMPC)J/Trank1em1(IMPC)J
(C57BL/6NJ-Trank1em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Trap1em1(IMPC)Mbp/Trap1em1(IMPC)Mbp
(C57BL/6N-Trap1em1(IMPC)Mbp/MbpMmucd)
|
thrombocytopenia
|
J:211773
|
Trappc2lem1(IMPC)Mbp/Trappc2lem1(IMPC)Mbp
(C57BL/6N-Trappc2lem1(IMPC)Mbp/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Trappc9tm1a(EUCOMM)Wtsi/Trappc9tm1a(EUCOMM)Wtsi
(C57BL/6N-Trappc9tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Trappc10tm1b(KOMP)Wtsi/Trappc10tm1b(KOMP)Wtsi
(C57BL/6N-Trappc10tm1b(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Trbv13-2tm1(CD2)Zhu/Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6)
|
abnormal T cell differentiation
|
J:121608
|
Trbv13-2tm1(CD2)Zhu/Trbv13-2tm1(CD2)Zhu
(involves: 129 * C57BL/6 * SJL)
|
abnormal T cell differentiation
|
J:121608
|
Trdmt1tm1b(EUCOMM)Hmgu/Trdmt1tm1b(EUCOMM)Hmgu
(C57BL/6N-Trdmt1tm1b(EUCOMM)Hmgu/H)
|
decreased mean platelet volume
|
J:211773
|
Trehem1(IMPC)H/Trehem1(IMPC)H
(C57BL/6N-Trehem1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
Trem1tm1.1Ahoru/Trem1tm1.1Ahoru
(C57BL/6-Trem1tm1.1Ahoru)
|
decreased neutrophil cell number
|
J:191035
|
Treml1tm1Mcvic/Treml1tm1Mcvic
(C57BL/6-Treml1tm1Mcvic)
|
thrombocytopenia
|
J:150578
|
Trfem1(IMPC)J/Trf+
(C57BL/6NJ-Trfem1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Trfem1(IMPC)Rbrc/Trf+
(C57BL/6NJcl-Trfem1(IMPC)Rbrc/Rbrc)
|
abnormal mean corpuscular hemoglobin
|
J:211773
|
Trfhpx/Trfhpx
(BALB/cJ-Trfhpx)
|
anisocytosis
|
J:8936
|
| decreased erythrocyte cell number
|
J:8936
|
| decreased hematocrit
|
J:8936
|
| decreased hemoglobin content
|
J:8936
|
| decreased mean corpuscular hemoglobin concentration
|
J:64456,
J:8936
|
| decreased mean corpuscular volume
|
J:8936
|
| poikilocytosis
|
J:8936
|
| spherocytosis
|
J:8936
|
Trib1tm1Aki/Trib1tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal common myeloid progenitor cell morphology
|
J:196449
|
| decreased eosinophil cell number
|
J:196449
|
| increased neutrophil cell number
|
J:196449
|
Trim8em1(IMPC)Wtsi/Trim8em1(IMPC)Wtsi
(C57BL/6N-Trim8em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Trim16em1(IMPC)Tcp/Trim16em1(IMPC)Tcp
(C57BL/6NCrl-Trim16em1(IMPC)Tcp/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Trim31em1Cya/Trim31em1Cya
(involves: C57BL/6)
|
increased neutrophil cell number
|
J:243237
|
Trim58em1(IMPC)Mbp/Trim58em1(IMPC)Mbp
(C57BL/6N-Trim58em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Trim66tm1a(EUCOMM)Wtsi/Trim66tm1a(EUCOMM)Wtsi
(C57BL/6N-Trim66tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Trioem1(IMPC)H/Trio+
(C57BL/6NTac-Trioem1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Trip13tm1.1(KOMP)Vlcg/Trip13tm1.1(KOMP)Vlcg
(C57BL/6N-Trip13tm1.1(KOMP)Vlcg/Ucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Trmt1tm1b(EUCOMM)Hmgu/Trmt1+
(C57BL/6N-Trmt1tm1b(EUCOMM)Hmgu/Ics)
|
increased mean corpuscular volume
|
J:211773
|
Trnt1tm1a(EUCOMM)Hmgu/Trnt1+
(Not Specified)
|
decreased mean corpuscular hemoglobin concentration
|
J:165965
|
Trp53tm1.1Awbr/Trp53tm1.1Awbr
(involves: C57BL/6)
|
increased pro-B cell number
|
J:169434
|
Trp53tm1.1Manf/Trp53tm1.1Manf
(Not Specified)
|
abnormal definitive hematopoiesis
|
J:201153
|
| decreased neutrophil cell number
|
J:201153
|
| extramedullary hematopoiesis
|
J:201153
|
| thrombocytopenia
|
J:201153
|
Trp53tm1.1Manf/Trp53tm1.1Manf
(involves: C57BL/6J)
|
abnormal definitive hematopoiesis
|
J:201153
|
| decreased neutrophil cell number
|
J:201153
|
| extramedullary hematopoiesis
|
J:201153
|
| thrombocytopenia
|
J:201153
|
Trp53tm1.2Awbr/Trp53+
(involves: C57BL/6)
|
extramedullary hematopoiesis
|
J:173271
|
Trp53tm1.2Awbr/Trp53tm1.2Awbr
(involves: C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:173271
|
| extramedullary hematopoiesis
|
J:173271
|
Trp53tm1Sia/Trp53tm1Sia
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
thrombocytopenia
|
J:233347
|
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal lymphopoiesis
|
J:61973
|
Trp53tm2Wahl/Trp53tm2Wahl
(involves: 129S4/SvJae * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:174375
|
| decreased common myeloid progenitor cell number
|
J:174375
|
| decreased erythrocyte cell number
|
J:174375
|
| decreased hematocrit
|
J:174375
|
| thrombocytopenia
|
J:174375
|
Trp53tm3.1Glo/Trp53+
(B6.129S7-Trp53tm3.1Glo)
|
extramedullary hematopoiesis
|
J:317504
|
Trp53bp1Gt(OST94324)Lex/Trp53bp1Gt(OST94324)Lex
(involves: 129S5/SvEvBrd)
|
abnormal T cell differentiation
|
J:83164
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:82512
|
Trp53bp1tm1Jc/Trp53bp1tm1Jc
(involves: 129)
|
abnormal class switch recombination
|
J:194603,
J:231089,
J:307190
|
Trp53bp2tm1b(EUCOMM)Hmgu/Trp53bp2+
(C57BL/6N-Trp53bp2tm1b(EUCOMM)Hmgu/H)
|
increased hemoglobin content
|
J:211773
|
Trp73em1(IMPC)H/Trp73+
(C57BL/6NTac-Trp73em1(IMPC)H/H)
|
increased eosinophil cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Trpc2tm1Dlc/Trpc2tm1Dlc
(involves: 129S1/Sv)
|
decreased mean corpuscular hemoglobin concentration
|
J:189490
|
| increased hematocrit
|
J:189490
|
| increased mean corpuscular volume
|
J:189490
|
Trpc2tm1Dlc/Trpc2tm1Dlc
Trpc3tm1.1Bmil/Trpc3tm1.1Bmil
(involves: 129S1/Sv * FVB/N)
|
decreased mean corpuscular hemoglobin concentration
|
J:189490
|
| increased hematocrit
|
J:189490
|
| increased mean corpuscular volume
|
J:189490
|
Trpm6tm1b(KOMP)Wtsi/Trpm6+
(C57BL/6N-Trpm6tm1b(KOMP)Wtsi/Orl)
|
decreased mean corpuscular volume
|
J:211773
|
Trpm7tm1Agry/Trpm7+
(involves: 129)
|
decreased erythrocyte magnesium level
|
J:205665
|
Trpm7tm1b(KOMP)Wtsi/Trpm7+
(C57BL/6N-Trpm7tm1b(KOMP)Wtsi/H)
|
thrombocytosis
|
J:211773
|
Trpm7tm1Clph/Trpm7tm1.1Clph
Tg(Lck-cre)548Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal T cell differentiation
|
J:140630
|
Trraptm1a(EUCOMM)Wtsi/Trrap+
(B6JTyr;B6N-Trraptm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular volume
|
J:175295
|
Trub1tm1b(EUCOMM)Hmgu/Trub1tm1b(EUCOMM)Hmgu
(C57BL/6N-Trub1tm1b(EUCOMM)Hmgu/Bay)
|
thrombocytosis
|
J:211773
|
Tsc2tm2.2Djk/Tsc2tm2.2Djk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal embryonic hematopoiesis
|
J:149326
|
Tsc22d3tm1.2Hum/Y
(involves: 129S1/SvImJ)
|
decreased DN3 thymocyte number
|
J:223992
|
| increased DN4 thymocyte number
|
J:223992
|
Tshrhyt/Tshrhyt
(CBy.RF-Tshrhyt/J)
|
increased pro-B cell number
|
J:111014
|
TsilTg(Myc)12ALvn/TsilTg(Myc)12ALvn
(involves: C57BL/6 * SJL/J)
|
increased double-positive T cell number
|
J:33857
|
tsl/tsl
(B6NTacTcu.CByJNarl-tsl)
|
abnormal hemopoiesis
|
J:275934
|
tsl/tsl
(CByJNarl(B6NTacTcu)-tsl)
|
abnormal hemopoiesis
|
J:275934
|
Tslptm1(KOMP)Vlcg/Tslptm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal T-helper 2 cell differentiation
|
J:187770
|
Tslptm1.1Pcn/Tslptm1.1Pcn
Tg(KRT14-cre)1Ipc/0
(involves: 129 * C57BL/6 * SJL)
|
decreased eosinophil cell number
|
J:146511
|
Tsntm1Jmat/Tsntm1Jmat
(involves: 129/Sv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:222381
|
Tspan9em1Tshu/Tspan9em1Tshu
(C57BL/6-Tspan9em1Tshu)
|
abnormal neutrophil morphology
|
J:307067
|
| decreased neutrophil cell number
|
J:307067
|
Tspan18tm1.1(KOMP)Vlcg/Tspan18tm1.1(KOMP)Vlcg
(C57BL/6N-Tspan18tm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Tspan32em1(IMPC)Mbp/Tspan32em1(IMPC)Mbp
(C57BL/6N-Tspan32em1(IMPC)Mbp/MbpMmucd)
|
decreased mean corpuscular volume
|
J:211773
|
Tspan33tm1Stsa/Tspan33tm1Stsa
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal erythrocyte morphology
|
J:143158
|
| decreased erythrocyte cell number
|
J:143158
|
| decreased hematocrit
|
J:143158
|
| extramedullary hematopoiesis
|
J:143158
|
| leptocytosis
|
J:143158
|
| macrocytosis
|
J:143158
|
| thrombocytopenia
|
J:143158
|
Tspo2em1Muti/Tspo2+
(C57BL/6-Tspo2em1Muti)
|
decreased erythrocyte cell number
|
J:292525
|
Tspo2em1Muti/Tspo2em1Muti
(C57BL/6-Tspo2em1Muti)
|
decreased erythrocyte cell number
|
J:292525
|
| decreased hematocrit
|
J:292525
|
| decreased hemoglobin content
|
J:292525
|
Tsttm1.1(KOMP)Vlcg/Tsttm1.1(KOMP)Vlcg
(C57BL/6N-Tsttm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Tstd1em1(IMPC)J/Tstd1em1(IMPC)J
(C57BL/6NJ-Tstd1em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Ttc7fsn-Jic/Ttc7fsn-Jic
(B6.INT-Ttc7fsn-Jic)
|
increased fetal derived definitive erythrocyte cell number
|
J:115742
|
Ttc7fsn-Jic/Ttc7fsn-Jic
(C3.INT-Ttc7fsn-Jic)
|
abnormal erythrocyte morphology
|
J:115742
|
| acanthocytosis
|
J:115742
|
| dacryocytosis
|
J:115742
|
| decreased hematocrit
|
J:115742
|
| extramedullary hematopoiesis
|
J:115742
|
| increased nucleated erythrocyte cell number
|
J:115742
|
| low mean erythrocyte cell number
|
J:115742
|
| thrombocytosis
|
J:115742
|
Ttc7fsn/Ttc7fsn
(CByJ.A-Ttc7fsn)
|
abnormal erythropoiesis
|
J:92699
|
| decreased hematocrit
|
J:92699
|
| decreased hemoglobin content
|
J:92699
|
| decreased mean corpuscular volume
|
J:92699
|
| extramedullary hematopoiesis
|
J:92699
|
| low mean erythrocyte cell number
|
J:92699
|
Ttc7hea/Ttc7hea
(CFO)
|
abnormal definitive hematopoiesis
|
J:7515
|
| abnormal erythrocyte cell number
|
J:7515
|
| abnormal erythrocyte morphology
|
J:7515
|
| anisocytosis
|
J:7515
|
| decreased hematocrit
|
J:7515
|
| decreased hemoglobin content
|
J:7515
|
| low mean erythrocyte cell number
|
J:7515
|
| poikilocytosis
|
J:7515
|
| polychromatophilia
|
J:7515
|
Ttc7hea/Ttc7hea
(WBB6F1)
|
abnormal erythrocyte cell number
|
J:92699
|
| abnormal erythrocyte morphology
|
J:92699
|
| abnormal erythropoiesis
|
J:92699
|
| anisocytosis
|
J:92699
|
| decreased hematocrit
|
J:92699
|
| decreased hemoglobin content
|
J:92699
|
| extramedullary hematopoiesis
|
J:92699
|
| low mean erythrocyte cell number
|
J:92699
|
| poikilocytosis
|
J:92699
|
| polychromatophilia
|
J:92699
|
Ttc28tm1b(EUCOMM)Hmgu/Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp)
|
increased red blood cell distribution width
|
J:211773
|
Ttc39atm1b(KOMP)Mbp/Ttc39atm1b(KOMP)Mbp
(C57BL/6N-Ttc39atm1b(KOMP)Mbp/Orl)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Ttc39btm1e(EUCOMM)Wtsi/Ttc39btm1e(EUCOMM)Wtsi
(Not Specified)
|
thrombocytosis
|
J:165965
|
Tti2tm1b(KOMP)Wtsi/Tti2+
(C57BL/6N-Tti2tm1b(KOMP)Wtsi/Ics)
|
increased neutrophil cell number
|
J:211773
|
Ttyh3em1(IMPC)Tcp/Ttyh3em1(IMPC)Tcp
(C57BL/6NCrl-Ttyh3em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular volume
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Tuba4am1Frla/Tuba4am1Frla
(BALB/c-Tuba4am1Frla)
|
abnormal platelet morphology
|
J:286522
|
| abnormal platelet shape
|
J:286522
|
| increased mean platelet volume
|
J:286522
|
| thrombocytopenia
|
J:286522
|
Tubal3em1(IMPC)J/Tubal3em1(IMPC)J
(C57BL/6NJ-Tubal3em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Tubb1tm1Shiv/Tubb1tm1Shiv
(involves: 129/Sv * BALB/c)
|
abnormal platelet shape
|
J:94498
|
| thrombocytopenia
|
J:94498
|
Tubb1tm1Shiv/Tubb1tm1Shiv
(Not Specified)
|
abnormal platelet shape
|
J:95293
|
Tusc2tm1Avi/Tusc2+
(involves: 129S1/Sv * C57BL/6J)
|
decreased erythrocyte cell number
|
J:119985
|
Tusc2tm1Avi/Tusc2tm1Avi
(involves: 129S1/Sv * C57BL/6J)
|
abnormal NK cell differentiation
|
J:119985
|
| decreased erythrocyte cell number
|
J:119985
|
Tut4tm1a(KOMP)Wtsi/Tut4tm1a(KOMP)Wtsi
(C57BL/6N-Tut4tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean platelet volume
|
J:211773
|
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal B cell differentiation
|
J:82738
|
| decreased double-positive T cell number
|
J:82738
|
| decreased erythrocyte cell number
|
J:82738
|
| decreased immature B cell number
|
J:82738
|
| decreased pro-B cell number
|
J:82738
|
| increased granulocyte number
|
J:82738
|
| thrombocytopenia
|
J:82738
|
Txlnatm1b(EUCOMM)Hmgu/Txlna+
(C57BL/6N-Txlnatm1b(EUCOMM)Hmgu/H)
|
decreased hemoglobin content
|
J:211773
|
Txndc11em1(IMPC)J/Txndc11em1(IMPC)J
(C57BL/6NJ-Txndc11em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Txnl1em1(IMPC)Tcp/Txnl1em1(IMPC)Tcp
(C57BL/6NCrl-Txnl1em1(IMPC)Tcp/Tcp)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Txnrd2tm1.1Marc/Txnrd2tm1.1Marc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:94136
|
Tyk2tm1Shmd/Tyk2tm1Shmd
(involves: 129P2/OlaHsd)
|
abnormal common myeloid progenitor cell morphology
|
J:109408
|
| abnormal T cell differentiation
|
J:65409
|
Tyk2tm2b(EUCOMM)Hmgu/Tyk2tm2b(EUCOMM)Hmgu
(C57BL/6N-Tyk2tm2b(EUCOMM)Hmgu/Ieg)
|
thrombocytopenia
|
J:211773
|
Tyro3em1(IMPC)Ccpcz/Tyro3em1(IMPC)Ccpcz
(C57BL/6NCrl-Tyro3em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(B6.129P2-Tyrobptm1.1Viv)
|
abnormal myelopoiesis
|
J:95232
|
Tyw1tm1b(KOMP)Wtsi/Tyw1tm1b(KOMP)Wtsi
(C57BL/6N-Tyw1tm1b(KOMP)Wtsi/J)
|
decreased hematocrit
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
U2surpem1(IMPC)J/U2surp+
(C57BL/6NJ-U2surpem1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Ubac1em1(IMPC)J/Ubac1em1(IMPC)J
(C57BL/6NJ-Ubac1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Ubctm1Rrk/Ubctm1Rrk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal embryonic hematopoiesis
|
J:122574
|
Ube2btm1b(EUCOMM)Wtsi/Ube2b+
(C57BL/6N-Ube2btm1b(EUCOMM)Wtsi/Ics)
|
decreased basophil cell number
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
Ube2d1tm3e(EUCOMM)Wtsi/Ube2d1tm3e(EUCOMM)Wtsi
(C57BL/6N-Ube2d1tm3e(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Ube2e2tm1b(KOMP)Wtsi/Ube2e2tm1b(KOMP)Wtsi
(C57BL/6N-Ube2e2tm1b(KOMP)Wtsi/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Ube2iem1(IMPC)J/Ube2i+
(C57BL/6NJ-Ube2iem1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ube2j2em1(IMPC)Rbrc/Ube2j2em1(IMPC)Rbrc
(C57BL/6NJcl-Ube2j2em1(IMPC)Rbrc/Rbrc)
|
abnormal mean corpuscular volume
|
J:211773
|
| abnormal platelet cell number
|
J:211773
|
| decreased erythrocyte cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ube2wtm1d(EUCOMM)Wtsi/Ube2wtm1d(EUCOMM)Wtsi
(involves: 129 * C57BL/6N)
|
increased neutrophil cell number
|
J:230053
|
Ube3aem1(IMPC)Hmgu/Ube3a+
(C57BL/6N-Ube3aem1(IMPC)Hmgu/Ieg)
|
increased hematocrit
|
J:211773
|
Ubl7em1(IMPC)Tcp/Ubl7em1(IMPC)Tcp
(C57BL/6N-Ubl7em1(IMPC)Tcp/Tcp)
|
increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Ubn2em1(IMPC)Tcp/Ubn2+
(C57BL/6N-Ubn2em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Ubox5tm1b(EUCOMM)Hmgu/Ubox5tm1b(EUCOMM)Hmgu
(C57BL/6N-Ubox5tm1b(EUCOMM)Hmgu/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Ubr7em1(IMPC)Tcp/Ubr7em1(IMPC)Tcp
(C57BL/6NCrl-Ubr7em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Ubxn1em1(IMPC)J/Ubxn1em1(IMPC)J
(C57BL/6N-Ubxn1em1(IMPC)J/J)
|
increased mean corpuscular volume
|
J:211773
|
Uck2em1(IMPC)J/Uck2em1(IMPC)J
(C57BL/6NJ-Uck2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Uckl1em1(IMPC)J/Uckl1em1(IMPC)J
(C57BL/6NJ-Uckl1em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Ucp1tm1b(EUCOMM)Hmgu/Ucp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ucp1tm1b(EUCOMM)Hmgu/Ieg)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Ufl1tm1a(EUCOMM)Wtsi/Ufl1tm1a(EUCOMM)Wtsi
(involves: C57BL/6N)
|
increased nucleated erythrocyte cell number
|
J:238253
|
Ufl1tm1c(EUCOMM)Wtsi/Ufl1tm1c(EUCOMM)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6N)
|
decreased erythrocyte cell number
|
J:238253
|
| decreased granulocyte number
|
J:238253
|
| decreased hematocrit
|
J:238253
|
| decreased hemoglobin content
|
J:238253
|
| thrombocytopenia
|
J:238253
|
Ugcgem1(IMPC)H/Ugcg+
(C57BL/6NTac-Ugcgem1(IMPC)H/H)
|
increased neutrophil cell number
|
J:211773
|
Ulk1tm1.1Thsn/Ulk1tm1.1Thsn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal erythrocyte morphology
|
J:139213
|
| abnormal erythropoiesis
|
J:139213
|
| increased mean corpuscular hemoglobin concentration
|
J:139213
|
| increased mean corpuscular volume
|
J:139213
|
| increased red blood cell distribution width
|
J:139213
|
Ulk3em2(IMPC)Tcp/Ulk3em2(IMPC)Tcp
(C57BL/6NCrl-Ulk3em2(IMPC)Tcp/Tcp)
|
decreased neutrophil cell number
|
J:211773
|
Umodl1tm1a(KOMP)Wtsi/Umodl1tm1a(KOMP)Wtsi
(C57BL/6N-Umodl1tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Unc13dJinx/Unc13dJinx
(C57BL/6J-Unc13dJinx/Mmucd)
|
increased neutrophil cell number
|
J:119974
|
| thrombocytopenia
|
J:119974
|
Unc93b1tm1.1Kmiy/Unc93b1tm1.1Kmiy
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T-helper 1 cell differentiation
|
J:174308
|
| abnormal T-helper 17 cell differentiation
|
J:174308
|
| thrombocytopenia
|
J:174308
|
Ungtm1Tld/Ungtm1Tld
(Not Specified)
|
abnormal class switch recombination
|
J:79590
|
Ungtm1Tld/Ungtm1Tld
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:306598
|
| abnormal somatic hypermutation frequency
|
J:155454
|
Unktm1a(KOMP)Wtsi/Unktm1a(KOMP)Wtsi
(C57BL/6N-Unktm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
Upf2tm1Btp/Upf2tm1Btp
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased granulocyte number
|
J:134765
|
| decreased hematocrit
|
J:134765
|
| decreased hemoglobin content
|
J:134765
|
| low mean erythrocyte cell number
|
J:134765
|
Upf3bem1(IMPC)Tcp/Upf3bem1(IMPC)Tcp
(C57BL/6NCrl-Upf3bem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Uqcrqtm1b(EUCOMM)Hmgu/Uqcrq+
(C57BL/6N-Uqcrqtm1b(EUCOMM)Hmgu/H)
|
decreased mean platelet volume
|
J:211773
|
Urahplt2/Urahplt2
(C57BL/6-Urahplt2)
|
thrombocytosis
|
J:164423
|
Urostm1Cged/Urostm1Cged
(involves: 129S2/SvPas)
|
anisocytosis
|
J:105776
|
| poikilocytosis
|
J:105776
|
Urostm2Rjde/Urostm3Rjde
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythropoiesis
|
J:132542
|
Ush1ctm1a(KOMP)Wtsi/Ush1ctm1a(KOMP)Wtsi
(C57BL/6N-Ush1ctm1a(KOMP)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Usp1tm1b(KOMP)Wtsi/Usp1tm1b(KOMP)Wtsi
(C57BL/6N-Usp1tm1b(KOMP)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
Usp2tm1b(EUCOMM)Wtsi/Usp2tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp2tm1b(EUCOMM)Wtsi/H)
|
decreased mean corpuscular volume
|
J:211773
|
Usp11tm1(KOMP)Wtsi/Usp11tm1(KOMP)Wtsi
(C57BL/6N-Usp11tm1(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Usp12tm1a(EUCOMM)Hmgu/Usp12tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased mean corpuscular hemoglobin concentration
|
J:165965
|
Usp15tm1b(EUCOMM)Wtsi/Usp15tm1b(EUCOMM)Wtsi
(C57BL/6N-Usp15tm1b(EUCOMM)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Usp16tm1b(EUCOMM)Hmgu/Usp16+
(C57BL/6N-Usp16tm1b(EUCOMM)Hmgu/Nju)
|
decreased mean platelet volume
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
Usp18ity9/Usp18ity9
(involves: 129S1/SvImJ * C57BL/6)
|
thrombocytopenia
|
J:163843
|
Usp19tm1b(EUCOMM)Hmgu/Usp19+
(C57BL/6N-Usp19tm1b(EUCOMM)Hmgu/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Usp21tm1.1Jhy/Usp21tm1.1Jhy
(B6.129S7(Cg)-Usp21tm1.1Jhy)
|
increased neutrophil cell number
|
J:208320
|
Usp21tm1a(EUCOMM)Wtsi/Usp21tm1a(EUCOMM)Wtsi
(C57BL/6N-Usp21tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Usp22tm1a(KOMP)Wtsi/Usp22+
(C57BL/6N-Usp22tm1a(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Usp24tm1a(KOMP)Wtsi/Usp24tm1a(KOMP)Wtsi
(C57BL/6N-Usp24tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Usp25Gt(RRS805)Byg/Usp25Gt(RRS805)Byg
(involves: 129P2/OlaHsd)
|
increased neutrophil cell number
|
J:188557
|
Usp30tm2b(EUCOMM)Hmgu/Usp30tm2b(EUCOMM)Hmgu
(C57BL/6N-Usp30tm2b(EUCOMM)Hmgu/Wtsi)
|
thrombocytopenia
|
J:211773
|
Usp32em1(IMPC)Mhzh/Usp32+
(C57BL/6N-Usp32em1(IMPC)Mhzh/Mhzh)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
| decreased neutrophil cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
| thrombocytosis
|
J:211773
|
Usp33tm1a(EUCOMM)Wtsi/Usp33tm1a(EUCOMM)Wtsi
(C57BL/6N-Usp33tm1a(EUCOMM)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
| thrombocytosis
|
J:175295
|
Usp37em1(IMPC)Wtsi/Usp37+
(C57BL/6N-Usp37em1(IMPC)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Usp38tm1b(EUCOMM)Hmgu/Usp38tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp38tm1b(EUCOMM)Hmgu/H)
|
increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Usp42tm2a(EUCOMM)Wtsi/Usp42tm2a(EUCOMM)Wtsi
(B6JTyr;B6N-Usp42tm2a(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:175295
|
Usp45em1(IMPC)H/Usp45em1(IMPC)H
(C57BL/6NTac-Usp45em1(IMPC)H/H)
|
decreased neutrophil cell number
|
J:211773
|
Usp54tm1b(KOMP)Wtsi/Usp54tm1b(KOMP)Wtsi
(C57BL/6N-Usp54tm1b(KOMP)Wtsi/H)
|
decreased hemoglobin content
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Vangl1tm1e(KOMP)Wtsi/Vangl1+
(C57BL/6N-Vangl1tm1e(KOMP)Wtsi/Wtsi)
|
increased mean corpuscular hemoglobin
|
J:175295
|
Vav1M4Btlr/Vav1M4Btlr
(C57BL/6J-Vav1M4Btlr)
|
abnormal CD4-positive T cell differentiation
|
J:272528
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272528
|
| abnormal T cell differentiation
|
J:272528
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas * 129S8/SvEv)
|
decreased double-negative T cell number
|
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal negative T cell selection
|
J:113270
|
Vav1tm1Tyb/Vav1tm1Tyb
(involves: 129S2/SvPas)
|
abnormal double-negative T cell morphology
|
J:79323
|
| decreased double-positive T cell number
|
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
(C.129S2-Vav1tm1Tyb)
|
abnormal negative T cell selection
|
J:79323
|
Vav1tm1Tyb/Vav1tm1Tyb
(either: (involves: 129S4/SvJae * 129S8/SvEv) or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
decreased double-positive T cell number
|
J:190087
|
| increased DN2 thymocyte number
|
J:190087
|
| increased DN3 thymocyte number
|
J:190087
|
| increased double-negative T cell number
|
J:190087
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased double-negative T cell number
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Kdf/Vav2tm1Kdf
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S1/Sv * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
arrested B cell differentiation
|
J:86654
|
| arrested T cell differentiation
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
| decreased transitional stage T2 B cell number
|
J:86654
|
| increased immature B cell number
|
J:86654
|
| increased transitional stage T1 B cell number
|
J:86654
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
decreased immature B cell number
|
J:69807
|
Vav1tm1Tyb/Vav1tm1Tyb
Vav3tm1Swat/Vav3tm1Swat
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
decreased double-negative T cell number
|
J:86654
|
| decreased double-positive T cell number
|
J:86654
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal T cell differentiation
|
J:47596
|
Vav1tm2Bbd/Vav1tm2Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal T cell differentiation
|
J:47596
|
| increased double-negative T cell number
|
J:47596
|
| increased transitional stage B cell number
|
J:69806
|
Vav1tm2Bbd/Vav1tm2Bbd
(B6.129-Vav1tm2Bbd)
|
abnormal CD4-positive T cell differentiation
|
J:141390
|
| abnormal positive T cell selection
|
J:141390
|
| decreased double-positive T cell number
|
J:141390
|
Vav1tm2Bbd/Vav1tm2Bbd
Vav2tm1Kdf/Vav2tm1Kdf
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal B cell differentiation
|
J:69806
|
| abnormal T cell differentiation
|
J:69806
|
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv)
|
decreased double-negative T cell number
|
J:113270
|
Vav1tm2Tyb/Vav1tm2Tyb
(involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd)
|
abnormal negative T cell selection
|
J:113270
|
Vav1tm4Tyb/Vav1tm4Tyb
(either: 129S8.129S4-Vav1tm4Tyb or (involves: 129S4/SvJae * 129S8/SvEv * C57BL/10 * C57BR/cd))
|
increased DN2 thymocyte number
|
J:190087
|
| increased DN3 thymocyte number
|
J:190087
|
Vav2tm1Tnr/Vav2tm1Tnr
(involves: 129P2/OlaHsd)
|
abnormal class switch recombination
|
J:69807
|
Vcam1tm2Flv/Vcam1tm3Flv
Tg(Tek-cre)12Flv/0
(involves: 129S1/Sv * C3H * C57BL/6)
|
decreased immature B cell number
|
J:68147
|
| increased immature B cell number
|
J:68147
|
Vcam1tm2Roml/Vcam1tm2Roml
Tg(Mx1-cre)1Cgn/?
(involves: 129S1/Sv * C57BL/6 * CBA)
|
decreased transitional stage B cell number
|
J:68148
|
| increased immature B cell number
|
J:68148
|
| increased transitional stage B cell number
|
J:68148
|
Vdrtm1Ska/Vdrtm1Ska
(NOD.Cg-Vdrtm1Ska/CmatJ)
|
abnormal dendritic cell differentiation
|
J:127787
|
Vegfatm2Gne/Vegfatm2Gne
Tg(Mx1-cre)1Cgn/0
(involves: 129/Sv * C57BL/6 * CBA)
|
extramedullary hematopoiesis
|
J:52793
|
Vegfbtm1b(EUCOMM)Hmgu/Vegfbtm1b(EUCOMM)Hmgu
(C57BL/6N-Vegfbtm1b(EUCOMM)Hmgu/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Vezttm1b(EUCOMM)Hmgu/Vezt+
(C57BL/6N-Vezttm1b(EUCOMM)Hmgu/J)
|
increased mean corpuscular volume
|
J:211773
|
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * BALB/c * C57BL/6 * DBA)
|
polycythemia
|
J:67505
|
Vhltm1Jae/Vhltm1Jae
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
(involves: 129S4/SvJae * C57BL/6 * DBA)
|
increased hematocrit
|
J:144666
|
Vhltm1Jae/Vhltm1Jae
Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/0
(involves: 129S4/SvJae * CD-1)
|
extramedullary hematopoiesis
|
J:186085
|
| increased erythrocyte cell number
|
J:186085
|
| increased hematocrit
|
J:186085
|
| polycythemia
|
J:186085
|
Vhltm1Mcs/Vhltm1Mcs
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal common myeloid progenitor cell morphology
|
J:130780
|
| abnormal erythropoiesis
|
J:130780
|
| increased erythrocyte cell number
|
J:130780
|
| increased hematocrit
|
J:130780
|
| increased hemoglobin content
|
J:130780
|
| polycythemia
|
J:130780
|
Vil1em1(IMPC)Wtsi/Vil1em1(IMPC)Wtsi
(C57BL/6N-Vil1em1(IMPC)Wtsi/Wtsi)
|
increased red blood cell distribution width
|
J:211773
|
Vkorc1l1em1(IMPC)J/Vkorc1l1em1(IMPC)J
(C57BL/6NJ-Vkorc1l1em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
(involves: 129P2/OlaHsd * C57BL/6)
|
arrested B cell differentiation
|
J:53512
|
Vpreb1atm1Ilm/Vpreb1atm1Ilm
Vpreb1btm1Ilm/Vpreb1btm1Ilm
(B6.129P2-Vpreb1atm1Ilm Vpreb1btm1Ilm)
|
abnormal B cell differentiation
|
J:67609
|
| abnormal immature B cell morphology
|
J:67609
|
Vps13atm1Asan/Vps13atm1Asan
(involves: 129S/SvEv * C57BL/6J)
|
acanthocytosis
|
J:96243
|
| anisopoikilocytosis
|
J:96243
|
Vps13bem1(IMPC)Tcp/Vps13bem1(IMPC)Tcp
(C57BL/6N-Vps13bem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
Vps13ctm1b(EUCOMM)Hmgu/Vps13ctm1b(EUCOMM)Hmgu
(C57BL/6N-Vps13ctm1b(EUCOMM)Hmgu/Ieg)
|
decreased hematocrit
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Vps13ctm1b(EUCOMM)Hmgu/Vps13ctm1b(EUCOMM)Hmgu
(C57BL/6NTac-Vps13ctm1b(EUCOMM)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Vps33aem2(IMPC)Tcp/Vps33a+
(C57BL/6NCrl-Vps33aem2(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Vps33btm1.1Arte/Vps33btm1.1Arte
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: C57BL/6 * C57BL/6J)
|
decreased mean platelet volume
|
J:222766
|
| decreased platelet alpha-granule number
|
J:222766
|
| extramedullary hematopoiesis
|
J:222766
|
| increased neutrophil cell number
|
J:222766
|
| thrombocytosis
|
J:222766
|
Vsig4tm1b(EUCOMM)Hmgu/Y
(C57BL/6N-Vsig4tm1b(EUCOMM)Hmgu/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Vtcn1tm1Lpc/Vtcn1tm1Lpc
(B6.129S-Vtcn1tm1Lpc)
|
abnormal myelopoiesis
|
J:145712
|
| increased neutrophil cell number
|
J:145712
|
Vwftm1.1Geno/Vwf+
(involves: C57BL/6)
|
increased hemoglobin content
|
J:250145
|
| increased mean platelet volume
|
J:250145
|
| thrombocytopenia
|
J:250145
|
Vwftm1.1Geno/Vwftm1.1Geno
(involves: C57BL/6)
|
increased hemoglobin content
|
J:250145
|
| increased mean platelet volume
|
J:250145
|
| thrombocytopenia
|
J:250145
|
Wactm2b(EUCOMM)Wtsi/Wac+
(C57BL/6N-Wactm2b(EUCOMM)Wtsi/Wtsi)
|
decreased eosinophil cell number
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
Wars1tm1b(EUCOMM)Hmgu/Wars1+
(C57BL/6N-Warstm1b(EUCOMM)Hmgu/Ieg)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Wastm1Itl/Y
(Not Specified)
|
thrombocytopenia
|
J:153247
|
Wastm1Itl/Wastm1Itl
(Not Specified)
|
thrombocytopenia
|
J:153247
|
Wastm1Kas/Wastm1Kas
(involves: 129/Sv * C57BL/6)
|
decreased double-positive T cell number
|
J:87875
|
| thrombocytopenia
|
J:87875
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac)
|
thrombocytopenia
|
J:153247
|
Wastm1Sbs/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
thrombocytopenia
|
J:182528
|
Wastm1Sbs/Wastm1Sbs
(either: (involves: 129S6/SvEvTac) or (involves: 129S6/SvEvTac * C57BL/6))
|
increased neutrophil cell number
|
J:48836
|
| thrombocytopenia
|
J:48836
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S/SvEv)
|
abnormal mast cell morphology
|
J:86835
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac)
|
abnormal double-negative T cell morphology
|
J:125309
|
| abnormal double-positive T cell morphology
|
J:125309
|
| thrombocytopenia
|
J:153247
|
Wastm1Sbs/Wastm1Sbs
(involves: 129S6/SvEvTac * C57BL/6)
|
thrombocytopenia
|
J:182528
|
Wastm1Sbs/Wastm1Sbs
Wasltm2Sbs/Wasltm2Sbs
Tg(Lck-cre)1Cwi/?
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal double-negative T cell morphology
|
J:125309
|
| abnormal double-positive T cell morphology
|
J:125309
|
Wastm2Itl/Y
(Not Specified)
|
thrombocytopenia
|
J:153247
|
Wastm2Itl/Wastm2Itl
(Not Specified)
|
thrombocytopenia
|
J:153247
|
Washc5tm1a(EUCOMM)Hmgu/Washc5+
(C57BL/6N-Washc5tm1a(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular hemoglobin concentration
|
J:165965
|
Wbp1ltm2a(EUCOMM)Hmgu/Wbp1ltm2a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal embryonic hematopoiesis
|
J:284781
|
| decreased pro-B cell number
|
J:284781
|
Wdfy4em1(IMPC)J/Wdfy4em1(IMPC)J
(C57BL/6NJ-Wdfy4em1(IMPC)J/J)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
Wdr1Gt(XN462)Byg/Wdr1rede
(involves: 129P2/OlaHsd * C57BL/6)
|
thrombocytopenia
|
J:134092
|
Wdr1rede/Wdr1rede
(C57BL/6-Wdr1rede)
|
abnormal erythropoiesis
|
J:134092
|
| abnormal myelopoiesis
|
J:134092
|
| abnormal platelet alpha-granule morphology
|
J:134092
|
| abnormal platelet dense granule morphology
|
J:134092
|
| abnormal platelet morphology
|
J:134092
|
| abnormal platelet shape
|
J:134092
|
| abnormal thrombopoiesis
|
J:134092
|
| increased mean platelet volume
|
J:134092
|
| increased neutrophil cell number
|
J:134092
|
| thrombocytopenia
|
J:134092
|
Wdr11em1(IMPC)Mbp/Wdr11em1(IMPC)Mbp
(C57BL/6NCrl-Wdr11em1(IMPC)Mbp/Mmucd)
|
increased red blood cell distribution width
|
J:211773
|
Wdr24tm1b(KOMP)Mbp/Wdr24+
(C57BL/6N-Wdr24tm1b(KOMP)Mbp/J)
|
decreased hematocrit
|
J:211773
|
Wdr33em1(IMPC)Tcp/Wdr33+
(C57BL/6NCrl-Wdr33em1(IMPC)Tcp/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Wdr41em1(IMPC)J/Wdr41em1(IMPC)J
(C57BL/6NJ-Wdr41em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Wdr45em1Wrst/Y
(involves: C57BL/6N * FVB)
|
anisocytosis
|
J:307284
|
| increased erythrocyte cell number
|
J:307284
|
| increased hemoglobin content
|
J:307284
|
Wdr45em1Wrst/Wdr45em1Wrst
(involves: C57BL/6N * FVB)
|
anisocytosis
|
J:307284
|
Wdr47tm1a(EUCOMM)Wtsi/Wdr47tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Wdr47tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased hemoglobin content
|
J:165965
|
Wdr53em1(IMPC)J/Wdr53em1(IMPC)J
(C57BL/6NJ-Wdr53em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
Wdr59tm1b(EUCOMM)Wtsi/Wdr59+
(C57BL/6N-Wdr59tm1b(EUCOMM)Wtsi/Wtsi)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Wee1tm1b(EUCOMM)Wtsi/Wee1+
(C57BL/6N-Wee1tm1b(EUCOMM)Wtsi/Tcp)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Wipf1tm1Geha/Wipf1tm1Geha
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal erythropoiesis
|
J:116168
|
| abnormal hemopoiesis
|
J:116168
|
| abnormal lymphopoiesis
|
J:116168
|
| increased granulocyte number
|
J:116168
|
Wlstm1.1Arte/Wlstm1.1Arte
Krt14tm1(cre)Wbm/Krt14+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:202499
|
| cutaneous mastocytosis
|
J:202499
|
| decreased double-positive T cell number
|
J:202499
|
| increased double-negative T cell number
|
J:202499
|
| increased neutrophil cell number
|
J:202499
|
Wnk1tm2.1Juha/Wnk1+
Tg(Pgk1-cre)1Lni/0
(involves: 129S2/SvPas * BALB/c * C57BL/6 * SJL)
|
decreased hematocrit
|
J:200742
|
Wnt6tm1b(NCOM)Mfgc/Wnt6+
(C57BL/6N-Wnt6tm1b(NCOM)Mfgc/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Wrnip1tm1b(EUCOMM)Wtsi/Wrnip1tm1b(EUCOMM)Wtsi
(C57BL/6N-Wrnip1tm1b(EUCOMM)Wtsi/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Xbp1tm1b(EUCOMM)Wtsi/Xbp1+
(C57BL/6N-Xbp1tm1b(EUCOMM)Wtsi/Ics)
|
decreased red blood cell distribution width
|
J:211773
|
| increased mean corpuscular hemoglobin
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
Xktm1Ariv/Y
(B6.Cg-Xktm1Ariv)
|
abnormal erythrocyte ion content
|
J:212528
|
| increased erythrocyte magnesium level
|
J:212528
|
| increased mean corpuscular hemoglobin concentration
|
J:212528
|
Xpo7em1.1Gmkf/Xpo7em1.1Gmkf
(involves: C57BL/6 * FVB/N)
|
abnormal stress erythropoiesis
|
J:331429
|
| decreased erythrocyte cell number
|
J:331429
|
| decreased hematocrit
|
J:331429
|
| increased red blood cell distribution width
|
J:331429
|
Xpo7tm1c(KOMP)Wtsi/Xpo7tm1c(KOMP)Wtsi
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
(involves: 129S4/SvJae * C57BL/6N)
|
decreased hematocrit
|
J:331429
|
Xpo7tm1d(KOMP)Wtsi/Xpo7tm1d(KOMP)Wtsi
(involves: C57BL/6N * FVB/N)
|
abnormal stress erythropoiesis
|
J:331429
|
| increased red blood cell distribution width
|
J:331429
|
Xrcc3tm1b(KOMP)Mbp/Xrcc3+
(C57BL/6N-Xrcc3tm1b(KOMP)Mbp/J)
|
decreased mean corpuscular volume
|
J:211773
|
Xrcc5m1Btlr/Xrcc5m1Btlr
(C57BL/6J-Xrcc5m1Btlr)
|
abnormal B cell differentiation
|
J:274736
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:274736
|
| abnormal T cell differentiation
|
J:274736
|
| increased neutrophil cell number
|
J:274736
|
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:34834
|
| arrested B cell differentiation
|
J:34834
|
| arrested T cell differentiation
|
J:34834
|
| increased double-negative T cell number
|
J:34834
|
Xrcc5tm1Nus/Xrcc5tm1Nus
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal class switch recombination
|
J:120658
|
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal B cell differentiation
|
J:44361
|
| abnormal T cell differentiation
|
J:44361
|
| absent immature B cells
|
J:44361
|
| arrested B cell differentiation
|
J:44361
|
| increased double-positive T cell number
|
J:44361
|
Xrcc6tm1Gcl/Xrcc6tm1Gcl
(involves: 129S1/Sv * C57BL/6)
|
abnormal B cell differentiation
|
J:108657
|
X/Yaa
((NZB x BXSB)F1)
|
decreased erythrocyte cell number
|
J:6235
|
X/Yaa
(BXSB/MpJ)
|
abnormal B cell differentiation
|
J:108760
|
| decreased erythrocyte cell number
|
J:6235
|
Ybx1tm1Tuch/Ybx1tm1Tuch
(involves: 129S/SvEv * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:117725
|
Ydjctm1.1(KOMP)Vlcg/Ydjctm1.1(KOMP)Vlcg
(C57BL/6N-Ydjctm1.1(KOMP)Vlcg/J)
|
increased erythrocyte cell number
|
J:211773
|
| increased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
Yeats4em1Zfa/Yeats4em1Zfa
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(involves: C57BL/6 * C57BL/10 * CBA/Ca)
|
abnormal lymphopoiesis
|
J:282740
|
Yipf5tm1b(EUCOMM)Hmgu/Yipf5+
(C57BL/6N-Yipf5tm1b(EUCOMM)Hmgu/Ics)
|
decreased erythrocyte cell number
|
J:211773
|
Yod1tm1bNarl/Yod1tm1bNarl
(C57BL/6N-Yod1tm1bNarl/Narl)
|
increased neutrophil cell number
|
J:211773
|
Ypel3tm1.1(KOMP)Vlcg/Ypel3tm1.1(KOMP)Vlcg
(C57BL/6N-Ypel3tm1.1(KOMP)Vlcg/Ucd)
|
increased mean corpuscular volume
|
J:211773
|
Ywhabtm1b(EUCOMM)Hmgu/Ywhabtm1b(EUCOMM)Hmgu
(C57BL/6N-Ywhabtm1b(EUCOMM)Hmgu/Ieg)
|
thrombocytopenia
|
J:211773
|
Zap70m1Btlr/Zap70m1Btlr
(involves: C57BL/6J)
|
abnormal class switch recombination
|
J:185495
|
Zap70m1Saka/Zap70m1Saka
(involves: BALB/c)
|
abnormal positive T cell selection
|
J:154166,
J:86607
|
| abnormal T cell clonal deletion
|
J:154166
|
| abnormal T cell differentiation
|
J:86607
|
| abnormal T cell selection
|
J:86607
|
Zap70m1Saka/Zap70m1Saka
Tg(TcraH-Y,TcrbH-Y)71Vbo/0
(involves: BALB/c * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:86607
|
Zap70m1Saka/Zap70tm2.1Weis
(involves: 129S4/SvJae * BALB/c)
|
abnormal T cell clonal deletion
|
J:154166
|
Zap70m6Hefl/Zap70m6Hefl
(C3HeB/FeJ-Zap70m6Hefl)
|
abnormal T cell differentiation
|
J:137446
|
Zap70mrtle/Zap70mrtle
(C57BL/6JSfdAnu-Zap70mrtle/Apb)
|
abnormal positive T cell selection
|
J:104190
|
| arrested T cell differentiation
|
J:104190
|
Zap70mrtle/Zap70mrtle
(involves: C57BL/6JSfdAnu)
|
abnormal double-positive T cell morphology
|
J:211510
|
| increased double-positive T cell number
|
J:211510
|
Zap70mrtle/Zap70rps
(involves: C57BL/6 * C57BL/6JSfdAnu)
|
abnormal double-positive T cell morphology
|
J:211510
|
| increased double-positive T cell number
|
J:211510
|
Zap70st/Zap70st
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
Zap70st/Zap70tm1Dlo
(involves: C57BL/6)
|
arrested T cell differentiation
|
J:41170
|
Zap70tm1Dlo/Zap70tm1Dlo
(involves: 129P2/OlaHsd)
|
increased double-positive T cell number
|
J:97610
|
Zap70tm1Weis/Zap70tm1Weis
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal T cell differentiation
|
J:74974
|
| arrested T cell differentiation
|
J:74974
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(B6.129S4-Zap70tm2.1Weis)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
(C.129S4-Zap70tm2.1Weis)
|
abnormal positive T cell selection
|
J:154166
|
| abnormal T cell clonal deletion
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(DO11.10)10Dlo/?
(involves: 129S4/SvJae * BALB/c * C3H * C57BL/6)
|
abnormal positive T cell selection
|
J:154166
|
Zap70tm2.1Weis/Zap70tm2.1Weis
Tg(TcraH-Y,TcrbH-Y)71Vbo/?
(involves: 129S4/SvJae * C57BL/6J * DBA/2J)
|
abnormal positive T cell selection
|
J:154166
|
| abnormal T cell clonal deletion
|
J:154166
|
Zbtb1m1Btlr/Zbtb1m1Btlr
(involves: C3H/HeN * C57BL/6J)
|
abnormal B cell differentiation
|
J:178820
|
| abnormal T cell differentiation
|
J:178820
|
| decreased DN2 thymocyte number
|
J:178820
|
| decreased DN3 thymocyte number
|
J:178820
|
| decreased DN4 thymocyte number
|
J:178820
|
| decreased double-positive T cell number
|
J:178820
|
| decreased transitional stage B cell number
|
J:178820
|
Zbtb1m2Btlr/Zbtb1m2Btlr
(C57BL/6J-Zbtb1m2Btlr)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:272845
|
Zbtb7atm1Ppp/Zbtb7atm1Ppp
(B6.129S1-Zbtb7atm1Ppp)
|
abnormal lymphopoiesis
|
J:121576
|
| decreased pro-B cell number
|
J:121576
|
Zbtb7atm1Ppp/Zbtb7atm2Ppp
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal B cell differentiation
|
J:121576
|
| abnormal double-positive T cell morphology
|
J:121576
|
Zbtb7bhd/Zbtb7bhd
(involves: 129/Sv * BALB/c * C3H * C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:48734
|
Zbtb7btm1.1Rbo/Zbtb7btm1.1Rbo
(Not Specified)
|
abnormal T cell differentiation
|
J:141145
|
Zbtb7btm1Itan/Zbtb7btm1Tani
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
Zbtb7btm1Itan/Zbtb7btm2Itan
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
Zbtb7btm1Litt/Zbtb7btm1.2Litt
(involves: C57BL/6)
|
abnormal double-positive T cell morphology
|
J:141144
|
Zbtb7btm1Tani/Zbtb7btm1Tani
(involves: 129 * C57BL/6)
|
increased double-negative T cell number
|
J:141142
|
Zbtb7btm2Litt/Zbtb7btm1.2Litt
Tg(Lck-cre)1Cwi/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal T cell differentiation
|
J:141144
|
Zbtb17tm1Cksn/Zbtb17tm1Cksn
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zbtb17tm1Cksn Commd10Tg(Vav1-icre)A2Kio)
|
arrested T cell differentiation
|
J:170508
|
| decreased DN1 thymic pro-T cell number
|
J:170508
|
| decreased DN2 thymocyte number
|
J:170508
|
| decreased DN3 thymocyte number
|
J:170508
|
| decreased double-negative T cell number
|
J:170508
|
Zbtb24tm1b(EUCOMM)Hmgu/Zbtb24+
(C57BL/6N-Zbtb24tm1b(EUCOMM)Hmgu/Ieg)
|
decreased red blood cell distribution width
|
J:211773
|
Zbtb32tm2Ppp/Zbtb32tm2Ppp
(involves: 129S1/Sv)
|
abnormal definitive hematopoiesis
|
J:95119
|
Zbtb43tm1b(KOMP)Mbp/Zbtb43tm1b(KOMP)Mbp
(C57BL/6N-Zbtb43tm1b(KOMP)Mbp/J)
|
increased mean corpuscular volume
|
J:211773
|
Zbtb46tm1(HBEGF)Mnz/Zbtb46+
(C57BL/6-Zbtb46tm1(HBEGF)Mnz)
|
increased neutrophil cell number
|
J:189122
|
Zc3h7aem1(IMPC)J/Zc3h7aem1(IMPC)J
(C57BL/6NJ-Zc3h7aem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Zc3h11aem1(IMPC)Mbp/Zc3h11a+
(C57BL/6NCrl-Zc3h11aem1(IMPC)Mbp/Mmucd)
|
decreased erythrocyte cell number
|
J:211773
|
| decreased hematocrit
|
J:211773
|
| decreased hemoglobin content
|
J:211773
|
Zc3h12atm1Aki/Zc3h12atm1Aki
(involves: 129X1/SvJ * C57BL/6)
|
abnormal class switch recombination
|
J:147868
|
| decreased hematocrit
|
J:147868
|
| decreased hemoglobin content
|
J:147868
|
| thrombocytosis
|
J:147868
|
Zc3h12atm1b(EUCOMM)Hmgu/Zc3h12a+
(C57BL/6N-Zc3h12atm1b(EUCOMM)Hmgu/Ieg)
|
increased mean corpuscular volume
|
J:211773
|
Zc3h12bem1(IMPC)Tcp/Zc3h12bem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12bem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Zc3h12cem1(IMPC)Tcp/Zc3h12cem1(IMPC)Tcp
(C57BL/6NCrl-Zc3h12cem1(IMPC)Tcp/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Zc3h12ctm2c(EUCOMM)Hmgu/Zc3h12ctm2c(EUCOMM)Hmgu
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
increased immature B cell number
|
J:277714
|
Zc3h12ctm2d(EUCOMM)Hmgu/Zc3h12ctm2d(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
extramedullary hematopoiesis
|
J:277714
|
| increased immature B cell number
|
J:277714
|
Zc3h12dtm1b(EUCOMM)Hmgu/Zc3h12dtm1b(EUCOMM)Hmgu
(C57BL/6N-Zc3h12dtm1b(EUCOMM)Hmgu/Orl)
|
increased neutrophil cell number
|
J:211773
|
Zc3h13em1(IMPC)J/Zc3h13+
(C57BL/6NJ-Zc3h13em1(IMPC)J/Mmjax)
|
decreased hemoglobin content
|
J:211773
|
Zc3hav1ltm1b(EUCOMM)Wtsi/Zc3hav1ltm1b(EUCOMM)Wtsi
(C57BL/6N-Zc3hav1ltm1b(EUCOMM)Wtsi/Tcp)
|
increased eosinophil cell number
|
J:211773
|
Zcchc2em1(IMPC)J/Zcchc2em1(IMPC)J
(C57BL/6NJ-Zcchc2em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Zcchc17em1(IMPC)Hmgu/Zcchc17em1(IMPC)Hmgu
(C57BL/6NCrl-Zcchc17em1(IMPC)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Zdhhc5tm1e.1(EUCOMM)Hmgu/Zdhhc5tm1e.1(EUCOMM)Hmgu
(C57BL/6NCrl-Zdhhc5tm1e.1(EUCOMM)Hmgu/Ieg)
|
increased mean platelet volume
|
J:211773
|
Zdhhc13skc4/Zdhhc13skc4
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
increased neutrophil cell number
|
J:161519
|
Zdhhc23tm1.1(KOMP)Vlcg/Zdhhc23tm1.1(KOMP)Vlcg
(C57BL/6N-Zdhhc23tm1.1(KOMP)Vlcg/Ucd)
|
thrombocytosis
|
J:211773
|
Zeb1m1Btlr/Zeb1m1Btlr
(involves: C57BL/6J)
|
abnormal B cell differentiation
|
J:185495
|
| abnormal class switch recombination
|
J:185495
|
| decreased double-positive T cell number
|
J:185495
|
Zeb1tm1Yhi/Zeb1tm1Yhi
(B6.129P2-Zeb1tm1Yhi)
|
abnormal T cell differentiation
|
J:39865
|
| decreased double-positive T cell number
|
J:39865
|
Zeb1Tw/Zeb1+
(B6.Cg-Zeb1Tw)
|
decreased neutrophil cell number
|
J:177274
|
Zfand2btm1Otin/Zfand2b+
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased granulocyte number
|
J:233169
|
Zfand2btm1Otin/Zfand2btm1Otin
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:233169
|
| extramedullary hematopoiesis
|
J:233169
|
| increased common myeloid progenitor cell number
|
J:233169
|
| increased granulocyte number
|
J:233169
|
| increased hematocrit
|
J:233169
|
| increased nucleated erythrocyte cell number
|
J:233169
|
| thrombocytosis
|
J:233169
|
Zfand3em1(IMPC)J/Zfand3em1(IMPC)J
(C57BL/6NJ-Zfand3em1(IMPC)J/Mmjax)
|
decreased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Zfand6em1(IMPC)Mbp/Zfand6em1(IMPC)Mbp
(C57BL/6N-Zfand6em1(IMPC)Mbp/MbpMmucd)
|
increased mean corpuscular volume
|
J:211773
|
Zfattm1Sawa/Zfattm1Sawa
(B6.Cg-Zfattm1Sawa)
|
abnormal embryonic hematopoiesis
|
J:163605
|
Zfattm2.1Sawa/Zfattm2.1Sawa
Tg(Cd4-cre)1Cwi/0
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc * DBA/2)
|
abnormal CD8-positive, alpha-beta T cell differentiation
|
J:187164
|
Zfp7em1(IMPC)J/Zfp7em1(IMPC)J
(C57BL/6NJ-Zfp7em1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Zfp13tm1a(EUCOMM)Hmgu/Zfp13tm1a(EUCOMM)Hmgu
(C57BL/6N-Zfp13tm1a(EUCOMM)Hmgu/Ics)
|
decreased hemoglobin content
|
J:165965
|
Zfp35tm1Naka/Zfp35tm1Naka
(either: B6.Cg-Zfp35tm1Naka or C.Cg-Zfp35tm1Naka)
|
abnormal T-helper 2 cell differentiation
|
J:153828
|
| increased eosinophil cell number
|
J:153828
|
Zfp36tm1(KOMP)Vlcg/Zfp36+
(C57BL/6N-Zfp36tm1(KOMP)Vlcg/Nju)
|
decreased mean corpuscular volume
|
J:211773
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(Not Specified)
|
extramedullary hematopoiesis
|
J:33986
|
Zfp36tm1Pjb/Zfp36tm1Pjb
(B6.Cg-Zfp36tm1Pjb)
|
increased granulocyte number
|
J:214114
|
| increased neutrophil cell number
|
J:214114
|
| thrombocytosis
|
J:214114
|
Zfp36l1tm1Seb/Zfp36l1tm1Seb
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal embryonic erythropoiesis
|
J:113396
|
Zfp36l2tm2Pjb/Zfp36l2tm2Pjb
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal definitive hematopoiesis
|
J:152911
|
| abnormal embryonic hematopoiesis
|
J:152911
|
| decreased erythrocyte cell number
|
J:152911
|
| decreased hematocrit
|
J:152911
|
| decreased hemoglobin content
|
J:152911
|
| decreased neutrophil cell number
|
J:152911
|
| extramedullary hematopoiesis
|
J:152911
|
| increased nucleated erythrocyte cell number
|
J:152911
|
| thrombocytopenia
|
J:152911
|
Zfp106tm1a(KOMP)Wtsi/Zfp106+
(B6JTyr;B6N-Zfp106tm1a(KOMP)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:165965
|
Zfp131tm1.1Mytk/Zfp131tm1.2Mytk
Tg(Lck-cre)1Jtak/0
(involves: C57BL/6N * FVB/N)
|
abnormal double-negative T cell morphology
|
J:271921
|
| abnormal T cell differentiation
|
J:271921
|
| arrested T cell differentiation
|
J:271921
|
| decreased DN2 thymocyte number
|
J:271921
|
| decreased DN3 thymocyte number
|
J:271921
|
| decreased DN4 thymocyte number
|
J:271921
|
| decreased double-negative T cell number
|
J:271921
|
| decreased double-positive T cell number
|
J:271921
|
Zfp174em1(IMPC)J/Zfp174em1(IMPC)J
(C57BL/6NJ-Zfp174em1(IMPC)J/J)
|
increased mean corpuscular hemoglobin concentration
|
J:211773
|
Zfp207tm1b(EUCOMM)Hmgu/Zfp207+
(C57BL/6N-Zfp207tm1b(EUCOMM)Hmgu/H)
|
decreased mean corpuscular volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
Zfp219tm1b(EUCOMM)Hmgu/Zfp219+
(C57BL/6N-Zfp219tm1b(EUCOMM)Hmgu/Wtsi)
|
thrombocytosis
|
J:211773
|
Zfp260tm1b(NCOM)Mfgc/Zfp260+
(C57BL/6N-Zfp260tm1b(NCOM)Mfgc/Tcp)
|
increased neutrophil cell number
|
J:211773
|
Zfp275tm1.1(NCOM)Mfgc/Y
(C57BL/6N-Zfp275tm1.1(NCOM)Mfgc/Tcp)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Zfp280dem1(IMPC)Hmgu/Zfp280dem1(IMPC)Hmgu
(C57BL/6N-Zfp280dem1(IMPC)Hmgu/Ieg)
|
decreased mean corpuscular hemoglobin concentration
|
J:211773
|
Zfp318tm1.1Jhws/Zfp318tm1.1Jhws
Commd10Tg(Vav1-icre)A2Kio/Commd10+
(B6.Cg-Zfp318tm1.1Jhws TgVav1-creA2Kio)
|
decreased transitional stage T2 B cell number
|
J:215815
|
Zfp335blt/Zfp335blt
(involves: C57BL/6)
|
abnormal CD4-positive T cell differentiation
|
J:214793
|
| abnormal CD8-positive, alpha-beta T cell differentiation
|
J:214793
|
| abnormal T cell differentiation
|
J:214793
|
Zfp385atm1Ber/Zfp385atm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal platelet morphology
|
J:93829
|
| decreased platelet alpha-granule number
|
J:93829
|
Zfp445tm1b(EUCOMM)Hmgu/Zfp445tm1b(EUCOMM)Hmgu
(C57BL/6N-Zfp445tm1b(EUCOMM)Hmgu/Ieg)
|
increased red blood cell distribution width
|
J:211773
|
Zfp462em1(IMPC)Tcp/Zfp462+
(C57BL/6N-Zfp462em1(IMPC)Tcp/Tcp)
|
thrombocytopenia
|
J:211773
|
Zfp474em1(IMPC)Ccpcz/Zfp474em1(IMPC)Ccpcz
(C57BL/6N-Zfp474em1(IMPC)Ccpcz/Ccpcz)
|
increased eosinophil cell number
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Zfp503em1(IMPC)Mbp/Zfp503+
(C57BL/6N-Zfp503em1(IMPC)Mbp/Ucd)
|
increased basophil cell number
|
J:211773
|
Zfp532em1(IMPC)J/Zfp532+
(C57BL/6NJ-Zfp532em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| thrombocytosis
|
J:211773
|
Zfp536tm1.1(KOMP)Wtsi/Zfp536+
(C57BL/6N-Zfp536tm1.1(KOMP)Wtsi/Ucd)
|
increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Zfp595tm1b(KOMP)Wtsi/Zfp595tm1b(KOMP)Wtsi
(C57BL/6N-Zfp595tm1b(KOMP)Wtsi/Bay)
|
decreased eosinophil cell number
|
J:211773
|
Zfp612em1(IMPC)J/Zfp612em1(IMPC)J
(C57BL/6NJ-Zfp612em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
Zfp637em1(IMPC)Wtsi/Zfp637em1(IMPC)Wtsi
(C57BL/6N-Zfp637em1(IMPC)Wtsi/Wtsi)
|
increased mean platelet volume
|
J:211773
|
Zfp638em1(IMPC)J/Zfp638+
(C57BL/6NJ-Zfp638em1(IMPC)J/Mmjax)
|
increased erythrocyte cell number
|
J:211773
|
Zfp639tm1.2Jaty/Zfp639tm1.2Jaty
(involves: 129 * BALB/cJ * C57BL/6 * SJL)
|
increased common myeloid progenitor cell number
|
J:305874
|
Zfp641em1(IMPC)J/Zfp641em1(IMPC)J
(C57BL/6NJ-Zfp641em1(IMPC)J/J)
|
decreased mean corpuscular volume
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
Zfp644em1(IMPC)Ccpcz/Zfp644em1(IMPC)Ccpcz
(C57BL/6N-Zfp644em1(IMPC)Ccpcz/Ccpcz)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
Zfp689tm1.1(KOMP)Vlcg/Zfp689tm1.1(KOMP)Vlcg
(C57BL/6N-Zfp689tm1.1(KOMP)Vlcg/J)
|
decreased hematocrit
|
J:211773
|
| increased hemoglobin content
|
J:211773
|
| thrombocytosis
|
J:211773
|
Zfp729bem1(IMPC)J/Zfp729bem1(IMPC)J
(C57BL/6NJ-Zfp729bem1(IMPC)J/Mmjax)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Zfp760tm1a(EUCOMM)Hmgu/Zfp760+
(C57BL/6N-Zfp760tm1a(EUCOMM)Hmgu/Ieg)
|
increased erythrocyte cell number
|
J:165965
|
| increased hematocrit
|
J:165965
|
| thrombocytopenia
|
J:165965
|
Zfp787em1(IMPC)J/Zfp787em1(IMPC)J
(C57BL/6NJ-Zfp787em1(IMPC)J/Mmjax)
|
thrombocytopenia
|
J:211773
|
Zfp804aem1(IMPC)Tcp/Zfp804aem1(IMPC)Tcp
(C57BL/6N-Zfp804aem1(IMPC)Tcp/Tcp)
|
increased mean corpuscular volume
|
J:211773
|
| thrombocytopenia
|
J:211773
|
Zfp950Gt(ROSA)76Sor/Zfp950Gt(ROSA)76Sor
(involves: 129S4/SvJaeSor)
|
decreased erythrocyte cell number
|
J:117491
|
| decreased hematocrit
|
J:117491
|
| decreased hemoglobin content
|
J:117491
|
| polychromatophilia
|
J:117491
|
Zfpm1tm1.1Esv/Zfpm1tm1.1Esv
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal common myeloid progenitor cell morphology
|
J:156475
|
| abnormal erythropoiesis
|
J:156475
|
| extramedullary hematopoiesis
|
J:156475
|
| increased erythrocyte cell number
|
J:156475
|
| increased granulocyte number
|
J:156475
|
| increased hemoglobin concentration distribution width
|
J:156475
|
| increased mean platelet volume
|
J:156475
|
| increased neutrophil cell number
|
J:156475
|
| thrombocytopenia
|
J:156475
|
Zfpm1tm1.1Geab/Zfpm1+
(Not Specified)
|
increased hemoglobin concentration distribution width
|
J:156393
|
| thrombocytopenia
|
J:156393
|
Zfpm1tm1.1Geab/Zfpm1tm1.1Geab
(Not Specified)
|
abnormal erythropoiesis
|
J:156393
|
| abnormal platelet morphology
|
J:156393
|
| decreased platelet alpha-granule number
|
J:156393
|
| extramedullary hematopoiesis
|
J:156393
|
| increased hemoglobin concentration distribution width
|
J:156393
|
| increased mean platelet volume
|
J:156393
|
| increased neutrophil cell number
|
J:156393
|
| increased red blood cell distribution width
|
J:156393
|
| thrombocytopenia
|
J:156393,
J:162629
|
Zfpm1tm1Sho/Zfpm1tm1Sho
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6))
|
abnormal embryonic erythropoiesis
|
J:47281
|
| abnormal erythropoiesis
|
J:47281
|
Zfpm1tm1Sho/Zfpm1tm1Sho
(involves: 129S1/Sv)
|
abnormal erythropoiesis
|
J:77724
|
Zfpm1tm2Sho/Zfpm1tm2Sho
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6))
|
abnormal embryonic erythropoiesis
|
J:47281
|
| abnormal erythropoiesis
|
J:47281
|
Zftraf1em1(IMPC)H/Zftraf1em1(IMPC)H
(C57BL/6NTac-Zftraf1em1(IMPC)H/H)
|
decreased eosinophil cell number
|
J:211773
|
| decreased red blood cell distribution width
|
J:211773
|
Zfyve26em1(IMPC)J/Zfyve26em1(IMPC)J
(C57BL/6NJ-Zfyve26em1(IMPC)J/J)
|
decreased mean corpuscular hemoglobin
|
J:211773
|
Zkscan17tm1b(EUCOMM)Wtsi/Zkscan17+
(C57BL/6N-Zkscan17tm1b(EUCOMM)Wtsi/Wtsi)
|
thrombocytopenia
|
J:211773
|
Zmynd8tm1a(EUCOMM)Wtsi/Zmynd8+
(B6JTyr;B6N-Zmynd8tm1a(EUCOMM)Wtsi/Wtsi)
|
decreased mean corpuscular hemoglobin
|
J:175295
|
Zranb1tm1a(EUCOMM)Hmgu/Zranb1tm1a(EUCOMM)Hmgu
(C57BL/6N-Zranb1tm1a(EUCOMM)Hmgu/Ics)
|
thrombocytosis
|
J:211773
|
Zrsr2em1(IMPC)Mbp/Y
(C57BL/6N-Zrsr2em1(IMPC)Mbp/MbpMmucd)
|
increased neutrophil cell number
|
J:211773
|
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased mean platelet volume
|
J:221010
|
| thrombocytopenia
|
J:221010
|
Zswim1tm1b(KOMP)Mbp/Zswim1tm1b(KOMP)Mbp
(C57BL/6N-Zswim1tm1b(KOMP)Mbp/Nju)
|
decreased hematocrit
|
J:211773
|
| decreased mean corpuscular hemoglobin
|
J:211773
|
| decreased mean corpuscular volume
|
J:211773
|
| increased basophil cell number
|
J:211773
|
| increased eosinophil cell number
|
J:211773
|
| increased erythrocyte cell number
|
J:211773
|
| increased mean corpuscular hemoglobin concentration
|
J:211773
|
| increased mean platelet volume
|
J:211773
|
| increased neutrophil cell number
|
J:211773
|
| increased red blood cell distribution width
|
J:211773
|
Zswim6em1(IMPC)J/Zswim6+
(C57BL/6NJ-Zswim6em1(IMPC)J/Mmjax)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Zwilchtm1.1(KOMP)Vlcg/Zwilch+
(C57BL/6N-Zwilchtm1.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Zzef1tm2.1(KOMP)Vlcg/Zzef1tm2.1(KOMP)Vlcg
(B6N(Cg)-Zzef1tm2.1(KOMP)Vlcg/J)
|
increased mean corpuscular hemoglobin
|
J:211773
|
Analysis Tools